mc2.model.csv

Attribute,Description,Valid Values,DependsOn,Required,Properties,Parent,DependsOn Component,Source,Validation Rules
Biospecimen,Metadata attributes for describing a tissue or tumor sample,,"Component, Biospecimen_id, Study Key, Individual Key, Model Key, Parent Biospecimen Key, Biospecimen Type, Biospecimen Acquisition Method, Biospecimen Stain, Biospecimen Species, Biospecimen Sex, Biospecimen Age at Collection, Biospecimen Age at Collection Unit, Biospecimen Disease Type, Biospecimen Primary Site, Biospecimen Primary Diagnosis, Biospecimen Site of Origin, Biospecimen Tumor Subtype, Biospecimen Tumor Grade, Biospecimen Known Metastasis Sites, Biospecimen Tumor Morphology, Biospecimen Pathology, Biospecimen Composition, Biospecimen Preservation Method, Biospecimen Fixative, Biospecimen Embedding Medium, Biospecimen Anatomic Site, Biospecimen Site of Resection or Biopsy, Biospecimen Timepoint Type, Biospecimen Timepoint Offset, Biospecimen Collection Site, Biospecimen Therapeutic Agent, Biospecimen Last Known Disease Status, Biospecimen BioSample Identifier, Biospecimen Description",FALSE,,,"Individual, Model",,
Biospecimen_id,"Unique ID associated with a biosample, used as a key for record linking and updates",,,TRUE,,,,MC2,unique
Biospecimen Type,The type of biospecimen,"Additional - New Primary, Additional Metastatic, Analyte, Benign Neoplasms, Blood Buffy Coat, Blood Clot, Blood Derived Cancer - Bone Marrow, Blood Derived Cancer - Bone Marrow; Post-treatment, Blood Derived Cancer - Peripheral Blood, Blood Derived Cancer - Peripheral Blood; Post-treatment, Blood Derived Liquid Biopsy, Blood Derived Normal, Body Fluid, Bone Marrow Normal, Buccal Cell Normal, Cell, Cell Line Derived Xenograft Tissue, Cell Lines, Control Analyte, DNA, EBV Immortalized Normal, Expanded Next Generation Cancer Model, FFPE Recurrent, FFPE Scrolls, Fibroblasts from Bone Marrow Normal, GenomePlex (Rubicon) Amplified DNA, Granulocytes, Human Tumor Original Cells, In Situ Neoplasms, Lymphoid Normal, Metastatic, Mixed Adherent Suspension, Mononuclear Cells from Bone Marrow Normal, Neoplasms of Uncertain and Unknown Behavior, Next Generation Cancer Model, Next Generation Cancer Model Expanded Under Non-conforming Conditions, Not Allowed To Collect, Pleural Effusion, Post neo-adjuvant therapy, Primary Blood Derived Cancer - Bone Marrow, Primary Blood Derived Cancer - Peripheral Blood, Primary Tumor, Primary Xenograft Tissue, Recurrent Blood Derived Cancer - Bone Marrow, Recurrent Blood Derived Cancer - Peripheral Blood, Recurrent Tumor, Repli-G (Qiagen) DNA, Repli-G X (Qiagen) DNA, RNA, Saliva, Slides, Solid Tissue Normal, Tissue, Total RNA, Tumor, Tumor Adjacent Normal - Post Neo-adjuvant Therapy, Whole Animal, Whole Blood, Xenograft Tissue, Unknown, Not Reported",,TRUE,,,,HTAN,
Biospecimen Species,The species from which the biospecimen originates,"African Bush Elephant, Armadillo, Asian Elephant, Boar, Cat, Chicken, Cow, Dog, Escherichia coli, Guinea Pig, Horse, Human, Human Patient, Human Cell Line, Mouse, Multispecies, Opossum, Rabbit, Rat, Rhesus monkey, Sheep, Trichoplax adhaerens, Unknown, Unspecified, Worm, Yeast, Fruit Fly, Zebrafish",,TRUE,,,,MC2,list like
Biospecimen Sex,Biological sex associated with the specimen donor,"Decline to answer, Don't know, Female, Intersex, Male, None of these describe me, Prefer not to answer, Unknown, X",,FALSE,,,,CDS Imaging v1.0,
Biospecimen Age at Collection,Age at the time the biospecimen was collected. Please provide the unit in field Biospecimen Age at Collection Unit.,,,FALSE,,,,HTAN,num
Biospecimen Age at Collection Unit,Unit associated with age at the time the biospecimen was collected.,,,FALSE,,,,HTAN,str
Biospecimen Disease Type,"The type of tumor associated with the specimen. Multiple values permitted, comma separated.","Acinar Cell Neoplasms, Adenomas and Adenocarcinomas, Adnexal and Skin Appendage Neoplasms, Basal Cell Neoplasms, Blood Vessel Tumors, Complex Mixed and Stromal Neoplasms, Cystic; Mucinous and Serous Neoplasms, Ductal and Lobular Neoplasms, Epithelial Neoplasms; NOS, Fibroepithelial Neoplasms, Fibromatous Neoplasms, Germ Cell Neoplasms, Giant Cell Tumors, Gliomas, Granular Cell Tumors and Alveolar Soft Part Sarcomas, Immunoproliferative Diseases, Leukemias, Lipomatous Neoplasms, Lymphatic Vessel Tumors, Mast Cell Neoplasm, Meningiomas, Mesothelial Neoplasms, Miscellaneous Bone Tumors, Miscellaneous Tumors, Mucoepidermoid Neoplasms, Myelodysplastic Syndromes, Myomatous Neoplasms, Myxomatous Neoplasms, Neoplasms; NOS, Nerve Sheath Tumors, Neuroepitheliomatous Neoplasms, Nevi and Melanomas, Not Applicable, Not Otherwise Specified, Not Reported, Odontogenic Tumors, Osseous and Chondromatous Neoplasms, Paragangliomas and Glomus Tumors, Plasma Cell Neoplasm, Soft Tissue Tumors and Sarcomas; NOS, Squamous Cell Neoplasms, Synovial-like Neoplasms, Thymic Epithelial Neoplasms, Transitional Cell Papillomas and Carcinomas, Trophoblastic neoplasms, Unknown",,FALSE,,,,MC2,
Biospecimen Tumor Subtype,"The subtype related to the scientific determination and investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms of tissue growth resulting from uncontrolled cell proliferation.",,,FALSE,,,,MC2/STE,str
Biospecimen Tumor Grade,"Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","G1, G2, G3, G4, GX, GB, High Grade, Intermediate Grade, Low Grade, Unknown, Not Reported, Not Applicable",,FALSE,,,,CDS Imaging v1.0,
Biospecimen Composition,"The text term used to describe the type(s) of tissue contained in the biospecimen. Multiple values permitted, comma separated.","Additional Primary, Atypia or hyperplasia, Local recurrence, Metastatic, Normal, Normal adjacent, Normal distant, NOS, Not applicable, Not reported, Premalignant, Premalignant - in situ, Primary, Recurrent, Tissue, Tumor post-adjuvant therapy, Tumor post-neoadjuvant therapy, Tumor post-therapy, Tumor specimen from de novo untreated malignancy of the bladder, Unknown, Xenograft",,FALSE,,,,CDS Imaging v1.0,list like
Biospecimen Tumor Status,Normal or Tumor Sample Pathology Indicator,"Tumor, Normal, Abnormal, Peritumoral, Unknown",,FALSE,,,,CDS Imaging v1.0/multiplex microscopy,
Biospecimen Preservation Method,Text term that represents the method used to preserve the sample.,"Cryopreserved, Cryopreservation in liquid nitrogen - dead tissue, Cryopreservation in dry ice - dead tissue, Cryopreservation in liquid nitrogen - live cells, Formalin fixed paraffin embedded - FFPE, Formalin fixed-unbuffered, Formalin fixed-buffered, Fresh, Fresh dissociated and single cell sorted into plates in NP40 buffer, OCT, Snap Frozen, Frozen, Negative 80 Deg C, Liquid Nitrogen, Fresh dissociated, Fresh dissociated and single cell sorted, Fresh dissociated and single cell sorted into plates, Methacarn fixed paraffin embedded - MFPE, unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,
Biospecimen Anatomic Site,Text term that represents the name of the primary disease site of the submitted tumor sample.,"Abdomen, Abdominal Wall, Acetabulum, Adenoid, Adipose, Adrenal, Alveolar Ridge, Amniotic Fluid, Ampulla Of Vater, Anal Sphincter, Ankle, Anorectum, Antecubital Fossa, Antrum, Anus, Aorta, Aortic Body, Appendix, Aqueous Fluid, Arm, Artery, Ascending Colon, Ascending Colon Hepatic Flexure, Auditory Canal, Autonomic Nervous System, Axilla, Back, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Bowel, Brain, Brain Stem, Breast, Broad Ligament, Bronchiole, Bronchus, Brow, Buccal Cavity, Buccal Mucosa, Buttock, Calf, Capillary, Cardia, Carina, Carotid Artery, Carotid Body, Cartilage, Cecum, Cell-Line, Central Nervous System, Cerebellum, Cerebral Cortex, Cerebrospinal Fluid, Cerebrum, Cervical Spine, Cervix, Chest, Chest Wall, Chin, Clavicle, Clitoris, Colon, Colon - Mucosa Only, Common Duct, Conjunctiva, Connective Tissue, Dermal, Descending Colon, Diaphragm, Duodenum, Ear, Ear Canal, Ear; Pinna (External), Effusion, Elbow, Endocrine Gland, Epididymis, Epidural Space, Esophageal; Distal, Esophageal; Mid, Esophageal; Proximal, Esophagogastric Junction, Esophagus, Esophagus - Mucosa Only, Eye, Fallopian Tube, Femoral Artery, Femoral Vein, Femur, Fibroblasts, Fibula, Finger, Floor Of Mouth, Fluid, Foot, Forearm, Forehead, Foreskin, Frontal Cortex, Frontal Lobe, Fundus Of Stomach, Gallbladder, Ganglia, Gastroesophageal Junction, Gastrointestinal Tract, Glottis, Groin, Gum, Hand, Hard Palate, Head - Face Or Neck; Nos, Head & Neck, Heart, Hepatic, Hepatic Duct, Hepatic Flexure, Hepatic Vein, Hip, Hippocampus, Humerus, Hypopharynx, Ileum, Ilium, Index Finger, Ischium, Islet Cells, Jaw, Jejunum, Joint, Kidney, Knee, Lacrimal Gland, Large Bowel, Laryngopharynx, Larynx, Leg, Leptomeninges, Ligament, Lip, Liver, Lumbar Spine, Lung, Lymph Node, Lymph Node(s) Axilla, Lymph Node(s) Cervical, Lymph Node(s) Distant, Lymph Node(s) Epitrochlear, Lymph Node(s) Femoral, Lymph Node(s) Hilar, Lymph Node(s) Iliac-Common, Lymph Node(s) Iliac-External, Lymph Node(s) Inguinal, Lymph Node(s) Internal Mammary, Lymph Node(s) Mammary, Lymph Node(s) Mesenteric, Lymph Node(s) Occipital, Lymph Node(s) Paraaortic, Lymph Node(s) Parotid, Lymph Node(s) Pelvic, Lymph Node(s) Popliteal, Lymph Node(s) Regional, Lymph Node(s) Retroperitoneal, Lymph Node(s) Scalene, Lymph Node(s) Splenic, Lymph Node(s) Subclavicular, Lymph Node(s) Submandibular, Lymph Node(s) Supraclavicular, Lymph Nodes(s) Mediastinal, Mandible, Maxilla, Mediastinal Soft Tissue, Mediastinum, Mesentery, Mesothelium, Middle Finger, Mitochondria, Muscle, Nails, Nasal Cavity, Nasal Soft Tissue, Nasopharynx, Neck, Nerve, Nerve(s) Cranial, Not Allowed To Collect, Occipital Cortex, Ocular Orbits, Omentum, Oral Cavity, Oral Cavity - Mucosa Only, Oropharynx, Other, Ovary, Palate, Pancreas, Paranasal Sinuses, Paraspinal Ganglion, Parathyroid, Parotid Gland, Patella, Pelvis, Penis, Pericardium, Periorbital Soft Tissue, Peritoneal Cavity, Peritoneum, Pharynx, Pineal, Pineal Gland, Pituitary Gland, Placenta, Pleura, Popliteal Fossa, Prostate, Pylorus, Rectosigmoid Junction, Rectum, Retina, Retro-Orbital Region, Retroperitoneum, Rib, Ring Finger, Round Ligament, Sacrum, Salivary Gland, Scalp, Scapula, Sciatic Nerve, Scrotum, Seminal Vesicle, Shoulder, Sigmoid Colon, Sinus, Sinus(es); Maxillary, Skeletal Muscle, Skin, Skull, Small Bowel, Small Bowel - Mucosa Only, Small Finger, Soft Tissue, Spinal Column, Spinal Cord, Spleen, Splenic Flexure, Sternum, Stomach, Stomach - Mucosa Only, Subcutaneous Tissue, Subglottis, Sublingual Gland, Submandibular Gland, Supraglottis, Synovium, Temporal Cortex, Tendon, Testis, Thigh, Thoracic Spine, Thorax, Throat, Thumb, Thymus, Thyroid, Tibia, Tongue, Tonsil, Tonsil (Pharyngeal), Trachea / Major Bronchi, Transverse Colon, Trunk, Umbilical Cord, Ureter, Urethra, Urinary Tract, Uterus, Uvula, Vagina, Vas Deferens, Vein, Venous, Vertebra, Vulva, White Blood Cells, Wrist, Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0/non-DICOM pathology,
Biospecimen Site of Resection or Biopsy,The text term used to describe the anatomic site of the resection or biopsy of the patient's malignant disease.,"Abdomen; NOS, Abdominal esophagus, Accessory sinus; NOS, Acoustic nerve, Adrenal gland; NOS, Ampulla of Vater, Anal canal, Anterior 2/3 of tongue; NOS, Anterior floor of mouth, Anterior mediastinum, Anterior surface of epiglottis, Anterior wall of bladder, Anterior wall of nasopharynx, Anus; NOS, Aortic body and other paraganglia, Appendix, Ascending colon, Autonomic nervous system; NOS, Axillary tail of breast, Base of tongue; NOS, Bladder neck, Bladder; NOS, Blood, Body of pancreas, Body of penis, Body of stomach, Bone marrow, Bone of limb; NOS, Bone; NOS, Bones of skull and face and associated joints, Border of tongue, Brain stem, Brain; NOS, Branchial cleft, Breast; NOS, Broad ligament, Cardia; NOS, Carotid body, Cauda equina, Cecum, Central portion of breast, Cerebellum; NOS, Cerebral meninges, Cerebrum, Cervical esophagus, Cervix uteri, Choroid, Ciliary body, Cloacogenic zone, Colon; NOS, Commissure of lip, Conjunctiva, Connective; subcutaneous and other soft tissues of abdomen, Connective; subcutaneous and other soft tissues of head; face; and neck, Connective; subcutaneous and other soft tissues of lower limb and hip, Connective; subcutaneous and other soft tissues of pelvis, Connective; subcutaneous and other soft tissues of thorax, Connective; subcutaneous and other soft tissues of trunk; NOS, Connective; subcutaneous and other soft tissues of upper limb and shoulder, Connective; subcutaneous and other soft tissues; NOS, Cornea; NOS, Corpus uteri, Cortex of adrenal gland, Cranial nerve; NOS, Craniopharyngeal duct, Descended testis, Descending colon, Dome of bladder, Dorsal surface of tongue; NOS, Duodenum, Endocervix, Endocrine gland; NOS, Endometrium, Epididymis, Esophagus; NOS, Ethmoid sinus, Exocervix, External ear, External lip; NOS, External lower lip, External upper lip, Extrahepatic bile duct, Eye; NOS, Eyelid, Fallopian tube, Female genital tract; NOS, Floor of mouth; NOS, Frontal lobe, Frontal sinus, Fundus of stomach, Fundus uteri, Gallbladder, Gastric antrum, Gastrointestinal tract; NOS, Glans penis, Glottis, Greater curvature of stomach; NOS, Gum; NOS, Hard palate, Head of pancreas, Head; face or neck; NOS, Heart, Hematopoietic system; NOS, Hepatic flexure of colon, Hypopharyngeal aspect of aryepiglottic fold, Hypopharynx; NOS, Ileum, Ill-defined sites within respiratory system, Intestinal tract; NOS, Intra-abdominal lymph nodes, Intrahepatic bile duct, Intrathoracic lymph nodes, Islets of Langerhans, Isthmus uteri, Jejunum, Kidney; NOS, Labium majus, Labium minus, Lacrimal gland, Laryngeal cartilage, Larynx; NOS, Lateral floor of mouth, Lateral wall of bladder, Lateral wall of nasopharynx, Lateral wall of oropharynx, Lesser curvature of stomach; NOS, Lingual tonsil, Lip; NOS, Liver, Long bones of lower limb and associated joints, Long bones of upper limb; scapula and associated joints, Lower gum, Lower limb; NOS, Lower lobe; lung, Lower third of esophagus, Lower-inner quadrant of breast, Lower-outer quadrant of breast, Lung; NOS, Lymph node; NOS, Lymph nodes of axilla or arm, Lymph nodes of head; face and neck, Lymph nodes of inguinal region or leg, Lymph nodes of multiple regions, Main bronchus, Major salivary gland; NOS, Male genital organs; NOS, Mandible, Maxillary sinus, Meckel diverticulum, Mediastinum; NOS, Medulla of adrenal gland, Meninges; NOS, Middle ear, Middle lobe; lung, Middle third of esophagus, Mouth; NOS, Mucosa of lip; NOS, Mucosa of lower lip, Mucosa of upper lip, Myometrium, Nasal cavity, Nasopharynx; NOS, Nervous system; NOS, Nipple, Occipital lobe, Olfactory nerve, Optic nerve, Orbit; NOS, Oropharynx; NOS, Other ill-defined sites, Other specified parts of female genital organs, Other specified parts of male genital organs, Other specified parts of pancreas, Ovary, Overlapping lesion of accessory sinuses, Overlapping lesion of bladder, Overlapping lesion of bones; joints and articular cartilage, Overlapping lesion of bones; joints and articular cartilage of limbs, Overlapping lesion of brain, Overlapping lesion of brain and central nervous system, Overlapping lesion of breast, Overlapping lesion of cervix uteri, Overlapping lesion of colon, Overlapping lesion of connective; subcutaneous and other soft tissues, Overlapping lesion of corpus uteri, Overlapping lesion of digestive system, Overlapping lesion of endocrine glands and related structures, Overlapping lesion of esophagus, Overlapping lesion of eye and adnexa, Overlapping lesion of female genital organs, Overlapping lesion of floor of mouth, Overlapping lesion of heart; mediastinum and pleura, Overlapping lesion of hypopharynx, Overlapping lesion of ill-defined sites, Overlapping lesion of larynx, Overlapping lesion of lip, Overlapping lesion of lip; oral cavity and pharynx, Overlapping lesion of lung, Overlapping lesion of major salivary glands, Overlapping lesion of male genital organs, Overlapping lesion of nasopharynx, Overlapping lesion of other and unspecified parts of mouth, Overlapping lesion of palate, Overlapping lesion of pancreas, Overlapping lesion of penis, Overlapping lesion of peripheral nerves and autonomic nervous system, Overlapping lesion of rectum; anus and anal canal, Overlapping lesion of respiratory system and intrathoracic organs, Overlapping lesion of retroperitoneum and peritoneum, Overlapping lesion of skin, Overlapping lesion of small intestine, Overlapping lesion of stomach, Overlapping lesion of tongue, Overlapping lesion of tonsil, Overlapping lesion of urinary organs, Overlapping lesion of vulva, Overlapping lesions of oropharynx, Palate; NOS, Pancreas; NOS, Pancreatic duct, Parametrium, Parathyroid gland, Paraurethral gland, Parietal lobe, Parotid gland, Pelvic bones; sacrum; coccyx and associated joints, Pelvic lymph nodes, Pelvis; NOS, Penis; NOS, Peripheral nerves and autonomic nervous system of abdomen, Peripheral nerves and autonomic nervous system of head; face; and neck, Peripheral nerves and autonomic nervous system of lower limb and hip, Peripheral nerves and autonomic nervous system of pelvis, Peripheral nerves and autonomic nervous system of thorax, Peripheral nerves and autonomic nervous system of trunk; NOS, Peripheral nerves and autonomic nervous system of upper limb and shoulder, Peritoneum; NOS, Pharynx; NOS, Pineal gland, Pituitary gland, Placenta, Pleura; NOS, Postcricoid region, Posterior mediastinum, Posterior wall of bladder, Posterior wall of hypopharynx, Posterior wall of nasopharynx, Posterior wall of oropharynx, Prepuce, Prostate gland, Pylorus, Pyriform sinus, Rectosigmoid junction, Rectum; NOS, Renal pelvis, Reticuloendothelial system; NOS, Retina, Retromolar area, Retroperitoneum, Rib; sternum; clavicle and associated joints, Round ligament, Scrotum; NOS, Short bones of lower limb and associated joints, Short bones of upper limb and associated joints, Sigmoid colon, Skin of lip; NOS, Skin of lower limb and hip, Skin of other and unspecified parts of face, Skin of scalp and neck, Skin of trunk, Skin of upper limb and shoulder, Skin; NOS, Small intestine; NOS, Soft palate; NOS, Specified parts of peritoneum, Spermatic cord, Sphenoid sinus, Spinal cord, Spinal meninges, Spleen, Splenic flexure of colon, Stomach; NOS, Subglottis, Sublingual gland, Submandibular gland, Superior wall of nasopharynx, Supraglottis, Tail of pancreas, Temporal lobe, Testis; NOS, Thoracic esophagus, Thorax; NOS, Thymus, Thyroid gland, Tongue; NOS, Tonsil; NOS, Tonsillar fossa, Tonsillar pillar, Trachea, Transverse colon, Trigone of bladder, Undescended testis, Unknown primary site, Upper gum, Upper limb; NOS, Upper lobe; lung, Upper respiratory tract; NOS, Upper third of esophagus, Upper-inner quadrant of breast, Upper-outer quadrant of breast, Urachus, Ureter, Ureteric orifice, Urethra, Urinary system; NOS, Uterine adnexa, Uterus; NOS, Uvula, Vagina; NOS, Vallecula, Ventral surface of tongue; NOS, Ventricle; NOS, Vertebral column, Vestibule of mouth, Vulva; NOS, Waldeyer ring, Biliary tract; NOS, Cheek mucosa, Clitoris, Overlapping lesion of biliary tract, Unknown, Not Reported",,FALSE,,,,HTAN,
Biospecimen Site of Origin,"The text term used to describe the anatomic site of origin, of the patient's malignant disease.","Abdomen, Abdominal Esophagus, Adrenal Cortex, Adrenal Gland, Adrenal Medulla, Ampulla of Vater, Anal Canal, Anal Transitional Zone, Anterior Mediastinum, Anterior Surface of the Epiglottis, Anterior Wall of the Bladder, Anterior Wall of the Nasopharynx, Antrum Pylori, Anus, Appendage of the Uterus, Appendix, Ascending Colon, Autonomic Nervous System, Axillary Lymph Node, Axillary Tail of the Breast, Base of the Tongue, Biliary Tract, Bladder Neck, Bladder Trigone, Bladder, Blood, Body of Stomach, Body of the Pancreas, Body of the Penis, Bone Marrow, Bone of the Extremity, Bone, Brain Stem, Brain Ventricle, Brain, Branchial Cleft Remnant, Breast, Broad Ligament, Buccal Mucosa, Carotid Body, Cauda Equina, Cecum, Central Portion of the Breast, Cerebellum, Cerebral Hemisphere, Cerebral Meninges, Cervical Esophagus, Cervix Uteri, Choroid, Ciliary Body, Clitoris, Cochlear Nerve, Colon, Commissure of the Lip, Conjunctiva, Cornea, Corpus Uteri, Cranial Nerve, Craniopharyngeal Duct, Descending Colon, Dome of the Bladder, Duodenum, Ectocervix, Endocervix, Endocrine Gland, Endometrium, Epididymis, Esophagus, Ethmoid Sinus, External Ear, External Lip, External Lower Lip, External Upper Lip, Extrahepatic Bile Duct, Eyelid, Eye, Fallopian Tube, Female Genitalia, Floor of Mouth, Frontal Lobe, Frontal Sinus, Fundus of the Stomach, Fundus Uteri, Gallbladder, Gastric Cardia, Gastrointestinal Tract, Gingiva, Glans Penis, Glottis, Greater Curvature of the Stomach, Hard Palate, Head and Neck Lymph Node, Head of the Pancreas, Heart, Hematopoietic System, Hepatic Flexure, Hypopharynx, Ileum, Ill-Defined Anatomic Site, Intestine, Intra-Abdominal Lymph Node, Intrahepatic Bile Duct, Intrathoracic Lymph Node, Islet of Langerhans, Isthmus Uteri, Jejunum, Kidney, Labium Majus, Labium Minus, Lacrimal Gland, Laryngeal Cartilage, Larynx, Lateral Wall of the Bladder, Lateral Wall of the Nasopharynx, Lateral Wall of the Oropharynx, Lesser Curvature of the Stomach, Lingual Tonsil, Lip, Liver, Lower Extremity, Lower Gingiva, Lower Lobe of the Lung, Lower Third of the Esophagus, Lower-Inner Quadrant of the Breast, Lower-Outer Quadrant of the Breast, Lung, Lymph Node of Inguinal Region or Leg, Lymph Node, Main Bronchus, Male Genitalia, Mandible, Maxillary Sinus, Meckel Diverticulum, Mediastinum, Meninges, Middle Ear, Middle Lobe of the Right Lung, Middle Third of the Esophagus, Mucosa of the Lip, Mucosa of the Lower Lip, Mucosa of the Upper Lip, Myometrium, Nasal Cavity, Nasopharynx, Nervous System, Nipple, Not Reported, Occipital Lobe, Olfactory Nerve, Optic Nerve, Oral Cavity, Orbit, Oropharynx, Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3, Other and Unspecified Female Genital Organs ICD-O-3, Other and Unspecified Male Genital Organs ICD-O-3, Other Specified Parts of Pancreas, Ovary, Palate, Palatine Tonsil, Pancreas, Pancreatic Duct, Parametrium, Paranasal Sinus, Parathyroid Gland, Parietal Lobe, Parotid Gland, Pelvic Lymph Node, Pelvis, Penis, Peritoneum, Pharynx, Pineal Gland, Pituitary Gland, Placenta, Pleura, Postcricoid Region, Posterior Mediastinum, Posterior Wall of the Bladder, Posterior Wall of the Hypopharynx, Posterior Wall of the Nasopharynx, Posterior Wall of the Oropharynx, Prepuce, Primary Site Unknown, Prostate Gland, Pylorus, Pyriform Sinus, Rectosigmoid Region, Rectum, Renal Pelvis, Reticuloendothelial System, Retina, Retromolar Trigone, Retroperitoneum, Round Ligament, Salivary Gland, Scrotum, Sigmoid Colon, Skene Gland, Skin of the Face, Skin of the Lip, Skin of the Lower Limb and Hip, Skin of the Scalp and Neck, Skin of the Trunk, Skin of the Upper Limb and Shoulder, Skin, Small Intestine, Soft Palate, Spermatic Cord, Sphenoid Sinus, Spinal Cord, Spinal Meninges, Spleen, Splenic Flexure, Stomach, Subglottis, Sublingual Salivary Gland, Submandibular Gland, Superior Wall of the Nasopharynx, Supraglottis, Tail of the Pancreas, Temporal Lobe, Testis, Thoracic Esophagus, Thorax, Thymus Gland, Thyroid Gland, Tongue, Tonsillar Fossa, Tonsillar Pillar, Trachea, Transverse Colon, Undescended Testes, Unknown, Upper Extremity, Upper Gingiva, Upper Lobe of the Lung, Upper Respiratory System, Upper Third of the Esophagus, Upper-Inner Quadrant of the Breast, Upper-Outer Quadrant of the Breast, Urachus, Ureteric Orifice, Ureter, Urethra, Urinary System, Uterus, Uvula, Vagina, Vallecula, Vertebral Column, Vestibule of Mouth, Vulva, Waldeyer Ring",,FALSE,,,,HTAN,
Biospecimen Timepoint Type,"Label to identify an event associated with the collection of the biospecimen (e.g. Baseline, End of Treatment, Overall survival, Final). Use Biospecimen Timepoint Offset to indicate the number of post-event days that elapsed before the biospecimen was collected. NO PHI/PII INFORMATION IS ALLOWED.",,,FALSE,,,,HTAN,str
Biospecimen Collection Site,The health care site at which the biospecimen sample was collected.,,,FALSE,,,,MC2/STE,str
Biospecimen Therapeutic Agent,Text identification of the individual agent(s) used as part of a treatment regimen.,"10-Deacetyltaxol, 11C Topotecan, 11D10 AluGel Anti-Idiotype Monoclonal Antibody, 12-Allyldeoxoartemisinin, 13-Deoxydoxorubicin, 14C BMS-275183, 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521, 2-Deoxy-D-glucose, 2-Ethylhydrazide, 2-Fluoroadenine, 2-Fluorofucose-containing SGN-2FF, 2-Hydroxyestradiol, 2-Hydroxyestrone, 2-Hydroxyflutamide Depot, 2-Hydroxyoleic Acid, 2-Methoxyestradiol, 2-Methoxyestradiol Nanocrystal Colloidal Dispersion, 2-Methoxyestrone, 2-O; 3-O Desulfated Heparin, 2;6-Diaminopurine, 2;6-Dimethoxyquinone, 2'-F-ara-deoxyuridine, 3'-C-ethynylcytidine, 3'-dA Phosphoramidate NUC-7738, 4-Nitroestrone 3-Methyl Ether, 4-Thio-2-deoxycytidine, 4'-Iodo-4'-Deoxydoxorubicin, 5-Aza-4'-thio-2'-deoxycytidine, 5-Fluoro-2-Deoxycytidine, 6-Phosphofructo-2-kinase/fructose-2;6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158, 7-Cyanoquinocarcinol, 7-Ethyl-10-Hydroxycamptothecin, 7-Hydroxystaurosporine, 8-Azaguanine, 9-Ethyl 6-Mercaptopurine, 9H-Purine-6Thio-98D, A2A Receptor Antagonist EOS100850, Abagovomab, Abarelix, Abemaciclib, Abemaciclib Mesylate, Abexinostat, Abexinostat Tosylate, Abiraterone, Abiraterone Acetate, Abituzumab, Acai Berry Juice, Acalabrutinib, Acalisib, Aceglatone, Acetylcysteine, Acitretin, Acivicin, Aclacinomycin B, Aclarubicin, Acodazole, Acodazole Hydrochloride, Acolbifene Hydrochloride, Acridine, Acridine Carboxamide, Acronine, Actinium Ac 225 Lintuzumab, Actinium Ac 225-FPI-1434, Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591, Actinomycin C2, Actinomycin C3, Actinomycin F1, Activin Type 2B Receptor Fc Fusion Protein STM 434, Acyclic Nucleoside Phosphonate Prodrug ABI-1968, Ad-RTS-hIL-12, Adagloxad Simolenin, Adavosertib, Adecatumumab, Adenosine A2A Receptor Antagonist AZD4635, Adenosine A2A Receptor Antagonist CS3005, Adenosine A2A Receptor Antagonist NIR178, Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999, Adenosine A2A/A2B Receptor Antagonist AB928, Adenosine A2B Receptor Antagonist PBF-1129, Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201, Adenoviral Brachyury Vaccine ETBX-051, Adenoviral Cancer Vaccine PF-06936308, Adenoviral MUC1 Vaccine ETBX-061, Adenoviral PSA Vaccine ETBX-071, Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001, Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901, Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE, Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918, Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931, Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3, Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001, Aderbasib, ADH-1, AE37 Peptide/GM-CSF Vaccine, AEE788, Aerosol Gemcitabine, Aerosolized Aldesleukin, Aerosolized Liposomal Rubitecan, Afatinib, Afatinib Dimaleate, Afimoxifene, Afuresertib, Agatolimod Sodium, Agerafenib, Aglatimagene Besadenovec, Agonistic Anti-CD40 Monoclonal Antibody ADC-1013, Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949, Agonistic Anti-OX40 Monoclonal Antibody MEDI6469, AKR1C3-activated Prodrug OBI-3424, AKT 1/2 Inhibitor BAY1125976, AKT Inhibitor ARQ 092, Akt Inhibitor LY2780301, Akt Inhibitor MK2206, Akt Inhibitor SR13668, Akt/ERK Inhibitor ONC201, Alacizumab Pegol, Alanosine, Albumin-binding Cisplatin Prodrug BTP-114, Aldesleukin, Aldoxorubicin, Alectinib, Alefacept, Alemtuzumab, Alestramustine, Alflutinib Mesylate, Algenpantucel-L, Alisertib, Alitretinoin, ALK Inhibitor, ALK Inhibitor ASP3026, ALK Inhibitor PLB 1003, ALK Inhibitor RO5424802, ALK Inhibitor TAE684, ALK Inhibitor WX-0593, ALK-2 Inhibitor TP-0184, ALK-FAK Inhibitor CEP-37440, ALK/c-Met Inhibitor TQ-B3139, ALK/FAK/Pyk2 Inhibitor CT-707, ALK/ROS1/Met Inhibitor TQ-B3101, ALK/TRK Inhibitor TSR-011, Alkotinib, Allodepleted T Cell Immunotherapeutic ATIR101, Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715, Allogeneic Anti-BCMA-CAR T-cells PBCAR269A, Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells, Allogeneic Anti-CD19 CAR T-cells ALLO-501A, Allogeneic Anti-CD19 Universal CAR-T Cells CTA101, Allogeneic Anti-CD19-CAR T-cells PBCAR0191, Allogeneic Anti-CD20 CAR T-cells LUCAR-20S, Allogeneic Anti-CD20-CAR T-cells PBCAR20A, Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22, Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100, Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001, Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001, Allogeneic Cellular Vaccine 1650-G, Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120, Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130, Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A, Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM, Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine, Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine, Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo, Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo, Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2, Allogeneic Irradiated Melanoma Cell Vaccine CSF470, Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307, Allogeneic Melanoma Vaccine AGI-101H, Allogeneic Natural Killer Cell Line MG4101, Allogeneic Natural Killer Cell Line NK-92, Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01, Allogeneic Renal Cell Carcinoma Vaccine MGN1601, Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19, Allosteric ErbB Inhibitor BDTX-189, Allovectin-7, Almurtide, Alobresib, Alofanib, Alpelisib, Alpha Galactosylceramide, Alpha V Beta 1 Inhibitor ATN-161, Alpha V Beta 8 Antagonist PF-06940434, alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801, Alpha-Gal AGI-134, Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H, Alpha-Thioguanine Deoxyriboside, Alpha-tocopheryloxyacetic Acid, Alsevalimab, Altiratinib, Altretamine, Alvespimycin, Alvespimycin Hydrochloride, Alvocidib, Alvocidib Hydrochloride, Alvocidib Prodrug TP-1287, Amatuximab, Ambamustine, Ambazone, Amblyomin-X, Amcasertib, Ametantrone, Amifostine, Amino Acid Injection, Aminocamptothecin, Aminocamptothecin Colloidal Dispersion, Aminoflavone Prodrug AFP464, Aminopterin, Aminopterin Sodium, Amivantamab, Amolimogene Bepiplasmid, Amonafide L-Malate, Amrubicin, Amrubicin Hydrochloride, Amsacrine, Amsacrine Lactate, Amsilarotene, Amustaline, Amustaline Dihydrochloride, Amuvatinib, Amuvatinib Hydrochloride, Anakinra, Anastrozole, Anaxirone, Ancitabine, Ancitabine Hydrochloride, Andecaliximab, Androgen Antagonist APC-100, Androgen Receptor Antagonist BAY 1161116, Androgen Receptor Antagonist SHR3680, Androgen Receptor Antagonist TAS3681, Androgen Receptor Antagonist TRC253, Androgen Receptor Antisense Oligonucleotide AZD5312, Androgen Receptor Antisense Oligonucleotide EZN-4176, Androgen Receptor Degrader ARV-110, Androgen Receptor Degrader CC-94676, Androgen Receptor Downregulator AZD3514, Androgen Receptor Inhibitor EPI-7386, Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118, Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10, Andrographolide, Androstane Steroid HE3235, Anetumab Ravtansine, Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241, Angiogenesis Inhibitor GT-111, Angiogenesis Inhibitor JI-101, Angiogenesis/Heparanase Inhibitor PG545, Angiopoietin-2-specific Fusion Protein PF-04856884, Anhydrous Enol-oxaloacetate, Anhydrovinblastine, Aniline Mustard, Anlotinib Hydrochloride, Annamycin, Annamycin Liposomal, Annonaceous Acetogenins, Ansamitomicin P-3, Anthramycin, Anthrapyrazole, Anti c-KIT Antibody-drug Conjugate LOP628, Anti-5T4 Antibody-drug Conjugate ASN004, Anti-5T4 Antibody-Drug Conjugate PF-06263507, Anti-5T4 Antibody-drug Conjugate SYD1875, Anti-A33 Monoclonal Antibody KRN330, Anti-A5B1 Integrin Monoclonal Antibody PF-04605412, Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087, Anti-AG7 Antibody Drug Conjugate AbGn-107, Anti-AGS-16 Monoclonal Antibody AGS-16M18, Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME, Anti-AGS-8 Monoclonal Antibody AGS-8M4, Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B, Anti-alpha5beta1 Integrin Antibody MINT1526A, Anti-ANG2 Monoclonal Antibody MEDI-3617, Anti-angiopoietin Monoclonal Antibody AMG 780, Anti-APRIL Monoclonal Antibody BION-1301, Anti-AXL Fusion Protein AVB-S6-500, Anti-AXL/PBD Antibody-drug Conjugate ADCT-601, Anti-B7-H3 Antibody DS-5573a, Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a, Anti-B7-H4 Monoclonal Antibody FPA150, Anti-B7H3 Antibody-drug Conjugate MGC018, Anti-BCMA Antibody SEA-BCMA, Anti-BCMA Antibody-drug Conjugate AMG 224, Anti-BCMA Antibody-drug Conjugate CC-99712, Anti-BCMA Antibody-drug Conjugate GSK2857916, Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA, Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459, Anti-BCMA/CD3 BiTE Antibody AMG 420, Anti-BCMA/CD3 BiTE Antibody AMG 701, Anti-BCMA/CD3 BiTE Antibody REGN5458, Anti-BCMA/PBD ADC MEDI2228, Anti-BTLA Monoclonal Antibody TAB004, Anti-BTN3A Agonistic Monoclonal Antibody ICT01, Anti-c-fms Monoclonal Antibody AMG 820, Anti-c-KIT Monoclonal Antibody CDX 0158, Anti-c-Met Antibody-drug Conjugate HTI-1066, Anti-c-Met Antibody-drug Conjugate TR1801, Anti-c-Met Monoclonal Antibody ABT-700, Anti-c-Met Monoclonal Antibody ARGX-111, Anti-c-Met Monoclonal Antibody HLX55, Anti-c-MET Monoclonal Antibody LY2875358, Anti-C-met Monoclonal Antibody SAIT301, Anti-C4.4a Antibody-Drug Conjugate BAY1129980, Anti-C5aR Monoclonal Antibody IPH5401, Anti-CA19-9 Monoclonal Antibody 5B1, Anti-CA6-DM4 Immunoconjugate SAR566658, Anti-CCR7 Antibody-drug Conjugate JBH492, Anti-CD117 Monoclonal Antibody JSP191, Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1, Anti-CD123 ADC IMGN632, Anti-CD123 Monoclonal Antibody CSL360, Anti-CD123 Monoclonal Antibody KHK2823, Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404, Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A, Anti-CD123/CD3 Bispecific Antibody APVO436, Anti-CD123/CD3 Bispecific Antibody JNJ-63709178, Anti-CD123/CD3 BiTE Antibody SAR440234, Anti-CD137 Agonistic Monoclonal Antibody ADG106, Anti-CD137 Agonistic Monoclonal Antibody AGEN2373, Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017, Anti-CD137 Agonistic Monoclonal Antibody CTX-471, Anti-CD137 Agonistic Monoclonal Antibody LVGN6051, Anti-CD157 Monoclonal Antibody MEN1112, Anti-CD166 Probody-drug Conjugate CX-2009, Anti-CD19 Antibody-drug Conjugate SGN-CD19B, Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003, Anti-CD19 iCAR NK Cells, Anti-CD19 Monoclonal Antibody DI-B4, Anti-CD19 Monoclonal Antibody MDX-1342, Anti-CD19 Monoclonal Antibody MEDI-551, Anti-CD19 Monoclonal Antibody XmAb5574, Anti-CD19-DM4 Immunoconjugate SAR3419, Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL, Anti-CD19/CD22 CAR NK Cells, Anti-CD19/CD3 BiTE Antibody AMG 562, Anti-CD19/CD3 Tetravalent Antibody AFM11, Anti-CD20 Monoclonal Antibody B001, Anti-CD20 Monoclonal Antibody BAT4306F, Anti-CD20 Monoclonal Antibody MIL62, Anti-CD20 Monoclonal Antibody PRO131921, Anti-CD20 Monoclonal Antibody SCT400, Anti-CD20 Monoclonal Antibody TL011, Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002, Anti-CD20-engineered Toxin Body MT-3724, Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323, Anti-CD20/CD3 Monoclonal Antibody REGN1979, Anti-CD20/CD3 Monoclonal Antibody XmAb13676, Anti-CD205 Antibody-drug Conjugate OBT076, Anti-CD22 ADC TRPH-222, Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S, Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A, Anti-CD25 Monoclonal Antibody RO7296682, Anti-CD25-PBD Antibody-drug Conjugate ADCT-301, Anti-CD26 Monoclonal Antibody YS110, Anti-CD27 Agonistic Monoclonal Antibody MK-5890, Anti-CD27L Antibody-Drug Conjugate AMG 172, Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1), Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044, Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957, Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135, Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05, Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564, Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119, Anti-CD3/CD20 Bispecific Antibody GEN3013, Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424, Anti-CD3/CD7-Ricin Toxin A Immunotoxin, Anti-CD30 Monoclonal Antibody MDX-1401, Anti-CD30 Monoclonal Antibody XmAb2513, Anti-CD30/CD16A Monoclonal Antibody AFM13, Anti-CD30/DM1 Antibody-drug Conjugate F0002, Anti-CD32B Monoclonal Antibody BI-1206, Anti-CD33 Antibody-drug Conjugate IMGN779, Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564, Anti-CD33 Monoclonal Antibody BI 836858, Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633, Anti-CD33/CD3 Bispecific Antibody GEM 333, Anti-CD33/CD3 Bispecific Antibody JNJ-67571244, Anti-CD33/CD3 BiTE Antibody AMG 330, Anti-CD33/CD3 BiTE Antibody AMG 673, Anti-CD352 Antibody-drug Conjugate SGN-CD352A, Anti-CD37 Antibody-Drug Conjugate IMGN529, Anti-CD37 Bispecific Monoclonal Antibody GEN3009, Anti-CD37 MMAE Antibody-drug Conjugate AGS67E, Anti-CD37 Monoclonal Antibody BI 836826, Anti-CD38 Antibody-drug Conjugate STI-6129, Anti-CD38 Monoclonal Antibody MOR03087, Anti-CD38 Monoclonal Antibody SAR442085, Anti-CD38 Monoclonal Antibody TAK-079, Anti-CD38-targeted IgG4-attenuated IFNa TAK-573, Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257, Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342, Anti-CD39 Monoclonal Antibody SRF617, Anti-CD39 Monoclonal Antibody TTX-030, Anti-CD40 Agonist Monoclonal Antibody ABBV-927, Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Anti-CD40 Monoclonal Antibody Chi Lob 7/4, Anti-CD40 Monoclonal Antibody SEA-CD40, Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042, Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428, Anti-CD40L Fc-Fusion Protein BMS-986004, Anti-CD44 Monoclonal Antibody RO5429083, Anti-CD45 Monoclonal Antibody AHN-12, Anti-CD46 Antibody-drug Conjugate FOR46, Anti-CD47 ADC SGN-CD47M, Anti-CD47 Monoclonal Antibody AO-176, Anti-CD47 Monoclonal Antibody CC-90002, Anti-CD47 Monoclonal Antibody Hu5F9-G4, Anti-CD47 Monoclonal Antibody IBI188, Anti-CD47 Monoclonal Antibody IMC-002, Anti-CD47 Monoclonal Antibody SHR-1603, Anti-CD47 Monoclonal Antibody SRF231, Anti-CD47 Monoclonal Antibody TJC4, Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801, Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A, Anti-CD52 Monoclonal Antibody ALLO-647, Anti-CD70 Antibody-Drug Conjugate MDX-1203, Anti-CD70 Antibody-drug Conjugate SGN-CD70A, Anti-CD70 CAR-expressing T Lymphocytes, Anti-CD70 Monoclonal Antibody MDX-1411, Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029, Anti-CD73 Monoclonal Antibody BMS-986179, Anti-CD73 Monoclonal Antibody CPI-006, Anti-CD73 Monoclonal Antibody NZV930, Anti-CD73 Monoclonal Antibody TJ4309, Anti-CD74 Antibody-drug Conjugate STRO-001, Anti-CD98 Monoclonal Antibody IGN523, Anti-CDH6 Antibody-drug Conjugate HKT288, Anti-CEA BiTE Monoclonal Antibody AMG211, Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody, Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2, Anti-CEACAM1 Monoclonal Antibody CM-24, Anti-CEACAM5 Antibody-Drug Conjugate SAR408701, Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47, Anti-CEACAM6 Antibody BAY1834942, Anti-claudin18.2 Monoclonal Antibody AB011, Anti-Claudin18.2 Monoclonal Antibody TST001, Anti-CLDN6 Monoclonal Antibody ASP1650, Anti-CLEC12A/CD3 Bispecific Antibody MCLA117, Anti-CLEVER-1 Monoclonal Antibody FP-1305, Anti-CSF1 Monoclonal Antibody PD-0360324, Anti-CSF1R Monoclonal Antibody IMC-CS4, Anti-CSF1R Monoclonal Antibody SNDX-6352, Anti-CTGF Monoclonal Antibody FG-3019, Anti-CTLA-4 Monoclonal Antibody ADG116, Anti-CTLA-4 Monoclonal Antibody ADU-1604, Anti-CTLA-4 Monoclonal Antibody AGEN1181, Anti-CTLA-4 Monoclonal Antibody BCD-145, Anti-CTLA-4 Monoclonal Antibody HBM4003, Anti-CTLA-4 Monoclonal Antibody MK-1308, Anti-CTLA-4 Monoclonal Antibody ONC-392, Anti-CTLA-4 Monoclonal Antibody REGN4659, Anti-CTLA-4 Probody BMS-986288, Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217, Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841, Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015, Anti-CTLA4 Antibody Fc Fusion Protein KN044, Anti-CTLA4 Monoclonal Antibody BMS-986218, Anti-CXCR4 Monoclonal Antibody PF-06747143, Anti-Denatured Collagen Monoclonal Antibody TRC093, Anti-DKK-1 Monoclonal Antibody LY2812176, Anti-DKK1 Monoclonal Antibody BHQ880, Anti-DLL3/CD3 BiTE Antibody AMG 757, Anti-DLL4 Monoclonal Antibody MEDI0639, Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83, Anti-DR5 Agonist Monoclonal Antibody TRA-8, Anti-DR5 Agonistic Antibody DS-8273a, Anti-DR5 Agonistic Monoclonal Antibody INBRX-109, Anti-EGFR Monoclonal Antibody CPGJ 602, Anti-EGFR Monoclonal Antibody EMD 55900, Anti-EGFR Monoclonal Antibody GC1118, Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX, Anti-EGFR Monoclonal Antibody HLX-07, Anti-EGFR Monoclonal Antibody Mixture MM-151, Anti-EGFR Monoclonal Antibody RO5083945, Anti-EGFR Monoclonal Antibody SCT200, Anti-EGFR Monoclonal Antibody SYN004, Anti-EGFR TAP Antibody-drug Conjugate IMGN289, Anti-EGFR/c-Met Bispecific Antibody EMB-01, Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372, Anti-EGFR/CD16A Bispecific Antibody AFM24, Anti-EGFR/DM1 Antibody-drug Conjugate AVID100, Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013, Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321, Anti-EGFRvIII Antibody Drug Conjugate AMG 595, Anti-EGFRvIII Immunotoxin MR1-1, Anti-EGFRvIII/CD3 BiTE Antibody AMG 596, Anti-EGP-2 Immunotoxin MOC31-PE, Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F, Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F, Anti-Ep-CAM Monoclonal Antibody ING-1, Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310, Anti-EphA2 Monoclonal Antibody DS-8895a, Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547, Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111, Anti-ErbB3 Antibody ISU104, Anti-ErbB3 Monoclonal Antibody AV-203, Anti-ErbB3 Monoclonal Antibody CDX-3379, Anti-ErbB3 Monoclonal Antibody REGN1400, Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141, Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A, Anti-FAP/Interleukin-2 Fusion Protein RO6874281, Anti-FCRH5/CD3 BiTE Antibody BFCR4350A, Anti-FGFR2 Antibody BAY1179470, Anti-FGFR3 Antibody-drug Conjugate LY3076226, Anti-FGFR4 Monoclonal Antibody U3-1784, Anti-FLT3 Antibody-drug Conjugate AGS62P1, Anti-FLT3 Monoclonal Antibody 4G8-SDIEM, Anti-FLT3 Monoclonal Antibody IMC-EB10, Anti-FLT3/CD3 BiTE Antibody AMG 427, Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002, Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202, Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012, Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962, Anti-GARP Monoclonal Antibody ABBV-151, Anti-GCC Antibody-Drug Conjugate MLN0264, Anti-GCC Antibody-Drug Conjugate TAK-164, Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody, Anti-GD2 Monoclonal Antibody hu14.18K322A, Anti-GD2 Monoclonal Antibody MORAb-028, Anti-GD3 Antibody-drug Conjugate PF-06688992, Anti-GITR Agonistic Monoclonal Antibody ASP1951, Anti-GITR Agonistic Monoclonal Antibody BMS-986156, Anti-GITR Agonistic Monoclonal Antibody INCAGN01876, Anti-GITR Monoclonal Antibody GWN 323, Anti-GITR Monoclonal Antibody MK-4166, Anti-Globo H Monoclonal Antibody OBI-888, Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999, Anti-Glypican 3/CD3 Bispecific Antibody ERY974, Anti-GnRH Vaccine PEP223, Anti-gpA33/CD3 Monoclonal Antibody MGD007, Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a, Anti-gremlin-1 Monoclonal Antibody UCB6114, Anti-GRP78 Monoclonal Antibody PAT-SM6, Anti-HA Epitope Monoclonal Antibody MEDI8852, Anti-HB-EGF Monoclonal Antibody KHK2866, Anti-HBEGF Monoclonal Antibody U3-1565, Anti-hepcidin Monoclonal Antibody LY2787106, Anti-HER-2 Bispecific Antibody KN026, Anti-HER2 ADC DS-8201a, Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702, Anti-HER2 Antibody-drug Conjugate A166, Anti-HER2 Antibody-drug Conjugate ARX788, Anti-HER2 Antibody-drug Conjugate BAT8001, Anti-HER2 Antibody-drug Conjugate DP303c, Anti-HER2 Antibody-drug Conjugate MEDI4276, Anti-HER2 Antibody-drug Conjugate RC48, Anti-HER2 Bi-specific Monoclonal Antibody ZW25, Anti-HER2 Bispecific Antibody-drug Conjugate ZW49, Anti-HER2 Immune Stimulator-antibody Conjugate NJH395, Anti-HER2 Monoclonal Antibody B002, Anti-HER2 Monoclonal Antibody CT-P6, Anti-HER2 Monoclonal Antibody HLX22, Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343, Anti-HER2-DM1 ADC B003, Anti-HER2-DM1 Antibody-drug Conjugate GQ1001, Anti-HER2-vc0101 ADC PF-06804103, Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A, Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302, Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128, Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522, Anti-HER2/MMAE Antibody-drug Conjugate MRG002, Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A, Anti-HER3 Antibody-drug Conjugate U3 1402, Anti-HER3 Monoclonal Antibody GSK2849330, Anti-HGF Monoclonal Antibody TAK-701, Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968, Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1, Anti-HLA-DR Monoclonal Antibody IMMU-114, Anti-HLA-G Antibody TTX-080, Anti-human GITR Monoclonal Antibody AMG 228, Anti-human GITR Monoclonal Antibody TRX518, Anti-ICAM-1 Monoclonal Antibody BI-505, Anti-ICOS Agonist Antibody GSK3359609, Anti-ICOS Agonist Monoclonal Antibody BMS-986226, Anti-ICOS Monoclonal Antibody KY1044, Anti-ICOS Monoclonal Antibody MEDI-570, Anti-IGF-1R Monoclonal Antibody AVE1642, Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022, Anti-IL-1 alpha Monoclonal Antibody MABp1, Anti-IL-13 Humanized Monoclonal Antibody TNX-650, Anti-IL-15 Monoclonal Antibody AMG 714, Anti-IL-8 Monoclonal Antibody BMS-986253, Anti-IL-8 Monoclonal Antibody HuMax-IL8, Anti-ILDR2 Monoclonal Antibody BAY 1905254, Anti-ILT4 Monoclonal Antibody MK-4830, Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A, Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388, Anti-IRF4 Antisense Oligonucleotide ION251, Anti-KIR Monoclonal Antibody IPH 2101, Anti-KSP/Anti-VEGF siRNAs ALN-VSP02, Anti-LAG-3 Monoclonal Antibody IBI-110, Anti-LAG-3 Monoclonal Antibody INCAGN02385, Anti-LAG-3 Monoclonal Antibody LAG525, Anti-LAG-3 Monoclonal Antibody REGN3767, Anti-LAG-3/PD-L1 Bispecific Antibody FS118, Anti-LAG3 Monoclonal Antibody BI 754111, Anti-LAG3 Monoclonal Antibody MK-4280, Anti-LAG3 Monoclonal Antibody TSR-033, Anti-LAMP1 Antibody-drug Conjugate SAR428926, Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181, Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102, Anti-LGR5 Monoclonal Antibody BNC101, Anti-LIF Monoclonal Antibody MSC-1, Anti-LILRB4 Monoclonal Antibody IO-202, Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A, Anti-Ly6E Antibody-Drug Conjugate RG 7841, Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C, Anti-Melanin Monoclonal Antibody PTI-6D2, Anti-mesothelin Antibody-drug Conjugate BMS-986148, Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100, Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A, Anti-mesothelin/MMAE Antibody-drug Conjugate RC88, Anti-Met Monoclonal Antibody Mixture Sym015, Anti-Met/EGFR Monoclonal Antibody LY3164530, Anti-MMP-9 Monoclonal Antibody GS-5745, Anti-MUC1 Monoclonal Antibody BTH1704, Anti-MUC16/CD3 Bispecific Antibody REGN4018, Anti-MUC16/CD3 BiTE Antibody REGN4018, Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A, Anti-MUC17/CD3 BiTE Antibody AMG 199, Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062, Anti-myostatin Monoclonal Antibody LY2495655, Anti-NaPi2b Antibody-drug Conjugate XMT-1592, Anti-NaPi2b Monoclonal Antibody XMT-1535, Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E, Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A, Anti-nf-P2X7 Antibody Ointment BIL-010t, Anti-NRP1 Antibody ASP1948, Anti-Nucleolin Aptamer AS1411, Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A, Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso, Anti-OFA Immunotherapeutic BB-MPI-03, Anti-OX40 Agonist Monoclonal Antibody ABBV-368, Anti-OX40 Agonist Monoclonal Antibody BGB-A445, Anti-OX40 Agonist Monoclonal Antibody PF-04518600, Anti-OX40 Antibody BMS 986178, Anti-OX40 Hexavalent Agonist Antibody INBRX-106, Anti-OX40 Monoclonal Antibody GSK3174998, Anti-OX40 Monoclonal Antibody IBI101, Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256, Anti-PD-1 Checkpoint Inhibitor PF-06801591, Anti-PD-1 Fusion Protein AMP-224, Anti-PD-1 Monoclonal Antibody 609A, Anti-PD-1 Monoclonal Antibody AK105, Anti-PD-1 Monoclonal Antibody AMG 404, Anti-PD-1 Monoclonal Antibody BAT1306, Anti-PD-1 Monoclonal Antibody BCD-100, Anti-PD-1 Monoclonal Antibody BI 754091, Anti-PD-1 Monoclonal Antibody CS1003, Anti-PD-1 Monoclonal Antibody F520, Anti-PD-1 Monoclonal Antibody GLS-010, Anti-PD-1 Monoclonal Antibody HLX10, Anti-PD-1 Monoclonal Antibody HX008, Anti-PD-1 Monoclonal Antibody JTX-4014, Anti-PD-1 Monoclonal Antibody LZM009, Anti-PD-1 Monoclonal Antibody MEDI0680, Anti-PD-1 Monoclonal Antibody MGA012, Anti-PD-1 Monoclonal Antibody SCT-I10A, Anti-PD-1 Monoclonal Antibody Sym021, Anti-PD-1 Monoclonal Antibody TSR-042, Anti-PD-1/Anti-CTLA4 DART Protein MGD019, Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315, Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669, Anti-PD-1/Anti-LAG-3 DART Protein MGD013, Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318, Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172, Anti-PD-1/CD47 Infusion Protein HX009, Anti-PD-1/CTLA-4 Bispecific Antibody AK104, Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752, Anti-PD-1/TIM-3 Bispecific Antibody RO7121661, Anti-PD-1/VEGF Bispecific Antibody AK112, Anti-PD-L1 Monoclonal Antibody A167, Anti-PD-L1 Monoclonal Antibody BCD-135, Anti-PD-L1 Monoclonal Antibody BGB-A333, Anti-PD-L1 Monoclonal Antibody CBT-502, Anti-PD-L1 Monoclonal Antibody CK-301, Anti-PD-L1 Monoclonal Antibody CS1001, Anti-PD-L1 Monoclonal Antibody FAZ053, Anti-PD-L1 Monoclonal Antibody GR1405, Anti-PD-L1 Monoclonal Antibody HLX20, Anti-PD-L1 Monoclonal Antibody IMC-001, Anti-PD-L1 Monoclonal Antibody LY3300054, Anti-PD-L1 Monoclonal Antibody MDX-1105, Anti-PD-L1 Monoclonal Antibody MSB2311, Anti-PD-L1 Monoclonal Antibody RC98, Anti-PD-L1 Monoclonal Antibody SHR-1316, Anti-PD-L1 Monoclonal Antibody TG-1501, Anti-PD-L1 Monoclonal Antibody ZKAB001, Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105, Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046, Anti-PD-L1/CD137 Bispecific Antibody MCLA-145, Anti-PD-L1/IL-15 Fusion Protein KD033, Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244, Anti-PD1 Monoclonal Antibody AGEN2034, Anti-PD1/CTLA4 Bispecific Antibody XmAb20717, Anti-PGF Monoclonal Antibody RO5323441, Anti-PKN3 siRNA Atu027, Anti-PLGF Monoclonal Antibody TB-403, Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4, Anti-PRAME Immunotherapeutic GSK2302032A, Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Anti-PRL-3 Monoclonal Antibody PRL3-zumab, Anti-prolactin Receptor Antibody LFA102, Anti-PSCA Monoclonal Antibody AGS-1C4D4, Anti-PSMA Monoclonal Antibody MDX1201-A488, Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704, Anti-PSMA Monoclonal Antibody-MMAE Conjugate, Anti-PSMA/CD28 Bispecific Antibody REGN5678, Anti-PSMA/CD3 Bispecific Antibody CCW702, Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081, Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414, Anti-PSMA/PBD ADC MEDI3726, Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020, Anti-PVRIG Monoclonal Antibody COM701, Anti-RANKL Monoclonal Antibody GB-223, Anti-RANKL Monoclonal Antibody JMT103, Anti-Ribonucleoprotein Antibody ATRC-101, Anti-ROR1 ADC VLS-101, Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002, Anti-S15 Monoclonal Antibody NC318, Anti-sCLU Monoclonal Antibody AB-16B5, Anti-SIRPa Monoclonal Antibody CC-95251, Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E, Anti-TAG-72 Monoclonal Antibody scFV CC-49/218, Anti-TF Monoclonal Antibody ALT-836, Anti-TGF-beta Monoclonal Antibody NIS793, Anti-TGF-beta Monoclonal Antibody SAR-439459, Anti-TGF-beta RII Monoclonal Antibody IMC-TR1, Anti-TIGIT Monoclonal Antibody AB154, Anti-TIGIT Monoclonal Antibody BGB-A1217, Anti-TIGIT Monoclonal Antibody BMS-986207, Anti-TIGIT Monoclonal Antibody COM902, Anti-TIGIT Monoclonal Antibody OMP-313M32, Anti-TIGIT Monoclonal Antibody SGN-TGT, Anti-TIM-3 Antibody BMS-986258, Anti-TIM-3 Monoclonal Antibody BGB-A425, Anti-TIM-3 Monoclonal Antibody INCAGN02390, Anti-TIM-3 Monoclonal Antibody MBG453, Anti-TIM-3 Monoclonal Antibody Sym023, Anti-TIM-3 Monoclonal Antibody TSR-022, Anti-TIM3 Monoclonal Antibody LY3321367, Anti-TIM3 Monoclonal Antibody SHR-1702, Anti-Tissue Factor Monoclonal Antibody MORAb-066, Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711, Anti-TROP2 Antibody-drug Conjugate BAT8003, Anti-TROP2 Antibody-drug Conjugate SKB264, Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a, Anti-TWEAK Monoclonal Antibody RG7212, Anti-VEGF Anticalin PRS-050-PEG40, Anti-VEGF Monoclonal Antibody hPV19, Anti-VEGF/ANG2 Nanobody BI 836880, Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T, Anti-VEGFC Monoclonal Antibody VGX-100, Anti-VEGFR2 Monoclonal Antibody HLX06, Anti-VEGFR2 Monoclonal Antibody MSB0254, Anti-VEGFR3 Monoclonal Antibody IMC-3C5, Anti-VISTA Monoclonal Antibody JNJ 61610588, Antiangiogenic Drug Combination TL-118, Antibody-drug Conjugate ABBV-011, Antibody-drug Conjugate ABBV-085, Antibody-drug Conjugate ABBV-155, Antibody-drug Conjugate ABBV-176, Antibody-drug Conjugate ABBV-838, Antibody-drug Conjugate ADC XMT-1536, Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014, Antibody-Drug Conjugate DFRF4539A, Antibody-drug Conjugate MEDI7247, Antibody-drug Conjugate PF-06647263, Antibody-drug Conjugate PF-06664178, Antibody-drug Conjugate SC-002, Antibody-drug Conjugate SC-003, Antibody-drug Conjugate SC-004, Antibody-drug Conjugate SC-005, Antibody-drug Conjugate SC-006, Antibody-drug Conjugate SC-007, Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008, Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV, Antimetabolite FF-10502, Antineoplastic Agent Combination SM-88, Antineoplastic Vaccine, Antineoplastic Vaccine GV-1301, Antineoplaston A10, Antineoplaston AS2-1, Antisense Oligonucleotide GTI-2040, Antisense Oligonucleotide QR-313, Antitumor B Key Active Component-alpha, Antrodia cinnamomea Supplement, Antroquinonol Capsule, Apalutamide, Apatorsen, Apaziquone, APC8015F, APE1/Ref-1 Redox Inhibitor APX3330, Aphidicoline Glycinate, Apilimod Dimesylate Capsule, Apitolisib, Apolizumab, Apomab, Apomine, Apoptosis Inducer BZL101, Apoptosis Inducer GCS-100, Apoptosis Inducer MPC-2130, Apricoxib, Aprinocarsen, Aprutumab, Aprutumab Ixadotin, AR Antagonist BMS-641988, Arabinoxylan Compound MGN3, Aranose, ARC Fusion Protein SL-279252, Archexin, Arcitumomab, Arfolitixorin, Arginase Inhibitor INCB001158, Arginine Butyrate, Arnebia Indigo Jade Pearl Topical Cream, Arsenic Trioxide, Arsenic Trioxide Capsule Formulation ORH 2014, Artemether Sublingual Spray, Artemisinin Dimer, Artesunate, Arugula Seed Powder, Aryl Hydrocarbon Receptor Antagonist BAY2416964, Aryl Hydrocarbon Receptor Inhibitor IK-175, Asaley, Asciminib, Ascrinvacumab, Ashwagandha Root Powder Extract, ASP4132, Aspacytarabine, Asparaginase, Asparaginase Erwinia chrysanthemi, Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, Astuprotimut-R, Asulacrine, Asulacrine Isethionate, Asunercept, At 211 Monoclonal Antibody 81C6, Atamestane, Atezolizumab, Atiprimod, Atiprimod Dihydrochloride, Atiprimod Dimaleate, ATM Inhibitor M 3541, ATM Kinase Inhibitor AZD0156, ATM Kinase Inhibitor AZD1390, Atorvastatin Calcium, Atorvastatin Sodium, ATR Inhibitor RP-3500, ATR Kinase Inhibitor BAY1895344, ATR Kinase Inhibitor M1774, ATR Kinase Inhibitor M6620, ATR Kinase Inhibitor VX-803, Atrasentan Hydrochloride, Attenuated Listeria monocytogenes CRS-100, Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001, Attenuated Measles Virus Encoding SCD Transgene TMV-018, Atuveciclib, Audencel, Auranofin, Aurora A Kinase Inhibitor LY3295668, Aurora A Kinase Inhibitor LY3295668 Erbumine, Aurora A Kinase Inhibitor MK5108, Aurora A Kinase Inhibitor TAS-119, Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076, Aurora B Serine/Threonine Kinase Inhibitor TAK-901, Aurora B/C Kinase Inhibitor GSK1070916A, Aurora kinase A/B inhibitor TT-00420, Aurora Kinase Inhibitor AMG 900, Aurora Kinase Inhibitor BI 811283, Aurora Kinase Inhibitor MLN8054, Aurora Kinase Inhibitor PF-03814735, Aurora Kinase Inhibitor SNS-314, Aurora Kinase Inhibitor TTP607, Aurora Kinase/VEGFR2 Inhibitor CYC116, Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707, Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055, Autologous Anti-BCMA CAR T-cells PHE885, Autologous Anti-BCMA CAR-transduced T-cells KITE-585, Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11, Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053, Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143, Autologous Anti-CD123 CAR-T Cells, Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx, Autologous Anti-CD19 CAR T-cells IM19, Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19, Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19, Autologous Anti-CD19 CAR-CD28 T-cells ET019002, Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01, Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901, Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1, Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19, Autologous Anti-CD19 T-cell Receptor T cells ET190L1, Autologous Anti-CD19 TAC-T cells TAC01-CD19, Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells, Autologous Anti-CD19/CD22 CAR T-cells AUTO3, Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014, Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells, Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1, Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s, Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes, Autologous Anti-FLT3 CAR T Cells AMG 553, Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202, Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1, Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100, Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes, Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794, Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes, Autologous Anti-PSMA CAR-T Cells P-PSMA-101, Autologous AXL-targeted CAR T-cells CCT301-38, Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B, Autologous BCMA-targeted CAR T Cells CC-98633, Autologous BCMA-targeted CAR T Cells LCAR-B4822M, Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528, Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F, Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022, Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001, Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005, Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006, Autologous CD123-4SCAR-expressing T-cells 4SCAR123, Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1, Autologous CD19-targeted CAR T Cells CC-97540, Autologous CD19-targeted CAR T Cells JWCAR029, Autologous CD19-targeted CAR-T Cells GC007F, Autologous CD19/PD-1 Bispecific CAR-T Cells, Autologous CD20-4SCAR-expressing T-cells 4SCAR20, Autologous CD22-4SCAR-expressing T-cells 4SCAR22, Autologous CD38-4SCAR-expressing T-cells 4SCAR38, Autologous Clonal Neoantigen T Cells ATL001, Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19, Autologous Deep IL-15 Primed T-cells TRQ15-01, Autologous Dendritic Cell Vaccine ACT2001, Autologous Dendritic Cell-based Immunotherapeutic AV0113, Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa, Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells, Autologous Genetically-modified MAGE-A4 C1032 T Cells, Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858, Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439, Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001, Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718, Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Autologous Mesenchymal Stem Cells Apceth_101, Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11, Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC, Autologous Multi-lineage Potential Cells, Autologous Nectin-4/FAP-targeted CAR-T Cells, Autologous NKG2D CAR T-cells CYAD-02, Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01, Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine, Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001, Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101, Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601, Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201, Autologous ROR2-targeted CAR T-cells CCT301-59, Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1, Autologous TCR-engineered T-cells IMA201, Autologous TCR-engineered T-cells IMA202, Autologous TCR-engineered T-cells IMA203, Autologous TCRm-expressing T-cells ET140203, Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG, Autologous Tumor Infiltrating Lymphocytes LN-144, Autologous Tumor Infiltrating Lymphocytes LN-145, Autologous Tumor Infiltrating Lymphocytes LN-145-S1, Autologous Tumor Infiltrating Lymphocytes MDA-TIL, Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T, Avadomide, Avadomide Hydrochloride, Avapritinib, Avdoralimab, Avelumab, Aviscumine, Avitinib Maleate, Axalimogene Filolisbac, Axatilimab, Axicabtagene Ciloleucel, Axitinib, AXL Inhibitor DS-1205c, AXL Inhibitor SLC-391, AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M, AXL/ FLT3/VEGFR2 Inhibitor KC1036, Axl/Mer Inhibitor INCB081776, Axl/Mer Inhibitor PF-07265807, Azacitidine, Azapicyl, Azaribine, Azaserine, Azathioprine, Azimexon, Azintuxizumab Vedotin, Aziridinylbenzoquinone RH1, Azotomycin, Azurin:50-77 Cell Penetrating Peptide p28, B-Raf/VEGFR-2 Inhibitor RAF265, Babaodan Capsule, Bacillus Calmette-Guerin Substrain Connaught Live Antigen, Bactobolin, Bafetinib, Balixafortide, Balstilimab, Baltaleucel-T, Banoxantrone, Barasertib, Bardoxolone, Bardoxolone Methyl, Baricitinib, Batabulin, Batabulin Sodium, Batimastat, Bavituximab, Bazedoxifene, Bazlitoran, BC-819 Plasmid/Polyethylenimine Complex, BCG Solution, BCG Tokyo-172 Strain Solution, BCG Vaccine, Bcl-2 Inhibitor APG 2575, Bcl-2 Inhibitor BCL201, Bcl-2 Inhibitor BGB-11417, Bcl-2 Inhibitor LP-108, Bcl-2 Inhibitor S65487, Bcl-Xs Adenovirus Vaccine, BCMA x CD3 T-cell Engaging Antibody CC-93269, BCMA-CD19 Compound CAR T Cells, BCMA/CD3e Tri-specific T-cell Activating Construct HPN217, Bcr-Abl Kinase Inhibitor K0706, Bcr-Abl Kinase Inhibitor PF-114, BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351, Beauvericin, Becatecarin, Belagenpumatucel-L, Belantamab Mafodotin, Belapectin, Belimumab, Belinostat, Belotecan Hydrochloride, Belvarafenib, Belzutifan, Bemarituzumab, Bemcentinib, Bempegaldesleukin, Benaxibine, Bendamustine, Bendamustine Hydrochloride, Bendamustine-containing Nanoparticle-based Formulation RXDX-107, Benzaldehyde Dimethane Sulfonate, Benzoylphenylurea, Berberine Chloride, Bermekimab, Bersanlimab, Berubicin Hydrochloride, Berzosertib, BET Bromodomain Inhibitor ZEN-3694, BET Inhibitor ABBV-744, BET Inhibitor BAY1238097, BET inhibitor BI 894999, BET Inhibitor BMS-986158, BET Inhibitor CC-90010, BET Inhibitor CPI-0610, BET Inhibitor FT-1101, BET Inhibitor GS-5829, BET Inhibitor GSK2820151, BET Inhibitor INCB054329, BET Inhibitor INCB057643, BET Inhibitor RO6870810, BET-bromodomain Inhibitor ODM-207, Beta Alethine, Beta-Carotene, Beta-elemene, Beta-Glucan, Beta-Glucan MM-10-001, Beta-lapachone Prodrug ARQ 761, Beta-Thioguanine Deoxyriboside, Betaglucin Gel, Betulinic Acid, Bevacizumab, Bexarotene, Bexmarilimab, BF-200 Gel Formulation, BH3 Mimetic ABT-737, Bi-functional Alkylating Agent VAL-083, Bicalutamide, Bimiralisib, Binetrakin, Binimetinib, Bintrafusp Alfa, Birabresib, Birinapant, Bis(choline)tetrathiomolybdate, Bisantrene, Bisantrene Hydrochloride, Bisnafide, Bisnafide Dimesylate, Bispecific Antibody 2B1, Bispecific Antibody AGEN1223, Bispecific Antibody AMG 509, Bispecific Antibody GS-1423, Bispecific Antibody MDX-H210, Bispecific Antibody MDX447, Bisthianostat, BiTE Antibody AMG 910, Bivalent BRD4 Inhibitor AZD5153, Bizalimogene Ralaplasmid, Bizelesin, BL22 Immunotoxin, Black Cohosh, Black Raspberry Nectar, Bleomycin, Bleomycin A2, Bleomycin B2, Bleomycin Sulfate, Blinatumomab, Blueberry Powder Supplement, BMI1 Inhibitor PTC596, BMS-184476, BMS-188797, BMS-214662, BMS-275183, Boanmycin Hydrochloride, Bomedemstat, Boronophenylalanine-Fructose Complex, Bortezomib, Bosutinib, Bosutinib Monohydrate, Botanical Agent BEL-X-HG, Botanical Agent LEAC-102, Bovine Cartilage, Bozitinib, BP-Cx1-Platinum Complex BP-C1, BR96-Doxorubicin Immunoconjugate, Brachyury-expressing Yeast Vaccine GI-6301, BRAF Inhibitor, BRAF Inhibitor ARQ 736, BRAF Inhibitor BGB-3245, BRAF Inhibitor PLX8394, BRAF(V600E) Kinase Inhibitor ABM-1310, BRAF(V600E) Kinase Inhibitor RO5212054, BRAF/EGFR Inhibitor BGB-283, BRAFV600/PI3K Inhibitor ASN003, BRD4 Inhibitor PLX2853, BRD4 Inhibitor PLX51107, Breflate, Brentuximab, Brentuximab Vedotin, Brequinar, Brequinar Sodium, Briciclib Sodium, Brigatinib, Brilanestrant, Brimonidine Tartrate Nanoemulsion OCU-300, Brivanib, Brivanib Alaninate, Brivudine, Brivudine Phosphoramidate, Broad-Spectrum Human Papillomavirus Vaccine V505, Broccoli Sprout/Broccoli Seed Extract Supplement, Bromacrylide, Bromebric Acid, Bromocriptine Mesylate, Brontictuzumab, Brostacillin Hydrochloride, Brostallicin, Broxuridine, Bruceanol A, Bruceanol B, Bruceanol C, Bruceanol D, Bruceanol E, Bruceanol F, Bruceanol G, Bruceanol H, Bruceantin, Bryostatin 1, BTK Inhibitor ARQ 531, BTK Inhibitor CT-1530, BTK Inhibitor DTRMWXHS-12, BTK Inhibitor HZ-A-018, BTK Inhibitor ICP-022, BTK Inhibitor LOXO-305, BTK Inhibitor M7583, BTK inhibitor TG-1701, Budigalimab, Budotitane, Bufalin, Buparlisib, Burixafor, Burixafor Hydrobromide, Burosumab, Buserelin, Bushen Culuan Decoction, Bushen-Jianpi Decoction, Busulfan, Buthionine Sulfoximine, BXQ-350 Nanovesicle Formulation, c-Kit Inhibitor PLX9486, c-Met Inhibitor ABN401, c-Met Inhibitor AL2846, c-Met Inhibitor AMG 208, c-Met Inhibitor AMG 337, c-Met Inhibitor GST-HG161, c-Met Inhibitor HS-10241, c-Met Inhibitor JNJ-38877605, c-Met Inhibitor MK2461, c-Met Inhibitor MK8033, c-Met Inhibitor MSC2156119J, C-myb Antisense Oligonucleotide G4460, c-raf Antisense Oligonucleotide ISIS 5132, C-VISA BikDD:Liposome, C/EBP Beta Antagonist ST101, CAB-ROR2-ADC BA3021, Cabazitaxel, Cabiralizumab, Cabozantinib, Cabozantinib S-malate, Cactinomycin, Caffeic Acid Phenethyl Ester, CAIX Inhibitor DTP348, CAIX Inhibitor SLC-0111, Calaspargase Pegol-mknl, Calcitriol, Calcium Release-activated Channel Inhibitor CM4620, Calcium Release-activated Channels Inhibitor RP4010, Calcium Saccharate, Calculus bovis/Moschus/Olibanum/Myrrha Capsule, Calicheamicin Gamma 1I, Camidanlumab Tesirine, Camptothecin, Camptothecin Analogue TLC388, Camptothecin Glycoconjugate BAY 38-3441, Camptothecin Sodium, Camptothecin-20(S)-O-Propionate Hydrate, Camrelizumab, Camsirubicin, Cancell, Cancer Peptide Vaccine S-588410, Canerpaturev, Canertinib Dihydrochloride, Canfosfamide, Canfosfamide Hydrochloride, Cannabidiol, Cantrixil, Cantuzumab Ravtansine, Capecitabine, Capecitabine Rapidly Disintegrating Tablet, Capivasertib, Capmatinib, Captopril, CAR T-Cells AMG 119, Caracemide, Carbendazim, Carbetimer, Carbogen, Carbon C 14-pamiparib, Carboplatin, Carboquone, Carboxyamidotriazole, Carboxyamidotriazole Orotate, Carboxyphenyl Retinamide, Carfilzomib, Caricotamide/Tretazicar, Carlumab, Carmofur, Carmustine, Carmustine Implant, Carmustine in Ethanol, Carmustine Sustained-Release Implant Wafer, Carotuximab, Carubicin, Carubicin Hydrochloride, Carzelesin, Carzinophilin, Cathelicidin LL-37, Cationic Liposome-Encapsulated Paclitaxel, Cationic Peptide Cream Cypep-1, Catumaxomab, CBP/beta-catenin Antagonist PRI-724, CBP/beta-catenin Modulator E7386, CCR2 Antagonist CCX872-B, CCR2 Antagonist PF-04136309, CCR2/CCR5 Antagonist BMS-813160, CCR4 Inhibitor FLX475, CD11b Agonist GB1275, CD123-CD33 Compound CAR T Cells, CD123-specific Targeting Module TM123, CD20-CD19 Compound CAR T Cells, CD28/ICOS Antagonist ALPN-101, CD4-specific Telomerase Peptide Vaccine UCPVax, CD40 Agonist Monoclonal Antibody CP-870;893, CD40 Agonistic Monoclonal Antibody APX005M, CD44 Targeted Agent SPL-108, CD44v6-specific CAR T-cells, CD47 Antagonist ALX148, CD73 Inhibitor AB680, CD73 Inhibitor LY3475070, CD80-Fc Fusion Protein ALPN-202, CD80-Fc Fusion Protein FPT155, CDC7 Inhibitor TAK-931, CDC7 Kinase Inhibitor BMS-863233, CDC7 Kinase Inhibitor LY3143921 Hydrate, CDC7 Kinase Inhibitor NMS-1116354, CDK Inhibitor AT7519, CDK Inhibitor R547, CDK Inhibitor SNS-032, CDK/JAK2/FLT3 Inhibitor TG02 Citrate, CDK1 Inhibitor BEY1107, CDK1/2/4 Inhibitor AG-024322, CDK2 Inhibitor PF-07104091, CDK2/4/6/FLT3 Inhibitor FN-1501, CDK2/5/9 Inhibitor CYC065, CDK4 Inhibitor P1446A-05, CDK4/6 Inhibitor, CDK4/6 Inhibitor BPI-16350, CDK4/6 Inhibitor CS3002, CDK4/6 Inhibitor FCN-437, CDK4/6 Inhibitor G1T38, CDK4/6 Inhibitor HS-10342, CDK4/6 Inhibitor SHR6390, CDK4/6 Inhibitor TQB3616, CDK7 Inhibitor CT7001, CDK7 Inhibitor SY-1365, CDK7 Inhibitor SY-5609, CDK8/19 Inhibitor SEL 120, CDK9 Inhibitor AZD4573, CEA-MUC-1-TRICOM Vaccine CV301, CEA-targeting Agent RG6123, CEBPA-targeting saRNA MTL-CEBPA Liposome, Cedazuridine, Cedazuridine/Azacitidine Combination Agent ASTX030, Cedazuridine/Decitabine Combination Agent ASTX727, Cedefingol, Cediranib, Cediranib Maleate, Celecoxib, Cell Cycle Checkpoint/DNA Repair Antagonist IC83, Cemadotin, Cemadotin Hydrochloride, Cemiplimab, Cenersen, Cenisertib, CENP-E Inhibitor GSK-923295, Ceralasertib, Ceramide Nanoliposome, Cerdulatinib, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282, Cereblon Modulator CC-90009, Cergutuzumab Amunaleukin, Ceritinib, Cesalin, cEt KRAS Antisense Oligonucleotide AZD4785, Cetrelimab, Cetuximab, Cetuximab Sarotalocan, Cetuximab-IR700 Conjugate RM-1929, Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY), Cevipabulin, Cevipabulin Fumarate, Cevipabulin Succinate, Cevostamab, cFMS Tyrosine Kinase Inhibitor ARRY-382, Chaparrin, Chaparrinone, Checkpoint Kinase Inhibitor AZD7762, Checkpoint Kinase Inhibitor XL844, Chemotherapy, Chiauranib, Chimeric Monoclonal Antibody 81C6, ChiNing Decoction, Chk1 Inhibitor CCT245737, Chk1 Inhibitor GDC-0425, Chk1 Inhibitor GDC-0575, CHK1 Inhibitor MK-8776, CHK1 Inhibitor PF-477736, Chlorambucil, Chlorodihydropyrimidine, Chloroquine, Chloroquinoxaline Sulfonamide, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes, Chlorozotocin, Choline Kinase Alpha Inhibitor TCD-717, CHP-NY-ESO-1 Peptide Vaccine IMF-001, Chromomycin A3, Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement, Cibisatamab, Ciclopirox Prodrug CPX-POM, Cidan Herbal Capsule, Ciforadenant, Cilengitide, Ciltacabtagene Autoleucel, Cimetidine, Cinacalcet Hydrochloride, Cinobufagin, Cinobufotalin, Cinrebafusp Alfa, Cintirorgon, Cintredekin Besudotox, Cirmtuzumab, cis-Urocanic Acid, Cisplatin, Cisplatin Liposomal, Cisplatin-E Therapeutic Implant, Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6, Citarinostat, Citatuzumab Bogatox, Cixutumumab, CK1alpha/CDK7/CDK9 Inhibitor BTX-A51, CK2-targeting Synthetic Peptide CIGB-300, CL 246738, Cladribine, Clanfenur, Clarithromycin, Class 1/4 Histone Deacetylase Inhibitor OKI-179, Clinical Trial, Clinical Trial Agent, Clioquinol, Clivatuzumab, Clodronate Disodium, Clodronic Acid, Clofarabine, Clomesone, Clomiphene, Clomiphene Citrate, Clostridium Novyi-NT Spores, Cobimetinib, Cobolimab, Cobomarsen, Codrituzumab, Coenzyme Q10, Cofetuzumab Pelidotin, Colchicine-Site Binding Agent ABT-751, Cold Contaminant-free Iobenguane I-131, Colloidal Gold-Bound Tumor Necrosis Factor, Colorectal Cancer Peptide Vaccine PolyPEPI1018, Colorectal Tumor-Associated Peptides Vaccine IMA910, Coltuximab Ravtansine, Combretastatin, Combretastatin A-1, Combretastatin A1 Diphosphate, Commensal Bacterial Strain Formulation VE800, Compound Kushen Injection, Conatumumab, Conbercept, Concentrated Lingzhi Mushroom Extract, Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011, Copanlisib, Copanlisib Hydrochloride, Copper Cu 64-ATSM, Copper Cu 67 Tyr3-octreotate, Copper Gluconate, Cord Blood Derived CAR T-Cells, Cord Blood-derived Expanded Natural Killer Cells PNK-007, Cordycepin, Cordycepin Triphosphate, Coriolus Versicolor Extract, Corticorelin Acetate, Cortisone Acetate, Cosibelimab, Cositecan, Coxsackievirus A21, Coxsackievirus V937, CpG Oligodeoxynucleotide GNKG168, Crenolanib, Crenolanib Besylate, Crizotinib, Crolibulin, Cryptophycin, Cryptophycin 52, Crystalline Genistein Formulation AXP107-11, CSF-1R Inhibitor BLZ945, CSF1R Inhibitor ABSK021, CSF1R Inhibitor DCC-3014, CSF1R Inhibitor PLX73086, CT2584 HMS, CTLA-4-directed Probody BMS-986249, Curcumin, Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110, Cusatuzumab, Custirsen Sodium, CXC Chemokine Receptor 2 Antagonist AZD5069, CXCR1/2 Inhibitor SX-682, CXCR2 Antagonist QBM076, CXCR4 Antagonist BL-8040, CXCR4 Antagonist USL311, CXCR4 Inhibitor Q-122, CXCR4 Peptide Antagonist LY2510924, CXCR4/E-selectin Antagonist GMI-1359, Cyclin-dependent Kinase 8/19 Inhibitor BCD 115, Cyclin-dependent Kinase Inhibitor PF-06873600, Cyclodextrin-Based Polymer-Camptothecin CRLX101, Cyclodisone, Cycloleucine, Cyclopentenyl Cytosine, Cyclophosphamide, Cyclophosphamide Anhydrous, Cyclosporine, CYL-02 Plasmid DNA, CYP11A1 inhibitor ODM-208, CYP11A1 Inhibitor ODM-209, CYP17 Inhibitor CFG920, CYP17 Lyase Inhibitor ASN001, CYP17/Androgen Receptor Inhibitor ODM 204, CYP17/CYP11B2 Inhibitor LAE001, Cyproterone, Cyproterone Acetate, Cytarabine, Cytarabine Monophosphate Prodrug MB07133, Cytarabine-asparagine Prodrug BST-236, Cytidine Analog RX-3117, Cytochlor, Cytokine-based Biologic Agent IRX-2, D-methionine Formulation MRX-1024, DAB389 Epidermal Growth Factor, Dabrafenib, Dabrafenib Mesylate, Dacarbazine, Dacetuzumab, DACH Polymer Platinate AP5346, DACH-Platin Micelle NC-4016, Daclizumab, Dacomitinib, Dacplatinum, Dactinomycin, Dactolisib, Dactolisib Tosylate, Dalantercept, Dalotuzumab, Daniquidone, Danusertib, Danvatirsen, Daporinad, Daratumumab, Daratumumab and Hyaluronidase-fihj, Daratumumab/rHuPH20, Darinaparsin, Darleukin, Darolutamide, Daromun, Dasatinib, Daunorubicin, Daunorubicin Citrate, Daunorubicin Hydrochloride, DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Decitabine, Decitabine and Cedazuridine, Defactinib, Defactinib Hydrochloride, Deferoxamine, Deferoxamine Mesylate, Degarelix, Degarelix Acetate, Delanzomib, Delolimogene Mupadenorepvec, Demcizumab, Demecolcine, Demplatin Pegraglumer, Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466, Dendritic Cell Vaccine, Dendritic Cell-Autologous Lung Tumor Vaccine, Dendritic Cell-targeting Lentiviral Vector ID-LV305, Denenicokin, Dengue Virus Adjuvant PV-001-DV, Denibulin, Denibulin Hydrochloride, Denileukin Diftitox, Denintuzumab Mafodotin, Denosumab, Deoxycytidine Analogue TAS-109, Deoxycytidine Analogue TAS-109 Hydrochloride, Depatuxizumab, Depatuxizumab Mafodotin, Derazantinib, Deslorelin, Deslorelin Acetate, Detirelix, Detorubicin, Deuteporfin, Deuterated Enzalutamide, Devimistat, Dexamethason, Dexamethasone, Dexamethasone Phosphate, Dexamethasone Sodium Phosphate, Dexanabinol, Dexrazoxane, Dexrazoxane Hydrochloride, Dezaguanine, Dezaguanine Mesylate, Dezapelisib, DHA-Paclitaxel, DHEA Mustard, DI-Leu16-IL2 Immunocytokine, Dianhydrogalactitol, Diarylsulfonylurea Compound ILX-295501, Diazepinomicin, Diaziquone, Diazooxonorleucine, Dibrospidium Chloride, Dichloroallyl Lawsone, Dicycloplatin, Didox, Dienogest, Diethylnorspermine, Digitoxin, Digoxin, Dihydro-5-Azacytidine, Dihydrolenperone, Dihydroorotate Dehydrogenase Inhibitor AG-636, Dihydroorotate Dehydrogenase Inhibitor BAY2402234, Diindolylmethane, Dilpacimab, Dimethylmyleran, Dinaciclib, Dinutuximab, Dioscorea nipponica Makino Extract DNE3, Diphencyprone, Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777, Ditiocarb, DKK1-Neutralizing Monoclonal Antibody DKN-01, DM-CHOC-PEN, DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015, DNA Interference Oligonucleotide PNT2258, DNA Minor Groove Binding Agent SG2000, DNA Plasmid Encoding Interleukin-12 INO-9012, DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151, DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457, DNA Vaccine VB10.16, DNA-dependent Protein Kinase Inhibitor VX-984, DNA-PK inhibitor AZD7648, DNA-PK/PI3K-delta Inhibitor BR101801, DNA-PK/TOR Kinase Inhibitor CC-115, DNMT1 Inhibitor NTX-301, DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98, Docetaxel, Docetaxel Anhydrous, Docetaxel Emulsion ANX-514, Docetaxel Formulation CKD-810, Docetaxel Lipid Microspheres, Docetaxel Nanoparticle CPC634, Docetaxel Polymeric Micelles, Docetaxel-loaded Nanopharmaceutical CRLX301, Docetaxel-PNP, Docetaxel/Ritonavir, Dociparstat sodium, Dolastatin 10, Dolastatin 15, Domatinostat, Donafenib, Dopamine-Somatostatin Chimeric Molecule BIM-23A760, Dostarlimab, Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703, Dovitinib, Dovitinib Lactate, Doxazosin, Doxercalciferol, Doxifluridine, Doxorubicin, Doxorubicin Hydrochloride, Doxorubicin Prodrug L-377;202, Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370, Doxorubicin-Eluting Beads, Doxorubicin-HPMA Conjugate, Doxorubicin-loaded EGFR-targeting Nanocells, Doxorubicin-Magnetic Targeted Carrier Complex, DPT/BCG/Measles/Serratia/Pneumococcus Vaccine, DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine, DPX-E7 HPV Vaccine, DR5 HexaBody Agonist GEN1029, DR5-targeting Tetrameric Nanobody Agonist TAS266, Dromostanolone Propionate, Drozitumab, DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555, Dual IGF-1R/InsR Inhibitor BMS-754807, Dual Variable Domain Immunoglobulin ABT-165, Dual-affinity B7-H3/CD3-targeted Protein MGD009, Dubermatinib, Duborimycin, Dulanermin, Duligotuzumab, Dupilumab, Durvalumab, Dusigitumab, dUTPase/DPD Inhibitor TAS-114, Duvelisib, Duvortuxizumab, Dynemicin, Dynemicin A, E2F1 Pathway Activator ARQ 171, EBNA-1 inhibitor VK-2019, Echinomycin, Ecromeximab, Edatrexate, Edelfosine, Edicotinib, Edodekin alfa, Edotecarin, Edrecolomab, EED Inhibitor MAK683, Efatutazone, Efatutazone Dihydrochloride, Efizonerimod, Eflornithine, Eflornithine Hydrochloride, Eftilagimod Alpha, Eftozanermin Alfa, Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205, Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621, EGb761, EGFR Antagonist Hemay022, EGFR Antisense DNA BB-401, EGFR Inhibitor AZD3759, EGFR Inhibitor BIBX 1382, EGFR Inhibitor DBPR112, EGFR Inhibitor PD-168393, EGFR Inhibitor TY-9591, EGFR Mutant-selective Inhibitor TQB3804, EGFR Mutant-specific Inhibitor BPI-7711, EGFR Mutant-specific Inhibitor CK-101, EGFR Mutant-specific Inhibitor D-0316, EGFR Mutant-specific Inhibitor ZN-e4, EGFR T790M Antagonist BPI-15086, EGFR T790M Inhibitor HS-10296, EGFR/EGFRvIII Inhibitor WSD0922-FU, EGFR/FLT3/Abl Inhibitor SKLB1028, EGFR/HER1/HER2 Inhibitor PKI166, EGFR/HER2 Inhibitor AP32788, EGFR/HER2 Inhibitor AV-412, EGFR/HER2 Inhibitor DZD9008, EGFR/HER2 Kinase Inhibitor TAK-285, EGFR/TGFb Fusion Monoclonal Antibody BCA101, EGFR/VEGFR/RET Inhibitor HA121-28, Eicosapentaenoic Acid, eIF4E Antisense Oligonucleotide ISIS 183750, Elacestrant, Elacytarabine, Elagolix, Elbasvir/Grazoprevir, Elesclomol, Elesclomol Sodium, Elgemtumab, Elinafide, Elisidepsin, Elliptinium, Elliptinium Acetate, Elmustine, Elotuzumab, Elpamotide, Elsamitrucin, Eltanexor, Emactuzumab, Emapalumab, Emepepimut-S, Emibetuzumab, Emitefur, Emofolin Sodium, Empesertib, Enadenotucirev, Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A, Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641, Enasidenib, Enasidenib Mesylate, Enavatuzumab, Encapsulated Rapamycin, Encelimab, Enclomiphene, Enclomiphene Citrate, Encorafenib, Endothelin B Receptor Blocker ENB 003, Endothelin Receptor Type A Antagonist YM598, Enfortumab Vedotin, Engineered Human Umbilical Vein Endothelial Cells AB-205, Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240, Engineered Toxin Body Targeting CD38 TAK-169, Engineered Toxin Body Targeting HER2 MT-5111, Eniluracil/5-FU Combination Tablet, Enloplatin, Enoblituzumab, Enobosarm, Enoticumab, Enpromate, Ensartinib, Ensituximab, Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride, Enterococcus gallinarum Strain MRx0518, Entinostat, Entolimod, Entospletinib, Entrectinib, Envafolimab, Enzalutamide, Enzastaurin, Enzastaurin Hydrochloride, EP2/EP4 Antagonist TPST-1495, EP4 Antagonist INV-1120, EP4 Antagonist ONO-4578, Epacadostat, Epcoritamab, EphA2-targeting Bicycle Toxin Conjugate BT5528, Epipodophyllotoxin Analog GL331, Epipropidine, Epirubicin, Epirubicin Hydrochloride, Epitinib Succinate, Epitiostanol, Epothilone Analog UTD1, Epothilone KOS-1584, Epratuzumab, Epratuzumab-cys-tesirine, ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471, ERa36 Modulator Icaritin, Erastin Analogue PRLX 93936, Erbulozole, Erdafitinib, Eribulin, Eribulin Mesylate, ERK 1/2 Inhibitor ASTX029, ERK Inhibitor CC-90003, ERK Inhibitor GDC-0994, ERK Inhibitor LTT462, ERK Inhibitor MK-8353, ERK1/2 Inhibitor ASN007, ERK1/2 Inhibitor HH2710, ERK1/2 Inhibitor JSI-1187, ERK1/2 Inhibitor KO-947, ERK1/2 Inhibitor LY3214996, Erlotinib, Erlotinib Hydrochloride, Ertumaxomab, Erythrocyte-encapsulated L-asparaginase Suspension, Esorubicin, Esorubicin Hydrochloride, Esperamicin A1, Essiac, Esterified Estrogens, Estradiol Valerate, Estramustine, Estramustine Phosphate Sodium, Estrogen Receptor Agonist GTx-758, Estrogens; Conjugated, Etalocib, Etanercept, Etanidazole, Etaracizumab, Etarotene, Ethaselen, Ethinyl Estradiol, Ethyleneimine, Ethylnitrosourea, Etidronate-Cytarabine Conjugate MBC-11, Etigilimab, Etirinotecan Pegol, Etoglucid, Etoposide, Etoposide Phosphate, Etoposide Toniribate, Etoprine, Etoricoxib, Ets-family Transcription Factor Inhibitor TK216, Everolimus, Everolimus Tablets for Oral Suspension, Evofosfamide, Ex Vivo-expanded Autologous T Cells IMA101, Exatecan Mesylate, Exatecan Mesylate Anhydrous, Exemestane, Exicorilant, Exisulind, Extended Release Flucytosine, Extended Release Metformin Hydrochloride, Extended-release Onapristone, Ezabenlimab, EZH1/2 Inhibitor DS-3201, EZH1/2 Inhibitor HH2853, EZH2 inhibitor CPI-0209, EZH2 Inhibitor CPI-1205, EZH2 Inhibitor PF-06821497, EZH2 Inhibitor SHR2554, F16-IL2 Fusion Protein, FACT Complex-targeting Curaxin CBL0137, Factor VII-targeting Immunoconjugate Protein ICON-1, Factor VIIa Inhibitor PCI-27483, Fadraciclib, Fadrozole Hydrochloride, FAK Inhibitor GSK2256098, FAK Inhibitor PF-00562271, FAK Inhibitor VS-4718, FAK/ALK/ROS1 Inhibitor APG-2449, Falimarev, Famitinib, FAP/4-1BB-targeting DARPin MP0310, FAP/4-1BB-targeting Fusion Protein RO7122290, Farletuzumab, Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778;123, Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells, Fas Receptor Agonist APO010, Fascin Inhibitor NP-G2-044, FASN Inhibitor TVB-2640, Favezelimab, Fazarabine, Fc-engineered Anti-CD40 Agonist Antibody 2141-V11, Febuxostat, Fedratinib, Fedratinib Hydrochloride, Feladilimab, Felzartamab, Fenebrutinib, Fenretinide, Fenretinide Lipid Matrix, Fenretinide Phospholipid Suspension ST-001, FGF Receptor Antagonist HGS1036, FGF/FGFR Pathway Inhibitor E7090, FGFR Inhibitor ASP5878, FGFR Inhibitor AZD4547, FGFR Inhibitor CPL304110, FGFR Inhibitor Debio 1347, FGFR Inhibitor TAS-120, FGFR/CSF-1R Inhibitor 3D185, FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999, FGFR1/2/3 Inhibitor HMPL-453, FGFR2 Inhibitor RLY-4008, FGFR4 Antagonist INCB062079, FGFR4 Inhibitor BLU 9931, FGFR4 Inhibitor FGF401, FGFR4 Inhibitor H3B-6527, FGFR4 Inhibitor ICP-105, Fianlimab, Fibromun, Ficlatuzumab, Figitumumab, Filanesib, Filgotinib, Filgrastim, Fimaporfin A, Fimepinostat, Firtecan Pegol, Fisogatinib, Flanvotumab, Flotetuzumab, Floxuridine, FLT3 Inhibitor FF-10101 Succinate, FLT3 Inhibitor HM43239, FLT3 Inhibitor SKI-G-801, Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01, FLT3 Tyrosine Kinase Inhibitor TTT-3002, FLT3/ABL/Aurora Kinase Inhibitor KW-2449, FLT3/CDK4/6 Inhibitor FLX925, FLT3/FGFR Dual Kinase Inhibitor MAX-40279, FLT3/KIT Kinase Inhibitor AKN-028, FLT3/KIT/CSF1R Inhibitor NMS-03592088, Flt3/MerTK Inhibitor MRX-2843, Fludarabine, Fludarabine Phosphate, Flumatinib, Flumatinib Mesylate, Fluorine F 18 Ara-G, Fluorodopan, Fluorouracil, Fluorouracil Implant, Fluorouracil-E Therapeutic Implant, Fluoxymesterone, Flutamide, Fluvastatin, Fluvastatin Sodium, Fluzoparib, FMS Inhibitor JNJ-40346527, Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate, Folate Receptor Targeted Epothilone BMS753493, Folate Receptor-Targeted Tubulysin Conjugate EC1456, Folate Receptor-Targeted Vinca Alkaloid EC0489, Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225, Folate-FITC, Folic Acid, Folitixorin, Foretinib, Foritinib Succinate, Formestane, Forodesine Hydrochloride, Fosaprepitant, Fosbretabulin, Fosbretabulin Disodium, Fosbretabulin Tromethamine, Fosgemcitabine Palabenamide, Fosifloxuridine Nafalbenamide, Foslinanib, Foslinanib Disodium, Fosquidone, Fostriecin, Fotemustine, Fotretamine, FPV Vaccine CV301, FPV-Brachyury-TRICOM Vaccine, Fresolimumab, Fruquintinib, Fulvestrant, Fumagillin-Derived Polymer Conjugate XMT-1107, Fursultiamine, Futibatinib, Futuximab, Futuximab/Modotuximab Mixture, G Protein-coupled Estrogen Receptor Agonist LNS8801, G-Quadruplex Stabilizer BMVC, Galamustine, Galarubicin, Galectin Inhibitor GR-MD-02, Galectin-1 Inhibitor OTX008, Galeterone, Galiximab, Gallium-based Bone Resorption Inhibitor AP-002, Galocitabine, Galunisertib, Gamboge Resin Extract TSB-9-W1, Gamma-delta Tocotrienol, Gamma-Secretase Inhibitor LY3039478, Gamma-Secretase Inhibitor RO4929097, Gandotinib, Ganetespib, Ganglioside GD2, Ganglioside GM2, Ganitumab, Ganoderma lucidum Spores Powder Capsule, Garlic, Gastrin Immunotoxin, Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360, Gataparsen Sodium, Gatipotuzumab, GBM Antigens and Alloantigens Immunotherapeutic Vaccine, Gedatolisib, Gefitinib, Geldanamycin, Gelonin, Gemcitabine, Gemcitabine Elaidate, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride Emulsion, Gemcitabine Prodrug LY2334737, Gemcitabine-Phosphoramidate Hydrochloride NUC-1031, Gemcitabine-Releasing Intravesical System, Gemtuzumab Ozogamicin, Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum, Genistein, Gentuximab, Geranylgeranyltransferase I Inhibitor, GI-4000 Vaccine, Giloralimab, Gilteritinib, Gilteritinib Fumarate, Gimatecan, Gimeracil, Ginsenoside Rg3 Capsule, Giredestrant, Girentuximab, Girodazole, GITR Agonist MEDI1873, Givinostat, Glasdegib, Glasdegib Maleate, Glaucarubolone, Glecaprevir/Pibrentasvir, Glembatumumab Vedotin, Glesatinib, Glioblastoma Cancer Vaccine ERC1671, Glioblastoma Multiforme Multipeptide Vaccine IMA950, Glioma Lysate Vaccine GBM6-AD, Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701, Globo H-DT Vaccine OBI-833, Glofitamab, Glucarpidase, Glucocorticoid Receptor Antagonist ORIC-101, Glufosfamide, Glumetinib, Glutaminase Inhibitor CB-839, Glutaminase Inhibitor CB-839 Hydrochloride, Glutaminase Inhibitor IPN60090, Glutamine Antagonist DRP-104, Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101, Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01, Glycooptimized Trastuzumab-GEX, GM-CSF-encoding Oncolytic Adenovirus CGTG-102, Gold Sodium Thiomalate, Golnerminogene Pradenovec, Golotimod, Golvatinib, Gonadotropin-releasing Hormone Analog, Goserelin, Goserelin Acetate, Goserelin Acetate Extended-release Microspheres LY01005, Gossypol, Gossypol Acetic Acid, Grapiprant, Green Tea Extract-based Antioxidant Supplement, GS/pan-Notch Inhibitor AL101, GS/pan-Notch Inhibitor BMS-986115, GSK-3 Inhibitor 9-ING-41, GSK-3 Inhibitor LY2090314, Guadecitabine, Guanabenz Acetate, Guselkumab, Gusperimus Trihydrochloride, Gutolactone, H-ras Antisense Oligodeoxynucleotide ISIS 2503, H1299 Tumor Cell Lysate Vaccine, HAAH Lambda phage Vaccine SNS-301, Hafnium Oxide-containing Nanoparticles NBTXR3, Halichondrin Analogue E7130, Halichondrin B, Halofuginone, Halofuginone Hydrobromide, HCV DNA Vaccine INO-8000, HDAC Class I/IIb Inhibitor HG146, HDAC Inhibitor AR-42, HDAC inhibitor CG200745, HDAC Inhibitor CHR-2845, HDAC Inhibitor CKD-581, HDAC Inhibitor CXD101, HDAC Inhibitor MPT0E028, HDAC Inhibitor OBP-801, HDAC/EGFR/HER2 Inhibitor CUDC-101, HDAC6 Inhibitor KA2507, HDAC8 Inhibitor NBM-BMX, HDM2 Inhibitor HDM201, HDM2 Inhibitor MK-8242, Hedgehog Inhibitor IPI-609, Hematoporphyrin Derivative, Hemiasterlin Analog E7974, Henatinib Maleate, Heparan Sulfate Glycosaminoglycan Mimetic M402, Heparin Derivative SST0001, HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131, HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901, HER2 Inhibitor CP-724;714, HER2 Inhibitor DZD1516, HER2 Inhibitor TAS0728, HER2 Tri-specific Natural Killer Cell Engager DF1001, HER2-directed TLR8 Agonist SBT6050, HER2-targeted DARPin MP0274, HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302, HER2-targeting Antibody Fc Fragment FS102, Herba Scutellaria Barbata, Herbimycin, Heterodimeric Interleukin-15, Hexamethylene Bisacetamide, Hexaminolevulinate, Hexylresorcinol, HIF-1alpha Inhibitor PX-478, HIF-2alpha Inhibitor PT2385, HIF-2alpha Inhibitor PT2977, HIF2a RNAi ARO-HIF2, Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126, Histrelin Acetate, HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001, HLA-A*2402-Restricted Multipeptide Vaccine S-488410, HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201, HM2/MMAE Antibody-Drug Conjugate ALT-P7, Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine, Holmium Ho 166 Poly(L-Lactic Acid) Microspheres, Hormone Therapy, HPPH, HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202, HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c, HPV DNA Plasmids Therapeutic Vaccine VGX-3100, HPV E6/E7 DNA Vaccine GX-188E, HPV E6/E7-encoding Arenavirus Vaccine HB-201, HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C, HPV-16 E6 Peptides Vaccine/Candida albicans Extract, HPV-6-targeting Immunotherapeutic Vaccine INO-3106, HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101, HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN, HPV6/11-targeted DNA Plasmid Vaccine INO-3107, Hsp90 Antagonist KW-2478, Hsp90 Inhibitor AB-010, Hsp90 Inhibitor BIIB021, Hsp90 Inhibitor BIIB028, Hsp90 Inhibitor Debio 0932, Hsp90 Inhibitor DS-2248, Hsp90 Inhibitor HSP990, Hsp90 Inhibitor MPC-3100, Hsp90 Inhibitor PU-H71, Hsp90 Inhibitor SNX-5422 Mesylate, Hsp90 Inhibitor SNX-5542 Mesylate, Hsp90 Inhibitor TQB3474, Hsp90 Inhibitor XL888, Hsp90-targeted Photosensitizer HS-201, HSP90-targeted SN-38 Conjugate PEN-866, HSP90alpha/beta Inhibitor TAS-116, hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301, hTERT Vaccine V934/V935, hTERT-encoding DNA Vaccine INVAC-1, Hu14.18-IL2 Fusion Protein EMD 273063, HuaChanSu, Huaier Extract Granule, Huang Lian, huBC1-huIL12 Fusion Protein AS1409, Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736, Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104, Human MOAB LICO 28a32, Human Monoclonal Antibody 216, Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307, Human Papillomavirus 16 E7 Peptide/Padre 965.10, Hyaluronidase-zzxf/Pertuzumab/Trastuzumab, Hycanthone, Hydralazine Hydrochloride, Hydrocortisone Sodium Succinate, Hydroxychloroquine, Hydroxyprogesterone Caproate, Hydroxytyrosol, Hydroxyurea, Hypericin, Hypoxia-activated Prodrug TH-4000, I 131 Antiferritin Immunoglobulin, I 131 Monoclonal Antibody A33, I 131 Monoclonal Antibody CC49, I 131 Monoclonal Antibody F19, I 131 Monoclonal Antibody Lym-1, Iadademstat, Ianalumab, IAP Inhibitor APG-1387, IAP Inhibitor AT-406, IAP Inhibitor HGS1029, Ibandronate Sodium, Iberdomide, Iboctadekin, Ibritumomab Tiuxetan, Ibrutinib, Icotinib Hydrochloride, Icrucumab, ICT-121 Dendritic Cell Vaccine, Idarubicin, Idarubicin Hydrochloride, Idarubicin-Eluting Beads, Idasanutlin, Idecabtagene Vicleucel, Idelalisib, Idetrexed, IDH1 Mutant Inhibitor LY3410738, IDH1(R132) Inhibitor IDH305, IDH1R132H-Specific Peptide Vaccine PEPIDH1M, Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020, IDO Peptide Vaccine IO102, IDO-1 Inhibitor LY3381916, IDO/TDO Inhibitor HTI-1090, IDO/TDO Inhibitor LY-01013, IDO1 Inhibitor KHK2455, IDO1 Inhibitor MK-7162, IDO1 Inhibitor PF-06840003, IDO1/TDO2 Inhibitor DN1406131, IDO1/TDO2 Inhibitor M4112, Idronoxil, Idronoxil Suppository NOX66, Ieramilimab, Ifabotuzumab, Ifetroban, Ifosfamide, IGF-1R Inhibitor, IGF-1R Inhibitor PL225B, IGF-1R/IR Inhibitor KW-2450, IGF-methotrexate Conjugate, IL-10 Immunomodulator MK-1966, IL-12-expressing HSV-1 NSC 733972, IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051, IL-12sc; IL-15sushi; IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000, IL-2 Recombinant Fusion Protein ALT-801, IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1, IL4-Pseudomonas Exotoxin Fusion Protein MDNA55, Ilginatinib, Ilixadencel, Iloprost, Ilorasertib, Imalumab, Imaradenant, Imatinib, Imatinib Mesylate, Imetelstat, Imetelstat Sodium, Imexon, Imgatuzumab, Imidazole Mustard, Imidazole-Pyrazole, Imifoplatin, Imipramine Blue, Imiquimod, Immediate-release Onapristone, Immediate-release Tablet Afuresertib, Immune Checkpoint Inhibitor ASP8374, Immunoconjugate RO5479599, Immunocytokine NHS-IL12, Immunocytokine NHS-IL2-LT, Immunomodulator LAM-003, Immunomodulator OHR/AVR118, Immunomodulatory Agent CC-11006, Immunomodulatory Oligonucleotide HYB2055, Immunotherapeutic Combination Product CMB305, Immunotherapeutic GSK1572932A, Immunotherapy Regimen MKC-1106-MT, Immunotoxin CMD-193, IMT-1012 Immunotherapeutic Vaccine, Inactivated Oncolytic Virus Particle GEN0101, Inalimarev, Incyclinide, Indatuximab Ravtansine, Indibulin, Indicine-N-Oxide, Indisulam, Individualized MVA-based Vaccine TG4050, Indocyanine Green-labeled Polymeric Micelles ONM-100, Indole-3-Carbinol, Indomethacin, Indoximod, Indoximod Prodrug NLG802, Indusatumab Vedotin, Inebilizumab, Inecalcitol, Infigratinib, Infigratinib Mesylate, Infliximab, Ingenol Mebutate, Ingenol Mebutate Gel, Iniparib, iNKT Cell Agonist ABX196, Innate Immunostimulator rBBX-01, INO-1001, Inodiftagene Vixteplasmid, iNOS Dimerization Inhibitor ASP9853, Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01, Inosine Monophosphate Dehydrogenase Inhibitor AVN944, Inositol, Inotuzumab Ozogamicin, Inproquone, Integrin alpha-2 Inhibitor E7820, Integrin Receptor Antagonist GLPG0187, Interferon, Interferon Alfa-2B, Interferon Alfa-N1, Interferon Alfa-N3, Interferon Alfacon-1, Interferon Beta-1A, Interferon Gamma-1b, Interferon-gamma-expressing Adenovirus Vaccine ASN-002, Interleukin Therapy, Interleukin-12-Fc Fusion Protein DF6002, Interleukin-15 Agonist Fusion Protein SHR1501, Interleukin-15 Fusion Protein BJ-001, Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306, Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101, Interleukin-2 Liposome, Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230, Intetumumab, Intiquinatine, Intoplicine, Inulin, Iobenguane I-131, Iodine I 124 Monoclonal Antibody A33, Iodine I 124 Monoclonal Antibody M5A, Iodine I 125-Anti-EGFR-425 Monoclonal Antibody, Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP, Iodine I 131 Apamistamab, Iodine I 131 Derlotuximab Biotin, Iodine I 131 Ethiodized Oil, Iodine I 131 IPA, Iodine I 131 MIP-1095, Iodine I 131 Monoclonal Antibody 81C6, Iodine I 131 Monoclonal Antibody BC8, Iodine I 131 Monoclonal Antibody CC49-deltaCH2, Iodine I 131 Monoclonal Antibody F16SIP, Iodine I 131 Monoclonal Antibody G-250, Iodine I 131 Monoclonal Antibody muJ591, Iodine I 131 Omburtamab, Iodine I 131 Rituximab, Iodine I 131 Tenatumomab, Iodine I 131 TM-601, Iodine I 131 Tositumomab, Iodine I-131, Ioflubenzamide I-131, Ionomycin, Ipafricept, Ipatasertib, Ipilimumab, Ipomeanol, Iproplatin, iPSC-derived CD16-expressing Natural Killer Cells FT516, iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596, iPSC-derived Natural Killer Cells FT500, IRAK4 Inhibitor CA-4948, Iratumumab, Iridium Ir 192, Irinotecan, Irinotecan Hydrochloride, Irinotecan Sucrosofate, Irinotecan-Eluting Beads, Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet, Irofulven, Iroplact, Irosustat, Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130, Isatuximab, Iso-fludelone, Isobrucein B, Isocoumarin NM-3, Isotretinoin, Ispinesib, Ispinesib Mesylate, ISS 1018 CpG Oligodeoxynucleotide, Istiratumab, Itacitinib, Itacitinib Adipate, ITK Inhibitor CPI-818, Itraconazole, Itraconazole Dispersion In Polymer Matrix, Ivaltinostat, Ivosidenib, Ivuxolimab, Ixabepilone, Ixazomib, Ixazomib Citrate, JAK Inhibitor, JAK Inhibitor INCB047986, JAK1 Inhibitor AZD4205, JAK1 Inhibitor INCB052793, JAK2 Inhibitor AZD1480, JAK2 Inhibitor BMS-911543, JAK2 Inhibitor XL019, JAK2/Src Inhibitor NS-018, Jin Fu Kang, JNK Inhibitor CC-401, Kanglaite, Kanitinib, Ketoconazole, Ketotrexate, KRAS G12C Inhibitor GDC-6036, KRAS G12C Inhibitor LY3499446, KRAS G12C Inhibitor MRTX849, KRAS Mutant-targeting AMG 510, KRAS-MAPK Signaling Pathway Inhibitor JAB-3312, KRASG12C Inhibitor JNJ-74699157, KRN5500, KSP Inhibitor AZD4877, KSP Inhibitor SB-743921, Kunecatechins Ointment, L-Gossypol, L-methylfolate, Labetuzumab Govitecan, Lactoferrin-derived Lytic Peptide LTX-315, Lacutamab, Ladiratuzumab Vedotin, Ladirubicin, Laetrile, LAIR-2 Fusion Protein NC410, Landogrozumab, Laniquidar, Lanreotide Acetate, Lapachone, Lapatinib, Lapatinib Ditosylate, Laprituximab Emtansine, Lapuleucel-T, Laromustine, Larotaxel, Larotinib Mesylate, Larotrectinib, Larotrectinib Sulfate, Lavendustin A, Lazertinib, Lead Pb 212 TCMC-trastuzumab, Lefitolimod, Leflunomide, Lenalidomide, Lenalidomide Analog KPG-121, Lentinan, Lenvatinib, Lenvatinib Mesylate, Lenzilumab, Lerociclib, Lestaurtinib, Letetresgene Autoleucel, Letolizumab, Letrozole, Leucovorin, Leucovorin Calcium, Leuprolide, Leuprolide Acetate, Leuprolide Mesylate Injectable Suspension, Leurubicin, Levetiracetam, Levoleucovorin Calcium, Levothyroxine, Levothyroxine Sodium, Lexatumumab, Lexibulin, Liarozole, Liarozole Fumarate, Liarozole Hydrochloride, Licartin, Licorice, Lifastuzumab Vedotin, Lifileucel, Lifirafenib, Light-activated AU-011, Light-Emitting Oncolytic Vaccinia Virus GL-ONC1, Lilotomab, Limonene; (+)-, Limonene; (+/-)-, Linifanib, Linoleyl Carbonate-Paclitaxel, Linperlisib, Linrodostat, Linsitinib, Lintuzumab, Liothyronine I-131, Liothyronine Sodium, Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1, Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191, Lipid Nanoparticle Encapsulated OX40L mRNA-2416, Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006, Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752, Liposomal Bcl-2 Antisense Oligonucleotide BP1002, Liposomal c-raf Antisense Oligonucleotide, Liposomal Curcumin, Liposomal Cytarabine, Liposomal Daunorubicin Citrate, Liposomal Docetaxel, Liposomal Eribulin Mesylate, Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Liposomal Irinotecan, Liposomal Mitoxantrone Hydrochloride, Liposomal MUC1/PET-lipid A Vaccine ONT-10, Liposomal NDDP, Liposomal Rhenium Re 186, Liposomal SN-38, Liposomal Topotecan FF-10850, Liposomal Vinorelbine, Liposomal Vinorelbine Tartrate, Liposome, Liposome-encapsulated Daunorubicin-Cytarabine, Liposome-Encapsulated Doxorubicin Citrate, Liposome-encapsulated miR-34 Mimic MRX34, Liposome-encapsulated OSI-7904, Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94, Liposome-encapsulated TAAs mRNA Vaccine W_ova1, Lirilumab, Lisavanbulin, Lisocabtagene Maraleucel, Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142, Litronesib, Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809, Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207, Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623, Liver X Receptor beta Agonist RGX-104, Lm-tLLO-neoantigens Vaccine ADXS-NEO, LMB-1 Immunotoxin, LMB-2 Immunotoxin, LMB-7 Immunotoxin, LMB-9 Immunotoxin, LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164, LMP-2:340-349 Peptide Vaccine, LMP-2:419-427 Peptide Vaccine, LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes, LMP7 Inhibitor M3258, Lobaplatin, Lodapolimab, Lometrexol, Lometrexol Sodium, Lomustine, Lonafarnib, Loncastuximab Tesirine, Long Peptide Vaccine 7, Long-acting Release Pasireotide, Lontucirev, Lorlatinib, Lorukafusp alfa, Lorvotuzumab Mertansine, Losatuxizumab Vedotin, Losoxantrone, Losoxantrone Hydrochloride, Lovastatin, LOXL2 Inhibitor PAT-1251, LRP5 Antagonist BI 905681, LRP5/6 Antagonist BI 905677, LSD1 Inhibitor CC-90011, LSD1 Inhibitor GSK2879552, LSD1 Inhibitor IMG-7289, LSD1 Inhibitor RO7051790, LSD1 Inhibitor SYHA1807, Lucanthone, Lucatumumab, Lucitanib, Luminespib, Luminespib Mesylate, Lumretuzumab, Lung-targeted Immunomodulator QBKPN, Lupartumab Amadotin, Lurbinectedin, Lurtotecan, Lurtotecan Liposome, Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1, Lutetium Lu 177 DOTA-biotin, Lutetium Lu 177 DOTA-N3-CTT1403, Lutetium Lu 177 DOTA-Tetulomab, Lutetium Lu 177 Dotatate, Lutetium Lu 177 Lilotomab-satetraxetan, Lutetium Lu 177 Monoclonal Antibody CC49, Lutetium Lu 177 Monoclonal Antibody J591, Lutetium Lu 177 PP-F11N, Lutetium Lu 177 Satoreotide Tetraxetan, Lutetium Lu 177-DOTA-EB-TATE, Lutetium Lu 177-DTPA-omburtamab, Lutetium Lu 177-Edotreotide, Lutetium Lu 177-NeoB, Lutetium Lu 177-PSMA-617, Lutetium Lu-177 Capromab, Lutetium Lu-177 Girentuximab, Lutetium Lu-177 PSMA-R2, Lutetium Lu-177 Rituximab, LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1, Lyophilized Black Raspberry Lozenge, Lyophilized Black Raspberry Saliva Substitute, Lysine-specific Demethylase 1 Inhibitor INCB059872, Lyso-Thermosensitive Liposome Doxorubicin, Maackia amurensis Seed Lectin, Macimorelin, Macitentan, Macrocycle-bridged STING Agonist E7766, Maekmoondong-tang, Mafosfamide, MAGE-10.A2, MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells, MAGE-A3 Multipeptide Vaccine GL-0817, MAGE-A3 Peptide Vaccine, MAGE-A3-specific Immunotherapeutic GSK 2132231A, MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201, Magnesium Valproate, Magrolimab, MALT1 Inhibitor JNJ-67856633, Manelimab, Mannosulfan, Mannosylerythritol Lipid, Mapatumumab, Maraba Oncolytic Virus Expressing Mutant HPV E6/E7, Marcellomycin, MARCKS Protein Inhibitor BIO-11006, Margetuximab, Marimastat, Marizomib, Masitinib Mesylate, Masoprocol, MAT2A Inhibitor AG-270, Matrix Metalloproteinase Inhibitor MMI270, Matuzumab, Mavelertinib, Mavorixafor, Maytansine, MCL-1 Inhibitor ABBV-467, MCL-1 Inhibitor AMG 176, MCL-1 inhibitor AMG 397, Mcl-1 Inhibitor AZD5991, Mcl-1 Inhibitor MIK665, MDM2 Antagonist ASTX295, MDM2 Antagonist RO5045337, MDM2 Antagonist RO6839921, MDM2 Inhibitor AMG-232, MDM2 Inhibitor AMGMDS3, MDM2 Inhibitor BI 907828, MDM2 Inhibitor KRT-232, MDM2/MDMX Inhibitor ALRN-6924, MDR Modulator CBT-1, Mechlorethamine, Mechlorethamine Hydrochloride, Mechlorethamine Hydrochloride Gel, Medorubicin, Medroxyprogesterone, Medroxyprogesterone Acetate, Megestrol Acetate, MEK 1/2 Inhibitor AS703988/MSC2015103B, MEK 1/2 Inhibitor FCN-159, MEK Inhibitor AZD8330, MEK Inhibitor CI-1040, MEK inhibitor CS3006, MEK Inhibitor GDC-0623, MEK Inhibitor HL-085, MEK Inhibitor PD0325901, MEK Inhibitor RO4987655, MEK Inhibitor SHR 7390, MEK Inhibitor TAK-733, MEK Inhibitor WX-554, MEK-1/MEKK-1 Inhibitor E6201, MEK/Aurora Kinase Inhibitor BI 847325, Melanoma Monoclonal Antibody hIgG2A, Melanoma TRP2 CTL Epitope Vaccine SCIB1, Melapuldencel-T, MELK Inhibitor OTS167, Melphalan, Melphalan Flufenamide, Melphalan Hydrochloride, Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex, Membrane-Disrupting Peptide EP-100, Menatetrenone, Menin-MLL Interaction Inhibitor SNDX-5613, Menogaril, Merbarone, Mercaptopurine, Mercaptopurine Anhydrous, Mercaptopurine Oral Suspension, Merestinib, Mesna, Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536, MET Kinase Inhibitor OMO-1, MET Tyrosine Kinase Inhibitor BMS-777607, MET Tyrosine Kinase Inhibitor EMD 1204831, MET Tyrosine Kinase Inhibitor PF-04217903, MET Tyrosine Kinase Inhibitor SAR125844, MET Tyrosine Kinase Inhibitor SGX523, MET x MET Bispecific Antibody REGN5093, Metamelfalan, MetAP2 Inhibitor APL-1202, MetAP2 Inhibitor SDX-7320, Metarrestin, Metatinib Tromethamine, Metformin, Metformin Hydrochloride, Methanol Extraction Residue of BCG, Methazolamide, Methionine Aminopeptidase 2 Inhibitor M8891, Methionine Aminopeptidase 2 Inhibitor PPI-2458, Methotrexate, Methotrexate Sodium, Methotrexate-E Therapeutic Implant, Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles, Methoxsalen, Methoxyamine, Methoxyamine Hydrochloride, Methyl-5-Aminolevulinate Hydrochloride Cream, Methylcantharidimide, Methylmercaptopurine Riboside, Methylprednisolone, Methylprednisolone Acetate, Methylprednisolone Sodium Succinate, Methylselenocysteine, Methyltestosterone, Metoprine, Mevociclib, Mezagitamab, Mibefradil, Mibefradil Dihydrochloride, Micellar Nanoparticle-encapsulated Epirubicin, Micro Needle Array-Doxorubicin, Microbiome GEN-001, Microbiome-derived Peptide Vaccine EO2401, Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300, Microtubule Inhibitor SCB01A, Midostaurin, Mifamurtide, Mifepristone, Milademetan Tosylate, Milataxel, Milatuzumab, Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110, Milciclib Maleate, Milk Thistle, Miltefosine, Minretumomab, Mipsagargin, Miptenalimab, Mirabegron, Miransertib, Mirdametinib, Mirvetuximab Soravtansine, Mirzotamab Clezutoclax, Misonidazole, Mistletoe Extract, Mitazalimab, Mitindomide, Mitobronitol, Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101, Mitoclomine, Mitoflaxone, Mitoguazone, Mitoguazone Dihydrochloride, Mitolactol, Mitomycin, Mitomycin A, Mitomycin B, Mitomycin C Analog KW-2149, Mitosis Inhibitor T 1101 Tosylate, Mitotane, Mitotenamine, Mitoxantrone, Mitoxantrone Hydrochloride, Mitozolomide, Mivavotinib, Mivebresib, Mivobulin, Mivobulin Isethionate, Mixed Bacteria Vaccine, MK0731, MKC-1, MKNK1 Inhibitor BAY 1143269, MMP Inhibitor S-3304, MNK1/2 Inhibitor ETC-1907206, Mobocertinib, Mocetinostat, Modakafusp Alfa, Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208, Modified Vitamin D Binding Protein Macrophage Activator EF-022, Modotuximab, MOF Compound RiMO-301, Mofarotene, Mogamulizumab, Molibresib, Molibresib Besylate, Momelotinib, Monalizumab, Monocarboxylate Transporter 1 Inhibitor AZD3965, Monoclonal Antibody 105AD7 Anti-idiotype Vaccine, Monoclonal Antibody 11D10, Monoclonal Antibody 11D10 Anti-Idiotype Vaccine, Monoclonal Antibody 14G2A, Monoclonal Antibody 1F5, Monoclonal Antibody 3622W94, Monoclonal Antibody 3F8, Monoclonal Antibody 3H1 Anti-Idiotype Vaccine, Monoclonal Antibody 4B5 Anti-Idiotype Vaccine, Monoclonal Antibody 7C11, Monoclonal Antibody 81C6, Monoclonal Antibody A1G4 Anti-Idiotype Vaccine, Monoclonal Antibody A27.15, Monoclonal Antibody A33, Monoclonal Antibody AbGn-7, Monoclonal Antibody AK002, Monoclonal Antibody ASP1948, Monoclonal Antibody CAL, Monoclonal Antibody CC49-delta CH2, Monoclonal Antibody CEP-37250/KHK2804, Monoclonal Antibody D6.12, Monoclonal Antibody E2.3, Monoclonal Antibody F19, Monoclonal Antibody GD2 Anti-Idiotype Vaccine, Monoclonal Antibody HeFi-1, Monoclonal Antibody Hu3S193, Monoclonal Antibody HuAFP31, Monoclonal Antibody HuHMFG1, Monoclonal Antibody huJ591, Monoclonal Antibody HuPAM4, Monoclonal Antibody IMMU-14, Monoclonal Antibody L6, Monoclonal Antibody Lym-1, Monoclonal Antibody m170, Monoclonal Antibody Me1-14 F(ab')2, Monoclonal Antibody muJ591, Monoclonal Antibody MX35 F(ab')2, Monoclonal Antibody NEO-201, Monoclonal Antibody R24, Monoclonal Antibody RAV12, Monoclonal Antibody SGN-14, Monoclonal Antibody TRK-950, Monoclonal Microbial EDP1503, Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100, Monomethyl Auristatin E, Morinda Citrifolia Fruit Extract, Morpholinodoxorubicin, Mosedipimod, Mosunetuzumab, Motesanib, Motesanib Diphosphate, Motexafin Gadolinium, Motexafin Lutetium, Motixafortide, Motolimod, MOv-gamma Chimeric Receptor Gene, Moxetumomab Pasudotox, Mps1 Inhibitor BAY 1217389, Mps1 Inhibitor BOS172722, mRNA-based Personalized Cancer Vaccine mRNA-4157, mRNA-based Personalized Cancer Vaccine NCI-4650, mRNA-based TriMix Melanoma Vaccine ECI-006, mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902, mRNA-derived KRAS-targeted Vaccine V941, mRNA-derived Lung Cancer Vaccine BI 1361849, mRNA-Derived Prostate Cancer Vaccine CV9103, mRNA-derived Prostate Cancer Vaccine CV9104, MTF-1 Inhibitor APTO-253 HCl, mTOR Inhibitor GDC-0349, mTOR Kinase Inhibitor AZD8055, mTOR Kinase Inhibitor CC-223, mTOR Kinase Inhibitor OSI-027, mTOR Kinase Inhibitor PP242, mTOR1/2 Kinase Inhibitor ME-344, mTORC 1/2 Inhibitor LXI-15029, mTORC1/2 Kinase Inhibitor BI 860585, mTORC1/mTORC2/DHFR Inhibitor ABTL0812, MUC-1/WT1 Peptide-primed Autologous Dendritic Cells, MUC1-targeted Peptide GO-203-2C, Mucoadhesive Paclitaxel Formulation, Multi-AGC Kinase Inhibitor AT13148, Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200, Multi-epitope HER2 Peptide Vaccine H2NVAC, Multi-epitope HER2 Peptide Vaccine TPIV100, Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107, Multi-kinase Inhibitor TPX-0022, Multi-kinase Inhibitor XL092, Multi-mode Kinase Inhibitor EOC317, Multi-neo-epitope Vaccine OSE 2101, Multifunctional/Multitargeted Anticancer Agent OMN54, Multikinase Inhibitor 4SC-203, Multikinase Inhibitor AEE788, Multikinase Inhibitor AT9283, Multikinase Inhibitor SAR103168, Multipeptide Vaccine S-588210, Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327, Muparfostat, Mureletecan, Murizatoclax, Muscadine Grape Extract, Mutant IDH1 Inhibitor DS-1001, Mutant p53 Activator COTI-2, Mutant-selective EGFR Inhibitor PF-06459988, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, MVA-BN Smallpox Vaccine, MVA-FCU1 TG4023, MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1, MYC-targeting siRNA DCR-MYC, Mycobacterium tuberculosis Arabinomannan Z-100, Mycobacterium w, Mycophenolic Acid, N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea, N-dihydrogalactochitosan, N-Methylformamide, N;N-Dibenzyl Daunomycin, NA17-A Antigen, NA17.A2 Peptide Vaccine, Nab-paclitaxel, Nab-paclitaxel/Rituximab-coated Nanoparticle AR160, Nadofaragene Firadenovec, Nagrestipen, Namirotene, Namodenoson, NAMPT Inhibitor OT-82, Nanafrocin, Nanatinostat, Nanocell-encapsulated miR-16-based microRNA Mimic, Nanoparticle Albumin-Bound Docetaxel, Nanoparticle Albumin-Bound Rapamycin, Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404, Nanoparticle Paclitaxel Ointment SOR007, Nanoparticle-based Paclitaxel Suspension, Nanoparticle-encapsulated Doxorubicin Hydrochloride, Nanoscale Coordination Polymer Nanoparticles CPI-100, Nanosomal Docetaxel Lipid Suspension, Napabucasin, Naphthalimide Analogue UNBS5162, Naptumomab Estafenatox, Naquotinib, Naratuximab Emtansine, Narnatumab, Natalizumab, Natural IFN-alpha OPC-18, Natural Killer Cells ZRx101, Navarixin, Navicixizumab, Navitoclax, Navoximod, Navy Bean Powder, Naxitamab, Nazartinib, ncmtRNA Oligonucleotide Andes-1537, Necitumumab, Nedaplatin, NEDD8 Activating Enzyme E1 Inhibitor TAS4464, Nedisertib, Nelarabine, Nelipepimut-S, Nelipepimut-S Plus GM-CSF Vaccine, Nemorubicin, Nemorubicin Hydrochloride, Neoantigen Vaccine GEN-009, Neoantigen-based Glioblastoma Vaccine, Neoantigen-based Melanoma-Poly-ICLC Vaccine, Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine, Neoantigen-based Therapeutic Cancer Vaccine GRT-C903, Neoantigen-based Therapeutic Cancer Vaccine GRT-R904, Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017, Neratinib, Neratinib Maleate, Nesvacumab, NG-nitro-L-arginine, Niacinamide, Niclosamide, Nicotinamide Riboside, Nidanilimab, Nifurtimox, Nilotinib, Nilotinib Hydrochloride Anhydrous, Nilotinib Hydrochloride Monohydrate, Nilutamide, Nimesulide-Hyaluronic Acid Conjugate CA102N, Nimodipine, Nimotuzumab, Nimustine, Nimustine Hydrochloride, Ningetinib Tosylate, Nintedanib, Niraparib, Niraparib Tosylate Monohydrate, Nirogacestat, Nitric Oxide-Releasing Acetylsalicylic Acid Derivative, Nitrogen Mustard Prodrug PR-104, Nitroglycerin Transdermal Patch, Nivolumab, NLRP3 Agonist BMS-986299, Nocodazole, Nogalamycin, Nogapendekin Alfa, Nolatrexed Dihydrochloride, Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201, Norgestrel, North American Ginseng Extract AFX-2, Nortopixantrone, Noscapine, Noscapine Hydrochloride, Not Otherwise Specified, Notch Signaling Inhibitor PF-06650808, Notch Signaling Pathway Inhibitor MK0752, NTRK/ROS1 Inhibitor DS-6051b, Nucleolin Antagonist IPP-204106N, Nucleoside Analog DFP-10917, Nucleotide Analog Prodrug NUC-3373, Nucleotide Analogue GS 9219, Numidargistat, Nurulimab, Nutlin-3a, Nutraceutical TBL-12, NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611, NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301, NY-ESO-1/GLA-SE Vaccine ID-G305, NY-ESO-B, O-Chloroacetylcarbamoylfumagillol, O6-Benzylguanine, Obatoclax Mesylate, Obinutuzumab, Oblimersen Sodium, Ocaratuzumab, Ocrelizumab, Octreotide, Octreotide Acetate, Octreotide Pamoate, Odronextamab, Ofatumumab, Ofranergene Obadenovec, Oglufanide Disodium, Olaparib, Olaptesed Pegol, Olaratumab, Oleandrin, Oleclumab, Oligo-fucoidan, Oligonucleotide SPC2996, Olinvacimab, Olivomycin, Olmutinib, Oltipraz, Olutasidenib, Olvimulogene Nanivacirepvec, Omacetaxine Mepesuccinate, Ombrabulin, Omipalisib, Onalespib, Onalespib Lactate, Onartuzumab, Onatasertib, Oncolytic Adenovirus Ad5-DNX-2401, Oncolytic Adenovirus ORCA-010, Oncolytic Herpes Simplex Virus-1 ONCR-177, Oncolytic HSV-1 C134, Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011, Oncolytic HSV-1 G207, Oncolytic HSV-1 NV1020, Oncolytic HSV-1 rQNestin34.5v.2, Oncolytic HSV-1 rRp450, Oncolytic HSV1716, Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein, Oncolytic Newcastle Disease Virus MEDI5395, Oncolytic Newcastle Disease Virus MTH-68H, Oncolytic Newcastle Disease Virus Strain PV701, Oncolytic Virus ASP9801, Oncolytic Virus RP1, Ondansetron Hydrochloride, Ontorpacept, Ontuxizumab, Onvansertib, Onvatilimab, Opaganib, OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule, Opioid Growth Factor, Opolimogene Capmilisbac, Oportuzumab Monatox, Oprozomib, Opucolimab, Oral Aminolevulinic Acid Hydrochloride, Oral Azacitidine, Oral Cancer Vaccine V3-OVA, Oral Docetaxel, Oral Fludarabine Phosphate, Oral Hsp90 Inhibitor IPI-493, Oral Ixabepilone, Oral Microencapsulated Diindolylmethane, Oral Milataxel, Oral Myoma Vaccine V3-myoma, Oral Pancreatic Cancer Vaccine V3-P, Oral Picoplatin, Oral Sodium Phenylbutyrate, Oral Topotecan Hydrochloride, Orantinib, Oraxol, Oregovomab, Orelabrutinib, Ormaplatin, Ortataxel, Orteronel, Orvacabtagene Autoleucel, Osilodrostat, Osimertinib, Other, Otlertuzumab, Ovapuldencel-T, Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006, Ovine Submaxillary Mucin, OX40L-expressing Oncolytic Adenovirus DNX-2440, Oxaliplatin, Oxaliplatin Eluting Beads, Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome, Oxcarbazepine, Oxeclosporin, Oxidative Phosphorylation Inhibitor IACS-010759, Oxidative Phosphorylation Inhibitor IM156, Oxidopamine, OxPhos Inhibitor VLX600, Ozarelix, P-cadherin Antagonist PF-03732010, P-cadherin Inhibitor PCA062, P-cadherin-targeting Agent PF-06671008, P-p68 Inhibitor RX-5902, P-TEFb Inhibitor BAY1143572, p300/CBP Bromodomain Inhibitor CCS1477, p38 MAPK Inhibitor LY3007113, p53 Peptide Vaccine MPS-128, p53-HDM2 Interaction Inhibitor MI-773, p53-HDM2 Protein-protein Interaction Inhibitor APG-115, p53/HDM2 Interaction Inhibitor CGM097, p70S6K Inhibitor LY2584702, p70S6K/Akt Inhibitor MSC2363318A, p97 Inhibitor CB-5083, p97 Inhibitor CB-5339, p97 Inhibitor CB-5339 Tosylate, Paclitaxel, Paclitaxel Ceribate, Paclitaxel Injection Concentrate for Nanodispersion, Paclitaxel Liposome, Paclitaxel Poliglumex, Paclitaxel Polymeric Micelle Formulation NANT-008, Paclitaxel PPE Microspheres, Paclitaxel Trevatide, Paclitaxel Vitamin E-Based Emulsion, Paclitaxel-Loaded Polymeric Micelle, Pacmilimab, Pacritinib, Padeliporfin, Padoporfin, PAK4 Inhibitor PF-03758309, PAK4/NAMPT Inhibitor KPT-9274, Palbociclib, Palbociclib Isethionate, Palifosfamide, Palifosfamide Tromethamine, Palladium Pd-103, Palonosetron Hydrochloride, Pamidronate Disodium, Pamidronic Acid, Pamiparib, Pamrevlumab, pan FGFR Inhibitor PRN1371, Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514, Pan-AKT Inhibitor ARQ751, Pan-AKT Kinase Inhibitor GSK690693, Pan-FGFR Inhibitor LY2874455, Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806, pan-HER Kinase Inhibitor AC480, Pan-IDH Mutant Inhibitor AG-881, Pan-KRAS Inhibitor BI 1701963, Pan-Mutant-IDH1 Inhibitor Bay-1436032, Pan-mutation-selective EGFR Inhibitor CLN-081, pan-PI3K Inhibitor CLR457, pan-PI3K/mTOR Inhibitor SF1126, Pan-PIM Inhibitor INCB053914, pan-PIM Kinase Inhibitor AZD1208, pan-PIM Kinase Inhibitor NVP-LGB-321, pan-RAF Inhibitor LXH254, Pan-RAF Inhibitor LY3009120, pan-RAF Kinase Inhibitor CCT3833, pan-RAF Kinase Inhibitor TAK-580, Pan-RAR Agonist/AP-1 Inhibitor LGD 1550, Pan-TRK Inhibitor NOV1601, Pan-TRK Inhibitor ONO-7579, Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981, Pancratistatin, Panitumumab, Panobinostat, Panobinostat Nanoparticle Formulation MTX110, Panulisib, Paricalcitol, PARP 1/2 Inhibitor IMP4297, PARP 1/2 Inhibitor NOV1401, PARP Inhibitor AZD2461, PARP Inhibitor CEP-9722, PARP Inhibitor E7016, PARP Inhibitor NMS-03305293, PARP-1/2 Inhibitor ABT-767, PARP/Tankyrase Inhibitor 2X-121, PARP7 Inhibitor RBN-2397, Parsaclisib, Parsaclisib Hydrochloride, Parsatuzumab, Partially Engineered T-regulatory Cell Donor Graft TRGFT-201, Parvovirus H-1, Pasireotide, Pasotuxizumab, Patidegib, Patidegib Topical Gel, Patritumab, Patritumab Deruxtecan, Patupilone, Paxalisib, Pazopanib, Pazopanib Hydrochloride, pbi-shRNA STMN1 Lipoplex, PBN Derivative OKN-007, PCNU, PD-1 Directed Probody CX-188, PD-1 Inhibitor, PD-L1 Inhibitor GS-4224, PD-L1 Inhibitor INCB086550, PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480, PD-L1/PD-L2/VISTA Antagonist CA-170, PDK1 Inhibitor AR-12, pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0, PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1, PEG-interleukin-2, PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1, PEG-Proline-Interferon Alfa-2b, Pegargiminase, Pegaspargase, Pegdinetanib, Pegfilgrastim, Pegilodecakin, Peginterferon Alfa-2a, Peginterferon Alfa-2b, Pegvisomant, Pegvorhyaluronidase Alfa, Pegylated Deoxycytidine Analogue DFP-14927, Pegylated Interferon Alfa, Pegylated Liposomal Belotecan, Pegylated Liposomal Doxorubicin Hydrochloride, Pegylated Liposomal Irinotecan, Pegylated Liposomal Mitomycin C Lipid-based Prodrug, Pegylated Liposomal Mitoxantrone Hydrochloride, Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010, Pegylated Paclitaxel, Pegylated Recombinant Human Arginase I BCT-100, Pegylated Recombinant Human Hyaluronidase PH20, Pegylated Recombinant Interleukin-2 THOR-707, Pegylated Recombinant L-asparaginase Erwinia chrysanthemi, Pegylated SN-38 Conjugate PLX038, Pegzilarginase, Pelabresib, Pelareorep, Peldesine, Pelitinib, Pelitrexol, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Pemigatinib, Pemlimogene Merolisbac, Penberol, Penclomedine, Penicillamine, Pentamethylmelamine, Pentamustine, Pentostatin, Pentoxifylline, PEOX-based Polymer Encapsulated Paclitaxel FID-007, PEP-3-KLH Conjugate Vaccine, Pepinemab, Peplomycin, Peplomycin Sulfate, Peposertib, Peptichemio, Peptide 946 Melanoma Vaccine, Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine, Peretinoin, Perflenapent Emulsion, Perfosfamide, Perifosine, Perillyl Alcohol, Personalized ALL-specific Multi-HLA-binding Peptide Vaccine, Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC, Personalized Cancer Vaccine RO7198457, Personalized Neoantigen DNA Vaccine GNOS-PV01, Personalized Neoantigen DNA Vaccine GNOS-PVO2, Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01, Personalized Neoepitope Yeast Vaccine YE-NEO-001, Personalized Peptide Cancer Vaccine NEO-PV-01, Pertuzumab, Pevonedistat, Pexastimogene Devacirepvec, Pexidartinib, Pexmetinib, PGG Beta-Glucan, PGLA/PEG Copolymer-Based Paclitaxel, PH20 Hyaluronidase-expressing Adenovirus VCN-01, Phaleria macrocarpa Extract DLBS-1425, Pharmacological Ascorbate, Phellodendron amurense Bark Extract, Phenesterin, Phenethyl Isothiocyanate, Phenethyl Isothiocyanate-containing Watercress Juice, Phenyl Acetate, Phenytoin Sodium, Phosphaplatin PT-112, Phosphatidylcholine-Bound Silybin, Phospholipid Ether-drug Conjugate CLR 131, Phosphoramide Mustard, Phosphorodiamidate Morpholino Oligomer AVI-4126, Phosphorus P-32, Photodynamic Compound TLD-1433, Photosensitizer LUZ 11, Phytochlorin Sodium-Polyvinylpyrrolidone Complex, PI3K Alpha/Beta Inhibitor BAY1082439, PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate, PI3K Inhibitor ACP-319, PI3K Inhibitor BGT226, PI3K Inhibitor GDC-0084, PI3K Inhibitor GDC0077, PI3K Inhibitor GSK1059615, PI3K Inhibitor WX-037, PI3K Inhibitor ZSTK474, PI3K p110beta/delta Inhibitor KA2237, PI3K-alpha Inhibitor MEN1611, PI3K-beta Inhibitor GSK2636771, PI3K-beta Inhibitor SAR260301, PI3K-delta Inhibitor AMG 319, PI3K-delta Inhibitor HMPL 689, PI3K-delta Inhibitor INCB050465, PI3K-delta Inhibitor PWT143, PI3K-delta Inhibitor SHC014748M, PI3K-delta Inhibitor YY-20394, PI3K-gamma Inhibitor IPI-549, PI3K/BET Inhibitor LY294002, PI3K/mTOR Kinase Inhibitor DS-7423, PI3K/mTOR Kinase Inhibitor PF-04691502, PI3K/mTOR Kinase Inhibitor VS-5584, PI3K/mTOR Kinase Inhibitor WXFL10030390, PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170, PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901, PI3Ka/mTOR Inhibitor PKI-179, PI3Kalpha Inhibitor AZD8835, PI3Kbeta Inhibitor AZD8186, PI3Kdelta Inhibitor GS-9901, Pibenzimol, Pibrozelesin, Pibrozelesin Hydrobromide, Picibanil, Picoplatin, Picrasinoside H, Picropodophyllin, Pictilisib, Pictilisib Bismesylate, Pidilizumab, Pilaralisib, PIM Kinase Inhibitor LGH447, PIM Kinase Inhibitor SGI-1776, PIM Kinase Inhibitor TP-3654, PIM/FLT3 Kinase Inhibitor SEL24, Pimasertib, Pimitespib, Pimurutamab, Pinatuzumab Vedotin, Pingyangmycin, Pinometostat, Pioglitazone, Pioglitazone Hydrochloride, Pipendoxifene, Piperazinedione, Piperine Extract (Standardized), Pipobroman, Piposulfan, Pirarubicin, Pirarubicin Hydrochloride, Pirfenidone, Piritrexim, Piritrexim Isethionate, Pirotinib, Piroxantrone, Piroxantrone Hydrochloride, Pixantrone, Pixantrone Dimaleate, Pixatimod, PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231, PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521, PKC-beta Inhibitor MS-553, Placebo, Pladienolide Derivative E7107, Plamotamab, Plasmid DNA Vaccine pING-hHER3FL, Platinum, Platinum Acetylacetonate-Titanium Dioxide Nanoparticles, Platinum Compound, Plevitrexed, Plicamycin, Plinabulin, Plitidepsin, Plk1 Inhibitor BI 2536, PLK1 Inhibitor CYC140, PLK1 Inhibitor TAK-960, Plocabulin, Plozalizumab, pNGVL4a-CRT-E6E7L2 DNA Vaccine, pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2, Pol I Inhibitor CX5461, Polatuzumab Vedotin, Polidocanol, Poliglusam, Polo-like Kinase 1 Inhibitor GSK461364, Polo-like Kinase 1 Inhibitor MK1496, Polo-like Kinase 1 Inhibitor NMS-1286937, Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate, Poly-alendronate Dextran-Guanidine Conjugate, Poly-gamma Glutamic Acid, Polyamine Analog SL11093, Polyamine Analogue PG11047, Polyamine Analogue SBP-101, Polyamine Transport Inhibitor AMXT-1501 Dicaprate, Polyandrol, Polyethylene Glycol Recombinant Endostatin, Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318, Polymer-conjugated IL-15 Receptor Agonist NKTR-255, Polymer-encapsulated Luteolin Nanoparticle, Polymeric Camptothecin Prodrug XMT-1001, Polypodium leucotomos Extract, Polysaccharide-K, Polysialic Acid, Polyunsaturated Fatty Acid, Polyvalent Melanoma Vaccine, Pomalidomide, Pomegranate Juice, Pomegranate Liquid Extract, Ponatinib, Ponatinib Hydrochloride, Porcupine Inhibitor CGX1321, Porcupine Inhibitor ETC-1922159, Porcupine Inhibitor RXC004, Porcupine Inhibitor WNT974, Porcupine Inhibitor XNW7201, Porfimer Sodium, Porfiromycin, Poziotinib, PPAR Alpha Antagonist TPST-1120, PR1 Leukemia Peptide Vaccine, Pracinostat, Pralatrexate, Pralsetinib, Praluzatamab Ravtansine, PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701, Pravastatin Sodium, Prednimustine, Prednisolone, Prednisolone Acetate, Prednisolone Sodium Phosphate, Prednisone, Prexasertib, Prexigebersen, PRIMA-1 Analog APR-246, Prime Cancer Vaccine MVA-BN-CV301, Prinomastat, PRMT1 Inhibitor GSK3368715, PRMT5 Inhibitor JNJ-64619178, PRMT5 Inhibitor PRT811, Proapoptotic Sulindac Analog CP-461, Procarbazine, Procarbazine Hydrochloride, Procaspase Activating Compound-1 VO-100, Progestational IUD, Prohibitin-Targeting Peptide 1, Prolgolimab, Prostaglandin E2 EP4 Receptor Inhibitor AN0025, Prostaglandin E2 EP4 Receptor Inhibitor E7046, Prostate Cancer Vaccine ONY-P1, Prostate Health Cocktail Dietary Supplement, Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024, Protease-activated Anti-PD-L1 Antibody Prodrug CX-072, Protein Arginine Methyltransferase 5 Inhibitor GSK3326595, Protein Arginine Methyltransferase 5 Inhibitor PF-06939999, Protein Arginine Methyltransferase 5 Inhibitor PRT543, Protein Kinase C Inhibitor IDE196, Protein Phosphatase 2A Inhibitor LB-100, Protein Stabilized Liposomal Docetaxel Nanoparticles, Protein Tyrosine Kinase 2 Inhibitor IN10018, Proxalutamide, PSA/IL-2/GM-CSF Vaccine, PSA/PSMA DNA Plasmid INO-5150, Pseudoisocytidine, PSMA-targeted Docetaxel Nanoparticles BIND-014, PSMA-targeted Tubulysin B-containing Conjugate EC1169, PSMA/CD3 Tri-specific T-cell Activating Construct HPN424, PTEF-b/CDK9 Inhibitor BAY1251152, Pterostilbene, Pumitepa, Puquitinib, Puquitinib Mesylate, Puromycin, Puromycin Hydrochloride, PV-10, PVA Microporous Hydrospheres/Doxorubicin Hydrochloride, Pyrazinamide, Pyrazoloacridine, Pyridyl Cyanoguanidine CHS 828, Pyrotinib, Pyrotinib Dimaleate, Pyroxamide, Pyruvate Kinase Inhibitor TLN-232, Pyruvate Kinase M2 Isoform Activator TP-1454, Qilisheng Immunoregulatory Oral Solution, Quadrivalent Human Papillomavirus (types 6; 11; 16; 18) Recombinant Vaccine, Quarfloxin, Quinacrine Hydrochloride, Quinine, Quisinostat, Quizartinib, R-(-)-Gossypol Acetic Acid, Rabusertib, Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88, Racotumomab, RAD51 Inhibitor CYT-0851, Radgocitabine, Radgocitabine Hydrochloride, Radioactive Iodine, Radiolabeled CC49, Radium Ra 223 Dichloride, Radium Ra 224-labeled Calcium Carbonate Microparticles, Radix Angelicae Sinensis/Radix Astragali Herbal Supplement, Radotinib Hydrochloride, Raf Kinase Inhibitor HM95573, RAF Kinase Inhibitor L-779450, RAF Kinase Inhibitor XL281, Ragifilimab, Ralaniten Acetate, Ralimetinib Mesylate, Raloxifene, Raloxifene Hydrochloride, Raltitrexed, Ramucirumab, Ranibizumab, Ranimustine, Ranolazine, Ranpirnase, RARalpha Agonist IRX5183, Ras Inhibitor, Ras Peptide ASP, Ras Peptide CYS, Ras Peptide VAL, Razoxane, Realgar-Indigo naturalis Formulation, Rebastinib Tosylate, Rebeccamycin, Rebimastat, Receptor Tyrosine Kinase Inhibitor R1530, Recombinant Adenovirus-p53 SCH-58500, Recombinant Anti-WT1 Immunotherapeutic GSK2302024A, Recombinant Bacterial Minicells VAX014, Recombinant Bispecific Single-Chain Antibody rM28, Recombinant CD40-Ligand, Recombinant Erwinia asparaginase JZP-458, Recombinant Erythropoietin, Recombinant Fas Ligand, Recombinant Fractalkine, Recombinant Granulocyte-Macrophage Colony-Stimulating Factor, Recombinant Human 6Ckine, Recombinant Human Adenovirus Type 5 H101, Recombinant Human Angiotensin Converting Enzyme 2 APN01, Recombinant Human Apolipoprotein(a) Kringle V MG1102, Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine, Recombinant Human Endostatin, Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine, Recombinant Human Papillomavirus 11-valent Vaccine, Recombinant Human Papillomavirus Bivalent Vaccine, Recombinant Human Papillomavirus Nonavalent Vaccine, Recombinant Human Plasminogen Kringle 5 Domain ABT 828, Recombinant Human TRAIL-Trimer Fusion Protein SCB-313, Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301, Recombinant Interferon, Recombinant Interferon Alfa, Recombinant Interferon Alfa-1b, Recombinant Interferon Alfa-2a, Recombinant Interferon Alfa-2b, Recombinant Interferon Alpha 2b-like Protein, Recombinant Interferon Beta, Recombinant Interferon Gamma, Recombinant Interleukin-12, Recombinant Interleukin-13, Recombinant Interleukin-18, Recombinant Interleukin-2, Recombinant Interleukin-6, Recombinant KSA Glycoprotein CO17-1A, Recombinant Leukocyte Interleukin, Recombinant Leukoregulin, Recombinant Luteinizing Hormone, Recombinant Macrophage Colony-Stimulating Factor, Recombinant MAGE-3.1 Antigen, Recombinant MIP1-alpha Variant ECI301, Recombinant Modified Vaccinia Ankara-5T4 Vaccine, Recombinant Oncolytic Poliovirus PVS-RIPO, Recombinant Platelet Factor 4, Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A, Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207, Recombinant Super-compound Interferon, Recombinant Thyroglobulin, Recombinant Thyrotropin Alfa, Recombinant Transforming Growth Factor-Beta, Recombinant Transforming Growth Factor-Beta-2, Recombinant Tumor Necrosis Factor-Alpha, Recombinant Tyrosinase-Related Protein-2, Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter, Redaporfin, Refametinib, Regorafenib, Relacorilant, Relatlimab, Relugolix, Remetinostat, Renal Cell Carcinoma Peptides Vaccine IMA901, Reparixin, Repotrectinib, Resiquimod, Resiquimod Topical Gel, Resistant Starch, Resminostat, Resveratrol, Resveratrol Formulation SRT501, RET Inhibitor DS-5010, RET Mutation/Fusion Inhibitor BLU-667, RET/SRC Inhibitor TPX-0046, Retaspimycin, Retaspimycin Hydrochloride, Retelliptine, Retifanlimab, Retinoic Acid Agent Ro 16-9100, Retinoid 9cUAB30, Retinol, Retinyl Acetate, Retinyl Palmitate, Retrovector Encoding Mutant Anti-Cyclin G1, Revdofilimab, Rexinoid NRX 194204, Rezivertinib, RFT5-dgA Immunotoxin IMTOX25, Rhenium Re 188 BMEDA-labeled Liposomes, Rhenium Re-186 Hydroxyethylidene Diphosphonate, Rhenium Re-188 Ethiodized Oil, Rhenium Re-188 Etidronate, Rhizoxin, RhoC Peptide Vaccine RV001V, Ribociclib, Ribociclib/Letrozole, Ribonuclease QBI-139, Ribosome-Inactivating Protein CY503, Ribozyme RPI.4610, Rice Bran, Ricolinostat, Ridaforolimus, Rigosertib, Rigosertib Sodium, Rilimogene Galvacirepvec, Rilimogene Galvacirepvec/Rilimogene Glafolivec, Rilimogene Glafolivec, Rilotumumab, Rindopepimut, Ripertamab, RIPK1 Inhibitor GSK3145095, Ripretinib, Risperidone Formulation in Rumenic Acid, Ritrosulfan, Rituximab, Rituximab and Hyaluronidase Human, Rituximab Conjugate CON-4619, Riviciclib, Rivoceranib, Rivoceranib Mesylate, RNR Inhibitor COH29, Robatumumab, Roblitinib, ROBO1-targeted BiCAR-NKT Cells, Rocakinogene Sifuplasmid, Rocapuldencel-T, Rociletinib, Rodorubicin, Roducitabine, Rofecoxib, Roflumilast, Rogaratinib, Rogletimide, Rolinsatamab Talirine, Romidepsin, Roneparstat, Roniciclib, Ropeginterferon Alfa-2B, Ropidoxuridine, Ropocamptide, Roquinimex, RORgamma Agonist LYC-55716, Rosabulin, Rose Bengal Solution PV-10, Rosiglitazone Maleate, Rosmantuzumab, Rosopatamab, Rosuvastatin, Rovalpituzumab Tesirine, RSK1-4 Inhibitor PMD-026, Rubitecan, Rucaparib, Rucaparib Camsylate, Rucaparib Phosphate, Ruthenium Ru-106, Ruthenium-based Small Molecule Therapeutic BOLD-100, Ruthenium-based Transferrin Targeting Agent NKP-1339, Ruxolitinib, Ruxolitinib Phosphate, Ruxotemitide, S-Adenosylmethionine, S-equol, S1P Receptor Agonist KRP203, Sabarubicin, Sabatolimab, Sacituzumab Govitecan, Sacubitril/Valsartan, Safingol, Sagopilone, Salirasib, Salmonella VNP20009, Sam68 Modulator CWP232291, Samalizumab, Samarium Sm 153-DOTMP, Samotolisib, Samrotamab Vedotin, Samuraciclib, Sapacitabine, Sapanisertib, Sapitinib, Saracatinib, Saracatinib Difumarate, SarCNU, Sardomozide, Sargramostim, Sasanlimab, Satraplatin, Savolitinib, SBIL-2, Scopoletin, SDF-1 Receptor Antagonist PTX-9908, Seclidemstat, Sedoxantrone Trihydrochloride, Selatinib Ditosilate, Selective Androgen Receptor Modulator RAD140, Selective Cytokine Inhibitory Drug CC-1088, Selective Estrogen Receptor Degrader AZD9496, Selective Estrogen Receptor Degrader AZD9833, Selective Estrogen Receptor Degrader LSZ102, Selective Estrogen Receptor Degrader LX-039, Selective Estrogen Receptor Degrader LY3484356, Selective Estrogen Receptor Degrader SRN-927, Selective Estrogen Receptor Modulator CC-8490, Selective Estrogen Receptor Modulator TAS-108, Selective Glucocorticoid Receptor Antagonist CORT125281, Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352, Seliciclib, Selicrelumab, Selinexor, Selitrectinib, Selonsertib, Selpercatinib, Selumetinib, Selumetinib Sulfate, Semaxanib, Semuloparin, Semustine, Seneca Valley Virus-001, Seocalcitol, Sepantronium Bromide, Serabelisib, Serclutamab Talirine, SERD D-0502, SERD G1T48, SERD GDC-9545, SERD SAR439859, SERD SHR9549, SERD ZN-c5, Serdemetan, Sergiolide, Seribantumab, Serine/Threonine Kinase Inhibitor CBP501, Serine/Threonine Kinase Inhibitor XL418, Serplulimab, Sevacizumab, Seviteronel, Shared Anti-Idiotype-AB-S006, Shared Anti-Idiotype-AB-S024A, Shark Cartilage, Shark Cartilage Extract AE-941, Shenqi Fuzheng Injection SQ001, Sho-Saiko-To, Short Chain Fatty Acid HQK-1004, SHP-1 Agonist SC-43, SHP2 Inhibitor JAB-3068, SHP2 Inhibitor RLY-1971, SHP2 Inhibitor RMC-4630, SHP2 Inhibitor TNO155, Shu Yu Wan Formula, Sialyl Tn Antigen, Sialyl Tn-KLH Vaccine, Sibrotuzumab, siG12D LODER, Silatecan AR-67, Silibinin, Silicon Phthalocyanine 4, Silmitasertib Sodium, Siltuximab, Simalikalactone D, Simeprevir, Simlukafusp Alfa, Simmitinib, Simotaxel, Simtuzumab, Simurosertib, Sintilimab, Siplizumab, Sipuleucel-T, Siremadlin, siRNA-transfected Peripheral Blood Mononuclear Cells APN401, Sirolimus, SIRPa-4-1BBL Fusion Protein DSP107, SIRPa-Fc Fusion Protein TTI-621, SIRPa-Fc-CD40L Fusion Protein SL-172154, SIRPa-IgG4-Fc Fusion Protein TTI-622, Sitimagene Ceradenovec, Sitravatinib, Sivifene, Sizofiran, SLC6A8 Inhibitor RGX-202, SLCT Inhibitor GNS561, SMAC Mimetic BI 891065, Smac Mimetic GDC-0152, Smac Mimetic GDC-0917, Smac Mimetic LCL161, SMO Protein Inhibitor ZSP1602, Smoothened Antagonist BMS-833923, Smoothened Antagonist LDE225 Topical, Smoothened Antagonist LEQ506, Smoothened Antagonist TAK-441, SN-38-Loaded Polymeric Micelles NK012, SNS01-T Nanoparticles, Sobuzoxane, Sodium Borocaptate, Sodium Butyrate, Sodium Dichloroacetate, Sodium Iodide I-131, Sodium Metaarsenite, Sodium Phenylbutyrate, Sodium Salicylate, Sodium Selenite, Sodium Stibogluconate, Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108, Sofituzumab Vedotin, Solitomab, Sonepcizumab, Sonidegib, Sonolisib, Sorafenib, Sorafenib Tosylate, Sorghum bicolor Supplement, Sotigalimab, Sotorasib, Sotrastaurin, Sotrastaurin Acetate, Soy Isoflavones, Soy Protein Isolate, Spanlecortemlocel, Sparfosate Sodium, Sparfosic Acid, Spartalizumab, Spebrutinib, Spherical Nucleic Acid Nanoparticle NU-0129, Spirogermanium, Spiromustine, Spiroplatin, Splicing Inhibitor H3B-8800, Spongistatin, Squalamine Lactate, SR-BP1/HSI Inhibitor SR31747A, SR-T100 Gel, Src Kinase Inhibitor AP 23846, Src Kinase Inhibitor KX2-391, Src Kinase Inhibitor KX2-391 Ointment, Src Kinase Inhibitor M475271, Src/Abl Kinase Inhibitor AZD0424, Src/tubulin Inhibitor KX02, SRPK1/ABCG2 Inhibitor SCO-101, ssRNA-based Immunomodulator CV8102, SSTR2-targeting Protein/DM1 Conjugate PEN-221, St. John's Wort, Stallimycin, Staphylococcal Enterotoxin A, Staphylococcal Enterotoxin B, STAT Inhibitor OPB-111077, STAT3 Inhibitor DSP-0337, STAT3 Inhibitor OPB-31121, STAT3 Inhibitor OPB-51602, STAT3 Inhibitor TTI-101, STAT3 Inhibitor WP1066, Staurosporine, STING Agonist BMS-986301, STING Agonist GSK3745417, STING Agonist IMSA101, STING Agonist MK-1454, STING Agonist SB 11285, STING Agonist TAK-676, STING-activating Cyclic Dinucleotide Agonist MIW815, STING-expressing E. coli SYNB1891, Streptonigrin, Streptozocin, Strontium Chloride Sr-89, Submicron Particle Paclitaxel Sterile Suspension, Sugemalimab, Sulfatinib, Sulforaphane, Sulindac, Sulofenur, Sumoylation Inhibitor TAK-981, Sunitinib, Sunitinib Malate, Super Enhancer Inhibitor GZ17-6.02, Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803, Superoxide Dismutase Mimetic GC4711, Suramin, Suramin Sodium, Survivin Antigen, Survivin Antigen Vaccine DPX-Survivac, Survivin mRNA Antagonist EZN-3042, Survivin-expressing CVD908ssb-TXSVN Vaccine, Sustained-release Lipid Inhaled Cisplatin, Sustained-release Mitomycin C Hydrogel Formulation UGN-101, Sustained-release Mitomycin C Hydrogel Formulation UGN-102, Syk Inhibitor HMPL-523, Synchrotope TA2M Plasmid DNA Vaccine, Synchrovax SEM Plasmid DNA Vaccine, Synthetic Alkaloid PM00104, Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2, Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1, Synthetic hTERT DNA Vaccine INO-1400, Synthetic hTERT DNA Vaccine INO-1401, Synthetic Hypericin, Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201, Synthetic Long E6/E7 Peptides Vaccine HPV-01, Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b, Synthetic Plumbagin PCUR-101, T900607, Tabalumab, Tabelecleucel, Tacedinaline, Tafasitamab, Tagraxofusp-erzs, Talabostat, Talabostat Mesylate, Talacotuzumab, Talactoferrin Alfa, Taladegib, Talampanel, Talaporfin Sodium, Talazoparib, Taletrectinib, Talimogene Laherparepvec, Tallimustine, Talmapimod, Talotrexin, Talotrexin Ammonium, Taltobulin, TAM/c-Met Inhibitor RXDX-106, Tamibarotene, Taminadenant, Tamoxifen, Tamoxifen Citrate, Tamrintamab Pamozirine, Tandutinib, Tanespimycin, Tanibirumab, Tankyrase Inhibitor STP1002, Tanomastat, Tapotoclax, Tarenflurbil, Tarextumab, Tariquidar, Tasadenoturev, Taselisib, Tasidotin, Tasisulam, Tasisulam Sodium, Tasquinimod, Taurolidine, Tauromustine, Taurultam, Taurultam Analogue GP-2250, Tavokinogene Telseplasmid, Tavolimab, Taxane Analogue TPI 287, Taxane Compound, Taxol Analogue SID 530, Tazarotene, Tazemetostat, Tebentafusp, Teclistamab, Tecogalan Sodium, Tefinostat, Tegafur, Tegafur-gimeracil-oteracil Potassium, Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation, Tegafur-Uracil, Tegavivint, Teglarinad, Teglarinad Chloride, Telaglenastat, Telaglenastat Hydrochloride, Telapristone, Telapristone Acetate, Telatinib Mesylate, Telisotuzumab, Telisotuzumab Vedotin, Telomerase Inhibitor FJ5002, Telomerase-specific Type 5 Adenovirus OBP-301, Teloxantrone, Teloxantrone Hydrochloride, Telratolimod, Temarotene, Temoporfin, Temozolomide, Temsirolimus, Tenalisib, Tenifatecan, Teniposide, Tepoditamab, Tepotinib, Teprotumumab, Terameprocol, Terfluranol, Tergenpumatucel-L, Teroxirone, Tertomotide, Tesetaxel, Tesevatinib, Tesidolumab, Testolactone, Testosterone Enanthate, Tetanus Toxoid Vaccine, Tetradecanoylphorbol Acetate, Tetrahydrouridine, Tetraphenyl Chlorin Disulfonate, Tetrathiomolybdate, Tezacitabine, Tezacitabine Anhydrous, TGF-beta Receptor 1 Inhibitor PF-06952229, TGF-beta Receptor 1 Kinase Inhibitor SH3051, TGF-beta Receptor 1 Kinase Inhibitor YL-13027, TGFa-PE38 Immunotoxin, TGFbeta Inhibitor LY3200882, TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200, Thalicarpine, Thalidomide, Theliatinib, Theramide, Therapeutic Angiotensin-(1-7), Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907, Therapeutic Cancer Vaccine ATP128, Therapeutic Estradiol, Therapeutic Hydrocortisone, Therapeutic Liver Cancer Peptide Vaccine IMA970A, Thiarabine, Thiodiglycol, Thioguanine, Thioguanine Anhydrous, Thioinosine, Thioredoxin-1 Inhibitor PX-12, Thiotepa, Thioureidobutyronitrile, THL-P, Thorium Th 227 Anetumab, Thorium Th 227 Anetumab Corixetan, Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439, Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497, Threonine Tyrosine Kinase Inhibitor CFI-402257, Thymidylate Synthase Inhibitor CX1106, Thymidylate Synthase Inhibitor DFP-11207, Thymopentin, Thyroid Extract, Tiazofurin, Tidutamab, Tigapotide, Tigatuzumab, TIGIT Inhibitor M6223, TIGIT-targeting Agent MK-7684, Tilarginine, Tilogotamab, Tilsotolimod Sodium, Timonacic, Tin Ethyl Etiopurpurin, Tinostamustine, Tinzaparin Sodium, Tiomolibdate Choline, Tiomolibdate Diammonium, Tipapkinogene Sovacivec, Tipifarnib, Tipiracil, Tipiracil Hydrochloride, Tirabrutinib, Tiragolumab, Tirapazamine, Tirbanibulin, Tisagenlecleucel, Tislelizumab, Tisotumab Vedotin, Tivantinib, Tivozanib, TLC ELL-12, TLR Agonist BDB001, TLR Agonist BSG-001, TLR Agonist CADI-05, TLR-Directed Cationic Lipid-DNA Complex JVRS-100, TLR7 Agonist 852A, TLR7 agonist BNT411, TLR7 Agonist LHC165, TLR7/8/9 Antagonist IMO-8400, TLR8 Agonist DN1508052, TLR9 Agonist AST-008, TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells, Tocilizumab, Tocladesine, Tocotrienol, Tocotrienol-rich Fraction, Tolebrutinib, Toll-like Receptor 7 Agonist DSP-0509, Tolnidamine, Tomaralimab, Tomato-Soy Juice, Tomivosertib, Topical Betulinic Acid, Topical Celecoxib, Topical Fluorouracil, Topical Gemcitabine Hydrochloride, Topical Potassium Dobesilate, Topical Trichloroacetic Acid, Topixantrone, Topoisomerase I Inhibitor Genz-644282, Topoisomerase I Inhibitor LMP400, Topoisomerase I Inhibitor LMP776, Topoisomerase I/II Inhibitor NEV-801, Topoisomerase-1 Inhibitor LMP744, Topoisomerase-II Inhibitor Racemic XK469, Topoisomerase-II-beta Inhibitor Racemic XK469, Topotecan, Topotecan Hydrochloride, Topotecan Hydrochloride Liposomes, Topotecan Sustained-release Episcleral Plaque, Topsalysin, TORC1/2 Kinase Inhibitor DS-3078a, Toremifene, Toremifene Citrate, Toripalimab, Tosedostat, Tositumomab, Total Androgen Blockade, Tovetumab, Tozasertib Lactate, TP40 Immunotoxin, Trabectedin, Trabedersen, TRAIL Receptor Agonist ABBV-621, Trametinib, Trametinib Dimethyl Sulfoxide, Trans Sodium Crocetinate, Transdermal 17beta-Estradiol Gel BHR-200, Transdermal 4-Hydroxytestosterone, Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01, Transferrin Receptor-Targeted Liposomal p53 cDNA, Transferrin-CRM107, Tranylcypromine Sulfate, Trapoxin, Trastuzumab, Trastuzumab Conjugate BI-CON-02, Trastuzumab Deruxtecan, Trastuzumab Duocarmazine, Trastuzumab Emtansine, Trastuzumab Monomethyl Auristatin F, Trastuzumab-TLR 7/8 Agonist BDC-1001, Trastuzumab/Hyaluronidase-oysk, Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502, Trebananib, Tremelimumab, Treosulfan, Tretazicar, Tretinoin, Tretinoin Liposome, Triamcinolone Acetonide, Triamcinolone Hexacetonide, Triapine, Triazene Derivative CB10-277, Triazene Derivative TriN2755, Triazinate, Triaziquone, Tributyrin, Triciribine Phosphate, Trientine Hydrochloride, Triethylenemelamine, Trifluridine, Trifluridine and Tipiracil Hydrochloride, Trigriluzole, Trilaciclib, Trimelamol, Trimeric GITRL-Fc OMP-336B11, Trimethylcolchicinic Acid, Trimetrexate, Trimetrexate Glucuronate, Trioxifene, Triplatin Tetranitrate, Triptolide Analog, Triptorelin, Triptorelin Pamoate, Tris-acryl Gelatin Microspheres, Tritylcysteine, TRK Inhibitor AZD6918, TRK Inhibitor TQB3558, TrkA Inhibitor VMD-928, Trodusquemine, Trofosfamide, Troglitazone, Tropomyosin Receptor Kinase Inhibitor AZD7451, Troriluzole, Troxacitabine, Troxacitabine Nucleotide Prodrug MIV-818, TRPM8 Agonist D-3263, TRPV6 Calcium Channel Inhibitor SOR-C13, TSP-1 Mimetic ABT-510, TSP-1 Mimetic Fusion Protein CVX-045, Tubercidin, Tubulin Binding Agent TTI-237, Tubulin Inhibitor ALB 109564 Dihydrochloride, Tubulin Inhibitor ALB-109564, Tubulin Polymerization Inhibitor AEZS 112, Tubulin Polymerization Inhibitor CKD-516, Tubulin Polymerization Inhibitor VERU-111, Tubulin-Binding Agent SSR97225, Tucatinib, Tucidinostat, Tucotuzumab Celmoleukin, Tyroserleutide, Tyrosinase Peptide, Tyrosinase-KLH, Tyrosinase:146-156 Peptide, Tyrosine Kinase Inhibitor, Tyrosine Kinase Inhibitor OSI-930, Tyrosine Kinase Inhibitor SU5402, Tyrosine Kinase Inhibitor TL-895, Tyrosine Kinase Inhibitor XL228, UAE Inhibitor TAK-243, Ubenimex, Ubidecarenone Nanodispersion BPM31510n, Ublituximab, Ulinastatin, Ulixertinib, Ulocuplumab, Umbralisib, Uncaria tomentosa Extract, Upamostat, Upifitamab, Uproleselan, Uprosertib, Urabrelimab, Uracil Ointment, Urelumab, Uroacitides, Urokinase-Derived Peptide A6, Ursolic Acid, USP14/UCHL5 Inhibitor VLX1570, Utomilumab, Uzansertib, V930 Vaccine, Vaccine-Sensitized Draining Lymph Node Cells, Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules, Vactosertib, Vadacabtagene Leraleucel, Vadastuximab Talirine, Vadimezan, Valecobulin, Valemetostat, Valproic Acid, Valrubicin, Valspodar, Vandetanib, Vandetanib-eluting Radiopaque Bead BTG-002814, Vandortuzumab Vedotin, Vantictumab, Vanucizumab, Vapreotide, Varlilumab, Varlitinib, Varlitinib Tosylate, Vascular Disrupting Agent BNC105, Vascular Disrupting Agent BNC105P, Vascular Disrupting Agent ZD6126, Vatalanib, Vatalanib Succinate, Vecabrutinib, Vector-peptide Conjugated Paclitaxel, Vedolizumab, VEGF Inhibitor PTC299, VEGF/HGF-targeting DARPin MP0250, VEGFR Inhibitor KRN951, VEGFR-2 DNA Vaccine VXM01, VEGFR/FGFR Inhibitor ODM-203, VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593, VEGFR2 Tyrosine Kinase Inhibitor PF-00337210, VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813, Veliparib, Veltuzumab, Vemurafenib, Venetoclax, Verapamil, Verpasep Caltespen, Verubulin, Verubulin Hydrochloride, Vesencumab, Vesigenurtucel-L, VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220, VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820, Viagenpumatucel-L, Vibecotamab, Vibostolimab, Vilaprisan, Vinblastine, Vinblastine Sulfate, Vincristine, Vincristine Liposomal, Vincristine Sulfate, Vincristine Sulfate Liposome, Vindesine, Vinepidine, Vinflunine, Vinflunine Ditartrate, Vinfosiltine, Vinorelbine, Vinorelbine Tartrate, Vinorelbine Tartrate Emulsion, Vinorelbine Tartrate Oral, Vintafolide, Vinzolidine, Vinzolidine Sulfate, Virulizin, Vismodegib, Vistusertib, Vitamin D3 Analogue ILX23-7553, Vitamin E Compound, Vitespen, VLP-encapsulated TLR9 Agonist CMP-001, Vocimagene Amiretrorepvec, Vofatamab, Volasertib, Volociximab, Vonlerolizumab, Vopratelimab, Vorasidenib, Vorinostat, Vorolanib, Vorsetzumab Mafodotin, Vosaroxin, Vosilasarm, Voxtalisib, Vulinacimab, Warfarin Sodium, Wee1 Inhibitor ZN-c3, Wee1 Kinase Inhibitor Debio 0123, White Carrot, Wnt Signaling Inhibitor SM04755, Wnt Signaling Pathway Inhibitor SM08502, Wnt-5a Mimic Hexapeptide Foxy-5, Wobe-Mugos E, WT1 Peptide Vaccine OCV-501, WT1 Peptide Vaccine WT2725, WT1 Protein-derived Peptide Vaccine DSP-7888, WT1-A10/AS01B Immunotherapeutic GSK2130579A, WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401, Xanthohumol, XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410, Xeloda, Xentuzumab, Xevinapant, Xiaoai Jiedu Decoction, XIAP Antisense Oligonucleotide AEG35156, XIAP/cIAP1 Antagonist ASTX660, Xiliertinib, Xisomab 3G3, XPO1 Inhibitor SL-801, Y 90 Monoclonal Antibody CC49, Y 90 Monoclonal Antibody HMFG1, Y 90 Monoclonal Antibody Lym-1, Y 90 Monoclonal Antibody m170, Y 90 Monoclonal Antibody M195, Yang Yin Fu Zheng, Yangzheng Xiaoji Extract, Yiqi-yangyin-jiedu Herbal Decoction, Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12, Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12, Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8, Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101, Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66, Yttrium Y 90 Basiliximab, Yttrium Y 90 Colloid, Yttrium Y 90 Daclizumab, Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A, Yttrium Y 90 Glass Microspheres, Yttrium Y 90 Monoclonal Antibody B3, Yttrium Y 90 Monoclonal Antibody BrE-3, Yttrium Y 90 Monoclonal Antibody Hu3S193, Yttrium Y 90 Monoclonal Antibody MN-14, Yttrium Y 90 Resin Microspheres, Yttrium Y 90 Tabituximab Barzuxetan, Yttrium Y 90-DOTA-Biotin, Yttrium Y 90-DOTA-di-HSG Peptide IMP-288, Yttrium Y 90-Edotreotide, Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101, Yttrium Y-90 Clivatuzumab Tetraxetan, Yttrium Y-90 Epratuzumab Tetraxetan, Yttrium Y-90 Ibritumomab Tiuxetan, Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium-90 Polycarbonate Brachytherapy Plaque, Z-Endoxifen Hydrochloride, Zalcitabine, Zalifrelimab, Zalutumumab, Zandelisib, Zanidatamab, Zanolimumab, Zanubrutinib, Zebularine, Zelavespib, Zibotentan, Zinc Finger Nuclease ZFN-603, Zinc Finger Nuclease ZFN-758, Zinostatin, Zinostatin Stimalamer, Zirconium Zr 89 Panitumumab, Ziv-Aflibercept, Zolbetuximab, Zoledronic Acid, Zoptarelin Doxorubicin, Zorifertinib, Zorubicin, Zorubicin Hydrochloride, Zotatifin, Zotiraciclib Citrate, Zuclomiphene Citrate, Unknown, Not Reported",,FALSE,,,,CDS/participant,
Biospecimen Tumor Morphology,"Morphology code from the third edition of the International Classification of Diseases for Oncology, published in 2000, and used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms.","8000/0, 8000/1, 8000/3, 8000/6, 8000/9, 8001/0, 8001/1, 8001/3, 8002/3, 8003/3, 8004/3, 8005/0, 8005/3, 8010/0, 8010/2, 8010/3, 8010/6, 8010/9, 8011/0, 8011/3, 8012/3, 8013/3, 8014/3, 8015/3, 8020/3, 8020/6, 8021/3, 8022/3, 8023/3, 8030/3, 8031/3, 8032/3, 8033/3, 8034/3, 8035/3, 8040/0, 8040/1, 8040/3, 8041/3, 8041/34, 8041/6, 8042/3, 8043/3, 8044/3, 8045/3, 8046/3, 8046/6, 8050/0, 8050/2, 8050/3, 8051/0, 8051/3, 8052/0, 8052/2, 8052/3, 8053/0, 8060/0, 8070/2, 8070/3, 8070/33, 8070/6, 8071/2, 8071/3, 8072/3, 8073/3, 8074/3, 8075/3, 8076/2, 8076/3, 8077/0, 8077/2, 8078/3, 8080/2, 8081/2, 8082/3, 8083/3, 8084/3, 8085/3, 8086/3, 8090/1, 8090/3, 8091/3, 8092/3, 8093/3, 8094/3, 8095/3, 8096/0, 8097/3, 8098/3, 8100/0, 8101/0, 8102/0, 8102/3, 8103/0, 8110/0, 8110/3, 8120/0, 8120/1, 8120/2, 8120/3, 8121/0, 8121/1, 8121/3, 8122/3, 8123/3, 8124/3, 8130/1, 8130/2, 8130/3, 8131/3, 8140/0, 8140/1, 8140/2, 8140/3, 8140/33, 8140/6, 8141/3, 8142/3, 8143/3, 8144/3, 8145/3, 8146/0, 8147/0, 8147/3, 8148/0, 8148/2, 8149/0, 8150/0, 8150/1, 8150/3, 8151/0, 8151/3, 8152/1, 8152/3, 8153/1, 8153/3, 8154/3, 8155/1, 8155/3, 8156/1, 8156/3, 8158/1, 8160/0, 8160/3, 8161/0, 8161/3, 8162/3, 8163/0, 8163/2, 8163/3, 8170/0, 8170/3, 8171/3, 8172/3, 8173/3, 8174/3, 8175/3, 8180/3, 8190/0, 8190/3, 8191/0, 8200/0, 8200/3, 8201/2, 8201/3, 8202/0, 8204/0, 8210/0, 8210/2, 8210/3, 8211/0, 8211/3, 8212/0, 8213/0, 8213/3, 8214/3, 8215/3, 8220/0, 8220/3, 8221/0, 8221/3, 8230/2, 8230/3, 8231/3, 8240/1, 8240/3, 8240/6, 8241/3, 8242/1, 8242/3, 8243/3, 8244/3, 8245/1, 8245/3, 8246/3, 8246/6, 8247/3, 8248/1, 8249/3, 8249/6, 8250/1, 8250/2, 8250/3, 8251/0, 8251/3, 8252/3, 8253/3, 8254/3, 8255/3, 8256/3, 8257/3, 8260/0, 8260/3, 8261/0, 8261/2, 8261/3, 8262/3, 8263/0, 8263/2, 8263/3, 8264/0, 8265/3, 8270/0, 8270/3, 8271/0, 8272/0, 8272/3, 8280/0, 8280/3, 8281/0, 8281/3, 8290/0, 8290/3, 8300/0, 8300/3, 8310/0, 8310/3, 8310/6, 8311/1, 8311/3, 8311/6, 8312/3, 8313/0, 8313/1, 8313/3, 8314/3, 8315/3, 8316/3, 8317/3, 8318/3, 8319/3, 8320/3, 8321/0, 8322/0, 8322/3, 8323/0, 8323/3, 8324/0, 8325/0, 8330/0, 8330/1, 8330/3, 8331/3, 8332/3, 8333/0, 8333/3, 8334/0, 8335/3, 8336/0, 8337/3, 8339/3, 8340/3, 8341/3, 8342/3, 8343/2, 8343/3, 8344/3, 8345/3, 8346/3, 8347/3, 8350/3, 8360/1, 8361/0, 8370/0, 8370/1, 8370/3, 8371/0, 8372/0, 8373/0, 8374/0, 8375/0, 8380/0, 8380/1, 8380/2, 8380/3, 8380/6, 8381/0, 8381/1, 8381/3, 8382/3, 8383/3, 8384/3, 8390/0, 8390/3, 8391/0, 8392/0, 8400/0, 8400/1, 8400/3, 8401/0, 8401/3, 8402/0, 8402/3, 8403/0, 8403/3, 8404/0, 8405/0, 8406/0, 8407/0, 8407/3, 8408/0, 8408/1, 8408/3, 8409/0, 8409/3, 8410/0, 8410/3, 8413/3, 8420/0, 8420/3, 8430/1, 8430/3, 8440/0, 8440/3, 8441/0, 8441/2, 8441/3, 8441/6, 8442/1, 8443/0, 8444/1, 8450/0, 8450/3, 8451/1, 8452/1, 8452/3, 8453/0, 8453/2, 8453/3, 8454/0, 8460/0, 8460/2, 8460/3, 8461/0, 8461/3, 8461/6, 8462/1, 8463/1, 8470/0, 8470/2, 8470/3, 8471/0, 8471/1, 8471/3, 8472/1, 8473/1, 8474/1, 8474/3, 8480/0, 8480/1, 8480/3, 8480/6, 8481/3, 8482/3, 8482/6, 8490/3, 8490/6, 8500/2, 8500/3, 8500/6, 8501/2, 8501/3, 8502/3, 8503/0, 8503/2, 8503/3, 8504/0, 8504/2, 8504/3, 8505/0, 8506/0, 8507/2, 8507/3, 8508/3, 8509/2, 8509/3, 8510/3, 8512/3, 8513/3, 8514/3, 8519/2, 8520/2, 8520/3, 8521/1, 8521/3, 8522/1, 8522/2, 8522/3, 8522/6, 8523/3, 8524/3, 8525/3, 8530/3, 8540/3, 8541/3, 8542/3, 8543/3, 8550/0, 8550/1, 8550/3, 8551/3, 8552/3, 8560/0, 8560/3, 8561/0, 8562/3, 8570/3, 8571/3, 8572/3, 8573/3, 8574/3, 8575/3, 8576/3, 8580/0, 8580/1, 8580/3, 8581/1, 8581/3, 8582/1, 8582/3, 8583/1, 8583/3, 8584/1, 8584/3, 8585/1, 8585/3, 8586/3, 8587/0, 8588/3, 8589/3, 8590/1, 8591/1, 8592/1, 8593/1, 8594/1, 8600/0, 8600/3, 8601/0, 8602/0, 8610/0, 8620/1, 8620/3, 8621/1, 8622/1, 8623/1, 8630/0, 8630/1, 8630/3, 8631/0, 8631/1, 8631/3, 8632/1, 8633/1, 8634/1, 8634/3, 8640/1, 8640/3, 8641/0, 8642/1, 8650/0, 8650/1, 8650/3, 8660/0, 8670/0, 8670/3, 8671/0, 8680/0, 8680/1, 8680/3, 8681/1, 8682/1, 8683/0, 8690/1, 8691/1, 8692/1, 8693/1, 8693/3, 8700/0, 8700/3, 8710/3, 8711/0, 8711/3, 8712/0, 8713/0, 8714/3, 8720/0, 8720/2, 8720/3, 8720/6, 8721/3, 8722/0, 8722/3, 8723/0, 8723/3, 8725/0, 8726/0, 8727/0, 8728/0, 8728/1, 8728/3, 8730/0, 8730/3, 8740/0, 8740/3, 8741/2, 8741/3, 8742/2, 8742/3, 8743/3, 8744/3, 8745/3, 8746/3, 8750/0, 8760/0, 8761/0, 8761/1, 8761/3, 8762/1, 8770/0, 8770/3, 8771/0, 8771/3, 8772/0, 8772/3, 8773/3, 8774/3, 8780/0, 8780/3, 8790/0, 8800/0, 8800/3, 8800/6, 8800/9, 8801/3, 8801/6, 8802/3, 8803/3, 8804/3, 8804/6, 8805/3, 8806/3, 8806/6, 8810/0, 8810/1, 8810/3, 8811/0, 8811/1, 8811/3, 8812/0, 8812/3, 8813/0, 8813/3, 8814/3, 8815/0, 8815/1, 8815/3, 8820/0, 8821/1, 8822/1, 8823/0, 8824/0, 8824/1, 8825/0, 8825/1, 8825/3, 8826/0, 8827/1, 8830/0, 8830/1, 8830/3, 8831/0, 8832/0, 8832/3, 8833/3, 8834/1, 8835/1, 8836/1, 8840/0, 8840/3, 8841/1, 8842/0, 8842/3, 8850/0, 8850/1, 8850/3, 8851/0, 8851/3, 8852/0, 8852/3, 8853/3, 8854/0, 8854/3, 8855/3, 8856/0, 8857/0, 8857/3, 8858/3, 8860/0, 8861/0, 8862/0, 8870/0, 8880/0, 8881/0, 8890/0, 8890/1, 8890/3, 8891/0, 8891/3, 8892/0, 8893/0, 8894/0, 8894/3, 8895/0, 8895/3, 8896/3, 8897/1, 8898/1, 8900/0, 8900/3, 8901/3, 8902/3, 8903/0, 8904/0, 8905/0, 8910/3, 8912/3, 8920/3, 8920/6, 8921/3, 8930/0, 8930/3, 8931/3, 8932/0, 8933/3, 8934/3, 8935/0, 8935/1, 8935/3, 8936/0, 8936/1, 8936/3, 8940/0, 8940/3, 8941/3, 8950/3, 8950/6, 8951/3, 8959/0, 8959/1, 8959/3, 8960/1, 8960/3, 8963/3, 8964/3, 8965/0, 8966/0, 8967/0, 8970/3, 8971/3, 8972/3, 8973/3, 8974/1, 8975/1, 8980/3, 8981/3, 8982/0, 8982/3, 8983/0, 8983/3, 8990/0, 8990/1, 8990/3, 8991/3, 9000/0, 9000/1, 9000/3, 9010/0, 9011/0, 9012/0, 9013/0, 9014/0, 9014/1, 9014/3, 9015/0, 9015/1, 9015/3, 9016/0, 9020/0, 9020/1, 9020/3, 9030/0, 9040/0, 9040/3, 9041/3, 9042/3, 9043/3, 9044/3, 9045/3, 9050/0, 9050/3, 9051/0, 9051/3, 9052/0, 9052/3, 9053/3, 9054/0, 9055/0, 9055/1, 9060/3, 9061/3, 9062/3, 9063/3, 9064/2, 9064/3, 9065/3, 9070/3, 9071/3, 9072/3, 9073/1, 9080/0, 9080/1, 9080/3, 9081/3, 9082/3, 9083/3, 9084/0, 9084/3, 9085/3, 9086/3, 9090/0, 9090/3, 9091/1, 9100/0, 9100/1, 9100/3, 9101/3, 9102/3, 9103/0, 9104/1, 9105/3, 9110/0, 9110/1, 9110/3, 9120/0, 9120/3, 9121/0, 9122/0, 9123/0, 9124/3, 9125/0, 9130/0, 9130/1, 9130/3, 9131/0, 9132/0, 9133/1, 9133/3, 9135/1, 9136/1, 9137/3, 9140/3, 9141/0, 9142/0, 9150/0, 9150/1, 9150/3, 9160/0, 9161/0, 9161/1, 9170/0, 9170/3, 9171/0, 9172/0, 9173/0, 9174/0, 9174/1, 9175/0, 9180/0, 9180/3, 9180/6, 9181/3, 9182/3, 9183/3, 9184/3, 9185/3, 9186/3, 9187/3, 9191/0, 9192/3, 9193/3, 9194/3, 9195/3, 9200/0, 9200/1, 9210/0, 9210/1, 9220/0, 9220/1, 9220/3, 9221/0, 9221/3, 9230/0, 9230/3, 9231/3, 9240/3, 9241/0, 9242/3, 9243/3, 9250/1, 9250/3, 9251/1, 9251/3, 9252/0, 9252/3, 9260/3, 9261/3, 9262/0, 9270/0, 9270/1, 9270/3, 9271/0, 9272/0, 9273/0, 9274/0, 9275/0, 9280/0, 9281/0, 9282/0, 9290/0, 9290/3, 9300/0, 9301/0, 9302/0, 9302/3, 9310/0, 9310/3, 9311/0, 9312/0, 9320/0, 9321/0, 9322/0, 9330/0, 9330/3, 9340/0, 9341/1, 9341/3, 9342/3, 9350/1, 9351/1, 9352/1, 9360/1, 9361/1, 9362/3, 9363/0, 9364/3, 9365/3, 9370/3, 9371/3, 9372/3, 9373/0, 9380/3, 9381/3, 9382/3, 9383/1, 9384/1, 9385/3, 9390/0, 9390/1, 9390/3, 9391/3, 9392/3, 9393/3, 9394/1, 9395/3, 9396/3, 9400/3, 9401/3, 9410/3, 9411/3, 9412/1, 9413/0, 9420/3, 9421/1, 9423/3, 9424/3, 9425/3, 9430/3, 9431/1, 9432/1, 9440/3, 9440/6, 9441/3, 9442/1, 9442/3, 9444/1, 9445/3, 9450/3, 9451/3, 9460/3, 9470/3, 9471/3, 9472/3, 9473/3, 9474/3, 9475/3, 9476/3, 9477/3, 9478/3, 9480/3, 9490/0, 9490/3, 9491/0, 9492/0, 9493/0, 9500/3, 9501/0, 9501/3, 9502/0, 9502/3, 9503/3, 9504/3, 9505/1, 9505/3, 9506/1, 9507/0, 9508/3, 9509/1, 9510/0, 9510/3, 9511/3, 9512/3, 9513/3, 9514/1, 9520/3, 9521/3, 9522/3, 9523/3, 9530/0, 9530/1, 9530/3, 9531/0, 9532/0, 9533/0, 9534/0, 9535/0, 9537/0, 9538/1, 9538/3, 9539/1, 9539/3, 9540/0, 9540/1, 9540/3, 9541/0, 9542/3, 9550/0, 9560/0, 9560/1, 9560/3, 9561/3, 9562/0, 9570/0, 9571/0, 9571/3, 9580/0, 9580/3, 9581/3, 9582/0, 9590/3, 9591/3, 9596/3, 9597/3, 9650/3, 9651/3, 9652/3, 9653/3, 9654/3, 9655/3, 9659/3, 9661/3, 9662/3, 9663/3, 9664/3, 9665/3, 9667/3, 9670/3, 9671/3, 9673/3, 9675/3, 9678/3, 9679/3, 9680/3, 9684/3, 9687/3, 9688/3, 9689/3, 9690/3, 9691/3, 9695/3, 9698/3, 9699/3, 9700/3, 9701/3, 9702/3, 9705/3, 9708/3, 9709/3, 9712/3, 9714/3, 9716/3, 9717/3, 9718/3, 9719/3, 9724/3, 9725/3, 9726/3, 9727/3, 9728/3, 9729/3, 9731/3, 9732/3, 9733/3, 9734/3, 9735/3, 9737/3, 9738/3, 9740/1, 9740/3, 9741/1, 9741/3, 9742/3, 9750/3, 9751/1, 9751/3, 9752/1, 9753/1, 9754/3, 9755/3, 9756/3, 9757/3, 9758/3, 9759/3, 9760/3, 9761/3, 9762/3, 9764/3, 9765/1, 9766/1, 9767/1, 9768/1, 9769/1, 9800/3, 9801/3, 9805/3, 9806/3, 9807/3, 9808/3, 9809/3, 9811/3, 9812/3, 9813/3, 9814/3, 9815/3, 9816/3, 9817/3, 9818/3, 9820/3, 9823/3, 9826/3, 9827/3, 9831/3, 9832/3, 9833/3, 9834/3, 9835/3, 9836/3, 9837/3, 9840/3, 9860/3, 9861/3, 9863/3, 9865/3, 9866/3, 9867/3, 9869/3, 9870/3, 9871/3, 9872/3, 9873/3, 9874/3, 9875/3, 9876/3, 9891/3, 9895/3, 9896/3, 9897/3, 9898/1, 9898/3, 9910/3, 9911/3, 9920/3, 9930/3, 9931/3, 9940/3, 9945/3, 9946/3, 9948/3, 9950/3, 9960/3, 9961/3, 9962/3, 9963/3, 9964/3, 9965/3, 9966/3, 9967/3, 9970/1, 9971/1, 9971/3, 9975/3, 9980/3, 9982/3, 9983/3, 9984/3, 9985/3, 9986/3, 9987/3, 9989/3, 9991/3, 9992/3, Unknown, Not Reported",,FALSE,,,,CDS/participant,
Biospecimen Fixative,The name of the compound that preserves tissues and cells in this sample for microscopic study.,"Acetone, Alcohol, Formalin, Glutaraldehyde, OCT media, RNAlater, Saline, 95% Ethanol, Dimidoester, Carbodiimide, Dimethylacetamide, Para-benzoquinone, PAXgene tissue, TCL lysis buffer, NP40 lysis buffer, Methacarn, Cryo-store, Carnoy's Fixative, Polaxamer, Other, None, unknown",,TRUE,,,,CDS/NDpathology,
Biospecimen Embedding Medium,The name of the material that infiltrates and supports the specimen and preserves its shape and structure for sectioning and microscopy.,"Paraffin wax, Carbowax, Methacrylate, Epoxy Resin (Araldite), Agar embedding, Celloidin media, Gelatin, Other, None, Unknown",,TRUE,,,,CDS/NDpathology,
Biospecimen Acquisition Method,Records the method of acquisition or source for the specimen under consideration,,,FALSE,,,,CDS/NDpathology,
Biospecimen Description,A description of the biospecimen.,,,FALSE,,,,CDS/NDpathology,
Biospecimen Pathology,The pathology identifier associated with the biospecimen.,"Metastatic Neoplasm, Not Applicable, Not Otherwise Specified, Not Reported, Premalignant Neoplasm, Primary Neoplasm, Recurrent Neoplasm, Unknown, Xenograft",,FALSE,,,,CDS/NDpathology,
Biospecimen BioSample Identifier,BioSample (SAMN) accession number corresponding to the source of this biospecimen.,,,FALSE,,,,CDS/NDpathology,
Parent Biospecimen Key,Biospecimen Key identifer of a biospecimen from which this sample was derived. Do not use this field to reference the source model or individual.,,,FALSE,,,,CDS/NDpathology,
Biospecimen Stain,"Any of the various methods that use a dye, reagent, or other material for producing coloration in tissues or microorganisms for microscopic examination.",,,TRUE,,,,CDS/NDpathology,
Biospecimen Timepoint Offset,"The number of days that elapsed before the biospecimen was collected, relative to the event described by Biospecimen Timepoint Type. Floating point values are allowed.",,,FALSE,,,,CDS/file,num
Biospecimen Last Known Disease Status,Text term that describes the last known status of an individual associated with this specimen.,"Distant met recurrence/progression, Loco-regional recurrence/progression, Biochemical evidence of disease without structural correlate, Tumor free, Unknown Tumor Status, With Tumor, Not Reported, Not Allowed To Collect, Not Applicable, Deceased",,FALSE,,,,CDS/participant,
Biospecimen Known Metastasis Sites,The text term(s) used to describe the anatomic site(s) of metastasis associated with the malignant disease of the individual or model.,"Abdomen, Abdominal Wall, Acetabulum, Adenoid, Adipose, Adrenal, Alveolar Ridge, Amniotic Fluid, Ampulla Of Vater, Anal Sphincter, Ankle, Anorectum, Antecubital Fossa, Antrum, Anus, Aorta, Aortic Body, Appendix, Aqueous Fluid, Arm, Artery, Ascending Colon, Ascending Colon Hepatic Flexure, Auditory Canal, Autonomic Nervous System, Axilla, Back, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Bowel, Brain, Brain Stem, Breast, Broad Ligament, Bronchiole, Bronchus, Brow, Buccal Cavity, Buccal Mucosa, Buttock, Calf, Capillary, Cardia, Carina, Carotid Artery, Carotid Body, Cartilage, Cecum, Cell-Line, Central Nervous System, Cerebellum, Cerebral Cortex, Cerebrospinal Fluid, Cerebrum, Cervical Spine, Cervix, Chest, Chest Wall, Chin, Clavicle, Clitoris, Colon, Colon - Mucosa Only, Common Duct, Conjunctiva, Connective Tissue, Dermal, Descending Colon, Diaphragm, Duodenum, Ear, Ear Canal, Ear; Pinna (External), Effusion, Elbow, Endocrine Gland, Epididymis, Epidural Space, Esophageal; Distal, Esophageal; Mid, Esophageal; Proximal, Esophagogastric Junction, Esophagus, Esophagus - Mucosa Only, Eye, Fallopian Tube, Femoral Artery, Femoral Vein, Femur, Fibroblasts, Fibula, Finger, Floor Of Mouth, Fluid, Foot, Forearm, Forehead, Foreskin, Frontal Cortex, Frontal Lobe, Fundus Of Stomach, Gallbladder, Ganglia, Gastroesophageal Junction, Gastrointestinal Tract, Glottis, Groin, Gum, Hand, Hard Palate, Head - Face Or Neck; Nos, Head & Neck, Heart, Hepatic, Hepatic Duct, Hepatic Flexure, Hepatic Vein, Hip, Hippocampus, Humerus, Hypopharynx, Ileum, Ilium, Index Finger, Ischium, Islet Cells, Jaw, Jejunum, Joint, Kidney, Knee, Lacrimal Gland, Large Bowel, Laryngopharynx, Larynx, Leg, Leptomeninges, Ligament, Lip, Liver, Lumbar Spine, Lung, Lymph Node, Lymph Node(s) Axilla, Lymph Node(s) Cervical, Lymph Node(s) Distant, Lymph Node(s) Epitrochlear, Lymph Node(s) Femoral, Lymph Node(s) Hilar, Lymph Node(s) Iliac-Common, Lymph Node(s) Iliac-External, Lymph Node(s) Inguinal, Lymph Node(s) Internal Mammary, Lymph Node(s) Mammary, Lymph Node(s) Mesenteric, Lymph Node(s) Occipital, Lymph Node(s) Paraaortic, Lymph Node(s) Parotid, Lymph Node(s) Pelvic, Lymph Node(s) Popliteal, Lymph Node(s) Regional, Lymph Node(s) Retroperitoneal, Lymph Node(s) Scalene, Lymph Node(s) Splenic, Lymph Node(s) Subclavicular, Lymph Node(s) Submandibular, Lymph Node(s) Supraclavicular, Lymph Nodes(s) Mediastinal, Mandible, Maxilla, Mediastinal Soft Tissue, Mediastinum, Mesentery, Mesothelium, Middle Finger, Mitochondria, Muscle, Nails, Nasal Cavity, Nasal Soft Tissue, Nasopharynx, Neck, Nerve, Nerve(s) Cranial, Not Allowed To Collect, Occipital Cortex, Ocular Orbits, Omentum, Oral Cavity, Oral Cavity - Mucosa Only, Oropharynx, Other, Ovary, Palate, Pancreas, Paranasal Sinuses, Paraspinal Ganglion, Parathyroid, Parotid Gland, Patella, Pelvis, Penis, Pericardium, Periorbital Soft Tissue, Peritoneal Cavity, Peritoneum, Pharynx, Pineal, Pineal Gland, Pituitary Gland, Placenta, Pleura, Popliteal Fossa, Prostate, Pylorus, Rectosigmoid Junction, Rectum, Retina, Retro-Orbital Region, Retroperitoneum, Rib, Ring Finger, Round Ligament, Sacrum, Salivary Gland, Scalp, Scapula, Sciatic Nerve, Scrotum, Seminal Vesicle, Shoulder, Sigmoid Colon, Sinus, Sinus(es); Maxillary, Skeletal Muscle, Skin, Skull, Small Bowel, Small Bowel - Mucosa Only, Small Finger, Soft Tissue, Spinal Column, Spinal Cord, Spleen, Splenic Flexure, Sternum, Stomach, Stomach - Mucosa Only, Subcutaneous Tissue, Subglottis, Sublingual Gland, Submandibular Gland, Supraglottis, Synovium, Temporal Cortex, Tendon, Testis, Thigh, Thoracic Spine, Thorax, Throat, Thumb, Thymus, Thyroid, Tibia, Tongue, Tonsil, Tonsil (Pharyngeal), Trachea / Major Bronchi, Transverse Colon, Trunk, Umbilical Cord, Ureter, Urethra, Urinary Tract, Uterus, Uvula, Vagina, Vas Deferens, Vein, Venous, Vertebra, Vulva, White Blood Cells, Wrist, Unknown, Not Reported",,FALSE,,,,MC2/STE,
Biospecimen Primary Site,Primary site in the body associated with the primary diagnosis.,"Adrenal Gland, Base of the Tongue, Bladder, Brain, Breast, Cervix Uteri, Colon, Corpus Uteri, Esophagus, Floor of Mouth, Gallbladder, Gingiva, Hypopharynx, Kidney, Larynx, Limb Skeletal System, Lip, Lung/Bronchus, Lymph Node, Meninges, Nasopharynx, Not Reported, Oropharynx, Other and Ill Defined Digestive Organs ICD-O-3, Other and Ill-Defined Sites ICD-O-3, Other and Ill-Defined Sites in Lip; Oral Cavity and Pharynx ICD-O-3, Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3, Other and Unspecified Female Genital Organs ICD-O-3, Other and Unspecified Major Salivary Glands ICD-O-3, Other and Unspecified Male Genital Organs ICD-O-3, Other and Unspecified Parts of Biliary Tract ICD-O-3, Other and Unspecified Parts of Mouth ICD-O-3, Other and Unspecified Parts of Tongue ICD-O-3, Other and Unspecified Urinary Organs ICD-O-3, Other Endocrine Glands and Related Structures ICD-O-3, Ovary, Palate, Pancreas, Paranasal Sinus, Parotid Gland, Penis, Peritoneum and Retroperitoneum, Placenta, Prostate Gland, Pyriform Sinus, Rectosigmoid Region, Rectum, Renal Pelvis, Skin, Small Intestine, Stomach, Testis, Thymus Gland, Thyroid Gland, Tonsil, Trachea, Unknown, Ureter, Uterus, Vagina, Vulva",,FALSE,,,,CDS Metadata v1.3.3/Diagnosis,
Biospecimen Primary Diagnosis,"Text term used to describe the histologic diagnosis relevant to the model system, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","Abdominal desmoid, Abdominal fibromatosis, Achromic nevus, Acidophil adenocarcinoma, Acidophil adenoma, Acidophil carcinoma, Acinar adenocarcinoma, Acinar adenocarcinoma; sarcomatoid, Acinar adenoma, Acinar carcinoma, Acinar cell adenoma, Acinar cell carcinoma, Acinar cell cystadenocarcinoma, Acinar cell tumor, Acinic cell adenocarcinoma, Acinic cell adenoma, Acinic cell tumor, Acoustic neuroma, Acquired cystic disease-associated renal cell carcinoma (RCC), Acquired tufted hemangioma, Acral lentiginous melanoma; malignant, ACTH-producing tumor, Acute basophilic leukaemia, Acute bilineal leukemia, Acute biphenotypic leukemia, Acute erythremia, Acute erythremic myelosis, Acute erythroid leukaemia, Acute granulocytic leukemia, Acute leukemia; Burkitt type, Acute leukemia; NOS, Acute lymphatic leukemia, Acute lymphoblastic leukemia-lymphoma; NOS, Acute lymphoblastic leukemia; L2 type; NOS, Acute lymphoblastic leukemia; mature B-cell type, Acute lymphoblastic leukemia; NOS, Acute lymphoblastic leukemia; precursor cell type, Acute lymphocytic leukemia, Acute lymphoid leukemia, Acute megakaryoblastic leukaemia, Acute mixed lineage leukemia, Acute monoblastic and monocytic leukemia, Acute monoblastic leukemia, Acute monocytic leukemia, Acute myeloblastic leukemia, Acute myelocytic leukemia, Acute myelofibrosis, Acute myelogenous leukemia, Acute myeloid leukaemia; t(8;21)(q22;q22), Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1, Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants), Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1, Acute myeloid leukemia with maturation, Acute myeloid leukemia with multilineage dysplasia, Acute myeloid leukemia with mutated CEBPA, Acute myeloid leukemia with mutated NPM1, Acute myeloid leukemia with myelodysplasia-related changes, Acute myeloid leukemia with prior myelodysplastic syndrome, Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214, Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1, Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL, Acute myeloid leukemia without maturation, Acute myeloid leukemia without prior myelodysplastic syndrome, Acute myeloid leukemia; AML1(CBF-alpha)/ETO, Acute myeloid leukemia; CBF-beta/MYH11, Acute myeloid leukemia; inv(16)(p13;q22), Acute myeloid leukemia; M6 type, Acute myeloid leukemia; minimal differentiation, Acute myeloid leukemia; MLL, Acute myeloid leukemia; NOS, Acute myeloid leukemia; PML/RAR-alpha, Acute myeloid leukemia; t(15:17)(g22;q11-12), Acute myeloid leukemia; t(16;16)(p 13;q 11), Acute myelomonocytic leukemia, Acute myelomonocytic leukemia with abnormal eosinophils, Acute myelosclerosis; NOS, Acute myloid leukemia; 11q23 abnormalities, Acute non-lymphocytic leukemia, Acute panmyelosis with myelofibrosis, Acute panmyelosis; NOS, Acute progressive histiocytosis X, Acute promyelocytic leukaemia; PML-RAR-alpha, Acute promyelocytic leukaemia; t(15;17)(q22;q11-12), Acute promyelocytic leukemia; NOS, Adamantinoma of long bones, Adamantinoma; malignant, Adamantinoma; NOS, Adenoacanthoma, Adenoameloblastoma, Adenocarcinoid tumor, Adenocarcinoma admixed with neuroendocrine carcinoma, Adenocarcinoma combined with other types of carcinoma, Adenocarcinoma in a polyp; NOS, Adenocarcinoma in adenomatous polyp, Adenocarcinoma in adenomatous polyposis coli, Adenocarcinoma in multiple adenomatous polyps, Adenocarcinoma in polypoid adenoma, Adenocarcinoma in situ in a polyp; NOS, Adenocarcinoma in situ in adenomatous polyp, Adenocarcinoma in situ in polypoid adenoma, Adenocarcinoma in situ in tubular adenoma, Adenocarcinoma in situ in tubulovillous adenoma, Adenocarcinoma in situ in villous adenoma, Adenocarcinoma in situ; mucinous, Adenocarcinoma in situ; non-mucinous, Adenocarcinoma in situ; NOS, Adenocarcinoma in tubolovillous adenoma, Adenocarcinoma in tubular adenoma, Adenocarcinoma in villous adenoma, Adenocarcinoma of anal ducts, Adenocarcinoma of anal glands, Adenocarcinoma of rete ovarii, Adenocarcinoma with apocrine metaplasia, Adenocarcinoma with cartilaginous and osseous metaplasia, Adenocarcinoma with cartilaginous metaplasia, Adenocarcinoma with mixed subtypes, Adenocarcinoma with neuroendocrine differentiation, Adenocarcinoma with osseous metaplasia, Adenocarcinoma with spindle cell metaplasia, Adenocarcinoma with squamous metaplasia, Adenocarcinoma; cribriform comedo-type, Adenocarcinoma; cylindroid, Adenocarcinoma; diffuse type, Adenocarcinoma; endocervical type, Adenocarcinoma; intestinal type, Adenocarcinoma; metastatic; NOS, Adenocarcinoma; NOS, Adenocarcinoma; pancreatobiliary type, Adenocystic carcinoma, Adenofibroma; NOS, Adenoid basal carcinoma, Adenoid cystic carcinoma, Adenolipoma, Adenolymphoma, Adenoma of nipple, Adenoma; NOS, Adenomatoid odontogenic tumor, Adenomatoid tumor; NOS, Adenomatosis; NOS, Adenomatous polyp; NOS, Adenomatous polyposis coli, Adenomyoepithelioma, Adenomyoepithelioma with carcinoma, Adenomyoma, Adenosarcoma, Adenosquamous carcinoma, Adnexal carcinoma, Adnexal tumor; benign, Adrenal cortical adenocarcinoma, Adrenal cortical adenoma; clear cell, Adrenal cortical adenoma; compact cell, Adrenal cortical adenoma; glomerulosa cell, Adrenal cortical adenoma; mixed cell, Adrenal cortical adenoma; NOS, Adrenal cortical adenoma; pigmented, Adrenal cortical carcinoma, Adrenal cortical tumor; benign, Adrenal cortical tumor; malignant, Adrenal cortical tumor; NOS, Adrenal medullary paraganglioma, Adrenal medullary paraganglioma; malignant, Adrenal rest tumor, Adult cystic teratoma, Adult granulosa cell tumor, Adult rhabdomyoma, Adult T-cell leukemia, Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants), Adult T-cell lymphoma, Adult T-cell lymphoma/leukemia, Adult teratoma; NOS, Aggressive angiomyxoma, Aggressive digital papillary adenoma, Aggressive fibromatosis, Aggressive NK-cell leukaemia, Aggressive osteoblastoma, Aggressive systemic mastocytosis, Agnogenic myeloid metaplasia, AIN III, Aleukemic granulocytic leukemia, Aleukemic leukemia; NOS, Aleukemic lymphatic leukemia, Aleukemic lymphocytic leukemia, Aleukemic lymphoid leukemia, Aleukemic monocytic leukemia, Aleukemic myelogenous leukemia, Aleukemic myeloid leukemia, ALK positive large B-cell lymphoma, Alpha cell tumor; malignant, Alpha cell tumor; NOS, Alpha heavy chain disease, Alveolar adenocarcinoma, Alveolar adenoma, Alveolar carcinoma, Alveolar cell carcinoma, Alveolar rhabdomyosarcoma, Alveolar soft part sarcoma, Amelanotic melanoma, Ameloblastic carcinoma, Ameloblastic fibro-odontoma, Ameloblastic fibro-odontosarcoma, Ameloblastic fibrodentinoma, Ameloblastic fibrodentinosarcoma, Ameloblastic fibroma, Ameloblastic fibrosarcoma, Ameloblastic odontosarcoma, Ameloblastic sarcoma, Ameloblastoma; malignant, Ameloblastoma; NOS, AML M6, Anal intraepithelial neoplasia; grade III, Anal intraepithelial neoplasia; low grade, Anaplastic astrocytoma; IDH-mutant, Anaplastic astrocytoma; IDH-wildtype, Anaplastic large B-cell lymphoma, Anaplastic large cell lymphoma; ALK negative, Anaplastic large cell lymphoma; ALK positive, Anaplastic large cell lymphoma; CD30+, Anaplastic large cell lymphoma; NOS, Anaplastic large cell lymphoma; T cell and Null cell type, Anaplastic medulloblastoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma; IDH-mutant and 1p/19q-codeleted, Anaplastic pleomorphic xanthroastrocytoma, Ancient schwannoma, Androblastoma; benign, Androblastoma; malignant, Androblastoma; NOS, Angioblastic meningioma, Angioblastoma, Angiocentric glioma, Angiocentric immunoproliferative lesion, Angiocentric T-cell lymphoma, Angioendothelioma, Angioendotheliomatosis, Angiofibroma; NOS, Angioimmunoblastic lymphadenopathy, Angioimmunoblastic lymphoma, Angioimmunoblastic T-cell lymphoma, Angiokeratoma, Angioleiomyoma, Angiolipoma; NOS, Angioma; NOS, Angiomatoid fibrous histiocytoma, Angiomatous meningioma, Angiomyofibroblastoma, Angiomyolipoma, Angiomyoma, Angiomyosarcoma, Angiomyxoma, Angiosarcoma, Angiotropic lymphoma, Aortic body paraganglioma, Aortic body tumor, Aorticopulmonary paraganglioma, Apocrine adenocarcinoma, Apocrine adenoma, Apocrine cystadenoma, Apudoma, Argentaffinoma; malignant, Argentaffinoma; NOS, Arrhenoblastoma; benign, Arrhenoblastoma; malignant, Arrhenoblastoma; NOS, Arteriovenous hemangioma, Askin tumor, Astroblastoma, Astrocytic glioma, Astrocytoma; anaplastic, Astrocytoma; low grade, Astrocytoma; NOS, Astroglioma, Atypical adenoma, Atypical carcinoid tumor, Atypical choroid plexus papilloma, Atypical chronic myeloid leukemia; BCR/ABL negative, Atypical chronic myeloid leukemia; Philadelphia chromosome (Ph1) negative, Atypical fibrous histiocytoma, Atypical fibroxanthoma, Atypical follicular adenoma, Atypical hyperplasia/Endometrioid intraepithelial neoplasm, Atypical leiomyoma, Atypical lipoma, Atypical medullary carcinoma, Atypical meningioma, Atypical polypoid adenomyoma, Atypical proliferating clear cell tumor, Atypical proliferating serous tumor, Atypical proliferative endometrioid tumor, Atypical proliferative mucinous tumor, Atypical proliferative papillary serous tumor, Atypical teratoid/rhabdoid tumor, B cell lymphoma; NOS, B lymphoblastic leukemia/lymphoma with hyperdiploidy, B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL), B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1), B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH, B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged, B lymphoblastic leukemia/lymphoma; NOS, B-ALL, B-cell lymphocytic leukemia/small lymphocytic lymphoma, B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma, B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma, Balloon cell melanoma, Balloon cell nevus, BALT lymphoma, Basal cell adenocarcinoma, Basal cell adenoma, Basal cell carcinoma; desmoplastic type, Basal cell carcinoma; fibroepithelial, Basal cell carcinoma; micronodular, Basal cell carcinoma; morpheic, Basal cell carcinoma; nodular, Basal cell carcinoma; NOS, Basal cell epithelioma, Basal cell tumor, Basaloid carcinoma, Basaloid squamous cell carcinoma, Basophil adenocarcinoma, Basophil adenoma, Basophil carcinoma, Basosquamous carcinoma, Bednar tumor, Bellini duct carcinoma, Benign cystic nephroma, Benign fibrous histiocytoma, Beta cell adenoma, Beta cell tumor; malignant, Bile duct adenocarcinoma, Bile duct adenoma, Bile duct carcinoma, Bile duct cystadenocarcinoma, Bile duct cystadenoma, Biliary intraepithelial neoplasia; grade 3, Biliary intraepithelial neoplasia; high grade, Biliary intraepithelial neoplasia; low grade, Biliary papillomatosis, Biphenotypic sinonasal sarcoma, Bizarre leiomyoma, Black adenoma, Blast cell leukemia, Blastic NK cell lymphoma, Blastic plasmacytoid dendritic cell neoplasm, Blastoma; NOS, Blue nevus; malignant, Blue nevus; NOS, Botryoid sarcoma, Bowen disease, Brenner tumor; borderline malignancy, Brenner tumor; malignant, Brenner tumor; NOS, Brenner tumor; proliferating, Bronchial adenoma; carcinoid, Bronchial adenoma; cylindroid, Bronchial adenoma; NOS, Bronchial-associated lymphoid tissue lymphoma, Bronchio-alveolar carcinoma; mixed mucinous and non-mucinous, Bronchio-alveolar carcinoma; mucinous, Bronchiolar adenocarcinoma, Bronchiolar carcinoma, Bronchiolo-alveolar adenocarcinoma; NOS, Bronchiolo-alveolar carcinoma; Clara cell, Bronchiolo-alveolar carcinoma; Clara cell and goblet cell type, Bronchiolo-alveolar carcinoma; goblet cell type, Bronchiolo-alveolar carcinoma; indeterminate type, Bronchiolo-alveolar carcinoma; non-mucinous, Bronchiolo-alveolar carcinoma; NOS, Bronchiolo-alveolar carcinoma; type II pneumocyte and goblet cell type, Bronchiolo-alveolar carcinoma; type II pneumocyte, Brooke tumor, Brown fat tumor, Burkitt cell leukemia, Burkitt lymphoma; NOS (Includes all variants), Burkitt tumor, Burkitt-like lymphoma, C cell carcinoma, c-ALL, Calcifying epithelial odontogenic tumor, Calcifying epithelioma of Malherbe, Calcifying nested epithelial stromal tumor, Calcifying odontogenic cyst, Canalicular adenoma, Cancer, Capillary hemangioma, Capillary lymphangioma, Carcinofibroma, Carcinoid tumor of uncertain malignant potential, Carcinoid tumor; argentaffin; malignant, Carcinoid tumor; argentaffin; NOS, Carcinoid tumor; NOS, Carcinoid tumor; NOS; of appendix, Carcinoid; NOS, Carcinoid; NOS; of appendix, Carcinoma in a polyp; NOS, Carcinoma in adenomatous polyp, Carcinoma in pleomorphic adenoma, Carcinoma in situ in a polyp; NOS, Carcinoma in situ in adenomatous polyp, Carcinoma in situ; NOS, Carcinoma showing thymus-like differentiation, Carcinoma showing thymus-like element, Carcinoma simplex, Carcinoma with apocrine metaplasia, Carcinoma with chondroid differentiation, Carcinoma with neuroendocrine differentiation, Carcinoma with osseous differentiation, Carcinoma with osteoclast-like giant cells, Carcinoma with other types mesenchymal differentiation, Carcinoma with productive fibrosis, Carcinoma; anaplastic; NOS, Carcinoma; diffuse type, Carcinoma; intestinal type, Carcinoma; metastatic; NOS, Carcinoma; NOS, Carcinoma; undifferentiated; NOS, Carcinomatosis, Carcinosarcoma; embryonal, Carcinosarcoma; NOS, Carotid body paraganglioma, Carotid body tumor, Cartilaginous exostosis, CASTLE, Cavernous hemangioma, Cavernous lymphangioma, Cellular angiofibroma, Cellular blue nevus, Cellular ependymoma, Cellular fibroma, Cellular leiomyoma, Cellular schwannoma, Cementifying fibroma, Cemento-ossifying fibroma, Cementoblastoma; benign, Cementoma; NOS, Central neuroblastoma, Central neurocytoma, Central odontogenic fibroma, Central osteosarcoma, Central primitive neuroectodermal tumor; NOS, Cerebellar liponeurocytoma, Cerebellar sarcoma; NOS, Ceruminous adenocarcinoma, Ceruminous adenoma, Ceruminous carcinoma, Cervical intraepithelial neoplasia; grade III, Cervical intraepithelial neoplasia; low grade, Chemodectoma, Chief cell adenoma, Chloroma, Cholangiocarcinoma, Cholangioma, Chondroblastic osteosarcoma, Chondroblastoma; malignant, Chondroblastoma; NOS, Chondroid chordoma, Chondroid lipoma, Chondroid syringoma, Chondroma; NOS, Chondromatosis; NOS, Chondromatous giant cell tumor, Chondromyxoid fibroma, Chondrosarcoma grade 2/3, Chondrosarcoma; NOS, Chordoid glioma, Chordoid glioma of third ventricle, Chordoid meningioma, Chordoma; NOS, Chorioadenoma, Chorioadenoma destruens, Chorioangioma, Choriocarcinoma combined with embryonal carcinoma, Choriocarcinoma combined with other germ cell elements, Choriocarcinoma combined with teratorna, Choriocarcinoma; NOS, Chorioepithelioma, Chorionepithelioma, Choroid plexus carcinoma, Choroid plexus papilloma; anaplastic, Choroid plexus papilloma; malignant, Choroid plexus papilloma; NOS, Chromaffin paraganglioma, Chromaffin tumor, Chromaffinoma, Chromophobe adenocarcinoma, Chromophobe adenoma, Chromophobe carcinoma, Chromophobe cell renal carcinoma, Chronic eosinophilic leukemia; NOS, Chronic erythremia, Chronic granulocytic leukemia; BCR/ABL, Chronic granulocytic leukemia; NOS, Chronic granulocytic leukemia; Philadelphia chromosome (Ph1) positive, Chronic granulocytic leukemia; t(9;22)(q34;q11), Chronic idiopathic myelofibrosis, Chronic leukemia; NOS, Chronic lymphatic leukemia, Chronic lymphocytic leukemia, Chronic lymphocytic leukemia; B-cell type (includes all variants of BCLL), Chronic lymphoid leukemia, Chronic lymphoproliferative disorder of NK cells, Chronic monocytic leukemia, Chronic myelocytic leukemia; NOS, Chronic myelogenous leukemia; BCR-ABL positive, Chronic myelogenous leukemia; Philadelphia chromosome (Ph 1) positive, Chronic myelogenous leukemia; t(9;22)(q34;q11), Chronic myeloid leukemia; NOS, Chronic myelomonocytic leukemia in transformation, Chronic myelomonocytic leukemia; NOS, Chronic myelomonocytic leukemia; Type 1, Chronic myelomonocytic leukemia; Type II, Chronic myeloproliferative disease; NOS, Chronic myeloproliferative disorder, Chronic neutrophilic leukemia, CIN III with severe dysplasia, Cin III; NOS, Circumscribed arachnoidal cerebellar sarcoma, Classical Hodgkin lymphoma; lymphocyte depletion; diffuse fibrosis, Classical Hodgkin lymphoma; lymphocyte depletion; NOS, Classical Hodgkin lymphoma; lymphocyte depletion; reticular, Classical Hodgkin lymphoma; lymphocyte-rich, Classical Hodgkin lymphoma; mixed cellularity; NOS, Classical Hodgkin lymphoma; nodular sclerosis; cellular phase, Classical Hodgkin lymphoma; nodular sclerosis; grade 1, Classical Hodgkin lymphoma; nodular sclerosis; grade 2, Classical Hodgkin lymphoma; nodular sclerosis; NOS, Clear cell (glycogen-rich) urothelial carcinoma, Clear cell adenocarcinofibroma, Clear cell adenocarcinoma; mesonephroid, Clear cell adenocarcinoma; NOS, Clear cell adenofibroma, Clear cell adenofibroma of borderline malignancy, Clear cell adenoma, Clear cell carcinoma, Clear cell chondrosarcoma, Clear cell cystadenocarcinofibroma, Clear cell cystadenofibroma, Clear cell cystadenofibroma of borderline malignancy, Clear cell cystadenoma, Clear cell cystic tumor of borderline malignancy, Clear cell ependymoma, Clear cell hidradenoma, Clear cell meningioma, Clear cell odontogenic carcinoma, Clear cell odontogenic tumor, Clear cell sarcoma of kidney, Clear cell sarcoma; NOS, Clear cell sarcoma; of tendons and aponeuroses, Clear cell tumor; NOS, Cloacogenic carcinoma, CNS Embryonal tumor with rhabdoid features, Codman tumor, Collecting duct carcinoma, Colloid adenocarcinoma, Colloid adenoma, Colloid carcinoma, Columnar cell papilloma, Combined carcinoid and adenocarcinoma, Combined hepatocellular carcinoma and cholangiocarcinoma, Combined large cell neuroendocrine carcinoma, Combined small cell carcinoma, Combined small cell-adenocarcinoma, Combined small cell-large carcinoma, Combined small cell-squamous cell carcinoma, Combined/mixed carcinoid and adenocarcinoma, Comedocarcinoma; noninfiltrating, Comedocarcinoma; NOS, Common ALL, Common precursor B ALL, Complete hydatidiform mole, Complex odontoma, Composite carcinoid, Composite Hodgkin and non-Hodgkin lymphoma, Compound nevus, Compound odontoma, Condylomatous carcinoma, Congenital fibrosarcoma, Congenital generalized fibromatosis, Congenital peribronchial myofibroblastic tumor, Conventional central osteosarcoma, Cortical T ALL, CPNET, Craniopharyngioma, Craniopharyngioma; adamantinomatous, Craniopharyngioma; papillary, Cribriform carcinoma in situ, Cribriform carcinoma; NOS, Cribriform comedo-type carcinoma, Cutaneous histiocytoma; NOS, Cutaneous lymphoma; NOS, Cutaneous mastocytosis, Cutaneous T-cell lymphoma; NOS, Cylindrical cell carcinoma, Cylindrical cell papilloma, Cylindroma of skin, Cylindroma; NOS, Cyst-associated renal cell carcinoma, Cystadenocarcinoma; NOS, Cystadenofibroma; NOS, Cystadenoma; NOS, Cystic astrocytoma, Cystic hygroma, Cystic hypersecretory carcinoma, Cystic lymphangioma, Cystic mesothelioma; benign, Cystic mesothelioma; NOS, Cystic partially differentiated nephroblastoma, Cystic teratoma; NOS, Cystic tumor of atrio-ventricular node, Cystoma; NOS, Cystosarcoma phyllodes; benign, Cystosarcoma phyllodes; malignant, Cystosarcoma phyllodes; NOS, Dabska tumor, DCIS; comedo type, DCIS; NOS, DCIS; papillary, Dedifferentiated chondrosarcoma, Dedifferentiated chordoma, Dedifferentiated liposarcoma, Deep histiocytoma, Degenerated schwannoma, Dendritic cell sarcoma; NOS, Dentinoma, Dermal and epidermal nevus, Dermal nevus, Dermatofibroma lenticulare, Dermatofibroma; NOS, Dermatofibrosarcoma protuberans; NOS, Dermatofibrosarcoma; NOS, Dermoid cyst with malignant transformation, Dermoid cyst with secondary tumor, Dermoid cyst; NOS, Dermoid; NOS, Desmoid; NOS, Desmoplastic fibroma, Desmoplastic infantile astrocytoma, Desmoplastic infantile ganglioglioma, Desmoplastic medulloblastoma, Desmoplastic melanoma; amelanotic, Desmoplastic melanoma; malignant, Desmoplastic mesothelioma, Desmoplastic nodular medulloblastoma, Desmoplastic small round cell tumor, Di Guglielmo disease, Differentiated penile intraepithelial neoplasia, Differentiated-type vulvar intraepithelial neoplasia, Diffuse astrocytoma, Diffuse astrocytoma; IDH-mutant, Diffuse astrocytoma; IDH-wildtype, Diffuse astrocytoma; low grade, Diffuse cutaneous mastocytosis, Diffuse intraductal papillomatosis, Diffuse large B-cell lymphoma associated with chronic inflammation, Diffuse large B-cell lymphoma; NOS, Diffuse leptomeningeal glioneuronal tumor, Diffuse melanocytosis, Diffuse meningiomatosis, Diffuse midline glioma; H3 K27M-mutant, Digital papillary adenocarcinoma, Diktyoma; benign, Diktyoma; malignant, DIN 3, Duct adenocarcinoma; NOS, Duct adenoma; NOS, Duct carcinoma; desmoplastic type, Duct carcinoma; NOS, Duct cell carcinoma, Ductal carcinoma in situ; comedo type, Ductal carcinoma in situ; cribriform type, Ductal carcinoma in situ; micropapillary, Ductal carcinoma in situ; NOS, Ductal carcinoma in situ; papillary, Ductal carcinoma in situ; solid type, Ductal carcinoma; cribriform type, Ductal carcinoma; NOS, Ductal intraepithelial neoplasia 3, Ductal papilloma, Dysembryoplastic neuroepithelial tumor, Dysgerminoma, Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos), Dysplastic nevus, EBV positive diffuse large B-cell lymphoma of the elderly, EC cell carcinoid, Ecchondroma, Ecchondrosis, Eccrine acrospiroma, Eccrine adenocarcinoma, Eccrine cystadenoma, Eccrine dermal cylindroma, Eccrine papillary adenocarcinoma, Eccrine papillary adenoma, Eccrine poroma, Eccrine poroma; malignant, Eccrine spiradenoma, ECL cell carcinoid; malignant, ECL cell carcinoid; NOS, Ectomesenchymoma, Ectopic hamartomatous thymoma, Elastofibroma, Embryonal adenocarcinoma, Embryonal adenoma, Embryonal carcinoma; infantile, Embryonal carcinoma; NOS, Embryonal carcinoma; polyembryonal type, Embryonal hepatoma, Embryonal rhabdomyosarcoma; NOS, Embryonal rhabdomyosarcoma; pleomorphic, Embryonal sarcoma, Embryonal teratoma, Embryonal tumor with multilayered rosettes C19MC-altered, Embryonal tumor with multilayered rosettes; NOS, Embryonal tumor with rhabdoid features, Encapsulated follicular variant of papillary thyroid carcinoma; NOS (EFVPTC; NOS), Encapsulated papillary carcinoma, Encapsulated papillary carcinoma with invasion, Enchondroma, Endocervical adenocarcinoma usual type, Endocrine adenomatosis, Endocrine tumor; functioning; NOS, Endodermal sinus tumor, Endolymphatic stromal myosis, Endometrial sarcoma; NOS, Endometrial stromal nodule, Endometrial stromal sarcoma; high grade, Endometrial stromal sarcoma; low grade, Endometrial stromal sarcoma; NOS, Endometrial stromatosis, Endometrioid adenocarcinoma; ciliated cell variant, Endometrioid adenocarcinoma; NOS, Endometrioid adenocarcinoma; secretory variant, Endometrioid adenocarcinoma; villoglandular, Endometrioid adenofibroma; borderline malignancy, Endometrioid adenofibroma; malignant, Endometrioid adenofibroma; NOS, Endometrioid adenoma; borderline malignancy, Endometrioid adenoma; NOS, Endometrioid carcinoma with squamous differentiation, Endometrioid carcinoma; NOS, Endometrioid cystadenocarcinoma, Endometrioid cystadenofibroma; borderline malignancy, Endometrioid cystadenofibroma; malignant, Endometrioid cystadenofibroma; NOS, Endometrioid cystadenoma; borderline malignancy, Endometrioid cystadenoma; NOS, Endometrioid tumor of low malignant potential, Endotheliomatous meningioma, Endovascular papillary angioendothelioma, Enteric adenocarcinoma, Enterochromaffin cell carcinoid, Enterochromaffin-like cell carcinoid; NOS, Enterochromaffin-like cell tumor; malignant, Enteroglucagonoma; malignant, Enteroglucagonoma; NOS, Enteropathy associated T-cell lymphoma, Enteropathy type intestinal T-cell lymphoma, Eosinophil adenocarcinoma, Eosinophil adenoma, Eosinophil carcinoma, Eosinophilic granuloma, Eosinophilic leukemia, Ependymoblastoma, Ependymoma; anaplastic, Ependymoma; NOS, Ependymoma; RELA fusion-positive, Epidermoid carcinoma in situ with questionable stromal invasion, Epidermoid carcinoma in situ; NOS, Epidermoid carcinoma; keratinizing, Epidermoid carcinoma; large cell; nonkeratinizing, Epidermoid carcinoma; NOS, Epidermoid carcinoma; small cell; nonkeratinizing, Epidermoid carcinoma; spindle cell, Epithelial ependymoma, Epithelial tumor; benign, Epithelial tumor; malignant, Epithelial-myoepithelial carcinoma, Epithelioid and spindle cell nevus, Epithelioid cell melanoma, Epithelioid cell nevus, Epithelioid cell sarcoma, Epithelioid glioblastoma, Epithelioid hemangioendothelioma; malignant, Epithelioid hemangioendothelioma; NOS, Epithelioid hemangioma, Epithelioid leiomyoma, Epithelioid leiomyosarcoma, Epithelioid malignant peripheral nerve sheath tumor, Epithelioid mesothelioma; benign, Epithelioid mesothelioma; malignant, Epithelioid mesothelioma; NOS, Epithelioid MPNST, Epithelioid sarcoma, Epithelioma adenoides cysticum, Epithelioma; benign, Epithelioma; malignant, Epithelioma; NOS, Erythremic myelosis; NOS, Erythroleukemia, Esophageal glandular dysplasia (intraepithelial neoplasia); high grade, Esophageal glandular dysplasia (intraepithelial neoplasia); low grade, Esophageal intraepithelial neoplasia; high grade, Esophageal squamous intraepithelial neoplasia (dysplasia); high grade, Esophageal squamous intraepithelial neoplasia (dysplasia); low grade, Essential hemorrhagic thrombocythaemia, Essential thrombocythemia, Esthesioneuroblastoma, Esthesioneurocytoma, Esthesioneuroepithelioma, Ewing sarcoma, Ewing tumor, Extra-abdominal desmoid, Extra-adrenal paraganglioma; malignant, Extra-adrenal paraganglioma; NOS, Extracutaneous mastocytoma, Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, Extranodal NK/T-cell lymphoma; nasal type, Extraosseous plasmacytoma, Extraventricular neurocytoma, FAB L2, FAB L3, FAB Ll, FAB M1, FAB M2; AML1(CBF-alpha)/ETO, FAB M2; NOS, FAB M2; t(8;21)(q22;q22), FAB M3 (includes all variants), FAB M4, FAB M4Eo, FAB M5 (includes all variants), FAB M6, FAB M7, FAB MO, Familial polyposis coli, Fascial fibroma, Fascial fibrosarcoma, Fetal adenocarcinoma, Fetal adenoma, Fetal fat cell lipoma, Fetal lipoma; NOS, Fetal lipomatosis, Fetal rhabdomyoma, Fibrillary astrocytoma, Fibro-osteoma, Fibroadenoma; NOS, Fibroameloblastic odontoma, Fibroblastic liposarcoma, Fibroblastic meningioma, Fibroblastic osteosarcoma, Fibroblastic reticular cell tumor, Fibrochondrosarcoma, Fibroepithelial basal cell carcinoma; Pinkus type, Fibroepithelioma of Pinkus type, Fibroepithelioma; NOS, Fibrofolliculoma, Fibroid uterus, Fibrolipoma, Fibroliposarcoma, Fibroma; NOS, Fibromatosis-like metaplastic carcinoma, Fibromyoma, Fibromyxolipoma, Fibromyxoma, Fibromyxosarcoma, Fibrosarcoma; NOS, Fibrosarcomatous dermatofibrosarcoma protuberans, Fibrous astrocytoma, Fibrous histiocytoma of tendon sheath, Fibrous histiocytoma; NOS, Fibrous meningioma, Fibrous mesothelioma; benign, Fibrous mesothelioma; malignant, Fibrous mesothelioma; NOS, Fibrous papule of nose, Fibroxanthoma; malignant, Fibroxanthoma; NOS, Flat adenoma, Flat intraepithelial glandular neoplasia; high grade, Flat intraepithelial neoplasia; high grade, Florid osseous dysplasia, Follicular adenocarcinoma; moderately differentiated, Follicular adenocarcinoma; NOS, Follicular adenocarcinoma; trabecular, Follicular adenocarcinoma; well differentiated, Follicular adenoma, Follicular adenoma; oxyphilic cell, Follicular carcinoma; encapsulated, Follicular carcinoma; minimally invasive, Follicular carcinoma; moderately differentiated, Follicular carcinoma; NOS, Follicular carcinoma; oxyphilic cell, Follicular carcinoma; trabecular, Follicular carcinoma; well differentiated, Follicular dendritic cell sarcoma, Follicular dendritic cell tumor, Follicular fibroma, Follicular lymphoma; grade 1, Follicular lymphoma; grade 2, Follicular lymphoma; grade 3, Follicular lymphoma; grade 3A, Follicular lymphoma; grade 3B, Follicular lymphoma; NOS, Follicular lymphoma; small cleaved cell, Follicular thyroid carcinoma (FTC); encapsulated angioinvasive, Folliculome lipidique, Franklin disease, G cell tumor; malignant, G cell tumor; NOS, Gamma heavy chain disease, Gangliocytic paraganglioma, Gangliocytoma, Ganglioglioma; anaplastic, Ganglioglioma; NOS, Ganglioneuroblastoma, Ganglioneuroma, Ganglioneuromatosis, GANT, Gastrin cell tumor, Gastrin cell tumor; malignant, Gastrinoma; malignant, Gastrinoma; NOS, Gastrointestinal autonomic nerve tumor, Gastrointestinal pacemaker cell tumor, Gastrointestinal stromal sarcoma, Gastrointestinal stromal tumor; benign, Gastrointestinal stromal tumor; malignant, Gastrointestinal stromal tumor; NOS, Gastrointestinal stromal tumor; uncertain malignant potential, Gelatinous adenocarcinoma, Gelatinous carcinoma, Gemistocytic astrocytoma, Gemistocytoma, Genital rhabdomyoma, Germ cell tumor; nonseminomatous, Germ cell tumor; NOS, Germ cell tumors with associated hematological malignancy, Germinoma, Ghost cell odontogenic carcinoma, Giant cell and spindle cell carcinoma, Giant cell angiofibroma, Giant cell carcinoma, Giant cell fibroblastoma, Giant cell glioblastoma, Giant cell sarcoma, Giant cell sarcoma of bone, Giant cell tumor of bone; malignant, Giant cell tumor of bone; NOS, Giant cell tumor of soft parts; NOS, Giant cell tumor of tendon sheath, Giant cell tumor of tendon sheath; malignant, Giant fibroadenoma, Giant osteoid osteoma, Giant pigmented nevus; NOS, Gigantiform cementoma, GIST; benign, GIST; malignant, GIST; NOS, Glandular intraepithelial neoplasia; grade I, Glandular intraepithelial neoplasia; grade II, Glandular intraepithelial neoplasia; grade III, Glandular intraepithelial neoplasia; high grade, Glandular intraepithelial neoplasia; low grade, Glandular papilloma, Glassy cell carcinoma, Glioblastoma, Glioblastoma multiforme, Glioblastoma with sarcomatous component, Glioblastoma; IDH wildtype, Glioblastoma; IDH-mutant, Gliofibroma, Glioma; malignant, Glioma; NOS, Gliomatosis cerebri, Glioneuroma, Gliosarcoma, Glomangioma, Glomangiomyoma, Glomangiosarcoma, Glomoid sarcoma, Glomus jugulare tumor; NOS, Glomus tumor; malignant, Glomus tumor; NOS, Glucagon-like peptide-producing tumor, Glucagonoma; malignant, Glucagonoma; NOS, Glycogen-rich carcinoma, Glycogenic rhabdomyoma, Goblet cell carcinoid, Gonadal stromal tumor; NOS, Gonadoblastoma, Gonocytoma, Granular cell adenocarcinoma, Granular cell carcinoma, Granular cell myoblastoma; malignant, Granular cell myoblastoma; NOS, Granular cell tumor of the sellar region, Granular cell tumor; malignant, Granular cell tumor; NOS, Granulocytic leukemia; NOS, Granulocytic sarcoma, Granulosa cell carcinoma, Granulosa cell tumor; adult type, Granulosa cell tumor; juvenile, Granulosa cell tumor; malignant, Granulosa cell tumor; NOS, Granulosa cell tumor; sarcomatoid, Granulosa cell-theca cell tumor, Grawitz tumor, Gynandroblastoma, Haemangioblastoma, Haemangiosarcoma, Hairy cell leukaemia variant, Hairy cell leukemia, Hairy cell leukemia variant, Hairy nevus, Halo nevus, Hand-Schuller-Christian disease, Heavy chain disease; NOS, Hemangioblastic meningioma, Hemangioendothelial sarcoma, Hemangioendothelioma; benign, Hemangioendothelioma; malignant, Hemangioendothelioma; NOS, Hemangioma simplex, Hemangioma; NOS, Hemangiopericytic meningioma, Hemangiopericytoma; benign, Hemangiopericytoma; malignant, Hemangiopericytoma; NOS, Hemolymphangioma, Hepatoblastoma, Hepatoblastoma; epithelioid, Hepatoblastoma; mixed epithelial-mesenchymal, Hepatocarcinoma, Hepatocellular adenoma, Hepatocellular carcinoma; clear cell type, Hepatocellular carcinoma; fibrolamellar, Hepatocellular carcinoma; NOS, Hepatocellular carcinoma; pleomorphic type, Hepatocellular carcinoma; sarcomatoid, Hepatocellular carcinoma; scirrhous, Hepatocellular carcinoma; spindle cell variant, Hepatocholangiocarcinoma, Hepatoid adenocarcinoma, Hepatoid carcinoma, Hepatoid yolk sac tumor, Hepatoma; benign, Hepatoma; malignant, Hepatoma; NOS, Hepatosplenic gamma-delta cell lymphoma, Hepatosplenic T-cell lymphoma, Hereditary leiomyomatosis & RCC-associated renal cell carcinoma, Hibernoma, Hidradenocarcinoma, Hidradenoma papilliferum, Hidradenoma; NOS, Hidrocystoma, High grade surface osteosarcoma, High-grade neuroendocrine carcinoma, High-grade serous carcinoma, Hilar cell tumor, Hilus cell tumor, Histiocyte-rich large B-cell lymphoma, Histiocytic medullary reticulosis, Histiocytic sarcoma, Histiocytoid hemangioma, Histiocytoma; NOS, Histiocytosis X; NOS, Hodgkin disease; lymphocyte predominance; diffuse, Hodgkin disease; lymphocyte predominance; NOS, Hodgkin disease; lymphocytic-histiocytic predominance, Hodgkin disease; nodular sclerosis; lymphocyte depletion, Hodgkin disease; nodular sclerosis; lymphocyte predominance, Hodgkin disease; nodular sclerosis; mixed cellularity, Hodgkin disease; nodular sclerosis; NOS, Hodgkin disease; nodular sclerosis; syncytial variant, Hodgkin disease; NOS, Hodgkin granuloma, Hodgkin lymphoma; lymphocyte depletion; diffuse fibrosis, Hodgkin lymphoma; lymphocyte depletion; NOS, Hodgkin lymphoma; lymphocyte depletion; reticular, Hodgkin lymphoma; lymphocyte predominance; nodular, Hodgkin lymphoma; lymphocyte-rich, Hodgkin lymphoma; mixed cellularity; NOS, Hodgkin lymphoma; nodular lymphocyte predominance, Hodgkin lymphoma; nodular sclerosis; cellular phase, Hodgkin lymphoma; nodular sclerosis; grade 1, Hodgkin lymphoma; nodular sclerosis; grade 2, Hodgkin lymphoma; nodular sclerosis; NOS, Hodgkin lymphoma; NOS, Hodgkin paragranuloma; nodular, Hodgkin paragranuloma; NOS, Hodgkin sarcoma, Hurthle cell adenocarcinoma, Hurthle cell adenoma, Hurthle cell carcinoma, Hurthle cell tumor, Hutchinson melanotic freckle; NOS, Hyalinizing trabecular adenoma, Hydatid mole, Hydatidiform mole; NOS, Hydroa vacciniforme-like lymphoma, Hygroma; NOS, Hypereosinophilic syndrome, Hypernephroid tumor, Hypernephroma, Idiopathic hemorrhagic thrombocythaemia, Idiopathic thrombocythemia, Immature teratoma; malignant, Immature teratoma; NOS, Immunoblastic sarcoma, Immunocytoma, Immunoglobulin deposition disease, Immunoproliferative disease; NOS, Immunoproliferative small intestinal disease, Indeterminate dendritic cell tumor, Indolent systemic mastocytosis, Infantile fibrosarcoma, Infantile hemangioma, Infantile myofibromatosis, Infiltrating and papillary adenocarcinoma, Infiltrating angiolipoma, Infiltrating basal cell carcinoma; non-sclerosing, Infiltrating basal cell carcinoma; NOS, Infiltrating basal cell carcinoma; sclerosing, Infiltrating duct adenocarcinoma, Infiltrating duct and colloid carcinoma, Infiltrating duct and cribriform carcinoma, Infiltrating duct and lobular carcinoma, Infiltrating duct and lobular carcinoma in situ, Infiltrating duct and mucinous carcinoma, Infiltrating duct and tubular carcinoma, Infiltrating duct carcinoma; NOS, Infiltrating duct mixed with other types of carcinoma, Infiltrating ductular carcinoma, Infiltrating lipoma, Infiltrating lobular carcinoma and ductal carcinoma in situ, Infiltrating lobular carcinoma; NOS, Infiltrating lobular mixed with other types of carcinoma, Infiltrating papillary adenocarcinoma, Inflammatory adenocarcinoma, Inflammatory carcinoma, Inflammatory liposarcoma, Inflammatory myofibroblastic tumor, Insular carcinoma, Insulinoma; malignant, Insulinoma; NOS, Interdigitating cell sarcoma, Interdigitating dendritic cell sarcoma, Intermediate and giant congenital nevus, Interstitial cell tumor; benign, Interstitial cell tumor; malignant, Interstitial cell tumor; NOS, Intestinal T-cell lymphoma, Intestinal-type adenocarcinoma, Intimal sarcoma, Intracanalicular fibroadenoma, Intracortical osteosarcoma, Intracystic carcinoma; NOS, Intracystic papillary adenocarcinoma, Intracystic papillary adenoma, Intracystic papillary neoplasm with associated invasive carcinoma, Intracystic papillary neoplasm with high grade intraepithelial neoplasia, Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia, Intracystic papillary neoplasm with low grade intraepithelial neoplasia, Intracystic papillary tumor with high grade dysplasia, Intracystic papillary tumor with high grade entraepithelial neoplasia, Intracystic papillary tumor with high grade intraepithelial neoplasia, Intracystic papilloma, Intradermal nevus, Intraductal adenocarcinoma; noninfiltrating; NOS, Intraductal and lobular carcinoma, Intraductal carcinoma and lobular carcinoma in situ, Intraductal carcinoma; clinging, Intraductal carcinoma; noninfiltrating; NOS, Intraductal carcinoma; NOS, Intraductal carcinoma; solid type, Intraductal micropapillary carcinoma, Intraductal papillary adenocarcinoma with invasion, Intraductal papillary adenocarcinoma; NOS, Intraductal papillary carcinoma, Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma, Intraductal papillary mucinous neoplasm with an associated invasive carcinoma, Intraductal papillary mucinous neoplasm with high grade dysplasia, Intraductal papillary neoplasm with associated invasive carcinoma, Intraductal papillary neoplasm with high grade dysplasia, Intraductal papillary neoplasm with high grade intraepithelial neoplasia, Intraductal papillary neoplasm with intermediate grade neoplasia, Intraductal papillary neoplasm with low grade intraepithelial neoplasia, Intraductal papillary neoplasm; NOS, Intraductal papillary tumor with high grade dysplasia, Intraductal papillary tumor with high grade intraepithelial neoplasia, Intraductal papillary-mucinous adenoma, Intraductal papillary-mucinous carcinoma; invasive, Intraductal papillary-mucinous carcinoma; non-invasive, Intraductal papillary-mucinous neoplasm with low grade dysplasia, Intraductal papillary-mucinous neoplasm with moderate dysplasia, Intraductal papillary-mucinous tumor with intermediate dysplasia, Intraductal papillary-mucinous tumor with low grade dysplasia, Intraductal papillary-mucinous tumor with moderate dysplasia, Intraductal papilloma, Intraductal papilloma with ductal carcinoma in situ, Intraductal papilloma with lobular carcinoma in situ, Intraductal papillomatosis; NOS, Intraductal tubular-papillary neoplasm; high grade, Intraductal tubular-papillary neoplasm; low grade, Intraductal tubulopapillary neoplasm, Intraepidermal carcinoma; NOS, Intraepidermal epithelioma of Jadassohn, Intraepidermal nevus, Intraepidermal squamous cell carcinoma; Bowen type, Intraepithelial carcinoma; NOS, Intraepithelial squamous cell carcinoma, Intraglandular papillary neoplasm with low grade intraepithelial neoplasia, Intramuscular hemangioma, Intramuscular lipoma, Intraneural perineurioma, Intraosseous low grade osteosarcoma, Intraosseous well differentiated osteosarcoma, Intratubular germ cell neoplasia, Intratubular malignant germ cells, Intravascular B-cell lymphoma, Intravascular bronchial alveolar tumor, Intravascular large B-cell lymphoma, Intravascular leiomyomatosis, Invasive carcinoma of no special type, Invasive carcinoma; NST, Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC), Invasive fibroma, Invasive hydatidiform mole, Invasive lobular carcinoma, Invasive lobular carcinoma; alveolar type, Invasive lobular carcinoma; solid type, Invasive lobular carcinoma; tubulolobular variant, Invasive mammary carcinoma, Invasive micropapillary carcinoma, Invasive mole; NOS, Invasive mucinous adenocarcinoma, Involuting nevus, Islet cell adenocarcinoma, Islet cell adenoma, Islet cell adenomatosis, Islet cell carcinoma, Islet cell tumor; benign, Islet cell tumor; NOS, Jadassohn blue nevus, Jugular paraganglioma, Jugulotympanic paraganglioma, Junction nevus, Junctional nevus; NOS, Juvenile angiofibroma, Juvenile astrocytoma, Juvenile carcinoma of breast, Juvenile chronic myelomonocytic leukemia, Juvenile fibroadenoma, Juvenile hemangioma, Juvenile histiocytoma, Juvenile melanoma, Juvenile myelomonocytic leukemia, Juvenile nevus, Juxtacortical chondroma, Juxtacortical chondrosarcoma, Juxtacortical osteosarcoma, Juxtaglomerular tumor, Kaposi sarcoma, Kaposiform hemangioendothelioma, Keratotoc papilloma, Klatskin tumor, Krukenberg tumor, Kupffer cell sarcoma, L-cell tumor, Lactating adenoma, Langerhans cell granulomatosis, Langerhans cell granulomatosis; unifocal, Langerhans cell histiocytosis; disseminated, Langerhans cell histiocytosis; generalized, Langerhans cell histiocytosis; mono-ostotic, Langerhans cell histiocytosis; multifocal, Langerhans cell histiocytosis; NOS, Langerhans cell histiocytosis; poly-ostotic, Langerhans cell histiocytosis; unifocal, Langerhans cell sarcoma, Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease, Large cell (Ki-1+) lymphoma, Large cell calcifying Sertoli cell tumor, Large cell carcinoma with rhabdoid phenotype, Large cell carcinoma; NOS, Large cell medulloblastoma, Large cell neuroendocrine carcinoma, Large granular lymphocytosis; NOS, LCIS; NOS, Leiomyoblastoma, Leiomyofibroma, Leiomyoma; NOS, Leiomyomatosis; NOS, Leiomyosarcoma; NOS, Lennert lymphoma, Lentigo maligna, Lentigo maligna melanoma, Lepidic adenocarcinoma, Lepidic predominant adenocarcinoma, Leptomeningeal sarcoma, Letterer-Siwe disease, Leukemia; NOS, Leukemic reticuloendotheliosis, Leydig cell tumor; benign, Leydig cell tumor; malignant, Leydig cell tumor; NOS, Linitis plastica, Lipid cell tumor of ovary, Lipid-rich carcinoma, Lipid-rich Sertoli cell tumor, Lipid-rich urothelial carcinoma, Lipoadenoma, Lipoblastoma, Lipoblastomatosis, Lipoid cell tumor of ovary, Lipoleiomyoma, Lipoma-like liposarcoma, Lipoma; NOS, Lipomatous medulloblastoma, Liposarcoma; differentiated, Liposarcoma; NOS, Liposarcoma; well differentiated, Liver cell adenoma, Liver cell carcinoma, Lobular adenocarcinoma, Lobular and ductal carcinoma, Lobular carcinoma in situ; NOS, Lobular carcinoma; noninfiltrating, Lobular carcinoma; NOS, Localized fibrous tumor, Low grade adenosquamous carcinoma, Low grade appendiceal mucinous neoplasm, Low grade cribriform cystadenocarcinoma (LGCCC), Low-grade central osteosarcoma, Low-grade fibromyxoid sarcoma, Low-grade intramedullary osteosarcoma, Low-grade myofibroblastic sarcoma, Low-grade serous carcinoma, Luteinoma, Luteoma; NOS, Lymphangioendothelial sarcoma, Lymphangioendothelioma; malignant, Lymphangioendothelioma; NOS, Lymphangioleiomyomatosis, Lymphangioma; NOS, Lymphangiomyoma, Lymphangiomyomatosis, Lymphangiosarcoma, Lymphatic leukemic; NOS, Lymphoblastic leukemia; NOS, Lymphoblastoma, Lymphocytic leukemia; NOS, Lymphoepithelial carcinoma, Lymphoepithelioid lymphoma, Lymphoepithelioma, Lymphoepithelioma-like carcinoma, Lymphoid leukemia; NOS, Lymphoma; NOS, Lymphomatoid granulomatosis, Lymphomatoid papulosis, Lymphoplasmacyte-rich meningioma, Lymphoproliferative disease; NOS, Lymphoproliferative disorder; NOS, Lymphosarcoma cell leukemia, Lymphosarcoma; diffuse, Lymphosarcoma; NOS, M6A, M6B, Macrofollicular adenoma, Magnocellular nevus, Malignancy, Malignant chondroid syringoma, Malignant cystic nephroma, Malignant eccrine spiradenoma, Malignant fibrous histiocytoma, Malignant fibrous histiocytoma (MFH) of bone, Malignant giant cell tumor of soft parts, Malignant histiocytosis, Malignant hydatidiform mole, Malignant lymphoma; centroblastic; diffuse, Malignant lymphoma; centroblastic; follicular, Malignant lymphoma; centroblastic; NOS, Malignant lymphoma; centroblasticcentrocytic; diffuse, Malignant lymphoma; centroblasticcentrocytic; follicular, Malignant lymphoma; centroblasticcentrocytic; NOS, Malignant lymphoma; centrocytic, Malignant lymphoma; cleaved cell; NOS, Malignant lymphoma; convoluted cell, Malignant lymphoma; diffuse; NOS, Malignant lymphoma; follicle center; follicular, Malignant lymphoma; follicle center; NOS, Malignant lymphoma; follicular; NOS, Malignant lymphoma; histiocytic; diffuse, Malignant lymphoma; histiocytic; nodular, Malignant lymphoma; histiocytic; NOS, Malignant lymphoma; Hodgkin, Malignant lymphoma; immunoblastic; NOS, Malignant lymphoma; large B-cell; diffuse; centroblastic; NOS, Malignant lymphoma; large B-cell; diffuse; immunoblastic; NOS, Malignant lymphoma; large B-cell; diffuse; NOS, Malignant lymphoma; large B-cell; NOS, Malignant lymphoma; large cell; cleaved and noncleaved, Malignant lymphoma; large cell; cleaved; diffuse, Malignant lymphoma; large cell; cleaved; NOS, Malignant lymphoma; large cell; diffuse; NOS, Malignant lymphoma; large cell; follicular; NOS, Malignant lymphoma; large cell; immunoblastic, Malignant lymphoma; large cell; noncleaved; diffuse, Malignant lymphoma; large cell; noncleaved; follicular, Malignant lymphoma; large cell; noncleaved; NOS, Malignant lymphoma; large cell; NOS, Malignant lymphoma; large cleaved cell; follicular, Malignant lymphoma; large cleaved cell; NOS, Malignant lymphoma; lymphoblastic; NOS, Malignant lymphoma; lymphocytic; diffuse; NOS, Malignant lymphoma; lymphocytic; intermediate differentiation; diffuse, Malignant lymphoma; lymphocytic; intermediate differentiation; nodular, Malignant lymphoma; lymphocytic; nodular; NOS, Malignant lymphoma; lymphocytic; NOS, Malignant lymphoma; lymphocytic; poorly differentiated; diffuse, Malignant lymphoma; lymphocytic; poorly differentiated; nodular, Malignant lymphoma; lymphocytic; well differentiated; diffuse, Malignant lymphoma; lymphocytic; well differentiated; nodular, Malignant lymphoma; lymphoplasmacytic, Malignant lymphoma; lymphoplasmacytoid, Malignant lymphoma; mixed cell type; diffuse, Malignant lymphoma; mixed cell type; follicular, Malignant lymphoma; mixed cell type; nodular, Malignant lymphoma; mixed lymphocytic-histiocytic; diffuse, Malignant lymphoma; mixed lymphocytic-histiocytic; nodular, Malignant lymphoma; mixed small and large cell; diffuse, Malignant lymphoma; mixed small cleaved and large cell; follicular, Malignant lymphoma; nodular; NOS, Malignant lymphoma; non-cleaved cell; NOS, Malignant lymphoma; non-Hodgkin; NOS, Malignant lymphoma; noncleaved cell; follicular; NOS, Malignant lymphoma; noncleaved; diffuse; NOS, Malignant lymphoma; noncleaved; NOS, Malignant lymphoma; NOS, Malignant lymphoma; plasmacytoid, Malignant lymphoma; small B lymphocytic; NOS, Malignant lymphoma; small cell diffuse, Malignant lymphoma; small cell; noncleaved; diffuse, Malignant lymphoma; small cell; NOS, Malignant lymphoma; small cleaved cell; diffuse, Malignant lymphoma; small cleaved cell; follicular, Malignant lymphoma; small cleaved cell; NOS, Malignant lymphoma; small lymphocytic; diffuse, Malignant lymphoma; small lymphocytic; NOS, Malignant lymphoma; small noncleaved; Burkitt type, Malignant lymphoma; undifferentiated cell type; NOS, Malignant lymphoma; undifferentiated cell; non-Burkitt, Malignant lymphoma; undifferentiated; Burkitt type, Malignant lymphomatous polyposis, Malignant mast cell tumor, Malignant mastocytoma, Malignant mastocytosis, Malignant melanoma in congenital melanocytic nevus, Malignant melanoma in giant pigmented nevus, Malignant melanoma in Hutchinson melanotic freckle, Malignant melanoma in junctional nevus, Malignant melanoma in precancerous melanosis, Malignant melanoma; NOS, Malignant melanoma; regressing, Malignant midline reticulosis, Malignant mucinous adenofibroma, Malignant mucinous cystadenofibroma, Malignant multilocular cystic nephroma, Malignant myelosclerosis, Malignant myoepithelioma, Malignant peripheral nerve sheath tumor, Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation, Malignant perivascular epithelial cell tumor, Malignant reticulosis; NOS, Malignant rhabdoid tumor, Malignant schwannoma with rhabdomyoblastic differentiation, Malignant schwannoma; NOS, Malignant serous adenofibroma, Malignant serous cystadenofibroma, Malignant tenosynovial giant cell tumor, Malignant teratoma; anaplastic, Malignant teratoma; intermediate, Malignant teratoma; trophoblastic, Malignant teratoma; undifferentiated, Malignant tumor; clear cell type, Malignant tumor; fusiform cell type, Malignant tumor; giant cell type, Malignant tumor; small cell type, Malignant tumor; spindle cell type, MALT lymphoma, Mammary carcinoma; in situ, MANEC, Mantle cell lymphoma (Includes all variants blastic; pleomorphic; small cell), Mantle zone lymphoma, Marginal zone B-cell lymphoma; NOS, Marginal zone lymphoma; NOS, Masculinovoblastoma, Mast cell leukaemia, Mast cell sarcoma, Mast cell tumor; NOS, Mastocytoma; NOS, Matrical carcinoma, Mature T ALL, Mature T-cell lymphoma; NOS, Mature teratoma, Mediastinal (thymic) large B-cell lymphoma, Mediterranean lymphoma, Medullary adenocarcinoma, Medullary carcinoma with amyloid stroma, Medullary carcinoma with lymphoid stroma, Medullary carcinoma; NOS, Medullary osteosarcoma, Medulloblastoma with extensive nodularity, Medulloblastoma; classic, Medulloblastoma; group 3, Medulloblastoma; group 4, Medulloblastoma; non-WNT/non-SHH, Medulloblastoma; NOS, Medulloblastoma; SHH-activated and TP53-mutant, Medulloblastoma; SHH-activated and TP53-wildtype, Medulloblastoma; WNT-activated, Medullocytoma, Medulloepithelioma; benign, Medulloepithelioma; NOS, Medullomyoblastoma, Megakaryocytic leukemia, Megakaryocytic myelosclerosis, Melanoameloblastoma, Melanocytic nevus, Melanocytoma; eyeball, Melanocytoma; NOS, Melanoma in situ, Melanoma; malignant; of soft parts, Melanoma; NOS, Melanotic medulloblastoma, Melanotic MPNST, Melanotic neuroectodermal tumor, Melanotic neurofibroma, Melanotic progonoma, Melanotic psammomatous MPNST, Melanotic schwannoma, Meningeal melanocytoma, Meningeal melanoma, Meningeal melanomatosis, Meningeal sarcoma, Meningeal sarcomatosis, Meningioma; anaplastic, Meningioma; malignant, Meningioma; NOS, Meningiomatosis; NOS, Meningothelial meningioma, Meningothelial sarcoma, Merkel cell carcinoma, Merkel cell tumor, Mesenchymal chondrosarcoma, Mesenchymal tumor; malignant, Mesenchymoma; benign, Mesenchymoma; malignant, Mesenchymoma; NOS, Mesenteric fibromatosis, Mesoblastic nephroma, Mesodermal mixed tumor, Mesonephric adenocarcinoma, Mesonephric adenoma, Mesonephric tumor; NOS, Mesonephroma; benign, Mesonephroma; malignant, Mesonephroma; NOS, Mesothelial papilloma, Mesothelioma; benign, Mesothelioma; biphasic; malignant, Mesothelioma; biphasic; NOS, Mesothelioma; malignant, Mesothelioma; NOS, Metanephric adenoma, Metaplastic carcinoma of no special type, Metaplastic carcinoma with chondroid differentiation, Metaplastic carcinoma with osseous differentiation, Metaplastic carcinoma with other types mesenchymal differentiation, Metaplastic carcinoma; NOS, Metaplastic meningioma, Metastasizing leiomyoma, Metastatic signet ring cell carcinoma, Metatypical carcinoma, MGUS, Microcystic adenoma, Microcystic adnexal carcinoma, Microcystic meningioma, Microcystic urothelial carcinoma, Microfollicular adenoma; NOS, Microglioma, Micropapillary adenocarcinoma, Micropapillary carcinoma; NOS, Micropapillary serous carcinoma, Midline carcinoma of children and young adults with NUT rearrangement, Minimally invasive adenocarcinoma; mucinous, Minimally invasive adenocarcinoma; non-mucinous, Minimally invasive adenocarcinoma; NOS, MiT family translocation renal cell carcinoma, Mixed acidophil-basophil adenoma, Mixed acidophil-basophil carcinoma, Mixed acinar-ductal carcinoma, Mixed acinar-endocrine carcinoma, Mixed acinar-endocrine-ductal carcinoma, Mixed adenocarcinoma and epidermoid carcinoma, Mixed adenocarcinoma and squamous cell carcinoma, Mixed adenomatous and hyperplastic polyp, Mixed adenoneuroendocrine carcinoma, Mixed basal-squamous cell carcinoma, Mixed carcinoid-adenocarcinoma, Mixed cell adenocarcinoma, Mixed cell adenoma, Mixed ductal-endocrine carcinoma, Mixed embryonal carcinoma and teratoma, Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma, Mixed endocrine and exocrine adenocarcinoma, Mixed epithelioid and spindle cell melanoma, Mixed germ cell sex cord-stromal tumor; unclassified, Mixed germ cell tumor, Mixed glioma, Mixed hepatocellular and bile duct carcinoma, Mixed invasive mucinous and non-mucinous adenocarcinoma, Mixed islet cell and exocrine adenocarcinoma, Mixed liposarcoma, Mixed medullary-follicular carcinoma, Mixed medullary-papillary carcinoma, Mixed meningioma, Mixed mesenchymal sarcoma, Mixed mesenchymal tumor, Mixed pancreatic endocrine and exocrine tumor; malignant, Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1, Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged, Mixed phenotype acute leukemia; B/myeloid; NOS, Mixed phenotype acute leukemia; T/myeloid; NOS, Mixed pineal tumor, Mixed pineocytoma-pineoblastoma, Mixed small cell carcinoma, Mixed squamous cell and glandular papilloma, Mixed subependymoma-ependymoma, Mixed teratoma and seminoma, Mixed tumor; malignant; NOS, Mixed tumor; NOS, Mixed tumor; salivary gland type; malignant, Mixed tumor; salivary gland type; NOS, Mixed type rhabdomyosarcoma, Monoblastic leukemia; NOS, Monoclonal gammopathy of undetermined significance, Monoclonal gammopathy; NOS, Monocytic leukemia; NOS, Monocytoid B-cell lymphoma, Monomorphic adenoma, Monstrocellular sarcoma, MPNST with glandular differentiation, MPNST with mesenchymal differentiation, MPNST with rhabdomyoblastic differentiation, MPNST; NOS, Mu heavy chain disease, Mucin-producing adenocarcinoma, Mucin-producing carcinoma, Mucin-secreting adenocarcinoma, Mucin-secreting carcinoma, Mucinous adenocarcinofibroma, Mucinous adenocarcinoma, Mucinous adenocarcinoma; endocervical type, Mucinous adenofibroma of borderline malignancy, Mucinous adenofibroma; NOS, Mucinous adenoma, Mucinous carcinoid, Mucinous carcinoma, Mucinous carcinoma; gastric type, Mucinous carcinoma; intestinal type, Mucinous cystadenocarcinofibroma, Mucinous cystadenocarcinoma; non-invasive, Mucinous cystadenocarcinoma; NOS, Mucinous cystadenofibroma of borderline malignancy, Mucinous cystadenofibroma; NOS, Mucinous cystadenoma; borderline malignancy, Mucinous cystadenoma; NOS, Mucinous cystic neoplasm with an associated invasive carcinoma, Mucinous cystic neoplasm with high-grade dysplasia, Mucinous cystic neoplasm with high-grade intraepithelial neoplasia, Mucinous cystic neoplasm with intermediate-grade dysplasia, Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia, Mucinous cystic neoplasm with low-grade dysplasia, Mucinous cystic neoplasm with low-grade intraepithelial neoplasia, Mucinous cystic tumor of borderline malignancy, Mucinous cystic tumor with an associated invasive carcinoma, Mucinous cystic tumor with high-grade dysplasia, Mucinous cystic tumor with intermediate dysplasia, Mucinous cystic tumor with low grade dysplasia, Mucinous cystic tumor with moderate dysplasia, Mucinous cystoma, Mucinous tubular and spindle cell carcinoma, Mucinous tumor; NOS; of low malignant potential, Mucocarcinoid tumor, Mucoepidermoid carcinoma, Mucoepidermoid tumor, Mucoid adenocarcinoma, Mucoid carcinoma, Mucoid cell adenocarcinoma, Mucoid cell adenoma, Mucosal lentiginous melanoma, Mucosal-associated lymphoid tissue lymphoma, Mucous adenocarcinoma, Mucous carcinoma, Mullerian adenosarcoma, Mullerian mixed tumor, Multicentric basal cell carcinoma, Multicystic mesothelioma; benign, Multifocal superficial basal cell carcinoma, Multiple adenomatous polyps, Multiple endocrine adenomas, Multiple hemorrhagic sarcoma, Multiple meningiomas, Multiple myeloma, Multiple neurofibromatosis, Mycosis fungoides, Myelocytic leukemia; NOS, Myelodysplastic syndrome with 5q deletion (5q-) syndrome, Myelodysplastic syndrome with isolated del (5q), Myelodysplastic syndrome; NOS, Myelodysplastic syndrome; unclassifiable, Myelodysplastic/myeloproliferative neoplasm; unclassifiable, Myelofibrosis as a result of myeloproliferative disease, Myelofibrosis with myeloid metaplasia, Myelogenous leukemia; NOS, Myeloid and lymphoid neoplasms with FGFR1 abnormalities, Myeloid and lymphoid neoplasms with PDGFRA rearrangement, Myeloid leukemia associated with Down Syndrome, Myeloid leukemia; NOS, Myeloid neoplasms with PDGFRB rearrangement, Myeloid sarcoma, Myelolipoma, Myeloma; NOS, Myelomatosis, Myelomonocytic leukemia; NOS, Myeloproliferative disease; NOS, Myeloproliferative neoplasm; NOS, Myelosclerosis with myeloid metaplasia, Myloproliferative neoplasm; unclassifiable, Myoepithelial adenoma, Myoepithelial carcinoma, Myoepithelial tumor, Myoepithelioma, Myofibroblastic sarcoma, Myofibroblastic tumor; NOS, Myofibroblastic tumor; peribronchial, Myofibroblastoma, Myofibroma, Myofibromatosis, Myoma, Myosarcoma, Myxofibroma; NOS, Myxoid chondrosarcoma, Myxoid fibroma, Myxoid leiomyosarcoma, Myxoid liposarcoma, Myxoinflammatory fibroblastic sarcoma (MIFS), Myxolipoma, Myxoliposarcoma, Myxoma; NOS, Myxopapillary ependymoma, Myxosarcoma, Neoplasm; benign, Neoplasm; malignant, Neoplasm; malignant; uncertain whether primary or metastatic, Neoplasm; metastatic, Neoplasm; NOS, Neoplasm; secondary, Neoplasm; uncertain whether benign or malignant, Nephroblastoma; NOS, Nephrogenic adenofibroma, Nephroma; NOS, Nerve sheath myxoma, Nesidioblastoma, Nested urothelial carcinoma, Neurilemoma; malignant, Neurilemoma; NOS, Neurilemosarcoma, Neurinoma, Neurinomatosis, Neuroastrocytoma, Neuroblastoma; NOS, Neurocytoma, Neuroectodermal tumor; NOS, Neuroendocrine carcinoma; low grade, Neuroendocrine carcinoma; moderately differentiated, Neuroendocrine carcinoma; NOS, Neuroendocrine carcinoma; poorly differentiated, Neuroendocrine carcinoma; well-differentiated, Neuroendocrine tumor; grade 1, Neuroendocrine tumor; grade 2, Neuroendocrine tumor; well differentiated, Neuroepithelioma; NOS, Neurofibroma; NOS, Neurofibromatosis; NOS, Neurofibrosarcoma, Neurogenic sarcoma, Neurolipocytoma, Neuroma; NOS, Neuronevus, Neurosarcoma, Neurothekeoma, Neurotropic melanoma; malignant, Nevus; NOS, NK-cell large granular lymphocytic leukemia, NK/T-cell lymphoma; nasal and nasal-type, Nodal marginal zone lymphoma, Nodular hidradenoma, Nodular hidradenoma; malignant, Nodular melanoma, Non-Hodgkin lymphoma; NOS, Non-invasive EFVPTC, Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC), Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), Non-invasive FTP, Non-invasive low grade serous carcinoma, Non-invasive mammary carcinoma, Non-lymphocytic leukemia; NOS, Non-small cell carcinoma, Nonchromaffin paraganglioma; malignant, Nonchromaffin paraganglioma; NOS, Nonencapsulated sclerosing adenocarcinoma, Nonencapsulated sclerosing carcinoma, Nonencapsulated sclerosing tumor, Noninfiltrating intracystic carcinoma, Noninfiltrating intraductal papillary adenocarcinoma, Noninfiltrating intraductal papillary carcinoma, Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia, Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia, Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia, Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia, Nonlipid reticuloendotheliosis, Nonpigmented nevus, NUT carcinoma, NUT midline carcinoma, Oat cell carcinoma, Odontoameloblastoma, Odontogenic carcinoma, Odontogenic carcinosarcoma, Odontogenic fibroma; NOS, Odontogenic fibrosarcoma, Odontogenic ghost cell tumor, Odontogenic myxofibroma, Odontogenic myxoma, Odontogenic sarcoma, Odontogenic tumor; benign, Odontogenic tumor; malignant, Odontogenic tumor; NOS, Odontoma; NOS, Olfactory neuroblastoma, Olfactory neurocytoma, Olfactory neuroepithelioma, Olfactory neurogenic tumor, Oligoastrocytoma, Oligodendroblastoma, Oligodendroglioma; anaplastic, Oligodendroglioma; IDH-mutant and 1p/19q-codeleted, Oligodendroglioma; NOS, Oncocytic adenocarcinoma, Oncocytic adenoma, Oncocytic carcinoma, Oncocytic Schneiderian papilloma, Oncocytoma, Orchioblastoma, Ossifying fibroma, Ossifying fibromyxoid tumor, Ossifying fibromyxoid tumor; malignant, Ossifying renal tumor, Osteoblastic sarcoma, Osteoblastoma; malignant, Osteoblastoma; NOS, Osteocartilaginous exostosis, Osteochondroma, Osteochondromatosis; NOS, Osteochondrosarcoma, Osteofibroma, Osteofibrosarcoma, Osteogenic sarcoma; NOS, Osteoid osteoma; NOS, Osteoma; NOS, Osteosarcoma in Paget disease of bone, Osteosarcoma; NOS, Ovarian stromal tumor, Oxyphilic adenocarcinoma, Oxyphilic adenoma, Pacinian tumor, Paget disease and infiltrating duct carcinoma of breast, Paget disease and intraductal carcinoma of breast, Paget disease of breast, Paget disease; extramammary, Paget disease; mammary, Pagetoid reticulosis, Pancreatic endocrine tumor; benign, Pancreatic endocrine tumor; malignant, Pancreatic endocrine tumor; nonfunctioning, Pancreatic endocrine tumor; NOS, Pancreatic microadenoma, Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor, Pancreatobiliary neoplasm; non-invasive, Pancreatobiliary-type carcinoma, Pancreatoblastoma, Papillary adenocarcinoma; follicular variant, Papillary adenocarcinoma; NOS, Papillary adenofibroma, Papillary adenoma; NOS, Papillary and follicular adenocarcinoma, Papillary and follicular carcinoma, Papillary carcinoma in situ, Papillary carcinoma of thyroid, Papillary carcinoma; columnar cell, Papillary carcinoma; diffuse sclerosing, Papillary carcinoma; encapsulated, Papillary carcinoma; follicular variant, Papillary carcinoma; NOS, Papillary carcinoma; oxyphilic cell, Papillary carcinoma; tall cell, Papillary cystadenocarcinoma; NOS, Papillary cystadenoma lymphomatosum, Papillary cystadenoma; borderline malignancy, Papillary cystadenoma; NOS, Papillary cystic tumor, Papillary ependymoma, Papillary epidermoid carcinoma, Papillary glioneuronal tumor, Papillary hidradenoma, Papillary meningioma, Papillary microcarcinoma, Papillary mucinous cystadenocarcinoma, Papillary mucinous cystadenoma; borderline malignancy, Papillary mucinous cystadenoma; NOS, Papillary mucinous tumor of low malignant potential, Papillary neoplasm; pancreatobiliary-type; with high grade intraepithelial neoplasia, Papillary pseudomucinous cystadenocarcinoma, Papillary pseudomucinous cystadenoma; borderline malignancy, Papillary pseudomucinous cystadenoma; NOS, Papillary renal cell carcinoma, Papillary serous adenocarcinoma, Papillary serous cystadenocarcinoma, Papillary serous cystadenoma; borderline malignancy, Papillary serous cystadenoma; NOS, Papillary serous tumor of low malignant potential, Papillary squamous cell carcinoma, Papillary squamous cell carcinoma in situ, Papillary squamous cell carcinoma; non-invasive, Papillary syringadenoma, Papillary syringocystadenoma, Papillary transitional cell carcinoma, Papillary transitional cell carcinoma; non-invasive, Papillary transitional cell neoplasm of low malignant potential, Papillary tumor of the pineal region, Papillary urothelial carcinoma, Papillary urothelial carcinoma; non-invasive, Papillary urothelial neoplasm of low malignant potential, Papillocystic adenocarcinoma, Papilloma of bladder, Papilloma; NOS, Papillomatosis; glandular, Papillomatosis; NOS, Papillotubular adenocarcinoma, Papillotubular adenoma, Parachordoma, Parafollicular cell carcinoma, Paraganglioma; benign, Paraganglioma; malignant, Paraganglioma; NOS, Parasympathetic paraganglioma, Parietal cell adenocarcinoma, Parietal cell carcinoma, Parosteal osteosarcoma, Partial hydatidiform mole, PEComa; malignant, Periapical cemental dysplasia, Periapical cemento-osseous dysplasia, Pericanalicular fibroadenoma, Periductal stromal tumor; low grade, Perifollicular fibroma, Perineural MPNST, Perineurioma; malignant, Perineurioma; NOS, Periosteal chondroma, Periosteal chondrosarcoma, Periosteal fibroma, Periosteal fibrosarcoma, Periosteal osteosarcoma, Periosteal sarcoma; NOS, Peripheral neuroectodermal tumor, Peripheral odontogenic fibroma, Peripheral primitive neuroectodermal tumor; NOS, Peripheral T-cell lymphoma; AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia), Peripheral T-cell lymphoma; large cell, Peripheral T-cell lymphoma; NOS, Peripheral T-cell lymphoma; pleomorphic medium and large cell, Peripheral T-cell lymphoma; pleomorphic small cell, Perivascular epithelioid cell tumor; malignant, Pheochromoblastoma, Pheochromocytoma; malignant, Pheochromocytoma; NOS, Phosphaturic mesenchymal tumor; malignant, Phyllodes tumor; benign, Phyllodes tumor; borderline, Phyllodes tumor; malignant, Phyllodes tumor; NOS, Pick tubular adenoma, Pigmented adenoma, Pigmented basal cell carcinoma, Pigmented dermatofibrosarcoma protuberans, Pigmented nevus; NOS, Pigmented schwannoma, Pigmented spindle cell nevus of Reed, Pilar tumor, Pilocytic astrocytoma, Piloid astrocytoma, Pilomatricoma; malignant, Pilomatricoma; NOS, Pilomatrix carcinoma, Pilomatrixoma; malignant, Pilomatrixoma; NOS, Pilomyxoid astrocytoma, PIN III, Pindborg tumor, Pineal parenchymal tumor of intermediate differentiation, Pinealoma, Pineoblastoma, Pineocytoma, Pinkus tumor, Pituicytoma, Pituitary adenoma; NOS, Pituitary carcinoma; NOS, Placental site trophoblastic tumor, Plasma cell leukemia, Plasma cell myeloma, Plasma cell tumor, Plasmablastic lymphoma, Plasmacytic leukemia, Plasmacytic lymphoma, Plasmacytoma of bone, Plasmacytoma; extramedullary, Plasmacytoma; NOS, Pleomorphic adenoma, Pleomorphic carcinoma, Pleomorphic cell sarcoma, Pleomorphic leiomyoma, Pleomorphic lipoma, Pleomorphic liposarcoma, Pleomorphic lobular carcinoma, Pleomorphic lobular carcinoma in situ, Pleomorphic rhabdomyosarcoma; adult type, Pleomorphic rhabdomyosarcoma; NOS, Pleomorphic xanthoastrocytoma, Pleuropulmonary blastoma, Plexiform fibrohistiocytic tumor, Plexiform fibromyxoma, Plexiform hemangioma, Plexiform leiomyoma, Plexiform neurofibroma, Plexiform neuroma, Plexiform schwannoma, PNET; NOS, Pneumoblastoma, Polar spongioblastoma, Polycythemia rubra vera, Polycythemia vera, Polyembryoma, Polygonal cell carcinoma, Polymorphic post transplant lymphoproliferative disorder, Polymorphic reticulosis, Polymorphous low grade adenocarcinoma, Polypoid adenoma, Polyvesicular vitelline tumor, Poorly cohesive carcinoma, Porocarcinoma, Post transplant lymphoproliferative disorder; NOS, PP/PYY producing tumor, PPNET, Pre-B ALL, Pre-pre-B ALL, Pre-T ALL, Precancerous melanosis; NOS, Precursor B-cell lymphoblastic leukemia, Precursor B-cell lymphoblastic lymphoma, Precursor cell lymphoblastic leukemia; NOS, Precursor cell lymphoblastic leukemia; not phenotyped, Precursor cell lymphoblastic lymphoma; NOS, Precursor T-cell lymphoblastic leukemia, Precursor T-cell lymphoblastic lymphoma, Preleukemia, Preleukemic syndrome, Primary amyloidosis, Primary cutaneous anaplastic large cell lymphoma, Primary cutaneous CD30+ large T-cell lymphoma, Primary cutaneous CD30+ T-cell lymphoproliferative disorder, Primary cutaneous CD4-positive small/medium T-cell lymphoma, Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma, Primary cutaneous DLBCL; leg type, Primary cutaneous follicle centre lymphoma, Primary cutaneous gamma-delta T-cell lymphoma, Primary cutaneous neuroendocrine carcinoma, Primary diffuse large B-cell lymphoma of the CNS, Primary effusion lymphoma, Primary intraosseous carcinoma, Primary myelofibrosis, Primary serous papillary carcinoma of peritoneum, Primitive neuroectodermal tumor; NOS, Primitive polar spongioblastoma, Pro-B ALL, Pro-T ALL, Prolactinoma, Proliferating trichilemmal cyst, Proliferating trichilemmal tumor, Proliferative dermal lesion in congenital nevus, Proliferative polycythemia, Prolymphocytic leukemia; B-cell type, Prolymphocytic leukemia; NOS, Prolymphocytic leukemia; T-cell type, Prostatic intraepithelial neoplasia; grade III, Protoplasmic astrocytoma, Psammomatous meningioma, Psammomatous schwannoma, Pseudomucinous adenocarcinoma, Pseudomucinous cystadenocarcinoma; NOS, Pseudomucinous cystadenoma; borderline malignancy, Pseudomucinous cystadenoma; NOS, Pseudomyxoma peritonei, Pseudomyxoma peritonei with unknown primary site, Pseudosarcomatous carcinoma, PTLD; NOS, Pulmonary adenomatosis, Pulmonary artery intimal sarcoma, Pulmonary blastoma, Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation, Queyrat erythroplasia, Racemose hemangioma, RAEB, RAEB I, RAEB II, RAEB-T, RARS, Rathke pouch tumor, Recklinghausen disease, Refractory anemia, Refractory anemia with excess blasts, Refractory anemia with excess blasts in transformation, Refractory anemia with ring sideroblasts associated with marked thrombocytosis, Refractory anemia with ringed sideroblasts, Refractory anemia with sideroblasts, Refractory anemia without sideroblasts, Refractory cytopenia of childhood, Refractory cytopenia with multilineage dysplasia, Refractory neutropenia, Refractory thrombocytopenia, Regressing nevus, Renal carcinoma; collecting duct type, Renal cell adenocarcinoma, Renal cell carcinoma; chromophobe type, Renal cell carcinoma; NOS, Renal cell carcinoma; sarcomatoid, Renal cell carcinoma; spindle cell, Renal cell carcinoma; unclassified, Renal medullary carcinoma, Reninoma, Renomedullary fibroma, Renomedullary interstitial cell tumor, Reserve cell carcinoma, Reticulohistiocytoma, Reticulosarcoma; diffuse, Reticulosarcoma; NOS, Reticulum cell sarcoma; diffuse, Reticulum cell sarcoma; NOS, Retinal anlage tumor, Retinoblastoma; differentiated, Retinoblastoma; diffuse, Retinoblastoma; NOS, Retinoblastoma; spontaneously regressed, Retinoblastoma; undifferentiated, Retinocytoma, Retroperitoneal fibromatosis, Rhabdoid meningioma, Rhabdoid sarcoma, Rhabdoid tumor; NOS, Rhabdomyoma; NOS, Rhabdomyosarcoma with ganglionic differentiation, Rhabdomyosarcoma; NOS, Rhabdosarcoma, Rodent ulcer, Rosette-forming glioneuronal tumor, Round cell carcinoma, Round cell liposarcoma, Round cell osteosarcoma, Round cell sarcoma, Salivary duct carcinoma, SALT lymphoma, Sarcoma botryoides, Sarcoma; NOS, Sarcomatoid carcinoma, Sarcomatoid mesothelioma, Sarcomatosis; NOS, Schmincke tumor, Schneiderian carcinoma, Schneiderian papilloma; inverted, Schneiderian papilloma; NOS, Schwannoma; NOS, Scirrhous adenocarcinoma, Scirrhous carcinoma, Sclerosing epithelioid fibrosarcoma, Sclerosing hemangioma, Sclerosing hepatic carcinoma, Sclerosing liposarcoma, Sclerosing rhabdomyosarcoma, Sclerosing stromal tumor, Sclerosing sweat duct carcinoma, Sebaceous adenocarcinoma, Sebaceous adenoma, Sebaceous carcinoma, Sebaceous epithelioma, Secondary carcinoma, Secretory carcinoma of breast, Secretory meningioma, Seminoma with high mitotic index, Seminoma; anaplastic, Seminoma; NOS, Seromucinous carcinoma, Serotonin producing carcinoid, Serous adenocarcinofibroma, Serous adenocarcinoma; NOS, Serous adenofibroma of borderline malignancy, Serous adenofibroma; NOS, Serous borderline tumor-micropapillary variant, Serous carcinoma; NOS, Serous cystadenocarcinofibroma, Serous cystadenocarcinoma; NOS, Serous cystadenofibroma of borderline malignancy, Serous cystadenofibroma; NOS, Serous cystadenoma; borderline malignancy, Serous cystadenoma; NOS, Serous cystoma, Serous endometrial intraepithelial carcinoma, Serous microcystic adenoma, Serous papillary cystic tumor of borderline malignancy, Serous surface papillary carcinoma, Serous surface papillary tumor of borderline malignancy, Serous surface papilloma, Serous tubal intraepithelial carcinoma, Serous tumor; NOS; of low malignant potential, Serrated adenocarcinoma, Serrated adenoma, Sertoli cell adenoma, Sertoli cell carcinoma, Sertoli cell tumor with lipid storage, Sertoli cell tumor; NOS, Sertoli-Leydig cell tumor of intermediate differentiation, Sertoli-Leydig cell tumor; intermediate differentiation; with heterologous elements, Sertoli-Leydig cell tumor; NOS, Sertoli-Leydig cell tumor; poorly differentiated, Sertoli-Leydig cell tumor; poorly differentiated; with heterologous elements, Sertoli-Leydig cell tumor; retiform, Sertoli-Leydig cell tumor; retiform; with heterologous elements, Sertoli-Leydig cell tumor; sarcomatoid, Sertoli-Leydig cell tumor; well differentiated, Sessile serrated adenoma, Sessile serrated polyp, SETTLE, Sex cord tumor with annular tubules, Sex cord tumor; NOS, Sex cord-gonadal stromal tumor; incompletely differentiated, Sex cord-gonadal stromal tumor; mixed forms, Sex cord-gonadal stromal tumor; NOS, Sezary disease, Sezary syndrome, Sialoblastoma, Signet ring cell adenocarcinoma, Signet ring cell carcinoma, Sinonasal papilloma; exophytic, Sinonasal papilloma; fungiform, Sinonasal papilloma; NOS, Skin appendage adenoma, Skin appendage carcinoma, Skin appendage tumor; benign, Skin-associated lymphoid tissue lymphoma, Small cell carcinoma pulmonary type, Small cell carcinoma; fusiform cell, Small cell carcinoma; hypercalcemic type, Small cell carcinoma; intermediate cell, Small cell carcinoma; NOS, Small cell neuroendocrine carcinoma, Small cell osteosarcoma, Small cell sarcoma, Small congenital nevus, Smooth muscle tumor of uncertain malignant potential, Smooth muscle tumor; NOS, Soft tissue perineurioma, Soft tissue sarcoma, Soft tissue tumor; benign, Soft tissue tumor; malignant, Solid adenocarcinoma with mucin formation, Solid and cystic tumor, Solid and papillary epithelial neoplasm, Solid carcinoma with mucin formation, Solid carcinoma; NOS, Solid papillary carcinoma in situ, Solid papillary carcinoma with invasion, Solid pseudopapillary carcinoma, Solid pseudopapillary tumor, Solid teratoma, Solitary fibrous tumor, Solitary fibrous tumor; malignant, Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS), Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS), Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS), Solitary mastocytoma of skin, Solitary myeloma, Solitary plasmacytoma, Somatostatin cell tumor; malignant, Somatostatin cell tumor; NOS, Somatostatinoma; malignant, Somatostatinoma; NOS, Spermatocytic seminoma, Spermatocytoma, Spindle cell angioendothelioma, Spindle cell carcinoma; NOS, Spindle cell hemangioendothelioma, Spindle cell lipoma, Spindle cell melanoma; NOS, Spindle cell melanoma; type A, Spindle cell melanoma; type B, Spindle cell nevus; NOS, Spindle cell oncocytoma, Spindle cell rhabdomyosarcoma, Spindle cell sarcoma, Spindle epithelial tumor with thymus-like differentiation, Spindle epithelial tumor with thymus-like element, Spindled mesothelioma, Spiradenoma; NOS, Spitz nevus, Splenic B-cell lymphoma/leukemia; unclassifiable, Splenic diffuse red pulp small B-cell lymphoma, Splenic lymphoma with villous lymphocytes, Splenic marginal zone B-cell lymphoma, Splenic marginal zone lymphoma; NOS, Spongioblastoma multiforme, Spongioblastoma polare, Spongioblastoma; NOS, Spongioneuroblastoma, Squamotransitional cell carcinoma, Squamous carcinoma, Squamous cell carcinoma in situ with questionable stromal invasion, Squamous cell carcinoma in situ; NOS, Squamous cell carcinoma with horn formation, Squamous cell carcinoma; acantholytic, Squamous cell carcinoma; adenoid, Squamous cell carcinoma; clear cell type, Squamous cell carcinoma; HPV-negative, Squamous cell carcinoma; HPV-positive, Squamous cell carcinoma; keratinizing; NOS, Squamous cell carcinoma; large cell; keratinizing, Squamous cell carcinoma; large cell; nonkeratinizing; NOS, Squamous cell carcinoma; metastatic; NOS, Squamous cell carcinoma; microinvasive, Squamous cell carcinoma; nonkeratinizing; NOS, Squamous cell carcinoma; NOS, Squamous cell carcinoma; pseudoglandular, Squamous cell carcinoma; sarcomatoid, Squamous cell carcinoma; small cell; nonkeratinizing, Squamous cell carcinoma; spindle cell, Squamous cell epithelioma, Squamous cell papilloma; inverted, Squamous cell papilloma; NOS, Squamous intraepithelial neoplasia; grade I, Squamous intraepithelial neoplasia; grade II, Squamous intraepithelial neoplasia; grade III, Squamous intraepithelial neoplasia; high grade, Squamous intraepithelial neoplasia; low grade, Squamous odontogenic tumor, Squamous papilloma, Squamous papillomatosis, Stem cell leukemia, Steroid cell tumor; malignant, Steroid cell tumor; NOS, Stromal endometriosis, Stromal myosis; NOS, Stromal sarcoma; NOS, Stromal tumor with minor sex cord elements, Stromal tumor; benign, Stromal tumor; NOS, Struma ovarii and carcinoid, Struma ovarii; malignant, Struma ovarii; NOS, Strumal carcinoid, Subacute granulocytic leukemia, Subacute leukemia; NOS, Subacute lymphatic leukemia, Subacute lymphocytic leukemia, Subacute lymphoid leukemia, Subacute monocytic leukemia, Subacute myelogenous leukemia, Subacute myeloid leukemia, Subareolar duct papillomatosis, Subcutaneous panniculitis-like T-cell lymphoma, Subependymal astrocytoma; NOS, Subependymal giant cell astrocytoma, Subependymal glioma, Subependymoma, Subepidermal nodular fibrosis, Superficial spreading adenocarcinoma, Superficial spreading melanoma, Superficial well differentiated liposarcoma, Supratentorial PNET, Sweat gland adenocarcinoma, Sweat gland adenoma, Sweat gland carcinoma, Sweat gland tumor; benign, Sweat gland tumor; malignant, Sweat gland tumor; NOS, Sympathetic paraganglioma, Sympathicoblastoma, Symplastic leiomyoma, Syncytial meningioma, Synovial sarcoma; biphasic, Synovial sarcoma; epithelioid cell, Synovial sarcoma; monophasic fibrous, Synovial sarcoma; NOS, Synovial sarcoma; spindle cell, Synovioma; benign, Synovioma; malignant, Synovioma; NOS, Syringadenoma; NOS, Syringocystadenoma papilliferum, Syringofibroadenoma, Syringoma; NOS, Syringomatous carcinoma, Systemic EBV positive T-cell lymphoproliferative disease of childhood, Systemic light chain disease, Systemic mastocytosis with AHNMD, Systemic mastocytosis with associated hematological clonal non-mast cell disorder, Systemic tissue mast cell disease, T lymphoblastic leukemia/lymphoma, T-cell large granular lymphocytic leukemia, T-cell large granular lymphocytosis, T-cell lymphoma; NOS, T-cell rich large B-cell lymphoma, T-cell rich/histiocyte-rich large B-cell lymphoma, T-gamma lymphoproliferative disease, T-zone lymphoma, T/NK-cell lymphoma, Tanycytic ependymoma, Telangiectatic osteosarcoma, Tenosynovial giant cell tumor, Teratoblastoma; malignant, Teratocarcinoma, Teratoid medulloepithelioma, Teratoid medulloepithelioma; benign, Teratoma with malignant transformation, Teratoma; benign, Teratoma; differentiated, Teratoma; malignant; NOS, Teratoma; NOS, Terminal duct adenocarcinoma, Testicular adenoma, Testicular stromal tumor, Theca cell tumor, Theca cell-granulosa cell tumor, Thecoma; luteinized, Thecoma; malignant, Thecoma; NOS, Therapy related myeloid neoplasm, Therapy-related acute myeloid leukemia; alkylating agent related, Therapy-related acute myeloid leukemia; epipodophyllotoxin-related, Therapy-related acute myeloid leukemia; NOS, Therapy-related myelodysplastic syndrome; alkylating agent related, Therapy-related myelodysplastic syndrome; epipodophyllotoxin-related, Therapy-related myelodysplastic syndrome; NOS, Thymic carcinoma with adenoid cystic carcinoma-like features, Thymic carcinoma; NOS, Thymic large B-cell lymphoma, Thymoma; atypical; malignant, Thymoma; atypical; NOS, Thymoma; benign, Thymoma; cortical; malignant, Thymoma; cortical; NOS, Thymoma; epithelial; malignant, Thymoma; epithelial; NOS, Thymoma; lymphocyte-rich; malignant, Thymoma; lymphocyte-rich; NOS, Thymoma; lymphocytic; malignant, Thymoma; lymphocytic; NOS, Thymoma; malignant; NOS, Thymoma; medullary; malignant, Thymoma; medullary; NOS, Thymoma; mixed type; malignant, Thymoma; mixed type; NOS, Thymoma; NOS, Thymoma; organoid; malignant, Thymoma; organoid; NOS, Thymoma; predominantly cortical; malignant, Thymoma; predominantly cortical; NOS, Thymoma; spindle cell; malignant, Thymoma; spindle cell; NOS, Thymoma; type A; malignant, Thymoma; type A; NOS, Thymoma; type AB; malignant, Thymoma; type AB; NOS, Thymoma; type B1; malignant, Thymoma; type B1; NOS, Thymoma; type B2; malignant, Thymoma; type B2; NOS, Thymoma; type B3; malignant, Thymoma; type B3; NOS, Thymoma; type C, Tibial adamantinoma, Trabecular adenocarcinoma, Trabecular adenoma, Trabecular carcinoma, Traditional serrated adenoma, Traditional sessile serrated adenoma, Transient abnormal myelopoiesis, Transitional carcinoma, Transitional cell carcinoma, Transitional cell carcinoma in situ, Transitional cell carcinoma; micropapillary, Transitional cell carcinoma; sarcomatoid, Transitional cell carcinoma; spindle cell, Transitional cell papilloma; benign, Transitional cell papilloma; inverted; benign, Transitional cell papilloma; inverted; NOS, Transitional cell papilloma; NOS, Transitional meningioma, Transitional papilloma, Transitional papilloma; inverted; benign, Transitional papilloma; inverted; NOS, Transitional pineal tumor, Trichilemmal carcinoma, Trichilemmocarcinoma, Trichilemmoma, Trichodiscoma, Trichoepithelioma, Trichofolliculoma, Triton tumor; malignant, Trophoblastic tumor; epithelioid, True histiocytic lymphoma, Tubular adenocarcinoma, Tubular adenoma; NOS, Tubular androblastoma with lipid storage, Tubular androblastoma; NOS, Tubular carcinoid, Tubular carcinoma, Tubulo-papillary adenoma, Tubulocystic renal cell carcinoma, Tubulolobular carcinoma, Tubulopapillary adenocarcinoma, Tubulovillous adenoma; NOS, Tumor cells; benign, Tumor cells; malignant, Tumor cells; NOS, Tumor cells; uncertain whether benign or malignant, Tumor embolus, Tumor; benign, Tumor; malignant; NOS, Tumor; metastatic, Tumor; NOS, Tumor; secondary, Tumorlet; benign, Tumorlet; NOS, Turban tumor, Typical carcinoid, Unclassified tumor; benign, Unclassified tumor; borderline malignancy, Unclassified tumor; malignant, Unclassified tumor; malignant; uncertain whether primary or metastatic, Unclassified tumor; uncertain whether benign or malignant, Undifferentiated epithelioid sarcoma, Undifferentiated high-grade pleomorphic sarcoma, Undifferentiated leukaemia, Undifferentiated pleomorphic sarcoma, Undifferentiated round cell sarcoma, Undifferentiated sarcoma, Undifferentiated spindle cell sarcoma, Undifferentiated uterine sarcoma, Urachal carcinoma, Urothelial carcinoma in situ, Urothelial carcinoma with divergent differentiation, Urothelial carcinoma with squamous differentiation, Urothelial carcinoma with trophoblastic differentiation, Urothelial carcinoma; NOS, Urothelial papilloma; NOS, Urticaria pigmentosa, Vaginal intraepithelial neoplasia; grade III, VAIN III, Vascular leiomyoma, Venous hemangioma, Verrucous carcinoma; NOS, Verrucous epidermoid carcinoma, Verrucous keratotic hemangioma, Verrucous papilloma, Verrucous squamous cell carcinoma, Villoglandular adenoma, Villoglandular carcinoma, Villous adenocarcinoma, Villous adenoma; NOS, Villous papilloma, VIN III, Vipoma; malignant, Vipoma; NOS, Von Recklinghausen disease, Vulvar intraepithelial neoplasia; grade III, Waldenstrom macroglobulinemia, Warthin tumor, Warty carcinoma, Water-clear cell adenocarcinoma, Water-clear cell adenoma, Water-clear cell carcinoma, Well differentiated liposarcoma of superficial soft tissue, Well differentiated papillary mesothelioma; benign, Well differentiated thymic carcinoma, Wilms tumor, Wolffian duct adenoma, Wolffian duct carcinoma, Wolffian duct tumor, Xanthofibroma, Yolk sac tumor, Unknown, Not Reported, Source Data Not Available ",,FALSE,,,,CDS Metadata v1.3.3/Diagnosis,
Collection,The set of metadata entries associated with a Study. A collection defines which resources should be grouped for sharing and reuse.,,"Study Key, PublicationView Key, Biospecimen Key, Source Key, DatasetView Key, ToolView Key, EducationalResource Key",FALSE,,,,,
Collection_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Consortium,Consortium information,,"Component, Consortium_id, Consortium Name, Consortium Display Name, Consortium Full Name, Consortium Description, Consortium Funding Agency, Website",FALSE,,,,,
Consortium Name,"Machine readable name of the research consortium. (e.g. sage_bionetworks, csbc_pson, etc.)",,,TRUE,,,,,
Consortium Display Name,"Human readable display name of research consortium (e.g. Sage Bionetworks, CSBC, PS-ON, etc.)",,,TRUE,,,,,
Consortium Full Name,Full name of research consortium. (e.g. Cancer Systems Biology Consortium).,,,TRUE,,,,,
Consortium Description,Description of research consortium,,,TRUE,,,,,
Consortium Funding Agency,Funding agency of research consortium ,NIH,,TRUE,,,,,
Website,Website of research consortium,,,TRUE,,,,,url
Consortium_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Dataset Name,Name of the dataset,,,TRUE,,,,,
Dataset Alias,"Alias of the dataset. Must be unique. Can be the GEO identifier such as GSE12345, or a DOI. No Greek Letters.",,,TRUE,,,,,unique
Dataset Description,Description of the dataset.,,,FALSE,,,,,
Dataset Design,The overall design of the dataset.,,,FALSE,,,,,
Dataset Url,The url of where the dataset is stored.,,,TRUE,,,,,url
Dataset Assay,"The assay the dataset is representative of. Multiple values permitted, comma separated.","10-cell RNA Sequencing, 16S Ribosomal Gene Sequencing Assay, 3' RNA-seq, 3C, 3C-qPCR, 3D Bioprinting, 3D Cell Culture, 4C, 5C, ATAC-Seq, ATP Bioluminescence Assay, Affinity Purification Mass Spectrometry, Allograft, Amplicon Sequencing, Angiogenesis Assay, Apoptosis Assay, Atomic Absorption Spectrophotometry, Atomic Absorption Spectroscopy, Atomic Force Microscopy, Autoradiography, Barcode-Seq, Bicinchoninic Acid Assay, Binding Assay, Bio-Layer Interferometry, Bioluminescence Imaging, Bisulfite Sequencing, Brightfield Microscopy, Brillouin Microscopy, CASFISH, CITE-seq, CLIP-qPCR, CRISPR, CUT&RUN, CUT&Tag-Sequencing, Cell Adhesion Assay, Cell Proliferation Assay, Cell Viability Assay, Cell-spreading Assay, CellTiter-Glo Luminescent Cell Viability Assay, Cerenkov Luminescence Imaging, ChIA-PET, ChIP-PCR, ChIP-Seq, ChIP-qPCR assay, Chemiluminescent Assay, Chemotaxis Assay, Circular Dichroism Spectroscopy, Co-Immunoprecipitation, Co-culture Assay, Collision-Induced Dissociation, Colorimetric Cell Viability Assay, Computational Modeling, Computational Tool, Computed Tomography, Confocal Microscopy, Confocal Reflectance Quantitative Phase Microscopy, Cross-Linking Immunoprecipitation High-throughput Sequencing, Cross-Linking Mass Spectrometry, Cyclic Immunofluorescence, Cytochemical Stain, Cytokine Expression Profile, Cytometric Bead Array Assay, Cytotoxicity Assay, DBiT-Seq, DNA Gene-Expression Microarray, DNA Methylation Array, DNA Sequencing, DNase-Seq, DRIP-seq, Dark Field Microscopy, Deep Mutational Scanning, Desorption Electrospray Ionization, Dideoxy Chain Termination DNA Sequencing, Differential Interference Contrast Microscopy, Differential Scanning Fluorimetry, Diffusion Weighted Imaging, Direct Long-Read RNA Sequencing, Drop-Seq, Droplet Digital PCR, Dual-Luciferase Reporter Assay, Dye Endocytosis Assay, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Force Spectroscopy, Dynamic Light Scattering, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, ELISA, Efferocytosis Assay, Electron Diffraction, Electron Microscopy, Electron Paramagnetic Resonance Spectroscopy, Electrophoretic Mobility Shift Assay, Electrospray Ionization Time-of-Flight Mass Spectrometry, Endotoxin Assay, Energy-Dispersive X-Ray Spectroscopy, Enzyme Activity Assay, Enzyme-Linked Immunospot Assay, Epidemiological Method, FAIRE-Seq, FISH, Flow Cytometry, Fluorescence Activated Cell Sorting, Fluorescence Correlation Spectroscopy, Fluorescence Imaging, Fluorescence Lifetime Imaging Microscopy, Fluorescence Microscopy, Fluorescence Recovery After Photo-Bleaching, Fluorescent Antibody Procedure, Fluorescent Cell Barcoding, Fluorescent In Situ Sequencing , Focused Ion Beam Scanning Electron Microscopy, Forster Resonance Energy Transfer, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Fourier-Transform Infrared Spectroscopy, Gas Chromatography Mass Spectrometry, Gelatin Zymography, Genotyping, Global Chromatin Profiling, Global Run-On Sequencing, Graphite Furnace Atomic Absorption Spectrometry, HL-Chip, HPLC-MSMS, Hematoxylin and Eosin Staining Method, Hi-C, HiChIP, High Throughput Screening, High-Content Screen, Hydrogels, Hydrophilic Interaction Chromatography, Image Cytometry, Imaging, Immobilized Metal Affinity Chromatography, ImmunoFISH, Immunoassay, Immunocytochemistry, Immunohistochemistry Staining Method, Immunoprecipitation, In Situ Hybridization, In Vitro Cell Killing Assay, In Vitro Model, In Vitro Selection, In Vitro Translation, In Vivo Bioluminescence, In-Cell Western Assay, Inductively-Coupled Plasma Mass Spectrometry, Interference Reflection Microscopy, Intravital Microscopy, Invasion Assay, Karyotyping, Knife-Edge Scanning Microscopy, L1000 mRNA Profiling Assay, Lattice Light Sheet Microscopy, Liquid Chromatography Mass Spectrometry, Liquid Chromatography/Tandem Mass Spectrometry, Low-Vacuum Scanning Electron Microscopy, Luciferase Reporter Assay, Luminescent Cell Viability Assay, MALDI-TOF Mass Spectrometry, MEMA Cell Growth Assay, MNase-Seq, MULTI-Seq, Macrophage Polarization Assay, Magnetic Resonance Imaging, Magnetic Tweezers, Magnetic Twisting Cytometry, Magnetically Activated Cell Sorting, Mammosphere Formation Assay, Mass Cytometry, Mass Spectrometry, Mathematical Modeling, MeDIP, MeRIP-Seq, Methyl Binding Domain Sequencing, Methylation-Specific PCR, Micro-computed Tomography, MicroRNA Expression Array, MicroRNA Sequencing, Microcontact Printing, Microfluidics, Micropipette Adhesion Assay, Micropipette Aspiration, Microscopy, Migration Assay, Mint-ChIP, Modeling, Molecular Simulations, Monolayer Stress Microscopy, Multi-Angle Light Scattering, Multi-Isotope Mass Spectrometry, Multiparametric Magnetic Resonance Imaging, Multiphoton Microscopy, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Multiplexed Immunofluorescence, Multiplexed Immunohistochemistry, Multiplexed Ion Beam Imaging, Murine Model, Nano-hmC-Seal, NanoString Digital Spatial Profiling, Nanopatterning, Nanopore Sequencing, Nanowire, Nested PCR, Next Generation Sequencing, Nm-seq, Not Applicable, Nuclear Magnetic Resonance, Optical Coherence Tomography, Optical Emission Spectroscopy, Optical Mapping, Optical Stretcher, Optical Tweezers, Optogenetic Assay, Organoid, PCR, PET-CT, Paraquat Survival Assay, Partial Wave Spectroscopy, Patient Derived Xenograft, Pending Annotation, Permeability Assay, Phagocytosis Assay, Photoacoustic Imaging, Photolithography, Plasmid Construction, PlateSeq, Point Accumulation for Imaging in Nanoscale Topography, Positron Emission Tomography, Precision Run-On Sequencing, Proteomics Assay, Proximity Ligation Assay, Pull-Down Assay, QFISH, Quantitative Multiplex Immunofluorescence, Quantitative Point Accumulation for Imaging in Nanoscale Topography, Questionnaire, RAS Protein Family Activation Assay, RIP, RIP-Seq, RNA Sequencing, RNAi Screen, RT-PCR, RT-qPCR, Raman Spectroscopy, Reduced Representation Bisulfite Sequencing, Reverse Phase Protein Array, Reverse-Phase High-Performance liquid Chromatography, Rheometry, Ribo-Seq, Ribosomal P Protein Antibody Measurement, Scanning Angle Interference Microscopy, Scanning Electron Microscopy, Second-Harmonic Imaging Microscopy, Shotgun Mass Spectrometry, Single Cell ATAC-Seq, Single Cell Cytokine Detection Chip Assay, Single Cell DNA Sequencing, Single Cell Gel Electrophoresis, Single Cell RNA-Sequencing, Single Molecule Forster Resonance Energy Transfer, Single Nucleotide Polymorphism Array, Single Nucleus RNA-Sequencing, Single-Cell BCR Sequencing, Single-Cell Barcode Chip, Single-Cell TCR Sequencing, Single-Molecule Tracking, Sirius Red Staining, Size Exclusion Chromatography, Small-Angle X-ray Scattering, Soft Agar Assay, Southern Blotting, Spectroscopy, Statistical Modeling, Stimulated Emission Depletion Microscopy, Stimulated Raman Scattering, Stochastic Optical Reconstruction Microscopy, Super-Resolution Microscopy, Surface Plasmon Resonance, Surveyor Nuclease Assay, Synaptophysin Staining Method, Synthetic Genetic Array, TAB-Seq, TCR Sequencing, TIRF Microscopy, TRAP Staining, TUNEL assay, Tandem Mass Spectrometry, Tandem Mass Tagging, Target Engagement Assay, Targeted Genome Sequencing, Targeted Transcriptome Sequencing, Thermal Shift Assay, Thin-Layer Chromatography, Tiling Array, Time Lapse Microscopy, Time-Correlated Single Photon Counting, Tissue Engineering, Tissue Microarray, Total Internal Reflection Fluorescence Microscopy, Traction Force Microscopy, Transmission Electron Microscopy, Transwell Assay, UPLC-MSMS, UV Photocrosslinking, Unspecified, Vibrational Spectroscopy, Virus Plaque Assay, Von Kossa Staining, Western Blotting, Whole Exome Sequencing, Whole Genome Bisulfite Sequencing, Whole Genome Sequencing, Widefield Fluorescence Microscopy, Wound-Healing Assay, X-Ray Crystallography, X-Ray Diffraction, X-Ray Micro-Computed Tomography, Xenograft, cDNA Array, eCLIP-Seq, mRNA Sequencing, qPCR, scCGI-seq, scNT-Seq, scSLAM-seq, seqFISH, shRNA, siRNA, smFISH, smRNA-seq, snRNA-seq, Isothermal Titration Calorimetry, Suspended Microchannel Resonator, 10x Multiome, Visium Spatial Gene Expression, Antitumor Drug Screening Assay, Bioelectrochemical Analysis, Chimeric Antigen Receptor T-Cell Therapy, Cell Cycle Assay, Clonality Analysis, Comparative Genomic Hybridization, Cryo-Electron Microscopy, Cryo-Electron Tomography, Data Integration, Field-Emission Scanning Electron Microscopy, Label-free Protein Quantification by LC/MS, Metabolite Profiling Assay, Reporter Gene Assay, Single-Molecule Localization Microscopy, Synthesis, Targeted Therapy Agent, Trichrome Staining Method, Ultrasound Imaging, Transcription profiling by NanoString, Alcian Blue Staining Method, Artificial Intelligence, Cell Culture, Clinical Study, Cell-free Circulating Tumor DNA Assay, Co-Immunoprecipitation Mass Spectrometry, Deep Learning, Fluorescent In Situ Sequencing, Gene Ontology Enrichment Analysis, Gene Set Enrichment Analysis, Gene Silencing , Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Culture, Imaging Mass Cytometry, Immunofluorescent Staining Method, Immunotherapy, Viral Transduction, Metastatic Colonization Assay, Phylogenetic Analysis, Picrosirius Staining, Scratch Assay, Structural Variant Analysis, Survival Analysis, Targeted Error Correction Sequencing, Tuba-Seq, SDS-PAGE, Cell Fractionation, Multiscale Light Sheet Microscopy, Light Sheet Microscopy",,TRUE,,,,,list like
Dataset Species,"The species the data was collected on. Multiple values permitted, comma separated.","African Bush Elephant, Armadillo, Asian Elephant, Boar, Cat, Chicken, Cow, Dog, Escherichia coli, Guinea Pig, Horse, Human, Human Patient, Human Cell Line, Mouse, Multispecies, Opossum, Rabbit, Rat, Rhesus monkey, Sheep, Trichoplax adhaerens, Unknown, Unspecified, Worm, Yeast, Fruit Fly, Zebrafish",,TRUE,,,,,list like
Dataset Tumor Type,"The tumor type(s), if applicable, of the data collected on. Multiple values permitted, comma separated.","Cutaneous Melanoma, Acinar Cell Carcinoma, Acute Lymphoblastic Leukemia, Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Adenocarcinoma, Angiosarcoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, B Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Barrett Esophagus, Basal Cell Neoplasm, Basal-Like Breast Carcinoma, Biliary Tract Carcinoma, Bladder Carcinoma, Bladder Neoplasm, Bone Neoplasm, Brain Neoplasm, Breast Adenocarcinoma, Breast Carcinoma, Breast Neoplasm, Carcinoma, Carcinoma In Situ, Castration-Resistant Prostate Carcinoma, Cellular Schwannoma, Central Nervous System Cavernous Hemangioma, Central Nervous System Neoplasm, Cerebellar Neoplasm, Cervical Carcinoma, Cervical Neoplasm, Cervical Small Cell Carcinoma, Cholangiocarcinoma, Chondroblastoma, Choriocarcinoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Clear Cell Renal Cell Carcinoma, Colon Adenocarcinoma, Colon Carcinoma, Colorectal Adenocarcinoma, Colorectal Adenoma, Colorectal Carcinoma, Colorectal Neoplasm, Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Craniopharyngioma, Cutaneous T Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Ductal Breast Carcinoma In Situ, Dysembryoplastic Neuroepithelial Neoplasm, Endometrial Carcinoma, Endometrial Neoplasm, Ependymoma, Esophageal Adenocarcinoma, Esophageal Carcinoma, Esophageal Squamous Cell Carcinoma, Ewing Sarcoma, Extraventricular Neurocytoma, Fibroepithelial Polyp, Fibrolamellar Carcinoma, Fibrosarcoma, Follicular Lymphoma, Gallbladder Carcinoma, Gastric Adenocarcinoma, Gastric Carcinoma, Gastric Neoplasm, Gastroesophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Gastrointestinal Stromal Neoplasm, Giant Cell Tumor, Glioblastoma, Glioma, Head and Neck Carcinoma, Head and Neck Neoplasm, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High Grade Ovarian Serous Adenocarcinoma, Histiocytic Sarcoma, Hodgkin Lymphoma, Intestinal Neoplasm, Intrahepatic Cholangiocarcinoma, Invasive Ductal Breast Carcinoma, Kaposi Sarcoma, Leiomyoma, Leukemia, Liver and Intrahepatic Bile Duct Carcinoma, Liver and Intrahepatic Bile Duct Neoplasm, Low Grade Glioma, Luminal A Breast Carcinoma, Lung Adenocarcinoma, Lung Carcinoma, Lung Neoplasm, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Lung Squamous Cell Carcinoma, Lymphoid Leukemia, Lymphoma, Malignant Brain Neoplasm, Malignant Digestive System Neoplasm, Malignant Genitourinary System Neoplasm, Malignant Glioma, Malignant Neoplasm, Malignant Ovarian Neoplasm, Malignant Pancreatic Neoplasm, Malignant Peripheral Nerve Sheath Tumor, Malignant Peritoneal Neoplasm, Malignant Skin Neoplasm, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Medulloblastoma, Melanoma, Meningioma, Mesothelioma, Multiple Myeloma, Mycosis Fungoides, Myeloid Leukemia, Myeloid Neoplasm, Myeloproliferative Neoplasm, Myoepithelioma, Nasopharyngeal Carcinoma, Neuroblastoma, Neuroendocrine Neoplasm, Neuroepithelial Neoplasm, Neurofibroma, Non-Functioning Pituitary Gland Adenoma, Non-Hodgkin Lymphoma, Not Applicable, Oral Cavity Neoplasm, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Neoplasm, Osteosarcoma, Ovarian Adenosarcoma, Ovarian Carcinoma, Ovarian Neoplasm, Ovarian Serous Adenocarcinoma, Pan-cancer, Pancreatic Adenocarcinoma, Pancreatic Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm, Pancreatic Neuroendocrine Carcinoma, Pending Annotation, Penile Carcinoma, Pheochromocytoma, Pilocytic Astrocytoma, Pituitary Gland Adenoma, Plasmablastic Lymphoma, Plasmacytoma, Plexiform Schwannoma, Precursor B-cell lymphoblastic leukemia, Primary Central Nervous System Lymphoma, Primary Myelofibrosis, Prostate Adenocarcinoma, Prostate Carcinoma, Prostate Neoplasm, Rectal Adenocarcinoma, Renal Cell Carcinoma, Retinoblastoma, Rhabdomyosarcoma, Rosette-Forming Glioneuronal Tumor, Salivary Gland Adenoid Cystic Carcinoma, Sarcoma, Schwannoma, Serous Tubal Intraepithelial Carcinoma, Sinonasal Squamous Cell Carcinoma, Skin Carcinoma, Skin Neoplasm, Soft Tissue Sarcoma, Squamous Cell Carcinoma, Synovial Sarcoma, T Acute Lymphoblastic Leukemia, T-Cell Lymphoma, Teratoma, Testicular Embryonal Carcinoma, Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Carcinoma, Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features, Triple-Negative Breast Carcinoma, Urothelial Carcinoma, Uterine Adenosarcoma, Uveal Melanoma, Uveal Neoplasm, Vascular Neoplasm, Not-Applicable, Plexiform Neurofibroma",,FALSE,,,,,list like
Dataset Tissue,"Tissue type(s) associated with the dataset. Multiple values permitted, comma separated.","Gonad, Abdominal Esophagus, Adipose Tissue, Adrenal Gland, Alveolus, Aorta, Artery, Ascending Colon, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Brain, Breast, Caecum, Cancer-Associated Fibroblast, Cardia, Cartilage, Cervix Uteri, Choroid, Colon, Connective and Soft Tissue, Cornea, Duodenum, Ear, Embryo, Embryonic Heart, Endocervix, Endometrium, Endothelium, Epithelium, Esophagus, Eye, Fallopian Tube, Foreskin, Frontal Lobe, Gastroesophageal Junction, Gastrointestinal Tract, Genitourinary, Hair Follicle, Head and Neck, Heart, Heart Muscle, Hematopoietic System, Hippocampus, Intestine, Intra-Abdominal Lymph Nodes, Intrathoracic Lymph Nodes, Joint, Kidney, Larynx, Ligament, Liver, Lung, Lymph, Lymph Node, Lymph Nodes of Axilla or Arm, Lymph Nodes of Inguinal Region or Leg, Lymphatic System, Lymphoid Tissue, Main Bronchus, Mammary Gland, Meninges, Mesenchyme, Mucosa, Muscle, Nasal Cavity, Nervous System, Not Applicable, Olfactory Mucosa, Omentum, Oral Cavity, Oral Mucosa, Ovary, Pancreas, Pelvic Lymph Nodes, Pending Annotation, Periodontal Ligament, Peripheral Nerves, Peritoneum, Pharynx, Pituitary Gland, Placenta, Pleura, Prostate Gland, Rectum, Reproductive System, Respiratory System, Salivary Gland, Sclera, Sinonasal Tract, Skin, Small Intestine, Spinal Cord, Spleen, Stomach, Synovial Membrane, Tendon, Testis, Thymus, Thyroid Gland, Tongue, Tonsil, Trachea, Umbilical Cord, Unspecified, Uterus, Vagina, Vascular Endothelium, Vein, Vertebra, Peripheral Blood Mononuclear Cell",,FALSE,,,,,list like
Dataset File Formats,"A list of file formats associated with the dataset. Multiple values permitted, comma separated.","AVI, BAI, BAM, BED, CDS, CHP, COOL, CSV, DAE, DB, DS_Store, FASTA, FASTQ, FCS, FIG, FREQ, GCG, GCT, GCTx, GFF3, GTF, GZIP Format, HDF, HDF5, HTML, IDAT, JPG, JSON, LIF, MAP, MAT, MATLAB script, MSF, MTX, PDF, PNG, PZFX, Python Script, R File Format, RAW, RDS, ROUT, RPROJ, RTF, SGI, SRA, STAT, TAR Format, TDF, TIFF, TSV, TXT, VCF, WIG, XML, ZIP, bed12, bedgraph, cel, cloupe, docx, mzIdentML, mzXML, pptx, rcc, xls, xlsx, MGF, BIGWIG, H5AD, H5, SF, PKL, BPM, Unspecified, Pending Annotation, maf, CLS, SCN, SVS",,FALSE,,,,,list like
Dataset View,The denormalized manifest for dataset submission.,,"Component, DatasetView_id, Study Key, PublicationView Key, Dataset Name, Dataset Alias, Dataset Description, Dataset Design, Dataset Assay, Dataset Species, Dataset Tumor Type, Dataset Tissue, Dataset Url, Dataset File Formats, Data Use Codes",FALSE,,,Study,,
Dataset Grant Number,"Grant number(s) associated with the dataset's development. Multiple values permitted, comma separated.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
Dataset Pubmed Id,"The PubMed identifer(s) associated with the development of the dataset. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
DatasetView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Educational Resource,Manifest for describing educational resources.,,"Component, EducationalResource_id, Resource Title, Resource Link, Resource Topic, Resource Activity Type, Resource Primary Format, Resource Intended Use, Resource Primary Audience, Resource Educational Level, Resource Description, Resource Origin Institution, Resource Language, Resource Contributors, Resource Grant Number, Resource Secondary Topic, Resource License, Resource Use Requirements, Resource Alias, Resource Internal Identifier, Resource Media Accessibility, Resource Access Hazard, Resource Dataset Alias, Resource Tool Link",FALSE,,,Grant View,,
Resource Title,Title of the item.,,,TRUE,,,,OER,str
Resource Link,The URL or DOI that links to the item.,,,TRUE,,,,OER,url
Resource Topic,"General topic or research context of the item. If 'other' is selected, please provide additional topics in the 'Resource Secondary Topic' field. Multiple values should be provided as a comma separated list.","Computational Model Development, Computational Resource, Diversity/Equity/Inclusion, Drug Resistance/Sensitivity, Epigenetics, Evolution, Experimental Model Development, Heterogeneity, Immunotherapy, Mechano-genetics, Mechano-resistance, Metabolism, Metastasis, Method/Assay Development, Microenvironment, Oncogenic Stress, Other, Outreach, Platform Development, Training Material, Tumor Progression, Tumor-Immune, Computer Science, Environmental Science, Information Science, Educational Technology, Anatomy/Physiology, Biology, Ecology, Genetics, Nutrition, Measurement and Data, Statistics and Probability, Chemistry, Physics, Systems Biology, Patient Advocacy",,TRUE,,,,OER,list like
Resource Activity Type,The type(s) of activities for which the item is intended to be used. Multiple values should be provided as a comma separated list.,"Activity/Lab, Assessment, Case Study, Data Set, Diagram/Illustration, Full Course, Game, Homework/Assignment, Interactive, Lecture, Lecture Notes, Lesson, Lesson Plan, Module, Primary Source, Reading, Simulation, Student Guide, Syllabus, Teaching/Learning Strategy, Textbook, Unit of Study",,TRUE,,,,OER,list like
Resource Primary Format,"The media type(s) of the item (video, audio, text, etc.) Multiple values should be provided as a comma separated list.","Audio, Braille/BNF, Downloadable docs, eBook, Graphics/Photos, Interactive, Mobile, Text/HTML, Video, Other",,TRUE,,,,OER,list like
Resource Intended Use,The purpose of the material for education. Multiple values should be provided as a comma separated list.,"Curriculum/Instruction, Assessment, Professional Development, Other",,TRUE,,,,OER,list like
Resource Primary Audience,The intended end user audience for the resource. Multiple values should be provided as a comma separated list.,"Student, Teacher, Administrator, Parent, Professor, General Audience, Other",,TRUE,,,,OER,list like
Resource Educational Level,"Educational context (pre-school, lower-primary, upper-primary…) in which the item was intended to be used. Multiple values should be provided as a comma separated list.","Preschool, Lower Primary, Upper Primary, Middle School, High School, Community College / Lower Division, College / Upper Division, Graduate / Profession, Career / Technical, Adult Education",,TRUE,,,,OER,list like
Resource Description,Abstract or summary of the item.,,,TRUE,,,,OER,str
Resource Origin Institution,Institution(s) of origin for this item. Multiple values should be provided as a comma separated list.,,,TRUE,,,,OER,list like
Resource Language,Language of the item (not of the metadata). Multiple values should be provided as a comma separated list.,"aa, ab, ae, af, ak, am, an, ar, as, av, ay, az, ba, be, bg, bh, bi, bm, bn, bo, br, bs, ca, ca, ce, ch, co, cr, cs, cu, cv, cy, da, de, dv, dv, dz, ee, el, en, eo, es, et, eu, fa, ff, fi, fj, fo, fr, fy, ga, gd, gl, gn, gu, gv, ha, he, hi, ho, hr, ht, hu, hy, hz, ia, id, ie, ig, ii, ik, io, is, it, iu, ja, jv, ka, kg, ki, kj, kk, kl, km, kn, ko, kr, ks, ku, kv, kw, ky, la, lb, lg, li, ln, lo, lt, lu, lv, mg, mh, mi, mk, ml, mn, mr, ms, mt, my, na, nb, nd, ne, ng, nl, nn, no, nr, nv, ny, oc, oj, om, or, os, pa, pi, pl, ps, pt, qu, rm, rn, ro, ru, rw, sa, sc, sd, se, sg, si, sk, sl, sm, sn, so, sq, sr, ss, st, su, sv, sw, ta, te, tg, th, ti, tk, tl, tn, to, tr, ts, tt, tw, ty, ug, uk, ur, uz, ve, vi, vo, wa, wo, xh, yi, yo, za, zh, zu",,TRUE,,,,OER,list like::regex search [a-z]{2}
Resource Contributors,The name(s) of the contributor(s) to the item. Multiple contributor names should be provided as a comma-separated list.,,,TRUE,,,,OER,list like
Resource Grant Number,"The grant number(s) associated with the contributor(s) of the item. If no grant number listed is applicable, please select 'Affiliated/Non-Grant Associated'. Multiple values should be provided as a comma separated list.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,MC2/grant,list like
Resource Secondary Topic,"Additional topics or keywords to describe the content of the item, in addition to the primary topic. Multiple values should be provided as a comma-separated list.",,,FALSE,,,,OER,list like
Resource License,"The name of the license applied to the item by the contributor(s), if applicable. Multiple values should be provided as a comma separated list.","AAL, ADSL, AFL-1.1, AFL-1.2, AFL-2.0, AFL-2.1, AFL-3.0, AGPL-1.0, AGPL-3.0, AMDPLPA, AML, AMPAS, ANTLR-PD, APAFML, APL-1.0, APSL-1.0, APSL-1.1, APSL-1.2, APSL-2.0, Abstyles, Adobe-2006, Adobe-Glyph, Afmparse, Aladdin, Apache-1.0, Apache-1.1, Apache-2.0, Artistic-1.0, Artistic-1.0-Perl, Artistic-1.0-cl8, Artistic-2.0, BSD-2-Clause, BSD-2-Clause-FreeBSD, BSD-2-Clause-NetBSD, BSD-3-Clause, BSD-3-Clause-Attribution, BSD-3-Clause-Clear, BSD-3-Clause-LBNL, BSD-3-Clause-No-Nuclear-License, BSD-3-Clause-No-Nuclear-License-2014, BSD-3-Clause-No-Nuclear-Warranty, BSD-4-Clause, BSD-4-Clause-UC, BSD-Protection, BSD-Source-Code, BSD-style, BSL-1.0, Bahyph, Barr, Beerware, BitTorrent-1.0, BitTorrent-1.1, Borceux, CATOSL-1.1, CC-BY-1.0, CC-BY-2.0, CC-BY-2.5, CC-BY-3.0, CC-BY-4.0, CC-BY-NC-1.0, CC-BY-NC-2.0, CC-BY-NC-2.5, CC-BY-NC-3.0, CC-BY-NC-4.0, CC-BY-NC-ND-1.0, CC-BY-NC-ND-2.0, CC-BY-NC-ND-2.5, CC-BY-NC-ND-3.0, CC-BY-NC-ND-4.0, CC-BY-NC-SA-1.0, CC-BY-NC-SA-2.0, CC-BY-NC-SA-2.5, CC-BY-NC-SA-3.0, CC-BY-NC-SA-4.0, CC-BY-ND-1.0, CC-BY-ND-2.0, CC-BY-ND-2.5, CC-BY-ND-3.0, CC-BY-ND-4.0, CC-BY-SA-1.0, CC-BY-SA-2.0, CC-BY-SA-2.5, CC-BY-SA-3.0, CC-BY-SA-4.0, CC0-1.0, CDDL-1.0, CDDL-1.1, CECILL-1.0, CECILL-1.1, CECILL-2.0, CECILL-2.1, CECILL-B, CECILL-C, CNRI-Jython, CNRI-Python, CNRI-Python-GPL-Compatible, CPAL-1.0, CPL-1.0, CPOL-1.02, CUA-OPL-1.0, Caldera, ClArtistic, Condor-1.1, Crossword, CrystalStacker, Cube, D-FSL-1.0, DOC, DSDP, Dotseqn, ECL-1.0, ECL-2.0, EFL-1.0, EFL-2.0, EPL-1.0, EUDatagrid, EUPL-1.0, EUPL-1.1, Entessa, ErlPL-1.1, Eurosym, FSFAP, FSFUL, FSFULLR, FTL, Fair, Frameworx-1.0, FreeImage, Freeware, GFDL-1.1, GFDL-1.2, GFDL-1.3, GL2PS, GPL-1.0, GPL-2.0, GPL-3.0, Giftware, Glide, Glulxe, HPND, HaskellReport, IBM-pibs, ICU, IJG, IPA, IPL-1.0, ISC, ImageMagick, Imlib2, Info-ZIP, Intel, Intel-ACPI, Interbase-1.0, JSON, JasPer-2.0, LAL-1.2, LAL-1.3, LGPL-2.0, LGPL-2.1, LGPL-3.0, LGPLLR, LPL-1.0, LPL-1.02, LPPL-1.0, LPPL-1.1, LPPL-1.2, LPPL-1.3a, LPPL-1.3c, Latex2e, Leptonica, LiLiQ-P-1.1, LiLiQ-R-1.1, LiLiQ-Rplus-1.1, Libpng, MIT, MIT-CMU, MIT-advertising, MIT-enna, MIT-feh, MITNFA, MPL-1.0, MPL-1.1, MPL-2.0, MPL-2.0-no-copyleft-exception, MS-PL, MS-RL, MTLL, MakeIndex, MirOS, Motosoto, Multics, Mup, NASA-1.3, NBPL-1.0, NCSA, NGPL, NLOD-1.0, NLPL, NOSL, NPL-1.0, NPL-1.1, NPOSL-3.0, NRL, NTP, Naumen, NetCDF, Newsletr, Nokia, Not licensed, Noweb, Nunit, OCCT-PL, OCLC-2.0, ODbL-1.0, OFL-1.0, OFL-1.1, OGTSL, OLDAP-1.1, OLDAP-1.2, OLDAP-1.3, OLDAP-1.4, OLDAP-2.0, OLDAP-2.0.1, OLDAP-2.1, OLDAP-2.2, OLDAP-2.2.1, OLDAP-2.2.2, OLDAP-2.3, OLDAP-2.4, OLDAP-2.5, OLDAP-2.6, OLDAP-2.7, OLDAP-2.8, OML, OPL-1.0, OSET-PL-2.1, OSL-1.0, OSL-1.1, OSL-2.0, OSL-2.1, OSL-3.0, OpenSSL, Other, PDDL-1.0, PHP-3.0, PHP-3.01, Plexus, PostgreSQL, Proprietary, Python-2.0, QPL-1.0, Qhull, RHeCos-1.1, RPL-1.1, RPL-1.5, RPSL-1.0, RSA-MD, RSCPL, Rdisc, Ruby, SAX-PD, SCEA, SGI-B-1.0, SGI-B-1.1, SGI-B-2.0, SISSL, SISSL-1.2, SMLNJ, SMPPL, SNIA, SPL-1.0, SWL, Saxpath, Sendmail, SimPL-2.0, Sleepycat, Spencer-86, Spencer-94, Spencer-99, SugarCRM-1.1.3, TCL, TMate, TORQUE-1.1, TOSL, UPL-1.0, Unicode-TOU, Unlicense, VOSTROM, VSL-1.0, Vim, W3C, W3C-19980720, WTFPL, Watcom-1.0, Wsuipa, X11, XFree86-1.1, XSkat, Xerox, Xnet, YPL-1.0, YPL-1.1, ZPL-1.1, ZPL-2.0, ZPL-2.1, Zed, Zend-2.0, Zimbra-1.3, Zimbra-1.4, Zlib, bzip2-1.0.5, bzip2-1.0.6, curl, diffmark, dvipdfm, eGenix, gSOAP-1.3b, gnuplot, iMatix, libtiff, mpich2, psfrag, psutils, xinetd, xpp, zlib-acknowledgement",,FALSE,,,,OER,list like
Resource Use Requirements,"A list of materials, hardware, software, computing power, and network requirements that the end user would need to satisfy before using the resource, if applicable. Multiple values should be provided as a comma separated list.",,,FALSE,,,,OER,str
Resource Alias,"A unique identifier (DOI, Synapse ID) for the item, if it exists.",,,FALSE,,,,OER,unique
Resource Internal Identifier,"The institution-specific ID for the item, if applicable. May be non-unique. Multiple values should be provided as a comma separated list.",,,FALSE,,,,OER,list like
Resource Media Accessibility,"Accessibility features (Alternative Text, Audio Description, etc.) incorporated into the item. Multiple values should be provided as a comma separated list.","Alternative Text, Audio Description, Braille, Captions, ChemML, Described Math, Display Transformability, Haptic, High Contrast, Large Print, Latex, Long Description, MathML, Nemeth Braille, Sign Language, Structural Navigation, Tactile Graphics, Text Transcript",,FALSE,,,,OER,list like
Resource Access Hazard,"Sensory hazards (Flashing, Motion, etc.) applicable to the item. Multiple values should be provided as a comma separated list.","Flashing, Motion, Simulation, Sound",,FALSE,,,,OER,list like
Resource Dataset Alias,"URL or persistent identifier (DOI, Synapse ID) for any dataset(s) that is intended to be used with the item. Multiple values should be provided as a comma separated list.",,,FALSE,,,,MC2/dataset,list like
Resource Tool Link,"URL or persistent identifier (DOI, Synapse ID) for any software or tool that is intended to be used with the item. Multiple values should be provided as a comma separated list.",,,FALSE,,,,MC2/tool,list like
EducationalResource_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
File Description,Description of the file.,,,FALSE,,,,,str
File Design,The overall design of the dataset or file.,,,FALSE,,,,,str
File Url,The url of where the file is stored.,,,TRUE,,,,,url
File Assay,The assay the file is representative of.,"10-cell RNA Sequencing, 16S Ribosomal Gene Sequencing Assay, 3' RNA-seq, 3C, 3C-qPCR, 3D Bioprinting, 3D Cell Culture, 4C, 5C, ATAC-Seq, ATP Bioluminescence Assay, Affinity Purification Mass Spectrometry, Allograft, Amplicon Sequencing, Angiogenesis Assay, Apoptosis Assay, Atomic Absorption Spectrophotometry, Atomic Absorption Spectroscopy, Atomic Force Microscopy, Autoradiography, Barcode-Seq, Bicinchoninic Acid Assay, Binding Assay, Bio-Layer Interferometry, Bioluminescence Imaging, Bisulfite Sequencing, Brightfield Microscopy, Brillouin Microscopy, CASFISH, CITE-seq, CLIP-qPCR, CRISPR, CUT&RUN, CUT&Tag-Sequencing, Cell Adhesion Assay, Cell Proliferation Assay, Cell Viability Assay, Cell-spreading Assay, CellTiter-Glo Luminescent Cell Viability Assay, Cerenkov Luminescence Imaging, ChIA-PET, ChIP-PCR, ChIP-Seq, ChIP-qPCR assay, Chemiluminescent Assay, Chemotaxis Assay, Circular Dichroism Spectroscopy, Co-Immunoprecipitation, Co-culture Assay, Collision-Induced Dissociation, Colorimetric Cell Viability Assay, Computational Modeling, Computational Tool, Computed Tomography, Confocal Microscopy, Confocal Reflectance Quantitative Phase Microscopy, Cross-Linking Immunoprecipitation High-throughput Sequencing, Cross-Linking Mass Spectrometry, Cyclic Immunofluorescence, Cytochemical Stain, Cytokine Expression Profile, Cytometric Bead Array Assay, Cytotoxicity Assay, DBiT-Seq, DNA Gene-Expression Microarray, DNA Methylation Array, DNA Sequencing, DNase-Seq, DRIP-seq, Dark Field Microscopy, Deep Mutational Scanning, Desorption Electrospray Ionization, Dideoxy Chain Termination DNA Sequencing, Differential Interference Contrast Microscopy, Differential Scanning Fluorimetry, Diffusion Weighted Imaging, Direct Long-Read RNA Sequencing, Drop-Seq, Droplet Digital PCR, Dual-Luciferase Reporter Assay, Dye Endocytosis Assay, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Force Spectroscopy, Dynamic Light Scattering, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, ELISA, Efferocytosis Assay, Electron Diffraction, Electron Microscopy, Electron Paramagnetic Resonance Spectroscopy, Electrophoretic Mobility Shift Assay, Electrospray Ionization Time-of-Flight Mass Spectrometry, Endotoxin Assay, Energy-Dispersive X-Ray Spectroscopy, Enzyme Activity Assay, Enzyme-Linked Immunospot Assay, Epidemiological Method, FAIRE-Seq, FISH, Flow Cytometry, Fluorescence Activated Cell Sorting, Fluorescence Correlation Spectroscopy, Fluorescence Imaging, Fluorescence Lifetime Imaging Microscopy, Fluorescence Microscopy, Fluorescence Recovery After Photo-Bleaching, Fluorescent Antibody Procedure, Fluorescent Cell Barcoding, Fluorescent In Situ Sequencing , Focused Ion Beam Scanning Electron Microscopy, Forster Resonance Energy Transfer, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Fourier-Transform Infrared Spectroscopy, Gas Chromatography Mass Spectrometry, Gelatin Zymography, Genotyping, Global Chromatin Profiling, Global Run-On Sequencing, Graphite Furnace Atomic Absorption Spectrometry, HL-Chip, HPLC-MSMS, Hematoxylin and Eosin Staining Method, Hi-C, HiChIP, High Throughput Screening, High-Content Screen, Hydrogels, Hydrophilic Interaction Chromatography, Image Cytometry, Imaging, Immobilized Metal Affinity Chromatography, ImmunoFISH, Immunoassay, Immunocytochemistry, Immunohistochemistry Staining Method, Immunoprecipitation, In Situ Hybridization, In Vitro Cell Killing Assay, In Vitro Model, In Vitro Selection, In Vitro Translation, In Vivo Bioluminescence, In-Cell Western Assay, Inductively-Coupled Plasma Mass Spectrometry, Interference Reflection Microscopy, Intravital Microscopy, Invasion Assay, Karyotyping, Knife-Edge Scanning Microscopy, L1000 mRNA Profiling Assay, Lattice Light Sheet Microscopy, Liquid Chromatography Mass Spectrometry, Liquid Chromatography/Tandem Mass Spectrometry, Low-Vacuum Scanning Electron Microscopy, Luciferase Reporter Assay, Luminescent Cell Viability Assay, MALDI-TOF Mass Spectrometry, MEMA Cell Growth Assay, MNase-Seq, MULTI-Seq, Macrophage Polarization Assay, Magnetic Resonance Imaging, Magnetic Tweezers, Magnetic Twisting Cytometry, Magnetically Activated Cell Sorting, Mammosphere Formation Assay, Mass Cytometry, Mass Spectrometry, Mathematical Modeling, MeDIP, MeRIP-Seq, Methyl Binding Domain Sequencing, Methylation-Specific PCR, Micro-computed Tomography, MicroRNA Expression Array, MicroRNA Sequencing, Microcontact Printing, Microfluidics, Micropipette Adhesion Assay, Micropipette Aspiration, Microscopy, Migration Assay, Mint-ChIP, Modeling, Molecular Simulations, Monolayer Stress Microscopy, Multi-Angle Light Scattering, Multi-Isotope Mass Spectrometry, Multiparametric Magnetic Resonance Imaging, Multiphoton Microscopy, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Multiplexed Immunofluorescence, Multiplexed Immunohistochemistry, Multiplexed Ion Beam Imaging, Murine Model, Nano-hmC-Seal, NanoString Digital Spatial Profiling, Nanopatterning, Nanopore Sequencing, Nanowire, Nested PCR, Next Generation Sequencing, Nm-seq, Not Applicable, Nuclear Magnetic Resonance, Optical Coherence Tomography, Optical Emission Spectroscopy, Optical Mapping, Optical Stretcher, Optical Tweezers, Optogenetic Assay, Organoid, PCR, PET-CT, Paraquat Survival Assay, Partial Wave Spectroscopy, Patient Derived Xenograft, Pending Annotation, Permeability Assay, Phagocytosis Assay, Photoacoustic Imaging, Photolithography, Plasmid Construction, PlateSeq, Point Accumulation for Imaging in Nanoscale Topography, Positron Emission Tomography, Precision Run-On Sequencing, Proteomics Assay, Proximity Ligation Assay, Pull-Down Assay, QFISH, Quantitative Multiplex Immunofluorescence, Quantitative Point Accumulation for Imaging in Nanoscale Topography, Questionnaire, RAS Protein Family Activation Assay, RIP, RIP-Seq, RNA Sequencing, RNAi Screen, RT-PCR, RT-qPCR, Raman Spectroscopy, Reduced Representation Bisulfite Sequencing, Reverse Phase Protein Array, Reverse-Phase High-Performance liquid Chromatography, Rheometry, Ribo-Seq, Ribosomal P Protein Antibody Measurement, Scanning Angle Interference Microscopy, Scanning Electron Microscopy, Second-Harmonic Imaging Microscopy, Shotgun Mass Spectrometry, Single Cell ATAC-Seq, Single Cell Cytokine Detection Chip Assay, Single Cell DNA Sequencing, Single Cell Gel Electrophoresis, Single Cell RNA-Sequencing, Single Molecule Forster Resonance Energy Transfer, Single Nucleotide Polymorphism Array, Single Nucleus RNA-Sequencing, Single-Cell BCR Sequencing, Single-Cell Barcode Chip, Single-Cell TCR Sequencing, Single-Molecule Tracking, Sirius Red Staining, Size Exclusion Chromatography, Small-Angle X-ray Scattering, Soft Agar Assay, Southern Blotting, Spectroscopy, Statistical Modeling, Stimulated Emission Depletion Microscopy, Stimulated Raman Scattering, Stochastic Optical Reconstruction Microscopy, Super-Resolution Microscopy, Surface Plasmon Resonance, Surveyor Nuclease Assay, Synaptophysin Staining Method, Synthetic Genetic Array, TAB-Seq, TCR Sequencing, TIRF Microscopy, TRAP Staining, TUNEL assay, Tandem Mass Spectrometry, Tandem Mass Tagging, Target Engagement Assay, Targeted Genome Sequencing, Targeted Transcriptome Sequencing, Thermal Shift Assay, Thin-Layer Chromatography, Tiling Array, Time Lapse Microscopy, Time-Correlated Single Photon Counting, Tissue Engineering, Tissue Microarray, Total Internal Reflection Fluorescence Microscopy, Traction Force Microscopy, Transmission Electron Microscopy, Transwell Assay, UPLC-MSMS, UV Photocrosslinking, Unspecified, Vibrational Spectroscopy, Virus Plaque Assay, Von Kossa Staining, Western Blotting, Whole Exome Sequencing, Whole Genome Bisulfite Sequencing, Whole Genome Sequencing, Widefield Fluorescence Microscopy, Wound-Healing Assay, X-Ray Crystallography, X-Ray Diffraction, X-Ray Micro-Computed Tomography, Xenograft, cDNA Array, eCLIP-Seq, mRNA Sequencing, qPCR, scCGI-seq, scNT-Seq, scSLAM-seq, seqFISH, shRNA, siRNA, smFISH, smRNA-seq, snRNA-seq, Isothermal Titration Calorimetry, Suspended Microchannel Resonator, 10x Multiome, Visium Spatial Gene Expression, Antitumor Drug Screening Assay, Bioelectrochemical Analysis, Chimeric Antigen Receptor T-Cell Therapy, Cell Cycle Assay, Clonality Analysis, Comparative Genomic Hybridization, Cryo-Electron Microscopy, Cryo-Electron Tomography, Data Integration, Field-Emission Scanning Electron Microscopy, Label-free Protein Quantification by LC/MS, Metabolite Profiling Assay, Reporter Gene Assay, Single-Molecule Localization Microscopy, Synthesis, Targeted Therapy Agent, Trichrome Staining Method, Ultrasound Imaging, Transcription profiling by NanoString, Alcian Blue Staining Method, Artificial Intelligence, Cell Culture, Clinical Study, Cell-free Circulating Tumor DNA Assay, Co-Immunoprecipitation Mass Spectrometry, Deep Learning, Fluorescent In Situ Sequencing, Gene Ontology Enrichment Analysis, Gene Set Enrichment Analysis, Gene Silencing , Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Culture, Imaging Mass Cytometry, Immunofluorescent Staining Method, Immunotherapy, Viral Transduction, Metastatic Colonization Assay, Phylogenetic Analysis, Picrosirius Staining, Scratch Assay, Structural Variant Analysis, Survival Analysis, Targeted Error Correction Sequencing, Tuba-Seq, SDS-PAGE, Cell Fractionation, Multiscale Light Sheet Microscopy, Light Sheet Microscopy",,TRUE,,,,,
File Level,The processing level the file can be mapped to. ,"Level 1, Level 2, Level 3, Level 4, Auxiliary, Not Applicable",,TRUE,,,,HTAN,
File Species,"The species the data was collected on. Multiple values permitted, comma separated.","African Bush Elephant, Armadillo, Asian Elephant, Boar, Cat, Chicken, Cow, Dog, Escherichia coli, Guinea Pig, Horse, Human, Human Patient, Human Cell Line, Mouse, Multispecies, Opossum, Rabbit, Rat, Rhesus monkey, Sheep, Trichoplax adhaerens, Unknown, Unspecified, Worm, Yeast, Fruit Fly, Zebrafish",,TRUE,,,,,list like
File Tumor Type,"The tumor type(s), if applicable, of the data collected. Multiple values permitted, comma separated.","Cutaneous Melanoma, Acinar Cell Carcinoma, Acute Lymphoblastic Leukemia, Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Adenocarcinoma, Angiosarcoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, B Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Barrett Esophagus, Basal Cell Neoplasm, Basal-Like Breast Carcinoma, Biliary Tract Carcinoma, Bladder Carcinoma, Bladder Neoplasm, Bone Neoplasm, Brain Neoplasm, Breast Adenocarcinoma, Breast Carcinoma, Breast Neoplasm, Carcinoma, Carcinoma In Situ, Castration-Resistant Prostate Carcinoma, Cellular Schwannoma, Central Nervous System Cavernous Hemangioma, Central Nervous System Neoplasm, Cerebellar Neoplasm, Cervical Carcinoma, Cervical Neoplasm, Cervical Small Cell Carcinoma, Cholangiocarcinoma, Chondroblastoma, Choriocarcinoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Clear Cell Renal Cell Carcinoma, Colon Adenocarcinoma, Colon Carcinoma, Colorectal Adenocarcinoma, Colorectal Adenoma, Colorectal Carcinoma, Colorectal Neoplasm, Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Craniopharyngioma, Cutaneous T Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Ductal Breast Carcinoma In Situ, Dysembryoplastic Neuroepithelial Neoplasm, Endometrial Carcinoma, Endometrial Neoplasm, Ependymoma, Esophageal Adenocarcinoma, Esophageal Carcinoma, Esophageal Squamous Cell Carcinoma, Ewing Sarcoma, Extraventricular Neurocytoma, Fibroepithelial Polyp, Fibrolamellar Carcinoma, Fibrosarcoma, Follicular Lymphoma, Gallbladder Carcinoma, Gastric Adenocarcinoma, Gastric Carcinoma, Gastric Neoplasm, Gastroesophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Gastrointestinal Stromal Neoplasm, Giant Cell Tumor, Glioblastoma, Glioma, Head and Neck Carcinoma, Head and Neck Neoplasm, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High Grade Ovarian Serous Adenocarcinoma, Histiocytic Sarcoma, Hodgkin Lymphoma, Intestinal Neoplasm, Intrahepatic Cholangiocarcinoma, Invasive Ductal Breast Carcinoma, Kaposi Sarcoma, Leiomyoma, Leukemia, Liver and Intrahepatic Bile Duct Carcinoma, Liver and Intrahepatic Bile Duct Neoplasm, Low Grade Glioma, Luminal A Breast Carcinoma, Lung Adenocarcinoma, Lung Carcinoma, Lung Neoplasm, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Lung Squamous Cell Carcinoma, Lymphoid Leukemia, Lymphoma, Malignant Brain Neoplasm, Malignant Digestive System Neoplasm, Malignant Genitourinary System Neoplasm, Malignant Glioma, Malignant Neoplasm, Malignant Ovarian Neoplasm, Malignant Pancreatic Neoplasm, Malignant Peripheral Nerve Sheath Tumor, Malignant Peritoneal Neoplasm, Malignant Skin Neoplasm, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Medulloblastoma, Melanoma, Meningioma, Mesothelioma, Multiple Myeloma, Mycosis Fungoides, Myeloid Leukemia, Myeloid Neoplasm, Myeloproliferative Neoplasm, Myoepithelioma, Nasopharyngeal Carcinoma, Neuroblastoma, Neuroendocrine Neoplasm, Neuroepithelial Neoplasm, Neurofibroma, Non-Functioning Pituitary Gland Adenoma, Non-Hodgkin Lymphoma, Not Applicable, Oral Cavity Neoplasm, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Neoplasm, Osteosarcoma, Ovarian Adenosarcoma, Ovarian Carcinoma, Ovarian Neoplasm, Ovarian Serous Adenocarcinoma, Pan-cancer, Pancreatic Adenocarcinoma, Pancreatic Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm, Pancreatic Neuroendocrine Carcinoma, Pending Annotation, Penile Carcinoma, Pheochromocytoma, Pilocytic Astrocytoma, Pituitary Gland Adenoma, Plasmablastic Lymphoma, Plasmacytoma, Plexiform Schwannoma, Precursor B-cell lymphoblastic leukemia, Primary Central Nervous System Lymphoma, Primary Myelofibrosis, Prostate Adenocarcinoma, Prostate Carcinoma, Prostate Neoplasm, Rectal Adenocarcinoma, Renal Cell Carcinoma, Retinoblastoma, Rhabdomyosarcoma, Rosette-Forming Glioneuronal Tumor, Salivary Gland Adenoid Cystic Carcinoma, Sarcoma, Schwannoma, Serous Tubal Intraepithelial Carcinoma, Sinonasal Squamous Cell Carcinoma, Skin Carcinoma, Skin Neoplasm, Soft Tissue Sarcoma, Squamous Cell Carcinoma, Synovial Sarcoma, T Acute Lymphoblastic Leukemia, T-Cell Lymphoma, Teratoma, Testicular Embryonal Carcinoma, Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Carcinoma, Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features, Triple-Negative Breast Carcinoma, Urothelial Carcinoma, Uterine Adenosarcoma, Uveal Melanoma, Uveal Neoplasm, Vascular Neoplasm, Not-Applicable, Plexiform Neurofibroma",,FALSE,,,,,list like
File Tissue,"Tissue type(s) associated with the file. Multiple values permitted, comma separated.","Gonad, Abdominal Esophagus, Adipose Tissue, Adrenal Gland, Alveolus, Aorta, Artery, Ascending Colon, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Brain, Breast, Caecum, Cancer-Associated Fibroblast, Cardia, Cartilage, Cervix Uteri, Choroid, Colon, Connective and Soft Tissue, Cornea, Duodenum, Ear, Embryo, Embryonic Heart, Endocervix, Endometrium, Endothelium, Epithelium, Esophagus, Eye, Fallopian Tube, Foreskin, Frontal Lobe, Gastroesophageal Junction, Gastrointestinal Tract, Genitourinary, Hair Follicle, Head and Neck, Heart, Heart Muscle, Hematopoietic System, Hippocampus, Intestine, Intra-Abdominal Lymph Nodes, Intrathoracic Lymph Nodes, Joint, Kidney, Larynx, Ligament, Liver, Lung, Lymph, Lymph Node, Lymph Nodes of Axilla or Arm, Lymph Nodes of Inguinal Region or Leg, Lymphatic System, Lymphoid Tissue, Main Bronchus, Mammary Gland, Meninges, Mesenchyme, Mucosa, Muscle, Nasal Cavity, Nervous System, Not Applicable, Olfactory Mucosa, Omentum, Oral Cavity, Oral Mucosa, Ovary, Pancreas, Pelvic Lymph Nodes, Pending Annotation, Periodontal Ligament, Peripheral Nerves, Peritoneum, Pharynx, Pituitary Gland, Placenta, Pleura, Prostate Gland, Rectum, Reproductive System, Respiratory System, Salivary Gland, Sclera, Sinonasal Tract, Skin, Small Intestine, Spinal Cord, Spleen, Stomach, Synovial Membrane, Tendon, Testis, Thymus, Thyroid Gland, Tongue, Tonsil, Trachea, Umbilical Cord, Unspecified, Uterus, Vagina, Vascular Endothelium, Vein, Vertebra, Peripheral Blood Mononuclear Cell",,FALSE,,,,,list like
File View,The denormalized manifest for file submission.,,"Component, FileView_id, Biospecimen Key, Study Key, DatasetView Key, Filename, File Alias, File Description, File Design, File Level, File Assay, File Species, File Tumor Type, File Tissue, File Url, File Format, Data Use Codes, File Longitudinal Group, File Longitudinal Event Type, File Longitudinal Sequence Identifier, File Longitudinal Time Elapsed Unit, File Longitudinal Sequential Time Elapsed, File Longitudinal Total Time Elapsed",FALSE,,,Study,,
FileView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
File Longitudinal Group,A label that can be used to identify groups of files from the same longitudinal/time-resolved experiment,,,FALSE,,,,,str
File Longitudinal Event Type,"The type of event associated with collection of the data contained in the file (e.g., time increment, treatment time elapsed)",,,FALSE,,,,,str
File Longitudinal Sequence Identifier,"The order in which this file was collected with respect to the longitudinal experiment (e.g., 1, 2, etc.). Integer.",,,FALSE,,,,,int
File Longitudinal Time Elapsed Unit,The unit of time associated with Sequential and Total Time Elapsed attributes.,,,FALSE,,,,,str
File Longitudinal Sequential Time Elapsed,The time elapsed between collecting the current and previous files in this longitudinal group. ,,,FALSE,,,,,num
File Longitudinal Total Time Elapsed,The total time elapsed between the first and current files contained this longitudinal group. ,,,FALSE,,,,,num
File Format,The format of the file described by this entry.,"AVI, BAI, BAM, BED, CDS, CHP, COOL, CSV, DAE, DB, DS_Store, FASTA, FASTQ, FCS, FIG, FREQ, GCG, GCT, GCTx, GFF3, GTF, GZIP Format, HDF, HDF5, HTML, IDAT, JPG, JSON, LIF, MAP, MAT, MATLAB script, MSF, MTX, PDF, PNG, PZFX, Python Script, R File Format, RAW, RDS, ROUT, RPROJ, RTF, SGI, SRA, STAT, TAR Format, TDF, TIFF, TSV, TXT, VCF, WIG, XML, ZIP, bed12, bedgraph, cel, cloupe, docx, mzIdentML, mzXML, pptx, rcc, xls, xlsx, MGF, BIGWIG, H5AD, H5, SF, PKL, BPM, Unspecified, Pending Annotation, maf, CLS, SCN, SVS",,TRUE,,,,,
File Alias,"A string identifier associated with the file. Must be unique. Can be the repository accesssion number (e.g., Synapse ID, GEO identifier such as GSE12345). No Greek Letters or DOIs.",,,TRUE,,,,,unique
NanoString GeoMx Auxiliary Files,Contains identifiers for auxiliary files associated with Nanostring GeoMx Spatial Profiling experiments.,,"Component, NanoStringGeoMxAuxiliaryFiles_id, Synapse ID of GeoMx DSP ROI Segment Annotation File, Synapse ID of GeoMx DSP PKC File, Synapse ID of GeoMx Lab Worksheet File, Synapse ID of GeoMx DSP Config File",FALSE,,,,MC2/STE,
NanoStringGeoMxAuxiliaryFiles_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,MC2/STE,unique
Synapse ID of GeoMx Lab Worksheet File,Synapse ID(s) of Lab Worksheet Files output from the GeoMx DSP workflow. Multiple files are listed as comma separated values.,,,FALSE,,,,HTAN,list like::regex match syn\d+
Synapse ID of GeoMx DSP PKC File,The Synapse ID(s) associated with the PKC mapping file for the assay. Multiple files are listed as comma separated values.,,,FALSE,,,,HTAN,list like::regex match syn\d+
Synapse ID of GeoMx DSP ROI Segment Annotation File,Synapse ID(s) for ROI/AOI/Segmentation annotations in the GeoMx DSP experiment.,,,FALSE,,,,HTAN,list like::regex match syn\d+
Synapse ID of GeoMx DSP Config File,Synapse ID of config.ini file generated by the GeoMx DSP workflow.,,,FALSE,,,,MC2/STE,list like::regex match syn\d+
NanoString GeoMx DSP Imaging,Images acquired by the GeoMx instrument,,"Component, NanoStringGeoMxDSPImaging_id, Filename, NanoStringGeoMxDSPLevel1 Key, NanoStringGeoMxDSPLevel2 Key, NanoStringGeoMxAuxiliaryFiles Key, NanoStringGeoMXROISegmentAnnotation Key, GeoMx Imaging Channel Names",FALSE,,,"File View, NanoString GeoMx Auxiliary Files",HTAN,
NanoStringGeoMxDSPImaging_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,MC2,unique
GeoMx Imaging Channel Names,Name(s) of imaging channel(s) associated with the image; multiple values should be provided as a comma-separated list.,,,FALSE,,,,HTAN,list like
NanoString GeoMx DSP Level 1,Raw sequencing files from GeoMX experiments,,"Component, NanoStringGeoMxDSPLevel1_id, NanoStringGeoMxAuxiliaryFiles Key, NanoStringGeoMXROISegmentAnnotation Key, Filename, GeoMx DSP Assay Type, NGS Target Sequencing Depth, NGS Read Length, NGS Sequencing Platform, NGS Library Selection Method, NGS Library Preparation Kit Name, NGS Library Preparation Kit Vendor, NGS Library Preparation Kit Version",FALSE,,,"File View, NanoString GeoMX ROI Segment Annotation",MC2/STE,
NanoStringGeoMxDSPLevel1_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,MC2,unique
GeoMx DSP Assay Type,The assay type which was used for the GeoMx DSP pipeline.,"RNA nCounter, Protein nCounter, Protein NGS, RNA NGS",,FALSE,,,,HTAN,
NanoString GeoMx DSP Level 2,Processed count conversion (DCC/RCC) files from GeoMX experiments,,"Component, NanoStringGeoMxDSPLevel2_id, Filename, NanoStringGeoMxDSPLevel1 Key, NanoStringGeoMxAuxiliaryFiles Key, NanoStringGeoMXROISegmentAnnotation Key, GeoMx DSP Assay Type, Software and Version, Genomic Reference, NGS Sequencing Platform, NGS Library Selection Method, NGS Library Preparation Kit Name, NGS Library Preparation Kit Vendor, NGS Library Preparation Kit Version",FALSE,,,"File View, NanoString GeoMx Auxiliary Files",HTAN,
NanoStringGeoMxDSPLevel2_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,MC2,unique
NanoString GeoMx DSP Level 3,Files contain processed count data from the NanoString GeoMx DSP Pipeline.,,"Component, NanoStringGeoMxDSPLevel3_id, Filename, NanoStringGeoMxDSPLevel1 Key, NanoStringGeoMxDSPLevel2 Key, NanoStringGeoMxAuxiliaryFiles Key, NGS Unique Probe Count, NGS Unique Target Count, NGS Matrix Type, Workflow Type, Workflow Parameter Description, Workflow Link",FALSE,,,"File View, NanoString GeoMx Auxiliary Files",HTAN,
NanoStringGeoMxDSPLevel3_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,MC2,unique
NanoString GeoMX ROI Segment Annotation,"GeoMx ROI and Segment Metadata Attributes. The assayed biospecimen should be reported one per row with the associated ROI and AOI coordinates. ",,"Component, NanoStringGeoMXROISegmentAnnotation_id, Biospecimen Key, GeoMx Scan name, GeoMx ROI Name, GeoMx AOI Name, GeoMx Tags, GeoMx ROI X Coordinate, GeoMx ROI Y Coordinate, GeoMx AOI X Coordinate, GeoMx AOI Y Coordinate, GeoMx QC status, GeoMx Scan Height, GeoMx Scan Width, GeoMx Scan Offset X, GeoMx Scan Offset Y, GeoMx Binding Density, GeoMx Positive norm factor, GeoMx Surface area, GeoMx Nuclei count, GeoMx Tissue Stain, GeoMx Slide name, NGS Raw reads, NGS Stitched reads, NGS Aligned reads, NGS Deduplicated reads, NGS Trimmed reads, NGS Sequencing Coverage, NGS MapQ30, GeoMx Negative count mean, GeoMx No Template Control count, GeoMx Excluded Outlier Probes, GeoMx Limit of Quantification",FALSE,,,Biospecimen,"MC2/STE, HTAN",
NanoStringGeoMXROISegmentAnnotation_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,MC2,unique
GeoMx Scan name,GeoMx Scan name (as appears in Segment Summary),,,TRUE,,,,HTAN,str
GeoMx ROI Name,Name of Region of Interest corresponding to file. Multiple names should be comma-separated,,,TRUE,,,,HTAN,list like
GeoMx AOI Name,Name of Area of Illumination corresponding to file. Multiple names should be comma-separated,,,TRUE,,,,HTAN,list like
GeoMx ROI X Coordinate,Region of Interest X location within the image,,,FALSE,,,,HTAN,num
GeoMx ROI Y Coordinate,Region of Interest Y location within the image,,,FALSE,,,,HTAN,num
GeoMx AOI X Coordinate,Area of Illumination X location within the image,,,FALSE,,,,MC2/STE,num
GeoMx AOI Y Coordinate,Area of Illumination Y location within the image,,,FALSE,,,,MC2/STE,num
GeoMx QC status,ROI quality control flag as reported by the application,,,FALSE,,,,HTAN,list like
GeoMx Scan Height,Height of the scan for GeoMx Analysis,,,FALSE,,,,HTAN,num
GeoMx Scan Width,Width of the scan for GeoMx Analysis,,,FALSE,,,,HTAN,num
GeoMx Scan Offset X,Offset X of the scan for GeoMx Analysis,,,FALSE,,,,HTAN,num
GeoMx Scan Offset Y,Offset Y of the scan for GeoMx Analysis,,,FALSE,,,,HTAN,num
GeoMx Binding Density,The binding density as reported by the application,,,FALSE,,,,HTAN,num
GeoMx Positive norm factor,The Positive Control Normalization factor calculated using pos-hyb controls,,,FALSE,,,,HTAN,num
GeoMx Surface area,Surface area of the ROI in square microns (µm2),,,FALSE,,,,HTAN,num
GeoMx Nuclei count,Number of nuclei detected in the segment (if applicable),,,FALSE,,,,HTAN,num
GeoMx Slide name,"Similar to a Run ID, the slide name indicates the slide a given ROI is linked to (as reported in Segment Summary).",,,FALSE,,,,HTAN,str
GeoMx In Situ Negative median,Is the median of all negative control probes for a given segment. A measure of signal to background for each segment.,,,FALSE,,,,HTAN,num
GeoMx Biological probe median,Is the median count from all probes except the negative control probes. A measure of signal to background for each segment,,,FALSE,,,,HTAN,num
GeoMx Negative count mean,The geometric mean of the unique negative probes in a GeoMx panel that do not target mRNA and establish the background count level per segment,,,FALSE,,,,STE,num
GeoMx No Template Control count,The number of reads detected by the GeoMx probe panel in the control associated with this ROI.,,,FALSE,,,,STE,num
GeoMx Excluded Outlier Probes,The list of probes excluded from analysis.,,,FALSE,,,,STE,num
GeoMx Limit of Quantification,The calculated limit of quantification associated with the segment.,,,FALSE,,,,STE,num
GeoMx Sequencing Saturation,"The fraction of reads originating from an already-observed UMI. This is a function of library complexity and sequencing depth. More specifically, this is the fraction of confidently mapped, valid spot-barcode, valid UMI reads that had a non-unique (spot-barcode, UMI, gene).",,,FALSE,,,,HTAN,num
Grant Name,Name of the grant,,,TRUE,,,,,
Grant Number,"Number of the grant (i.e. ""CA------"" format)",,,TRUE,,,,,regex search ^CA\d{6}$
Grant Abstract,Abstract for the grant,,,TRUE,,,,,
Grant Type,Type of grant,"R01, R21, R37, U01, U24, U54",,TRUE,,,,,
Grant View,The denormalized manifest for grant submission.,,"Component, GrantView_id, Grant Name, Grant Number, Grant Abstract, Grant Type, Grant Theme Name, Grant Institution Name, Grant Institution Alias, Grant Investigator, Grant Consortium Name, Grant Start Date, NIH RePORTER Link, Duration of Funding, Embargo End Date, Grant Synapse Team, Grant Synapse Project",FALSE,,,,,
Grant Theme Name,Theme(s) associated with the grant. 1...*,"Computational Model Development, Computational Resource, Drug Resistance/Sensitivity, Epigenetics, Evolution, Experimental Model Development, Heterogeneity, Immunotherapy, Mechano-genetics, Mechano-resistance, Metabolism, Metastasis, Method/Assay Development, Microenvironment, Oncogenic Stress, Platform Development, Tumor Progression, Tumor-Immune",,TRUE,,,,,list like
Grant Institution Name,The full name of the institution(s) associated with the grant. (e.g. Harvard University). 1...*,"Arizona State University, Auburn University, Barrow Neurological Institute, Baylor College Of Medicine, Beth Israel Deaconess Hospital, Boston Medical Center, Boston University, Brigham and Womens Hospital, California Institute of Technology, Childrens Hospital of Philadelphia, City Of Hope, Cleveland Clinic, Cold Spring Harbor Laboratory, Columbia University, Cornell University, Dana-Farber Cancer Institute, Dartmouth College, Duke University, Emory University, Georgia Institute of Technology, Harvard Medical School, Harvard University, Hebrew University of Jerusalem, Houston Methodist, Indiana University, Indiana University - Purdue University Indianapolis, Institute for Systems Biology, Jackson Laboratory, Johns Hopkins University, Lurie Children's Hospital, Massachusetts General Hospital, Massachusetts Institute of Technology, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Northeastern University, New York University, Northwestern University, Oregon Health & Science University, Pacific Northwest National Laboratory, Rockefeller University, Sage Bionetworks, Salk Institute for Biological Studies, St. Jude Children's Research Hospital, Stanford University, Stony Brook University, The University of Texas Health Science Center at San Antonio, University of Alabama at Birmingham, University of Arizona, University of California; Berkeley, University of California; Irvine, University of California; Los Angeles, University of California; San Diego, University of California; San Francisco, University of Chicago, University of Chicago Medical Center, University of Colorado Denver, University of Delaware, University of Florida, University of Illinois, University of Illinois at Chicago, University of Massachusetts Medical School, University of Miami, University of Michigan, University of Nevada Reno, University of Minnesota, University of New South Wales, University of North Carolina at Chapel Hill, University of Pennsylvania, University of Pittsburgh, University of Southern California, University of Texas MD Anderson Cancer Center, University of Texas Southwestern Medical Center, University of Texas at Austin, University of Utah, University of Virginia, University of Washington, University of Wisconsin-Madison, Vanderbilt University, Washington University in St. Louis, Wake Forest, Weill Cornell Medicine, Wistar Institute, Yale University",,TRUE,,,,,list like
Grant Institution Alias,The alias of the institution(s) associated with the grant (e.g. UCSD). 1...*,"ASU, AU, BCM, BIDMC, BMC, BU, BWH, Barrow, CHOP, COH, CSHL, Caltech, Cleveland Clinic, Columbia, Cornell, DFCI, Dartmouth, Duke, Emory, GTech, HMS, HUJI, Harvard, Houston Methodist, ISB, IU, IUPUI, JHU, Jackson Laboratory, Lurie Children's Hospital, MGH, MIT, MSKCC, Mayo, Moffitt, NEU, NU, NYU, OHSU, PNNL, Pitt, Rockefeller University, SBU, Sage, Salk, StJude, Stanford, U Miami, UA, UAB, UCBerkeley, UCD, UCI, UCLA, UCMC, UCSD, UCSF, UChicago, UD, UFL, UIC, UMMS, UMichigan, UMinn, UNC, UNR, UNSW, UPenn, USC, UT Austin, UT Southwestern, UTHSCSA, UUtah, UVA, UW, UWM, University of Illinois, University of Texas MD Anderson Cancer Center, Vanderbilt, WUSTL, WCM, Wake Forest, Wistar, Yale",,TRUE,,,,,list like
Grant Investigator,Investigator(s) associated witht the grant. 1...*,,,TRUE,,,,,list like
Grant Consortium Name,Consortium(s) associated with the grant. 1...1,"CCBIR, CSBC, HTAN, ICBP, MetNet, NCI, NCI Clinical and Translational Exploratory/Developmental Studies, PDMC, PS-ON, Sage Bionetworks, TEC",,TRUE,,,,,
GrantView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Grant Synapse Team,"The Synapse team associated with the grant, created by the MC2 Center",,,FALSE,,,,,url
Grant Synapse Project,"The Synapse project associated with the grant, created by the MC2 Center",,,FALSE,,,,,url
Grant Start Date,The start date of the grant YYYY-MM-DD format,,,TRUE,,,,,date
NIH RePORTER Link,Link to the search results for this grant number on the NIH Reporter website,,,TRUE,,,,,url
Duration of Funding,"Duration of the funding period, in years",,,FALSE,,,,,int
Embargo End Date,Date at which an embargo on related resources had lifted,,,FALSE,,,,,date
Imaging Channel,Channel-level Metadata Attributes,,"Component, ImagingChannel_id, Study Key, Channel Identifier, Channel Name, Channel Passed QC, Channel Cycle Number, Channel Sub-cycle Number, Channel Antibody Role, Channel Target Name, Channel Antibody Name, Channel Resource ID, Channel Fluorophore, Channel Antibody Clone, Channel Antibody Lot, Channel Antibody Vendor, Channel Antibody Catalog Number, Channel Excitation Wavelength, Channel Emission Wavelength, Channel Excitation Bandwidth, Channel Emission Bandwidth, Channel Metal Symbol, Channel Metal Isotope, Channel Oligo Barcode Upper Strand, Channel Oligo Barcode Lower Strand, Channel Probe Dilution Ratio, Channel Probe Concentration",FALSE,,,,HTAN,
ImagingChannel_id,A unique identifier used by schematic for record updates and as a reference key in other schemas.,,,TRUE,,,,MC2,
Channel Identifier,This must match the corresponding field in the OME-XML / TIFF header. (eg 'Channel:0:1'),,,TRUE,,,,HTAN,
Channel Name,This must match the corresponding field in the OME-XML / TIFF header. (eg 'Blue' or 'CD45' or 'E-cadherin'),,,TRUE,,,,HTAN,
Channel Passed QC,Identify stains that did not pass QC but are included in the dataset.,"Yes, No - Channel Failed QC",,FALSE,,,,HTAN,
Channel Cycle Number,The cycle # in which the co-listed reagent(s) was(were) used. Integer >= 1 (up to number of cycles),,,FALSE,,,,HTAN,
Channel Sub-cycle Number,Sub cycle number,,,FALSE,,,,HTAN,
Channel Antibody Role,Is this antibody acting as a primary or secondary antibody?,"Primary, Secondary",,FALSE,,,,HTAN,
Channel Target Name,Short descriptive name (abbreviation) for this target (antigen),,,TRUE,,,,HTAN,
Channel Antibody Name,"Antibody Name (free text (eg “Keratin”, “CD163”, “DNA”))",,,FALSE,,,,HTAN,
Channel Resource ID,Research Resource Identifier (eg “RRID: AB_394606”),,,FALSE,,,,HTAN,
Channel Fluorophore,Fluorescent dye label (eg Alexa Fluor 488),,,FALSE,,,,HTAN,
Channel Antibody Clone,Clone,,,FALSE,,,,HTAN,
Channel Antibody Lot,Lot number from vendor,,,FALSE,,,,HTAN,
Channel Antibody Vendor,Vendor,,,FALSE,,,,HTAN,
Channel Antibody Catalog Number,Catalog Number,,,FALSE,,,,HTAN,
Channel Excitation Wavelength,Center/peak of the excitation spectrum (nm),,,FALSE,,,,HTAN,
Channel Emission Wavelength,Center/peak of the emission spectrum (nm),,,FALSE,,,,HTAN,
Channel Excitation Bandwidth,Nominal width of excitation spectrum (nm),,,FALSE,,,,HTAN,
Channel Emission Bandwidth,Nominal width of emission spectrum (nm),,,FALSE,,,,HTAN,
Channel Metal Symbol,Element abbreviation. eg “La” or “Nd”,"H, He, Li, Be, B, C, N, O, F, Ne, Na, Mg, Al, Si, P, S, Cl, Ar, K, Ca, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, As, Se, Br, Kr, Rb, Sr, Y, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, In, Sn, Sb, Te, I, Xe, Cs, Ba, La, Ce, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, Tl, Pb, Bi, Po, At, Rn, Fr, Ra, Ac, Th, Pa, U, Np, Pu, Am, Bk, Cf, Es, Fm, Md, No, Lr, Rf, Db, Sg, Bh, Hs, Mt, Ds, Rg, Cn, Nh, Fl, Mc, Lv, Ts, Og",,FALSE,,,,HTAN,
Channel Metal Isotope,Element mass number,,,FALSE,,,,HTAN,
Channel Oligo Barcode Upper Strand,Oligo Barcode - Upper Strand,,,FALSE,,,,HTAN,
Channel Oligo Barcode Lower Strand,Oligo Barcode - Lower Strand,,,FALSE,,,,HTAN,
Channel Probe Dilution Ratio,Dilution (eg 1:1000),,,FALSE,,,,HTAN,
Channel Probe Concentration,Concentration (eg 10ug/mL),,,FALSE,,,,HTAN,
Imaging Level 1,Raw imaging data,,"Component, ImagingLevel1_id, Filename, Image Assay Type, Image Protocol Link, Image Platform Model, Image Platform Manufacturer, Image Software, ImagingChannel Key",FALSE,,,File View,HTAN,
ImagingLevel1_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,,,Mc2,
Image Assay Type,Type of imaging assay,"H&E, CyCIF, t-CyCIF, IHC, mIHC, MxIF, SABER, IMC, CODEX, GeoMX-DSP, MIBI, MERFISH, ExSeq, RareCyte Orion, Not Applicable",,TRUE,,,,HTAN,
Image Protocol Link,"Protocols.io ID or DOI link to a free/open protocol resource describing in detail the assay protocol (e.g. surface markers used in Smart-seq, dissociation duration,  lot/batch numbers for key reagents such as primers, sequencing reagent kits, etc.) or the protocol by which the sample was obtained or generated.",,,FALSE,,,,HTAN,
Image Platform Model,The specific model of the instrument used to carry out an imaging experiment.,,,FALSE,,,,HTAN,
Image Platform Manufacturer,Producer of the imaging equipment that was used to generate the digital image,,,FALSE,,,,CDS/imaging,
Image Software,"The name of the software package that was used to capture, generate, and process the image.",,,FALSE,,,,CDS/imaging,
Imaging Level 2,Raw and pre-processed image data,,"Component, ImagingLevel2_id, Filename, ImagingLevel1 Key, ImagingChannel Key, Image Assay Type, Image Protocol Link, Image Platform Model, Image Platform Manufacturer, Image Software, Image Objective, Image Nominal Magnification, Image Lense Aperture, Image Working Distance, Image Working Distance Unit, Image Immersion Type, Image Pyramidal, Image Z stack, Image Timeseries, Image FOV Index, Image FOV Size X, Image FOV Size X Unit, Image FOV Size Y, Image FOV Size Y Unit, Image Frame Averaging, Image Identifier, Image Dimension Order, Image Physical Size X, Image Physical Size X Unit, Image Physical Size Y, Image Physical Size Y Unit, Image Physical Size Z, Image Physical Size Z Unit, Image Pixels BigEndian, Image Plane Count, Image Channel Size, Image Number of Timepoints, Image X Pixels, Image Y Pixels, Image Z Pixels, Image Pixel Type",FALSE,,,File View,HTAN,
ImagingLevel2_id,A unique identifier used by schematic for record updates and as a reference key in other schemas.,,,TRUE,,,,MC2,
Image Protocol Link,"Protocols.io ID or DOI link to a free/open protocol resource describing in detail the assay protocol (e.g. surface markers used in Smart-seq, dissociation duration,  lot/batch numbers for key reagents such as primers, sequencing reagent kits, etc.) or the protocol by which the sample was obtained or generated.",,,FALSE,,,,HTAN,
Image Platform Model,The specific model of the instrument used to carry out an imaging experiment.,,,FALSE,,,,HTAN,
Image Platform Manufacturer,Producer of the imaging equipment that was used to generate the digital image,,,FALSE,,,,HTAN,
Image Software,"The name of the software package that was used to capture, generate, and process the image.",,,FALSE,,,,HTAN,
Image Objective,Objective lens identifier,,,FALSE,,,,HTAN,
Image Nominal Magnification,The magnification of the lens as specified by the manufacturer - i.e. '60' is a 60X lens. floating point value > 1(no units),,,FALSE,,,,HTAN,
Image Lense Aperture,The numerical aperture of the lens. Floating point value > 0.,,,FALSE,,,,HTAN,
Image Working Distance,"The working distance of the lens, expressed as a floating point number. Floating point > 0.",,,FALSE,,,,HTAN,
Image Working Distance Unit,The units of the working distance. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um),"cm, mm, µm, nm, Å",,FALSE,,,,HTAN,
Image Immersion Type,Immersion medium,"Air, Oil, Water, Other",,FALSE,,,,HTAN,
Image Pyramidal,Does data file contain pyramid of images,,,FALSE,,,,HTAN,
Image Z stack,Does data file contain a Z-stack of images,,,FALSE,,,,HTAN,
Image Timeseries,Does data file contain a time-series of images,,,FALSE,,,,HTAN,
Image FOV Index,Index of FOV (as it pertains to its sequence order). Integer >= 1,,,FALSE,,,,HTAN,
Image FOV Size X,Field of view X dimension. Floating point,,,FALSE,,,,HTAN,
Image FOV Size X Unit,Field of view X dimension units. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um),,,FALSE,,,,HTAN,
Image FOV Size Y,Field  of view Y dimension. Floating point value,,,FALSE,,,,HTAN,
Image FOV Size Y Unit,Field of view Y dimension units. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um),,,FALSE,,,,HTAN,
Image Frame Averaging,"Number of frames averaged together (if no averaging, set to 1). Integer >= 1",,,FALSE,,,,HTAN,
Image Identifier,"Unique internal image identifier. eg ""Image:0"". (To be extracted from OME-XML)",,,FALSE,,,,HTAN,
Image Dimension Order,The order in which the individual planes of data are interleaved.,,,FALSE,,,,HTAN,
Image Physical Size X,Physical size (X-dimension) of a pixel. Units are set by PhysicalSizeXUnit. Floating point value > 0.,,,FALSE,,,,HTAN,
Image Physical Size X Unit,The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um),,,FALSE,,,,HTAN,
Image Physical Size Y,Physical size (Y-dimension) of a pixel. Units are set by PhysicalSizeYUnit. Floating point value > 0.,,,FALSE,,,,HTAN,
Image Physical Size Y Unit,The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um),,,FALSE,,,,HTAN,
Image Physical Size Z,Physical size (Z-dimension) of a pixel. Units are set by PhysicalSizeZUnit. Floating point value > 0.,,,FALSE,,,,HTAN,
Image Physical Size Z Unit,The units of the physical size of a pixel. See OME enumeration of allowed values for the UnitsLength attribute -- default: microns (um),,,FALSE,,,,HTAN,
Image Pixels BigEndian,Boolean (True/False),,,FALSE,,,,HTAN,
Image Plane Count,"Number of Z-planes (not to be confused with downsampled ""pyramid""). Integer >=1",,,FALSE,,,,HTAN,
Image Channel Size,Number of channels. Integer >= 1,,,FALSE,,,,HTAN,
Image Number of Timepoints,Number of time points. Integer >= 1,,,FALSE,,,,HTAN,
Image X Pixels,Size of image: X dimension (in pixels). Integer >= 1,,,FALSE,,,,HTAN,
Image Y Pixels,Size of image: Y dimension (in pixels). Integer >= 1,,,FALSE,,,,HTAN,
Image Z Pixels,Size of image: Z dimension (in pixels). Integer >= 1,,,FALSE,,,,HTAN,
Image Pixel Type,"Data type for each pixel value. E.g. ""uint16""",,,FALSE,,,,HTAN,
Imaging Level 3 Image,Quality controlled image data,,"Component, ImagingLevel3Image_id, Filename, ImagingChannel Key, ImagingLevel2 Key, Image Assay Type, Image Protocol Link, Image Platform Model, Image Platform Manufacturer, Image Software, Image Objective, Image Nominal Magnification, Image Lense Aperture, Image Working Distance, Image Immersion Type, Image Pyramidal, Image Z stack, Image Timeseries, Image FOV Index, Image FOV Size X, Image FOV Size Y, Image FOV Size Y Unit, Image Frame Averaging",FALSE,,,File View,HTAN,
ImagingLevel3Image_id,A unique identifier used by schematic for record updates and as a reference key in other schemas.,,,TRUE,,,,MC2,
Imaging Level 3 Segments,Image segmentation mask information,,"Component, ImagingLevel3Segments_id, Filename, ImagingLevel2 Key, ImagingLevel3Image Key, Image Segmentation Data Type, Image Parameter file, Software and Version, Image Object Class, Image Object Class Description, Image Number of Objects",FALSE,,,File View,HTAN,
ImagingLevel3Segments_id,A unique identifier used by schematic for record updates and as a reference key in other schemas.,,,TRUE,,,,MC2,
Image Segmentation Data Type,Specifies how the segmentation is stored,"Mask, Outline, Polygon, Probability Map, Point",,TRUE,,,,HTAN,str
Image Parameter file,Path in Synapse to a text file listing algorithm version numbers and relevant parameters needed to reproduce the analysis,,,FALSE,,,,HTAN,
Image Object Class,Defines the structure that the mask delineates,"Nucleus, Cytoplasm, Plasma Membrane, Whole Cell, Spot, Other",,FALSE,,,,HTAN,str
Image Number of Objects,The number of objects (eg cells) described,,,FALSE,,,,HTAN,num
Image Object Class Description,"If Imaging Object Class is ""Other"", please use this field to provide a text description of the imaging object class associated with the segmentation data",,,FALSE,,,,HTAN,str
Imaging Level 4,Derived imaging data or object by feature array,,"Component, ImagingLevel4_id, Filename, ImagingLevel2 Key, ImagingLevel3Image Key, ImagingLevel3Segments Key, Image Parameter file, Image Software, Image Number of Objects, Image Number of Features, Image Object Class, Image Summary Statistic",FALSE,,,File View,HTAN,
ImagingLevel4_id,A unique identifier used by schematic for record updates and as a reference key in other schemas.,,,TRUE,,,,MC2,
Image Number of Features,The number of features (eg channels) described,,,TRUE,,,,HTAN,num
Image Summary Statistic,Function used to summarize object/feature intensity,"Mean, Median, Not Specified",,TRUE,,,,HTAN,
Individual,Information about models and individuals from which biospecimen(s) were collected.,,"Component, Individual_id, Study Key, Individual dbGaP Subject Id, Individual Sex, Individual Gender, Individual Age at Diagnosis, Individual Disease Type, Individual Primary Diagnosis, Individual Primary Site, Individual Primary Tumor Stage, Individual Site of Origin, Individual Tumor Subtype, Individual Tumor Grade, Individual Tumor Lymph Node Stage, Individual Known Metastasis Sites, Individual Metastasis Stage, Individual Treatment Type, Individual Therapeutic Agent, Individual Days to Treatment, Individual Treatment Outcome, Individual Days to Last Followup, Individual Recurrence Status, Individual Days To Recurrence, Individual Days to Last Known Disease Status, Individual Last Known Disease Status",FALSE,,,Study,,
Individual_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Individual Known Metastasis Sites,The text term(s) used to describe the anatomic site(s) of metastasis associated with the patient's malignant disease.,"Abdomen, Abdominal Wall, Acetabulum, Adenoid, Adipose, Adrenal, Alveolar Ridge, Amniotic Fluid, Ampulla Of Vater, Anal Sphincter, Ankle, Anorectum, Antecubital Fossa, Antrum, Anus, Aorta, Aortic Body, Appendix, Aqueous Fluid, Arm, Artery, Ascending Colon, Ascending Colon Hepatic Flexure, Auditory Canal, Autonomic Nervous System, Axilla, Back, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Bowel, Brain, Brain Stem, Breast, Broad Ligament, Bronchiole, Bronchus, Brow, Buccal Cavity, Buccal Mucosa, Buttock, Calf, Capillary, Cardia, Carina, Carotid Artery, Carotid Body, Cartilage, Cecum, Cell-Line, Central Nervous System, Cerebellum, Cerebral Cortex, Cerebrospinal Fluid, Cerebrum, Cervical Spine, Cervix, Chest, Chest Wall, Chin, Clavicle, Clitoris, Colon, Colon - Mucosa Only, Common Duct, Conjunctiva, Connective Tissue, Dermal, Descending Colon, Diaphragm, Duodenum, Ear, Ear Canal, Ear; Pinna (External), Effusion, Elbow, Endocrine Gland, Epididymis, Epidural Space, Esophageal; Distal, Esophageal; Mid, Esophageal; Proximal, Esophagogastric Junction, Esophagus, Esophagus - Mucosa Only, Eye, Fallopian Tube, Femoral Artery, Femoral Vein, Femur, Fibroblasts, Fibula, Finger, Floor Of Mouth, Fluid, Foot, Forearm, Forehead, Foreskin, Frontal Cortex, Frontal Lobe, Fundus Of Stomach, Gallbladder, Ganglia, Gastroesophageal Junction, Gastrointestinal Tract, Glottis, Groin, Gum, Hand, Hard Palate, Head - Face Or Neck; Nos, Head & Neck, Heart, Hepatic, Hepatic Duct, Hepatic Flexure, Hepatic Vein, Hip, Hippocampus, Humerus, Hypopharynx, Ileum, Ilium, Index Finger, Ischium, Islet Cells, Jaw, Jejunum, Joint, Kidney, Knee, Lacrimal Gland, Large Bowel, Laryngopharynx, Larynx, Leg, Leptomeninges, Ligament, Lip, Liver, Lumbar Spine, Lung, Lymph Node, Lymph Node(s) Axilla, Lymph Node(s) Cervical, Lymph Node(s) Distant, Lymph Node(s) Epitrochlear, Lymph Node(s) Femoral, Lymph Node(s) Hilar, Lymph Node(s) Iliac-Common, Lymph Node(s) Iliac-External, Lymph Node(s) Inguinal, Lymph Node(s) Internal Mammary, Lymph Node(s) Mammary, Lymph Node(s) Mesenteric, Lymph Node(s) Occipital, Lymph Node(s) Paraaortic, Lymph Node(s) Parotid, Lymph Node(s) Pelvic, Lymph Node(s) Popliteal, Lymph Node(s) Regional, Lymph Node(s) Retroperitoneal, Lymph Node(s) Scalene, Lymph Node(s) Splenic, Lymph Node(s) Subclavicular, Lymph Node(s) Submandibular, Lymph Node(s) Supraclavicular, Lymph Nodes(s) Mediastinal, Mandible, Maxilla, Mediastinal Soft Tissue, Mediastinum, Mesentery, Mesothelium, Middle Finger, Mitochondria, Muscle, Nails, Nasal Cavity, Nasal Soft Tissue, Nasopharynx, Neck, Nerve, Nerve(s) Cranial, Not Allowed To Collect, Occipital Cortex, Ocular Orbits, Omentum, Oral Cavity, Oral Cavity - Mucosa Only, Oropharynx, Other, Ovary, Palate, Pancreas, Paranasal Sinuses, Paraspinal Ganglion, Parathyroid, Parotid Gland, Patella, Pelvis, Penis, Pericardium, Periorbital Soft Tissue, Peritoneal Cavity, Peritoneum, Pharynx, Pineal, Pineal Gland, Pituitary Gland, Placenta, Pleura, Popliteal Fossa, Prostate, Pylorus, Rectosigmoid Junction, Rectum, Retina, Retro-Orbital Region, Retroperitoneum, Rib, Ring Finger, Round Ligament, Sacrum, Salivary Gland, Scalp, Scapula, Sciatic Nerve, Scrotum, Seminal Vesicle, Shoulder, Sigmoid Colon, Sinus, Sinus(es); Maxillary, Skeletal Muscle, Skin, Skull, Small Bowel, Small Bowel - Mucosa Only, Small Finger, Soft Tissue, Spinal Column, Spinal Cord, Spleen, Splenic Flexure, Sternum, Stomach, Stomach - Mucosa Only, Subcutaneous Tissue, Subglottis, Sublingual Gland, Submandibular Gland, Supraglottis, Synovium, Temporal Cortex, Tendon, Testis, Thigh, Thoracic Spine, Thorax, Throat, Thumb, Thymus, Thyroid, Tibia, Tongue, Tonsil, Tonsil (Pharyngeal), Trachea / Major Bronchi, Transverse Colon, Trunk, Umbilical Cord, Ureter, Urethra, Urinary Tract, Uterus, Uvula, Vagina, Vas Deferens, Vein, Venous, Vertebra, Vulva, White Blood Cells, Wrist, Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,list like
Individual Last Known Disease Status,Text term that describes the last known status of an individual.,"Distant met recurrence/progression, Loco-regional recurrence/progression, Biochemical evidence of disease without structural correlate, Tumor free, Unknown Tumor Status, With Tumor, Not Reported, Not Allowed To Collect, Not Applicable, Deceased",,FALSE,,,,CDS Imaging v1.0,
Individual Sex,Biological sex associated with the specimen donor,"Decline to answer, Don't know, Female, Intersex, Male, None of these describe me, Prefer not to answer, Unknown, X",,FALSE,,,,CDS Imaging v1.0,str
Individual Disease Type,"The type of tumor associated with the specimen. Multiple values permitted, comma separated.","Acinar Cell Neoplasms, Adenomas and Adenocarcinomas, Adnexal and Skin Appendage Neoplasms, Basal Cell Neoplasms, Blood Vessel Tumors, Complex Mixed and Stromal Neoplasms, Cystic; Mucinous and Serous Neoplasms, Ductal and Lobular Neoplasms, Epithelial Neoplasms; NOS, Fibroepithelial Neoplasms, Fibromatous Neoplasms, Germ Cell Neoplasms, Giant Cell Tumors, Gliomas, Granular Cell Tumors and Alveolar Soft Part Sarcomas, Immunoproliferative Diseases, Leukemias, Lipomatous Neoplasms, Lymphatic Vessel Tumors, Mast Cell Neoplasm, Meningiomas, Mesothelial Neoplasms, Miscellaneous Bone Tumors, Miscellaneous Tumors, Mucoepidermoid Neoplasms, Myelodysplastic Syndromes, Myomatous Neoplasms, Myxomatous Neoplasms, Neoplasms; NOS, Nerve Sheath Tumors, Neuroepitheliomatous Neoplasms, Nevi and Melanomas, Not Applicable, Not Otherwise Specified, Not Reported, Odontogenic Tumors, Osseous and Chondromatous Neoplasms, Paragangliomas and Glomus Tumors, Plasma Cell Neoplasm, Soft Tissue Tumors and Sarcomas; NOS, Squamous Cell Neoplasms, Synovial-like Neoplasms, Thymic Epithelial Neoplasms, Transitional Cell Papillomas and Carcinomas, Trophoblastic neoplasms, Unknown",,FALSE,,,,CDS Imaging v1.0,
Individual Primary Diagnosis,"Text term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","Abdominal desmoid, Abdominal fibromatosis, Achromic nevus, Acidophil adenocarcinoma, Acidophil adenoma, Acidophil carcinoma, Acinar adenocarcinoma, Acinar adenocarcinoma; sarcomatoid, Acinar adenoma, Acinar carcinoma, Acinar cell adenoma, Acinar cell carcinoma, Acinar cell cystadenocarcinoma, Acinar cell tumor, Acinic cell adenocarcinoma, Acinic cell adenoma, Acinic cell tumor, Acoustic neuroma, Acquired cystic disease-associated renal cell carcinoma (RCC), Acquired tufted hemangioma, Acral lentiginous melanoma; malignant, ACTH-producing tumor, Acute basophilic leukaemia, Acute bilineal leukemia, Acute biphenotypic leukemia, Acute erythremia, Acute erythremic myelosis, Acute erythroid leukaemia, Acute granulocytic leukemia, Acute leukemia; Burkitt type, Acute leukemia; NOS, Acute lymphatic leukemia, Acute lymphoblastic leukemia-lymphoma; NOS, Acute lymphoblastic leukemia; L2 type; NOS, Acute lymphoblastic leukemia; mature B-cell type, Acute lymphoblastic leukemia; NOS, Acute lymphoblastic leukemia; precursor cell type, Acute lymphocytic leukemia, Acute lymphoid leukemia, Acute megakaryoblastic leukaemia, Acute mixed lineage leukemia, Acute monoblastic and monocytic leukemia, Acute monoblastic leukemia, Acute monocytic leukemia, Acute myeloblastic leukemia, Acute myelocytic leukemia, Acute myelofibrosis, Acute myelogenous leukemia, Acute myeloid leukaemia; t(8;21)(q22;q22), Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1, Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants), Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1, Acute myeloid leukemia with maturation, Acute myeloid leukemia with multilineage dysplasia, Acute myeloid leukemia with mutated CEBPA, Acute myeloid leukemia with mutated NPM1, Acute myeloid leukemia with myelodysplasia-related changes, Acute myeloid leukemia with prior myelodysplastic syndrome, Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214, Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1, Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL, Acute myeloid leukemia without maturation, Acute myeloid leukemia without prior myelodysplastic syndrome, Acute myeloid leukemia; AML1(CBF-alpha)/ETO, Acute myeloid leukemia; CBF-beta/MYH11, Acute myeloid leukemia; inv(16)(p13;q22), Acute myeloid leukemia; M6 type, Acute myeloid leukemia; minimal differentiation, Acute myeloid leukemia; MLL, Acute myeloid leukemia; NOS, Acute myeloid leukemia; PML/RAR-alpha, Acute myeloid leukemia; t(15:17)(g22;q11-12), Acute myeloid leukemia; t(16;16)(p 13;q 11), Acute myelomonocytic leukemia, Acute myelomonocytic leukemia with abnormal eosinophils, Acute myelosclerosis; NOS, Acute myloid leukemia; 11q23 abnormalities, Acute non-lymphocytic leukemia, Acute panmyelosis with myelofibrosis, Acute panmyelosis; NOS, Acute progressive histiocytosis X, Acute promyelocytic leukaemia; PML-RAR-alpha, Acute promyelocytic leukaemia; t(15;17)(q22;q11-12), Acute promyelocytic leukemia; NOS, Adamantinoma of long bones, Adamantinoma; malignant, Adamantinoma; NOS, Adenoacanthoma, Adenoameloblastoma, Adenocarcinoid tumor, Adenocarcinoma admixed with neuroendocrine carcinoma, Adenocarcinoma combined with other types of carcinoma, Adenocarcinoma in a polyp; NOS, Adenocarcinoma in adenomatous polyp, Adenocarcinoma in adenomatous polyposis coli, Adenocarcinoma in multiple adenomatous polyps, Adenocarcinoma in polypoid adenoma, Adenocarcinoma in situ in a polyp; NOS, Adenocarcinoma in situ in adenomatous polyp, Adenocarcinoma in situ in polypoid adenoma, Adenocarcinoma in situ in tubular adenoma, Adenocarcinoma in situ in tubulovillous adenoma, Adenocarcinoma in situ in villous adenoma, Adenocarcinoma in situ; mucinous, Adenocarcinoma in situ; non-mucinous, Adenocarcinoma in situ; NOS, Adenocarcinoma in tubolovillous adenoma, Adenocarcinoma in tubular adenoma, Adenocarcinoma in villous adenoma, Adenocarcinoma of anal ducts, Adenocarcinoma of anal glands, Adenocarcinoma of rete ovarii, Adenocarcinoma with apocrine metaplasia, Adenocarcinoma with cartilaginous and osseous metaplasia, Adenocarcinoma with cartilaginous metaplasia, Adenocarcinoma with mixed subtypes, Adenocarcinoma with neuroendocrine differentiation, Adenocarcinoma with osseous metaplasia, Adenocarcinoma with spindle cell metaplasia, Adenocarcinoma with squamous metaplasia, Adenocarcinoma; cribriform comedo-type, Adenocarcinoma; cylindroid, Adenocarcinoma; diffuse type, Adenocarcinoma; endocervical type, Adenocarcinoma; intestinal type, Adenocarcinoma; metastatic; NOS, Adenocarcinoma; NOS, Adenocarcinoma; pancreatobiliary type, Adenocystic carcinoma, Adenofibroma; NOS, Adenoid basal carcinoma, Adenoid cystic carcinoma, Adenolipoma, Adenolymphoma, Adenoma of nipple, Adenoma; NOS, Adenomatoid odontogenic tumor, Adenomatoid tumor; NOS, Adenomatosis; NOS, Adenomatous polyp; NOS, Adenomatous polyposis coli, Adenomyoepithelioma, Adenomyoepithelioma with carcinoma, Adenomyoma, Adenosarcoma, Adenosquamous carcinoma, Adnexal carcinoma, Adnexal tumor; benign, Adrenal cortical adenocarcinoma, Adrenal cortical adenoma; clear cell, Adrenal cortical adenoma; compact cell, Adrenal cortical adenoma; glomerulosa cell, Adrenal cortical adenoma; mixed cell, Adrenal cortical adenoma; NOS, Adrenal cortical adenoma; pigmented, Adrenal cortical carcinoma, Adrenal cortical tumor; benign, Adrenal cortical tumor; malignant, Adrenal cortical tumor; NOS, Adrenal medullary paraganglioma, Adrenal medullary paraganglioma; malignant, Adrenal rest tumor, Adult cystic teratoma, Adult granulosa cell tumor, Adult rhabdomyoma, Adult T-cell leukemia, Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants), Adult T-cell lymphoma, Adult T-cell lymphoma/leukemia, Adult teratoma; NOS, Aggressive angiomyxoma, Aggressive digital papillary adenoma, Aggressive fibromatosis, Aggressive NK-cell leukaemia, Aggressive osteoblastoma, Aggressive systemic mastocytosis, Agnogenic myeloid metaplasia, AIN III, Aleukemic granulocytic leukemia, Aleukemic leukemia; NOS, Aleukemic lymphatic leukemia, Aleukemic lymphocytic leukemia, Aleukemic lymphoid leukemia, Aleukemic monocytic leukemia, Aleukemic myelogenous leukemia, Aleukemic myeloid leukemia, ALK positive large B-cell lymphoma, Alpha cell tumor; malignant, Alpha cell tumor; NOS, Alpha heavy chain disease, Alveolar adenocarcinoma, Alveolar adenoma, Alveolar carcinoma, Alveolar cell carcinoma, Alveolar rhabdomyosarcoma, Alveolar soft part sarcoma, Amelanotic melanoma, Ameloblastic carcinoma, Ameloblastic fibro-odontoma, Ameloblastic fibro-odontosarcoma, Ameloblastic fibrodentinoma, Ameloblastic fibrodentinosarcoma, Ameloblastic fibroma, Ameloblastic fibrosarcoma, Ameloblastic odontosarcoma, Ameloblastic sarcoma, Ameloblastoma; malignant, Ameloblastoma; NOS, AML M6, Anal intraepithelial neoplasia; grade III, Anal intraepithelial neoplasia; low grade, Anaplastic astrocytoma; IDH-mutant, Anaplastic astrocytoma; IDH-wildtype, Anaplastic large B-cell lymphoma, Anaplastic large cell lymphoma; ALK negative, Anaplastic large cell lymphoma; ALK positive, Anaplastic large cell lymphoma; CD30+, Anaplastic large cell lymphoma; NOS, Anaplastic large cell lymphoma; T cell and Null cell type, Anaplastic medulloblastoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma; IDH-mutant and 1p/19q-codeleted, Anaplastic pleomorphic xanthroastrocytoma, Ancient schwannoma, Androblastoma; benign, Androblastoma; malignant, Androblastoma; NOS, Angioblastic meningioma, Angioblastoma, Angiocentric glioma, Angiocentric immunoproliferative lesion, Angiocentric T-cell lymphoma, Angioendothelioma, Angioendotheliomatosis, Angiofibroma; NOS, Angioimmunoblastic lymphadenopathy, Angioimmunoblastic lymphoma, Angioimmunoblastic T-cell lymphoma, Angiokeratoma, Angioleiomyoma, Angiolipoma; NOS, Angioma; NOS, Angiomatoid fibrous histiocytoma, Angiomatous meningioma, Angiomyofibroblastoma, Angiomyolipoma, Angiomyoma, Angiomyosarcoma, Angiomyxoma, Angiosarcoma, Angiotropic lymphoma, Aortic body paraganglioma, Aortic body tumor, Aorticopulmonary paraganglioma, Apocrine adenocarcinoma, Apocrine adenoma, Apocrine cystadenoma, Apudoma, Argentaffinoma; malignant, Argentaffinoma; NOS, Arrhenoblastoma; benign, Arrhenoblastoma; malignant, Arrhenoblastoma; NOS, Arteriovenous hemangioma, Askin tumor, Astroblastoma, Astrocytic glioma, Astrocytoma; anaplastic, Astrocytoma; low grade, Astrocytoma; NOS, Astroglioma, Atypical adenoma, Atypical carcinoid tumor, Atypical choroid plexus papilloma, Atypical chronic myeloid leukemia; BCR/ABL negative, Atypical chronic myeloid leukemia; Philadelphia chromosome (Ph1) negative, Atypical fibrous histiocytoma, Atypical fibroxanthoma, Atypical follicular adenoma, Atypical hyperplasia/Endometrioid intraepithelial neoplasm, Atypical leiomyoma, Atypical lipoma, Atypical medullary carcinoma, Atypical meningioma, Atypical polypoid adenomyoma, Atypical proliferating clear cell tumor, Atypical proliferating serous tumor, Atypical proliferative endometrioid tumor, Atypical proliferative mucinous tumor, Atypical proliferative papillary serous tumor, Atypical teratoid/rhabdoid tumor, B cell lymphoma; NOS, B lymphoblastic leukemia/lymphoma with hyperdiploidy, B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL), B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1), B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH, B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged, B lymphoblastic leukemia/lymphoma; NOS, B-ALL, B-cell lymphocytic leukemia/small lymphocytic lymphoma, B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma, B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma, Balloon cell melanoma, Balloon cell nevus, BALT lymphoma, Basal cell adenocarcinoma, Basal cell adenoma, Basal cell carcinoma; desmoplastic type, Basal cell carcinoma; fibroepithelial, Basal cell carcinoma; micronodular, Basal cell carcinoma; morpheic, Basal cell carcinoma; nodular, Basal cell carcinoma; NOS, Basal cell epithelioma, Basal cell tumor, Basaloid carcinoma, Basaloid squamous cell carcinoma, Basophil adenocarcinoma, Basophil adenoma, Basophil carcinoma, Basosquamous carcinoma, Bednar tumor, Bellini duct carcinoma, Benign cystic nephroma, Benign fibrous histiocytoma, Beta cell adenoma, Beta cell tumor; malignant, Bile duct adenocarcinoma, Bile duct adenoma, Bile duct carcinoma, Bile duct cystadenocarcinoma, Bile duct cystadenoma, Biliary intraepithelial neoplasia; grade 3, Biliary intraepithelial neoplasia; high grade, Biliary intraepithelial neoplasia; low grade, Biliary papillomatosis, Biphenotypic sinonasal sarcoma, Bizarre leiomyoma, Black adenoma, Blast cell leukemia, Blastic NK cell lymphoma, Blastic plasmacytoid dendritic cell neoplasm, Blastoma; NOS, Blue nevus; malignant, Blue nevus; NOS, Botryoid sarcoma, Bowen disease, Brenner tumor; borderline malignancy, Brenner tumor; malignant, Brenner tumor; NOS, Brenner tumor; proliferating, Bronchial adenoma; carcinoid, Bronchial adenoma; cylindroid, Bronchial adenoma; NOS, Bronchial-associated lymphoid tissue lymphoma, Bronchio-alveolar carcinoma; mixed mucinous and non-mucinous, Bronchio-alveolar carcinoma; mucinous, Bronchiolar adenocarcinoma, Bronchiolar carcinoma, Bronchiolo-alveolar adenocarcinoma; NOS, Bronchiolo-alveolar carcinoma; Clara cell, Bronchiolo-alveolar carcinoma; Clara cell and goblet cell type, Bronchiolo-alveolar carcinoma; goblet cell type, Bronchiolo-alveolar carcinoma; indeterminate type, Bronchiolo-alveolar carcinoma; non-mucinous, Bronchiolo-alveolar carcinoma; NOS, Bronchiolo-alveolar carcinoma; type II pneumocyte and goblet cell type, Bronchiolo-alveolar carcinoma; type II pneumocyte, Brooke tumor, Brown fat tumor, Burkitt cell leukemia, Burkitt lymphoma; NOS (Includes all variants), Burkitt tumor, Burkitt-like lymphoma, C cell carcinoma, c-ALL, Calcifying epithelial odontogenic tumor, Calcifying epithelioma of Malherbe, Calcifying nested epithelial stromal tumor, Calcifying odontogenic cyst, Canalicular adenoma, Cancer, Capillary hemangioma, Capillary lymphangioma, Carcinofibroma, Carcinoid tumor of uncertain malignant potential, Carcinoid tumor; argentaffin; malignant, Carcinoid tumor; argentaffin; NOS, Carcinoid tumor; NOS, Carcinoid tumor; NOS; of appendix, Carcinoid; NOS, Carcinoid; NOS; of appendix, Carcinoma in a polyp; NOS, Carcinoma in adenomatous polyp, Carcinoma in pleomorphic adenoma, Carcinoma in situ in a polyp; NOS, Carcinoma in situ in adenomatous polyp, Carcinoma in situ; NOS, Carcinoma showing thymus-like differentiation, Carcinoma showing thymus-like element, Carcinoma simplex, Carcinoma with apocrine metaplasia, Carcinoma with chondroid differentiation, Carcinoma with neuroendocrine differentiation, Carcinoma with osseous differentiation, Carcinoma with osteoclast-like giant cells, Carcinoma with other types mesenchymal differentiation, Carcinoma with productive fibrosis, Carcinoma; anaplastic; NOS, Carcinoma; diffuse type, Carcinoma; intestinal type, Carcinoma; metastatic; NOS, Carcinoma; NOS, Carcinoma; undifferentiated; NOS, Carcinomatosis, Carcinosarcoma; embryonal, Carcinosarcoma; NOS, Carotid body paraganglioma, Carotid body tumor, Cartilaginous exostosis, CASTLE, Cavernous hemangioma, Cavernous lymphangioma, Cellular angiofibroma, Cellular blue nevus, Cellular ependymoma, Cellular fibroma, Cellular leiomyoma, Cellular schwannoma, Cementifying fibroma, Cemento-ossifying fibroma, Cementoblastoma; benign, Cementoma; NOS, Central neuroblastoma, Central neurocytoma, Central odontogenic fibroma, Central osteosarcoma, Central primitive neuroectodermal tumor; NOS, Cerebellar liponeurocytoma, Cerebellar sarcoma; NOS, Ceruminous adenocarcinoma, Ceruminous adenoma, Ceruminous carcinoma, Cervical intraepithelial neoplasia; grade III, Cervical intraepithelial neoplasia; low grade, Chemodectoma, Chief cell adenoma, Chloroma, Cholangiocarcinoma, Cholangioma, Chondroblastic osteosarcoma, Chondroblastoma; malignant, Chondroblastoma; NOS, Chondroid chordoma, Chondroid lipoma, Chondroid syringoma, Chondroma; NOS, Chondromatosis; NOS, Chondromatous giant cell tumor, Chondromyxoid fibroma, Chondrosarcoma grade 2/3, Chondrosarcoma; NOS, Chordoid glioma, Chordoid glioma of third ventricle, Chordoid meningioma, Chordoma; NOS, Chorioadenoma, Chorioadenoma destruens, Chorioangioma, Choriocarcinoma combined with embryonal carcinoma, Choriocarcinoma combined with other germ cell elements, Choriocarcinoma combined with teratorna, Choriocarcinoma; NOS, Chorioepithelioma, Chorionepithelioma, Choroid plexus carcinoma, Choroid plexus papilloma; anaplastic, Choroid plexus papilloma; malignant, Choroid plexus papilloma; NOS, Chromaffin paraganglioma, Chromaffin tumor, Chromaffinoma, Chromophobe adenocarcinoma, Chromophobe adenoma, Chromophobe carcinoma, Chromophobe cell renal carcinoma, Chronic eosinophilic leukemia; NOS, Chronic erythremia, Chronic granulocytic leukemia; BCR/ABL, Chronic granulocytic leukemia; NOS, Chronic granulocytic leukemia; Philadelphia chromosome (Ph1) positive, Chronic granulocytic leukemia; t(9;22)(q34;q11), Chronic idiopathic myelofibrosis, Chronic leukemia; NOS, Chronic lymphatic leukemia, Chronic lymphocytic leukemia, Chronic lymphocytic leukemia; B-cell type (includes all variants of BCLL), Chronic lymphoid leukemia, Chronic lymphoproliferative disorder of NK cells, Chronic monocytic leukemia, Chronic myelocytic leukemia; NOS, Chronic myelogenous leukemia; BCR-ABL positive, Chronic myelogenous leukemia; Philadelphia chromosome (Ph 1) positive, Chronic myelogenous leukemia; t(9;22)(q34;q11), Chronic myeloid leukemia; NOS, Chronic myelomonocytic leukemia in transformation, Chronic myelomonocytic leukemia; NOS, Chronic myelomonocytic leukemia; Type 1, Chronic myelomonocytic leukemia; Type II, Chronic myeloproliferative disease; NOS, Chronic myeloproliferative disorder, Chronic neutrophilic leukemia, CIN III with severe dysplasia, Cin III; NOS, Circumscribed arachnoidal cerebellar sarcoma, Classical Hodgkin lymphoma; lymphocyte depletion; diffuse fibrosis, Classical Hodgkin lymphoma; lymphocyte depletion; NOS, Classical Hodgkin lymphoma; lymphocyte depletion; reticular, Classical Hodgkin lymphoma; lymphocyte-rich, Classical Hodgkin lymphoma; mixed cellularity; NOS, Classical Hodgkin lymphoma; nodular sclerosis; cellular phase, Classical Hodgkin lymphoma; nodular sclerosis; grade 1, Classical Hodgkin lymphoma; nodular sclerosis; grade 2, Classical Hodgkin lymphoma; nodular sclerosis; NOS, Clear cell (glycogen-rich) urothelial carcinoma, Clear cell adenocarcinofibroma, Clear cell adenocarcinoma; mesonephroid, Clear cell adenocarcinoma; NOS, Clear cell adenofibroma, Clear cell adenofibroma of borderline malignancy, Clear cell adenoma, Clear cell carcinoma, Clear cell chondrosarcoma, Clear cell cystadenocarcinofibroma, Clear cell cystadenofibroma, Clear cell cystadenofibroma of borderline malignancy, Clear cell cystadenoma, Clear cell cystic tumor of borderline malignancy, Clear cell ependymoma, Clear cell hidradenoma, Clear cell meningioma, Clear cell odontogenic carcinoma, Clear cell odontogenic tumor, Clear cell sarcoma of kidney, Clear cell sarcoma; NOS, Clear cell sarcoma; of tendons and aponeuroses, Clear cell tumor; NOS, Cloacogenic carcinoma, CNS Embryonal tumor with rhabdoid features, Codman tumor, Collecting duct carcinoma, Colloid adenocarcinoma, Colloid adenoma, Colloid carcinoma, Columnar cell papilloma, Combined carcinoid and adenocarcinoma, Combined hepatocellular carcinoma and cholangiocarcinoma, Combined large cell neuroendocrine carcinoma, Combined small cell carcinoma, Combined small cell-adenocarcinoma, Combined small cell-large carcinoma, Combined small cell-squamous cell carcinoma, Combined/mixed carcinoid and adenocarcinoma, Comedocarcinoma; noninfiltrating, Comedocarcinoma; NOS, Common ALL, Common precursor B ALL, Complete hydatidiform mole, Complex odontoma, Composite carcinoid, Composite Hodgkin and non-Hodgkin lymphoma, Compound nevus, Compound odontoma, Condylomatous carcinoma, Congenital fibrosarcoma, Congenital generalized fibromatosis, Congenital peribronchial myofibroblastic tumor, Conventional central osteosarcoma, Cortical T ALL, CPNET, Craniopharyngioma, Craniopharyngioma; adamantinomatous, Craniopharyngioma; papillary, Cribriform carcinoma in situ, Cribriform carcinoma; NOS, Cribriform comedo-type carcinoma, Cutaneous histiocytoma; NOS, Cutaneous lymphoma; NOS, Cutaneous mastocytosis, Cutaneous T-cell lymphoma; NOS, Cylindrical cell carcinoma, Cylindrical cell papilloma, Cylindroma of skin, Cylindroma; NOS, Cyst-associated renal cell carcinoma, Cystadenocarcinoma; NOS, Cystadenofibroma; NOS, Cystadenoma; NOS, Cystic astrocytoma, Cystic hygroma, Cystic hypersecretory carcinoma, Cystic lymphangioma, Cystic mesothelioma; benign, Cystic mesothelioma; NOS, Cystic partially differentiated nephroblastoma, Cystic teratoma; NOS, Cystic tumor of atrio-ventricular node, Cystoma; NOS, Cystosarcoma phyllodes; benign, Cystosarcoma phyllodes; malignant, Cystosarcoma phyllodes; NOS, Dabska tumor, DCIS; comedo type, DCIS; NOS, DCIS; papillary, Dedifferentiated chondrosarcoma, Dedifferentiated chordoma, Dedifferentiated liposarcoma, Deep histiocytoma, Degenerated schwannoma, Dendritic cell sarcoma; NOS, Dentinoma, Dermal and epidermal nevus, Dermal nevus, Dermatofibroma lenticulare, Dermatofibroma; NOS, Dermatofibrosarcoma protuberans; NOS, Dermatofibrosarcoma; NOS, Dermoid cyst with malignant transformation, Dermoid cyst with secondary tumor, Dermoid cyst; NOS, Dermoid; NOS, Desmoid; NOS, Desmoplastic fibroma, Desmoplastic infantile astrocytoma, Desmoplastic infantile ganglioglioma, Desmoplastic medulloblastoma, Desmoplastic melanoma; amelanotic, Desmoplastic melanoma; malignant, Desmoplastic mesothelioma, Desmoplastic nodular medulloblastoma, Desmoplastic small round cell tumor, Di Guglielmo disease, Differentiated penile intraepithelial neoplasia, Differentiated-type vulvar intraepithelial neoplasia, Diffuse astrocytoma, Diffuse astrocytoma; IDH-mutant, Diffuse astrocytoma; IDH-wildtype, Diffuse astrocytoma; low grade, Diffuse cutaneous mastocytosis, Diffuse intraductal papillomatosis, Diffuse large B-cell lymphoma associated with chronic inflammation, Diffuse large B-cell lymphoma; NOS, Diffuse leptomeningeal glioneuronal tumor, Diffuse melanocytosis, Diffuse meningiomatosis, Diffuse midline glioma; H3 K27M-mutant, Digital papillary adenocarcinoma, Diktyoma; benign, Diktyoma; malignant, DIN 3, Duct adenocarcinoma; NOS, Duct adenoma; NOS, Duct carcinoma; desmoplastic type, Duct carcinoma; NOS, Duct cell carcinoma, Ductal carcinoma in situ; comedo type, Ductal carcinoma in situ; cribriform type, Ductal carcinoma in situ; micropapillary, Ductal carcinoma in situ; NOS, Ductal carcinoma in situ; papillary, Ductal carcinoma in situ; solid type, Ductal carcinoma; cribriform type, Ductal carcinoma; NOS, Ductal intraepithelial neoplasia 3, Ductal papilloma, Dysembryoplastic neuroepithelial tumor, Dysgerminoma, Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos), Dysplastic nevus, EBV positive diffuse large B-cell lymphoma of the elderly, EC cell carcinoid, Ecchondroma, Ecchondrosis, Eccrine acrospiroma, Eccrine adenocarcinoma, Eccrine cystadenoma, Eccrine dermal cylindroma, Eccrine papillary adenocarcinoma, Eccrine papillary adenoma, Eccrine poroma, Eccrine poroma; malignant, Eccrine spiradenoma, ECL cell carcinoid; malignant, ECL cell carcinoid; NOS, Ectomesenchymoma, Ectopic hamartomatous thymoma, Elastofibroma, Embryonal adenocarcinoma, Embryonal adenoma, Embryonal carcinoma; infantile, Embryonal carcinoma; NOS, Embryonal carcinoma; polyembryonal type, Embryonal hepatoma, Embryonal rhabdomyosarcoma; NOS, Embryonal rhabdomyosarcoma; pleomorphic, Embryonal sarcoma, Embryonal teratoma, Embryonal tumor with multilayered rosettes C19MC-altered, Embryonal tumor with multilayered rosettes; NOS, Embryonal tumor with rhabdoid features, Encapsulated follicular variant of papillary thyroid carcinoma; NOS (EFVPTC; NOS), Encapsulated papillary carcinoma, Encapsulated papillary carcinoma with invasion, Enchondroma, Endocervical adenocarcinoma usual type, Endocrine adenomatosis, Endocrine tumor; functioning; NOS, Endodermal sinus tumor, Endolymphatic stromal myosis, Endometrial sarcoma; NOS, Endometrial stromal nodule, Endometrial stromal sarcoma; high grade, Endometrial stromal sarcoma; low grade, Endometrial stromal sarcoma; NOS, Endometrial stromatosis, Endometrioid adenocarcinoma; ciliated cell variant, Endometrioid adenocarcinoma; NOS, Endometrioid adenocarcinoma; secretory variant, Endometrioid adenocarcinoma; villoglandular, Endometrioid adenofibroma; borderline malignancy, Endometrioid adenofibroma; malignant, Endometrioid adenofibroma; NOS, Endometrioid adenoma; borderline malignancy, Endometrioid adenoma; NOS, Endometrioid carcinoma with squamous differentiation, Endometrioid carcinoma; NOS, Endometrioid cystadenocarcinoma, Endometrioid cystadenofibroma; borderline malignancy, Endometrioid cystadenofibroma; malignant, Endometrioid cystadenofibroma; NOS, Endometrioid cystadenoma; borderline malignancy, Endometrioid cystadenoma; NOS, Endometrioid tumor of low malignant potential, Endotheliomatous meningioma, Endovascular papillary angioendothelioma, Enteric adenocarcinoma, Enterochromaffin cell carcinoid, Enterochromaffin-like cell carcinoid; NOS, Enterochromaffin-like cell tumor; malignant, Enteroglucagonoma; malignant, Enteroglucagonoma; NOS, Enteropathy associated T-cell lymphoma, Enteropathy type intestinal T-cell lymphoma, Eosinophil adenocarcinoma, Eosinophil adenoma, Eosinophil carcinoma, Eosinophilic granuloma, Eosinophilic leukemia, Ependymoblastoma, Ependymoma; anaplastic, Ependymoma; NOS, Ependymoma; RELA fusion-positive, Epidermoid carcinoma in situ with questionable stromal invasion, Epidermoid carcinoma in situ; NOS, Epidermoid carcinoma; keratinizing, Epidermoid carcinoma; large cell; nonkeratinizing, Epidermoid carcinoma; NOS, Epidermoid carcinoma; small cell; nonkeratinizing, Epidermoid carcinoma; spindle cell, Epithelial ependymoma, Epithelial tumor; benign, Epithelial tumor; malignant, Epithelial-myoepithelial carcinoma, Epithelioid and spindle cell nevus, Epithelioid cell melanoma, Epithelioid cell nevus, Epithelioid cell sarcoma, Epithelioid glioblastoma, Epithelioid hemangioendothelioma; malignant, Epithelioid hemangioendothelioma; NOS, Epithelioid hemangioma, Epithelioid leiomyoma, Epithelioid leiomyosarcoma, Epithelioid malignant peripheral nerve sheath tumor, Epithelioid mesothelioma; benign, Epithelioid mesothelioma; malignant, Epithelioid mesothelioma; NOS, Epithelioid MPNST, Epithelioid sarcoma, Epithelioma adenoides cysticum, Epithelioma; benign, Epithelioma; malignant, Epithelioma; NOS, Erythremic myelosis; NOS, Erythroleukemia, Esophageal glandular dysplasia (intraepithelial neoplasia); high grade, Esophageal glandular dysplasia (intraepithelial neoplasia); low grade, Esophageal intraepithelial neoplasia; high grade, Esophageal squamous intraepithelial neoplasia (dysplasia); high grade, Esophageal squamous intraepithelial neoplasia (dysplasia); low grade, Essential hemorrhagic thrombocythaemia, Essential thrombocythemia, Esthesioneuroblastoma, Esthesioneurocytoma, Esthesioneuroepithelioma, Ewing sarcoma, Ewing tumor, Extra-abdominal desmoid, Extra-adrenal paraganglioma; malignant, Extra-adrenal paraganglioma; NOS, Extracutaneous mastocytoma, Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, Extranodal NK/T-cell lymphoma; nasal type, Extraosseous plasmacytoma, Extraventricular neurocytoma, FAB L2, FAB L3, FAB Ll, FAB M1, FAB M2; AML1(CBF-alpha)/ETO, FAB M2; NOS, FAB M2; t(8;21)(q22;q22), FAB M3 (includes all variants), FAB M4, FAB M4Eo, FAB M5 (includes all variants), FAB M6, FAB M7, FAB MO, Familial polyposis coli, Fascial fibroma, Fascial fibrosarcoma, Fetal adenocarcinoma, Fetal adenoma, Fetal fat cell lipoma, Fetal lipoma; NOS, Fetal lipomatosis, Fetal rhabdomyoma, Fibrillary astrocytoma, Fibro-osteoma, Fibroadenoma; NOS, Fibroameloblastic odontoma, Fibroblastic liposarcoma, Fibroblastic meningioma, Fibroblastic osteosarcoma, Fibroblastic reticular cell tumor, Fibrochondrosarcoma, Fibroepithelial basal cell carcinoma; Pinkus type, Fibroepithelioma of Pinkus type, Fibroepithelioma; NOS, Fibrofolliculoma, Fibroid uterus, Fibrolipoma, Fibroliposarcoma, Fibroma; NOS, Fibromatosis-like metaplastic carcinoma, Fibromyoma, Fibromyxolipoma, Fibromyxoma, Fibromyxosarcoma, Fibrosarcoma; NOS, Fibrosarcomatous dermatofibrosarcoma protuberans, Fibrous astrocytoma, Fibrous histiocytoma of tendon sheath, Fibrous histiocytoma; NOS, Fibrous meningioma, Fibrous mesothelioma; benign, Fibrous mesothelioma; malignant, Fibrous mesothelioma; NOS, Fibrous papule of nose, Fibroxanthoma; malignant, Fibroxanthoma; NOS, Flat adenoma, Flat intraepithelial glandular neoplasia; high grade, Flat intraepithelial neoplasia; high grade, Florid osseous dysplasia, Follicular adenocarcinoma; moderately differentiated, Follicular adenocarcinoma; NOS, Follicular adenocarcinoma; trabecular, Follicular adenocarcinoma; well differentiated, Follicular adenoma, Follicular adenoma; oxyphilic cell, Follicular carcinoma; encapsulated, Follicular carcinoma; minimally invasive, Follicular carcinoma; moderately differentiated, Follicular carcinoma; NOS, Follicular carcinoma; oxyphilic cell, Follicular carcinoma; trabecular, Follicular carcinoma; well differentiated, Follicular dendritic cell sarcoma, Follicular dendritic cell tumor, Follicular fibroma, Follicular lymphoma; grade 1, Follicular lymphoma; grade 2, Follicular lymphoma; grade 3, Follicular lymphoma; grade 3A, Follicular lymphoma; grade 3B, Follicular lymphoma; NOS, Follicular lymphoma; small cleaved cell, Follicular thyroid carcinoma (FTC); encapsulated angioinvasive, Folliculome lipidique, Franklin disease, G cell tumor; malignant, G cell tumor; NOS, Gamma heavy chain disease, Gangliocytic paraganglioma, Gangliocytoma, Ganglioglioma; anaplastic, Ganglioglioma; NOS, Ganglioneuroblastoma, Ganglioneuroma, Ganglioneuromatosis, GANT, Gastrin cell tumor, Gastrin cell tumor; malignant, Gastrinoma; malignant, Gastrinoma; NOS, Gastrointestinal autonomic nerve tumor, Gastrointestinal pacemaker cell tumor, Gastrointestinal stromal sarcoma, Gastrointestinal stromal tumor; benign, Gastrointestinal stromal tumor; malignant, Gastrointestinal stromal tumor; NOS, Gastrointestinal stromal tumor; uncertain malignant potential, Gelatinous adenocarcinoma, Gelatinous carcinoma, Gemistocytic astrocytoma, Gemistocytoma, Genital rhabdomyoma, Germ cell tumor; nonseminomatous, Germ cell tumor; NOS, Germ cell tumors with associated hematological malignancy, Germinoma, Ghost cell odontogenic carcinoma, Giant cell and spindle cell carcinoma, Giant cell angiofibroma, Giant cell carcinoma, Giant cell fibroblastoma, Giant cell glioblastoma, Giant cell sarcoma, Giant cell sarcoma of bone, Giant cell tumor of bone; malignant, Giant cell tumor of bone; NOS, Giant cell tumor of soft parts; NOS, Giant cell tumor of tendon sheath, Giant cell tumor of tendon sheath; malignant, Giant fibroadenoma, Giant osteoid osteoma, Giant pigmented nevus; NOS, Gigantiform cementoma, GIST; benign, GIST; malignant, GIST; NOS, Glandular intraepithelial neoplasia; grade I, Glandular intraepithelial neoplasia; grade II, Glandular intraepithelial neoplasia; grade III, Glandular intraepithelial neoplasia; high grade, Glandular intraepithelial neoplasia; low grade, Glandular papilloma, Glassy cell carcinoma, Glioblastoma, Glioblastoma multiforme, Glioblastoma with sarcomatous component, Glioblastoma; IDH wildtype, Glioblastoma; IDH-mutant, Gliofibroma, Glioma; malignant, Glioma; NOS, Gliomatosis cerebri, Glioneuroma, Gliosarcoma, Glomangioma, Glomangiomyoma, Glomangiosarcoma, Glomoid sarcoma, Glomus jugulare tumor; NOS, Glomus tumor; malignant, Glomus tumor; NOS, Glucagon-like peptide-producing tumor, Glucagonoma; malignant, Glucagonoma; NOS, Glycogen-rich carcinoma, Glycogenic rhabdomyoma, Goblet cell carcinoid, Gonadal stromal tumor; NOS, Gonadoblastoma, Gonocytoma, Granular cell adenocarcinoma, Granular cell carcinoma, Granular cell myoblastoma; malignant, Granular cell myoblastoma; NOS, Granular cell tumor of the sellar region, Granular cell tumor; malignant, Granular cell tumor; NOS, Granulocytic leukemia; NOS, Granulocytic sarcoma, Granulosa cell carcinoma, Granulosa cell tumor; adult type, Granulosa cell tumor; juvenile, Granulosa cell tumor; malignant, Granulosa cell tumor; NOS, Granulosa cell tumor; sarcomatoid, Granulosa cell-theca cell tumor, Grawitz tumor, Gynandroblastoma, Haemangioblastoma, Haemangiosarcoma, Hairy cell leukaemia variant, Hairy cell leukemia, Hairy cell leukemia variant, Hairy nevus, Halo nevus, Hand-Schuller-Christian disease, Heavy chain disease; NOS, Hemangioblastic meningioma, Hemangioendothelial sarcoma, Hemangioendothelioma; benign, Hemangioendothelioma; malignant, Hemangioendothelioma; NOS, Hemangioma simplex, Hemangioma; NOS, Hemangiopericytic meningioma, Hemangiopericytoma; benign, Hemangiopericytoma; malignant, Hemangiopericytoma; NOS, Hemolymphangioma, Hepatoblastoma, Hepatoblastoma; epithelioid, Hepatoblastoma; mixed epithelial-mesenchymal, Hepatocarcinoma, Hepatocellular adenoma, Hepatocellular carcinoma; clear cell type, Hepatocellular carcinoma; fibrolamellar, Hepatocellular carcinoma; NOS, Hepatocellular carcinoma; pleomorphic type, Hepatocellular carcinoma; sarcomatoid, Hepatocellular carcinoma; scirrhous, Hepatocellular carcinoma; spindle cell variant, Hepatocholangiocarcinoma, Hepatoid adenocarcinoma, Hepatoid carcinoma, Hepatoid yolk sac tumor, Hepatoma; benign, Hepatoma; malignant, Hepatoma; NOS, Hepatosplenic gamma-delta cell lymphoma, Hepatosplenic T-cell lymphoma, Hereditary leiomyomatosis & RCC-associated renal cell carcinoma, Hibernoma, Hidradenocarcinoma, Hidradenoma papilliferum, Hidradenoma; NOS, Hidrocystoma, High grade surface osteosarcoma, High-grade neuroendocrine carcinoma, High-grade serous carcinoma, Hilar cell tumor, Hilus cell tumor, Histiocyte-rich large B-cell lymphoma, Histiocytic medullary reticulosis, Histiocytic sarcoma, Histiocytoid hemangioma, Histiocytoma; NOS, Histiocytosis X; NOS, Hodgkin disease; lymphocyte predominance; diffuse, Hodgkin disease; lymphocyte predominance; NOS, Hodgkin disease; lymphocytic-histiocytic predominance, Hodgkin disease; nodular sclerosis; lymphocyte depletion, Hodgkin disease; nodular sclerosis; lymphocyte predominance, Hodgkin disease; nodular sclerosis; mixed cellularity, Hodgkin disease; nodular sclerosis; NOS, Hodgkin disease; nodular sclerosis; syncytial variant, Hodgkin disease; NOS, Hodgkin granuloma, Hodgkin lymphoma; lymphocyte depletion; diffuse fibrosis, Hodgkin lymphoma; lymphocyte depletion; NOS, Hodgkin lymphoma; lymphocyte depletion; reticular, Hodgkin lymphoma; lymphocyte predominance; nodular, Hodgkin lymphoma; lymphocyte-rich, Hodgkin lymphoma; mixed cellularity; NOS, Hodgkin lymphoma; nodular lymphocyte predominance, Hodgkin lymphoma; nodular sclerosis; cellular phase, Hodgkin lymphoma; nodular sclerosis; grade 1, Hodgkin lymphoma; nodular sclerosis; grade 2, Hodgkin lymphoma; nodular sclerosis; NOS, Hodgkin lymphoma; NOS, Hodgkin paragranuloma; nodular, Hodgkin paragranuloma; NOS, Hodgkin sarcoma, Hurthle cell adenocarcinoma, Hurthle cell adenoma, Hurthle cell carcinoma, Hurthle cell tumor, Hutchinson melanotic freckle; NOS, Hyalinizing trabecular adenoma, Hydatid mole, Hydatidiform mole; NOS, Hydroa vacciniforme-like lymphoma, Hygroma; NOS, Hypereosinophilic syndrome, Hypernephroid tumor, Hypernephroma, Idiopathic hemorrhagic thrombocythaemia, Idiopathic thrombocythemia, Immature teratoma; malignant, Immature teratoma; NOS, Immunoblastic sarcoma, Immunocytoma, Immunoglobulin deposition disease, Immunoproliferative disease; NOS, Immunoproliferative small intestinal disease, Indeterminate dendritic cell tumor, Indolent systemic mastocytosis, Infantile fibrosarcoma, Infantile hemangioma, Infantile myofibromatosis, Infiltrating and papillary adenocarcinoma, Infiltrating angiolipoma, Infiltrating basal cell carcinoma; non-sclerosing, Infiltrating basal cell carcinoma; NOS, Infiltrating basal cell carcinoma; sclerosing, Infiltrating duct adenocarcinoma, Infiltrating duct and colloid carcinoma, Infiltrating duct and cribriform carcinoma, Infiltrating duct and lobular carcinoma, Infiltrating duct and lobular carcinoma in situ, Infiltrating duct and mucinous carcinoma, Infiltrating duct and tubular carcinoma, Infiltrating duct carcinoma; NOS, Infiltrating duct mixed with other types of carcinoma, Infiltrating ductular carcinoma, Infiltrating lipoma, Infiltrating lobular carcinoma and ductal carcinoma in situ, Infiltrating lobular carcinoma; NOS, Infiltrating lobular mixed with other types of carcinoma, Infiltrating papillary adenocarcinoma, Inflammatory adenocarcinoma, Inflammatory carcinoma, Inflammatory liposarcoma, Inflammatory myofibroblastic tumor, Insular carcinoma, Insulinoma; malignant, Insulinoma; NOS, Interdigitating cell sarcoma, Interdigitating dendritic cell sarcoma, Intermediate and giant congenital nevus, Interstitial cell tumor; benign, Interstitial cell tumor; malignant, Interstitial cell tumor; NOS, Intestinal T-cell lymphoma, Intestinal-type adenocarcinoma, Intimal sarcoma, Intracanalicular fibroadenoma, Intracortical osteosarcoma, Intracystic carcinoma; NOS, Intracystic papillary adenocarcinoma, Intracystic papillary adenoma, Intracystic papillary neoplasm with associated invasive carcinoma, Intracystic papillary neoplasm with high grade intraepithelial neoplasia, Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia, Intracystic papillary neoplasm with low grade intraepithelial neoplasia, Intracystic papillary tumor with high grade dysplasia, Intracystic papillary tumor with high grade entraepithelial neoplasia, Intracystic papillary tumor with high grade intraepithelial neoplasia, Intracystic papilloma, Intradermal nevus, Intraductal adenocarcinoma; noninfiltrating; NOS, Intraductal and lobular carcinoma, Intraductal carcinoma and lobular carcinoma in situ, Intraductal carcinoma; clinging, Intraductal carcinoma; noninfiltrating; NOS, Intraductal carcinoma; NOS, Intraductal carcinoma; solid type, Intraductal micropapillary carcinoma, Intraductal papillary adenocarcinoma with invasion, Intraductal papillary adenocarcinoma; NOS, Intraductal papillary carcinoma, Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma, Intraductal papillary mucinous neoplasm with an associated invasive carcinoma, Intraductal papillary mucinous neoplasm with high grade dysplasia, Intraductal papillary neoplasm with associated invasive carcinoma, Intraductal papillary neoplasm with high grade dysplasia, Intraductal papillary neoplasm with high grade intraepithelial neoplasia, Intraductal papillary neoplasm with intermediate grade neoplasia, Intraductal papillary neoplasm with low grade intraepithelial neoplasia, Intraductal papillary neoplasm; NOS, Intraductal papillary tumor with high grade dysplasia, Intraductal papillary tumor with high grade intraepithelial neoplasia, Intraductal papillary-mucinous adenoma, Intraductal papillary-mucinous carcinoma; invasive, Intraductal papillary-mucinous carcinoma; non-invasive, Intraductal papillary-mucinous neoplasm with low grade dysplasia, Intraductal papillary-mucinous neoplasm with moderate dysplasia, Intraductal papillary-mucinous tumor with intermediate dysplasia, Intraductal papillary-mucinous tumor with low grade dysplasia, Intraductal papillary-mucinous tumor with moderate dysplasia, Intraductal papilloma, Intraductal papilloma with ductal carcinoma in situ, Intraductal papilloma with lobular carcinoma in situ, Intraductal papillomatosis; NOS, Intraductal tubular-papillary neoplasm; high grade, Intraductal tubular-papillary neoplasm; low grade, Intraductal tubulopapillary neoplasm, Intraepidermal carcinoma; NOS, Intraepidermal epithelioma of Jadassohn, Intraepidermal nevus, Intraepidermal squamous cell carcinoma; Bowen type, Intraepithelial carcinoma; NOS, Intraepithelial squamous cell carcinoma, Intraglandular papillary neoplasm with low grade intraepithelial neoplasia, Intramuscular hemangioma, Intramuscular lipoma, Intraneural perineurioma, Intraosseous low grade osteosarcoma, Intraosseous well differentiated osteosarcoma, Intratubular germ cell neoplasia, Intratubular malignant germ cells, Intravascular B-cell lymphoma, Intravascular bronchial alveolar tumor, Intravascular large B-cell lymphoma, Intravascular leiomyomatosis, Invasive carcinoma of no special type, Invasive carcinoma; NST, Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC), Invasive fibroma, Invasive hydatidiform mole, Invasive lobular carcinoma, Invasive lobular carcinoma; alveolar type, Invasive lobular carcinoma; solid type, Invasive lobular carcinoma; tubulolobular variant, Invasive mammary carcinoma, Invasive micropapillary carcinoma, Invasive mole; NOS, Invasive mucinous adenocarcinoma, Involuting nevus, Islet cell adenocarcinoma, Islet cell adenoma, Islet cell adenomatosis, Islet cell carcinoma, Islet cell tumor; benign, Islet cell tumor; NOS, Jadassohn blue nevus, Jugular paraganglioma, Jugulotympanic paraganglioma, Junction nevus, Junctional nevus; NOS, Juvenile angiofibroma, Juvenile astrocytoma, Juvenile carcinoma of breast, Juvenile chronic myelomonocytic leukemia, Juvenile fibroadenoma, Juvenile hemangioma, Juvenile histiocytoma, Juvenile melanoma, Juvenile myelomonocytic leukemia, Juvenile nevus, Juxtacortical chondroma, Juxtacortical chondrosarcoma, Juxtacortical osteosarcoma, Juxtaglomerular tumor, Kaposi sarcoma, Kaposiform hemangioendothelioma, Keratotoc papilloma, Klatskin tumor, Krukenberg tumor, Kupffer cell sarcoma, L-cell tumor, Lactating adenoma, Langerhans cell granulomatosis, Langerhans cell granulomatosis; unifocal, Langerhans cell histiocytosis; disseminated, Langerhans cell histiocytosis; generalized, Langerhans cell histiocytosis; mono-ostotic, Langerhans cell histiocytosis; multifocal, Langerhans cell histiocytosis; NOS, Langerhans cell histiocytosis; poly-ostotic, Langerhans cell histiocytosis; unifocal, Langerhans cell sarcoma, Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease, Large cell (Ki-1+) lymphoma, Large cell calcifying Sertoli cell tumor, Large cell carcinoma with rhabdoid phenotype, Large cell carcinoma; NOS, Large cell medulloblastoma, Large cell neuroendocrine carcinoma, Large granular lymphocytosis; NOS, LCIS; NOS, Leiomyoblastoma, Leiomyofibroma, Leiomyoma; NOS, Leiomyomatosis; NOS, Leiomyosarcoma; NOS, Lennert lymphoma, Lentigo maligna, Lentigo maligna melanoma, Lepidic adenocarcinoma, Lepidic predominant adenocarcinoma, Leptomeningeal sarcoma, Letterer-Siwe disease, Leukemia; NOS, Leukemic reticuloendotheliosis, Leydig cell tumor; benign, Leydig cell tumor; malignant, Leydig cell tumor; NOS, Linitis plastica, Lipid cell tumor of ovary, Lipid-rich carcinoma, Lipid-rich Sertoli cell tumor, Lipid-rich urothelial carcinoma, Lipoadenoma, Lipoblastoma, Lipoblastomatosis, Lipoid cell tumor of ovary, Lipoleiomyoma, Lipoma-like liposarcoma, Lipoma; NOS, Lipomatous medulloblastoma, Liposarcoma; differentiated, Liposarcoma; NOS, Liposarcoma; well differentiated, Liver cell adenoma, Liver cell carcinoma, Lobular adenocarcinoma, Lobular and ductal carcinoma, Lobular carcinoma in situ; NOS, Lobular carcinoma; noninfiltrating, Lobular carcinoma; NOS, Localized fibrous tumor, Low grade adenosquamous carcinoma, Low grade appendiceal mucinous neoplasm, Low grade cribriform cystadenocarcinoma (LGCCC), Low-grade central osteosarcoma, Low-grade fibromyxoid sarcoma, Low-grade intramedullary osteosarcoma, Low-grade myofibroblastic sarcoma, Low-grade serous carcinoma, Luteinoma, Luteoma; NOS, Lymphangioendothelial sarcoma, Lymphangioendothelioma; malignant, Lymphangioendothelioma; NOS, Lymphangioleiomyomatosis, Lymphangioma; NOS, Lymphangiomyoma, Lymphangiomyomatosis, Lymphangiosarcoma, Lymphatic leukemic; NOS, Lymphoblastic leukemia; NOS, Lymphoblastoma, Lymphocytic leukemia; NOS, Lymphoepithelial carcinoma, Lymphoepithelioid lymphoma, Lymphoepithelioma, Lymphoepithelioma-like carcinoma, Lymphoid leukemia; NOS, Lymphoma; NOS, Lymphomatoid granulomatosis, Lymphomatoid papulosis, Lymphoplasmacyte-rich meningioma, Lymphoproliferative disease; NOS, Lymphoproliferative disorder; NOS, Lymphosarcoma cell leukemia, Lymphosarcoma; diffuse, Lymphosarcoma; NOS, M6A, M6B, Macrofollicular adenoma, Magnocellular nevus, Malignancy, Malignant chondroid syringoma, Malignant cystic nephroma, Malignant eccrine spiradenoma, Malignant fibrous histiocytoma, Malignant fibrous histiocytoma (MFH) of bone, Malignant giant cell tumor of soft parts, Malignant histiocytosis, Malignant hydatidiform mole, Malignant lymphoma; centroblastic; diffuse, Malignant lymphoma; centroblastic; follicular, Malignant lymphoma; centroblastic; NOS, Malignant lymphoma; centroblasticcentrocytic; diffuse, Malignant lymphoma; centroblasticcentrocytic; follicular, Malignant lymphoma; centroblasticcentrocytic; NOS, Malignant lymphoma; centrocytic, Malignant lymphoma; cleaved cell; NOS, Malignant lymphoma; convoluted cell, Malignant lymphoma; diffuse; NOS, Malignant lymphoma; follicle center; follicular, Malignant lymphoma; follicle center; NOS, Malignant lymphoma; follicular; NOS, Malignant lymphoma; histiocytic; diffuse, Malignant lymphoma; histiocytic; nodular, Malignant lymphoma; histiocytic; NOS, Malignant lymphoma; Hodgkin, Malignant lymphoma; immunoblastic; NOS, Malignant lymphoma; large B-cell; diffuse; centroblastic; NOS, Malignant lymphoma; large B-cell; diffuse; immunoblastic; NOS, Malignant lymphoma; large B-cell; diffuse; NOS, Malignant lymphoma; large B-cell; NOS, Malignant lymphoma; large cell; cleaved and noncleaved, Malignant lymphoma; large cell; cleaved; diffuse, Malignant lymphoma; large cell; cleaved; NOS, Malignant lymphoma; large cell; diffuse; NOS, Malignant lymphoma; large cell; follicular; NOS, Malignant lymphoma; large cell; immunoblastic, Malignant lymphoma; large cell; noncleaved; diffuse, Malignant lymphoma; large cell; noncleaved; follicular, Malignant lymphoma; large cell; noncleaved; NOS, Malignant lymphoma; large cell; NOS, Malignant lymphoma; large cleaved cell; follicular, Malignant lymphoma; large cleaved cell; NOS, Malignant lymphoma; lymphoblastic; NOS, Malignant lymphoma; lymphocytic; diffuse; NOS, Malignant lymphoma; lymphocytic; intermediate differentiation; diffuse, Malignant lymphoma; lymphocytic; intermediate differentiation; nodular, Malignant lymphoma; lymphocytic; nodular; NOS, Malignant lymphoma; lymphocytic; NOS, Malignant lymphoma; lymphocytic; poorly differentiated; diffuse, Malignant lymphoma; lymphocytic; poorly differentiated; nodular, Malignant lymphoma; lymphocytic; well differentiated; diffuse, Malignant lymphoma; lymphocytic; well differentiated; nodular, Malignant lymphoma; lymphoplasmacytic, Malignant lymphoma; lymphoplasmacytoid, Malignant lymphoma; mixed cell type; diffuse, Malignant lymphoma; mixed cell type; follicular, Malignant lymphoma; mixed cell type; nodular, Malignant lymphoma; mixed lymphocytic-histiocytic; diffuse, Malignant lymphoma; mixed lymphocytic-histiocytic; nodular, Malignant lymphoma; mixed small and large cell; diffuse, Malignant lymphoma; mixed small cleaved and large cell; follicular, Malignant lymphoma; nodular; NOS, Malignant lymphoma; non-cleaved cell; NOS, Malignant lymphoma; non-Hodgkin; NOS, Malignant lymphoma; noncleaved cell; follicular; NOS, Malignant lymphoma; noncleaved; diffuse; NOS, Malignant lymphoma; noncleaved; NOS, Malignant lymphoma; NOS, Malignant lymphoma; plasmacytoid, Malignant lymphoma; small B lymphocytic; NOS, Malignant lymphoma; small cell diffuse, Malignant lymphoma; small cell; noncleaved; diffuse, Malignant lymphoma; small cell; NOS, Malignant lymphoma; small cleaved cell; diffuse, Malignant lymphoma; small cleaved cell; follicular, Malignant lymphoma; small cleaved cell; NOS, Malignant lymphoma; small lymphocytic; diffuse, Malignant lymphoma; small lymphocytic; NOS, Malignant lymphoma; small noncleaved; Burkitt type, Malignant lymphoma; undifferentiated cell type; NOS, Malignant lymphoma; undifferentiated cell; non-Burkitt, Malignant lymphoma; undifferentiated; Burkitt type, Malignant lymphomatous polyposis, Malignant mast cell tumor, Malignant mastocytoma, Malignant mastocytosis, Malignant melanoma in congenital melanocytic nevus, Malignant melanoma in giant pigmented nevus, Malignant melanoma in Hutchinson melanotic freckle, Malignant melanoma in junctional nevus, Malignant melanoma in precancerous melanosis, Malignant melanoma; NOS, Malignant melanoma; regressing, Malignant midline reticulosis, Malignant mucinous adenofibroma, Malignant mucinous cystadenofibroma, Malignant multilocular cystic nephroma, Malignant myelosclerosis, Malignant myoepithelioma, Malignant peripheral nerve sheath tumor, Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation, Malignant perivascular epithelial cell tumor, Malignant reticulosis; NOS, Malignant rhabdoid tumor, Malignant schwannoma with rhabdomyoblastic differentiation, Malignant schwannoma; NOS, Malignant serous adenofibroma, Malignant serous cystadenofibroma, Malignant tenosynovial giant cell tumor, Malignant teratoma; anaplastic, Malignant teratoma; intermediate, Malignant teratoma; trophoblastic, Malignant teratoma; undifferentiated, Malignant tumor; clear cell type, Malignant tumor; fusiform cell type, Malignant tumor; giant cell type, Malignant tumor; small cell type, Malignant tumor; spindle cell type, MALT lymphoma, Mammary carcinoma; in situ, MANEC, Mantle cell lymphoma (Includes all variants blastic; pleomorphic; small cell), Mantle zone lymphoma, Marginal zone B-cell lymphoma; NOS, Marginal zone lymphoma; NOS, Masculinovoblastoma, Mast cell leukaemia, Mast cell sarcoma, Mast cell tumor; NOS, Mastocytoma; NOS, Matrical carcinoma, Mature T ALL, Mature T-cell lymphoma; NOS, Mature teratoma, Mediastinal (thymic) large B-cell lymphoma, Mediterranean lymphoma, Medullary adenocarcinoma, Medullary carcinoma with amyloid stroma, Medullary carcinoma with lymphoid stroma, Medullary carcinoma; NOS, Medullary osteosarcoma, Medulloblastoma with extensive nodularity, Medulloblastoma; classic, Medulloblastoma; group 3, Medulloblastoma; group 4, Medulloblastoma; non-WNT/non-SHH, Medulloblastoma; NOS, Medulloblastoma; SHH-activated and TP53-mutant, Medulloblastoma; SHH-activated and TP53-wildtype, Medulloblastoma; WNT-activated, Medullocytoma, Medulloepithelioma; benign, Medulloepithelioma; NOS, Medullomyoblastoma, Megakaryocytic leukemia, Megakaryocytic myelosclerosis, Melanoameloblastoma, Melanocytic nevus, Melanocytoma; eyeball, Melanocytoma; NOS, Melanoma in situ, Melanoma; malignant; of soft parts, Melanoma; NOS, Melanotic medulloblastoma, Melanotic MPNST, Melanotic neuroectodermal tumor, Melanotic neurofibroma, Melanotic progonoma, Melanotic psammomatous MPNST, Melanotic schwannoma, Meningeal melanocytoma, Meningeal melanoma, Meningeal melanomatosis, Meningeal sarcoma, Meningeal sarcomatosis, Meningioma; anaplastic, Meningioma; malignant, Meningioma; NOS, Meningiomatosis; NOS, Meningothelial meningioma, Meningothelial sarcoma, Merkel cell carcinoma, Merkel cell tumor, Mesenchymal chondrosarcoma, Mesenchymal tumor; malignant, Mesenchymoma; benign, Mesenchymoma; malignant, Mesenchymoma; NOS, Mesenteric fibromatosis, Mesoblastic nephroma, Mesodermal mixed tumor, Mesonephric adenocarcinoma, Mesonephric adenoma, Mesonephric tumor; NOS, Mesonephroma; benign, Mesonephroma; malignant, Mesonephroma; NOS, Mesothelial papilloma, Mesothelioma; benign, Mesothelioma; biphasic; malignant, Mesothelioma; biphasic; NOS, Mesothelioma; malignant, Mesothelioma; NOS, Metanephric adenoma, Metaplastic carcinoma of no special type, Metaplastic carcinoma with chondroid differentiation, Metaplastic carcinoma with osseous differentiation, Metaplastic carcinoma with other types mesenchymal differentiation, Metaplastic carcinoma; NOS, Metaplastic meningioma, Metastasizing leiomyoma, Metastatic signet ring cell carcinoma, Metatypical carcinoma, MGUS, Microcystic adenoma, Microcystic adnexal carcinoma, Microcystic meningioma, Microcystic urothelial carcinoma, Microfollicular adenoma; NOS, Microglioma, Micropapillary adenocarcinoma, Micropapillary carcinoma; NOS, Micropapillary serous carcinoma, Midline carcinoma of children and young adults with NUT rearrangement, Minimally invasive adenocarcinoma; mucinous, Minimally invasive adenocarcinoma; non-mucinous, Minimally invasive adenocarcinoma; NOS, MiT family translocation renal cell carcinoma, Mixed acidophil-basophil adenoma, Mixed acidophil-basophil carcinoma, Mixed acinar-ductal carcinoma, Mixed acinar-endocrine carcinoma, Mixed acinar-endocrine-ductal carcinoma, Mixed adenocarcinoma and epidermoid carcinoma, Mixed adenocarcinoma and squamous cell carcinoma, Mixed adenomatous and hyperplastic polyp, Mixed adenoneuroendocrine carcinoma, Mixed basal-squamous cell carcinoma, Mixed carcinoid-adenocarcinoma, Mixed cell adenocarcinoma, Mixed cell adenoma, Mixed ductal-endocrine carcinoma, Mixed embryonal carcinoma and teratoma, Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma, Mixed endocrine and exocrine adenocarcinoma, Mixed epithelioid and spindle cell melanoma, Mixed germ cell sex cord-stromal tumor; unclassified, Mixed germ cell tumor, Mixed glioma, Mixed hepatocellular and bile duct carcinoma, Mixed invasive mucinous and non-mucinous adenocarcinoma, Mixed islet cell and exocrine adenocarcinoma, Mixed liposarcoma, Mixed medullary-follicular carcinoma, Mixed medullary-papillary carcinoma, Mixed meningioma, Mixed mesenchymal sarcoma, Mixed mesenchymal tumor, Mixed pancreatic endocrine and exocrine tumor; malignant, Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1, Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged, Mixed phenotype acute leukemia; B/myeloid; NOS, Mixed phenotype acute leukemia; T/myeloid; NOS, Mixed pineal tumor, Mixed pineocytoma-pineoblastoma, Mixed small cell carcinoma, Mixed squamous cell and glandular papilloma, Mixed subependymoma-ependymoma, Mixed teratoma and seminoma, Mixed tumor; malignant; NOS, Mixed tumor; NOS, Mixed tumor; salivary gland type; malignant, Mixed tumor; salivary gland type; NOS, Mixed type rhabdomyosarcoma, Monoblastic leukemia; NOS, Monoclonal gammopathy of undetermined significance, Monoclonal gammopathy; NOS, Monocytic leukemia; NOS, Monocytoid B-cell lymphoma, Monomorphic adenoma, Monstrocellular sarcoma, MPNST with glandular differentiation, MPNST with mesenchymal differentiation, MPNST with rhabdomyoblastic differentiation, MPNST; NOS, Mu heavy chain disease, Mucin-producing adenocarcinoma, Mucin-producing carcinoma, Mucin-secreting adenocarcinoma, Mucin-secreting carcinoma, Mucinous adenocarcinofibroma, Mucinous adenocarcinoma, Mucinous adenocarcinoma; endocervical type, Mucinous adenofibroma of borderline malignancy, Mucinous adenofibroma; NOS, Mucinous adenoma, Mucinous carcinoid, Mucinous carcinoma, Mucinous carcinoma; gastric type, Mucinous carcinoma; intestinal type, Mucinous cystadenocarcinofibroma, Mucinous cystadenocarcinoma; non-invasive, Mucinous cystadenocarcinoma; NOS, Mucinous cystadenofibroma of borderline malignancy, Mucinous cystadenofibroma; NOS, Mucinous cystadenoma; borderline malignancy, Mucinous cystadenoma; NOS, Mucinous cystic neoplasm with an associated invasive carcinoma, Mucinous cystic neoplasm with high-grade dysplasia, Mucinous cystic neoplasm with high-grade intraepithelial neoplasia, Mucinous cystic neoplasm with intermediate-grade dysplasia, Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia, Mucinous cystic neoplasm with low-grade dysplasia, Mucinous cystic neoplasm with low-grade intraepithelial neoplasia, Mucinous cystic tumor of borderline malignancy, Mucinous cystic tumor with an associated invasive carcinoma, Mucinous cystic tumor with high-grade dysplasia, Mucinous cystic tumor with intermediate dysplasia, Mucinous cystic tumor with low grade dysplasia, Mucinous cystic tumor with moderate dysplasia, Mucinous cystoma, Mucinous tubular and spindle cell carcinoma, Mucinous tumor; NOS; of low malignant potential, Mucocarcinoid tumor, Mucoepidermoid carcinoma, Mucoepidermoid tumor, Mucoid adenocarcinoma, Mucoid carcinoma, Mucoid cell adenocarcinoma, Mucoid cell adenoma, Mucosal lentiginous melanoma, Mucosal-associated lymphoid tissue lymphoma, Mucous adenocarcinoma, Mucous carcinoma, Mullerian adenosarcoma, Mullerian mixed tumor, Multicentric basal cell carcinoma, Multicystic mesothelioma; benign, Multifocal superficial basal cell carcinoma, Multiple adenomatous polyps, Multiple endocrine adenomas, Multiple hemorrhagic sarcoma, Multiple meningiomas, Multiple myeloma, Multiple neurofibromatosis, Mycosis fungoides, Myelocytic leukemia; NOS, Myelodysplastic syndrome with 5q deletion (5q-) syndrome, Myelodysplastic syndrome with isolated del (5q), Myelodysplastic syndrome; NOS, Myelodysplastic syndrome; unclassifiable, Myelodysplastic/myeloproliferative neoplasm; unclassifiable, Myelofibrosis as a result of myeloproliferative disease, Myelofibrosis with myeloid metaplasia, Myelogenous leukemia; NOS, Myeloid and lymphoid neoplasms with FGFR1 abnormalities, Myeloid and lymphoid neoplasms with PDGFRA rearrangement, Myeloid leukemia associated with Down Syndrome, Myeloid leukemia; NOS, Myeloid neoplasms with PDGFRB rearrangement, Myeloid sarcoma, Myelolipoma, Myeloma; NOS, Myelomatosis, Myelomonocytic leukemia; NOS, Myeloproliferative disease; NOS, Myeloproliferative neoplasm; NOS, Myelosclerosis with myeloid metaplasia, Myloproliferative neoplasm; unclassifiable, Myoepithelial adenoma, Myoepithelial carcinoma, Myoepithelial tumor, Myoepithelioma, Myofibroblastic sarcoma, Myofibroblastic tumor; NOS, Myofibroblastic tumor; peribronchial, Myofibroblastoma, Myofibroma, Myofibromatosis, Myoma, Myosarcoma, Myxofibroma; NOS, Myxoid chondrosarcoma, Myxoid fibroma, Myxoid leiomyosarcoma, Myxoid liposarcoma, Myxoinflammatory fibroblastic sarcoma (MIFS), Myxolipoma, Myxoliposarcoma, Myxoma; NOS, Myxopapillary ependymoma, Myxosarcoma, Neoplasm; benign, Neoplasm; malignant, Neoplasm; malignant; uncertain whether primary or metastatic, Neoplasm; metastatic, Neoplasm; NOS, Neoplasm; secondary, Neoplasm; uncertain whether benign or malignant, Nephroblastoma; NOS, Nephrogenic adenofibroma, Nephroma; NOS, Nerve sheath myxoma, Nesidioblastoma, Nested urothelial carcinoma, Neurilemoma; malignant, Neurilemoma; NOS, Neurilemosarcoma, Neurinoma, Neurinomatosis, Neuroastrocytoma, Neuroblastoma; NOS, Neurocytoma, Neuroectodermal tumor; NOS, Neuroendocrine carcinoma; low grade, Neuroendocrine carcinoma; moderately differentiated, Neuroendocrine carcinoma; NOS, Neuroendocrine carcinoma; poorly differentiated, Neuroendocrine carcinoma; well-differentiated, Neuroendocrine tumor; grade 1, Neuroendocrine tumor; grade 2, Neuroendocrine tumor; well differentiated, Neuroepithelioma; NOS, Neurofibroma; NOS, Neurofibromatosis; NOS, Neurofibrosarcoma, Neurogenic sarcoma, Neurolipocytoma, Neuroma; NOS, Neuronevus, Neurosarcoma, Neurothekeoma, Neurotropic melanoma; malignant, Nevus; NOS, NK-cell large granular lymphocytic leukemia, NK/T-cell lymphoma; nasal and nasal-type, Nodal marginal zone lymphoma, Nodular hidradenoma, Nodular hidradenoma; malignant, Nodular melanoma, Non-Hodgkin lymphoma; NOS, Non-invasive EFVPTC, Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC), Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), Non-invasive FTP, Non-invasive low grade serous carcinoma, Non-invasive mammary carcinoma, Non-lymphocytic leukemia; NOS, Non-small cell carcinoma, Nonchromaffin paraganglioma; malignant, Nonchromaffin paraganglioma; NOS, Nonencapsulated sclerosing adenocarcinoma, Nonencapsulated sclerosing carcinoma, Nonencapsulated sclerosing tumor, Noninfiltrating intracystic carcinoma, Noninfiltrating intraductal papillary adenocarcinoma, Noninfiltrating intraductal papillary carcinoma, Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia, Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia, Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia, Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia, Nonlipid reticuloendotheliosis, Nonpigmented nevus, NUT carcinoma, NUT midline carcinoma, Oat cell carcinoma, Odontoameloblastoma, Odontogenic carcinoma, Odontogenic carcinosarcoma, Odontogenic fibroma; NOS, Odontogenic fibrosarcoma, Odontogenic ghost cell tumor, Odontogenic myxofibroma, Odontogenic myxoma, Odontogenic sarcoma, Odontogenic tumor; benign, Odontogenic tumor; malignant, Odontogenic tumor; NOS, Odontoma; NOS, Olfactory neuroblastoma, Olfactory neurocytoma, Olfactory neuroepithelioma, Olfactory neurogenic tumor, Oligoastrocytoma, Oligodendroblastoma, Oligodendroglioma; anaplastic, Oligodendroglioma; IDH-mutant and 1p/19q-codeleted, Oligodendroglioma; NOS, Oncocytic adenocarcinoma, Oncocytic adenoma, Oncocytic carcinoma, Oncocytic Schneiderian papilloma, Oncocytoma, Orchioblastoma, Ossifying fibroma, Ossifying fibromyxoid tumor, Ossifying fibromyxoid tumor; malignant, Ossifying renal tumor, Osteoblastic sarcoma, Osteoblastoma; malignant, Osteoblastoma; NOS, Osteocartilaginous exostosis, Osteochondroma, Osteochondromatosis; NOS, Osteochondrosarcoma, Osteofibroma, Osteofibrosarcoma, Osteogenic sarcoma; NOS, Osteoid osteoma; NOS, Osteoma; NOS, Osteosarcoma in Paget disease of bone, Osteosarcoma; NOS, Ovarian stromal tumor, Oxyphilic adenocarcinoma, Oxyphilic adenoma, Pacinian tumor, Paget disease and infiltrating duct carcinoma of breast, Paget disease and intraductal carcinoma of breast, Paget disease of breast, Paget disease; extramammary, Paget disease; mammary, Pagetoid reticulosis, Pancreatic endocrine tumor; benign, Pancreatic endocrine tumor; malignant, Pancreatic endocrine tumor; nonfunctioning, Pancreatic endocrine tumor; NOS, Pancreatic microadenoma, Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor, Pancreatobiliary neoplasm; non-invasive, Pancreatobiliary-type carcinoma, Pancreatoblastoma, Papillary adenocarcinoma; follicular variant, Papillary adenocarcinoma; NOS, Papillary adenofibroma, Papillary adenoma; NOS, Papillary and follicular adenocarcinoma, Papillary and follicular carcinoma, Papillary carcinoma in situ, Papillary carcinoma of thyroid, Papillary carcinoma; columnar cell, Papillary carcinoma; diffuse sclerosing, Papillary carcinoma; encapsulated, Papillary carcinoma; follicular variant, Papillary carcinoma; NOS, Papillary carcinoma; oxyphilic cell, Papillary carcinoma; tall cell, Papillary cystadenocarcinoma; NOS, Papillary cystadenoma lymphomatosum, Papillary cystadenoma; borderline malignancy, Papillary cystadenoma; NOS, Papillary cystic tumor, Papillary ependymoma, Papillary epidermoid carcinoma, Papillary glioneuronal tumor, Papillary hidradenoma, Papillary meningioma, Papillary microcarcinoma, Papillary mucinous cystadenocarcinoma, Papillary mucinous cystadenoma; borderline malignancy, Papillary mucinous cystadenoma; NOS, Papillary mucinous tumor of low malignant potential, Papillary neoplasm; pancreatobiliary-type; with high grade intraepithelial neoplasia, Papillary pseudomucinous cystadenocarcinoma, Papillary pseudomucinous cystadenoma; borderline malignancy, Papillary pseudomucinous cystadenoma; NOS, Papillary renal cell carcinoma, Papillary serous adenocarcinoma, Papillary serous cystadenocarcinoma, Papillary serous cystadenoma; borderline malignancy, Papillary serous cystadenoma; NOS, Papillary serous tumor of low malignant potential, Papillary squamous cell carcinoma, Papillary squamous cell carcinoma in situ, Papillary squamous cell carcinoma; non-invasive, Papillary syringadenoma, Papillary syringocystadenoma, Papillary transitional cell carcinoma, Papillary transitional cell carcinoma; non-invasive, Papillary transitional cell neoplasm of low malignant potential, Papillary tumor of the pineal region, Papillary urothelial carcinoma, Papillary urothelial carcinoma; non-invasive, Papillary urothelial neoplasm of low malignant potential, Papillocystic adenocarcinoma, Papilloma of bladder, Papilloma; NOS, Papillomatosis; glandular, Papillomatosis; NOS, Papillotubular adenocarcinoma, Papillotubular adenoma, Parachordoma, Parafollicular cell carcinoma, Paraganglioma; benign, Paraganglioma; malignant, Paraganglioma; NOS, Parasympathetic paraganglioma, Parietal cell adenocarcinoma, Parietal cell carcinoma, Parosteal osteosarcoma, Partial hydatidiform mole, PEComa; malignant, Periapical cemental dysplasia, Periapical cemento-osseous dysplasia, Pericanalicular fibroadenoma, Periductal stromal tumor; low grade, Perifollicular fibroma, Perineural MPNST, Perineurioma; malignant, Perineurioma; NOS, Periosteal chondroma, Periosteal chondrosarcoma, Periosteal fibroma, Periosteal fibrosarcoma, Periosteal osteosarcoma, Periosteal sarcoma; NOS, Peripheral neuroectodermal tumor, Peripheral odontogenic fibroma, Peripheral primitive neuroectodermal tumor; NOS, Peripheral T-cell lymphoma; AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia), Peripheral T-cell lymphoma; large cell, Peripheral T-cell lymphoma; NOS, Peripheral T-cell lymphoma; pleomorphic medium and large cell, Peripheral T-cell lymphoma; pleomorphic small cell, Perivascular epithelioid cell tumor; malignant, Pheochromoblastoma, Pheochromocytoma; malignant, Pheochromocytoma; NOS, Phosphaturic mesenchymal tumor; malignant, Phyllodes tumor; benign, Phyllodes tumor; borderline, Phyllodes tumor; malignant, Phyllodes tumor; NOS, Pick tubular adenoma, Pigmented adenoma, Pigmented basal cell carcinoma, Pigmented dermatofibrosarcoma protuberans, Pigmented nevus; NOS, Pigmented schwannoma, Pigmented spindle cell nevus of Reed, Pilar tumor, Pilocytic astrocytoma, Piloid astrocytoma, Pilomatricoma; malignant, Pilomatricoma; NOS, Pilomatrix carcinoma, Pilomatrixoma; malignant, Pilomatrixoma; NOS, Pilomyxoid astrocytoma, PIN III, Pindborg tumor, Pineal parenchymal tumor of intermediate differentiation, Pinealoma, Pineoblastoma, Pineocytoma, Pinkus tumor, Pituicytoma, Pituitary adenoma; NOS, Pituitary carcinoma; NOS, Placental site trophoblastic tumor, Plasma cell leukemia, Plasma cell myeloma, Plasma cell tumor, Plasmablastic lymphoma, Plasmacytic leukemia, Plasmacytic lymphoma, Plasmacytoma of bone, Plasmacytoma; extramedullary, Plasmacytoma; NOS, Pleomorphic adenoma, Pleomorphic carcinoma, Pleomorphic cell sarcoma, Pleomorphic leiomyoma, Pleomorphic lipoma, Pleomorphic liposarcoma, Pleomorphic lobular carcinoma, Pleomorphic lobular carcinoma in situ, Pleomorphic rhabdomyosarcoma; adult type, Pleomorphic rhabdomyosarcoma; NOS, Pleomorphic xanthoastrocytoma, Pleuropulmonary blastoma, Plexiform fibrohistiocytic tumor, Plexiform fibromyxoma, Plexiform hemangioma, Plexiform leiomyoma, Plexiform neurofibroma, Plexiform neuroma, Plexiform schwannoma, PNET; NOS, Pneumoblastoma, Polar spongioblastoma, Polycythemia rubra vera, Polycythemia vera, Polyembryoma, Polygonal cell carcinoma, Polymorphic post transplant lymphoproliferative disorder, Polymorphic reticulosis, Polymorphous low grade adenocarcinoma, Polypoid adenoma, Polyvesicular vitelline tumor, Poorly cohesive carcinoma, Porocarcinoma, Post transplant lymphoproliferative disorder; NOS, PP/PYY producing tumor, PPNET, Pre-B ALL, Pre-pre-B ALL, Pre-T ALL, Precancerous melanosis; NOS, Precursor B-cell lymphoblastic leukemia, Precursor B-cell lymphoblastic lymphoma, Precursor cell lymphoblastic leukemia; NOS, Precursor cell lymphoblastic leukemia; not phenotyped, Precursor cell lymphoblastic lymphoma; NOS, Precursor T-cell lymphoblastic leukemia, Precursor T-cell lymphoblastic lymphoma, Preleukemia, Preleukemic syndrome, Primary amyloidosis, Primary cutaneous anaplastic large cell lymphoma, Primary cutaneous CD30+ large T-cell lymphoma, Primary cutaneous CD30+ T-cell lymphoproliferative disorder, Primary cutaneous CD4-positive small/medium T-cell lymphoma, Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma, Primary cutaneous DLBCL; leg type, Primary cutaneous follicle centre lymphoma, Primary cutaneous gamma-delta T-cell lymphoma, Primary cutaneous neuroendocrine carcinoma, Primary diffuse large B-cell lymphoma of the CNS, Primary effusion lymphoma, Primary intraosseous carcinoma, Primary myelofibrosis, Primary serous papillary carcinoma of peritoneum, Primitive neuroectodermal tumor; NOS, Primitive polar spongioblastoma, Pro-B ALL, Pro-T ALL, Prolactinoma, Proliferating trichilemmal cyst, Proliferating trichilemmal tumor, Proliferative dermal lesion in congenital nevus, Proliferative polycythemia, Prolymphocytic leukemia; B-cell type, Prolymphocytic leukemia; NOS, Prolymphocytic leukemia; T-cell type, Prostatic intraepithelial neoplasia; grade III, Protoplasmic astrocytoma, Psammomatous meningioma, Psammomatous schwannoma, Pseudomucinous adenocarcinoma, Pseudomucinous cystadenocarcinoma; NOS, Pseudomucinous cystadenoma; borderline malignancy, Pseudomucinous cystadenoma; NOS, Pseudomyxoma peritonei, Pseudomyxoma peritonei with unknown primary site, Pseudosarcomatous carcinoma, PTLD; NOS, Pulmonary adenomatosis, Pulmonary artery intimal sarcoma, Pulmonary blastoma, Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation, Queyrat erythroplasia, Racemose hemangioma, RAEB, RAEB I, RAEB II, RAEB-T, RARS, Rathke pouch tumor, Recklinghausen disease, Refractory anemia, Refractory anemia with excess blasts, Refractory anemia with excess blasts in transformation, Refractory anemia with ring sideroblasts associated with marked thrombocytosis, Refractory anemia with ringed sideroblasts, Refractory anemia with sideroblasts, Refractory anemia without sideroblasts, Refractory cytopenia of childhood, Refractory cytopenia with multilineage dysplasia, Refractory neutropenia, Refractory thrombocytopenia, Regressing nevus, Renal carcinoma; collecting duct type, Renal cell adenocarcinoma, Renal cell carcinoma; chromophobe type, Renal cell carcinoma; NOS, Renal cell carcinoma; sarcomatoid, Renal cell carcinoma; spindle cell, Renal cell carcinoma; unclassified, Renal medullary carcinoma, Reninoma, Renomedullary fibroma, Renomedullary interstitial cell tumor, Reserve cell carcinoma, Reticulohistiocytoma, Reticulosarcoma; diffuse, Reticulosarcoma; NOS, Reticulum cell sarcoma; diffuse, Reticulum cell sarcoma; NOS, Retinal anlage tumor, Retinoblastoma; differentiated, Retinoblastoma; diffuse, Retinoblastoma; NOS, Retinoblastoma; spontaneously regressed, Retinoblastoma; undifferentiated, Retinocytoma, Retroperitoneal fibromatosis, Rhabdoid meningioma, Rhabdoid sarcoma, Rhabdoid tumor; NOS, Rhabdomyoma; NOS, Rhabdomyosarcoma with ganglionic differentiation, Rhabdomyosarcoma; NOS, Rhabdosarcoma, Rodent ulcer, Rosette-forming glioneuronal tumor, Round cell carcinoma, Round cell liposarcoma, Round cell osteosarcoma, Round cell sarcoma, Salivary duct carcinoma, SALT lymphoma, Sarcoma botryoides, Sarcoma; NOS, Sarcomatoid carcinoma, Sarcomatoid mesothelioma, Sarcomatosis; NOS, Schmincke tumor, Schneiderian carcinoma, Schneiderian papilloma; inverted, Schneiderian papilloma; NOS, Schwannoma; NOS, Scirrhous adenocarcinoma, Scirrhous carcinoma, Sclerosing epithelioid fibrosarcoma, Sclerosing hemangioma, Sclerosing hepatic carcinoma, Sclerosing liposarcoma, Sclerosing rhabdomyosarcoma, Sclerosing stromal tumor, Sclerosing sweat duct carcinoma, Sebaceous adenocarcinoma, Sebaceous adenoma, Sebaceous carcinoma, Sebaceous epithelioma, Secondary carcinoma, Secretory carcinoma of breast, Secretory meningioma, Seminoma with high mitotic index, Seminoma; anaplastic, Seminoma; NOS, Seromucinous carcinoma, Serotonin producing carcinoid, Serous adenocarcinofibroma, Serous adenocarcinoma; NOS, Serous adenofibroma of borderline malignancy, Serous adenofibroma; NOS, Serous borderline tumor-micropapillary variant, Serous carcinoma; NOS, Serous cystadenocarcinofibroma, Serous cystadenocarcinoma; NOS, Serous cystadenofibroma of borderline malignancy, Serous cystadenofibroma; NOS, Serous cystadenoma; borderline malignancy, Serous cystadenoma; NOS, Serous cystoma, Serous endometrial intraepithelial carcinoma, Serous microcystic adenoma, Serous papillary cystic tumor of borderline malignancy, Serous surface papillary carcinoma, Serous surface papillary tumor of borderline malignancy, Serous surface papilloma, Serous tubal intraepithelial carcinoma, Serous tumor; NOS; of low malignant potential, Serrated adenocarcinoma, Serrated adenoma, Sertoli cell adenoma, Sertoli cell carcinoma, Sertoli cell tumor with lipid storage, Sertoli cell tumor; NOS, Sertoli-Leydig cell tumor of intermediate differentiation, Sertoli-Leydig cell tumor; intermediate differentiation; with heterologous elements, Sertoli-Leydig cell tumor; NOS, Sertoli-Leydig cell tumor; poorly differentiated, Sertoli-Leydig cell tumor; poorly differentiated; with heterologous elements, Sertoli-Leydig cell tumor; retiform, Sertoli-Leydig cell tumor; retiform; with heterologous elements, Sertoli-Leydig cell tumor; sarcomatoid, Sertoli-Leydig cell tumor; well differentiated, Sessile serrated adenoma, Sessile serrated polyp, SETTLE, Sex cord tumor with annular tubules, Sex cord tumor; NOS, Sex cord-gonadal stromal tumor; incompletely differentiated, Sex cord-gonadal stromal tumor; mixed forms, Sex cord-gonadal stromal tumor; NOS, Sezary disease, Sezary syndrome, Sialoblastoma, Signet ring cell adenocarcinoma, Signet ring cell carcinoma, Sinonasal papilloma; exophytic, Sinonasal papilloma; fungiform, Sinonasal papilloma; NOS, Skin appendage adenoma, Skin appendage carcinoma, Skin appendage tumor; benign, Skin-associated lymphoid tissue lymphoma, Small cell carcinoma pulmonary type, Small cell carcinoma; fusiform cell, Small cell carcinoma; hypercalcemic type, Small cell carcinoma; intermediate cell, Small cell carcinoma; NOS, Small cell neuroendocrine carcinoma, Small cell osteosarcoma, Small cell sarcoma, Small congenital nevus, Smooth muscle tumor of uncertain malignant potential, Smooth muscle tumor; NOS, Soft tissue perineurioma, Soft tissue sarcoma, Soft tissue tumor; benign, Soft tissue tumor; malignant, Solid adenocarcinoma with mucin formation, Solid and cystic tumor, Solid and papillary epithelial neoplasm, Solid carcinoma with mucin formation, Solid carcinoma; NOS, Solid papillary carcinoma in situ, Solid papillary carcinoma with invasion, Solid pseudopapillary carcinoma, Solid pseudopapillary tumor, Solid teratoma, Solitary fibrous tumor, Solitary fibrous tumor; malignant, Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS), Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS), Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS), Solitary mastocytoma of skin, Solitary myeloma, Solitary plasmacytoma, Somatostatin cell tumor; malignant, Somatostatin cell tumor; NOS, Somatostatinoma; malignant, Somatostatinoma; NOS, Spermatocytic seminoma, Spermatocytoma, Spindle cell angioendothelioma, Spindle cell carcinoma; NOS, Spindle cell hemangioendothelioma, Spindle cell lipoma, Spindle cell melanoma; NOS, Spindle cell melanoma; type A, Spindle cell melanoma; type B, Spindle cell nevus; NOS, Spindle cell oncocytoma, Spindle cell rhabdomyosarcoma, Spindle cell sarcoma, Spindle epithelial tumor with thymus-like differentiation, Spindle epithelial tumor with thymus-like element, Spindled mesothelioma, Spiradenoma; NOS, Spitz nevus, Splenic B-cell lymphoma/leukemia; unclassifiable, Splenic diffuse red pulp small B-cell lymphoma, Splenic lymphoma with villous lymphocytes, Splenic marginal zone B-cell lymphoma, Splenic marginal zone lymphoma; NOS, Spongioblastoma multiforme, Spongioblastoma polare, Spongioblastoma; NOS, Spongioneuroblastoma, Squamotransitional cell carcinoma, Squamous carcinoma, Squamous cell carcinoma in situ with questionable stromal invasion, Squamous cell carcinoma in situ; NOS, Squamous cell carcinoma with horn formation, Squamous cell carcinoma; acantholytic, Squamous cell carcinoma; adenoid, Squamous cell carcinoma; clear cell type, Squamous cell carcinoma; HPV-negative, Squamous cell carcinoma; HPV-positive, Squamous cell carcinoma; keratinizing; NOS, Squamous cell carcinoma; large cell; keratinizing, Squamous cell carcinoma; large cell; nonkeratinizing; NOS, Squamous cell carcinoma; metastatic; NOS, Squamous cell carcinoma; microinvasive, Squamous cell carcinoma; nonkeratinizing; NOS, Squamous cell carcinoma; NOS, Squamous cell carcinoma; pseudoglandular, Squamous cell carcinoma; sarcomatoid, Squamous cell carcinoma; small cell; nonkeratinizing, Squamous cell carcinoma; spindle cell, Squamous cell epithelioma, Squamous cell papilloma; inverted, Squamous cell papilloma; NOS, Squamous intraepithelial neoplasia; grade I, Squamous intraepithelial neoplasia; grade II, Squamous intraepithelial neoplasia; grade III, Squamous intraepithelial neoplasia; high grade, Squamous intraepithelial neoplasia; low grade, Squamous odontogenic tumor, Squamous papilloma, Squamous papillomatosis, Stem cell leukemia, Steroid cell tumor; malignant, Steroid cell tumor; NOS, Stromal endometriosis, Stromal myosis; NOS, Stromal sarcoma; NOS, Stromal tumor with minor sex cord elements, Stromal tumor; benign, Stromal tumor; NOS, Struma ovarii and carcinoid, Struma ovarii; malignant, Struma ovarii; NOS, Strumal carcinoid, Subacute granulocytic leukemia, Subacute leukemia; NOS, Subacute lymphatic leukemia, Subacute lymphocytic leukemia, Subacute lymphoid leukemia, Subacute monocytic leukemia, Subacute myelogenous leukemia, Subacute myeloid leukemia, Subareolar duct papillomatosis, Subcutaneous panniculitis-like T-cell lymphoma, Subependymal astrocytoma; NOS, Subependymal giant cell astrocytoma, Subependymal glioma, Subependymoma, Subepidermal nodular fibrosis, Superficial spreading adenocarcinoma, Superficial spreading melanoma, Superficial well differentiated liposarcoma, Supratentorial PNET, Sweat gland adenocarcinoma, Sweat gland adenoma, Sweat gland carcinoma, Sweat gland tumor; benign, Sweat gland tumor; malignant, Sweat gland tumor; NOS, Sympathetic paraganglioma, Sympathicoblastoma, Symplastic leiomyoma, Syncytial meningioma, Synovial sarcoma; biphasic, Synovial sarcoma; epithelioid cell, Synovial sarcoma; monophasic fibrous, Synovial sarcoma; NOS, Synovial sarcoma; spindle cell, Synovioma; benign, Synovioma; malignant, Synovioma; NOS, Syringadenoma; NOS, Syringocystadenoma papilliferum, Syringofibroadenoma, Syringoma; NOS, Syringomatous carcinoma, Systemic EBV positive T-cell lymphoproliferative disease of childhood, Systemic light chain disease, Systemic mastocytosis with AHNMD, Systemic mastocytosis with associated hematological clonal non-mast cell disorder, Systemic tissue mast cell disease, T lymphoblastic leukemia/lymphoma, T-cell large granular lymphocytic leukemia, T-cell large granular lymphocytosis, T-cell lymphoma; NOS, T-cell rich large B-cell lymphoma, T-cell rich/histiocyte-rich large B-cell lymphoma, T-gamma lymphoproliferative disease, T-zone lymphoma, T/NK-cell lymphoma, Tanycytic ependymoma, Telangiectatic osteosarcoma, Tenosynovial giant cell tumor, Teratoblastoma; malignant, Teratocarcinoma, Teratoid medulloepithelioma, Teratoid medulloepithelioma; benign, Teratoma with malignant transformation, Teratoma; benign, Teratoma; differentiated, Teratoma; malignant; NOS, Teratoma; NOS, Terminal duct adenocarcinoma, Testicular adenoma, Testicular stromal tumor, Theca cell tumor, Theca cell-granulosa cell tumor, Thecoma; luteinized, Thecoma; malignant, Thecoma; NOS, Therapy related myeloid neoplasm, Therapy-related acute myeloid leukemia; alkylating agent related, Therapy-related acute myeloid leukemia; epipodophyllotoxin-related, Therapy-related acute myeloid leukemia; NOS, Therapy-related myelodysplastic syndrome; alkylating agent related, Therapy-related myelodysplastic syndrome; epipodophyllotoxin-related, Therapy-related myelodysplastic syndrome; NOS, Thymic carcinoma with adenoid cystic carcinoma-like features, Thymic carcinoma; NOS, Thymic large B-cell lymphoma, Thymoma; atypical; malignant, Thymoma; atypical; NOS, Thymoma; benign, Thymoma; cortical; malignant, Thymoma; cortical; NOS, Thymoma; epithelial; malignant, Thymoma; epithelial; NOS, Thymoma; lymphocyte-rich; malignant, Thymoma; lymphocyte-rich; NOS, Thymoma; lymphocytic; malignant, Thymoma; lymphocytic; NOS, Thymoma; malignant; NOS, Thymoma; medullary; malignant, Thymoma; medullary; NOS, Thymoma; mixed type; malignant, Thymoma; mixed type; NOS, Thymoma; NOS, Thymoma; organoid; malignant, Thymoma; organoid; NOS, Thymoma; predominantly cortical; malignant, Thymoma; predominantly cortical; NOS, Thymoma; spindle cell; malignant, Thymoma; spindle cell; NOS, Thymoma; type A; malignant, Thymoma; type A; NOS, Thymoma; type AB; malignant, Thymoma; type AB; NOS, Thymoma; type B1; malignant, Thymoma; type B1; NOS, Thymoma; type B2; malignant, Thymoma; type B2; NOS, Thymoma; type B3; malignant, Thymoma; type B3; NOS, Thymoma; type C, Tibial adamantinoma, Trabecular adenocarcinoma, Trabecular adenoma, Trabecular carcinoma, Traditional serrated adenoma, Traditional sessile serrated adenoma, Transient abnormal myelopoiesis, Transitional carcinoma, Transitional cell carcinoma, Transitional cell carcinoma in situ, Transitional cell carcinoma; micropapillary, Transitional cell carcinoma; sarcomatoid, Transitional cell carcinoma; spindle cell, Transitional cell papilloma; benign, Transitional cell papilloma; inverted; benign, Transitional cell papilloma; inverted; NOS, Transitional cell papilloma; NOS, Transitional meningioma, Transitional papilloma, Transitional papilloma; inverted; benign, Transitional papilloma; inverted; NOS, Transitional pineal tumor, Trichilemmal carcinoma, Trichilemmocarcinoma, Trichilemmoma, Trichodiscoma, Trichoepithelioma, Trichofolliculoma, Triton tumor; malignant, Trophoblastic tumor; epithelioid, True histiocytic lymphoma, Tubular adenocarcinoma, Tubular adenoma; NOS, Tubular androblastoma with lipid storage, Tubular androblastoma; NOS, Tubular carcinoid, Tubular carcinoma, Tubulo-papillary adenoma, Tubulocystic renal cell carcinoma, Tubulolobular carcinoma, Tubulopapillary adenocarcinoma, Tubulovillous adenoma; NOS, Tumor cells; benign, Tumor cells; malignant, Tumor cells; NOS, Tumor cells; uncertain whether benign or malignant, Tumor embolus, Tumor; benign, Tumor; malignant; NOS, Tumor; metastatic, Tumor; NOS, Tumor; secondary, Tumorlet; benign, Tumorlet; NOS, Turban tumor, Typical carcinoid, Unclassified tumor; benign, Unclassified tumor; borderline malignancy, Unclassified tumor; malignant, Unclassified tumor; malignant; uncertain whether primary or metastatic, Unclassified tumor; uncertain whether benign or malignant, Undifferentiated epithelioid sarcoma, Undifferentiated high-grade pleomorphic sarcoma, Undifferentiated leukaemia, Undifferentiated pleomorphic sarcoma, Undifferentiated round cell sarcoma, Undifferentiated sarcoma, Undifferentiated spindle cell sarcoma, Undifferentiated uterine sarcoma, Urachal carcinoma, Urothelial carcinoma in situ, Urothelial carcinoma with divergent differentiation, Urothelial carcinoma with squamous differentiation, Urothelial carcinoma with trophoblastic differentiation, Urothelial carcinoma; NOS, Urothelial papilloma; NOS, Urticaria pigmentosa, Vaginal intraepithelial neoplasia; grade III, VAIN III, Vascular leiomyoma, Venous hemangioma, Verrucous carcinoma; NOS, Verrucous epidermoid carcinoma, Verrucous keratotic hemangioma, Verrucous papilloma, Verrucous squamous cell carcinoma, Villoglandular adenoma, Villoglandular carcinoma, Villous adenocarcinoma, Villous adenoma; NOS, Villous papilloma, VIN III, Vipoma; malignant, Vipoma; NOS, Von Recklinghausen disease, Vulvar intraepithelial neoplasia; grade III, Waldenstrom macroglobulinemia, Warthin tumor, Warty carcinoma, Water-clear cell adenocarcinoma, Water-clear cell adenoma, Water-clear cell carcinoma, Well differentiated liposarcoma of superficial soft tissue, Well differentiated papillary mesothelioma; benign, Well differentiated thymic carcinoma, Wilms tumor, Wolffian duct adenoma, Wolffian duct carcinoma, Wolffian duct tumor, Xanthofibroma, Yolk sac tumor, Unknown, Not Reported, Source Data Not Available ",,TRUE,,,,CDS Metadata v1.3.3/Diagnosis,
Individual Primary Site,Primary site in the body associated with the primary diagnosis.,"Adrenal Gland, Base of the Tongue, Bladder, Brain, Breast, Cervix Uteri, Colon, Corpus Uteri, Esophagus, Floor of Mouth, Gallbladder, Gingiva, Hypopharynx, Kidney, Larynx, Limb Skeletal System, Lip, Lung/Bronchus, Lymph Node, Meninges, Nasopharynx, Not Reported, Oropharynx, Other and Ill Defined Digestive Organs ICD-O-3, Other and Ill-Defined Sites ICD-O-3, Other and Ill-Defined Sites in Lip; Oral Cavity and Pharynx ICD-O-3, Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3, Other and Unspecified Female Genital Organs ICD-O-3, Other and Unspecified Major Salivary Glands ICD-O-3, Other and Unspecified Male Genital Organs ICD-O-3, Other and Unspecified Parts of Biliary Tract ICD-O-3, Other and Unspecified Parts of Mouth ICD-O-3, Other and Unspecified Parts of Tongue ICD-O-3, Other and Unspecified Urinary Organs ICD-O-3, Other Endocrine Glands and Related Structures ICD-O-3, Ovary, Palate, Pancreas, Paranasal Sinus, Parotid Gland, Penis, Peritoneum and Retroperitoneum, Placenta, Prostate Gland, Pyriform Sinus, Rectosigmoid Region, Rectum, Renal Pelvis, Skin, Small Intestine, Stomach, Testis, Thymus Gland, Thyroid Gland, Tonsil, Trachea, Unknown, Ureter, Uterus, Vagina, Vulva",,FALSE,,,,CDS Imaging v1.0/Diagnosis,
Individual Tumor Subtype,"The subtype related to the scientific determination and investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms of tissue growth resulting from uncontrolled cell proliferation.",,,FALSE,,,,MC2/STE,str
Individual Tumor Grade,"Numeric value to express the degree of abnormality of cancer cells, a measure of differentiation and aggressiveness.","G1, G2, G3, G4, GX, GB, High Grade, Intermediate Grade, Low Grade, Unknown, Not Reported, Not Applicable",,FALSE,,,,CDS Imaging v1.0,
Individual Site of Origin,"The text term used to describe the anatomic site of origin, of the patient's malignant disease.","Abdomen, Abdominal Esophagus, Adrenal Cortex, Adrenal Gland, Adrenal Medulla, Ampulla of Vater, Anal Canal, Anal Transitional Zone, Anterior Mediastinum, Anterior Surface of the Epiglottis, Anterior Wall of the Bladder, Anterior Wall of the Nasopharynx, Antrum Pylori, Anus, Appendage of the Uterus, Appendix, Ascending Colon, Autonomic Nervous System, Axillary Lymph Node, Axillary Tail of the Breast, Base of the Tongue, Biliary Tract, Bladder Neck, Bladder Trigone, Bladder, Blood, Body of Stomach, Body of the Pancreas, Body of the Penis, Bone Marrow, Bone of the Extremity, Bone, Brain Stem, Brain Ventricle, Brain, Branchial Cleft Remnant, Breast, Broad Ligament, Buccal Mucosa, Carotid Body, Cauda Equina, Cecum, Central Portion of the Breast, Cerebellum, Cerebral Hemisphere, Cerebral Meninges, Cervical Esophagus, Cervix Uteri, Choroid, Ciliary Body, Clitoris, Cochlear Nerve, Colon, Commissure of the Lip, Conjunctiva, Cornea, Corpus Uteri, Cranial Nerve, Craniopharyngeal Duct, Descending Colon, Dome of the Bladder, Duodenum, Ectocervix, Endocervix, Endocrine Gland, Endometrium, Epididymis, Esophagus, Ethmoid Sinus, External Ear, External Lip, External Lower Lip, External Upper Lip, Extrahepatic Bile Duct, Eyelid, Eye, Fallopian Tube, Female Genitalia, Floor of Mouth, Frontal Lobe, Frontal Sinus, Fundus of the Stomach, Fundus Uteri, Gallbladder, Gastric Cardia, Gastrointestinal Tract, Gingiva, Glans Penis, Glottis, Greater Curvature of the Stomach, Hard Palate, Head and Neck Lymph Node, Head of the Pancreas, Heart, Hematopoietic System, Hepatic Flexure, Hypopharynx, Ileum, Ill-Defined Anatomic Site, Intestine, Intra-Abdominal Lymph Node, Intrahepatic Bile Duct, Intrathoracic Lymph Node, Islet of Langerhans, Isthmus Uteri, Jejunum, Kidney, Labium Majus, Labium Minus, Lacrimal Gland, Laryngeal Cartilage, Larynx, Lateral Wall of the Bladder, Lateral Wall of the Nasopharynx, Lateral Wall of the Oropharynx, Lesser Curvature of the Stomach, Lingual Tonsil, Lip, Liver, Lower Extremity, Lower Gingiva, Lower Lobe of the Lung, Lower Third of the Esophagus, Lower-Inner Quadrant of the Breast, Lower-Outer Quadrant of the Breast, Lung, Lymph Node of Inguinal Region or Leg, Lymph Node, Main Bronchus, Male Genitalia, Mandible, Maxillary Sinus, Meckel Diverticulum, Mediastinum, Meninges, Middle Ear, Middle Lobe of the Right Lung, Middle Third of the Esophagus, Mucosa of the Lip, Mucosa of the Lower Lip, Mucosa of the Upper Lip, Myometrium, Nasal Cavity, Nasopharynx, Nervous System, Nipple, Not Reported, Occipital Lobe, Olfactory Nerve, Optic Nerve, Oral Cavity, Orbit, Oropharynx, Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3, Other and Unspecified Female Genital Organs ICD-O-3, Other and Unspecified Male Genital Organs ICD-O-3, Other Specified Parts of Pancreas, Ovary, Palate, Palatine Tonsil, Pancreas, Pancreatic Duct, Parametrium, Paranasal Sinus, Parathyroid Gland, Parietal Lobe, Parotid Gland, Pelvic Lymph Node, Pelvis, Penis, Peritoneum, Pharynx, Pineal Gland, Pituitary Gland, Placenta, Pleura, Postcricoid Region, Posterior Mediastinum, Posterior Wall of the Bladder, Posterior Wall of the Hypopharynx, Posterior Wall of the Nasopharynx, Posterior Wall of the Oropharynx, Prepuce, Primary Site Unknown, Prostate Gland, Pylorus, Pyriform Sinus, Rectosigmoid Region, Rectum, Renal Pelvis, Reticuloendothelial System, Retina, Retromolar Trigone, Retroperitoneum, Round Ligament, Salivary Gland, Scrotum, Sigmoid Colon, Skene Gland, Skin of the Face, Skin of the Lip, Skin of the Lower Limb and Hip, Skin of the Scalp and Neck, Skin of the Trunk, Skin of the Upper Limb and Shoulder, Skin, Small Intestine, Soft Palate, Spermatic Cord, Sphenoid Sinus, Spinal Cord, Spinal Meninges, Spleen, Splenic Flexure, Stomach, Subglottis, Sublingual Salivary Gland, Submandibular Gland, Superior Wall of the Nasopharynx, Supraglottis, Tail of the Pancreas, Temporal Lobe, Testis, Thoracic Esophagus, Thorax, Thymus Gland, Thyroid Gland, Tongue, Tonsillar Fossa, Tonsillar Pillar, Trachea, Transverse Colon, Undescended Testes, Unknown, Upper Extremity, Upper Gingiva, Upper Lobe of the Lung, Upper Respiratory System, Upper Third of the Esophagus, Upper-Inner Quadrant of the Breast, Upper-Outer Quadrant of the Breast, Urachus, Ureteric Orifice, Ureter, Urethra, Urinary System, Uterus, Uvula, Vagina, Vallecula, Vertebral Column, Vestibule of Mouth, Vulva, Waldeyer Ring",,FALSE,,,,CDS Imaging v1.0,
Individual Age at Diagnosis,"Age at the time the individual was diagnosed, expressed in years.",,,FALSE,,,,CDS Imaging v1.0,num
Individual Gender,"Text designations that identify gender. Gender is described as the assemblage of properties that distinguish people on the basis of their societal roles. Identification of gender is based upon self-report and may come from a form, questionnaire, interview, etc.","Female, Male, Non-Binary, Prefer Not to Answer, Unknown, Unspecified, Not Reported",,TRUE,,,,CDS Imaging v1.0/participant,str
Individual dbGaP Subject Id,The identifer assigned to the participant by dbGap,,,FALSE,,,,CDS Imaging v1.0,str
Individual Days to Last Followup,Number of days between the dates used for index and last follow-up,,,FALSE,,,,CDS Imaging v1.0,int
Individual Primary Tumor Stage,Extent of the primary cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.,"T0, T1, T1a, T1a1, T1a2, T1b, T1b1, T1b2, T1c, T1mi, T2, T2a, T2a1, T2a2, T2b, T2c, T2d, T3, T3a, T3b, T3c, T3d, T4, T4a, T4b, T4c, T4d, T4e, TX, Ta, Tis, Tis (DCIS), Tis (LCIS), Tis (Paget's), Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,
Individual Tumor Lymph Node Stage,Extent of the regional lymph node involvement for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.,"N0, N0 (i+), N0 (i-), N0 (mol+), N0 (mol-), N1, N1a, N1b, N1bI, N1bII, N1bIII, N1bIV, N1c, N1mi, N2, N2a, N2b, N2c, N3, N3a, N3b, N3c, N4, NX, Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,
Individual Days To Recurrence,Number of days between the date used for index and the date the patient's disease recurred,,,FALSE,,,,CDS Imaging v1.0,int
Individual Days to Last Known Disease Status,"Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days.",,,FALSE,,,,CDS Imaging v1.0,int
Individual Treatment Type,Text term that describes the kind of treatment administered.,"Ablation; Cryo, Ablation; Ethanol Injection, Ablation; Microwave, Ablation; NOS, Ablation; Radiofrequency, Ablation; Radiosurgical, Ancillary Treatment, Antiseizure Treatment, Bisphosphonate Therapy, Blinded Study; Treatment Unknown, Brachytherapy; High Dose, Brachytherapy; Low Dose, Brachytherapy; NOS, Chemoembolization, Chemoprotectant, Chemotherapy, Concurrent Chemoradiation, Cryoablation, Embolization, Ethanol Injection Ablation, External Beam Radiation, Hormone Therapy, I-131 Radiation Therapy, Immunotherapy (Including Vaccines), Internal Radiation, Isolated Limb Perfusion (ILP), Organ Transplantation, Other, Pharmaceutical Therapy; NOS, Pleurodesis, Pleurodesis; Talc, Pleurodesis; NOS, Radiation Therapy; NOS, Radiation; 2D Conventional, Radiation; 3D Conformal, Radiation; Combination, Radiation; Cyberknife, Radiation; External Beam, Radiation; Hypofractionated, Radiation; Implants, Radiation; Intensity-Modulated Radiotherapy, Radiation; Internal, Radiation; Mixed Photon Beam, Radiation; Photon Beam, Radiation; Proton Beam, Radiation; Radioisotope, Radiation; Stereotactic/Gamma Knife/SRS, Radiation; Systemic, Radioactive Iodine Therapy, Radioembolization, Radiosensitizing Agent, Stem Cell Transplantation; Allogeneic, Stem Cell Transplantation; Autologous, Stem Cell Transplantation; Double Autologous, Stem Cell Transplantation; Haploidentical, Stem Cell Transplantation; Non-Myeloablative, Stem Cell Transplantation; NOS, Stem Cell Transplantation; Syngenic, Stem Cell Treatment, Stereotactic Radiosurgery, Steroid Therapy, Surgery, Targeted Molecular Therapy, Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,
Individual Days to Treatment,Number of days between the date used for index and the date the treatment started.,,,FALSE,,,,CDS Imaging v1.0,int
Individual Therapeutic Agent,Text identification of the individual agent(s) used as part of a treatment regimen.,"10-Deacetyltaxol, 11C Topotecan, 11D10 AluGel Anti-Idiotype Monoclonal Antibody, 12-Allyldeoxoartemisinin, 13-Deoxydoxorubicin, 14C BMS-275183, 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521, 2-Deoxy-D-glucose, 2-Ethylhydrazide, 2-Fluoroadenine, 2-Fluorofucose-containing SGN-2FF, 2-Hydroxyestradiol, 2-Hydroxyestrone, 2-Hydroxyflutamide Depot, 2-Hydroxyoleic Acid, 2-Methoxyestradiol, 2-Methoxyestradiol Nanocrystal Colloidal Dispersion, 2-Methoxyestrone, 2-O; 3-O Desulfated Heparin, 2;6-Diaminopurine, 2;6-Dimethoxyquinone, 2'-F-ara-deoxyuridine, 3'-C-ethynylcytidine, 3'-dA Phosphoramidate NUC-7738, 4-Nitroestrone 3-Methyl Ether, 4-Thio-2-deoxycytidine, 4'-Iodo-4'-Deoxydoxorubicin, 5-Aza-4'-thio-2'-deoxycytidine, 5-Fluoro-2-Deoxycytidine, 6-Phosphofructo-2-kinase/fructose-2;6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158, 7-Cyanoquinocarcinol, 7-Ethyl-10-Hydroxycamptothecin, 7-Hydroxystaurosporine, 8-Azaguanine, 9-Ethyl 6-Mercaptopurine, 9H-Purine-6Thio-98D, A2A Receptor Antagonist EOS100850, Abagovomab, Abarelix, Abemaciclib, Abemaciclib Mesylate, Abexinostat, Abexinostat Tosylate, Abiraterone, Abiraterone Acetate, Abituzumab, Acai Berry Juice, Acalabrutinib, Acalisib, Aceglatone, Acetylcysteine, Acitretin, Acivicin, Aclacinomycin B, Aclarubicin, Acodazole, Acodazole Hydrochloride, Acolbifene Hydrochloride, Acridine, Acridine Carboxamide, Acronine, Actinium Ac 225 Lintuzumab, Actinium Ac 225-FPI-1434, Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591, Actinomycin C2, Actinomycin C3, Actinomycin F1, Activin Type 2B Receptor Fc Fusion Protein STM 434, Acyclic Nucleoside Phosphonate Prodrug ABI-1968, Ad-RTS-hIL-12, Adagloxad Simolenin, Adavosertib, Adecatumumab, Adenosine A2A Receptor Antagonist AZD4635, Adenosine A2A Receptor Antagonist CS3005, Adenosine A2A Receptor Antagonist NIR178, Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999, Adenosine A2A/A2B Receptor Antagonist AB928, Adenosine A2B Receptor Antagonist PBF-1129, Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201, Adenoviral Brachyury Vaccine ETBX-051, Adenoviral Cancer Vaccine PF-06936308, Adenoviral MUC1 Vaccine ETBX-061, Adenoviral PSA Vaccine ETBX-071, Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001, Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901, Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE, Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918, Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931, Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3, Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001, Aderbasib, ADH-1, AE37 Peptide/GM-CSF Vaccine, AEE788, Aerosol Gemcitabine, Aerosolized Aldesleukin, Aerosolized Liposomal Rubitecan, Afatinib, Afatinib Dimaleate, Afimoxifene, Afuresertib, Agatolimod Sodium, Agerafenib, Aglatimagene Besadenovec, Agonistic Anti-CD40 Monoclonal Antibody ADC-1013, Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949, Agonistic Anti-OX40 Monoclonal Antibody MEDI6469, AKR1C3-activated Prodrug OBI-3424, AKT 1/2 Inhibitor BAY1125976, AKT Inhibitor ARQ 092, Akt Inhibitor LY2780301, Akt Inhibitor MK2206, Akt Inhibitor SR13668, Akt/ERK Inhibitor ONC201, Alacizumab Pegol, Alanosine, Albumin-binding Cisplatin Prodrug BTP-114, Aldesleukin, Aldoxorubicin, Alectinib, Alefacept, Alemtuzumab, Alestramustine, Alflutinib Mesylate, Algenpantucel-L, Alisertib, Alitretinoin, ALK Inhibitor, ALK Inhibitor ASP3026, ALK Inhibitor PLB 1003, ALK Inhibitor RO5424802, ALK Inhibitor TAE684, ALK Inhibitor WX-0593, ALK-2 Inhibitor TP-0184, ALK-FAK Inhibitor CEP-37440, ALK/c-Met Inhibitor TQ-B3139, ALK/FAK/Pyk2 Inhibitor CT-707, ALK/ROS1/Met Inhibitor TQ-B3101, ALK/TRK Inhibitor TSR-011, Alkotinib, Allodepleted T Cell Immunotherapeutic ATIR101, Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715, Allogeneic Anti-BCMA-CAR T-cells PBCAR269A, Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells, Allogeneic Anti-CD19 CAR T-cells ALLO-501A, Allogeneic Anti-CD19 Universal CAR-T Cells CTA101, Allogeneic Anti-CD19-CAR T-cells PBCAR0191, Allogeneic Anti-CD20 CAR T-cells LUCAR-20S, Allogeneic Anti-CD20-CAR T-cells PBCAR20A, Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22, Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100, Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001, Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001, Allogeneic Cellular Vaccine 1650-G, Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120, Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130, Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A, Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM, Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine, Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine, Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo, Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo, Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2, Allogeneic Irradiated Melanoma Cell Vaccine CSF470, Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307, Allogeneic Melanoma Vaccine AGI-101H, Allogeneic Natural Killer Cell Line MG4101, Allogeneic Natural Killer Cell Line NK-92, Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01, Allogeneic Renal Cell Carcinoma Vaccine MGN1601, Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19, Allosteric ErbB Inhibitor BDTX-189, Allovectin-7, Almurtide, Alobresib, Alofanib, Alpelisib, Alpha Galactosylceramide, Alpha V Beta 1 Inhibitor ATN-161, Alpha V Beta 8 Antagonist PF-06940434, alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801, Alpha-Gal AGI-134, Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H, Alpha-Thioguanine Deoxyriboside, Alpha-tocopheryloxyacetic Acid, Alsevalimab, Altiratinib, Altretamine, Alvespimycin, Alvespimycin Hydrochloride, Alvocidib, Alvocidib Hydrochloride, Alvocidib Prodrug TP-1287, Amatuximab, Ambamustine, Ambazone, Amblyomin-X, Amcasertib, Ametantrone, Amifostine, Amino Acid Injection, Aminocamptothecin, Aminocamptothecin Colloidal Dispersion, Aminoflavone Prodrug AFP464, Aminopterin, Aminopterin Sodium, Amivantamab, Amolimogene Bepiplasmid, Amonafide L-Malate, Amrubicin, Amrubicin Hydrochloride, Amsacrine, Amsacrine Lactate, Amsilarotene, Amustaline, Amustaline Dihydrochloride, Amuvatinib, Amuvatinib Hydrochloride, Anakinra, Anastrozole, Anaxirone, Ancitabine, Ancitabine Hydrochloride, Andecaliximab, Androgen Antagonist APC-100, Androgen Receptor Antagonist BAY 1161116, Androgen Receptor Antagonist SHR3680, Androgen Receptor Antagonist TAS3681, Androgen Receptor Antagonist TRC253, Androgen Receptor Antisense Oligonucleotide AZD5312, Androgen Receptor Antisense Oligonucleotide EZN-4176, Androgen Receptor Degrader ARV-110, Androgen Receptor Degrader CC-94676, Androgen Receptor Downregulator AZD3514, Androgen Receptor Inhibitor EPI-7386, Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118, Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10, Andrographolide, Androstane Steroid HE3235, Anetumab Ravtansine, Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241, Angiogenesis Inhibitor GT-111, Angiogenesis Inhibitor JI-101, Angiogenesis/Heparanase Inhibitor PG545, Angiopoietin-2-specific Fusion Protein PF-04856884, Anhydrous Enol-oxaloacetate, Anhydrovinblastine, Aniline Mustard, Anlotinib Hydrochloride, Annamycin, Annamycin Liposomal, Annonaceous Acetogenins, Ansamitomicin P-3, Anthramycin, Anthrapyrazole, Anti c-KIT Antibody-drug Conjugate LOP628, Anti-5T4 Antibody-drug Conjugate ASN004, Anti-5T4 Antibody-Drug Conjugate PF-06263507, Anti-5T4 Antibody-drug Conjugate SYD1875, Anti-A33 Monoclonal Antibody KRN330, Anti-A5B1 Integrin Monoclonal Antibody PF-04605412, Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087, Anti-AG7 Antibody Drug Conjugate AbGn-107, Anti-AGS-16 Monoclonal Antibody AGS-16M18, Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME, Anti-AGS-8 Monoclonal Antibody AGS-8M4, Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B, Anti-alpha5beta1 Integrin Antibody MINT1526A, Anti-ANG2 Monoclonal Antibody MEDI-3617, Anti-angiopoietin Monoclonal Antibody AMG 780, Anti-APRIL Monoclonal Antibody BION-1301, Anti-AXL Fusion Protein AVB-S6-500, Anti-AXL/PBD Antibody-drug Conjugate ADCT-601, Anti-B7-H3 Antibody DS-5573a, Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a, Anti-B7-H4 Monoclonal Antibody FPA150, Anti-B7H3 Antibody-drug Conjugate MGC018, Anti-BCMA Antibody SEA-BCMA, Anti-BCMA Antibody-drug Conjugate AMG 224, Anti-BCMA Antibody-drug Conjugate CC-99712, Anti-BCMA Antibody-drug Conjugate GSK2857916, Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA, Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459, Anti-BCMA/CD3 BiTE Antibody AMG 420, Anti-BCMA/CD3 BiTE Antibody AMG 701, Anti-BCMA/CD3 BiTE Antibody REGN5458, Anti-BCMA/PBD ADC MEDI2228, Anti-BTLA Monoclonal Antibody TAB004, Anti-BTN3A Agonistic Monoclonal Antibody ICT01, Anti-c-fms Monoclonal Antibody AMG 820, Anti-c-KIT Monoclonal Antibody CDX 0158, Anti-c-Met Antibody-drug Conjugate HTI-1066, Anti-c-Met Antibody-drug Conjugate TR1801, Anti-c-Met Monoclonal Antibody ABT-700, Anti-c-Met Monoclonal Antibody ARGX-111, Anti-c-Met Monoclonal Antibody HLX55, Anti-c-MET Monoclonal Antibody LY2875358, Anti-C-met Monoclonal Antibody SAIT301, Anti-C4.4a Antibody-Drug Conjugate BAY1129980, Anti-C5aR Monoclonal Antibody IPH5401, Anti-CA19-9 Monoclonal Antibody 5B1, Anti-CA6-DM4 Immunoconjugate SAR566658, Anti-CCR7 Antibody-drug Conjugate JBH492, Anti-CD117 Monoclonal Antibody JSP191, Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1, Anti-CD123 ADC IMGN632, Anti-CD123 Monoclonal Antibody CSL360, Anti-CD123 Monoclonal Antibody KHK2823, Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404, Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A, Anti-CD123/CD3 Bispecific Antibody APVO436, Anti-CD123/CD3 Bispecific Antibody JNJ-63709178, Anti-CD123/CD3 BiTE Antibody SAR440234, Anti-CD137 Agonistic Monoclonal Antibody ADG106, Anti-CD137 Agonistic Monoclonal Antibody AGEN2373, Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017, Anti-CD137 Agonistic Monoclonal Antibody CTX-471, Anti-CD137 Agonistic Monoclonal Antibody LVGN6051, Anti-CD157 Monoclonal Antibody MEN1112, Anti-CD166 Probody-drug Conjugate CX-2009, Anti-CD19 Antibody-drug Conjugate SGN-CD19B, Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003, Anti-CD19 iCAR NK Cells, Anti-CD19 Monoclonal Antibody DI-B4, Anti-CD19 Monoclonal Antibody MDX-1342, Anti-CD19 Monoclonal Antibody MEDI-551, Anti-CD19 Monoclonal Antibody XmAb5574, Anti-CD19-DM4 Immunoconjugate SAR3419, Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL, Anti-CD19/CD22 CAR NK Cells, Anti-CD19/CD3 BiTE Antibody AMG 562, Anti-CD19/CD3 Tetravalent Antibody AFM11, Anti-CD20 Monoclonal Antibody B001, Anti-CD20 Monoclonal Antibody BAT4306F, Anti-CD20 Monoclonal Antibody MIL62, Anti-CD20 Monoclonal Antibody PRO131921, Anti-CD20 Monoclonal Antibody SCT400, Anti-CD20 Monoclonal Antibody TL011, Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002, Anti-CD20-engineered Toxin Body MT-3724, Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323, Anti-CD20/CD3 Monoclonal Antibody REGN1979, Anti-CD20/CD3 Monoclonal Antibody XmAb13676, Anti-CD205 Antibody-drug Conjugate OBT076, Anti-CD22 ADC TRPH-222, Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S, Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A, Anti-CD25 Monoclonal Antibody RO7296682, Anti-CD25-PBD Antibody-drug Conjugate ADCT-301, Anti-CD26 Monoclonal Antibody YS110, Anti-CD27 Agonistic Monoclonal Antibody MK-5890, Anti-CD27L Antibody-Drug Conjugate AMG 172, Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1), Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044, Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957, Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135, Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05, Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564, Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119, Anti-CD3/CD20 Bispecific Antibody GEN3013, Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424, Anti-CD3/CD7-Ricin Toxin A Immunotoxin, Anti-CD30 Monoclonal Antibody MDX-1401, Anti-CD30 Monoclonal Antibody XmAb2513, Anti-CD30/CD16A Monoclonal Antibody AFM13, Anti-CD30/DM1 Antibody-drug Conjugate F0002, Anti-CD32B Monoclonal Antibody BI-1206, Anti-CD33 Antibody-drug Conjugate IMGN779, Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564, Anti-CD33 Monoclonal Antibody BI 836858, Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633, Anti-CD33/CD3 Bispecific Antibody GEM 333, Anti-CD33/CD3 Bispecific Antibody JNJ-67571244, Anti-CD33/CD3 BiTE Antibody AMG 330, Anti-CD33/CD3 BiTE Antibody AMG 673, Anti-CD352 Antibody-drug Conjugate SGN-CD352A, Anti-CD37 Antibody-Drug Conjugate IMGN529, Anti-CD37 Bispecific Monoclonal Antibody GEN3009, Anti-CD37 MMAE Antibody-drug Conjugate AGS67E, Anti-CD37 Monoclonal Antibody BI 836826, Anti-CD38 Antibody-drug Conjugate STI-6129, Anti-CD38 Monoclonal Antibody MOR03087, Anti-CD38 Monoclonal Antibody SAR442085, Anti-CD38 Monoclonal Antibody TAK-079, Anti-CD38-targeted IgG4-attenuated IFNa TAK-573, Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257, Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342, Anti-CD39 Monoclonal Antibody SRF617, Anti-CD39 Monoclonal Antibody TTX-030, Anti-CD40 Agonist Monoclonal Antibody ABBV-927, Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Anti-CD40 Monoclonal Antibody Chi Lob 7/4, Anti-CD40 Monoclonal Antibody SEA-CD40, Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042, Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428, Anti-CD40L Fc-Fusion Protein BMS-986004, Anti-CD44 Monoclonal Antibody RO5429083, Anti-CD45 Monoclonal Antibody AHN-12, Anti-CD46 Antibody-drug Conjugate FOR46, Anti-CD47 ADC SGN-CD47M, Anti-CD47 Monoclonal Antibody AO-176, Anti-CD47 Monoclonal Antibody CC-90002, Anti-CD47 Monoclonal Antibody Hu5F9-G4, Anti-CD47 Monoclonal Antibody IBI188, Anti-CD47 Monoclonal Antibody IMC-002, Anti-CD47 Monoclonal Antibody SHR-1603, Anti-CD47 Monoclonal Antibody SRF231, Anti-CD47 Monoclonal Antibody TJC4, Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801, Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A, Anti-CD52 Monoclonal Antibody ALLO-647, Anti-CD70 Antibody-Drug Conjugate MDX-1203, Anti-CD70 Antibody-drug Conjugate SGN-CD70A, Anti-CD70 CAR-expressing T Lymphocytes, Anti-CD70 Monoclonal Antibody MDX-1411, Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029, Anti-CD73 Monoclonal Antibody BMS-986179, Anti-CD73 Monoclonal Antibody CPI-006, Anti-CD73 Monoclonal Antibody NZV930, Anti-CD73 Monoclonal Antibody TJ4309, Anti-CD74 Antibody-drug Conjugate STRO-001, Anti-CD98 Monoclonal Antibody IGN523, Anti-CDH6 Antibody-drug Conjugate HKT288, Anti-CEA BiTE Monoclonal Antibody AMG211, Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody, Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2, Anti-CEACAM1 Monoclonal Antibody CM-24, Anti-CEACAM5 Antibody-Drug Conjugate SAR408701, Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47, Anti-CEACAM6 Antibody BAY1834942, Anti-claudin18.2 Monoclonal Antibody AB011, Anti-Claudin18.2 Monoclonal Antibody TST001, Anti-CLDN6 Monoclonal Antibody ASP1650, Anti-CLEC12A/CD3 Bispecific Antibody MCLA117, Anti-CLEVER-1 Monoclonal Antibody FP-1305, Anti-CSF1 Monoclonal Antibody PD-0360324, Anti-CSF1R Monoclonal Antibody IMC-CS4, Anti-CSF1R Monoclonal Antibody SNDX-6352, Anti-CTGF Monoclonal Antibody FG-3019, Anti-CTLA-4 Monoclonal Antibody ADG116, Anti-CTLA-4 Monoclonal Antibody ADU-1604, Anti-CTLA-4 Monoclonal Antibody AGEN1181, Anti-CTLA-4 Monoclonal Antibody BCD-145, Anti-CTLA-4 Monoclonal Antibody HBM4003, Anti-CTLA-4 Monoclonal Antibody MK-1308, Anti-CTLA-4 Monoclonal Antibody ONC-392, Anti-CTLA-4 Monoclonal Antibody REGN4659, Anti-CTLA-4 Probody BMS-986288, Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217, Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841, Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015, Anti-CTLA4 Antibody Fc Fusion Protein KN044, Anti-CTLA4 Monoclonal Antibody BMS-986218, Anti-CXCR4 Monoclonal Antibody PF-06747143, Anti-Denatured Collagen Monoclonal Antibody TRC093, Anti-DKK-1 Monoclonal Antibody LY2812176, Anti-DKK1 Monoclonal Antibody BHQ880, Anti-DLL3/CD3 BiTE Antibody AMG 757, Anti-DLL4 Monoclonal Antibody MEDI0639, Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83, Anti-DR5 Agonist Monoclonal Antibody TRA-8, Anti-DR5 Agonistic Antibody DS-8273a, Anti-DR5 Agonistic Monoclonal Antibody INBRX-109, Anti-EGFR Monoclonal Antibody CPGJ 602, Anti-EGFR Monoclonal Antibody EMD 55900, Anti-EGFR Monoclonal Antibody GC1118, Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX, Anti-EGFR Monoclonal Antibody HLX-07, Anti-EGFR Monoclonal Antibody Mixture MM-151, Anti-EGFR Monoclonal Antibody RO5083945, Anti-EGFR Monoclonal Antibody SCT200, Anti-EGFR Monoclonal Antibody SYN004, Anti-EGFR TAP Antibody-drug Conjugate IMGN289, Anti-EGFR/c-Met Bispecific Antibody EMB-01, Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372, Anti-EGFR/CD16A Bispecific Antibody AFM24, Anti-EGFR/DM1 Antibody-drug Conjugate AVID100, Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013, Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321, Anti-EGFRvIII Antibody Drug Conjugate AMG 595, Anti-EGFRvIII Immunotoxin MR1-1, Anti-EGFRvIII/CD3 BiTE Antibody AMG 596, Anti-EGP-2 Immunotoxin MOC31-PE, Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F, Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F, Anti-Ep-CAM Monoclonal Antibody ING-1, Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310, Anti-EphA2 Monoclonal Antibody DS-8895a, Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547, Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111, Anti-ErbB3 Antibody ISU104, Anti-ErbB3 Monoclonal Antibody AV-203, Anti-ErbB3 Monoclonal Antibody CDX-3379, Anti-ErbB3 Monoclonal Antibody REGN1400, Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141, Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A, Anti-FAP/Interleukin-2 Fusion Protein RO6874281, Anti-FCRH5/CD3 BiTE Antibody BFCR4350A, Anti-FGFR2 Antibody BAY1179470, Anti-FGFR3 Antibody-drug Conjugate LY3076226, Anti-FGFR4 Monoclonal Antibody U3-1784, Anti-FLT3 Antibody-drug Conjugate AGS62P1, Anti-FLT3 Monoclonal Antibody 4G8-SDIEM, Anti-FLT3 Monoclonal Antibody IMC-EB10, Anti-FLT3/CD3 BiTE Antibody AMG 427, Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002, Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202, Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012, Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962, Anti-GARP Monoclonal Antibody ABBV-151, Anti-GCC Antibody-Drug Conjugate MLN0264, Anti-GCC Antibody-Drug Conjugate TAK-164, Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody, Anti-GD2 Monoclonal Antibody hu14.18K322A, Anti-GD2 Monoclonal Antibody MORAb-028, Anti-GD3 Antibody-drug Conjugate PF-06688992, Anti-GITR Agonistic Monoclonal Antibody ASP1951, Anti-GITR Agonistic Monoclonal Antibody BMS-986156, Anti-GITR Agonistic Monoclonal Antibody INCAGN01876, Anti-GITR Monoclonal Antibody GWN 323, Anti-GITR Monoclonal Antibody MK-4166, Anti-Globo H Monoclonal Antibody OBI-888, Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999, Anti-Glypican 3/CD3 Bispecific Antibody ERY974, Anti-GnRH Vaccine PEP223, Anti-gpA33/CD3 Monoclonal Antibody MGD007, Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a, Anti-gremlin-1 Monoclonal Antibody UCB6114, Anti-GRP78 Monoclonal Antibody PAT-SM6, Anti-HA Epitope Monoclonal Antibody MEDI8852, Anti-HB-EGF Monoclonal Antibody KHK2866, Anti-HBEGF Monoclonal Antibody U3-1565, Anti-hepcidin Monoclonal Antibody LY2787106, Anti-HER-2 Bispecific Antibody KN026, Anti-HER2 ADC DS-8201a, Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702, Anti-HER2 Antibody-drug Conjugate A166, Anti-HER2 Antibody-drug Conjugate ARX788, Anti-HER2 Antibody-drug Conjugate BAT8001, Anti-HER2 Antibody-drug Conjugate DP303c, Anti-HER2 Antibody-drug Conjugate MEDI4276, Anti-HER2 Antibody-drug Conjugate RC48, Anti-HER2 Bi-specific Monoclonal Antibody ZW25, Anti-HER2 Bispecific Antibody-drug Conjugate ZW49, Anti-HER2 Immune Stimulator-antibody Conjugate NJH395, Anti-HER2 Monoclonal Antibody B002, Anti-HER2 Monoclonal Antibody CT-P6, Anti-HER2 Monoclonal Antibody HLX22, Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343, Anti-HER2-DM1 ADC B003, Anti-HER2-DM1 Antibody-drug Conjugate GQ1001, Anti-HER2-vc0101 ADC PF-06804103, Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A, Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302, Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128, Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522, Anti-HER2/MMAE Antibody-drug Conjugate MRG002, Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A, Anti-HER3 Antibody-drug Conjugate U3 1402, Anti-HER3 Monoclonal Antibody GSK2849330, Anti-HGF Monoclonal Antibody TAK-701, Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968, Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1, Anti-HLA-DR Monoclonal Antibody IMMU-114, Anti-HLA-G Antibody TTX-080, Anti-human GITR Monoclonal Antibody AMG 228, Anti-human GITR Monoclonal Antibody TRX518, Anti-ICAM-1 Monoclonal Antibody BI-505, Anti-ICOS Agonist Antibody GSK3359609, Anti-ICOS Agonist Monoclonal Antibody BMS-986226, Anti-ICOS Monoclonal Antibody KY1044, Anti-ICOS Monoclonal Antibody MEDI-570, Anti-IGF-1R Monoclonal Antibody AVE1642, Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022, Anti-IL-1 alpha Monoclonal Antibody MABp1, Anti-IL-13 Humanized Monoclonal Antibody TNX-650, Anti-IL-15 Monoclonal Antibody AMG 714, Anti-IL-8 Monoclonal Antibody BMS-986253, Anti-IL-8 Monoclonal Antibody HuMax-IL8, Anti-ILDR2 Monoclonal Antibody BAY 1905254, Anti-ILT4 Monoclonal Antibody MK-4830, Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A, Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388, Anti-IRF4 Antisense Oligonucleotide ION251, Anti-KIR Monoclonal Antibody IPH 2101, Anti-KSP/Anti-VEGF siRNAs ALN-VSP02, Anti-LAG-3 Monoclonal Antibody IBI-110, Anti-LAG-3 Monoclonal Antibody INCAGN02385, Anti-LAG-3 Monoclonal Antibody LAG525, Anti-LAG-3 Monoclonal Antibody REGN3767, Anti-LAG-3/PD-L1 Bispecific Antibody FS118, Anti-LAG3 Monoclonal Antibody BI 754111, Anti-LAG3 Monoclonal Antibody MK-4280, Anti-LAG3 Monoclonal Antibody TSR-033, Anti-LAMP1 Antibody-drug Conjugate SAR428926, Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181, Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102, Anti-LGR5 Monoclonal Antibody BNC101, Anti-LIF Monoclonal Antibody MSC-1, Anti-LILRB4 Monoclonal Antibody IO-202, Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A, Anti-Ly6E Antibody-Drug Conjugate RG 7841, Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C, Anti-Melanin Monoclonal Antibody PTI-6D2, Anti-mesothelin Antibody-drug Conjugate BMS-986148, Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100, Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A, Anti-mesothelin/MMAE Antibody-drug Conjugate RC88, Anti-Met Monoclonal Antibody Mixture Sym015, Anti-Met/EGFR Monoclonal Antibody LY3164530, Anti-MMP-9 Monoclonal Antibody GS-5745, Anti-MUC1 Monoclonal Antibody BTH1704, Anti-MUC16/CD3 Bispecific Antibody REGN4018, Anti-MUC16/CD3 BiTE Antibody REGN4018, Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A, Anti-MUC17/CD3 BiTE Antibody AMG 199, Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062, Anti-myostatin Monoclonal Antibody LY2495655, Anti-NaPi2b Antibody-drug Conjugate XMT-1592, Anti-NaPi2b Monoclonal Antibody XMT-1535, Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E, Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A, Anti-nf-P2X7 Antibody Ointment BIL-010t, Anti-NRP1 Antibody ASP1948, Anti-Nucleolin Aptamer AS1411, Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A, Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso, Anti-OFA Immunotherapeutic BB-MPI-03, Anti-OX40 Agonist Monoclonal Antibody ABBV-368, Anti-OX40 Agonist Monoclonal Antibody BGB-A445, Anti-OX40 Agonist Monoclonal Antibody PF-04518600, Anti-OX40 Antibody BMS 986178, Anti-OX40 Hexavalent Agonist Antibody INBRX-106, Anti-OX40 Monoclonal Antibody GSK3174998, Anti-OX40 Monoclonal Antibody IBI101, Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256, Anti-PD-1 Checkpoint Inhibitor PF-06801591, Anti-PD-1 Fusion Protein AMP-224, Anti-PD-1 Monoclonal Antibody 609A, Anti-PD-1 Monoclonal Antibody AK105, Anti-PD-1 Monoclonal Antibody AMG 404, Anti-PD-1 Monoclonal Antibody BAT1306, Anti-PD-1 Monoclonal Antibody BCD-100, Anti-PD-1 Monoclonal Antibody BI 754091, Anti-PD-1 Monoclonal Antibody CS1003, Anti-PD-1 Monoclonal Antibody F520, Anti-PD-1 Monoclonal Antibody GLS-010, Anti-PD-1 Monoclonal Antibody HLX10, Anti-PD-1 Monoclonal Antibody HX008, Anti-PD-1 Monoclonal Antibody JTX-4014, Anti-PD-1 Monoclonal Antibody LZM009, Anti-PD-1 Monoclonal Antibody MEDI0680, Anti-PD-1 Monoclonal Antibody MGA012, Anti-PD-1 Monoclonal Antibody SCT-I10A, Anti-PD-1 Monoclonal Antibody Sym021, Anti-PD-1 Monoclonal Antibody TSR-042, Anti-PD-1/Anti-CTLA4 DART Protein MGD019, Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315, Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669, Anti-PD-1/Anti-LAG-3 DART Protein MGD013, Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318, Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172, Anti-PD-1/CD47 Infusion Protein HX009, Anti-PD-1/CTLA-4 Bispecific Antibody AK104, Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752, Anti-PD-1/TIM-3 Bispecific Antibody RO7121661, Anti-PD-1/VEGF Bispecific Antibody AK112, Anti-PD-L1 Monoclonal Antibody A167, Anti-PD-L1 Monoclonal Antibody BCD-135, Anti-PD-L1 Monoclonal Antibody BGB-A333, Anti-PD-L1 Monoclonal Antibody CBT-502, Anti-PD-L1 Monoclonal Antibody CK-301, Anti-PD-L1 Monoclonal Antibody CS1001, Anti-PD-L1 Monoclonal Antibody FAZ053, Anti-PD-L1 Monoclonal Antibody GR1405, Anti-PD-L1 Monoclonal Antibody HLX20, Anti-PD-L1 Monoclonal Antibody IMC-001, Anti-PD-L1 Monoclonal Antibody LY3300054, Anti-PD-L1 Monoclonal Antibody MDX-1105, Anti-PD-L1 Monoclonal Antibody MSB2311, Anti-PD-L1 Monoclonal Antibody RC98, Anti-PD-L1 Monoclonal Antibody SHR-1316, Anti-PD-L1 Monoclonal Antibody TG-1501, Anti-PD-L1 Monoclonal Antibody ZKAB001, Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105, Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046, Anti-PD-L1/CD137 Bispecific Antibody MCLA-145, Anti-PD-L1/IL-15 Fusion Protein KD033, Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244, Anti-PD1 Monoclonal Antibody AGEN2034, Anti-PD1/CTLA4 Bispecific Antibody XmAb20717, Anti-PGF Monoclonal Antibody RO5323441, Anti-PKN3 siRNA Atu027, Anti-PLGF Monoclonal Antibody TB-403, Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4, Anti-PRAME Immunotherapeutic GSK2302032A, Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Anti-PRL-3 Monoclonal Antibody PRL3-zumab, Anti-prolactin Receptor Antibody LFA102, Anti-PSCA Monoclonal Antibody AGS-1C4D4, Anti-PSMA Monoclonal Antibody MDX1201-A488, Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704, Anti-PSMA Monoclonal Antibody-MMAE Conjugate, Anti-PSMA/CD28 Bispecific Antibody REGN5678, Anti-PSMA/CD3 Bispecific Antibody CCW702, Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081, Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414, Anti-PSMA/PBD ADC MEDI3726, Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020, Anti-PVRIG Monoclonal Antibody COM701, Anti-RANKL Monoclonal Antibody GB-223, Anti-RANKL Monoclonal Antibody JMT103, Anti-Ribonucleoprotein Antibody ATRC-101, Anti-ROR1 ADC VLS-101, Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002, Anti-S15 Monoclonal Antibody NC318, Anti-sCLU Monoclonal Antibody AB-16B5, Anti-SIRPa Monoclonal Antibody CC-95251, Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E, Anti-TAG-72 Monoclonal Antibody scFV CC-49/218, Anti-TF Monoclonal Antibody ALT-836, Anti-TGF-beta Monoclonal Antibody NIS793, Anti-TGF-beta Monoclonal Antibody SAR-439459, Anti-TGF-beta RII Monoclonal Antibody IMC-TR1, Anti-TIGIT Monoclonal Antibody AB154, Anti-TIGIT Monoclonal Antibody BGB-A1217, Anti-TIGIT Monoclonal Antibody BMS-986207, Anti-TIGIT Monoclonal Antibody COM902, Anti-TIGIT Monoclonal Antibody OMP-313M32, Anti-TIGIT Monoclonal Antibody SGN-TGT, Anti-TIM-3 Antibody BMS-986258, Anti-TIM-3 Monoclonal Antibody BGB-A425, Anti-TIM-3 Monoclonal Antibody INCAGN02390, Anti-TIM-3 Monoclonal Antibody MBG453, Anti-TIM-3 Monoclonal Antibody Sym023, Anti-TIM-3 Monoclonal Antibody TSR-022, Anti-TIM3 Monoclonal Antibody LY3321367, Anti-TIM3 Monoclonal Antibody SHR-1702, Anti-Tissue Factor Monoclonal Antibody MORAb-066, Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711, Anti-TROP2 Antibody-drug Conjugate BAT8003, Anti-TROP2 Antibody-drug Conjugate SKB264, Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a, Anti-TWEAK Monoclonal Antibody RG7212, Anti-VEGF Anticalin PRS-050-PEG40, Anti-VEGF Monoclonal Antibody hPV19, Anti-VEGF/ANG2 Nanobody BI 836880, Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T, Anti-VEGFC Monoclonal Antibody VGX-100, Anti-VEGFR2 Monoclonal Antibody HLX06, Anti-VEGFR2 Monoclonal Antibody MSB0254, Anti-VEGFR3 Monoclonal Antibody IMC-3C5, Anti-VISTA Monoclonal Antibody JNJ 61610588, Antiangiogenic Drug Combination TL-118, Antibody-drug Conjugate ABBV-011, Antibody-drug Conjugate ABBV-085, Antibody-drug Conjugate ABBV-155, Antibody-drug Conjugate ABBV-176, Antibody-drug Conjugate ABBV-838, Antibody-drug Conjugate ADC XMT-1536, Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014, Antibody-Drug Conjugate DFRF4539A, Antibody-drug Conjugate MEDI7247, Antibody-drug Conjugate PF-06647263, Antibody-drug Conjugate PF-06664178, Antibody-drug Conjugate SC-002, Antibody-drug Conjugate SC-003, Antibody-drug Conjugate SC-004, Antibody-drug Conjugate SC-005, Antibody-drug Conjugate SC-006, Antibody-drug Conjugate SC-007, Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008, Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV, Antimetabolite FF-10502, Antineoplastic Agent Combination SM-88, Antineoplastic Vaccine, Antineoplastic Vaccine GV-1301, Antineoplaston A10, Antineoplaston AS2-1, Antisense Oligonucleotide GTI-2040, Antisense Oligonucleotide QR-313, Antitumor B Key Active Component-alpha, Antrodia cinnamomea Supplement, Antroquinonol Capsule, Apalutamide, Apatorsen, Apaziquone, APC8015F, APE1/Ref-1 Redox Inhibitor APX3330, Aphidicoline Glycinate, Apilimod Dimesylate Capsule, Apitolisib, Apolizumab, Apomab, Apomine, Apoptosis Inducer BZL101, Apoptosis Inducer GCS-100, Apoptosis Inducer MPC-2130, Apricoxib, Aprinocarsen, Aprutumab, Aprutumab Ixadotin, AR Antagonist BMS-641988, Arabinoxylan Compound MGN3, Aranose, ARC Fusion Protein SL-279252, Archexin, Arcitumomab, Arfolitixorin, Arginase Inhibitor INCB001158, Arginine Butyrate, Arnebia Indigo Jade Pearl Topical Cream, Arsenic Trioxide, Arsenic Trioxide Capsule Formulation ORH 2014, Artemether Sublingual Spray, Artemisinin Dimer, Artesunate, Arugula Seed Powder, Aryl Hydrocarbon Receptor Antagonist BAY2416964, Aryl Hydrocarbon Receptor Inhibitor IK-175, Asaley, Asciminib, Ascrinvacumab, Ashwagandha Root Powder Extract, ASP4132, Aspacytarabine, Asparaginase, Asparaginase Erwinia chrysanthemi, Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, Astuprotimut-R, Asulacrine, Asulacrine Isethionate, Asunercept, At 211 Monoclonal Antibody 81C6, Atamestane, Atezolizumab, Atiprimod, Atiprimod Dihydrochloride, Atiprimod Dimaleate, ATM Inhibitor M 3541, ATM Kinase Inhibitor AZD0156, ATM Kinase Inhibitor AZD1390, Atorvastatin Calcium, Atorvastatin Sodium, ATR Inhibitor RP-3500, ATR Kinase Inhibitor BAY1895344, ATR Kinase Inhibitor M1774, ATR Kinase Inhibitor M6620, ATR Kinase Inhibitor VX-803, Atrasentan Hydrochloride, Attenuated Listeria monocytogenes CRS-100, Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001, Attenuated Measles Virus Encoding SCD Transgene TMV-018, Atuveciclib, Audencel, Auranofin, Aurora A Kinase Inhibitor LY3295668, Aurora A Kinase Inhibitor LY3295668 Erbumine, Aurora A Kinase Inhibitor MK5108, Aurora A Kinase Inhibitor TAS-119, Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076, Aurora B Serine/Threonine Kinase Inhibitor TAK-901, Aurora B/C Kinase Inhibitor GSK1070916A, Aurora kinase A/B inhibitor TT-00420, Aurora Kinase Inhibitor AMG 900, Aurora Kinase Inhibitor BI 811283, Aurora Kinase Inhibitor MLN8054, Aurora Kinase Inhibitor PF-03814735, Aurora Kinase Inhibitor SNS-314, Aurora Kinase Inhibitor TTP607, Aurora Kinase/VEGFR2 Inhibitor CYC116, Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707, Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055, Autologous Anti-BCMA CAR T-cells PHE885, Autologous Anti-BCMA CAR-transduced T-cells KITE-585, Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11, Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053, Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143, Autologous Anti-CD123 CAR-T Cells, Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx, Autologous Anti-CD19 CAR T-cells IM19, Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19, Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19, Autologous Anti-CD19 CAR-CD28 T-cells ET019002, Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01, Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901, Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1, Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19, Autologous Anti-CD19 T-cell Receptor T cells ET190L1, Autologous Anti-CD19 TAC-T cells TAC01-CD19, Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells, Autologous Anti-CD19/CD22 CAR T-cells AUTO3, Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014, Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells, Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1, Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s, Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes, Autologous Anti-FLT3 CAR T Cells AMG 553, Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202, Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1, Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100, Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes, Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794, Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes, Autologous Anti-PSMA CAR-T Cells P-PSMA-101, Autologous AXL-targeted CAR T-cells CCT301-38, Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B, Autologous BCMA-targeted CAR T Cells CC-98633, Autologous BCMA-targeted CAR T Cells LCAR-B4822M, Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528, Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F, Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022, Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001, Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005, Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006, Autologous CD123-4SCAR-expressing T-cells 4SCAR123, Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1, Autologous CD19-targeted CAR T Cells CC-97540, Autologous CD19-targeted CAR T Cells JWCAR029, Autologous CD19-targeted CAR-T Cells GC007F, Autologous CD19/PD-1 Bispecific CAR-T Cells, Autologous CD20-4SCAR-expressing T-cells 4SCAR20, Autologous CD22-4SCAR-expressing T-cells 4SCAR22, Autologous CD38-4SCAR-expressing T-cells 4SCAR38, Autologous Clonal Neoantigen T Cells ATL001, Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19, Autologous Deep IL-15 Primed T-cells TRQ15-01, Autologous Dendritic Cell Vaccine ACT2001, Autologous Dendritic Cell-based Immunotherapeutic AV0113, Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa, Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells, Autologous Genetically-modified MAGE-A4 C1032 T Cells, Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858, Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439, Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001, Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718, Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Autologous Mesenchymal Stem Cells Apceth_101, Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11, Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC, Autologous Multi-lineage Potential Cells, Autologous Nectin-4/FAP-targeted CAR-T Cells, Autologous NKG2D CAR T-cells CYAD-02, Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01, Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine, Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001, Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101, Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601, Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201, Autologous ROR2-targeted CAR T-cells CCT301-59, Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1, Autologous TCR-engineered T-cells IMA201, Autologous TCR-engineered T-cells IMA202, Autologous TCR-engineered T-cells IMA203, Autologous TCRm-expressing T-cells ET140203, Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG, Autologous Tumor Infiltrating Lymphocytes LN-144, Autologous Tumor Infiltrating Lymphocytes LN-145, Autologous Tumor Infiltrating Lymphocytes LN-145-S1, Autologous Tumor Infiltrating Lymphocytes MDA-TIL, Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T, Avadomide, Avadomide Hydrochloride, Avapritinib, Avdoralimab, Avelumab, Aviscumine, Avitinib Maleate, Axalimogene Filolisbac, Axatilimab, Axicabtagene Ciloleucel, Axitinib, AXL Inhibitor DS-1205c, AXL Inhibitor SLC-391, AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M, AXL/ FLT3/VEGFR2 Inhibitor KC1036, Axl/Mer Inhibitor INCB081776, Axl/Mer Inhibitor PF-07265807, Azacitidine, Azapicyl, Azaribine, Azaserine, Azathioprine, Azimexon, Azintuxizumab Vedotin, Aziridinylbenzoquinone RH1, Azotomycin, Azurin:50-77 Cell Penetrating Peptide p28, B-Raf/VEGFR-2 Inhibitor RAF265, Babaodan Capsule, Bacillus Calmette-Guerin Substrain Connaught Live Antigen, Bactobolin, Bafetinib, Balixafortide, Balstilimab, Baltaleucel-T, Banoxantrone, Barasertib, Bardoxolone, Bardoxolone Methyl, Baricitinib, Batabulin, Batabulin Sodium, Batimastat, Bavituximab, Bazedoxifene, Bazlitoran, BC-819 Plasmid/Polyethylenimine Complex, BCG Solution, BCG Tokyo-172 Strain Solution, BCG Vaccine, Bcl-2 Inhibitor APG 2575, Bcl-2 Inhibitor BCL201, Bcl-2 Inhibitor BGB-11417, Bcl-2 Inhibitor LP-108, Bcl-2 Inhibitor S65487, Bcl-Xs Adenovirus Vaccine, BCMA x CD3 T-cell Engaging Antibody CC-93269, BCMA-CD19 Compound CAR T Cells, BCMA/CD3e Tri-specific T-cell Activating Construct HPN217, Bcr-Abl Kinase Inhibitor K0706, Bcr-Abl Kinase Inhibitor PF-114, BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351, Beauvericin, Becatecarin, Belagenpumatucel-L, Belantamab Mafodotin, Belapectin, Belimumab, Belinostat, Belotecan Hydrochloride, Belvarafenib, Belzutifan, Bemarituzumab, Bemcentinib, Bempegaldesleukin, Benaxibine, Bendamustine, Bendamustine Hydrochloride, Bendamustine-containing Nanoparticle-based Formulation RXDX-107, Benzaldehyde Dimethane Sulfonate, Benzoylphenylurea, Berberine Chloride, Bermekimab, Bersanlimab, Berubicin Hydrochloride, Berzosertib, BET Bromodomain Inhibitor ZEN-3694, BET Inhibitor ABBV-744, BET Inhibitor BAY1238097, BET inhibitor BI 894999, BET Inhibitor BMS-986158, BET Inhibitor CC-90010, BET Inhibitor CPI-0610, BET Inhibitor FT-1101, BET Inhibitor GS-5829, BET Inhibitor GSK2820151, BET Inhibitor INCB054329, BET Inhibitor INCB057643, BET Inhibitor RO6870810, BET-bromodomain Inhibitor ODM-207, Beta Alethine, Beta-Carotene, Beta-elemene, Beta-Glucan, Beta-Glucan MM-10-001, Beta-lapachone Prodrug ARQ 761, Beta-Thioguanine Deoxyriboside, Betaglucin Gel, Betulinic Acid, Bevacizumab, Bexarotene, Bexmarilimab, BF-200 Gel Formulation, BH3 Mimetic ABT-737, Bi-functional Alkylating Agent VAL-083, Bicalutamide, Bimiralisib, Binetrakin, Binimetinib, Bintrafusp Alfa, Birabresib, Birinapant, Bis(choline)tetrathiomolybdate, Bisantrene, Bisantrene Hydrochloride, Bisnafide, Bisnafide Dimesylate, Bispecific Antibody 2B1, Bispecific Antibody AGEN1223, Bispecific Antibody AMG 509, Bispecific Antibody GS-1423, Bispecific Antibody MDX-H210, Bispecific Antibody MDX447, Bisthianostat, BiTE Antibody AMG 910, Bivalent BRD4 Inhibitor AZD5153, Bizalimogene Ralaplasmid, Bizelesin, BL22 Immunotoxin, Black Cohosh, Black Raspberry Nectar, Bleomycin, Bleomycin A2, Bleomycin B2, Bleomycin Sulfate, Blinatumomab, Blueberry Powder Supplement, BMI1 Inhibitor PTC596, BMS-184476, BMS-188797, BMS-214662, BMS-275183, Boanmycin Hydrochloride, Bomedemstat, Boronophenylalanine-Fructose Complex, Bortezomib, Bosutinib, Bosutinib Monohydrate, Botanical Agent BEL-X-HG, Botanical Agent LEAC-102, Bovine Cartilage, Bozitinib, BP-Cx1-Platinum Complex BP-C1, BR96-Doxorubicin Immunoconjugate, Brachyury-expressing Yeast Vaccine GI-6301, BRAF Inhibitor, BRAF Inhibitor ARQ 736, BRAF Inhibitor BGB-3245, BRAF Inhibitor PLX8394, BRAF(V600E) Kinase Inhibitor ABM-1310, BRAF(V600E) Kinase Inhibitor RO5212054, BRAF/EGFR Inhibitor BGB-283, BRAFV600/PI3K Inhibitor ASN003, BRD4 Inhibitor PLX2853, BRD4 Inhibitor PLX51107, Breflate, Brentuximab, Brentuximab Vedotin, Brequinar, Brequinar Sodium, Briciclib Sodium, Brigatinib, Brilanestrant, Brimonidine Tartrate Nanoemulsion OCU-300, Brivanib, Brivanib Alaninate, Brivudine, Brivudine Phosphoramidate, Broad-Spectrum Human Papillomavirus Vaccine V505, Broccoli Sprout/Broccoli Seed Extract Supplement, Bromacrylide, Bromebric Acid, Bromocriptine Mesylate, Brontictuzumab, Brostacillin Hydrochloride, Brostallicin, Broxuridine, Bruceanol A, Bruceanol B, Bruceanol C, Bruceanol D, Bruceanol E, Bruceanol F, Bruceanol G, Bruceanol H, Bruceantin, Bryostatin 1, BTK Inhibitor ARQ 531, BTK Inhibitor CT-1530, BTK Inhibitor DTRMWXHS-12, BTK Inhibitor HZ-A-018, BTK Inhibitor ICP-022, BTK Inhibitor LOXO-305, BTK Inhibitor M7583, BTK inhibitor TG-1701, Budigalimab, Budotitane, Bufalin, Buparlisib, Burixafor, Burixafor Hydrobromide, Burosumab, Buserelin, Bushen Culuan Decoction, Bushen-Jianpi Decoction, Busulfan, Buthionine Sulfoximine, BXQ-350 Nanovesicle Formulation, c-Kit Inhibitor PLX9486, c-Met Inhibitor ABN401, c-Met Inhibitor AL2846, c-Met Inhibitor AMG 208, c-Met Inhibitor AMG 337, c-Met Inhibitor GST-HG161, c-Met Inhibitor HS-10241, c-Met Inhibitor JNJ-38877605, c-Met Inhibitor MK2461, c-Met Inhibitor MK8033, c-Met Inhibitor MSC2156119J, C-myb Antisense Oligonucleotide G4460, c-raf Antisense Oligonucleotide ISIS 5132, C-VISA BikDD:Liposome, C/EBP Beta Antagonist ST101, CAB-ROR2-ADC BA3021, Cabazitaxel, Cabiralizumab, Cabozantinib, Cabozantinib S-malate, Cactinomycin, Caffeic Acid Phenethyl Ester, CAIX Inhibitor DTP348, CAIX Inhibitor SLC-0111, Calaspargase Pegol-mknl, Calcitriol, Calcium Release-activated Channel Inhibitor CM4620, Calcium Release-activated Channels Inhibitor RP4010, Calcium Saccharate, Calculus bovis/Moschus/Olibanum/Myrrha Capsule, Calicheamicin Gamma 1I, Camidanlumab Tesirine, Camptothecin, Camptothecin Analogue TLC388, Camptothecin Glycoconjugate BAY 38-3441, Camptothecin Sodium, Camptothecin-20(S)-O-Propionate Hydrate, Camrelizumab, Camsirubicin, Cancell, Cancer Peptide Vaccine S-588410, Canerpaturev, Canertinib Dihydrochloride, Canfosfamide, Canfosfamide Hydrochloride, Cannabidiol, Cantrixil, Cantuzumab Ravtansine, Capecitabine, Capecitabine Rapidly Disintegrating Tablet, Capivasertib, Capmatinib, Captopril, CAR T-Cells AMG 119, Caracemide, Carbendazim, Carbetimer, Carbogen, Carbon C 14-pamiparib, Carboplatin, Carboquone, Carboxyamidotriazole, Carboxyamidotriazole Orotate, Carboxyphenyl Retinamide, Carfilzomib, Caricotamide/Tretazicar, Carlumab, Carmofur, Carmustine, Carmustine Implant, Carmustine in Ethanol, Carmustine Sustained-Release Implant Wafer, Carotuximab, Carubicin, Carubicin Hydrochloride, Carzelesin, Carzinophilin, Cathelicidin LL-37, Cationic Liposome-Encapsulated Paclitaxel, Cationic Peptide Cream Cypep-1, Catumaxomab, CBP/beta-catenin Antagonist PRI-724, CBP/beta-catenin Modulator E7386, CCR2 Antagonist CCX872-B, CCR2 Antagonist PF-04136309, CCR2/CCR5 Antagonist BMS-813160, CCR4 Inhibitor FLX475, CD11b Agonist GB1275, CD123-CD33 Compound CAR T Cells, CD123-specific Targeting Module TM123, CD20-CD19 Compound CAR T Cells, CD28/ICOS Antagonist ALPN-101, CD4-specific Telomerase Peptide Vaccine UCPVax, CD40 Agonist Monoclonal Antibody CP-870;893, CD40 Agonistic Monoclonal Antibody APX005M, CD44 Targeted Agent SPL-108, CD44v6-specific CAR T-cells, CD47 Antagonist ALX148, CD73 Inhibitor AB680, CD73 Inhibitor LY3475070, CD80-Fc Fusion Protein ALPN-202, CD80-Fc Fusion Protein FPT155, CDC7 Inhibitor TAK-931, CDC7 Kinase Inhibitor BMS-863233, CDC7 Kinase Inhibitor LY3143921 Hydrate, CDC7 Kinase Inhibitor NMS-1116354, CDK Inhibitor AT7519, CDK Inhibitor R547, CDK Inhibitor SNS-032, CDK/JAK2/FLT3 Inhibitor TG02 Citrate, CDK1 Inhibitor BEY1107, CDK1/2/4 Inhibitor AG-024322, CDK2 Inhibitor PF-07104091, CDK2/4/6/FLT3 Inhibitor FN-1501, CDK2/5/9 Inhibitor CYC065, CDK4 Inhibitor P1446A-05, CDK4/6 Inhibitor, CDK4/6 Inhibitor BPI-16350, CDK4/6 Inhibitor CS3002, CDK4/6 Inhibitor FCN-437, CDK4/6 Inhibitor G1T38, CDK4/6 Inhibitor HS-10342, CDK4/6 Inhibitor SHR6390, CDK4/6 Inhibitor TQB3616, CDK7 Inhibitor CT7001, CDK7 Inhibitor SY-1365, CDK7 Inhibitor SY-5609, CDK8/19 Inhibitor SEL 120, CDK9 Inhibitor AZD4573, CEA-MUC-1-TRICOM Vaccine CV301, CEA-targeting Agent RG6123, CEBPA-targeting saRNA MTL-CEBPA Liposome, Cedazuridine, Cedazuridine/Azacitidine Combination Agent ASTX030, Cedazuridine/Decitabine Combination Agent ASTX727, Cedefingol, Cediranib, Cediranib Maleate, Celecoxib, Cell Cycle Checkpoint/DNA Repair Antagonist IC83, Cemadotin, Cemadotin Hydrochloride, Cemiplimab, Cenersen, Cenisertib, CENP-E Inhibitor GSK-923295, Ceralasertib, Ceramide Nanoliposome, Cerdulatinib, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282, Cereblon Modulator CC-90009, Cergutuzumab Amunaleukin, Ceritinib, Cesalin, cEt KRAS Antisense Oligonucleotide AZD4785, Cetrelimab, Cetuximab, Cetuximab Sarotalocan, Cetuximab-IR700 Conjugate RM-1929, Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY), Cevipabulin, Cevipabulin Fumarate, Cevipabulin Succinate, Cevostamab, cFMS Tyrosine Kinase Inhibitor ARRY-382, Chaparrin, Chaparrinone, Checkpoint Kinase Inhibitor AZD7762, Checkpoint Kinase Inhibitor XL844, Chemotherapy, Chiauranib, Chimeric Monoclonal Antibody 81C6, ChiNing Decoction, Chk1 Inhibitor CCT245737, Chk1 Inhibitor GDC-0425, Chk1 Inhibitor GDC-0575, CHK1 Inhibitor MK-8776, CHK1 Inhibitor PF-477736, Chlorambucil, Chlorodihydropyrimidine, Chloroquine, Chloroquinoxaline Sulfonamide, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes, Chlorozotocin, Choline Kinase Alpha Inhibitor TCD-717, CHP-NY-ESO-1 Peptide Vaccine IMF-001, Chromomycin A3, Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement, Cibisatamab, Ciclopirox Prodrug CPX-POM, Cidan Herbal Capsule, Ciforadenant, Cilengitide, Ciltacabtagene Autoleucel, Cimetidine, Cinacalcet Hydrochloride, Cinobufagin, Cinobufotalin, Cinrebafusp Alfa, Cintirorgon, Cintredekin Besudotox, Cirmtuzumab, cis-Urocanic Acid, Cisplatin, Cisplatin Liposomal, Cisplatin-E Therapeutic Implant, Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6, Citarinostat, Citatuzumab Bogatox, Cixutumumab, CK1alpha/CDK7/CDK9 Inhibitor BTX-A51, CK2-targeting Synthetic Peptide CIGB-300, CL 246738, Cladribine, Clanfenur, Clarithromycin, Class 1/4 Histone Deacetylase Inhibitor OKI-179, Clinical Trial, Clinical Trial Agent, Clioquinol, Clivatuzumab, Clodronate Disodium, Clodronic Acid, Clofarabine, Clomesone, Clomiphene, Clomiphene Citrate, Clostridium Novyi-NT Spores, Cobimetinib, Cobolimab, Cobomarsen, Codrituzumab, Coenzyme Q10, Cofetuzumab Pelidotin, Colchicine-Site Binding Agent ABT-751, Cold Contaminant-free Iobenguane I-131, Colloidal Gold-Bound Tumor Necrosis Factor, Colorectal Cancer Peptide Vaccine PolyPEPI1018, Colorectal Tumor-Associated Peptides Vaccine IMA910, Coltuximab Ravtansine, Combretastatin, Combretastatin A-1, Combretastatin A1 Diphosphate, Commensal Bacterial Strain Formulation VE800, Compound Kushen Injection, Conatumumab, Conbercept, Concentrated Lingzhi Mushroom Extract, Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011, Copanlisib, Copanlisib Hydrochloride, Copper Cu 64-ATSM, Copper Cu 67 Tyr3-octreotate, Copper Gluconate, Cord Blood Derived CAR T-Cells, Cord Blood-derived Expanded Natural Killer Cells PNK-007, Cordycepin, Cordycepin Triphosphate, Coriolus Versicolor Extract, Corticorelin Acetate, Cortisone Acetate, Cosibelimab, Cositecan, Coxsackievirus A21, Coxsackievirus V937, CpG Oligodeoxynucleotide GNKG168, Crenolanib, Crenolanib Besylate, Crizotinib, Crolibulin, Cryptophycin, Cryptophycin 52, Crystalline Genistein Formulation AXP107-11, CSF-1R Inhibitor BLZ945, CSF1R Inhibitor ABSK021, CSF1R Inhibitor DCC-3014, CSF1R Inhibitor PLX73086, CT2584 HMS, CTLA-4-directed Probody BMS-986249, Curcumin, Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110, Cusatuzumab, Custirsen Sodium, CXC Chemokine Receptor 2 Antagonist AZD5069, CXCR1/2 Inhibitor SX-682, CXCR2 Antagonist QBM076, CXCR4 Antagonist BL-8040, CXCR4 Antagonist USL311, CXCR4 Inhibitor Q-122, CXCR4 Peptide Antagonist LY2510924, CXCR4/E-selectin Antagonist GMI-1359, Cyclin-dependent Kinase 8/19 Inhibitor BCD 115, Cyclin-dependent Kinase Inhibitor PF-06873600, Cyclodextrin-Based Polymer-Camptothecin CRLX101, Cyclodisone, Cycloleucine, Cyclopentenyl Cytosine, Cyclophosphamide, Cyclophosphamide Anhydrous, Cyclosporine, CYL-02 Plasmid DNA, CYP11A1 inhibitor ODM-208, CYP11A1 Inhibitor ODM-209, CYP17 Inhibitor CFG920, CYP17 Lyase Inhibitor ASN001, CYP17/Androgen Receptor Inhibitor ODM 204, CYP17/CYP11B2 Inhibitor LAE001, Cyproterone, Cyproterone Acetate, Cytarabine, Cytarabine Monophosphate Prodrug MB07133, Cytarabine-asparagine Prodrug BST-236, Cytidine Analog RX-3117, Cytochlor, Cytokine-based Biologic Agent IRX-2, D-methionine Formulation MRX-1024, DAB389 Epidermal Growth Factor, Dabrafenib, Dabrafenib Mesylate, Dacarbazine, Dacetuzumab, DACH Polymer Platinate AP5346, DACH-Platin Micelle NC-4016, Daclizumab, Dacomitinib, Dacplatinum, Dactinomycin, Dactolisib, Dactolisib Tosylate, Dalantercept, Dalotuzumab, Daniquidone, Danusertib, Danvatirsen, Daporinad, Daratumumab, Daratumumab and Hyaluronidase-fihj, Daratumumab/rHuPH20, Darinaparsin, Darleukin, Darolutamide, Daromun, Dasatinib, Daunorubicin, Daunorubicin Citrate, Daunorubicin Hydrochloride, DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Decitabine, Decitabine and Cedazuridine, Defactinib, Defactinib Hydrochloride, Deferoxamine, Deferoxamine Mesylate, Degarelix, Degarelix Acetate, Delanzomib, Delolimogene Mupadenorepvec, Demcizumab, Demecolcine, Demplatin Pegraglumer, Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466, Dendritic Cell Vaccine, Dendritic Cell-Autologous Lung Tumor Vaccine, Dendritic Cell-targeting Lentiviral Vector ID-LV305, Denenicokin, Dengue Virus Adjuvant PV-001-DV, Denibulin, Denibulin Hydrochloride, Denileukin Diftitox, Denintuzumab Mafodotin, Denosumab, Deoxycytidine Analogue TAS-109, Deoxycytidine Analogue TAS-109 Hydrochloride, Depatuxizumab, Depatuxizumab Mafodotin, Derazantinib, Deslorelin, Deslorelin Acetate, Detirelix, Detorubicin, Deuteporfin, Deuterated Enzalutamide, Devimistat, Dexamethason, Dexamethasone, Dexamethasone Phosphate, Dexamethasone Sodium Phosphate, Dexanabinol, Dexrazoxane, Dexrazoxane Hydrochloride, Dezaguanine, Dezaguanine Mesylate, Dezapelisib, DHA-Paclitaxel, DHEA Mustard, DI-Leu16-IL2 Immunocytokine, Dianhydrogalactitol, Diarylsulfonylurea Compound ILX-295501, Diazepinomicin, Diaziquone, Diazooxonorleucine, Dibrospidium Chloride, Dichloroallyl Lawsone, Dicycloplatin, Didox, Dienogest, Diethylnorspermine, Digitoxin, Digoxin, Dihydro-5-Azacytidine, Dihydrolenperone, Dihydroorotate Dehydrogenase Inhibitor AG-636, Dihydroorotate Dehydrogenase Inhibitor BAY2402234, Diindolylmethane, Dilpacimab, Dimethylmyleran, Dinaciclib, Dinutuximab, Dioscorea nipponica Makino Extract DNE3, Diphencyprone, Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777, Ditiocarb, DKK1-Neutralizing Monoclonal Antibody DKN-01, DM-CHOC-PEN, DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015, DNA Interference Oligonucleotide PNT2258, DNA Minor Groove Binding Agent SG2000, DNA Plasmid Encoding Interleukin-12 INO-9012, DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151, DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457, DNA Vaccine VB10.16, DNA-dependent Protein Kinase Inhibitor VX-984, DNA-PK inhibitor AZD7648, DNA-PK/PI3K-delta Inhibitor BR101801, DNA-PK/TOR Kinase Inhibitor CC-115, DNMT1 Inhibitor NTX-301, DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98, Docetaxel, Docetaxel Anhydrous, Docetaxel Emulsion ANX-514, Docetaxel Formulation CKD-810, Docetaxel Lipid Microspheres, Docetaxel Nanoparticle CPC634, Docetaxel Polymeric Micelles, Docetaxel-loaded Nanopharmaceutical CRLX301, Docetaxel-PNP, Docetaxel/Ritonavir, Dociparstat sodium, Dolastatin 10, Dolastatin 15, Domatinostat, Donafenib, Dopamine-Somatostatin Chimeric Molecule BIM-23A760, Dostarlimab, Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703, Dovitinib, Dovitinib Lactate, Doxazosin, Doxercalciferol, Doxifluridine, Doxorubicin, Doxorubicin Hydrochloride, Doxorubicin Prodrug L-377;202, Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370, Doxorubicin-Eluting Beads, Doxorubicin-HPMA Conjugate, Doxorubicin-loaded EGFR-targeting Nanocells, Doxorubicin-Magnetic Targeted Carrier Complex, DPT/BCG/Measles/Serratia/Pneumococcus Vaccine, DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine, DPX-E7 HPV Vaccine, DR5 HexaBody Agonist GEN1029, DR5-targeting Tetrameric Nanobody Agonist TAS266, Dromostanolone Propionate, Drozitumab, DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555, Dual IGF-1R/InsR Inhibitor BMS-754807, Dual Variable Domain Immunoglobulin ABT-165, Dual-affinity B7-H3/CD3-targeted Protein MGD009, Dubermatinib, Duborimycin, Dulanermin, Duligotuzumab, Dupilumab, Durvalumab, Dusigitumab, dUTPase/DPD Inhibitor TAS-114, Duvelisib, Duvortuxizumab, Dynemicin, Dynemicin A, E2F1 Pathway Activator ARQ 171, EBNA-1 inhibitor VK-2019, Echinomycin, Ecromeximab, Edatrexate, Edelfosine, Edicotinib, Edodekin alfa, Edotecarin, Edrecolomab, EED Inhibitor MAK683, Efatutazone, Efatutazone Dihydrochloride, Efizonerimod, Eflornithine, Eflornithine Hydrochloride, Eftilagimod Alpha, Eftozanermin Alfa, Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205, Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621, EGb761, EGFR Antagonist Hemay022, EGFR Antisense DNA BB-401, EGFR Inhibitor AZD3759, EGFR Inhibitor BIBX 1382, EGFR Inhibitor DBPR112, EGFR Inhibitor PD-168393, EGFR Inhibitor TY-9591, EGFR Mutant-selective Inhibitor TQB3804, EGFR Mutant-specific Inhibitor BPI-7711, EGFR Mutant-specific Inhibitor CK-101, EGFR Mutant-specific Inhibitor D-0316, EGFR Mutant-specific Inhibitor ZN-e4, EGFR T790M Antagonist BPI-15086, EGFR T790M Inhibitor HS-10296, EGFR/EGFRvIII Inhibitor WSD0922-FU, EGFR/FLT3/Abl Inhibitor SKLB1028, EGFR/HER1/HER2 Inhibitor PKI166, EGFR/HER2 Inhibitor AP32788, EGFR/HER2 Inhibitor AV-412, EGFR/HER2 Inhibitor DZD9008, EGFR/HER2 Kinase Inhibitor TAK-285, EGFR/TGFb Fusion Monoclonal Antibody BCA101, EGFR/VEGFR/RET Inhibitor HA121-28, Eicosapentaenoic Acid, eIF4E Antisense Oligonucleotide ISIS 183750, Elacestrant, Elacytarabine, Elagolix, Elbasvir/Grazoprevir, Elesclomol, Elesclomol Sodium, Elgemtumab, Elinafide, Elisidepsin, Elliptinium, Elliptinium Acetate, Elmustine, Elotuzumab, Elpamotide, Elsamitrucin, Eltanexor, Emactuzumab, Emapalumab, Emepepimut-S, Emibetuzumab, Emitefur, Emofolin Sodium, Empesertib, Enadenotucirev, Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A, Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641, Enasidenib, Enasidenib Mesylate, Enavatuzumab, Encapsulated Rapamycin, Encelimab, Enclomiphene, Enclomiphene Citrate, Encorafenib, Endothelin B Receptor Blocker ENB 003, Endothelin Receptor Type A Antagonist YM598, Enfortumab Vedotin, Engineered Human Umbilical Vein Endothelial Cells AB-205, Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240, Engineered Toxin Body Targeting CD38 TAK-169, Engineered Toxin Body Targeting HER2 MT-5111, Eniluracil/5-FU Combination Tablet, Enloplatin, Enoblituzumab, Enobosarm, Enoticumab, Enpromate, Ensartinib, Ensituximab, Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride, Enterococcus gallinarum Strain MRx0518, Entinostat, Entolimod, Entospletinib, Entrectinib, Envafolimab, Enzalutamide, Enzastaurin, Enzastaurin Hydrochloride, EP2/EP4 Antagonist TPST-1495, EP4 Antagonist INV-1120, EP4 Antagonist ONO-4578, Epacadostat, Epcoritamab, EphA2-targeting Bicycle Toxin Conjugate BT5528, Epipodophyllotoxin Analog GL331, Epipropidine, Epirubicin, Epirubicin Hydrochloride, Epitinib Succinate, Epitiostanol, Epothilone Analog UTD1, Epothilone KOS-1584, Epratuzumab, Epratuzumab-cys-tesirine, ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471, ERa36 Modulator Icaritin, Erastin Analogue PRLX 93936, Erbulozole, Erdafitinib, Eribulin, Eribulin Mesylate, ERK 1/2 Inhibitor ASTX029, ERK Inhibitor CC-90003, ERK Inhibitor GDC-0994, ERK Inhibitor LTT462, ERK Inhibitor MK-8353, ERK1/2 Inhibitor ASN007, ERK1/2 Inhibitor HH2710, ERK1/2 Inhibitor JSI-1187, ERK1/2 Inhibitor KO-947, ERK1/2 Inhibitor LY3214996, Erlotinib, Erlotinib Hydrochloride, Ertumaxomab, Erythrocyte-encapsulated L-asparaginase Suspension, Esorubicin, Esorubicin Hydrochloride, Esperamicin A1, Essiac, Esterified Estrogens, Estradiol Valerate, Estramustine, Estramustine Phosphate Sodium, Estrogen Receptor Agonist GTx-758, Estrogens; Conjugated, Etalocib, Etanercept, Etanidazole, Etaracizumab, Etarotene, Ethaselen, Ethinyl Estradiol, Ethyleneimine, Ethylnitrosourea, Etidronate-Cytarabine Conjugate MBC-11, Etigilimab, Etirinotecan Pegol, Etoglucid, Etoposide, Etoposide Phosphate, Etoposide Toniribate, Etoprine, Etoricoxib, Ets-family Transcription Factor Inhibitor TK216, Everolimus, Everolimus Tablets for Oral Suspension, Evofosfamide, Ex Vivo-expanded Autologous T Cells IMA101, Exatecan Mesylate, Exatecan Mesylate Anhydrous, Exemestane, Exicorilant, Exisulind, Extended Release Flucytosine, Extended Release Metformin Hydrochloride, Extended-release Onapristone, Ezabenlimab, EZH1/2 Inhibitor DS-3201, EZH1/2 Inhibitor HH2853, EZH2 inhibitor CPI-0209, EZH2 Inhibitor CPI-1205, EZH2 Inhibitor PF-06821497, EZH2 Inhibitor SHR2554, F16-IL2 Fusion Protein, FACT Complex-targeting Curaxin CBL0137, Factor VII-targeting Immunoconjugate Protein ICON-1, Factor VIIa Inhibitor PCI-27483, Fadraciclib, Fadrozole Hydrochloride, FAK Inhibitor GSK2256098, FAK Inhibitor PF-00562271, FAK Inhibitor VS-4718, FAK/ALK/ROS1 Inhibitor APG-2449, Falimarev, Famitinib, FAP/4-1BB-targeting DARPin MP0310, FAP/4-1BB-targeting Fusion Protein RO7122290, Farletuzumab, Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778;123, Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells, Fas Receptor Agonist APO010, Fascin Inhibitor NP-G2-044, FASN Inhibitor TVB-2640, Favezelimab, Fazarabine, Fc-engineered Anti-CD40 Agonist Antibody 2141-V11, Febuxostat, Fedratinib, Fedratinib Hydrochloride, Feladilimab, Felzartamab, Fenebrutinib, Fenretinide, Fenretinide Lipid Matrix, Fenretinide Phospholipid Suspension ST-001, FGF Receptor Antagonist HGS1036, FGF/FGFR Pathway Inhibitor E7090, FGFR Inhibitor ASP5878, FGFR Inhibitor AZD4547, FGFR Inhibitor CPL304110, FGFR Inhibitor Debio 1347, FGFR Inhibitor TAS-120, FGFR/CSF-1R Inhibitor 3D185, FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999, FGFR1/2/3 Inhibitor HMPL-453, FGFR2 Inhibitor RLY-4008, FGFR4 Antagonist INCB062079, FGFR4 Inhibitor BLU 9931, FGFR4 Inhibitor FGF401, FGFR4 Inhibitor H3B-6527, FGFR4 Inhibitor ICP-105, Fianlimab, Fibromun, Ficlatuzumab, Figitumumab, Filanesib, Filgotinib, Filgrastim, Fimaporfin A, Fimepinostat, Firtecan Pegol, Fisogatinib, Flanvotumab, Flotetuzumab, Floxuridine, FLT3 Inhibitor FF-10101 Succinate, FLT3 Inhibitor HM43239, FLT3 Inhibitor SKI-G-801, Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01, FLT3 Tyrosine Kinase Inhibitor TTT-3002, FLT3/ABL/Aurora Kinase Inhibitor KW-2449, FLT3/CDK4/6 Inhibitor FLX925, FLT3/FGFR Dual Kinase Inhibitor MAX-40279, FLT3/KIT Kinase Inhibitor AKN-028, FLT3/KIT/CSF1R Inhibitor NMS-03592088, Flt3/MerTK Inhibitor MRX-2843, Fludarabine, Fludarabine Phosphate, Flumatinib, Flumatinib Mesylate, Fluorine F 18 Ara-G, Fluorodopan, Fluorouracil, Fluorouracil Implant, Fluorouracil-E Therapeutic Implant, Fluoxymesterone, Flutamide, Fluvastatin, Fluvastatin Sodium, Fluzoparib, FMS Inhibitor JNJ-40346527, Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate, Folate Receptor Targeted Epothilone BMS753493, Folate Receptor-Targeted Tubulysin Conjugate EC1456, Folate Receptor-Targeted Vinca Alkaloid EC0489, Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225, Folate-FITC, Folic Acid, Folitixorin, Foretinib, Foritinib Succinate, Formestane, Forodesine Hydrochloride, Fosaprepitant, Fosbretabulin, Fosbretabulin Disodium, Fosbretabulin Tromethamine, Fosgemcitabine Palabenamide, Fosifloxuridine Nafalbenamide, Foslinanib, Foslinanib Disodium, Fosquidone, Fostriecin, Fotemustine, Fotretamine, FPV Vaccine CV301, FPV-Brachyury-TRICOM Vaccine, Fresolimumab, Fruquintinib, Fulvestrant, Fumagillin-Derived Polymer Conjugate XMT-1107, Fursultiamine, Futibatinib, Futuximab, Futuximab/Modotuximab Mixture, G Protein-coupled Estrogen Receptor Agonist LNS8801, G-Quadruplex Stabilizer BMVC, Galamustine, Galarubicin, Galectin Inhibitor GR-MD-02, Galectin-1 Inhibitor OTX008, Galeterone, Galiximab, Gallium-based Bone Resorption Inhibitor AP-002, Galocitabine, Galunisertib, Gamboge Resin Extract TSB-9-W1, Gamma-delta Tocotrienol, Gamma-Secretase Inhibitor LY3039478, Gamma-Secretase Inhibitor RO4929097, Gandotinib, Ganetespib, Ganglioside GD2, Ganglioside GM2, Ganitumab, Ganoderma lucidum Spores Powder Capsule, Garlic, Gastrin Immunotoxin, Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360, Gataparsen Sodium, Gatipotuzumab, GBM Antigens and Alloantigens Immunotherapeutic Vaccine, Gedatolisib, Gefitinib, Geldanamycin, Gelonin, Gemcitabine, Gemcitabine Elaidate, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride Emulsion, Gemcitabine Prodrug LY2334737, Gemcitabine-Phosphoramidate Hydrochloride NUC-1031, Gemcitabine-Releasing Intravesical System, Gemtuzumab Ozogamicin, Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum, Genistein, Gentuximab, Geranylgeranyltransferase I Inhibitor, GI-4000 Vaccine, Giloralimab, Gilteritinib, Gilteritinib Fumarate, Gimatecan, Gimeracil, Ginsenoside Rg3 Capsule, Giredestrant, Girentuximab, Girodazole, GITR Agonist MEDI1873, Givinostat, Glasdegib, Glasdegib Maleate, Glaucarubolone, Glecaprevir/Pibrentasvir, Glembatumumab Vedotin, Glesatinib, Glioblastoma Cancer Vaccine ERC1671, Glioblastoma Multiforme Multipeptide Vaccine IMA950, Glioma Lysate Vaccine GBM6-AD, Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701, Globo H-DT Vaccine OBI-833, Glofitamab, Glucarpidase, Glucocorticoid Receptor Antagonist ORIC-101, Glufosfamide, Glumetinib, Glutaminase Inhibitor CB-839, Glutaminase Inhibitor CB-839 Hydrochloride, Glutaminase Inhibitor IPN60090, Glutamine Antagonist DRP-104, Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101, Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01, Glycooptimized Trastuzumab-GEX, GM-CSF-encoding Oncolytic Adenovirus CGTG-102, Gold Sodium Thiomalate, Golnerminogene Pradenovec, Golotimod, Golvatinib, Gonadotropin-releasing Hormone Analog, Goserelin, Goserelin Acetate, Goserelin Acetate Extended-release Microspheres LY01005, Gossypol, Gossypol Acetic Acid, Grapiprant, Green Tea Extract-based Antioxidant Supplement, GS/pan-Notch Inhibitor AL101, GS/pan-Notch Inhibitor BMS-986115, GSK-3 Inhibitor 9-ING-41, GSK-3 Inhibitor LY2090314, Guadecitabine, Guanabenz Acetate, Guselkumab, Gusperimus Trihydrochloride, Gutolactone, H-ras Antisense Oligodeoxynucleotide ISIS 2503, H1299 Tumor Cell Lysate Vaccine, HAAH Lambda phage Vaccine SNS-301, Hafnium Oxide-containing Nanoparticles NBTXR3, Halichondrin Analogue E7130, Halichondrin B, Halofuginone, Halofuginone Hydrobromide, HCV DNA Vaccine INO-8000, HDAC Class I/IIb Inhibitor HG146, HDAC Inhibitor AR-42, HDAC inhibitor CG200745, HDAC Inhibitor CHR-2845, HDAC Inhibitor CKD-581, HDAC Inhibitor CXD101, HDAC Inhibitor MPT0E028, HDAC Inhibitor OBP-801, HDAC/EGFR/HER2 Inhibitor CUDC-101, HDAC6 Inhibitor KA2507, HDAC8 Inhibitor NBM-BMX, HDM2 Inhibitor HDM201, HDM2 Inhibitor MK-8242, Hedgehog Inhibitor IPI-609, Hematoporphyrin Derivative, Hemiasterlin Analog E7974, Henatinib Maleate, Heparan Sulfate Glycosaminoglycan Mimetic M402, Heparin Derivative SST0001, HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131, HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901, HER2 Inhibitor CP-724;714, HER2 Inhibitor DZD1516, HER2 Inhibitor TAS0728, HER2 Tri-specific Natural Killer Cell Engager DF1001, HER2-directed TLR8 Agonist SBT6050, HER2-targeted DARPin MP0274, HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302, HER2-targeting Antibody Fc Fragment FS102, Herba Scutellaria Barbata, Herbimycin, Heterodimeric Interleukin-15, Hexamethylene Bisacetamide, Hexaminolevulinate, Hexylresorcinol, HIF-1alpha Inhibitor PX-478, HIF-2alpha Inhibitor PT2385, HIF-2alpha Inhibitor PT2977, HIF2a RNAi ARO-HIF2, Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126, Histrelin Acetate, HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001, HLA-A*2402-Restricted Multipeptide Vaccine S-488410, HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201, HM2/MMAE Antibody-Drug Conjugate ALT-P7, Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine, Holmium Ho 166 Poly(L-Lactic Acid) Microspheres, Hormone Therapy, HPPH, HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202, HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c, HPV DNA Plasmids Therapeutic Vaccine VGX-3100, HPV E6/E7 DNA Vaccine GX-188E, HPV E6/E7-encoding Arenavirus Vaccine HB-201, HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C, HPV-16 E6 Peptides Vaccine/Candida albicans Extract, HPV-6-targeting Immunotherapeutic Vaccine INO-3106, HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101, HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN, HPV6/11-targeted DNA Plasmid Vaccine INO-3107, Hsp90 Antagonist KW-2478, Hsp90 Inhibitor AB-010, Hsp90 Inhibitor BIIB021, Hsp90 Inhibitor BIIB028, Hsp90 Inhibitor Debio 0932, Hsp90 Inhibitor DS-2248, Hsp90 Inhibitor HSP990, Hsp90 Inhibitor MPC-3100, Hsp90 Inhibitor PU-H71, Hsp90 Inhibitor SNX-5422 Mesylate, Hsp90 Inhibitor SNX-5542 Mesylate, Hsp90 Inhibitor TQB3474, Hsp90 Inhibitor XL888, Hsp90-targeted Photosensitizer HS-201, HSP90-targeted SN-38 Conjugate PEN-866, HSP90alpha/beta Inhibitor TAS-116, hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301, hTERT Vaccine V934/V935, hTERT-encoding DNA Vaccine INVAC-1, Hu14.18-IL2 Fusion Protein EMD 273063, HuaChanSu, Huaier Extract Granule, Huang Lian, huBC1-huIL12 Fusion Protein AS1409, Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736, Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104, Human MOAB LICO 28a32, Human Monoclonal Antibody 216, Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307, Human Papillomavirus 16 E7 Peptide/Padre 965.10, Hyaluronidase-zzxf/Pertuzumab/Trastuzumab, Hycanthone, Hydralazine Hydrochloride, Hydrocortisone Sodium Succinate, Hydroxychloroquine, Hydroxyprogesterone Caproate, Hydroxytyrosol, Hydroxyurea, Hypericin, Hypoxia-activated Prodrug TH-4000, I 131 Antiferritin Immunoglobulin, I 131 Monoclonal Antibody A33, I 131 Monoclonal Antibody CC49, I 131 Monoclonal Antibody F19, I 131 Monoclonal Antibody Lym-1, Iadademstat, Ianalumab, IAP Inhibitor APG-1387, IAP Inhibitor AT-406, IAP Inhibitor HGS1029, Ibandronate Sodium, Iberdomide, Iboctadekin, Ibritumomab Tiuxetan, Ibrutinib, Icotinib Hydrochloride, Icrucumab, ICT-121 Dendritic Cell Vaccine, Idarubicin, Idarubicin Hydrochloride, Idarubicin-Eluting Beads, Idasanutlin, Idecabtagene Vicleucel, Idelalisib, Idetrexed, IDH1 Mutant Inhibitor LY3410738, IDH1(R132) Inhibitor IDH305, IDH1R132H-Specific Peptide Vaccine PEPIDH1M, Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020, IDO Peptide Vaccine IO102, IDO-1 Inhibitor LY3381916, IDO/TDO Inhibitor HTI-1090, IDO/TDO Inhibitor LY-01013, IDO1 Inhibitor KHK2455, IDO1 Inhibitor MK-7162, IDO1 Inhibitor PF-06840003, IDO1/TDO2 Inhibitor DN1406131, IDO1/TDO2 Inhibitor M4112, Idronoxil, Idronoxil Suppository NOX66, Ieramilimab, Ifabotuzumab, Ifetroban, Ifosfamide, IGF-1R Inhibitor, IGF-1R Inhibitor PL225B, IGF-1R/IR Inhibitor KW-2450, IGF-methotrexate Conjugate, IL-10 Immunomodulator MK-1966, IL-12-expressing HSV-1 NSC 733972, IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051, IL-12sc; IL-15sushi; IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000, IL-2 Recombinant Fusion Protein ALT-801, IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1, IL4-Pseudomonas Exotoxin Fusion Protein MDNA55, Ilginatinib, Ilixadencel, Iloprost, Ilorasertib, Imalumab, Imaradenant, Imatinib, Imatinib Mesylate, Imetelstat, Imetelstat Sodium, Imexon, Imgatuzumab, Imidazole Mustard, Imidazole-Pyrazole, Imifoplatin, Imipramine Blue, Imiquimod, Immediate-release Onapristone, Immediate-release Tablet Afuresertib, Immune Checkpoint Inhibitor ASP8374, Immunoconjugate RO5479599, Immunocytokine NHS-IL12, Immunocytokine NHS-IL2-LT, Immunomodulator LAM-003, Immunomodulator OHR/AVR118, Immunomodulatory Agent CC-11006, Immunomodulatory Oligonucleotide HYB2055, Immunotherapeutic Combination Product CMB305, Immunotherapeutic GSK1572932A, Immunotherapy Regimen MKC-1106-MT, Immunotoxin CMD-193, IMT-1012 Immunotherapeutic Vaccine, Inactivated Oncolytic Virus Particle GEN0101, Inalimarev, Incyclinide, Indatuximab Ravtansine, Indibulin, Indicine-N-Oxide, Indisulam, Individualized MVA-based Vaccine TG4050, Indocyanine Green-labeled Polymeric Micelles ONM-100, Indole-3-Carbinol, Indomethacin, Indoximod, Indoximod Prodrug NLG802, Indusatumab Vedotin, Inebilizumab, Inecalcitol, Infigratinib, Infigratinib Mesylate, Infliximab, Ingenol Mebutate, Ingenol Mebutate Gel, Iniparib, iNKT Cell Agonist ABX196, Innate Immunostimulator rBBX-01, INO-1001, Inodiftagene Vixteplasmid, iNOS Dimerization Inhibitor ASP9853, Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01, Inosine Monophosphate Dehydrogenase Inhibitor AVN944, Inositol, Inotuzumab Ozogamicin, Inproquone, Integrin alpha-2 Inhibitor E7820, Integrin Receptor Antagonist GLPG0187, Interferon, Interferon Alfa-2B, Interferon Alfa-N1, Interferon Alfa-N3, Interferon Alfacon-1, Interferon Beta-1A, Interferon Gamma-1b, Interferon-gamma-expressing Adenovirus Vaccine ASN-002, Interleukin Therapy, Interleukin-12-Fc Fusion Protein DF6002, Interleukin-15 Agonist Fusion Protein SHR1501, Interleukin-15 Fusion Protein BJ-001, Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306, Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101, Interleukin-2 Liposome, Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230, Intetumumab, Intiquinatine, Intoplicine, Inulin, Iobenguane I-131, Iodine I 124 Monoclonal Antibody A33, Iodine I 124 Monoclonal Antibody M5A, Iodine I 125-Anti-EGFR-425 Monoclonal Antibody, Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP, Iodine I 131 Apamistamab, Iodine I 131 Derlotuximab Biotin, Iodine I 131 Ethiodized Oil, Iodine I 131 IPA, Iodine I 131 MIP-1095, Iodine I 131 Monoclonal Antibody 81C6, Iodine I 131 Monoclonal Antibody BC8, Iodine I 131 Monoclonal Antibody CC49-deltaCH2, Iodine I 131 Monoclonal Antibody F16SIP, Iodine I 131 Monoclonal Antibody G-250, Iodine I 131 Monoclonal Antibody muJ591, Iodine I 131 Omburtamab, Iodine I 131 Rituximab, Iodine I 131 Tenatumomab, Iodine I 131 TM-601, Iodine I 131 Tositumomab, Iodine I-131, Ioflubenzamide I-131, Ionomycin, Ipafricept, Ipatasertib, Ipilimumab, Ipomeanol, Iproplatin, iPSC-derived CD16-expressing Natural Killer Cells FT516, iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596, iPSC-derived Natural Killer Cells FT500, IRAK4 Inhibitor CA-4948, Iratumumab, Iridium Ir 192, Irinotecan, Irinotecan Hydrochloride, Irinotecan Sucrosofate, Irinotecan-Eluting Beads, Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet, Irofulven, Iroplact, Irosustat, Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130, Isatuximab, Iso-fludelone, Isobrucein B, Isocoumarin NM-3, Isotretinoin, Ispinesib, Ispinesib Mesylate, ISS 1018 CpG Oligodeoxynucleotide, Istiratumab, Itacitinib, Itacitinib Adipate, ITK Inhibitor CPI-818, Itraconazole, Itraconazole Dispersion In Polymer Matrix, Ivaltinostat, Ivosidenib, Ivuxolimab, Ixabepilone, Ixazomib, Ixazomib Citrate, JAK Inhibitor, JAK Inhibitor INCB047986, JAK1 Inhibitor AZD4205, JAK1 Inhibitor INCB052793, JAK2 Inhibitor AZD1480, JAK2 Inhibitor BMS-911543, JAK2 Inhibitor XL019, JAK2/Src Inhibitor NS-018, Jin Fu Kang, JNK Inhibitor CC-401, Kanglaite, Kanitinib, Ketoconazole, Ketotrexate, KRAS G12C Inhibitor GDC-6036, KRAS G12C Inhibitor LY3499446, KRAS G12C Inhibitor MRTX849, KRAS Mutant-targeting AMG 510, KRAS-MAPK Signaling Pathway Inhibitor JAB-3312, KRASG12C Inhibitor JNJ-74699157, KRN5500, KSP Inhibitor AZD4877, KSP Inhibitor SB-743921, Kunecatechins Ointment, L-Gossypol, L-methylfolate, Labetuzumab Govitecan, Lactoferrin-derived Lytic Peptide LTX-315, Lacutamab, Ladiratuzumab Vedotin, Ladirubicin, Laetrile, LAIR-2 Fusion Protein NC410, Landogrozumab, Laniquidar, Lanreotide Acetate, Lapachone, Lapatinib, Lapatinib Ditosylate, Laprituximab Emtansine, Lapuleucel-T, Laromustine, Larotaxel, Larotinib Mesylate, Larotrectinib, Larotrectinib Sulfate, Lavendustin A, Lazertinib, Lead Pb 212 TCMC-trastuzumab, Lefitolimod, Leflunomide, Lenalidomide, Lenalidomide Analog KPG-121, Lentinan, Lenvatinib, Lenvatinib Mesylate, Lenzilumab, Lerociclib, Lestaurtinib, Letetresgene Autoleucel, Letolizumab, Letrozole, Leucovorin, Leucovorin Calcium, Leuprolide, Leuprolide Acetate, Leuprolide Mesylate Injectable Suspension, Leurubicin, Levetiracetam, Levoleucovorin Calcium, Levothyroxine, Levothyroxine Sodium, Lexatumumab, Lexibulin, Liarozole, Liarozole Fumarate, Liarozole Hydrochloride, Licartin, Licorice, Lifastuzumab Vedotin, Lifileucel, Lifirafenib, Light-activated AU-011, Light-Emitting Oncolytic Vaccinia Virus GL-ONC1, Lilotomab, Limonene; (+)-, Limonene; (+/-)-, Linifanib, Linoleyl Carbonate-Paclitaxel, Linperlisib, Linrodostat, Linsitinib, Lintuzumab, Liothyronine I-131, Liothyronine Sodium, Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1, Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191, Lipid Nanoparticle Encapsulated OX40L mRNA-2416, Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006, Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752, Liposomal Bcl-2 Antisense Oligonucleotide BP1002, Liposomal c-raf Antisense Oligonucleotide, Liposomal Curcumin, Liposomal Cytarabine, Liposomal Daunorubicin Citrate, Liposomal Docetaxel, Liposomal Eribulin Mesylate, Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Liposomal Irinotecan, Liposomal Mitoxantrone Hydrochloride, Liposomal MUC1/PET-lipid A Vaccine ONT-10, Liposomal NDDP, Liposomal Rhenium Re 186, Liposomal SN-38, Liposomal Topotecan FF-10850, Liposomal Vinorelbine, Liposomal Vinorelbine Tartrate, Liposome, Liposome-encapsulated Daunorubicin-Cytarabine, Liposome-Encapsulated Doxorubicin Citrate, Liposome-encapsulated miR-34 Mimic MRX34, Liposome-encapsulated OSI-7904, Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94, Liposome-encapsulated TAAs mRNA Vaccine W_ova1, Lirilumab, Lisavanbulin, Lisocabtagene Maraleucel, Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142, Litronesib, Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809, Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207, Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623, Liver X Receptor beta Agonist RGX-104, Lm-tLLO-neoantigens Vaccine ADXS-NEO, LMB-1 Immunotoxin, LMB-2 Immunotoxin, LMB-7 Immunotoxin, LMB-9 Immunotoxin, LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164, LMP-2:340-349 Peptide Vaccine, LMP-2:419-427 Peptide Vaccine, LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes, LMP7 Inhibitor M3258, Lobaplatin, Lodapolimab, Lometrexol, Lometrexol Sodium, Lomustine, Lonafarnib, Loncastuximab Tesirine, Long Peptide Vaccine 7, Long-acting Release Pasireotide, Lontucirev, Lorlatinib, Lorukafusp alfa, Lorvotuzumab Mertansine, Losatuxizumab Vedotin, Losoxantrone, Losoxantrone Hydrochloride, Lovastatin, LOXL2 Inhibitor PAT-1251, LRP5 Antagonist BI 905681, LRP5/6 Antagonist BI 905677, LSD1 Inhibitor CC-90011, LSD1 Inhibitor GSK2879552, LSD1 Inhibitor IMG-7289, LSD1 Inhibitor RO7051790, LSD1 Inhibitor SYHA1807, Lucanthone, Lucatumumab, Lucitanib, Luminespib, Luminespib Mesylate, Lumretuzumab, Lung-targeted Immunomodulator QBKPN, Lupartumab Amadotin, Lurbinectedin, Lurtotecan, Lurtotecan Liposome, Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1, Lutetium Lu 177 DOTA-biotin, Lutetium Lu 177 DOTA-N3-CTT1403, Lutetium Lu 177 DOTA-Tetulomab, Lutetium Lu 177 Dotatate, Lutetium Lu 177 Lilotomab-satetraxetan, Lutetium Lu 177 Monoclonal Antibody CC49, Lutetium Lu 177 Monoclonal Antibody J591, Lutetium Lu 177 PP-F11N, Lutetium Lu 177 Satoreotide Tetraxetan, Lutetium Lu 177-DOTA-EB-TATE, Lutetium Lu 177-DTPA-omburtamab, Lutetium Lu 177-Edotreotide, Lutetium Lu 177-NeoB, Lutetium Lu 177-PSMA-617, Lutetium Lu-177 Capromab, Lutetium Lu-177 Girentuximab, Lutetium Lu-177 PSMA-R2, Lutetium Lu-177 Rituximab, LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1, Lyophilized Black Raspberry Lozenge, Lyophilized Black Raspberry Saliva Substitute, Lysine-specific Demethylase 1 Inhibitor INCB059872, Lyso-Thermosensitive Liposome Doxorubicin, Maackia amurensis Seed Lectin, Macimorelin, Macitentan, Macrocycle-bridged STING Agonist E7766, Maekmoondong-tang, Mafosfamide, MAGE-10.A2, MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells, MAGE-A3 Multipeptide Vaccine GL-0817, MAGE-A3 Peptide Vaccine, MAGE-A3-specific Immunotherapeutic GSK 2132231A, MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201, Magnesium Valproate, Magrolimab, MALT1 Inhibitor JNJ-67856633, Manelimab, Mannosulfan, Mannosylerythritol Lipid, Mapatumumab, Maraba Oncolytic Virus Expressing Mutant HPV E6/E7, Marcellomycin, MARCKS Protein Inhibitor BIO-11006, Margetuximab, Marimastat, Marizomib, Masitinib Mesylate, Masoprocol, MAT2A Inhibitor AG-270, Matrix Metalloproteinase Inhibitor MMI270, Matuzumab, Mavelertinib, Mavorixafor, Maytansine, MCL-1 Inhibitor ABBV-467, MCL-1 Inhibitor AMG 176, MCL-1 inhibitor AMG 397, Mcl-1 Inhibitor AZD5991, Mcl-1 Inhibitor MIK665, MDM2 Antagonist ASTX295, MDM2 Antagonist RO5045337, MDM2 Antagonist RO6839921, MDM2 Inhibitor AMG-232, MDM2 Inhibitor AMGMDS3, MDM2 Inhibitor BI 907828, MDM2 Inhibitor KRT-232, MDM2/MDMX Inhibitor ALRN-6924, MDR Modulator CBT-1, Mechlorethamine, Mechlorethamine Hydrochloride, Mechlorethamine Hydrochloride Gel, Medorubicin, Medroxyprogesterone, Medroxyprogesterone Acetate, Megestrol Acetate, MEK 1/2 Inhibitor AS703988/MSC2015103B, MEK 1/2 Inhibitor FCN-159, MEK Inhibitor AZD8330, MEK Inhibitor CI-1040, MEK inhibitor CS3006, MEK Inhibitor GDC-0623, MEK Inhibitor HL-085, MEK Inhibitor PD0325901, MEK Inhibitor RO4987655, MEK Inhibitor SHR 7390, MEK Inhibitor TAK-733, MEK Inhibitor WX-554, MEK-1/MEKK-1 Inhibitor E6201, MEK/Aurora Kinase Inhibitor BI 847325, Melanoma Monoclonal Antibody hIgG2A, Melanoma TRP2 CTL Epitope Vaccine SCIB1, Melapuldencel-T, MELK Inhibitor OTS167, Melphalan, Melphalan Flufenamide, Melphalan Hydrochloride, Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex, Membrane-Disrupting Peptide EP-100, Menatetrenone, Menin-MLL Interaction Inhibitor SNDX-5613, Menogaril, Merbarone, Mercaptopurine, Mercaptopurine Anhydrous, Mercaptopurine Oral Suspension, Merestinib, Mesna, Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536, MET Kinase Inhibitor OMO-1, MET Tyrosine Kinase Inhibitor BMS-777607, MET Tyrosine Kinase Inhibitor EMD 1204831, MET Tyrosine Kinase Inhibitor PF-04217903, MET Tyrosine Kinase Inhibitor SAR125844, MET Tyrosine Kinase Inhibitor SGX523, MET x MET Bispecific Antibody REGN5093, Metamelfalan, MetAP2 Inhibitor APL-1202, MetAP2 Inhibitor SDX-7320, Metarrestin, Metatinib Tromethamine, Metformin, Metformin Hydrochloride, Methanol Extraction Residue of BCG, Methazolamide, Methionine Aminopeptidase 2 Inhibitor M8891, Methionine Aminopeptidase 2 Inhibitor PPI-2458, Methotrexate, Methotrexate Sodium, Methotrexate-E Therapeutic Implant, Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles, Methoxsalen, Methoxyamine, Methoxyamine Hydrochloride, Methyl-5-Aminolevulinate Hydrochloride Cream, Methylcantharidimide, Methylmercaptopurine Riboside, Methylprednisolone, Methylprednisolone Acetate, Methylprednisolone Sodium Succinate, Methylselenocysteine, Methyltestosterone, Metoprine, Mevociclib, Mezagitamab, Mibefradil, Mibefradil Dihydrochloride, Micellar Nanoparticle-encapsulated Epirubicin, Micro Needle Array-Doxorubicin, Microbiome GEN-001, Microbiome-derived Peptide Vaccine EO2401, Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300, Microtubule Inhibitor SCB01A, Midostaurin, Mifamurtide, Mifepristone, Milademetan Tosylate, Milataxel, Milatuzumab, Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110, Milciclib Maleate, Milk Thistle, Miltefosine, Minretumomab, Mipsagargin, Miptenalimab, Mirabegron, Miransertib, Mirdametinib, Mirvetuximab Soravtansine, Mirzotamab Clezutoclax, Misonidazole, Mistletoe Extract, Mitazalimab, Mitindomide, Mitobronitol, Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101, Mitoclomine, Mitoflaxone, Mitoguazone, Mitoguazone Dihydrochloride, Mitolactol, Mitomycin, Mitomycin A, Mitomycin B, Mitomycin C Analog KW-2149, Mitosis Inhibitor T 1101 Tosylate, Mitotane, Mitotenamine, Mitoxantrone, Mitoxantrone Hydrochloride, Mitozolomide, Mivavotinib, Mivebresib, Mivobulin, Mivobulin Isethionate, Mixed Bacteria Vaccine, MK0731, MKC-1, MKNK1 Inhibitor BAY 1143269, MMP Inhibitor S-3304, MNK1/2 Inhibitor ETC-1907206, Mobocertinib, Mocetinostat, Modakafusp Alfa, Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208, Modified Vitamin D Binding Protein Macrophage Activator EF-022, Modotuximab, MOF Compound RiMO-301, Mofarotene, Mogamulizumab, Molibresib, Molibresib Besylate, Momelotinib, Monalizumab, Monocarboxylate Transporter 1 Inhibitor AZD3965, Monoclonal Antibody 105AD7 Anti-idiotype Vaccine, Monoclonal Antibody 11D10, Monoclonal Antibody 11D10 Anti-Idiotype Vaccine, Monoclonal Antibody 14G2A, Monoclonal Antibody 1F5, Monoclonal Antibody 3622W94, Monoclonal Antibody 3F8, Monoclonal Antibody 3H1 Anti-Idiotype Vaccine, Monoclonal Antibody 4B5 Anti-Idiotype Vaccine, Monoclonal Antibody 7C11, Monoclonal Antibody 81C6, Monoclonal Antibody A1G4 Anti-Idiotype Vaccine, Monoclonal Antibody A27.15, Monoclonal Antibody A33, Monoclonal Antibody AbGn-7, Monoclonal Antibody AK002, Monoclonal Antibody ASP1948, Monoclonal Antibody CAL, Monoclonal Antibody CC49-delta CH2, Monoclonal Antibody CEP-37250/KHK2804, Monoclonal Antibody D6.12, Monoclonal Antibody E2.3, Monoclonal Antibody F19, Monoclonal Antibody GD2 Anti-Idiotype Vaccine, Monoclonal Antibody HeFi-1, Monoclonal Antibody Hu3S193, Monoclonal Antibody HuAFP31, Monoclonal Antibody HuHMFG1, Monoclonal Antibody huJ591, Monoclonal Antibody HuPAM4, Monoclonal Antibody IMMU-14, Monoclonal Antibody L6, Monoclonal Antibody Lym-1, Monoclonal Antibody m170, Monoclonal Antibody Me1-14 F(ab')2, Monoclonal Antibody muJ591, Monoclonal Antibody MX35 F(ab')2, Monoclonal Antibody NEO-201, Monoclonal Antibody R24, Monoclonal Antibody RAV12, Monoclonal Antibody SGN-14, Monoclonal Antibody TRK-950, Monoclonal Microbial EDP1503, Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100, Monomethyl Auristatin E, Morinda Citrifolia Fruit Extract, Morpholinodoxorubicin, Mosedipimod, Mosunetuzumab, Motesanib, Motesanib Diphosphate, Motexafin Gadolinium, Motexafin Lutetium, Motixafortide, Motolimod, MOv-gamma Chimeric Receptor Gene, Moxetumomab Pasudotox, Mps1 Inhibitor BAY 1217389, Mps1 Inhibitor BOS172722, mRNA-based Personalized Cancer Vaccine mRNA-4157, mRNA-based Personalized Cancer Vaccine NCI-4650, mRNA-based TriMix Melanoma Vaccine ECI-006, mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902, mRNA-derived KRAS-targeted Vaccine V941, mRNA-derived Lung Cancer Vaccine BI 1361849, mRNA-Derived Prostate Cancer Vaccine CV9103, mRNA-derived Prostate Cancer Vaccine CV9104, MTF-1 Inhibitor APTO-253 HCl, mTOR Inhibitor GDC-0349, mTOR Kinase Inhibitor AZD8055, mTOR Kinase Inhibitor CC-223, mTOR Kinase Inhibitor OSI-027, mTOR Kinase Inhibitor PP242, mTOR1/2 Kinase Inhibitor ME-344, mTORC 1/2 Inhibitor LXI-15029, mTORC1/2 Kinase Inhibitor BI 860585, mTORC1/mTORC2/DHFR Inhibitor ABTL0812, MUC-1/WT1 Peptide-primed Autologous Dendritic Cells, MUC1-targeted Peptide GO-203-2C, Mucoadhesive Paclitaxel Formulation, Multi-AGC Kinase Inhibitor AT13148, Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200, Multi-epitope HER2 Peptide Vaccine H2NVAC, Multi-epitope HER2 Peptide Vaccine TPIV100, Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107, Multi-kinase Inhibitor TPX-0022, Multi-kinase Inhibitor XL092, Multi-mode Kinase Inhibitor EOC317, Multi-neo-epitope Vaccine OSE 2101, Multifunctional/Multitargeted Anticancer Agent OMN54, Multikinase Inhibitor 4SC-203, Multikinase Inhibitor AEE788, Multikinase Inhibitor AT9283, Multikinase Inhibitor SAR103168, Multipeptide Vaccine S-588210, Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327, Muparfostat, Mureletecan, Murizatoclax, Muscadine Grape Extract, Mutant IDH1 Inhibitor DS-1001, Mutant p53 Activator COTI-2, Mutant-selective EGFR Inhibitor PF-06459988, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, MVA-BN Smallpox Vaccine, MVA-FCU1 TG4023, MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1, MYC-targeting siRNA DCR-MYC, Mycobacterium tuberculosis Arabinomannan Z-100, Mycobacterium w, Mycophenolic Acid, N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea, N-dihydrogalactochitosan, N-Methylformamide, N;N-Dibenzyl Daunomycin, NA17-A Antigen, NA17.A2 Peptide Vaccine, Nab-paclitaxel, Nab-paclitaxel/Rituximab-coated Nanoparticle AR160, Nadofaragene Firadenovec, Nagrestipen, Namirotene, Namodenoson, NAMPT Inhibitor OT-82, Nanafrocin, Nanatinostat, Nanocell-encapsulated miR-16-based microRNA Mimic, Nanoparticle Albumin-Bound Docetaxel, Nanoparticle Albumin-Bound Rapamycin, Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404, Nanoparticle Paclitaxel Ointment SOR007, Nanoparticle-based Paclitaxel Suspension, Nanoparticle-encapsulated Doxorubicin Hydrochloride, Nanoscale Coordination Polymer Nanoparticles CPI-100, Nanosomal Docetaxel Lipid Suspension, Napabucasin, Naphthalimide Analogue UNBS5162, Naptumomab Estafenatox, Naquotinib, Naratuximab Emtansine, Narnatumab, Natalizumab, Natural IFN-alpha OPC-18, Natural Killer Cells ZRx101, Navarixin, Navicixizumab, Navitoclax, Navoximod, Navy Bean Powder, Naxitamab, Nazartinib, ncmtRNA Oligonucleotide Andes-1537, Necitumumab, Nedaplatin, NEDD8 Activating Enzyme E1 Inhibitor TAS4464, Nedisertib, Nelarabine, Nelipepimut-S, Nelipepimut-S Plus GM-CSF Vaccine, Nemorubicin, Nemorubicin Hydrochloride, Neoantigen Vaccine GEN-009, Neoantigen-based Glioblastoma Vaccine, Neoantigen-based Melanoma-Poly-ICLC Vaccine, Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine, Neoantigen-based Therapeutic Cancer Vaccine GRT-C903, Neoantigen-based Therapeutic Cancer Vaccine GRT-R904, Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017, Neratinib, Neratinib Maleate, Nesvacumab, NG-nitro-L-arginine, Niacinamide, Niclosamide, Nicotinamide Riboside, Nidanilimab, Nifurtimox, Nilotinib, Nilotinib Hydrochloride Anhydrous, Nilotinib Hydrochloride Monohydrate, Nilutamide, Nimesulide-Hyaluronic Acid Conjugate CA102N, Nimodipine, Nimotuzumab, Nimustine, Nimustine Hydrochloride, Ningetinib Tosylate, Nintedanib, Niraparib, Niraparib Tosylate Monohydrate, Nirogacestat, Nitric Oxide-Releasing Acetylsalicylic Acid Derivative, Nitrogen Mustard Prodrug PR-104, Nitroglycerin Transdermal Patch, Nivolumab, NLRP3 Agonist BMS-986299, Nocodazole, Nogalamycin, Nogapendekin Alfa, Nolatrexed Dihydrochloride, Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201, Norgestrel, North American Ginseng Extract AFX-2, Nortopixantrone, Noscapine, Noscapine Hydrochloride, Not Otherwise Specified, Notch Signaling Inhibitor PF-06650808, Notch Signaling Pathway Inhibitor MK0752, NTRK/ROS1 Inhibitor DS-6051b, Nucleolin Antagonist IPP-204106N, Nucleoside Analog DFP-10917, Nucleotide Analog Prodrug NUC-3373, Nucleotide Analogue GS 9219, Numidargistat, Nurulimab, Nutlin-3a, Nutraceutical TBL-12, NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611, NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301, NY-ESO-1/GLA-SE Vaccine ID-G305, NY-ESO-B, O-Chloroacetylcarbamoylfumagillol, O6-Benzylguanine, Obatoclax Mesylate, Obinutuzumab, Oblimersen Sodium, Ocaratuzumab, Ocrelizumab, Octreotide, Octreotide Acetate, Octreotide Pamoate, Odronextamab, Ofatumumab, Ofranergene Obadenovec, Oglufanide Disodium, Olaparib, Olaptesed Pegol, Olaratumab, Oleandrin, Oleclumab, Oligo-fucoidan, Oligonucleotide SPC2996, Olinvacimab, Olivomycin, Olmutinib, Oltipraz, Olutasidenib, Olvimulogene Nanivacirepvec, Omacetaxine Mepesuccinate, Ombrabulin, Omipalisib, Onalespib, Onalespib Lactate, Onartuzumab, Onatasertib, Oncolytic Adenovirus Ad5-DNX-2401, Oncolytic Adenovirus ORCA-010, Oncolytic Herpes Simplex Virus-1 ONCR-177, Oncolytic HSV-1 C134, Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011, Oncolytic HSV-1 G207, Oncolytic HSV-1 NV1020, Oncolytic HSV-1 rQNestin34.5v.2, Oncolytic HSV-1 rRp450, Oncolytic HSV1716, Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein, Oncolytic Newcastle Disease Virus MEDI5395, Oncolytic Newcastle Disease Virus MTH-68H, Oncolytic Newcastle Disease Virus Strain PV701, Oncolytic Virus ASP9801, Oncolytic Virus RP1, Ondansetron Hydrochloride, Ontorpacept, Ontuxizumab, Onvansertib, Onvatilimab, Opaganib, OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule, Opioid Growth Factor, Opolimogene Capmilisbac, Oportuzumab Monatox, Oprozomib, Opucolimab, Oral Aminolevulinic Acid Hydrochloride, Oral Azacitidine, Oral Cancer Vaccine V3-OVA, Oral Docetaxel, Oral Fludarabine Phosphate, Oral Hsp90 Inhibitor IPI-493, Oral Ixabepilone, Oral Microencapsulated Diindolylmethane, Oral Milataxel, Oral Myoma Vaccine V3-myoma, Oral Pancreatic Cancer Vaccine V3-P, Oral Picoplatin, Oral Sodium Phenylbutyrate, Oral Topotecan Hydrochloride, Orantinib, Oraxol, Oregovomab, Orelabrutinib, Ormaplatin, Ortataxel, Orteronel, Orvacabtagene Autoleucel, Osilodrostat, Osimertinib, Other, Otlertuzumab, Ovapuldencel-T, Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006, Ovine Submaxillary Mucin, OX40L-expressing Oncolytic Adenovirus DNX-2440, Oxaliplatin, Oxaliplatin Eluting Beads, Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome, Oxcarbazepine, Oxeclosporin, Oxidative Phosphorylation Inhibitor IACS-010759, Oxidative Phosphorylation Inhibitor IM156, Oxidopamine, OxPhos Inhibitor VLX600, Ozarelix, P-cadherin Antagonist PF-03732010, P-cadherin Inhibitor PCA062, P-cadherin-targeting Agent PF-06671008, P-p68 Inhibitor RX-5902, P-TEFb Inhibitor BAY1143572, p300/CBP Bromodomain Inhibitor CCS1477, p38 MAPK Inhibitor LY3007113, p53 Peptide Vaccine MPS-128, p53-HDM2 Interaction Inhibitor MI-773, p53-HDM2 Protein-protein Interaction Inhibitor APG-115, p53/HDM2 Interaction Inhibitor CGM097, p70S6K Inhibitor LY2584702, p70S6K/Akt Inhibitor MSC2363318A, p97 Inhibitor CB-5083, p97 Inhibitor CB-5339, p97 Inhibitor CB-5339 Tosylate, Paclitaxel, Paclitaxel Ceribate, Paclitaxel Injection Concentrate for Nanodispersion, Paclitaxel Liposome, Paclitaxel Poliglumex, Paclitaxel Polymeric Micelle Formulation NANT-008, Paclitaxel PPE Microspheres, Paclitaxel Trevatide, Paclitaxel Vitamin E-Based Emulsion, Paclitaxel-Loaded Polymeric Micelle, Pacmilimab, Pacritinib, Padeliporfin, Padoporfin, PAK4 Inhibitor PF-03758309, PAK4/NAMPT Inhibitor KPT-9274, Palbociclib, Palbociclib Isethionate, Palifosfamide, Palifosfamide Tromethamine, Palladium Pd-103, Palonosetron Hydrochloride, Pamidronate Disodium, Pamidronic Acid, Pamiparib, Pamrevlumab, pan FGFR Inhibitor PRN1371, Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514, Pan-AKT Inhibitor ARQ751, Pan-AKT Kinase Inhibitor GSK690693, Pan-FGFR Inhibitor LY2874455, Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806, pan-HER Kinase Inhibitor AC480, Pan-IDH Mutant Inhibitor AG-881, Pan-KRAS Inhibitor BI 1701963, Pan-Mutant-IDH1 Inhibitor Bay-1436032, Pan-mutation-selective EGFR Inhibitor CLN-081, pan-PI3K Inhibitor CLR457, pan-PI3K/mTOR Inhibitor SF1126, Pan-PIM Inhibitor INCB053914, pan-PIM Kinase Inhibitor AZD1208, pan-PIM Kinase Inhibitor NVP-LGB-321, pan-RAF Inhibitor LXH254, Pan-RAF Inhibitor LY3009120, pan-RAF Kinase Inhibitor CCT3833, pan-RAF Kinase Inhibitor TAK-580, Pan-RAR Agonist/AP-1 Inhibitor LGD 1550, Pan-TRK Inhibitor NOV1601, Pan-TRK Inhibitor ONO-7579, Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981, Pancratistatin, Panitumumab, Panobinostat, Panobinostat Nanoparticle Formulation MTX110, Panulisib, Paricalcitol, PARP 1/2 Inhibitor IMP4297, PARP 1/2 Inhibitor NOV1401, PARP Inhibitor AZD2461, PARP Inhibitor CEP-9722, PARP Inhibitor E7016, PARP Inhibitor NMS-03305293, PARP-1/2 Inhibitor ABT-767, PARP/Tankyrase Inhibitor 2X-121, PARP7 Inhibitor RBN-2397, Parsaclisib, Parsaclisib Hydrochloride, Parsatuzumab, Partially Engineered T-regulatory Cell Donor Graft TRGFT-201, Parvovirus H-1, Pasireotide, Pasotuxizumab, Patidegib, Patidegib Topical Gel, Patritumab, Patritumab Deruxtecan, Patupilone, Paxalisib, Pazopanib, Pazopanib Hydrochloride, pbi-shRNA STMN1 Lipoplex, PBN Derivative OKN-007, PCNU, PD-1 Directed Probody CX-188, PD-1 Inhibitor, PD-L1 Inhibitor GS-4224, PD-L1 Inhibitor INCB086550, PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480, PD-L1/PD-L2/VISTA Antagonist CA-170, PDK1 Inhibitor AR-12, pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0, PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1, PEG-interleukin-2, PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1, PEG-Proline-Interferon Alfa-2b, Pegargiminase, Pegaspargase, Pegdinetanib, Pegfilgrastim, Pegilodecakin, Peginterferon Alfa-2a, Peginterferon Alfa-2b, Pegvisomant, Pegvorhyaluronidase Alfa, Pegylated Deoxycytidine Analogue DFP-14927, Pegylated Interferon Alfa, Pegylated Liposomal Belotecan, Pegylated Liposomal Doxorubicin Hydrochloride, Pegylated Liposomal Irinotecan, Pegylated Liposomal Mitomycin C Lipid-based Prodrug, Pegylated Liposomal Mitoxantrone Hydrochloride, Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010, Pegylated Paclitaxel, Pegylated Recombinant Human Arginase I BCT-100, Pegylated Recombinant Human Hyaluronidase PH20, Pegylated Recombinant Interleukin-2 THOR-707, Pegylated Recombinant L-asparaginase Erwinia chrysanthemi, Pegylated SN-38 Conjugate PLX038, Pegzilarginase, Pelabresib, Pelareorep, Peldesine, Pelitinib, Pelitrexol, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Pemigatinib, Pemlimogene Merolisbac, Penberol, Penclomedine, Penicillamine, Pentamethylmelamine, Pentamustine, Pentostatin, Pentoxifylline, PEOX-based Polymer Encapsulated Paclitaxel FID-007, PEP-3-KLH Conjugate Vaccine, Pepinemab, Peplomycin, Peplomycin Sulfate, Peposertib, Peptichemio, Peptide 946 Melanoma Vaccine, Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine, Peretinoin, Perflenapent Emulsion, Perfosfamide, Perifosine, Perillyl Alcohol, Personalized ALL-specific Multi-HLA-binding Peptide Vaccine, Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC, Personalized Cancer Vaccine RO7198457, Personalized Neoantigen DNA Vaccine GNOS-PV01, Personalized Neoantigen DNA Vaccine GNOS-PVO2, Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01, Personalized Neoepitope Yeast Vaccine YE-NEO-001, Personalized Peptide Cancer Vaccine NEO-PV-01, Pertuzumab, Pevonedistat, Pexastimogene Devacirepvec, Pexidartinib, Pexmetinib, PGG Beta-Glucan, PGLA/PEG Copolymer-Based Paclitaxel, PH20 Hyaluronidase-expressing Adenovirus VCN-01, Phaleria macrocarpa Extract DLBS-1425, Pharmacological Ascorbate, Phellodendron amurense Bark Extract, Phenesterin, Phenethyl Isothiocyanate, Phenethyl Isothiocyanate-containing Watercress Juice, Phenyl Acetate, Phenytoin Sodium, Phosphaplatin PT-112, Phosphatidylcholine-Bound Silybin, Phospholipid Ether-drug Conjugate CLR 131, Phosphoramide Mustard, Phosphorodiamidate Morpholino Oligomer AVI-4126, Phosphorus P-32, Photodynamic Compound TLD-1433, Photosensitizer LUZ 11, Phytochlorin Sodium-Polyvinylpyrrolidone Complex, PI3K Alpha/Beta Inhibitor BAY1082439, PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate, PI3K Inhibitor ACP-319, PI3K Inhibitor BGT226, PI3K Inhibitor GDC-0084, PI3K Inhibitor GDC0077, PI3K Inhibitor GSK1059615, PI3K Inhibitor WX-037, PI3K Inhibitor ZSTK474, PI3K p110beta/delta Inhibitor KA2237, PI3K-alpha Inhibitor MEN1611, PI3K-beta Inhibitor GSK2636771, PI3K-beta Inhibitor SAR260301, PI3K-delta Inhibitor AMG 319, PI3K-delta Inhibitor HMPL 689, PI3K-delta Inhibitor INCB050465, PI3K-delta Inhibitor PWT143, PI3K-delta Inhibitor SHC014748M, PI3K-delta Inhibitor YY-20394, PI3K-gamma Inhibitor IPI-549, PI3K/BET Inhibitor LY294002, PI3K/mTOR Kinase Inhibitor DS-7423, PI3K/mTOR Kinase Inhibitor PF-04691502, PI3K/mTOR Kinase Inhibitor VS-5584, PI3K/mTOR Kinase Inhibitor WXFL10030390, PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170, PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901, PI3Ka/mTOR Inhibitor PKI-179, PI3Kalpha Inhibitor AZD8835, PI3Kbeta Inhibitor AZD8186, PI3Kdelta Inhibitor GS-9901, Pibenzimol, Pibrozelesin, Pibrozelesin Hydrobromide, Picibanil, Picoplatin, Picrasinoside H, Picropodophyllin, Pictilisib, Pictilisib Bismesylate, Pidilizumab, Pilaralisib, PIM Kinase Inhibitor LGH447, PIM Kinase Inhibitor SGI-1776, PIM Kinase Inhibitor TP-3654, PIM/FLT3 Kinase Inhibitor SEL24, Pimasertib, Pimitespib, Pimurutamab, Pinatuzumab Vedotin, Pingyangmycin, Pinometostat, Pioglitazone, Pioglitazone Hydrochloride, Pipendoxifene, Piperazinedione, Piperine Extract (Standardized), Pipobroman, Piposulfan, Pirarubicin, Pirarubicin Hydrochloride, Pirfenidone, Piritrexim, Piritrexim Isethionate, Pirotinib, Piroxantrone, Piroxantrone Hydrochloride, Pixantrone, Pixantrone Dimaleate, Pixatimod, PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231, PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521, PKC-beta Inhibitor MS-553, Placebo, Pladienolide Derivative E7107, Plamotamab, Plasmid DNA Vaccine pING-hHER3FL, Platinum, Platinum Acetylacetonate-Titanium Dioxide Nanoparticles, Platinum Compound, Plevitrexed, Plicamycin, Plinabulin, Plitidepsin, Plk1 Inhibitor BI 2536, PLK1 Inhibitor CYC140, PLK1 Inhibitor TAK-960, Plocabulin, Plozalizumab, pNGVL4a-CRT-E6E7L2 DNA Vaccine, pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2, Pol I Inhibitor CX5461, Polatuzumab Vedotin, Polidocanol, Poliglusam, Polo-like Kinase 1 Inhibitor GSK461364, Polo-like Kinase 1 Inhibitor MK1496, Polo-like Kinase 1 Inhibitor NMS-1286937, Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate, Poly-alendronate Dextran-Guanidine Conjugate, Poly-gamma Glutamic Acid, Polyamine Analog SL11093, Polyamine Analogue PG11047, Polyamine Analogue SBP-101, Polyamine Transport Inhibitor AMXT-1501 Dicaprate, Polyandrol, Polyethylene Glycol Recombinant Endostatin, Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318, Polymer-conjugated IL-15 Receptor Agonist NKTR-255, Polymer-encapsulated Luteolin Nanoparticle, Polymeric Camptothecin Prodrug XMT-1001, Polypodium leucotomos Extract, Polysaccharide-K, Polysialic Acid, Polyunsaturated Fatty Acid, Polyvalent Melanoma Vaccine, Pomalidomide, Pomegranate Juice, Pomegranate Liquid Extract, Ponatinib, Ponatinib Hydrochloride, Porcupine Inhibitor CGX1321, Porcupine Inhibitor ETC-1922159, Porcupine Inhibitor RXC004, Porcupine Inhibitor WNT974, Porcupine Inhibitor XNW7201, Porfimer Sodium, Porfiromycin, Poziotinib, PPAR Alpha Antagonist TPST-1120, PR1 Leukemia Peptide Vaccine, Pracinostat, Pralatrexate, Pralsetinib, Praluzatamab Ravtansine, PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701, Pravastatin Sodium, Prednimustine, Prednisolone, Prednisolone Acetate, Prednisolone Sodium Phosphate, Prednisone, Prexasertib, Prexigebersen, PRIMA-1 Analog APR-246, Prime Cancer Vaccine MVA-BN-CV301, Prinomastat, PRMT1 Inhibitor GSK3368715, PRMT5 Inhibitor JNJ-64619178, PRMT5 Inhibitor PRT811, Proapoptotic Sulindac Analog CP-461, Procarbazine, Procarbazine Hydrochloride, Procaspase Activating Compound-1 VO-100, Progestational IUD, Prohibitin-Targeting Peptide 1, Prolgolimab, Prostaglandin E2 EP4 Receptor Inhibitor AN0025, Prostaglandin E2 EP4 Receptor Inhibitor E7046, Prostate Cancer Vaccine ONY-P1, Prostate Health Cocktail Dietary Supplement, Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024, Protease-activated Anti-PD-L1 Antibody Prodrug CX-072, Protein Arginine Methyltransferase 5 Inhibitor GSK3326595, Protein Arginine Methyltransferase 5 Inhibitor PF-06939999, Protein Arginine Methyltransferase 5 Inhibitor PRT543, Protein Kinase C Inhibitor IDE196, Protein Phosphatase 2A Inhibitor LB-100, Protein Stabilized Liposomal Docetaxel Nanoparticles, Protein Tyrosine Kinase 2 Inhibitor IN10018, Proxalutamide, PSA/IL-2/GM-CSF Vaccine, PSA/PSMA DNA Plasmid INO-5150, Pseudoisocytidine, PSMA-targeted Docetaxel Nanoparticles BIND-014, PSMA-targeted Tubulysin B-containing Conjugate EC1169, PSMA/CD3 Tri-specific T-cell Activating Construct HPN424, PTEF-b/CDK9 Inhibitor BAY1251152, Pterostilbene, Pumitepa, Puquitinib, Puquitinib Mesylate, Puromycin, Puromycin Hydrochloride, PV-10, PVA Microporous Hydrospheres/Doxorubicin Hydrochloride, Pyrazinamide, Pyrazoloacridine, Pyridyl Cyanoguanidine CHS 828, Pyrotinib, Pyrotinib Dimaleate, Pyroxamide, Pyruvate Kinase Inhibitor TLN-232, Pyruvate Kinase M2 Isoform Activator TP-1454, Qilisheng Immunoregulatory Oral Solution, Quadrivalent Human Papillomavirus (types 6; 11; 16; 18) Recombinant Vaccine, Quarfloxin, Quinacrine Hydrochloride, Quinine, Quisinostat, Quizartinib, R-(-)-Gossypol Acetic Acid, Rabusertib, Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88, Racotumomab, RAD51 Inhibitor CYT-0851, Radgocitabine, Radgocitabine Hydrochloride, Radioactive Iodine, Radiolabeled CC49, Radium Ra 223 Dichloride, Radium Ra 224-labeled Calcium Carbonate Microparticles, Radix Angelicae Sinensis/Radix Astragali Herbal Supplement, Radotinib Hydrochloride, Raf Kinase Inhibitor HM95573, RAF Kinase Inhibitor L-779450, RAF Kinase Inhibitor XL281, Ragifilimab, Ralaniten Acetate, Ralimetinib Mesylate, Raloxifene, Raloxifene Hydrochloride, Raltitrexed, Ramucirumab, Ranibizumab, Ranimustine, Ranolazine, Ranpirnase, RARalpha Agonist IRX5183, Ras Inhibitor, Ras Peptide ASP, Ras Peptide CYS, Ras Peptide VAL, Razoxane, Realgar-Indigo naturalis Formulation, Rebastinib Tosylate, Rebeccamycin, Rebimastat, Receptor Tyrosine Kinase Inhibitor R1530, Recombinant Adenovirus-p53 SCH-58500, Recombinant Anti-WT1 Immunotherapeutic GSK2302024A, Recombinant Bacterial Minicells VAX014, Recombinant Bispecific Single-Chain Antibody rM28, Recombinant CD40-Ligand, Recombinant Erwinia asparaginase JZP-458, Recombinant Erythropoietin, Recombinant Fas Ligand, Recombinant Fractalkine, Recombinant Granulocyte-Macrophage Colony-Stimulating Factor, Recombinant Human 6Ckine, Recombinant Human Adenovirus Type 5 H101, Recombinant Human Angiotensin Converting Enzyme 2 APN01, Recombinant Human Apolipoprotein(a) Kringle V MG1102, Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine, Recombinant Human Endostatin, Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine, Recombinant Human Papillomavirus 11-valent Vaccine, Recombinant Human Papillomavirus Bivalent Vaccine, Recombinant Human Papillomavirus Nonavalent Vaccine, Recombinant Human Plasminogen Kringle 5 Domain ABT 828, Recombinant Human TRAIL-Trimer Fusion Protein SCB-313, Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301, Recombinant Interferon, Recombinant Interferon Alfa, Recombinant Interferon Alfa-1b, Recombinant Interferon Alfa-2a, Recombinant Interferon Alfa-2b, Recombinant Interferon Alpha 2b-like Protein, Recombinant Interferon Beta, Recombinant Interferon Gamma, Recombinant Interleukin-12, Recombinant Interleukin-13, Recombinant Interleukin-18, Recombinant Interleukin-2, Recombinant Interleukin-6, Recombinant KSA Glycoprotein CO17-1A, Recombinant Leukocyte Interleukin, Recombinant Leukoregulin, Recombinant Luteinizing Hormone, Recombinant Macrophage Colony-Stimulating Factor, Recombinant MAGE-3.1 Antigen, Recombinant MIP1-alpha Variant ECI301, Recombinant Modified Vaccinia Ankara-5T4 Vaccine, Recombinant Oncolytic Poliovirus PVS-RIPO, Recombinant Platelet Factor 4, Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A, Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207, Recombinant Super-compound Interferon, Recombinant Thyroglobulin, Recombinant Thyrotropin Alfa, Recombinant Transforming Growth Factor-Beta, Recombinant Transforming Growth Factor-Beta-2, Recombinant Tumor Necrosis Factor-Alpha, Recombinant Tyrosinase-Related Protein-2, Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter, Redaporfin, Refametinib, Regorafenib, Relacorilant, Relatlimab, Relugolix, Remetinostat, Renal Cell Carcinoma Peptides Vaccine IMA901, Reparixin, Repotrectinib, Resiquimod, Resiquimod Topical Gel, Resistant Starch, Resminostat, Resveratrol, Resveratrol Formulation SRT501, RET Inhibitor DS-5010, RET Mutation/Fusion Inhibitor BLU-667, RET/SRC Inhibitor TPX-0046, Retaspimycin, Retaspimycin Hydrochloride, Retelliptine, Retifanlimab, Retinoic Acid Agent Ro 16-9100, Retinoid 9cUAB30, Retinol, Retinyl Acetate, Retinyl Palmitate, Retrovector Encoding Mutant Anti-Cyclin G1, Revdofilimab, Rexinoid NRX 194204, Rezivertinib, RFT5-dgA Immunotoxin IMTOX25, Rhenium Re 188 BMEDA-labeled Liposomes, Rhenium Re-186 Hydroxyethylidene Diphosphonate, Rhenium Re-188 Ethiodized Oil, Rhenium Re-188 Etidronate, Rhizoxin, RhoC Peptide Vaccine RV001V, Ribociclib, Ribociclib/Letrozole, Ribonuclease QBI-139, Ribosome-Inactivating Protein CY503, Ribozyme RPI.4610, Rice Bran, Ricolinostat, Ridaforolimus, Rigosertib, Rigosertib Sodium, Rilimogene Galvacirepvec, Rilimogene Galvacirepvec/Rilimogene Glafolivec, Rilimogene Glafolivec, Rilotumumab, Rindopepimut, Ripertamab, RIPK1 Inhibitor GSK3145095, Ripretinib, Risperidone Formulation in Rumenic Acid, Ritrosulfan, Rituximab, Rituximab and Hyaluronidase Human, Rituximab Conjugate CON-4619, Riviciclib, Rivoceranib, Rivoceranib Mesylate, RNR Inhibitor COH29, Robatumumab, Roblitinib, ROBO1-targeted BiCAR-NKT Cells, Rocakinogene Sifuplasmid, Rocapuldencel-T, Rociletinib, Rodorubicin, Roducitabine, Rofecoxib, Roflumilast, Rogaratinib, Rogletimide, Rolinsatamab Talirine, Romidepsin, Roneparstat, Roniciclib, Ropeginterferon Alfa-2B, Ropidoxuridine, Ropocamptide, Roquinimex, RORgamma Agonist LYC-55716, Rosabulin, Rose Bengal Solution PV-10, Rosiglitazone Maleate, Rosmantuzumab, Rosopatamab, Rosuvastatin, Rovalpituzumab Tesirine, RSK1-4 Inhibitor PMD-026, Rubitecan, Rucaparib, Rucaparib Camsylate, Rucaparib Phosphate, Ruthenium Ru-106, Ruthenium-based Small Molecule Therapeutic BOLD-100, Ruthenium-based Transferrin Targeting Agent NKP-1339, Ruxolitinib, Ruxolitinib Phosphate, Ruxotemitide, S-Adenosylmethionine, S-equol, S1P Receptor Agonist KRP203, Sabarubicin, Sabatolimab, Sacituzumab Govitecan, Sacubitril/Valsartan, Safingol, Sagopilone, Salirasib, Salmonella VNP20009, Sam68 Modulator CWP232291, Samalizumab, Samarium Sm 153-DOTMP, Samotolisib, Samrotamab Vedotin, Samuraciclib, Sapacitabine, Sapanisertib, Sapitinib, Saracatinib, Saracatinib Difumarate, SarCNU, Sardomozide, Sargramostim, Sasanlimab, Satraplatin, Savolitinib, SBIL-2, Scopoletin, SDF-1 Receptor Antagonist PTX-9908, Seclidemstat, Sedoxantrone Trihydrochloride, Selatinib Ditosilate, Selective Androgen Receptor Modulator RAD140, Selective Cytokine Inhibitory Drug CC-1088, Selective Estrogen Receptor Degrader AZD9496, Selective Estrogen Receptor Degrader AZD9833, Selective Estrogen Receptor Degrader LSZ102, Selective Estrogen Receptor Degrader LX-039, Selective Estrogen Receptor Degrader LY3484356, Selective Estrogen Receptor Degrader SRN-927, Selective Estrogen Receptor Modulator CC-8490, Selective Estrogen Receptor Modulator TAS-108, Selective Glucocorticoid Receptor Antagonist CORT125281, Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352, Seliciclib, Selicrelumab, Selinexor, Selitrectinib, Selonsertib, Selpercatinib, Selumetinib, Selumetinib Sulfate, Semaxanib, Semuloparin, Semustine, Seneca Valley Virus-001, Seocalcitol, Sepantronium Bromide, Serabelisib, Serclutamab Talirine, SERD D-0502, SERD G1T48, SERD GDC-9545, SERD SAR439859, SERD SHR9549, SERD ZN-c5, Serdemetan, Sergiolide, Seribantumab, Serine/Threonine Kinase Inhibitor CBP501, Serine/Threonine Kinase Inhibitor XL418, Serplulimab, Sevacizumab, Seviteronel, Shared Anti-Idiotype-AB-S006, Shared Anti-Idiotype-AB-S024A, Shark Cartilage, Shark Cartilage Extract AE-941, Shenqi Fuzheng Injection SQ001, Sho-Saiko-To, Short Chain Fatty Acid HQK-1004, SHP-1 Agonist SC-43, SHP2 Inhibitor JAB-3068, SHP2 Inhibitor RLY-1971, SHP2 Inhibitor RMC-4630, SHP2 Inhibitor TNO155, Shu Yu Wan Formula, Sialyl Tn Antigen, Sialyl Tn-KLH Vaccine, Sibrotuzumab, siG12D LODER, Silatecan AR-67, Silibinin, Silicon Phthalocyanine 4, Silmitasertib Sodium, Siltuximab, Simalikalactone D, Simeprevir, Simlukafusp Alfa, Simmitinib, Simotaxel, Simtuzumab, Simurosertib, Sintilimab, Siplizumab, Sipuleucel-T, Siremadlin, siRNA-transfected Peripheral Blood Mononuclear Cells APN401, Sirolimus, SIRPa-4-1BBL Fusion Protein DSP107, SIRPa-Fc Fusion Protein TTI-621, SIRPa-Fc-CD40L Fusion Protein SL-172154, SIRPa-IgG4-Fc Fusion Protein TTI-622, Sitimagene Ceradenovec, Sitravatinib, Sivifene, Sizofiran, SLC6A8 Inhibitor RGX-202, SLCT Inhibitor GNS561, SMAC Mimetic BI 891065, Smac Mimetic GDC-0152, Smac Mimetic GDC-0917, Smac Mimetic LCL161, SMO Protein Inhibitor ZSP1602, Smoothened Antagonist BMS-833923, Smoothened Antagonist LDE225 Topical, Smoothened Antagonist LEQ506, Smoothened Antagonist TAK-441, SN-38-Loaded Polymeric Micelles NK012, SNS01-T Nanoparticles, Sobuzoxane, Sodium Borocaptate, Sodium Butyrate, Sodium Dichloroacetate, Sodium Iodide I-131, Sodium Metaarsenite, Sodium Phenylbutyrate, Sodium Salicylate, Sodium Selenite, Sodium Stibogluconate, Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108, Sofituzumab Vedotin, Solitomab, Sonepcizumab, Sonidegib, Sonolisib, Sorafenib, Sorafenib Tosylate, Sorghum bicolor Supplement, Sotigalimab, Sotorasib, Sotrastaurin, Sotrastaurin Acetate, Soy Isoflavones, Soy Protein Isolate, Spanlecortemlocel, Sparfosate Sodium, Sparfosic Acid, Spartalizumab, Spebrutinib, Spherical Nucleic Acid Nanoparticle NU-0129, Spirogermanium, Spiromustine, Spiroplatin, Splicing Inhibitor H3B-8800, Spongistatin, Squalamine Lactate, SR-BP1/HSI Inhibitor SR31747A, SR-T100 Gel, Src Kinase Inhibitor AP 23846, Src Kinase Inhibitor KX2-391, Src Kinase Inhibitor KX2-391 Ointment, Src Kinase Inhibitor M475271, Src/Abl Kinase Inhibitor AZD0424, Src/tubulin Inhibitor KX02, SRPK1/ABCG2 Inhibitor SCO-101, ssRNA-based Immunomodulator CV8102, SSTR2-targeting Protein/DM1 Conjugate PEN-221, St. John's Wort, Stallimycin, Staphylococcal Enterotoxin A, Staphylococcal Enterotoxin B, STAT Inhibitor OPB-111077, STAT3 Inhibitor DSP-0337, STAT3 Inhibitor OPB-31121, STAT3 Inhibitor OPB-51602, STAT3 Inhibitor TTI-101, STAT3 Inhibitor WP1066, Staurosporine, STING Agonist BMS-986301, STING Agonist GSK3745417, STING Agonist IMSA101, STING Agonist MK-1454, STING Agonist SB 11285, STING Agonist TAK-676, STING-activating Cyclic Dinucleotide Agonist MIW815, STING-expressing E. coli SYNB1891, Streptonigrin, Streptozocin, Strontium Chloride Sr-89, Submicron Particle Paclitaxel Sterile Suspension, Sugemalimab, Sulfatinib, Sulforaphane, Sulindac, Sulofenur, Sumoylation Inhibitor TAK-981, Sunitinib, Sunitinib Malate, Super Enhancer Inhibitor GZ17-6.02, Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803, Superoxide Dismutase Mimetic GC4711, Suramin, Suramin Sodium, Survivin Antigen, Survivin Antigen Vaccine DPX-Survivac, Survivin mRNA Antagonist EZN-3042, Survivin-expressing CVD908ssb-TXSVN Vaccine, Sustained-release Lipid Inhaled Cisplatin, Sustained-release Mitomycin C Hydrogel Formulation UGN-101, Sustained-release Mitomycin C Hydrogel Formulation UGN-102, Syk Inhibitor HMPL-523, Synchrotope TA2M Plasmid DNA Vaccine, Synchrovax SEM Plasmid DNA Vaccine, Synthetic Alkaloid PM00104, Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2, Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1, Synthetic hTERT DNA Vaccine INO-1400, Synthetic hTERT DNA Vaccine INO-1401, Synthetic Hypericin, Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201, Synthetic Long E6/E7 Peptides Vaccine HPV-01, Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b, Synthetic Plumbagin PCUR-101, T900607, Tabalumab, Tabelecleucel, Tacedinaline, Tafasitamab, Tagraxofusp-erzs, Talabostat, Talabostat Mesylate, Talacotuzumab, Talactoferrin Alfa, Taladegib, Talampanel, Talaporfin Sodium, Talazoparib, Taletrectinib, Talimogene Laherparepvec, Tallimustine, Talmapimod, Talotrexin, Talotrexin Ammonium, Taltobulin, TAM/c-Met Inhibitor RXDX-106, Tamibarotene, Taminadenant, Tamoxifen, Tamoxifen Citrate, Tamrintamab Pamozirine, Tandutinib, Tanespimycin, Tanibirumab, Tankyrase Inhibitor STP1002, Tanomastat, Tapotoclax, Tarenflurbil, Tarextumab, Tariquidar, Tasadenoturev, Taselisib, Tasidotin, Tasisulam, Tasisulam Sodium, Tasquinimod, Taurolidine, Tauromustine, Taurultam, Taurultam Analogue GP-2250, Tavokinogene Telseplasmid, Tavolimab, Taxane Analogue TPI 287, Taxane Compound, Taxol Analogue SID 530, Tazarotene, Tazemetostat, Tebentafusp, Teclistamab, Tecogalan Sodium, Tefinostat, Tegafur, Tegafur-gimeracil-oteracil Potassium, Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation, Tegafur-Uracil, Tegavivint, Teglarinad, Teglarinad Chloride, Telaglenastat, Telaglenastat Hydrochloride, Telapristone, Telapristone Acetate, Telatinib Mesylate, Telisotuzumab, Telisotuzumab Vedotin, Telomerase Inhibitor FJ5002, Telomerase-specific Type 5 Adenovirus OBP-301, Teloxantrone, Teloxantrone Hydrochloride, Telratolimod, Temarotene, Temoporfin, Temozolomide, Temsirolimus, Tenalisib, Tenifatecan, Teniposide, Tepoditamab, Tepotinib, Teprotumumab, Terameprocol, Terfluranol, Tergenpumatucel-L, Teroxirone, Tertomotide, Tesetaxel, Tesevatinib, Tesidolumab, Testolactone, Testosterone Enanthate, Tetanus Toxoid Vaccine, Tetradecanoylphorbol Acetate, Tetrahydrouridine, Tetraphenyl Chlorin Disulfonate, Tetrathiomolybdate, Tezacitabine, Tezacitabine Anhydrous, TGF-beta Receptor 1 Inhibitor PF-06952229, TGF-beta Receptor 1 Kinase Inhibitor SH3051, TGF-beta Receptor 1 Kinase Inhibitor YL-13027, TGFa-PE38 Immunotoxin, TGFbeta Inhibitor LY3200882, TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200, Thalicarpine, Thalidomide, Theliatinib, Theramide, Therapeutic Angiotensin-(1-7), Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907, Therapeutic Cancer Vaccine ATP128, Therapeutic Estradiol, Therapeutic Hydrocortisone, Therapeutic Liver Cancer Peptide Vaccine IMA970A, Thiarabine, Thiodiglycol, Thioguanine, Thioguanine Anhydrous, Thioinosine, Thioredoxin-1 Inhibitor PX-12, Thiotepa, Thioureidobutyronitrile, THL-P, Thorium Th 227 Anetumab, Thorium Th 227 Anetumab Corixetan, Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439, Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497, Threonine Tyrosine Kinase Inhibitor CFI-402257, Thymidylate Synthase Inhibitor CX1106, Thymidylate Synthase Inhibitor DFP-11207, Thymopentin, Thyroid Extract, Tiazofurin, Tidutamab, Tigapotide, Tigatuzumab, TIGIT Inhibitor M6223, TIGIT-targeting Agent MK-7684, Tilarginine, Tilogotamab, Tilsotolimod Sodium, Timonacic, Tin Ethyl Etiopurpurin, Tinostamustine, Tinzaparin Sodium, Tiomolibdate Choline, Tiomolibdate Diammonium, Tipapkinogene Sovacivec, Tipifarnib, Tipiracil, Tipiracil Hydrochloride, Tirabrutinib, Tiragolumab, Tirapazamine, Tirbanibulin, Tisagenlecleucel, Tislelizumab, Tisotumab Vedotin, Tivantinib, Tivozanib, TLC ELL-12, TLR Agonist BDB001, TLR Agonist BSG-001, TLR Agonist CADI-05, TLR-Directed Cationic Lipid-DNA Complex JVRS-100, TLR7 Agonist 852A, TLR7 agonist BNT411, TLR7 Agonist LHC165, TLR7/8/9 Antagonist IMO-8400, TLR8 Agonist DN1508052, TLR9 Agonist AST-008, TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells, Tocilizumab, Tocladesine, Tocotrienol, Tocotrienol-rich Fraction, Tolebrutinib, Toll-like Receptor 7 Agonist DSP-0509, Tolnidamine, Tomaralimab, Tomato-Soy Juice, Tomivosertib, Topical Betulinic Acid, Topical Celecoxib, Topical Fluorouracil, Topical Gemcitabine Hydrochloride, Topical Potassium Dobesilate, Topical Trichloroacetic Acid, Topixantrone, Topoisomerase I Inhibitor Genz-644282, Topoisomerase I Inhibitor LMP400, Topoisomerase I Inhibitor LMP776, Topoisomerase I/II Inhibitor NEV-801, Topoisomerase-1 Inhibitor LMP744, Topoisomerase-II Inhibitor Racemic XK469, Topoisomerase-II-beta Inhibitor Racemic XK469, Topotecan, Topotecan Hydrochloride, Topotecan Hydrochloride Liposomes, Topotecan Sustained-release Episcleral Plaque, Topsalysin, TORC1/2 Kinase Inhibitor DS-3078a, Toremifene, Toremifene Citrate, Toripalimab, Tosedostat, Tositumomab, Total Androgen Blockade, Tovetumab, Tozasertib Lactate, TP40 Immunotoxin, Trabectedin, Trabedersen, TRAIL Receptor Agonist ABBV-621, Trametinib, Trametinib Dimethyl Sulfoxide, Trans Sodium Crocetinate, Transdermal 17beta-Estradiol Gel BHR-200, Transdermal 4-Hydroxytestosterone, Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01, Transferrin Receptor-Targeted Liposomal p53 cDNA, Transferrin-CRM107, Tranylcypromine Sulfate, Trapoxin, Trastuzumab, Trastuzumab Conjugate BI-CON-02, Trastuzumab Deruxtecan, Trastuzumab Duocarmazine, Trastuzumab Emtansine, Trastuzumab Monomethyl Auristatin F, Trastuzumab-TLR 7/8 Agonist BDC-1001, Trastuzumab/Hyaluronidase-oysk, Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502, Trebananib, Tremelimumab, Treosulfan, Tretazicar, Tretinoin, Tretinoin Liposome, Triamcinolone Acetonide, Triamcinolone Hexacetonide, Triapine, Triazene Derivative CB10-277, Triazene Derivative TriN2755, Triazinate, Triaziquone, Tributyrin, Triciribine Phosphate, Trientine Hydrochloride, Triethylenemelamine, Trifluridine, Trifluridine and Tipiracil Hydrochloride, Trigriluzole, Trilaciclib, Trimelamol, Trimeric GITRL-Fc OMP-336B11, Trimethylcolchicinic Acid, Trimetrexate, Trimetrexate Glucuronate, Trioxifene, Triplatin Tetranitrate, Triptolide Analog, Triptorelin, Triptorelin Pamoate, Tris-acryl Gelatin Microspheres, Tritylcysteine, TRK Inhibitor AZD6918, TRK Inhibitor TQB3558, TrkA Inhibitor VMD-928, Trodusquemine, Trofosfamide, Troglitazone, Tropomyosin Receptor Kinase Inhibitor AZD7451, Troriluzole, Troxacitabine, Troxacitabine Nucleotide Prodrug MIV-818, TRPM8 Agonist D-3263, TRPV6 Calcium Channel Inhibitor SOR-C13, TSP-1 Mimetic ABT-510, TSP-1 Mimetic Fusion Protein CVX-045, Tubercidin, Tubulin Binding Agent TTI-237, Tubulin Inhibitor ALB 109564 Dihydrochloride, Tubulin Inhibitor ALB-109564, Tubulin Polymerization Inhibitor AEZS 112, Tubulin Polymerization Inhibitor CKD-516, Tubulin Polymerization Inhibitor VERU-111, Tubulin-Binding Agent SSR97225, Tucatinib, Tucidinostat, Tucotuzumab Celmoleukin, Tyroserleutide, Tyrosinase Peptide, Tyrosinase-KLH, Tyrosinase:146-156 Peptide, Tyrosine Kinase Inhibitor, Tyrosine Kinase Inhibitor OSI-930, Tyrosine Kinase Inhibitor SU5402, Tyrosine Kinase Inhibitor TL-895, Tyrosine Kinase Inhibitor XL228, UAE Inhibitor TAK-243, Ubenimex, Ubidecarenone Nanodispersion BPM31510n, Ublituximab, Ulinastatin, Ulixertinib, Ulocuplumab, Umbralisib, Uncaria tomentosa Extract, Upamostat, Upifitamab, Uproleselan, Uprosertib, Urabrelimab, Uracil Ointment, Urelumab, Uroacitides, Urokinase-Derived Peptide A6, Ursolic Acid, USP14/UCHL5 Inhibitor VLX1570, Utomilumab, Uzansertib, V930 Vaccine, Vaccine-Sensitized Draining Lymph Node Cells, Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules, Vactosertib, Vadacabtagene Leraleucel, Vadastuximab Talirine, Vadimezan, Valecobulin, Valemetostat, Valproic Acid, Valrubicin, Valspodar, Vandetanib, Vandetanib-eluting Radiopaque Bead BTG-002814, Vandortuzumab Vedotin, Vantictumab, Vanucizumab, Vapreotide, Varlilumab, Varlitinib, Varlitinib Tosylate, Vascular Disrupting Agent BNC105, Vascular Disrupting Agent BNC105P, Vascular Disrupting Agent ZD6126, Vatalanib, Vatalanib Succinate, Vecabrutinib, Vector-peptide Conjugated Paclitaxel, Vedolizumab, VEGF Inhibitor PTC299, VEGF/HGF-targeting DARPin MP0250, VEGFR Inhibitor KRN951, VEGFR-2 DNA Vaccine VXM01, VEGFR/FGFR Inhibitor ODM-203, VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593, VEGFR2 Tyrosine Kinase Inhibitor PF-00337210, VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813, Veliparib, Veltuzumab, Vemurafenib, Venetoclax, Verapamil, Verpasep Caltespen, Verubulin, Verubulin Hydrochloride, Vesencumab, Vesigenurtucel-L, VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220, VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820, Viagenpumatucel-L, Vibecotamab, Vibostolimab, Vilaprisan, Vinblastine, Vinblastine Sulfate, Vincristine, Vincristine Liposomal, Vincristine Sulfate, Vincristine Sulfate Liposome, Vindesine, Vinepidine, Vinflunine, Vinflunine Ditartrate, Vinfosiltine, Vinorelbine, Vinorelbine Tartrate, Vinorelbine Tartrate Emulsion, Vinorelbine Tartrate Oral, Vintafolide, Vinzolidine, Vinzolidine Sulfate, Virulizin, Vismodegib, Vistusertib, Vitamin D3 Analogue ILX23-7553, Vitamin E Compound, Vitespen, VLP-encapsulated TLR9 Agonist CMP-001, Vocimagene Amiretrorepvec, Vofatamab, Volasertib, Volociximab, Vonlerolizumab, Vopratelimab, Vorasidenib, Vorinostat, Vorolanib, Vorsetzumab Mafodotin, Vosaroxin, Vosilasarm, Voxtalisib, Vulinacimab, Warfarin Sodium, Wee1 Inhibitor ZN-c3, Wee1 Kinase Inhibitor Debio 0123, White Carrot, Wnt Signaling Inhibitor SM04755, Wnt Signaling Pathway Inhibitor SM08502, Wnt-5a Mimic Hexapeptide Foxy-5, Wobe-Mugos E, WT1 Peptide Vaccine OCV-501, WT1 Peptide Vaccine WT2725, WT1 Protein-derived Peptide Vaccine DSP-7888, WT1-A10/AS01B Immunotherapeutic GSK2130579A, WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401, Xanthohumol, XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410, Xeloda, Xentuzumab, Xevinapant, Xiaoai Jiedu Decoction, XIAP Antisense Oligonucleotide AEG35156, XIAP/cIAP1 Antagonist ASTX660, Xiliertinib, Xisomab 3G3, XPO1 Inhibitor SL-801, Y 90 Monoclonal Antibody CC49, Y 90 Monoclonal Antibody HMFG1, Y 90 Monoclonal Antibody Lym-1, Y 90 Monoclonal Antibody m170, Y 90 Monoclonal Antibody M195, Yang Yin Fu Zheng, Yangzheng Xiaoji Extract, Yiqi-yangyin-jiedu Herbal Decoction, Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12, Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12, Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8, Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101, Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66, Yttrium Y 90 Basiliximab, Yttrium Y 90 Colloid, Yttrium Y 90 Daclizumab, Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A, Yttrium Y 90 Glass Microspheres, Yttrium Y 90 Monoclonal Antibody B3, Yttrium Y 90 Monoclonal Antibody BrE-3, Yttrium Y 90 Monoclonal Antibody Hu3S193, Yttrium Y 90 Monoclonal Antibody MN-14, Yttrium Y 90 Resin Microspheres, Yttrium Y 90 Tabituximab Barzuxetan, Yttrium Y 90-DOTA-Biotin, Yttrium Y 90-DOTA-di-HSG Peptide IMP-288, Yttrium Y 90-Edotreotide, Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101, Yttrium Y-90 Clivatuzumab Tetraxetan, Yttrium Y-90 Epratuzumab Tetraxetan, Yttrium Y-90 Ibritumomab Tiuxetan, Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium-90 Polycarbonate Brachytherapy Plaque, Z-Endoxifen Hydrochloride, Zalcitabine, Zalifrelimab, Zalutumumab, Zandelisib, Zanidatamab, Zanolimumab, Zanubrutinib, Zebularine, Zelavespib, Zibotentan, Zinc Finger Nuclease ZFN-603, Zinc Finger Nuclease ZFN-758, Zinostatin, Zinostatin Stimalamer, Zirconium Zr 89 Panitumumab, Ziv-Aflibercept, Zolbetuximab, Zoledronic Acid, Zoptarelin Doxorubicin, Zorifertinib, Zorubicin, Zorubicin Hydrochloride, Zotatifin, Zotiraciclib Citrate, Zuclomiphene Citrate, Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,
Individual Metastasis Stage,Extent of the distant metastasis for the cancer based on evidence obtained from clinical assessment parameters determined prior to treatment.,"M0, M1, M1a, M1b, M1c, MX, cM0 (i+), Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0,
Individual Recurrence Status,Yes/No/Unknown indicator to identify whether a patient has had a new tumor event after initial treatment.,"Yes, No, Unknown, Not Reported, Not Allowed To Collect",,FALSE,,,,CDS Imaging v1.0,
Individual Treatment Outcome,Text term that describes the patient's final outcome after the treatment was administered.,"Complete Response, Mixed Response, No Measurable Disease, No Response, Partial Response, Persistent Disease, Progressive Disease, Stable Disease, Treatment Ongoing, Treatment Stopped Due to Toxicity, Very Good Partial Response, Unknown, Not Reported",,FALSE,,,,CDS Imaging v1.0/participant,
Institution,Institutions participating in consortia activities,,"Component, Institution Name, Institution Full Name, Institution Alias, Institution Location State, Institution Location City, Rorid",FALSE,,,,,
Institution Name,"Machine readable name of the institution. (e.g. ArizonaStatUniversity, BostonUniversity, etc.)",,,TRUE,,,,,
Institution Full Name,"Human readable, full name of the institution. (e.g. Arizona State University, Boston University, etc.)",,,TRUE,,,,,
Institution Alias,"Alias of the institution (e.g. ASU, BU, etc.)",,,TRUE,,,,,unique
Institution Location State,"The US state the institution is located in. Use Not Applicable, if not applicable. ","Alabama, Alaska, American Samoa, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Guam, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Minor Outlying Islands, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Northern Mariana Islands, Not Applicable, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, U.S. Virgin Islands, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming",,TRUE,,,,,
Institution Location City,The City the institution is located in. ,,,TRUE,,,,,
Rorid,Unique identifier (ROR ID) of an the institution,,,TRUE,,,,,
Model,Information about a non-human organism or any cell line from which experimental data is derived.,,"Component, Model_id, Study Key, Individual Key, Model Age, Model Age Unit, Model Sex, Model Primary Diagnosis, Model Site of Origin, Model Tumor Type, Model Tumor Subtype, Model Species, Model Type, Model Method, Model Source, Model Acquisition Type, Model Graft Source, Model Genotype, Model Treatment Type, Model Therapeutic Agent",FALSE,,,Study,,
Model_id,A unique identifier used by schematic for record updates and as a reference key in other schemas.,,,TRUE,,,,,unique
Model Age,"The age of the model when used for an experiment (mice, zebrafish, etc.) or model source (cell lines, organoids, etc.)",,,FALSE,,,,,num
Model Age Unit,The unit corresponding to the age provided for this model.,,,FALSE,,,,,str
Model Sex,The biological sex of the model or model source.,"Decline to answer, Don't know, Female, Intersex, Male, None of these describe me, Prefer not to answer, Unknown, X",,FALSE,,,,,
Model Disease Type,The tumor type associated with the model.,"Acinar Cell Neoplasms, Adenomas and Adenocarcinomas, Adnexal and Skin Appendage Neoplasms, Basal Cell Neoplasms, Blood Vessel Tumors, Complex Mixed and Stromal Neoplasms, Cystic; Mucinous and Serous Neoplasms, Ductal and Lobular Neoplasms, Epithelial Neoplasms; NOS, Fibroepithelial Neoplasms, Fibromatous Neoplasms, Germ Cell Neoplasms, Giant Cell Tumors, Gliomas, Granular Cell Tumors and Alveolar Soft Part Sarcomas, Immunoproliferative Diseases, Leukemias, Lipomatous Neoplasms, Lymphatic Vessel Tumors, Mast Cell Neoplasm, Meningiomas, Mesothelial Neoplasms, Miscellaneous Bone Tumors, Miscellaneous Tumors, Mucoepidermoid Neoplasms, Myelodysplastic Syndromes, Myomatous Neoplasms, Myxomatous Neoplasms, Neoplasms; NOS, Nerve Sheath Tumors, Neuroepitheliomatous Neoplasms, Nevi and Melanomas, Not Applicable, Not Otherwise Specified, Not Reported, Odontogenic Tumors, Osseous and Chondromatous Neoplasms, Paragangliomas and Glomus Tumors, Plasma Cell Neoplasm, Soft Tissue Tumors and Sarcomas; NOS, Squamous Cell Neoplasms, Synovial-like Neoplasms, Thymic Epithelial Neoplasms, Transitional Cell Papillomas and Carcinomas, Trophoblastic neoplasms, Unknown",,FALSE,,,,,
Model Tumor Subtype,The molecular subtype of the tumor associated with the model.,,,FALSE,,,,,list like
Model Species,The species of origin corresponding to the model.,"African Bush Elephant, Armadillo, Asian Elephant, Boar, Cat, Chicken, Cow, Dog, Escherichia coli, Guinea Pig, Horse, Human, Human Patient, Human Cell Line, Mouse, Multispecies, Opossum, Rabbit, Rat, Rhesus monkey, Sheep, Trichoplax adhaerens, Unknown, Unspecified, Worm, Yeast, Fruit Fly, Zebrafish",,FALSE,,,,,list like
Model Type,The general label used to identify the model type.,,,FALSE,,,,,str
Model Method,The term that describes the general method used to create the model.,,,FALSE,,,,,str
Model Source,"The reference organism from which the model was derived, if applicable. This could be a specific Model Key, mouse type, cell line, or other reference. Provide RRID if available, to link to existing cell line information. Do not use this field to designate an Individual as the source of the model.",,,FALSE,,,,,str
Model Acquisition Type,"The method by which the model was obtained. If applicable, please provide a link to the supplier of the model source.",,,FALSE,,,,,str
Model Graft Source,"If the model is an allograft or xenograft, as indicated by Model Type, please provide a unique identifier associated with the source of the graft material (e.g., RRID, Individual Key, Model Key, Biospecimen Key)",,,FALSE,,,,,str
Model Genotype,"The relevant genotype information associated with the model, including markers, background, etc.",,,FALSE,,,,,str
Model Treatment Type,Text term that describes the kind of treatment applied to the model.,"Ablation; Cryo, Ablation; Ethanol Injection, Ablation; Microwave, Ablation; NOS, Ablation; Radiofrequency, Ablation; Radiosurgical, Ancillary Treatment, Antiseizure Treatment, Bisphosphonate Therapy, Blinded Study; Treatment Unknown, Brachytherapy; High Dose, Brachytherapy; Low Dose, Brachytherapy; NOS, Chemoembolization, Chemoprotectant, Chemotherapy, Concurrent Chemoradiation, Cryoablation, Embolization, Ethanol Injection Ablation, External Beam Radiation, Hormone Therapy, I-131 Radiation Therapy, Immunotherapy (Including Vaccines), Internal Radiation, Isolated Limb Perfusion (ILP), Organ Transplantation, Other, Pharmaceutical Therapy; NOS, Pleurodesis, Pleurodesis; Talc, Pleurodesis; NOS, Radiation Therapy; NOS, Radiation; 2D Conventional, Radiation; 3D Conformal, Radiation; Combination, Radiation; Cyberknife, Radiation; External Beam, Radiation; Hypofractionated, Radiation; Implants, Radiation; Intensity-Modulated Radiotherapy, Radiation; Internal, Radiation; Mixed Photon Beam, Radiation; Photon Beam, Radiation; Proton Beam, Radiation; Radioisotope, Radiation; Stereotactic/Gamma Knife/SRS, Radiation; Systemic, Radioactive Iodine Therapy, Radioembolization, Radiosensitizing Agent, Stem Cell Transplantation; Allogeneic, Stem Cell Transplantation; Autologous, Stem Cell Transplantation; Double Autologous, Stem Cell Transplantation; Haploidentical, Stem Cell Transplantation; Non-Myeloablative, Stem Cell Transplantation; NOS, Stem Cell Transplantation; Syngenic, Stem Cell Treatment, Stereotactic Radiosurgery, Steroid Therapy, Surgery, Targeted Molecular Therapy, Unknown, Not Reported",,FALSE,,,,,
Model Therapeutic Agent,Text identification of the individual agent(s) used as part of an experimental protocol performed using the model.,"10-Deacetyltaxol, 11C Topotecan, 11D10 AluGel Anti-Idiotype Monoclonal Antibody, 12-Allyldeoxoartemisinin, 13-Deoxydoxorubicin, 14C BMS-275183, 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521, 2-Deoxy-D-glucose, 2-Ethylhydrazide, 2-Fluoroadenine, 2-Fluorofucose-containing SGN-2FF, 2-Hydroxyestradiol, 2-Hydroxyestrone, 2-Hydroxyflutamide Depot, 2-Hydroxyoleic Acid, 2-Methoxyestradiol, 2-Methoxyestradiol Nanocrystal Colloidal Dispersion, 2-Methoxyestrone, 2-O; 3-O Desulfated Heparin, 2;6-Diaminopurine, 2;6-Dimethoxyquinone, 2'-F-ara-deoxyuridine, 3'-C-ethynylcytidine, 3'-dA Phosphoramidate NUC-7738, 4-Nitroestrone 3-Methyl Ether, 4-Thio-2-deoxycytidine, 4'-Iodo-4'-Deoxydoxorubicin, 5-Aza-4'-thio-2'-deoxycytidine, 5-Fluoro-2-Deoxycytidine, 6-Phosphofructo-2-kinase/fructose-2;6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158, 7-Cyanoquinocarcinol, 7-Ethyl-10-Hydroxycamptothecin, 7-Hydroxystaurosporine, 8-Azaguanine, 9-Ethyl 6-Mercaptopurine, 9H-Purine-6Thio-98D, A2A Receptor Antagonist EOS100850, Abagovomab, Abarelix, Abemaciclib, Abemaciclib Mesylate, Abexinostat, Abexinostat Tosylate, Abiraterone, Abiraterone Acetate, Abituzumab, Acai Berry Juice, Acalabrutinib, Acalisib, Aceglatone, Acetylcysteine, Acitretin, Acivicin, Aclacinomycin B, Aclarubicin, Acodazole, Acodazole Hydrochloride, Acolbifene Hydrochloride, Acridine, Acridine Carboxamide, Acronine, Actinium Ac 225 Lintuzumab, Actinium Ac 225-FPI-1434, Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591, Actinomycin C2, Actinomycin C3, Actinomycin F1, Activin Type 2B Receptor Fc Fusion Protein STM 434, Acyclic Nucleoside Phosphonate Prodrug ABI-1968, Ad-RTS-hIL-12, Adagloxad Simolenin, Adavosertib, Adecatumumab, Adenosine A2A Receptor Antagonist AZD4635, Adenosine A2A Receptor Antagonist CS3005, Adenosine A2A Receptor Antagonist NIR178, Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999, Adenosine A2A/A2B Receptor Antagonist AB928, Adenosine A2B Receptor Antagonist PBF-1129, Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201, Adenoviral Brachyury Vaccine ETBX-051, Adenoviral Cancer Vaccine PF-06936308, Adenoviral MUC1 Vaccine ETBX-061, Adenoviral PSA Vaccine ETBX-071, Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001, Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901, Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE, Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918, Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931, Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3, Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001, Aderbasib, ADH-1, AE37 Peptide/GM-CSF Vaccine, AEE788, Aerosol Gemcitabine, Aerosolized Aldesleukin, Aerosolized Liposomal Rubitecan, Afatinib, Afatinib Dimaleate, Afimoxifene, Afuresertib, Agatolimod Sodium, Agerafenib, Aglatimagene Besadenovec, Agonistic Anti-CD40 Monoclonal Antibody ADC-1013, Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949, Agonistic Anti-OX40 Monoclonal Antibody MEDI6469, AKR1C3-activated Prodrug OBI-3424, AKT 1/2 Inhibitor BAY1125976, AKT Inhibitor ARQ 092, Akt Inhibitor LY2780301, Akt Inhibitor MK2206, Akt Inhibitor SR13668, Akt/ERK Inhibitor ONC201, Alacizumab Pegol, Alanosine, Albumin-binding Cisplatin Prodrug BTP-114, Aldesleukin, Aldoxorubicin, Alectinib, Alefacept, Alemtuzumab, Alestramustine, Alflutinib Mesylate, Algenpantucel-L, Alisertib, Alitretinoin, ALK Inhibitor, ALK Inhibitor ASP3026, ALK Inhibitor PLB 1003, ALK Inhibitor RO5424802, ALK Inhibitor TAE684, ALK Inhibitor WX-0593, ALK-2 Inhibitor TP-0184, ALK-FAK Inhibitor CEP-37440, ALK/c-Met Inhibitor TQ-B3139, ALK/FAK/Pyk2 Inhibitor CT-707, ALK/ROS1/Met Inhibitor TQ-B3101, ALK/TRK Inhibitor TSR-011, Alkotinib, Allodepleted T Cell Immunotherapeutic ATIR101, Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715, Allogeneic Anti-BCMA-CAR T-cells PBCAR269A, Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells, Allogeneic Anti-CD19 CAR T-cells ALLO-501A, Allogeneic Anti-CD19 Universal CAR-T Cells CTA101, Allogeneic Anti-CD19-CAR T-cells PBCAR0191, Allogeneic Anti-CD20 CAR T-cells LUCAR-20S, Allogeneic Anti-CD20-CAR T-cells PBCAR20A, Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22, Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100, Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001, Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001, Allogeneic Cellular Vaccine 1650-G, Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120, Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130, Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A, Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM, Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine, Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine, Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo, Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo, Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2, Allogeneic Irradiated Melanoma Cell Vaccine CSF470, Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307, Allogeneic Melanoma Vaccine AGI-101H, Allogeneic Natural Killer Cell Line MG4101, Allogeneic Natural Killer Cell Line NK-92, Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01, Allogeneic Renal Cell Carcinoma Vaccine MGN1601, Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19, Allosteric ErbB Inhibitor BDTX-189, Allovectin-7, Almurtide, Alobresib, Alofanib, Alpelisib, Alpha Galactosylceramide, Alpha V Beta 1 Inhibitor ATN-161, Alpha V Beta 8 Antagonist PF-06940434, alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801, Alpha-Gal AGI-134, Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H, Alpha-Thioguanine Deoxyriboside, Alpha-tocopheryloxyacetic Acid, Alsevalimab, Altiratinib, Altretamine, Alvespimycin, Alvespimycin Hydrochloride, Alvocidib, Alvocidib Hydrochloride, Alvocidib Prodrug TP-1287, Amatuximab, Ambamustine, Ambazone, Amblyomin-X, Amcasertib, Ametantrone, Amifostine, Amino Acid Injection, Aminocamptothecin, Aminocamptothecin Colloidal Dispersion, Aminoflavone Prodrug AFP464, Aminopterin, Aminopterin Sodium, Amivantamab, Amolimogene Bepiplasmid, Amonafide L-Malate, Amrubicin, Amrubicin Hydrochloride, Amsacrine, Amsacrine Lactate, Amsilarotene, Amustaline, Amustaline Dihydrochloride, Amuvatinib, Amuvatinib Hydrochloride, Anakinra, Anastrozole, Anaxirone, Ancitabine, Ancitabine Hydrochloride, Andecaliximab, Androgen Antagonist APC-100, Androgen Receptor Antagonist BAY 1161116, Androgen Receptor Antagonist SHR3680, Androgen Receptor Antagonist TAS3681, Androgen Receptor Antagonist TRC253, Androgen Receptor Antisense Oligonucleotide AZD5312, Androgen Receptor Antisense Oligonucleotide EZN-4176, Androgen Receptor Degrader ARV-110, Androgen Receptor Degrader CC-94676, Androgen Receptor Downregulator AZD3514, Androgen Receptor Inhibitor EPI-7386, Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118, Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10, Andrographolide, Androstane Steroid HE3235, Anetumab Ravtansine, Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241, Angiogenesis Inhibitor GT-111, Angiogenesis Inhibitor JI-101, Angiogenesis/Heparanase Inhibitor PG545, Angiopoietin-2-specific Fusion Protein PF-04856884, Anhydrous Enol-oxaloacetate, Anhydrovinblastine, Aniline Mustard, Anlotinib Hydrochloride, Annamycin, Annamycin Liposomal, Annonaceous Acetogenins, Ansamitomicin P-3, Anthramycin, Anthrapyrazole, Anti c-KIT Antibody-drug Conjugate LOP628, Anti-5T4 Antibody-drug Conjugate ASN004, Anti-5T4 Antibody-Drug Conjugate PF-06263507, Anti-5T4 Antibody-drug Conjugate SYD1875, Anti-A33 Monoclonal Antibody KRN330, Anti-A5B1 Integrin Monoclonal Antibody PF-04605412, Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087, Anti-AG7 Antibody Drug Conjugate AbGn-107, Anti-AGS-16 Monoclonal Antibody AGS-16M18, Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME, Anti-AGS-8 Monoclonal Antibody AGS-8M4, Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B, Anti-alpha5beta1 Integrin Antibody MINT1526A, Anti-ANG2 Monoclonal Antibody MEDI-3617, Anti-angiopoietin Monoclonal Antibody AMG 780, Anti-APRIL Monoclonal Antibody BION-1301, Anti-AXL Fusion Protein AVB-S6-500, Anti-AXL/PBD Antibody-drug Conjugate ADCT-601, Anti-B7-H3 Antibody DS-5573a, Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a, Anti-B7-H4 Monoclonal Antibody FPA150, Anti-B7H3 Antibody-drug Conjugate MGC018, Anti-BCMA Antibody SEA-BCMA, Anti-BCMA Antibody-drug Conjugate AMG 224, Anti-BCMA Antibody-drug Conjugate CC-99712, Anti-BCMA Antibody-drug Conjugate GSK2857916, Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA, Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459, Anti-BCMA/CD3 BiTE Antibody AMG 420, Anti-BCMA/CD3 BiTE Antibody AMG 701, Anti-BCMA/CD3 BiTE Antibody REGN5458, Anti-BCMA/PBD ADC MEDI2228, Anti-BTLA Monoclonal Antibody TAB004, Anti-BTN3A Agonistic Monoclonal Antibody ICT01, Anti-c-fms Monoclonal Antibody AMG 820, Anti-c-KIT Monoclonal Antibody CDX 0158, Anti-c-Met Antibody-drug Conjugate HTI-1066, Anti-c-Met Antibody-drug Conjugate TR1801, Anti-c-Met Monoclonal Antibody ABT-700, Anti-c-Met Monoclonal Antibody ARGX-111, Anti-c-Met Monoclonal Antibody HLX55, Anti-c-MET Monoclonal Antibody LY2875358, Anti-C-met Monoclonal Antibody SAIT301, Anti-C4.4a Antibody-Drug Conjugate BAY1129980, Anti-C5aR Monoclonal Antibody IPH5401, Anti-CA19-9 Monoclonal Antibody 5B1, Anti-CA6-DM4 Immunoconjugate SAR566658, Anti-CCR7 Antibody-drug Conjugate JBH492, Anti-CD117 Monoclonal Antibody JSP191, Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1, Anti-CD123 ADC IMGN632, Anti-CD123 Monoclonal Antibody CSL360, Anti-CD123 Monoclonal Antibody KHK2823, Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404, Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A, Anti-CD123/CD3 Bispecific Antibody APVO436, Anti-CD123/CD3 Bispecific Antibody JNJ-63709178, Anti-CD123/CD3 BiTE Antibody SAR440234, Anti-CD137 Agonistic Monoclonal Antibody ADG106, Anti-CD137 Agonistic Monoclonal Antibody AGEN2373, Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017, Anti-CD137 Agonistic Monoclonal Antibody CTX-471, Anti-CD137 Agonistic Monoclonal Antibody LVGN6051, Anti-CD157 Monoclonal Antibody MEN1112, Anti-CD166 Probody-drug Conjugate CX-2009, Anti-CD19 Antibody-drug Conjugate SGN-CD19B, Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003, Anti-CD19 iCAR NK Cells, Anti-CD19 Monoclonal Antibody DI-B4, Anti-CD19 Monoclonal Antibody MDX-1342, Anti-CD19 Monoclonal Antibody MEDI-551, Anti-CD19 Monoclonal Antibody XmAb5574, Anti-CD19-DM4 Immunoconjugate SAR3419, Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL, Anti-CD19/CD22 CAR NK Cells, Anti-CD19/CD3 BiTE Antibody AMG 562, Anti-CD19/CD3 Tetravalent Antibody AFM11, Anti-CD20 Monoclonal Antibody B001, Anti-CD20 Monoclonal Antibody BAT4306F, Anti-CD20 Monoclonal Antibody MIL62, Anti-CD20 Monoclonal Antibody PRO131921, Anti-CD20 Monoclonal Antibody SCT400, Anti-CD20 Monoclonal Antibody TL011, Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002, Anti-CD20-engineered Toxin Body MT-3724, Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323, Anti-CD20/CD3 Monoclonal Antibody REGN1979, Anti-CD20/CD3 Monoclonal Antibody XmAb13676, Anti-CD205 Antibody-drug Conjugate OBT076, Anti-CD22 ADC TRPH-222, Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S, Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A, Anti-CD25 Monoclonal Antibody RO7296682, Anti-CD25-PBD Antibody-drug Conjugate ADCT-301, Anti-CD26 Monoclonal Antibody YS110, Anti-CD27 Agonistic Monoclonal Antibody MK-5890, Anti-CD27L Antibody-Drug Conjugate AMG 172, Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1), Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044, Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957, Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135, Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05, Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564, Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119, Anti-CD3/CD20 Bispecific Antibody GEN3013, Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424, Anti-CD3/CD7-Ricin Toxin A Immunotoxin, Anti-CD30 Monoclonal Antibody MDX-1401, Anti-CD30 Monoclonal Antibody XmAb2513, Anti-CD30/CD16A Monoclonal Antibody AFM13, Anti-CD30/DM1 Antibody-drug Conjugate F0002, Anti-CD32B Monoclonal Antibody BI-1206, Anti-CD33 Antibody-drug Conjugate IMGN779, Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564, Anti-CD33 Monoclonal Antibody BI 836858, Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633, Anti-CD33/CD3 Bispecific Antibody GEM 333, Anti-CD33/CD3 Bispecific Antibody JNJ-67571244, Anti-CD33/CD3 BiTE Antibody AMG 330, Anti-CD33/CD3 BiTE Antibody AMG 673, Anti-CD352 Antibody-drug Conjugate SGN-CD352A, Anti-CD37 Antibody-Drug Conjugate IMGN529, Anti-CD37 Bispecific Monoclonal Antibody GEN3009, Anti-CD37 MMAE Antibody-drug Conjugate AGS67E, Anti-CD37 Monoclonal Antibody BI 836826, Anti-CD38 Antibody-drug Conjugate STI-6129, Anti-CD38 Monoclonal Antibody MOR03087, Anti-CD38 Monoclonal Antibody SAR442085, Anti-CD38 Monoclonal Antibody TAK-079, Anti-CD38-targeted IgG4-attenuated IFNa TAK-573, Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257, Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342, Anti-CD39 Monoclonal Antibody SRF617, Anti-CD39 Monoclonal Antibody TTX-030, Anti-CD40 Agonist Monoclonal Antibody ABBV-927, Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Anti-CD40 Monoclonal Antibody Chi Lob 7/4, Anti-CD40 Monoclonal Antibody SEA-CD40, Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042, Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428, Anti-CD40L Fc-Fusion Protein BMS-986004, Anti-CD44 Monoclonal Antibody RO5429083, Anti-CD45 Monoclonal Antibody AHN-12, Anti-CD46 Antibody-drug Conjugate FOR46, Anti-CD47 ADC SGN-CD47M, Anti-CD47 Monoclonal Antibody AO-176, Anti-CD47 Monoclonal Antibody CC-90002, Anti-CD47 Monoclonal Antibody Hu5F9-G4, Anti-CD47 Monoclonal Antibody IBI188, Anti-CD47 Monoclonal Antibody IMC-002, Anti-CD47 Monoclonal Antibody SHR-1603, Anti-CD47 Monoclonal Antibody SRF231, Anti-CD47 Monoclonal Antibody TJC4, Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801, Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A, Anti-CD52 Monoclonal Antibody ALLO-647, Anti-CD70 Antibody-Drug Conjugate MDX-1203, Anti-CD70 Antibody-drug Conjugate SGN-CD70A, Anti-CD70 CAR-expressing T Lymphocytes, Anti-CD70 Monoclonal Antibody MDX-1411, Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029, Anti-CD73 Monoclonal Antibody BMS-986179, Anti-CD73 Monoclonal Antibody CPI-006, Anti-CD73 Monoclonal Antibody NZV930, Anti-CD73 Monoclonal Antibody TJ4309, Anti-CD74 Antibody-drug Conjugate STRO-001, Anti-CD98 Monoclonal Antibody IGN523, Anti-CDH6 Antibody-drug Conjugate HKT288, Anti-CEA BiTE Monoclonal Antibody AMG211, Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody, Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2, Anti-CEACAM1 Monoclonal Antibody CM-24, Anti-CEACAM5 Antibody-Drug Conjugate SAR408701, Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47, Anti-CEACAM6 Antibody BAY1834942, Anti-claudin18.2 Monoclonal Antibody AB011, Anti-Claudin18.2 Monoclonal Antibody TST001, Anti-CLDN6 Monoclonal Antibody ASP1650, Anti-CLEC12A/CD3 Bispecific Antibody MCLA117, Anti-CLEVER-1 Monoclonal Antibody FP-1305, Anti-CSF1 Monoclonal Antibody PD-0360324, Anti-CSF1R Monoclonal Antibody IMC-CS4, Anti-CSF1R Monoclonal Antibody SNDX-6352, Anti-CTGF Monoclonal Antibody FG-3019, Anti-CTLA-4 Monoclonal Antibody ADG116, Anti-CTLA-4 Monoclonal Antibody ADU-1604, Anti-CTLA-4 Monoclonal Antibody AGEN1181, Anti-CTLA-4 Monoclonal Antibody BCD-145, Anti-CTLA-4 Monoclonal Antibody HBM4003, Anti-CTLA-4 Monoclonal Antibody MK-1308, Anti-CTLA-4 Monoclonal Antibody ONC-392, Anti-CTLA-4 Monoclonal Antibody REGN4659, Anti-CTLA-4 Probody BMS-986288, Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217, Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841, Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015, Anti-CTLA4 Antibody Fc Fusion Protein KN044, Anti-CTLA4 Monoclonal Antibody BMS-986218, Anti-CXCR4 Monoclonal Antibody PF-06747143, Anti-Denatured Collagen Monoclonal Antibody TRC093, Anti-DKK-1 Monoclonal Antibody LY2812176, Anti-DKK1 Monoclonal Antibody BHQ880, Anti-DLL3/CD3 BiTE Antibody AMG 757, Anti-DLL4 Monoclonal Antibody MEDI0639, Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83, Anti-DR5 Agonist Monoclonal Antibody TRA-8, Anti-DR5 Agonistic Antibody DS-8273a, Anti-DR5 Agonistic Monoclonal Antibody INBRX-109, Anti-EGFR Monoclonal Antibody CPGJ 602, Anti-EGFR Monoclonal Antibody EMD 55900, Anti-EGFR Monoclonal Antibody GC1118, Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX, Anti-EGFR Monoclonal Antibody HLX-07, Anti-EGFR Monoclonal Antibody Mixture MM-151, Anti-EGFR Monoclonal Antibody RO5083945, Anti-EGFR Monoclonal Antibody SCT200, Anti-EGFR Monoclonal Antibody SYN004, Anti-EGFR TAP Antibody-drug Conjugate IMGN289, Anti-EGFR/c-Met Bispecific Antibody EMB-01, Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372, Anti-EGFR/CD16A Bispecific Antibody AFM24, Anti-EGFR/DM1 Antibody-drug Conjugate AVID100, Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013, Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321, Anti-EGFRvIII Antibody Drug Conjugate AMG 595, Anti-EGFRvIII Immunotoxin MR1-1, Anti-EGFRvIII/CD3 BiTE Antibody AMG 596, Anti-EGP-2 Immunotoxin MOC31-PE, Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F, Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F, Anti-Ep-CAM Monoclonal Antibody ING-1, Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310, Anti-EphA2 Monoclonal Antibody DS-8895a, Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547, Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111, Anti-ErbB3 Antibody ISU104, Anti-ErbB3 Monoclonal Antibody AV-203, Anti-ErbB3 Monoclonal Antibody CDX-3379, Anti-ErbB3 Monoclonal Antibody REGN1400, Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141, Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A, Anti-FAP/Interleukin-2 Fusion Protein RO6874281, Anti-FCRH5/CD3 BiTE Antibody BFCR4350A, Anti-FGFR2 Antibody BAY1179470, Anti-FGFR3 Antibody-drug Conjugate LY3076226, Anti-FGFR4 Monoclonal Antibody U3-1784, Anti-FLT3 Antibody-drug Conjugate AGS62P1, Anti-FLT3 Monoclonal Antibody 4G8-SDIEM, Anti-FLT3 Monoclonal Antibody IMC-EB10, Anti-FLT3/CD3 BiTE Antibody AMG 427, Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002, Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202, Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012, Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962, Anti-GARP Monoclonal Antibody ABBV-151, Anti-GCC Antibody-Drug Conjugate MLN0264, Anti-GCC Antibody-Drug Conjugate TAK-164, Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody, Anti-GD2 Monoclonal Antibody hu14.18K322A, Anti-GD2 Monoclonal Antibody MORAb-028, Anti-GD3 Antibody-drug Conjugate PF-06688992, Anti-GITR Agonistic Monoclonal Antibody ASP1951, Anti-GITR Agonistic Monoclonal Antibody BMS-986156, Anti-GITR Agonistic Monoclonal Antibody INCAGN01876, Anti-GITR Monoclonal Antibody GWN 323, Anti-GITR Monoclonal Antibody MK-4166, Anti-Globo H Monoclonal Antibody OBI-888, Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999, Anti-Glypican 3/CD3 Bispecific Antibody ERY974, Anti-GnRH Vaccine PEP223, Anti-gpA33/CD3 Monoclonal Antibody MGD007, Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a, Anti-gremlin-1 Monoclonal Antibody UCB6114, Anti-GRP78 Monoclonal Antibody PAT-SM6, Anti-HA Epitope Monoclonal Antibody MEDI8852, Anti-HB-EGF Monoclonal Antibody KHK2866, Anti-HBEGF Monoclonal Antibody U3-1565, Anti-hepcidin Monoclonal Antibody LY2787106, Anti-HER-2 Bispecific Antibody KN026, Anti-HER2 ADC DS-8201a, Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702, Anti-HER2 Antibody-drug Conjugate A166, Anti-HER2 Antibody-drug Conjugate ARX788, Anti-HER2 Antibody-drug Conjugate BAT8001, Anti-HER2 Antibody-drug Conjugate DP303c, Anti-HER2 Antibody-drug Conjugate MEDI4276, Anti-HER2 Antibody-drug Conjugate RC48, Anti-HER2 Bi-specific Monoclonal Antibody ZW25, Anti-HER2 Bispecific Antibody-drug Conjugate ZW49, Anti-HER2 Immune Stimulator-antibody Conjugate NJH395, Anti-HER2 Monoclonal Antibody B002, Anti-HER2 Monoclonal Antibody CT-P6, Anti-HER2 Monoclonal Antibody HLX22, Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343, Anti-HER2-DM1 ADC B003, Anti-HER2-DM1 Antibody-drug Conjugate GQ1001, Anti-HER2-vc0101 ADC PF-06804103, Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A, Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302, Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128, Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522, Anti-HER2/MMAE Antibody-drug Conjugate MRG002, Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A, Anti-HER3 Antibody-drug Conjugate U3 1402, Anti-HER3 Monoclonal Antibody GSK2849330, Anti-HGF Monoclonal Antibody TAK-701, Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968, Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1, Anti-HLA-DR Monoclonal Antibody IMMU-114, Anti-HLA-G Antibody TTX-080, Anti-human GITR Monoclonal Antibody AMG 228, Anti-human GITR Monoclonal Antibody TRX518, Anti-ICAM-1 Monoclonal Antibody BI-505, Anti-ICOS Agonist Antibody GSK3359609, Anti-ICOS Agonist Monoclonal Antibody BMS-986226, Anti-ICOS Monoclonal Antibody KY1044, Anti-ICOS Monoclonal Antibody MEDI-570, Anti-IGF-1R Monoclonal Antibody AVE1642, Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022, Anti-IL-1 alpha Monoclonal Antibody MABp1, Anti-IL-13 Humanized Monoclonal Antibody TNX-650, Anti-IL-15 Monoclonal Antibody AMG 714, Anti-IL-8 Monoclonal Antibody BMS-986253, Anti-IL-8 Monoclonal Antibody HuMax-IL8, Anti-ILDR2 Monoclonal Antibody BAY 1905254, Anti-ILT4 Monoclonal Antibody MK-4830, Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A, Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388, Anti-IRF4 Antisense Oligonucleotide ION251, Anti-KIR Monoclonal Antibody IPH 2101, Anti-KSP/Anti-VEGF siRNAs ALN-VSP02, Anti-LAG-3 Monoclonal Antibody IBI-110, Anti-LAG-3 Monoclonal Antibody INCAGN02385, Anti-LAG-3 Monoclonal Antibody LAG525, Anti-LAG-3 Monoclonal Antibody REGN3767, Anti-LAG-3/PD-L1 Bispecific Antibody FS118, Anti-LAG3 Monoclonal Antibody BI 754111, Anti-LAG3 Monoclonal Antibody MK-4280, Anti-LAG3 Monoclonal Antibody TSR-033, Anti-LAMP1 Antibody-drug Conjugate SAR428926, Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181, Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102, Anti-LGR5 Monoclonal Antibody BNC101, Anti-LIF Monoclonal Antibody MSC-1, Anti-LILRB4 Monoclonal Antibody IO-202, Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A, Anti-Ly6E Antibody-Drug Conjugate RG 7841, Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C, Anti-Melanin Monoclonal Antibody PTI-6D2, Anti-mesothelin Antibody-drug Conjugate BMS-986148, Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100, Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A, Anti-mesothelin/MMAE Antibody-drug Conjugate RC88, Anti-Met Monoclonal Antibody Mixture Sym015, Anti-Met/EGFR Monoclonal Antibody LY3164530, Anti-MMP-9 Monoclonal Antibody GS-5745, Anti-MUC1 Monoclonal Antibody BTH1704, Anti-MUC16/CD3 Bispecific Antibody REGN4018, Anti-MUC16/CD3 BiTE Antibody REGN4018, Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A, Anti-MUC17/CD3 BiTE Antibody AMG 199, Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062, Anti-myostatin Monoclonal Antibody LY2495655, Anti-NaPi2b Antibody-drug Conjugate XMT-1592, Anti-NaPi2b Monoclonal Antibody XMT-1535, Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E, Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A, Anti-nf-P2X7 Antibody Ointment BIL-010t, Anti-NRP1 Antibody ASP1948, Anti-Nucleolin Aptamer AS1411, Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A, Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso, Anti-OFA Immunotherapeutic BB-MPI-03, Anti-OX40 Agonist Monoclonal Antibody ABBV-368, Anti-OX40 Agonist Monoclonal Antibody BGB-A445, Anti-OX40 Agonist Monoclonal Antibody PF-04518600, Anti-OX40 Antibody BMS 986178, Anti-OX40 Hexavalent Agonist Antibody INBRX-106, Anti-OX40 Monoclonal Antibody GSK3174998, Anti-OX40 Monoclonal Antibody IBI101, Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256, Anti-PD-1 Checkpoint Inhibitor PF-06801591, Anti-PD-1 Fusion Protein AMP-224, Anti-PD-1 Monoclonal Antibody 609A, Anti-PD-1 Monoclonal Antibody AK105, Anti-PD-1 Monoclonal Antibody AMG 404, Anti-PD-1 Monoclonal Antibody BAT1306, Anti-PD-1 Monoclonal Antibody BCD-100, Anti-PD-1 Monoclonal Antibody BI 754091, Anti-PD-1 Monoclonal Antibody CS1003, Anti-PD-1 Monoclonal Antibody F520, Anti-PD-1 Monoclonal Antibody GLS-010, Anti-PD-1 Monoclonal Antibody HLX10, Anti-PD-1 Monoclonal Antibody HX008, Anti-PD-1 Monoclonal Antibody JTX-4014, Anti-PD-1 Monoclonal Antibody LZM009, Anti-PD-1 Monoclonal Antibody MEDI0680, Anti-PD-1 Monoclonal Antibody MGA012, Anti-PD-1 Monoclonal Antibody SCT-I10A, Anti-PD-1 Monoclonal Antibody Sym021, Anti-PD-1 Monoclonal Antibody TSR-042, Anti-PD-1/Anti-CTLA4 DART Protein MGD019, Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315, Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669, Anti-PD-1/Anti-LAG-3 DART Protein MGD013, Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318, Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172, Anti-PD-1/CD47 Infusion Protein HX009, Anti-PD-1/CTLA-4 Bispecific Antibody AK104, Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752, Anti-PD-1/TIM-3 Bispecific Antibody RO7121661, Anti-PD-1/VEGF Bispecific Antibody AK112, Anti-PD-L1 Monoclonal Antibody A167, Anti-PD-L1 Monoclonal Antibody BCD-135, Anti-PD-L1 Monoclonal Antibody BGB-A333, Anti-PD-L1 Monoclonal Antibody CBT-502, Anti-PD-L1 Monoclonal Antibody CK-301, Anti-PD-L1 Monoclonal Antibody CS1001, Anti-PD-L1 Monoclonal Antibody FAZ053, Anti-PD-L1 Monoclonal Antibody GR1405, Anti-PD-L1 Monoclonal Antibody HLX20, Anti-PD-L1 Monoclonal Antibody IMC-001, Anti-PD-L1 Monoclonal Antibody LY3300054, Anti-PD-L1 Monoclonal Antibody MDX-1105, Anti-PD-L1 Monoclonal Antibody MSB2311, Anti-PD-L1 Monoclonal Antibody RC98, Anti-PD-L1 Monoclonal Antibody SHR-1316, Anti-PD-L1 Monoclonal Antibody TG-1501, Anti-PD-L1 Monoclonal Antibody ZKAB001, Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105, Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046, Anti-PD-L1/CD137 Bispecific Antibody MCLA-145, Anti-PD-L1/IL-15 Fusion Protein KD033, Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244, Anti-PD1 Monoclonal Antibody AGEN2034, Anti-PD1/CTLA4 Bispecific Antibody XmAb20717, Anti-PGF Monoclonal Antibody RO5323441, Anti-PKN3 siRNA Atu027, Anti-PLGF Monoclonal Antibody TB-403, Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4, Anti-PRAME Immunotherapeutic GSK2302032A, Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C, Anti-PRL-3 Monoclonal Antibody PRL3-zumab, Anti-prolactin Receptor Antibody LFA102, Anti-PSCA Monoclonal Antibody AGS-1C4D4, Anti-PSMA Monoclonal Antibody MDX1201-A488, Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704, Anti-PSMA Monoclonal Antibody-MMAE Conjugate, Anti-PSMA/CD28 Bispecific Antibody REGN5678, Anti-PSMA/CD3 Bispecific Antibody CCW702, Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081, Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414, Anti-PSMA/PBD ADC MEDI3726, Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020, Anti-PVRIG Monoclonal Antibody COM701, Anti-RANKL Monoclonal Antibody GB-223, Anti-RANKL Monoclonal Antibody JMT103, Anti-Ribonucleoprotein Antibody ATRC-101, Anti-ROR1 ADC VLS-101, Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002, Anti-S15 Monoclonal Antibody NC318, Anti-sCLU Monoclonal Antibody AB-16B5, Anti-SIRPa Monoclonal Antibody CC-95251, Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E, Anti-TAG-72 Monoclonal Antibody scFV CC-49/218, Anti-TF Monoclonal Antibody ALT-836, Anti-TGF-beta Monoclonal Antibody NIS793, Anti-TGF-beta Monoclonal Antibody SAR-439459, Anti-TGF-beta RII Monoclonal Antibody IMC-TR1, Anti-TIGIT Monoclonal Antibody AB154, Anti-TIGIT Monoclonal Antibody BGB-A1217, Anti-TIGIT Monoclonal Antibody BMS-986207, Anti-TIGIT Monoclonal Antibody COM902, Anti-TIGIT Monoclonal Antibody OMP-313M32, Anti-TIGIT Monoclonal Antibody SGN-TGT, Anti-TIM-3 Antibody BMS-986258, Anti-TIM-3 Monoclonal Antibody BGB-A425, Anti-TIM-3 Monoclonal Antibody INCAGN02390, Anti-TIM-3 Monoclonal Antibody MBG453, Anti-TIM-3 Monoclonal Antibody Sym023, Anti-TIM-3 Monoclonal Antibody TSR-022, Anti-TIM3 Monoclonal Antibody LY3321367, Anti-TIM3 Monoclonal Antibody SHR-1702, Anti-Tissue Factor Monoclonal Antibody MORAb-066, Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711, Anti-TROP2 Antibody-drug Conjugate BAT8003, Anti-TROP2 Antibody-drug Conjugate SKB264, Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a, Anti-TWEAK Monoclonal Antibody RG7212, Anti-VEGF Anticalin PRS-050-PEG40, Anti-VEGF Monoclonal Antibody hPV19, Anti-VEGF/ANG2 Nanobody BI 836880, Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T, Anti-VEGFC Monoclonal Antibody VGX-100, Anti-VEGFR2 Monoclonal Antibody HLX06, Anti-VEGFR2 Monoclonal Antibody MSB0254, Anti-VEGFR3 Monoclonal Antibody IMC-3C5, Anti-VISTA Monoclonal Antibody JNJ 61610588, Antiangiogenic Drug Combination TL-118, Antibody-drug Conjugate ABBV-011, Antibody-drug Conjugate ABBV-085, Antibody-drug Conjugate ABBV-155, Antibody-drug Conjugate ABBV-176, Antibody-drug Conjugate ABBV-838, Antibody-drug Conjugate ADC XMT-1536, Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014, Antibody-Drug Conjugate DFRF4539A, Antibody-drug Conjugate MEDI7247, Antibody-drug Conjugate PF-06647263, Antibody-drug Conjugate PF-06664178, Antibody-drug Conjugate SC-002, Antibody-drug Conjugate SC-003, Antibody-drug Conjugate SC-004, Antibody-drug Conjugate SC-005, Antibody-drug Conjugate SC-006, Antibody-drug Conjugate SC-007, Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008, Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV, Antimetabolite FF-10502, Antineoplastic Agent Combination SM-88, Antineoplastic Vaccine, Antineoplastic Vaccine GV-1301, Antineoplaston A10, Antineoplaston AS2-1, Antisense Oligonucleotide GTI-2040, Antisense Oligonucleotide QR-313, Antitumor B Key Active Component-alpha, Antrodia cinnamomea Supplement, Antroquinonol Capsule, Apalutamide, Apatorsen, Apaziquone, APC8015F, APE1/Ref-1 Redox Inhibitor APX3330, Aphidicoline Glycinate, Apilimod Dimesylate Capsule, Apitolisib, Apolizumab, Apomab, Apomine, Apoptosis Inducer BZL101, Apoptosis Inducer GCS-100, Apoptosis Inducer MPC-2130, Apricoxib, Aprinocarsen, Aprutumab, Aprutumab Ixadotin, AR Antagonist BMS-641988, Arabinoxylan Compound MGN3, Aranose, ARC Fusion Protein SL-279252, Archexin, Arcitumomab, Arfolitixorin, Arginase Inhibitor INCB001158, Arginine Butyrate, Arnebia Indigo Jade Pearl Topical Cream, Arsenic Trioxide, Arsenic Trioxide Capsule Formulation ORH 2014, Artemether Sublingual Spray, Artemisinin Dimer, Artesunate, Arugula Seed Powder, Aryl Hydrocarbon Receptor Antagonist BAY2416964, Aryl Hydrocarbon Receptor Inhibitor IK-175, Asaley, Asciminib, Ascrinvacumab, Ashwagandha Root Powder Extract, ASP4132, Aspacytarabine, Asparaginase, Asparaginase Erwinia chrysanthemi, Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10, Astuprotimut-R, Asulacrine, Asulacrine Isethionate, Asunercept, At 211 Monoclonal Antibody 81C6, Atamestane, Atezolizumab, Atiprimod, Atiprimod Dihydrochloride, Atiprimod Dimaleate, ATM Inhibitor M 3541, ATM Kinase Inhibitor AZD0156, ATM Kinase Inhibitor AZD1390, Atorvastatin Calcium, Atorvastatin Sodium, ATR Inhibitor RP-3500, ATR Kinase Inhibitor BAY1895344, ATR Kinase Inhibitor M1774, ATR Kinase Inhibitor M6620, ATR Kinase Inhibitor VX-803, Atrasentan Hydrochloride, Attenuated Listeria monocytogenes CRS-100, Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001, Attenuated Measles Virus Encoding SCD Transgene TMV-018, Atuveciclib, Audencel, Auranofin, Aurora A Kinase Inhibitor LY3295668, Aurora A Kinase Inhibitor LY3295668 Erbumine, Aurora A Kinase Inhibitor MK5108, Aurora A Kinase Inhibitor TAS-119, Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076, Aurora B Serine/Threonine Kinase Inhibitor TAK-901, Aurora B/C Kinase Inhibitor GSK1070916A, Aurora kinase A/B inhibitor TT-00420, Aurora Kinase Inhibitor AMG 900, Aurora Kinase Inhibitor BI 811283, Aurora Kinase Inhibitor MLN8054, Aurora Kinase Inhibitor PF-03814735, Aurora Kinase Inhibitor SNS-314, Aurora Kinase Inhibitor TTP607, Aurora Kinase/VEGFR2 Inhibitor CYC116, Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707, Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055, Autologous Anti-BCMA CAR T-cells PHE885, Autologous Anti-BCMA CAR-transduced T-cells KITE-585, Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11, Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088, Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053, Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143, Autologous Anti-CD123 CAR-T Cells, Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx, Autologous Anti-CD19 CAR T-cells IM19, Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19, Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19, Autologous Anti-CD19 CAR-CD28 T-cells ET019002, Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01, Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901, Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1, Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19, Autologous Anti-CD19 T-cell Receptor T cells ET190L1, Autologous Anti-CD19 TAC-T cells TAC01-CD19, Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells, Autologous Anti-CD19/CD22 CAR T-cells AUTO3, Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014, Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells, Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1, Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s, Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes, Autologous Anti-FLT3 CAR T Cells AMG 553, Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202, Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1, Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100, Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes, Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794, Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes, Autologous Anti-PSMA CAR-T Cells P-PSMA-101, Autologous AXL-targeted CAR T-cells CCT301-38, Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B, Autologous BCMA-targeted CAR T Cells CC-98633, Autologous BCMA-targeted CAR T Cells LCAR-B4822M, Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528, Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F, Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022, Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001, Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005, Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006, Autologous CD123-4SCAR-expressing T-cells 4SCAR123, Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1, Autologous CD19-targeted CAR T Cells CC-97540, Autologous CD19-targeted CAR T Cells JWCAR029, Autologous CD19-targeted CAR-T Cells GC007F, Autologous CD19/PD-1 Bispecific CAR-T Cells, Autologous CD20-4SCAR-expressing T-cells 4SCAR20, Autologous CD22-4SCAR-expressing T-cells 4SCAR22, Autologous CD38-4SCAR-expressing T-cells 4SCAR38, Autologous Clonal Neoantigen T Cells ATL001, Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19, Autologous Deep IL-15 Primed T-cells TRQ15-01, Autologous Dendritic Cell Vaccine ACT2001, Autologous Dendritic Cell-based Immunotherapeutic AV0113, Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa, Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells, Autologous Genetically-modified MAGE-A4 C1032 T Cells, Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858, Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439, Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001, Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718, Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Autologous Mesenchymal Stem Cells Apceth_101, Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11, Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC, Autologous Multi-lineage Potential Cells, Autologous Nectin-4/FAP-targeted CAR-T Cells, Autologous NKG2D CAR T-cells CYAD-02, Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01, Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine, Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001, Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101, Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601, Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201, Autologous ROR2-targeted CAR T-cells CCT301-59, Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1, Autologous TCR-engineered T-cells IMA201, Autologous TCR-engineered T-cells IMA202, Autologous TCR-engineered T-cells IMA203, Autologous TCRm-expressing T-cells ET140203, Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG, Autologous Tumor Infiltrating Lymphocytes LN-144, Autologous Tumor Infiltrating Lymphocytes LN-145, Autologous Tumor Infiltrating Lymphocytes LN-145-S1, Autologous Tumor Infiltrating Lymphocytes MDA-TIL, Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T, Avadomide, Avadomide Hydrochloride, Avapritinib, Avdoralimab, Avelumab, Aviscumine, Avitinib Maleate, Axalimogene Filolisbac, Axatilimab, Axicabtagene Ciloleucel, Axitinib, AXL Inhibitor DS-1205c, AXL Inhibitor SLC-391, AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M, AXL/ FLT3/VEGFR2 Inhibitor KC1036, Axl/Mer Inhibitor INCB081776, Axl/Mer Inhibitor PF-07265807, Azacitidine, Azapicyl, Azaribine, Azaserine, Azathioprine, Azimexon, Azintuxizumab Vedotin, Aziridinylbenzoquinone RH1, Azotomycin, Azurin:50-77 Cell Penetrating Peptide p28, B-Raf/VEGFR-2 Inhibitor RAF265, Babaodan Capsule, Bacillus Calmette-Guerin Substrain Connaught Live Antigen, Bactobolin, Bafetinib, Balixafortide, Balstilimab, Baltaleucel-T, Banoxantrone, Barasertib, Bardoxolone, Bardoxolone Methyl, Baricitinib, Batabulin, Batabulin Sodium, Batimastat, Bavituximab, Bazedoxifene, Bazlitoran, BC-819 Plasmid/Polyethylenimine Complex, BCG Solution, BCG Tokyo-172 Strain Solution, BCG Vaccine, Bcl-2 Inhibitor APG 2575, Bcl-2 Inhibitor BCL201, Bcl-2 Inhibitor BGB-11417, Bcl-2 Inhibitor LP-108, Bcl-2 Inhibitor S65487, Bcl-Xs Adenovirus Vaccine, BCMA x CD3 T-cell Engaging Antibody CC-93269, BCMA-CD19 Compound CAR T Cells, BCMA/CD3e Tri-specific T-cell Activating Construct HPN217, Bcr-Abl Kinase Inhibitor K0706, Bcr-Abl Kinase Inhibitor PF-114, BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351, Beauvericin, Becatecarin, Belagenpumatucel-L, Belantamab Mafodotin, Belapectin, Belimumab, Belinostat, Belotecan Hydrochloride, Belvarafenib, Belzutifan, Bemarituzumab, Bemcentinib, Bempegaldesleukin, Benaxibine, Bendamustine, Bendamustine Hydrochloride, Bendamustine-containing Nanoparticle-based Formulation RXDX-107, Benzaldehyde Dimethane Sulfonate, Benzoylphenylurea, Berberine Chloride, Bermekimab, Bersanlimab, Berubicin Hydrochloride, Berzosertib, BET Bromodomain Inhibitor ZEN-3694, BET Inhibitor ABBV-744, BET Inhibitor BAY1238097, BET inhibitor BI 894999, BET Inhibitor BMS-986158, BET Inhibitor CC-90010, BET Inhibitor CPI-0610, BET Inhibitor FT-1101, BET Inhibitor GS-5829, BET Inhibitor GSK2820151, BET Inhibitor INCB054329, BET Inhibitor INCB057643, BET Inhibitor RO6870810, BET-bromodomain Inhibitor ODM-207, Beta Alethine, Beta-Carotene, Beta-elemene, Beta-Glucan, Beta-Glucan MM-10-001, Beta-lapachone Prodrug ARQ 761, Beta-Thioguanine Deoxyriboside, Betaglucin Gel, Betulinic Acid, Bevacizumab, Bexarotene, Bexmarilimab, BF-200 Gel Formulation, BH3 Mimetic ABT-737, Bi-functional Alkylating Agent VAL-083, Bicalutamide, Bimiralisib, Binetrakin, Binimetinib, Bintrafusp Alfa, Birabresib, Birinapant, Bis(choline)tetrathiomolybdate, Bisantrene, Bisantrene Hydrochloride, Bisnafide, Bisnafide Dimesylate, Bispecific Antibody 2B1, Bispecific Antibody AGEN1223, Bispecific Antibody AMG 509, Bispecific Antibody GS-1423, Bispecific Antibody MDX-H210, Bispecific Antibody MDX447, Bisthianostat, BiTE Antibody AMG 910, Bivalent BRD4 Inhibitor AZD5153, Bizalimogene Ralaplasmid, Bizelesin, BL22 Immunotoxin, Black Cohosh, Black Raspberry Nectar, Bleomycin, Bleomycin A2, Bleomycin B2, Bleomycin Sulfate, Blinatumomab, Blueberry Powder Supplement, BMI1 Inhibitor PTC596, BMS-184476, BMS-188797, BMS-214662, BMS-275183, Boanmycin Hydrochloride, Bomedemstat, Boronophenylalanine-Fructose Complex, Bortezomib, Bosutinib, Bosutinib Monohydrate, Botanical Agent BEL-X-HG, Botanical Agent LEAC-102, Bovine Cartilage, Bozitinib, BP-Cx1-Platinum Complex BP-C1, BR96-Doxorubicin Immunoconjugate, Brachyury-expressing Yeast Vaccine GI-6301, BRAF Inhibitor, BRAF Inhibitor ARQ 736, BRAF Inhibitor BGB-3245, BRAF Inhibitor PLX8394, BRAF(V600E) Kinase Inhibitor ABM-1310, BRAF(V600E) Kinase Inhibitor RO5212054, BRAF/EGFR Inhibitor BGB-283, BRAFV600/PI3K Inhibitor ASN003, BRD4 Inhibitor PLX2853, BRD4 Inhibitor PLX51107, Breflate, Brentuximab, Brentuximab Vedotin, Brequinar, Brequinar Sodium, Briciclib Sodium, Brigatinib, Brilanestrant, Brimonidine Tartrate Nanoemulsion OCU-300, Brivanib, Brivanib Alaninate, Brivudine, Brivudine Phosphoramidate, Broad-Spectrum Human Papillomavirus Vaccine V505, Broccoli Sprout/Broccoli Seed Extract Supplement, Bromacrylide, Bromebric Acid, Bromocriptine Mesylate, Brontictuzumab, Brostacillin Hydrochloride, Brostallicin, Broxuridine, Bruceanol A, Bruceanol B, Bruceanol C, Bruceanol D, Bruceanol E, Bruceanol F, Bruceanol G, Bruceanol H, Bruceantin, Bryostatin 1, BTK Inhibitor ARQ 531, BTK Inhibitor CT-1530, BTK Inhibitor DTRMWXHS-12, BTK Inhibitor HZ-A-018, BTK Inhibitor ICP-022, BTK Inhibitor LOXO-305, BTK Inhibitor M7583, BTK inhibitor TG-1701, Budigalimab, Budotitane, Bufalin, Buparlisib, Burixafor, Burixafor Hydrobromide, Burosumab, Buserelin, Bushen Culuan Decoction, Bushen-Jianpi Decoction, Busulfan, Buthionine Sulfoximine, BXQ-350 Nanovesicle Formulation, c-Kit Inhibitor PLX9486, c-Met Inhibitor ABN401, c-Met Inhibitor AL2846, c-Met Inhibitor AMG 208, c-Met Inhibitor AMG 337, c-Met Inhibitor GST-HG161, c-Met Inhibitor HS-10241, c-Met Inhibitor JNJ-38877605, c-Met Inhibitor MK2461, c-Met Inhibitor MK8033, c-Met Inhibitor MSC2156119J, C-myb Antisense Oligonucleotide G4460, c-raf Antisense Oligonucleotide ISIS 5132, C-VISA BikDD:Liposome, C/EBP Beta Antagonist ST101, CAB-ROR2-ADC BA3021, Cabazitaxel, Cabiralizumab, Cabozantinib, Cabozantinib S-malate, Cactinomycin, Caffeic Acid Phenethyl Ester, CAIX Inhibitor DTP348, CAIX Inhibitor SLC-0111, Calaspargase Pegol-mknl, Calcitriol, Calcium Release-activated Channel Inhibitor CM4620, Calcium Release-activated Channels Inhibitor RP4010, Calcium Saccharate, Calculus bovis/Moschus/Olibanum/Myrrha Capsule, Calicheamicin Gamma 1I, Camidanlumab Tesirine, Camptothecin, Camptothecin Analogue TLC388, Camptothecin Glycoconjugate BAY 38-3441, Camptothecin Sodium, Camptothecin-20(S)-O-Propionate Hydrate, Camrelizumab, Camsirubicin, Cancell, Cancer Peptide Vaccine S-588410, Canerpaturev, Canertinib Dihydrochloride, Canfosfamide, Canfosfamide Hydrochloride, Cannabidiol, Cantrixil, Cantuzumab Ravtansine, Capecitabine, Capecitabine Rapidly Disintegrating Tablet, Capivasertib, Capmatinib, Captopril, CAR T-Cells AMG 119, Caracemide, Carbendazim, Carbetimer, Carbogen, Carbon C 14-pamiparib, Carboplatin, Carboquone, Carboxyamidotriazole, Carboxyamidotriazole Orotate, Carboxyphenyl Retinamide, Carfilzomib, Caricotamide/Tretazicar, Carlumab, Carmofur, Carmustine, Carmustine Implant, Carmustine in Ethanol, Carmustine Sustained-Release Implant Wafer, Carotuximab, Carubicin, Carubicin Hydrochloride, Carzelesin, Carzinophilin, Cathelicidin LL-37, Cationic Liposome-Encapsulated Paclitaxel, Cationic Peptide Cream Cypep-1, Catumaxomab, CBP/beta-catenin Antagonist PRI-724, CBP/beta-catenin Modulator E7386, CCR2 Antagonist CCX872-B, CCR2 Antagonist PF-04136309, CCR2/CCR5 Antagonist BMS-813160, CCR4 Inhibitor FLX475, CD11b Agonist GB1275, CD123-CD33 Compound CAR T Cells, CD123-specific Targeting Module TM123, CD20-CD19 Compound CAR T Cells, CD28/ICOS Antagonist ALPN-101, CD4-specific Telomerase Peptide Vaccine UCPVax, CD40 Agonist Monoclonal Antibody CP-870;893, CD40 Agonistic Monoclonal Antibody APX005M, CD44 Targeted Agent SPL-108, CD44v6-specific CAR T-cells, CD47 Antagonist ALX148, CD73 Inhibitor AB680, CD73 Inhibitor LY3475070, CD80-Fc Fusion Protein ALPN-202, CD80-Fc Fusion Protein FPT155, CDC7 Inhibitor TAK-931, CDC7 Kinase Inhibitor BMS-863233, CDC7 Kinase Inhibitor LY3143921 Hydrate, CDC7 Kinase Inhibitor NMS-1116354, CDK Inhibitor AT7519, CDK Inhibitor R547, CDK Inhibitor SNS-032, CDK/JAK2/FLT3 Inhibitor TG02 Citrate, CDK1 Inhibitor BEY1107, CDK1/2/4 Inhibitor AG-024322, CDK2 Inhibitor PF-07104091, CDK2/4/6/FLT3 Inhibitor FN-1501, CDK2/5/9 Inhibitor CYC065, CDK4 Inhibitor P1446A-05, CDK4/6 Inhibitor, CDK4/6 Inhibitor BPI-16350, CDK4/6 Inhibitor CS3002, CDK4/6 Inhibitor FCN-437, CDK4/6 Inhibitor G1T38, CDK4/6 Inhibitor HS-10342, CDK4/6 Inhibitor SHR6390, CDK4/6 Inhibitor TQB3616, CDK7 Inhibitor CT7001, CDK7 Inhibitor SY-1365, CDK7 Inhibitor SY-5609, CDK8/19 Inhibitor SEL 120, CDK9 Inhibitor AZD4573, CEA-MUC-1-TRICOM Vaccine CV301, CEA-targeting Agent RG6123, CEBPA-targeting saRNA MTL-CEBPA Liposome, Cedazuridine, Cedazuridine/Azacitidine Combination Agent ASTX030, Cedazuridine/Decitabine Combination Agent ASTX727, Cedefingol, Cediranib, Cediranib Maleate, Celecoxib, Cell Cycle Checkpoint/DNA Repair Antagonist IC83, Cemadotin, Cemadotin Hydrochloride, Cemiplimab, Cenersen, Cenisertib, CENP-E Inhibitor GSK-923295, Ceralasertib, Ceramide Nanoliposome, Cerdulatinib, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480, Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282, Cereblon Modulator CC-90009, Cergutuzumab Amunaleukin, Ceritinib, Cesalin, cEt KRAS Antisense Oligonucleotide AZD4785, Cetrelimab, Cetuximab, Cetuximab Sarotalocan, Cetuximab-IR700 Conjugate RM-1929, Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY), Cevipabulin, Cevipabulin Fumarate, Cevipabulin Succinate, Cevostamab, cFMS Tyrosine Kinase Inhibitor ARRY-382, Chaparrin, Chaparrinone, Checkpoint Kinase Inhibitor AZD7762, Checkpoint Kinase Inhibitor XL844, Chemotherapy, Chiauranib, Chimeric Monoclonal Antibody 81C6, ChiNing Decoction, Chk1 Inhibitor CCT245737, Chk1 Inhibitor GDC-0425, Chk1 Inhibitor GDC-0575, CHK1 Inhibitor MK-8776, CHK1 Inhibitor PF-477736, Chlorambucil, Chlorodihydropyrimidine, Chloroquine, Chloroquinoxaline Sulfonamide, Chlorotoxin, Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes, Chlorozotocin, Choline Kinase Alpha Inhibitor TCD-717, CHP-NY-ESO-1 Peptide Vaccine IMF-001, Chromomycin A3, Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement, Cibisatamab, Ciclopirox Prodrug CPX-POM, Cidan Herbal Capsule, Ciforadenant, Cilengitide, Ciltacabtagene Autoleucel, Cimetidine, Cinacalcet Hydrochloride, Cinobufagin, Cinobufotalin, Cinrebafusp Alfa, Cintirorgon, Cintredekin Besudotox, Cirmtuzumab, cis-Urocanic Acid, Cisplatin, Cisplatin Liposomal, Cisplatin-E Therapeutic Implant, Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6, Citarinostat, Citatuzumab Bogatox, Cixutumumab, CK1alpha/CDK7/CDK9 Inhibitor BTX-A51, CK2-targeting Synthetic Peptide CIGB-300, CL 246738, Cladribine, Clanfenur, Clarithromycin, Class 1/4 Histone Deacetylase Inhibitor OKI-179, Clinical Trial, Clinical Trial Agent, Clioquinol, Clivatuzumab, Clodronate Disodium, Clodronic Acid, Clofarabine, Clomesone, Clomiphene, Clomiphene Citrate, Clostridium Novyi-NT Spores, Cobimetinib, Cobolimab, Cobomarsen, Codrituzumab, Coenzyme Q10, Cofetuzumab Pelidotin, Colchicine-Site Binding Agent ABT-751, Cold Contaminant-free Iobenguane I-131, Colloidal Gold-Bound Tumor Necrosis Factor, Colorectal Cancer Peptide Vaccine PolyPEPI1018, Colorectal Tumor-Associated Peptides Vaccine IMA910, Coltuximab Ravtansine, Combretastatin, Combretastatin A-1, Combretastatin A1 Diphosphate, Commensal Bacterial Strain Formulation VE800, Compound Kushen Injection, Conatumumab, Conbercept, Concentrated Lingzhi Mushroom Extract, Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011, Copanlisib, Copanlisib Hydrochloride, Copper Cu 64-ATSM, Copper Cu 67 Tyr3-octreotate, Copper Gluconate, Cord Blood Derived CAR T-Cells, Cord Blood-derived Expanded Natural Killer Cells PNK-007, Cordycepin, Cordycepin Triphosphate, Coriolus Versicolor Extract, Corticorelin Acetate, Cortisone Acetate, Cosibelimab, Cositecan, Coxsackievirus A21, Coxsackievirus V937, CpG Oligodeoxynucleotide GNKG168, Crenolanib, Crenolanib Besylate, Crizotinib, Crolibulin, Cryptophycin, Cryptophycin 52, Crystalline Genistein Formulation AXP107-11, CSF-1R Inhibitor BLZ945, CSF1R Inhibitor ABSK021, CSF1R Inhibitor DCC-3014, CSF1R Inhibitor PLX73086, CT2584 HMS, CTLA-4-directed Probody BMS-986249, Curcumin, Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110, Cusatuzumab, Custirsen Sodium, CXC Chemokine Receptor 2 Antagonist AZD5069, CXCR1/2 Inhibitor SX-682, CXCR2 Antagonist QBM076, CXCR4 Antagonist BL-8040, CXCR4 Antagonist USL311, CXCR4 Inhibitor Q-122, CXCR4 Peptide Antagonist LY2510924, CXCR4/E-selectin Antagonist GMI-1359, Cyclin-dependent Kinase 8/19 Inhibitor BCD 115, Cyclin-dependent Kinase Inhibitor PF-06873600, Cyclodextrin-Based Polymer-Camptothecin CRLX101, Cyclodisone, Cycloleucine, Cyclopentenyl Cytosine, Cyclophosphamide, Cyclophosphamide Anhydrous, Cyclosporine, CYL-02 Plasmid DNA, CYP11A1 inhibitor ODM-208, CYP11A1 Inhibitor ODM-209, CYP17 Inhibitor CFG920, CYP17 Lyase Inhibitor ASN001, CYP17/Androgen Receptor Inhibitor ODM 204, CYP17/CYP11B2 Inhibitor LAE001, Cyproterone, Cyproterone Acetate, Cytarabine, Cytarabine Monophosphate Prodrug MB07133, Cytarabine-asparagine Prodrug BST-236, Cytidine Analog RX-3117, Cytochlor, Cytokine-based Biologic Agent IRX-2, D-methionine Formulation MRX-1024, DAB389 Epidermal Growth Factor, Dabrafenib, Dabrafenib Mesylate, Dacarbazine, Dacetuzumab, DACH Polymer Platinate AP5346, DACH-Platin Micelle NC-4016, Daclizumab, Dacomitinib, Dacplatinum, Dactinomycin, Dactolisib, Dactolisib Tosylate, Dalantercept, Dalotuzumab, Daniquidone, Danusertib, Danvatirsen, Daporinad, Daratumumab, Daratumumab and Hyaluronidase-fihj, Daratumumab/rHuPH20, Darinaparsin, Darleukin, Darolutamide, Daromun, Dasatinib, Daunorubicin, Daunorubicin Citrate, Daunorubicin Hydrochloride, DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Decitabine, Decitabine and Cedazuridine, Defactinib, Defactinib Hydrochloride, Deferoxamine, Deferoxamine Mesylate, Degarelix, Degarelix Acetate, Delanzomib, Delolimogene Mupadenorepvec, Demcizumab, Demecolcine, Demplatin Pegraglumer, Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466, Dendritic Cell Vaccine, Dendritic Cell-Autologous Lung Tumor Vaccine, Dendritic Cell-targeting Lentiviral Vector ID-LV305, Denenicokin, Dengue Virus Adjuvant PV-001-DV, Denibulin, Denibulin Hydrochloride, Denileukin Diftitox, Denintuzumab Mafodotin, Denosumab, Deoxycytidine Analogue TAS-109, Deoxycytidine Analogue TAS-109 Hydrochloride, Depatuxizumab, Depatuxizumab Mafodotin, Derazantinib, Deslorelin, Deslorelin Acetate, Detirelix, Detorubicin, Deuteporfin, Deuterated Enzalutamide, Devimistat, Dexamethason, Dexamethasone, Dexamethasone Phosphate, Dexamethasone Sodium Phosphate, Dexanabinol, Dexrazoxane, Dexrazoxane Hydrochloride, Dezaguanine, Dezaguanine Mesylate, Dezapelisib, DHA-Paclitaxel, DHEA Mustard, DI-Leu16-IL2 Immunocytokine, Dianhydrogalactitol, Diarylsulfonylurea Compound ILX-295501, Diazepinomicin, Diaziquone, Diazooxonorleucine, Dibrospidium Chloride, Dichloroallyl Lawsone, Dicycloplatin, Didox, Dienogest, Diethylnorspermine, Digitoxin, Digoxin, Dihydro-5-Azacytidine, Dihydrolenperone, Dihydroorotate Dehydrogenase Inhibitor AG-636, Dihydroorotate Dehydrogenase Inhibitor BAY2402234, Diindolylmethane, Dilpacimab, Dimethylmyleran, Dinaciclib, Dinutuximab, Dioscorea nipponica Makino Extract DNE3, Diphencyprone, Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777, Ditiocarb, DKK1-Neutralizing Monoclonal Antibody DKN-01, DM-CHOC-PEN, DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015, DNA Interference Oligonucleotide PNT2258, DNA Minor Groove Binding Agent SG2000, DNA Plasmid Encoding Interleukin-12 INO-9012, DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151, DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457, DNA Vaccine VB10.16, DNA-dependent Protein Kinase Inhibitor VX-984, DNA-PK inhibitor AZD7648, DNA-PK/PI3K-delta Inhibitor BR101801, DNA-PK/TOR Kinase Inhibitor CC-115, DNMT1 Inhibitor NTX-301, DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98, Docetaxel, Docetaxel Anhydrous, Docetaxel Emulsion ANX-514, Docetaxel Formulation CKD-810, Docetaxel Lipid Microspheres, Docetaxel Nanoparticle CPC634, Docetaxel Polymeric Micelles, Docetaxel-loaded Nanopharmaceutical CRLX301, Docetaxel-PNP, Docetaxel/Ritonavir, Dociparstat sodium, Dolastatin 10, Dolastatin 15, Domatinostat, Donafenib, Dopamine-Somatostatin Chimeric Molecule BIM-23A760, Dostarlimab, Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703, Dovitinib, Dovitinib Lactate, Doxazosin, Doxercalciferol, Doxifluridine, Doxorubicin, Doxorubicin Hydrochloride, Doxorubicin Prodrug L-377;202, Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370, Doxorubicin-Eluting Beads, Doxorubicin-HPMA Conjugate, Doxorubicin-loaded EGFR-targeting Nanocells, Doxorubicin-Magnetic Targeted Carrier Complex, DPT/BCG/Measles/Serratia/Pneumococcus Vaccine, DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine, DPX-E7 HPV Vaccine, DR5 HexaBody Agonist GEN1029, DR5-targeting Tetrameric Nanobody Agonist TAS266, Dromostanolone Propionate, Drozitumab, DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555, Dual IGF-1R/InsR Inhibitor BMS-754807, Dual Variable Domain Immunoglobulin ABT-165, Dual-affinity B7-H3/CD3-targeted Protein MGD009, Dubermatinib, Duborimycin, Dulanermin, Duligotuzumab, Dupilumab, Durvalumab, Dusigitumab, dUTPase/DPD Inhibitor TAS-114, Duvelisib, Duvortuxizumab, Dynemicin, Dynemicin A, E2F1 Pathway Activator ARQ 171, EBNA-1 inhibitor VK-2019, Echinomycin, Ecromeximab, Edatrexate, Edelfosine, Edicotinib, Edodekin alfa, Edotecarin, Edrecolomab, EED Inhibitor MAK683, Efatutazone, Efatutazone Dihydrochloride, Efizonerimod, Eflornithine, Eflornithine Hydrochloride, Eftilagimod Alpha, Eftozanermin Alfa, Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205, Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621, EGb761, EGFR Antagonist Hemay022, EGFR Antisense DNA BB-401, EGFR Inhibitor AZD3759, EGFR Inhibitor BIBX 1382, EGFR Inhibitor DBPR112, EGFR Inhibitor PD-168393, EGFR Inhibitor TY-9591, EGFR Mutant-selective Inhibitor TQB3804, EGFR Mutant-specific Inhibitor BPI-7711, EGFR Mutant-specific Inhibitor CK-101, EGFR Mutant-specific Inhibitor D-0316, EGFR Mutant-specific Inhibitor ZN-e4, EGFR T790M Antagonist BPI-15086, EGFR T790M Inhibitor HS-10296, EGFR/EGFRvIII Inhibitor WSD0922-FU, EGFR/FLT3/Abl Inhibitor SKLB1028, EGFR/HER1/HER2 Inhibitor PKI166, EGFR/HER2 Inhibitor AP32788, EGFR/HER2 Inhibitor AV-412, EGFR/HER2 Inhibitor DZD9008, EGFR/HER2 Kinase Inhibitor TAK-285, EGFR/TGFb Fusion Monoclonal Antibody BCA101, EGFR/VEGFR/RET Inhibitor HA121-28, Eicosapentaenoic Acid, eIF4E Antisense Oligonucleotide ISIS 183750, Elacestrant, Elacytarabine, Elagolix, Elbasvir/Grazoprevir, Elesclomol, Elesclomol Sodium, Elgemtumab, Elinafide, Elisidepsin, Elliptinium, Elliptinium Acetate, Elmustine, Elotuzumab, Elpamotide, Elsamitrucin, Eltanexor, Emactuzumab, Emapalumab, Emepepimut-S, Emibetuzumab, Emitefur, Emofolin Sodium, Empesertib, Enadenotucirev, Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A, Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641, Enasidenib, Enasidenib Mesylate, Enavatuzumab, Encapsulated Rapamycin, Encelimab, Enclomiphene, Enclomiphene Citrate, Encorafenib, Endothelin B Receptor Blocker ENB 003, Endothelin Receptor Type A Antagonist YM598, Enfortumab Vedotin, Engineered Human Umbilical Vein Endothelial Cells AB-205, Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240, Engineered Toxin Body Targeting CD38 TAK-169, Engineered Toxin Body Targeting HER2 MT-5111, Eniluracil/5-FU Combination Tablet, Enloplatin, Enoblituzumab, Enobosarm, Enoticumab, Enpromate, Ensartinib, Ensituximab, Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride, Enterococcus gallinarum Strain MRx0518, Entinostat, Entolimod, Entospletinib, Entrectinib, Envafolimab, Enzalutamide, Enzastaurin, Enzastaurin Hydrochloride, EP2/EP4 Antagonist TPST-1495, EP4 Antagonist INV-1120, EP4 Antagonist ONO-4578, Epacadostat, Epcoritamab, EphA2-targeting Bicycle Toxin Conjugate BT5528, Epipodophyllotoxin Analog GL331, Epipropidine, Epirubicin, Epirubicin Hydrochloride, Epitinib Succinate, Epitiostanol, Epothilone Analog UTD1, Epothilone KOS-1584, Epratuzumab, Epratuzumab-cys-tesirine, ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471, ERa36 Modulator Icaritin, Erastin Analogue PRLX 93936, Erbulozole, Erdafitinib, Eribulin, Eribulin Mesylate, ERK 1/2 Inhibitor ASTX029, ERK Inhibitor CC-90003, ERK Inhibitor GDC-0994, ERK Inhibitor LTT462, ERK Inhibitor MK-8353, ERK1/2 Inhibitor ASN007, ERK1/2 Inhibitor HH2710, ERK1/2 Inhibitor JSI-1187, ERK1/2 Inhibitor KO-947, ERK1/2 Inhibitor LY3214996, Erlotinib, Erlotinib Hydrochloride, Ertumaxomab, Erythrocyte-encapsulated L-asparaginase Suspension, Esorubicin, Esorubicin Hydrochloride, Esperamicin A1, Essiac, Esterified Estrogens, Estradiol Valerate, Estramustine, Estramustine Phosphate Sodium, Estrogen Receptor Agonist GTx-758, Estrogens; Conjugated, Etalocib, Etanercept, Etanidazole, Etaracizumab, Etarotene, Ethaselen, Ethinyl Estradiol, Ethyleneimine, Ethylnitrosourea, Etidronate-Cytarabine Conjugate MBC-11, Etigilimab, Etirinotecan Pegol, Etoglucid, Etoposide, Etoposide Phosphate, Etoposide Toniribate, Etoprine, Etoricoxib, Ets-family Transcription Factor Inhibitor TK216, Everolimus, Everolimus Tablets for Oral Suspension, Evofosfamide, Ex Vivo-expanded Autologous T Cells IMA101, Exatecan Mesylate, Exatecan Mesylate Anhydrous, Exemestane, Exicorilant, Exisulind, Extended Release Flucytosine, Extended Release Metformin Hydrochloride, Extended-release Onapristone, Ezabenlimab, EZH1/2 Inhibitor DS-3201, EZH1/2 Inhibitor HH2853, EZH2 inhibitor CPI-0209, EZH2 Inhibitor CPI-1205, EZH2 Inhibitor PF-06821497, EZH2 Inhibitor SHR2554, F16-IL2 Fusion Protein, FACT Complex-targeting Curaxin CBL0137, Factor VII-targeting Immunoconjugate Protein ICON-1, Factor VIIa Inhibitor PCI-27483, Fadraciclib, Fadrozole Hydrochloride, FAK Inhibitor GSK2256098, FAK Inhibitor PF-00562271, FAK Inhibitor VS-4718, FAK/ALK/ROS1 Inhibitor APG-2449, Falimarev, Famitinib, FAP/4-1BB-targeting DARPin MP0310, FAP/4-1BB-targeting Fusion Protein RO7122290, Farletuzumab, Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778;123, Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells, Fas Receptor Agonist APO010, Fascin Inhibitor NP-G2-044, FASN Inhibitor TVB-2640, Favezelimab, Fazarabine, Fc-engineered Anti-CD40 Agonist Antibody 2141-V11, Febuxostat, Fedratinib, Fedratinib Hydrochloride, Feladilimab, Felzartamab, Fenebrutinib, Fenretinide, Fenretinide Lipid Matrix, Fenretinide Phospholipid Suspension ST-001, FGF Receptor Antagonist HGS1036, FGF/FGFR Pathway Inhibitor E7090, FGFR Inhibitor ASP5878, FGFR Inhibitor AZD4547, FGFR Inhibitor CPL304110, FGFR Inhibitor Debio 1347, FGFR Inhibitor TAS-120, FGFR/CSF-1R Inhibitor 3D185, FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999, FGFR1/2/3 Inhibitor HMPL-453, FGFR2 Inhibitor RLY-4008, FGFR4 Antagonist INCB062079, FGFR4 Inhibitor BLU 9931, FGFR4 Inhibitor FGF401, FGFR4 Inhibitor H3B-6527, FGFR4 Inhibitor ICP-105, Fianlimab, Fibromun, Ficlatuzumab, Figitumumab, Filanesib, Filgotinib, Filgrastim, Fimaporfin A, Fimepinostat, Firtecan Pegol, Fisogatinib, Flanvotumab, Flotetuzumab, Floxuridine, FLT3 Inhibitor FF-10101 Succinate, FLT3 Inhibitor HM43239, FLT3 Inhibitor SKI-G-801, Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01, FLT3 Tyrosine Kinase Inhibitor TTT-3002, FLT3/ABL/Aurora Kinase Inhibitor KW-2449, FLT3/CDK4/6 Inhibitor FLX925, FLT3/FGFR Dual Kinase Inhibitor MAX-40279, FLT3/KIT Kinase Inhibitor AKN-028, FLT3/KIT/CSF1R Inhibitor NMS-03592088, Flt3/MerTK Inhibitor MRX-2843, Fludarabine, Fludarabine Phosphate, Flumatinib, Flumatinib Mesylate, Fluorine F 18 Ara-G, Fluorodopan, Fluorouracil, Fluorouracil Implant, Fluorouracil-E Therapeutic Implant, Fluoxymesterone, Flutamide, Fluvastatin, Fluvastatin Sodium, Fluzoparib, FMS Inhibitor JNJ-40346527, Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate, Folate Receptor Targeted Epothilone BMS753493, Folate Receptor-Targeted Tubulysin Conjugate EC1456, Folate Receptor-Targeted Vinca Alkaloid EC0489, Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225, Folate-FITC, Folic Acid, Folitixorin, Foretinib, Foritinib Succinate, Formestane, Forodesine Hydrochloride, Fosaprepitant, Fosbretabulin, Fosbretabulin Disodium, Fosbretabulin Tromethamine, Fosgemcitabine Palabenamide, Fosifloxuridine Nafalbenamide, Foslinanib, Foslinanib Disodium, Fosquidone, Fostriecin, Fotemustine, Fotretamine, FPV Vaccine CV301, FPV-Brachyury-TRICOM Vaccine, Fresolimumab, Fruquintinib, Fulvestrant, Fumagillin-Derived Polymer Conjugate XMT-1107, Fursultiamine, Futibatinib, Futuximab, Futuximab/Modotuximab Mixture, G Protein-coupled Estrogen Receptor Agonist LNS8801, G-Quadruplex Stabilizer BMVC, Galamustine, Galarubicin, Galectin Inhibitor GR-MD-02, Galectin-1 Inhibitor OTX008, Galeterone, Galiximab, Gallium-based Bone Resorption Inhibitor AP-002, Galocitabine, Galunisertib, Gamboge Resin Extract TSB-9-W1, Gamma-delta Tocotrienol, Gamma-Secretase Inhibitor LY3039478, Gamma-Secretase Inhibitor RO4929097, Gandotinib, Ganetespib, Ganglioside GD2, Ganglioside GM2, Ganitumab, Ganoderma lucidum Spores Powder Capsule, Garlic, Gastrin Immunotoxin, Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360, Gataparsen Sodium, Gatipotuzumab, GBM Antigens and Alloantigens Immunotherapeutic Vaccine, Gedatolisib, Gefitinib, Geldanamycin, Gelonin, Gemcitabine, Gemcitabine Elaidate, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride Emulsion, Gemcitabine Prodrug LY2334737, Gemcitabine-Phosphoramidate Hydrochloride NUC-1031, Gemcitabine-Releasing Intravesical System, Gemtuzumab Ozogamicin, Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum, Genistein, Gentuximab, Geranylgeranyltransferase I Inhibitor, GI-4000 Vaccine, Giloralimab, Gilteritinib, Gilteritinib Fumarate, Gimatecan, Gimeracil, Ginsenoside Rg3 Capsule, Giredestrant, Girentuximab, Girodazole, GITR Agonist MEDI1873, Givinostat, Glasdegib, Glasdegib Maleate, Glaucarubolone, Glecaprevir/Pibrentasvir, Glembatumumab Vedotin, Glesatinib, Glioblastoma Cancer Vaccine ERC1671, Glioblastoma Multiforme Multipeptide Vaccine IMA950, Glioma Lysate Vaccine GBM6-AD, Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701, Globo H-DT Vaccine OBI-833, Glofitamab, Glucarpidase, Glucocorticoid Receptor Antagonist ORIC-101, Glufosfamide, Glumetinib, Glutaminase Inhibitor CB-839, Glutaminase Inhibitor CB-839 Hydrochloride, Glutaminase Inhibitor IPN60090, Glutamine Antagonist DRP-104, Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101, Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01, Glycooptimized Trastuzumab-GEX, GM-CSF-encoding Oncolytic Adenovirus CGTG-102, Gold Sodium Thiomalate, Golnerminogene Pradenovec, Golotimod, Golvatinib, Gonadotropin-releasing Hormone Analog, Goserelin, Goserelin Acetate, Goserelin Acetate Extended-release Microspheres LY01005, Gossypol, Gossypol Acetic Acid, Grapiprant, Green Tea Extract-based Antioxidant Supplement, GS/pan-Notch Inhibitor AL101, GS/pan-Notch Inhibitor BMS-986115, GSK-3 Inhibitor 9-ING-41, GSK-3 Inhibitor LY2090314, Guadecitabine, Guanabenz Acetate, Guselkumab, Gusperimus Trihydrochloride, Gutolactone, H-ras Antisense Oligodeoxynucleotide ISIS 2503, H1299 Tumor Cell Lysate Vaccine, HAAH Lambda phage Vaccine SNS-301, Hafnium Oxide-containing Nanoparticles NBTXR3, Halichondrin Analogue E7130, Halichondrin B, Halofuginone, Halofuginone Hydrobromide, HCV DNA Vaccine INO-8000, HDAC Class I/IIb Inhibitor HG146, HDAC Inhibitor AR-42, HDAC inhibitor CG200745, HDAC Inhibitor CHR-2845, HDAC Inhibitor CKD-581, HDAC Inhibitor CXD101, HDAC Inhibitor MPT0E028, HDAC Inhibitor OBP-801, HDAC/EGFR/HER2 Inhibitor CUDC-101, HDAC6 Inhibitor KA2507, HDAC8 Inhibitor NBM-BMX, HDM2 Inhibitor HDM201, HDM2 Inhibitor MK-8242, Hedgehog Inhibitor IPI-609, Hematoporphyrin Derivative, Hemiasterlin Analog E7974, Henatinib Maleate, Heparan Sulfate Glycosaminoglycan Mimetic M402, Heparin Derivative SST0001, HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131, HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901, HER2 Inhibitor CP-724;714, HER2 Inhibitor DZD1516, HER2 Inhibitor TAS0728, HER2 Tri-specific Natural Killer Cell Engager DF1001, HER2-directed TLR8 Agonist SBT6050, HER2-targeted DARPin MP0274, HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302, HER2-targeting Antibody Fc Fragment FS102, Herba Scutellaria Barbata, Herbimycin, Heterodimeric Interleukin-15, Hexamethylene Bisacetamide, Hexaminolevulinate, Hexylresorcinol, HIF-1alpha Inhibitor PX-478, HIF-2alpha Inhibitor PT2385, HIF-2alpha Inhibitor PT2977, HIF2a RNAi ARO-HIF2, Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126, Histrelin Acetate, HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001, HLA-A*2402-Restricted Multipeptide Vaccine S-488410, HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201, HM2/MMAE Antibody-Drug Conjugate ALT-P7, Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine, Holmium Ho 166 Poly(L-Lactic Acid) Microspheres, Hormone Therapy, HPPH, HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202, HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c, HPV DNA Plasmids Therapeutic Vaccine VGX-3100, HPV E6/E7 DNA Vaccine GX-188E, HPV E6/E7-encoding Arenavirus Vaccine HB-201, HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C, HPV-16 E6 Peptides Vaccine/Candida albicans Extract, HPV-6-targeting Immunotherapeutic Vaccine INO-3106, HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101, HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN, HPV6/11-targeted DNA Plasmid Vaccine INO-3107, Hsp90 Antagonist KW-2478, Hsp90 Inhibitor AB-010, Hsp90 Inhibitor BIIB021, Hsp90 Inhibitor BIIB028, Hsp90 Inhibitor Debio 0932, Hsp90 Inhibitor DS-2248, Hsp90 Inhibitor HSP990, Hsp90 Inhibitor MPC-3100, Hsp90 Inhibitor PU-H71, Hsp90 Inhibitor SNX-5422 Mesylate, Hsp90 Inhibitor SNX-5542 Mesylate, Hsp90 Inhibitor TQB3474, Hsp90 Inhibitor XL888, Hsp90-targeted Photosensitizer HS-201, HSP90-targeted SN-38 Conjugate PEN-866, HSP90alpha/beta Inhibitor TAS-116, hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301, hTERT Vaccine V934/V935, hTERT-encoding DNA Vaccine INVAC-1, Hu14.18-IL2 Fusion Protein EMD 273063, HuaChanSu, Huaier Extract Granule, Huang Lian, huBC1-huIL12 Fusion Protein AS1409, Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736, Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104, Human MOAB LICO 28a32, Human Monoclonal Antibody 216, Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307, Human Papillomavirus 16 E7 Peptide/Padre 965.10, Hyaluronidase-zzxf/Pertuzumab/Trastuzumab, Hycanthone, Hydralazine Hydrochloride, Hydrocortisone Sodium Succinate, Hydroxychloroquine, Hydroxyprogesterone Caproate, Hydroxytyrosol, Hydroxyurea, Hypericin, Hypoxia-activated Prodrug TH-4000, I 131 Antiferritin Immunoglobulin, I 131 Monoclonal Antibody A33, I 131 Monoclonal Antibody CC49, I 131 Monoclonal Antibody F19, I 131 Monoclonal Antibody Lym-1, Iadademstat, Ianalumab, IAP Inhibitor APG-1387, IAP Inhibitor AT-406, IAP Inhibitor HGS1029, Ibandronate Sodium, Iberdomide, Iboctadekin, Ibritumomab Tiuxetan, Ibrutinib, Icotinib Hydrochloride, Icrucumab, ICT-121 Dendritic Cell Vaccine, Idarubicin, Idarubicin Hydrochloride, Idarubicin-Eluting Beads, Idasanutlin, Idecabtagene Vicleucel, Idelalisib, Idetrexed, IDH1 Mutant Inhibitor LY3410738, IDH1(R132) Inhibitor IDH305, IDH1R132H-Specific Peptide Vaccine PEPIDH1M, Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020, IDO Peptide Vaccine IO102, IDO-1 Inhibitor LY3381916, IDO/TDO Inhibitor HTI-1090, IDO/TDO Inhibitor LY-01013, IDO1 Inhibitor KHK2455, IDO1 Inhibitor MK-7162, IDO1 Inhibitor PF-06840003, IDO1/TDO2 Inhibitor DN1406131, IDO1/TDO2 Inhibitor M4112, Idronoxil, Idronoxil Suppository NOX66, Ieramilimab, Ifabotuzumab, Ifetroban, Ifosfamide, IGF-1R Inhibitor, IGF-1R Inhibitor PL225B, IGF-1R/IR Inhibitor KW-2450, IGF-methotrexate Conjugate, IL-10 Immunomodulator MK-1966, IL-12-expressing HSV-1 NSC 733972, IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051, IL-12sc; IL-15sushi; IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000, IL-2 Recombinant Fusion Protein ALT-801, IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1, IL4-Pseudomonas Exotoxin Fusion Protein MDNA55, Ilginatinib, Ilixadencel, Iloprost, Ilorasertib, Imalumab, Imaradenant, Imatinib, Imatinib Mesylate, Imetelstat, Imetelstat Sodium, Imexon, Imgatuzumab, Imidazole Mustard, Imidazole-Pyrazole, Imifoplatin, Imipramine Blue, Imiquimod, Immediate-release Onapristone, Immediate-release Tablet Afuresertib, Immune Checkpoint Inhibitor ASP8374, Immunoconjugate RO5479599, Immunocytokine NHS-IL12, Immunocytokine NHS-IL2-LT, Immunomodulator LAM-003, Immunomodulator OHR/AVR118, Immunomodulatory Agent CC-11006, Immunomodulatory Oligonucleotide HYB2055, Immunotherapeutic Combination Product CMB305, Immunotherapeutic GSK1572932A, Immunotherapy Regimen MKC-1106-MT, Immunotoxin CMD-193, IMT-1012 Immunotherapeutic Vaccine, Inactivated Oncolytic Virus Particle GEN0101, Inalimarev, Incyclinide, Indatuximab Ravtansine, Indibulin, Indicine-N-Oxide, Indisulam, Individualized MVA-based Vaccine TG4050, Indocyanine Green-labeled Polymeric Micelles ONM-100, Indole-3-Carbinol, Indomethacin, Indoximod, Indoximod Prodrug NLG802, Indusatumab Vedotin, Inebilizumab, Inecalcitol, Infigratinib, Infigratinib Mesylate, Infliximab, Ingenol Mebutate, Ingenol Mebutate Gel, Iniparib, iNKT Cell Agonist ABX196, Innate Immunostimulator rBBX-01, INO-1001, Inodiftagene Vixteplasmid, iNOS Dimerization Inhibitor ASP9853, Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01, Inosine Monophosphate Dehydrogenase Inhibitor AVN944, Inositol, Inotuzumab Ozogamicin, Inproquone, Integrin alpha-2 Inhibitor E7820, Integrin Receptor Antagonist GLPG0187, Interferon, Interferon Alfa-2B, Interferon Alfa-N1, Interferon Alfa-N3, Interferon Alfacon-1, Interferon Beta-1A, Interferon Gamma-1b, Interferon-gamma-expressing Adenovirus Vaccine ASN-002, Interleukin Therapy, Interleukin-12-Fc Fusion Protein DF6002, Interleukin-15 Agonist Fusion Protein SHR1501, Interleukin-15 Fusion Protein BJ-001, Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306, Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101, Interleukin-2 Liposome, Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230, Intetumumab, Intiquinatine, Intoplicine, Inulin, Iobenguane I-131, Iodine I 124 Monoclonal Antibody A33, Iodine I 124 Monoclonal Antibody M5A, Iodine I 125-Anti-EGFR-425 Monoclonal Antibody, Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP, Iodine I 131 Apamistamab, Iodine I 131 Derlotuximab Biotin, Iodine I 131 Ethiodized Oil, Iodine I 131 IPA, Iodine I 131 MIP-1095, Iodine I 131 Monoclonal Antibody 81C6, Iodine I 131 Monoclonal Antibody BC8, Iodine I 131 Monoclonal Antibody CC49-deltaCH2, Iodine I 131 Monoclonal Antibody F16SIP, Iodine I 131 Monoclonal Antibody G-250, Iodine I 131 Monoclonal Antibody muJ591, Iodine I 131 Omburtamab, Iodine I 131 Rituximab, Iodine I 131 Tenatumomab, Iodine I 131 TM-601, Iodine I 131 Tositumomab, Iodine I-131, Ioflubenzamide I-131, Ionomycin, Ipafricept, Ipatasertib, Ipilimumab, Ipomeanol, Iproplatin, iPSC-derived CD16-expressing Natural Killer Cells FT516, iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596, iPSC-derived Natural Killer Cells FT500, IRAK4 Inhibitor CA-4948, Iratumumab, Iridium Ir 192, Irinotecan, Irinotecan Hydrochloride, Irinotecan Sucrosofate, Irinotecan-Eluting Beads, Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet, Irofulven, Iroplact, Irosustat, Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130, Isatuximab, Iso-fludelone, Isobrucein B, Isocoumarin NM-3, Isotretinoin, Ispinesib, Ispinesib Mesylate, ISS 1018 CpG Oligodeoxynucleotide, Istiratumab, Itacitinib, Itacitinib Adipate, ITK Inhibitor CPI-818, Itraconazole, Itraconazole Dispersion In Polymer Matrix, Ivaltinostat, Ivosidenib, Ivuxolimab, Ixabepilone, Ixazomib, Ixazomib Citrate, JAK Inhibitor, JAK Inhibitor INCB047986, JAK1 Inhibitor AZD4205, JAK1 Inhibitor INCB052793, JAK2 Inhibitor AZD1480, JAK2 Inhibitor BMS-911543, JAK2 Inhibitor XL019, JAK2/Src Inhibitor NS-018, Jin Fu Kang, JNK Inhibitor CC-401, Kanglaite, Kanitinib, Ketoconazole, Ketotrexate, KRAS G12C Inhibitor GDC-6036, KRAS G12C Inhibitor LY3499446, KRAS G12C Inhibitor MRTX849, KRAS Mutant-targeting AMG 510, KRAS-MAPK Signaling Pathway Inhibitor JAB-3312, KRASG12C Inhibitor JNJ-74699157, KRN5500, KSP Inhibitor AZD4877, KSP Inhibitor SB-743921, Kunecatechins Ointment, L-Gossypol, L-methylfolate, Labetuzumab Govitecan, Lactoferrin-derived Lytic Peptide LTX-315, Lacutamab, Ladiratuzumab Vedotin, Ladirubicin, Laetrile, LAIR-2 Fusion Protein NC410, Landogrozumab, Laniquidar, Lanreotide Acetate, Lapachone, Lapatinib, Lapatinib Ditosylate, Laprituximab Emtansine, Lapuleucel-T, Laromustine, Larotaxel, Larotinib Mesylate, Larotrectinib, Larotrectinib Sulfate, Lavendustin A, Lazertinib, Lead Pb 212 TCMC-trastuzumab, Lefitolimod, Leflunomide, Lenalidomide, Lenalidomide Analog KPG-121, Lentinan, Lenvatinib, Lenvatinib Mesylate, Lenzilumab, Lerociclib, Lestaurtinib, Letetresgene Autoleucel, Letolizumab, Letrozole, Leucovorin, Leucovorin Calcium, Leuprolide, Leuprolide Acetate, Leuprolide Mesylate Injectable Suspension, Leurubicin, Levetiracetam, Levoleucovorin Calcium, Levothyroxine, Levothyroxine Sodium, Lexatumumab, Lexibulin, Liarozole, Liarozole Fumarate, Liarozole Hydrochloride, Licartin, Licorice, Lifastuzumab Vedotin, Lifileucel, Lifirafenib, Light-activated AU-011, Light-Emitting Oncolytic Vaccinia Virus GL-ONC1, Lilotomab, Limonene; (+)-, Limonene; (+/-)-, Linifanib, Linoleyl Carbonate-Paclitaxel, Linperlisib, Linrodostat, Linsitinib, Lintuzumab, Liothyronine I-131, Liothyronine Sodium, Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1, Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191, Lipid Nanoparticle Encapsulated OX40L mRNA-2416, Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006, Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752, Liposomal Bcl-2 Antisense Oligonucleotide BP1002, Liposomal c-raf Antisense Oligonucleotide, Liposomal Curcumin, Liposomal Cytarabine, Liposomal Daunorubicin Citrate, Liposomal Docetaxel, Liposomal Eribulin Mesylate, Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101, Liposomal Irinotecan, Liposomal Mitoxantrone Hydrochloride, Liposomal MUC1/PET-lipid A Vaccine ONT-10, Liposomal NDDP, Liposomal Rhenium Re 186, Liposomal SN-38, Liposomal Topotecan FF-10850, Liposomal Vinorelbine, Liposomal Vinorelbine Tartrate, Liposome, Liposome-encapsulated Daunorubicin-Cytarabine, Liposome-Encapsulated Doxorubicin Citrate, Liposome-encapsulated miR-34 Mimic MRX34, Liposome-encapsulated OSI-7904, Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94, Liposome-encapsulated TAAs mRNA Vaccine W_ova1, Lirilumab, Lisavanbulin, Lisocabtagene Maraleucel, Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142, Litronesib, Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809, Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207, Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623, Liver X Receptor beta Agonist RGX-104, Lm-tLLO-neoantigens Vaccine ADXS-NEO, LMB-1 Immunotoxin, LMB-2 Immunotoxin, LMB-7 Immunotoxin, LMB-9 Immunotoxin, LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164, LMP-2:340-349 Peptide Vaccine, LMP-2:419-427 Peptide Vaccine, LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes, LMP7 Inhibitor M3258, Lobaplatin, Lodapolimab, Lometrexol, Lometrexol Sodium, Lomustine, Lonafarnib, Loncastuximab Tesirine, Long Peptide Vaccine 7, Long-acting Release Pasireotide, Lontucirev, Lorlatinib, Lorukafusp alfa, Lorvotuzumab Mertansine, Losatuxizumab Vedotin, Losoxantrone, Losoxantrone Hydrochloride, Lovastatin, LOXL2 Inhibitor PAT-1251, LRP5 Antagonist BI 905681, LRP5/6 Antagonist BI 905677, LSD1 Inhibitor CC-90011, LSD1 Inhibitor GSK2879552, LSD1 Inhibitor IMG-7289, LSD1 Inhibitor RO7051790, LSD1 Inhibitor SYHA1807, Lucanthone, Lucatumumab, Lucitanib, Luminespib, Luminespib Mesylate, Lumretuzumab, Lung-targeted Immunomodulator QBKPN, Lupartumab Amadotin, Lurbinectedin, Lurtotecan, Lurtotecan Liposome, Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1, Lutetium Lu 177 DOTA-biotin, Lutetium Lu 177 DOTA-N3-CTT1403, Lutetium Lu 177 DOTA-Tetulomab, Lutetium Lu 177 Dotatate, Lutetium Lu 177 Lilotomab-satetraxetan, Lutetium Lu 177 Monoclonal Antibody CC49, Lutetium Lu 177 Monoclonal Antibody J591, Lutetium Lu 177 PP-F11N, Lutetium Lu 177 Satoreotide Tetraxetan, Lutetium Lu 177-DOTA-EB-TATE, Lutetium Lu 177-DTPA-omburtamab, Lutetium Lu 177-Edotreotide, Lutetium Lu 177-NeoB, Lutetium Lu 177-PSMA-617, Lutetium Lu-177 Capromab, Lutetium Lu-177 Girentuximab, Lutetium Lu-177 PSMA-R2, Lutetium Lu-177 Rituximab, LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1, Lyophilized Black Raspberry Lozenge, Lyophilized Black Raspberry Saliva Substitute, Lysine-specific Demethylase 1 Inhibitor INCB059872, Lyso-Thermosensitive Liposome Doxorubicin, Maackia amurensis Seed Lectin, Macimorelin, Macitentan, Macrocycle-bridged STING Agonist E7766, Maekmoondong-tang, Mafosfamide, MAGE-10.A2, MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells, MAGE-A3 Multipeptide Vaccine GL-0817, MAGE-A3 Peptide Vaccine, MAGE-A3-specific Immunotherapeutic GSK 2132231A, MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201, Magnesium Valproate, Magrolimab, MALT1 Inhibitor JNJ-67856633, Manelimab, Mannosulfan, Mannosylerythritol Lipid, Mapatumumab, Maraba Oncolytic Virus Expressing Mutant HPV E6/E7, Marcellomycin, MARCKS Protein Inhibitor BIO-11006, Margetuximab, Marimastat, Marizomib, Masitinib Mesylate, Masoprocol, MAT2A Inhibitor AG-270, Matrix Metalloproteinase Inhibitor MMI270, Matuzumab, Mavelertinib, Mavorixafor, Maytansine, MCL-1 Inhibitor ABBV-467, MCL-1 Inhibitor AMG 176, MCL-1 inhibitor AMG 397, Mcl-1 Inhibitor AZD5991, Mcl-1 Inhibitor MIK665, MDM2 Antagonist ASTX295, MDM2 Antagonist RO5045337, MDM2 Antagonist RO6839921, MDM2 Inhibitor AMG-232, MDM2 Inhibitor AMGMDS3, MDM2 Inhibitor BI 907828, MDM2 Inhibitor KRT-232, MDM2/MDMX Inhibitor ALRN-6924, MDR Modulator CBT-1, Mechlorethamine, Mechlorethamine Hydrochloride, Mechlorethamine Hydrochloride Gel, Medorubicin, Medroxyprogesterone, Medroxyprogesterone Acetate, Megestrol Acetate, MEK 1/2 Inhibitor AS703988/MSC2015103B, MEK 1/2 Inhibitor FCN-159, MEK Inhibitor AZD8330, MEK Inhibitor CI-1040, MEK inhibitor CS3006, MEK Inhibitor GDC-0623, MEK Inhibitor HL-085, MEK Inhibitor PD0325901, MEK Inhibitor RO4987655, MEK Inhibitor SHR 7390, MEK Inhibitor TAK-733, MEK Inhibitor WX-554, MEK-1/MEKK-1 Inhibitor E6201, MEK/Aurora Kinase Inhibitor BI 847325, Melanoma Monoclonal Antibody hIgG2A, Melanoma TRP2 CTL Epitope Vaccine SCIB1, Melapuldencel-T, MELK Inhibitor OTS167, Melphalan, Melphalan Flufenamide, Melphalan Hydrochloride, Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex, Membrane-Disrupting Peptide EP-100, Menatetrenone, Menin-MLL Interaction Inhibitor SNDX-5613, Menogaril, Merbarone, Mercaptopurine, Mercaptopurine Anhydrous, Mercaptopurine Oral Suspension, Merestinib, Mesna, Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536, MET Kinase Inhibitor OMO-1, MET Tyrosine Kinase Inhibitor BMS-777607, MET Tyrosine Kinase Inhibitor EMD 1204831, MET Tyrosine Kinase Inhibitor PF-04217903, MET Tyrosine Kinase Inhibitor SAR125844, MET Tyrosine Kinase Inhibitor SGX523, MET x MET Bispecific Antibody REGN5093, Metamelfalan, MetAP2 Inhibitor APL-1202, MetAP2 Inhibitor SDX-7320, Metarrestin, Metatinib Tromethamine, Metformin, Metformin Hydrochloride, Methanol Extraction Residue of BCG, Methazolamide, Methionine Aminopeptidase 2 Inhibitor M8891, Methionine Aminopeptidase 2 Inhibitor PPI-2458, Methotrexate, Methotrexate Sodium, Methotrexate-E Therapeutic Implant, Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles, Methoxsalen, Methoxyamine, Methoxyamine Hydrochloride, Methyl-5-Aminolevulinate Hydrochloride Cream, Methylcantharidimide, Methylmercaptopurine Riboside, Methylprednisolone, Methylprednisolone Acetate, Methylprednisolone Sodium Succinate, Methylselenocysteine, Methyltestosterone, Metoprine, Mevociclib, Mezagitamab, Mibefradil, Mibefradil Dihydrochloride, Micellar Nanoparticle-encapsulated Epirubicin, Micro Needle Array-Doxorubicin, Microbiome GEN-001, Microbiome-derived Peptide Vaccine EO2401, Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300, Microtubule Inhibitor SCB01A, Midostaurin, Mifamurtide, Mifepristone, Milademetan Tosylate, Milataxel, Milatuzumab, Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110, Milciclib Maleate, Milk Thistle, Miltefosine, Minretumomab, Mipsagargin, Miptenalimab, Mirabegron, Miransertib, Mirdametinib, Mirvetuximab Soravtansine, Mirzotamab Clezutoclax, Misonidazole, Mistletoe Extract, Mitazalimab, Mitindomide, Mitobronitol, Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101, Mitoclomine, Mitoflaxone, Mitoguazone, Mitoguazone Dihydrochloride, Mitolactol, Mitomycin, Mitomycin A, Mitomycin B, Mitomycin C Analog KW-2149, Mitosis Inhibitor T 1101 Tosylate, Mitotane, Mitotenamine, Mitoxantrone, Mitoxantrone Hydrochloride, Mitozolomide, Mivavotinib, Mivebresib, Mivobulin, Mivobulin Isethionate, Mixed Bacteria Vaccine, MK0731, MKC-1, MKNK1 Inhibitor BAY 1143269, MMP Inhibitor S-3304, MNK1/2 Inhibitor ETC-1907206, Mobocertinib, Mocetinostat, Modakafusp Alfa, Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208, Modified Vitamin D Binding Protein Macrophage Activator EF-022, Modotuximab, MOF Compound RiMO-301, Mofarotene, Mogamulizumab, Molibresib, Molibresib Besylate, Momelotinib, Monalizumab, Monocarboxylate Transporter 1 Inhibitor AZD3965, Monoclonal Antibody 105AD7 Anti-idiotype Vaccine, Monoclonal Antibody 11D10, Monoclonal Antibody 11D10 Anti-Idiotype Vaccine, Monoclonal Antibody 14G2A, Monoclonal Antibody 1F5, Monoclonal Antibody 3622W94, Monoclonal Antibody 3F8, Monoclonal Antibody 3H1 Anti-Idiotype Vaccine, Monoclonal Antibody 4B5 Anti-Idiotype Vaccine, Monoclonal Antibody 7C11, Monoclonal Antibody 81C6, Monoclonal Antibody A1G4 Anti-Idiotype Vaccine, Monoclonal Antibody A27.15, Monoclonal Antibody A33, Monoclonal Antibody AbGn-7, Monoclonal Antibody AK002, Monoclonal Antibody ASP1948, Monoclonal Antibody CAL, Monoclonal Antibody CC49-delta CH2, Monoclonal Antibody CEP-37250/KHK2804, Monoclonal Antibody D6.12, Monoclonal Antibody E2.3, Monoclonal Antibody F19, Monoclonal Antibody GD2 Anti-Idiotype Vaccine, Monoclonal Antibody HeFi-1, Monoclonal Antibody Hu3S193, Monoclonal Antibody HuAFP31, Monoclonal Antibody HuHMFG1, Monoclonal Antibody huJ591, Monoclonal Antibody HuPAM4, Monoclonal Antibody IMMU-14, Monoclonal Antibody L6, Monoclonal Antibody Lym-1, Monoclonal Antibody m170, Monoclonal Antibody Me1-14 F(ab')2, Monoclonal Antibody muJ591, Monoclonal Antibody MX35 F(ab')2, Monoclonal Antibody NEO-201, Monoclonal Antibody R24, Monoclonal Antibody RAV12, Monoclonal Antibody SGN-14, Monoclonal Antibody TRK-950, Monoclonal Microbial EDP1503, Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100, Monomethyl Auristatin E, Morinda Citrifolia Fruit Extract, Morpholinodoxorubicin, Mosedipimod, Mosunetuzumab, Motesanib, Motesanib Diphosphate, Motexafin Gadolinium, Motexafin Lutetium, Motixafortide, Motolimod, MOv-gamma Chimeric Receptor Gene, Moxetumomab Pasudotox, Mps1 Inhibitor BAY 1217389, Mps1 Inhibitor BOS172722, mRNA-based Personalized Cancer Vaccine mRNA-4157, mRNA-based Personalized Cancer Vaccine NCI-4650, mRNA-based TriMix Melanoma Vaccine ECI-006, mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902, mRNA-derived KRAS-targeted Vaccine V941, mRNA-derived Lung Cancer Vaccine BI 1361849, mRNA-Derived Prostate Cancer Vaccine CV9103, mRNA-derived Prostate Cancer Vaccine CV9104, MTF-1 Inhibitor APTO-253 HCl, mTOR Inhibitor GDC-0349, mTOR Kinase Inhibitor AZD8055, mTOR Kinase Inhibitor CC-223, mTOR Kinase Inhibitor OSI-027, mTOR Kinase Inhibitor PP242, mTOR1/2 Kinase Inhibitor ME-344, mTORC 1/2 Inhibitor LXI-15029, mTORC1/2 Kinase Inhibitor BI 860585, mTORC1/mTORC2/DHFR Inhibitor ABTL0812, MUC-1/WT1 Peptide-primed Autologous Dendritic Cells, MUC1-targeted Peptide GO-203-2C, Mucoadhesive Paclitaxel Formulation, Multi-AGC Kinase Inhibitor AT13148, Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200, Multi-epitope HER2 Peptide Vaccine H2NVAC, Multi-epitope HER2 Peptide Vaccine TPIV100, Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107, Multi-kinase Inhibitor TPX-0022, Multi-kinase Inhibitor XL092, Multi-mode Kinase Inhibitor EOC317, Multi-neo-epitope Vaccine OSE 2101, Multifunctional/Multitargeted Anticancer Agent OMN54, Multikinase Inhibitor 4SC-203, Multikinase Inhibitor AEE788, Multikinase Inhibitor AT9283, Multikinase Inhibitor SAR103168, Multipeptide Vaccine S-588210, Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327, Muparfostat, Mureletecan, Murizatoclax, Muscadine Grape Extract, Mutant IDH1 Inhibitor DS-1001, Mutant p53 Activator COTI-2, Mutant-selective EGFR Inhibitor PF-06459988, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, MVA-BN Smallpox Vaccine, MVA-FCU1 TG4023, MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1, MYC-targeting siRNA DCR-MYC, Mycobacterium tuberculosis Arabinomannan Z-100, Mycobacterium w, Mycophenolic Acid, N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea, N-dihydrogalactochitosan, N-Methylformamide, N;N-Dibenzyl Daunomycin, NA17-A Antigen, NA17.A2 Peptide Vaccine, Nab-paclitaxel, Nab-paclitaxel/Rituximab-coated Nanoparticle AR160, Nadofaragene Firadenovec, Nagrestipen, Namirotene, Namodenoson, NAMPT Inhibitor OT-82, Nanafrocin, Nanatinostat, Nanocell-encapsulated miR-16-based microRNA Mimic, Nanoparticle Albumin-Bound Docetaxel, Nanoparticle Albumin-Bound Rapamycin, Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404, Nanoparticle Paclitaxel Ointment SOR007, Nanoparticle-based Paclitaxel Suspension, Nanoparticle-encapsulated Doxorubicin Hydrochloride, Nanoscale Coordination Polymer Nanoparticles CPI-100, Nanosomal Docetaxel Lipid Suspension, Napabucasin, Naphthalimide Analogue UNBS5162, Naptumomab Estafenatox, Naquotinib, Naratuximab Emtansine, Narnatumab, Natalizumab, Natural IFN-alpha OPC-18, Natural Killer Cells ZRx101, Navarixin, Navicixizumab, Navitoclax, Navoximod, Navy Bean Powder, Naxitamab, Nazartinib, ncmtRNA Oligonucleotide Andes-1537, Necitumumab, Nedaplatin, NEDD8 Activating Enzyme E1 Inhibitor TAS4464, Nedisertib, Nelarabine, Nelipepimut-S, Nelipepimut-S Plus GM-CSF Vaccine, Nemorubicin, Nemorubicin Hydrochloride, Neoantigen Vaccine GEN-009, Neoantigen-based Glioblastoma Vaccine, Neoantigen-based Melanoma-Poly-ICLC Vaccine, Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine, Neoantigen-based Therapeutic Cancer Vaccine GRT-C903, Neoantigen-based Therapeutic Cancer Vaccine GRT-R904, Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017, Neratinib, Neratinib Maleate, Nesvacumab, NG-nitro-L-arginine, Niacinamide, Niclosamide, Nicotinamide Riboside, Nidanilimab, Nifurtimox, Nilotinib, Nilotinib Hydrochloride Anhydrous, Nilotinib Hydrochloride Monohydrate, Nilutamide, Nimesulide-Hyaluronic Acid Conjugate CA102N, Nimodipine, Nimotuzumab, Nimustine, Nimustine Hydrochloride, Ningetinib Tosylate, Nintedanib, Niraparib, Niraparib Tosylate Monohydrate, Nirogacestat, Nitric Oxide-Releasing Acetylsalicylic Acid Derivative, Nitrogen Mustard Prodrug PR-104, Nitroglycerin Transdermal Patch, Nivolumab, NLRP3 Agonist BMS-986299, Nocodazole, Nogalamycin, Nogapendekin Alfa, Nolatrexed Dihydrochloride, Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201, Norgestrel, North American Ginseng Extract AFX-2, Nortopixantrone, Noscapine, Noscapine Hydrochloride, Not Otherwise Specified, Notch Signaling Inhibitor PF-06650808, Notch Signaling Pathway Inhibitor MK0752, NTRK/ROS1 Inhibitor DS-6051b, Nucleolin Antagonist IPP-204106N, Nucleoside Analog DFP-10917, Nucleotide Analog Prodrug NUC-3373, Nucleotide Analogue GS 9219, Numidargistat, Nurulimab, Nutlin-3a, Nutraceutical TBL-12, NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611, NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301, NY-ESO-1/GLA-SE Vaccine ID-G305, NY-ESO-B, O-Chloroacetylcarbamoylfumagillol, O6-Benzylguanine, Obatoclax Mesylate, Obinutuzumab, Oblimersen Sodium, Ocaratuzumab, Ocrelizumab, Octreotide, Octreotide Acetate, Octreotide Pamoate, Odronextamab, Ofatumumab, Ofranergene Obadenovec, Oglufanide Disodium, Olaparib, Olaptesed Pegol, Olaratumab, Oleandrin, Oleclumab, Oligo-fucoidan, Oligonucleotide SPC2996, Olinvacimab, Olivomycin, Olmutinib, Oltipraz, Olutasidenib, Olvimulogene Nanivacirepvec, Omacetaxine Mepesuccinate, Ombrabulin, Omipalisib, Onalespib, Onalespib Lactate, Onartuzumab, Onatasertib, Oncolytic Adenovirus Ad5-DNX-2401, Oncolytic Adenovirus ORCA-010, Oncolytic Herpes Simplex Virus-1 ONCR-177, Oncolytic HSV-1 C134, Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011, Oncolytic HSV-1 G207, Oncolytic HSV-1 NV1020, Oncolytic HSV-1 rQNestin34.5v.2, Oncolytic HSV-1 rRp450, Oncolytic HSV1716, Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein, Oncolytic Newcastle Disease Virus MEDI5395, Oncolytic Newcastle Disease Virus MTH-68H, Oncolytic Newcastle Disease Virus Strain PV701, Oncolytic Virus ASP9801, Oncolytic Virus RP1, Ondansetron Hydrochloride, Ontorpacept, Ontuxizumab, Onvansertib, Onvatilimab, Opaganib, OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule, Opioid Growth Factor, Opolimogene Capmilisbac, Oportuzumab Monatox, Oprozomib, Opucolimab, Oral Aminolevulinic Acid Hydrochloride, Oral Azacitidine, Oral Cancer Vaccine V3-OVA, Oral Docetaxel, Oral Fludarabine Phosphate, Oral Hsp90 Inhibitor IPI-493, Oral Ixabepilone, Oral Microencapsulated Diindolylmethane, Oral Milataxel, Oral Myoma Vaccine V3-myoma, Oral Pancreatic Cancer Vaccine V3-P, Oral Picoplatin, Oral Sodium Phenylbutyrate, Oral Topotecan Hydrochloride, Orantinib, Oraxol, Oregovomab, Orelabrutinib, Ormaplatin, Ortataxel, Orteronel, Orvacabtagene Autoleucel, Osilodrostat, Osimertinib, Other, Otlertuzumab, Ovapuldencel-T, Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006, Ovine Submaxillary Mucin, OX40L-expressing Oncolytic Adenovirus DNX-2440, Oxaliplatin, Oxaliplatin Eluting Beads, Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome, Oxcarbazepine, Oxeclosporin, Oxidative Phosphorylation Inhibitor IACS-010759, Oxidative Phosphorylation Inhibitor IM156, Oxidopamine, OxPhos Inhibitor VLX600, Ozarelix, P-cadherin Antagonist PF-03732010, P-cadherin Inhibitor PCA062, P-cadherin-targeting Agent PF-06671008, P-p68 Inhibitor RX-5902, P-TEFb Inhibitor BAY1143572, p300/CBP Bromodomain Inhibitor CCS1477, p38 MAPK Inhibitor LY3007113, p53 Peptide Vaccine MPS-128, p53-HDM2 Interaction Inhibitor MI-773, p53-HDM2 Protein-protein Interaction Inhibitor APG-115, p53/HDM2 Interaction Inhibitor CGM097, p70S6K Inhibitor LY2584702, p70S6K/Akt Inhibitor MSC2363318A, p97 Inhibitor CB-5083, p97 Inhibitor CB-5339, p97 Inhibitor CB-5339 Tosylate, Paclitaxel, Paclitaxel Ceribate, Paclitaxel Injection Concentrate for Nanodispersion, Paclitaxel Liposome, Paclitaxel Poliglumex, Paclitaxel Polymeric Micelle Formulation NANT-008, Paclitaxel PPE Microspheres, Paclitaxel Trevatide, Paclitaxel Vitamin E-Based Emulsion, Paclitaxel-Loaded Polymeric Micelle, Pacmilimab, Pacritinib, Padeliporfin, Padoporfin, PAK4 Inhibitor PF-03758309, PAK4/NAMPT Inhibitor KPT-9274, Palbociclib, Palbociclib Isethionate, Palifosfamide, Palifosfamide Tromethamine, Palladium Pd-103, Palonosetron Hydrochloride, Pamidronate Disodium, Pamidronic Acid, Pamiparib, Pamrevlumab, pan FGFR Inhibitor PRN1371, Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514, Pan-AKT Inhibitor ARQ751, Pan-AKT Kinase Inhibitor GSK690693, Pan-FGFR Inhibitor LY2874455, Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806, pan-HER Kinase Inhibitor AC480, Pan-IDH Mutant Inhibitor AG-881, Pan-KRAS Inhibitor BI 1701963, Pan-Mutant-IDH1 Inhibitor Bay-1436032, Pan-mutation-selective EGFR Inhibitor CLN-081, pan-PI3K Inhibitor CLR457, pan-PI3K/mTOR Inhibitor SF1126, Pan-PIM Inhibitor INCB053914, pan-PIM Kinase Inhibitor AZD1208, pan-PIM Kinase Inhibitor NVP-LGB-321, pan-RAF Inhibitor LXH254, Pan-RAF Inhibitor LY3009120, pan-RAF Kinase Inhibitor CCT3833, pan-RAF Kinase Inhibitor TAK-580, Pan-RAR Agonist/AP-1 Inhibitor LGD 1550, Pan-TRK Inhibitor NOV1601, Pan-TRK Inhibitor ONO-7579, Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981, Pancratistatin, Panitumumab, Panobinostat, Panobinostat Nanoparticle Formulation MTX110, Panulisib, Paricalcitol, PARP 1/2 Inhibitor IMP4297, PARP 1/2 Inhibitor NOV1401, PARP Inhibitor AZD2461, PARP Inhibitor CEP-9722, PARP Inhibitor E7016, PARP Inhibitor NMS-03305293, PARP-1/2 Inhibitor ABT-767, PARP/Tankyrase Inhibitor 2X-121, PARP7 Inhibitor RBN-2397, Parsaclisib, Parsaclisib Hydrochloride, Parsatuzumab, Partially Engineered T-regulatory Cell Donor Graft TRGFT-201, Parvovirus H-1, Pasireotide, Pasotuxizumab, Patidegib, Patidegib Topical Gel, Patritumab, Patritumab Deruxtecan, Patupilone, Paxalisib, Pazopanib, Pazopanib Hydrochloride, pbi-shRNA STMN1 Lipoplex, PBN Derivative OKN-007, PCNU, PD-1 Directed Probody CX-188, PD-1 Inhibitor, PD-L1 Inhibitor GS-4224, PD-L1 Inhibitor INCB086550, PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480, PD-L1/PD-L2/VISTA Antagonist CA-170, PDK1 Inhibitor AR-12, pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0, PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1, PEG-interleukin-2, PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1, PEG-Proline-Interferon Alfa-2b, Pegargiminase, Pegaspargase, Pegdinetanib, Pegfilgrastim, Pegilodecakin, Peginterferon Alfa-2a, Peginterferon Alfa-2b, Pegvisomant, Pegvorhyaluronidase Alfa, Pegylated Deoxycytidine Analogue DFP-14927, Pegylated Interferon Alfa, Pegylated Liposomal Belotecan, Pegylated Liposomal Doxorubicin Hydrochloride, Pegylated Liposomal Irinotecan, Pegylated Liposomal Mitomycin C Lipid-based Prodrug, Pegylated Liposomal Mitoxantrone Hydrochloride, Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010, Pegylated Paclitaxel, Pegylated Recombinant Human Arginase I BCT-100, Pegylated Recombinant Human Hyaluronidase PH20, Pegylated Recombinant Interleukin-2 THOR-707, Pegylated Recombinant L-asparaginase Erwinia chrysanthemi, Pegylated SN-38 Conjugate PLX038, Pegzilarginase, Pelabresib, Pelareorep, Peldesine, Pelitinib, Pelitrexol, Pembrolizumab, Pemetrexed, Pemetrexed Disodium, Pemigatinib, Pemlimogene Merolisbac, Penberol, Penclomedine, Penicillamine, Pentamethylmelamine, Pentamustine, Pentostatin, Pentoxifylline, PEOX-based Polymer Encapsulated Paclitaxel FID-007, PEP-3-KLH Conjugate Vaccine, Pepinemab, Peplomycin, Peplomycin Sulfate, Peposertib, Peptichemio, Peptide 946 Melanoma Vaccine, Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine, Peretinoin, Perflenapent Emulsion, Perfosfamide, Perifosine, Perillyl Alcohol, Personalized ALL-specific Multi-HLA-binding Peptide Vaccine, Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC, Personalized Cancer Vaccine RO7198457, Personalized Neoantigen DNA Vaccine GNOS-PV01, Personalized Neoantigen DNA Vaccine GNOS-PVO2, Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01, Personalized Neoepitope Yeast Vaccine YE-NEO-001, Personalized Peptide Cancer Vaccine NEO-PV-01, Pertuzumab, Pevonedistat, Pexastimogene Devacirepvec, Pexidartinib, Pexmetinib, PGG Beta-Glucan, PGLA/PEG Copolymer-Based Paclitaxel, PH20 Hyaluronidase-expressing Adenovirus VCN-01, Phaleria macrocarpa Extract DLBS-1425, Pharmacological Ascorbate, Phellodendron amurense Bark Extract, Phenesterin, Phenethyl Isothiocyanate, Phenethyl Isothiocyanate-containing Watercress Juice, Phenyl Acetate, Phenytoin Sodium, Phosphaplatin PT-112, Phosphatidylcholine-Bound Silybin, Phospholipid Ether-drug Conjugate CLR 131, Phosphoramide Mustard, Phosphorodiamidate Morpholino Oligomer AVI-4126, Phosphorus P-32, Photodynamic Compound TLD-1433, Photosensitizer LUZ 11, Phytochlorin Sodium-Polyvinylpyrrolidone Complex, PI3K Alpha/Beta Inhibitor BAY1082439, PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate, PI3K Inhibitor ACP-319, PI3K Inhibitor BGT226, PI3K Inhibitor GDC-0084, PI3K Inhibitor GDC0077, PI3K Inhibitor GSK1059615, PI3K Inhibitor WX-037, PI3K Inhibitor ZSTK474, PI3K p110beta/delta Inhibitor KA2237, PI3K-alpha Inhibitor MEN1611, PI3K-beta Inhibitor GSK2636771, PI3K-beta Inhibitor SAR260301, PI3K-delta Inhibitor AMG 319, PI3K-delta Inhibitor HMPL 689, PI3K-delta Inhibitor INCB050465, PI3K-delta Inhibitor PWT143, PI3K-delta Inhibitor SHC014748M, PI3K-delta Inhibitor YY-20394, PI3K-gamma Inhibitor IPI-549, PI3K/BET Inhibitor LY294002, PI3K/mTOR Kinase Inhibitor DS-7423, PI3K/mTOR Kinase Inhibitor PF-04691502, PI3K/mTOR Kinase Inhibitor VS-5584, PI3K/mTOR Kinase Inhibitor WXFL10030390, PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170, PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901, PI3Ka/mTOR Inhibitor PKI-179, PI3Kalpha Inhibitor AZD8835, PI3Kbeta Inhibitor AZD8186, PI3Kdelta Inhibitor GS-9901, Pibenzimol, Pibrozelesin, Pibrozelesin Hydrobromide, Picibanil, Picoplatin, Picrasinoside H, Picropodophyllin, Pictilisib, Pictilisib Bismesylate, Pidilizumab, Pilaralisib, PIM Kinase Inhibitor LGH447, PIM Kinase Inhibitor SGI-1776, PIM Kinase Inhibitor TP-3654, PIM/FLT3 Kinase Inhibitor SEL24, Pimasertib, Pimitespib, Pimurutamab, Pinatuzumab Vedotin, Pingyangmycin, Pinometostat, Pioglitazone, Pioglitazone Hydrochloride, Pipendoxifene, Piperazinedione, Piperine Extract (Standardized), Pipobroman, Piposulfan, Pirarubicin, Pirarubicin Hydrochloride, Pirfenidone, Piritrexim, Piritrexim Isethionate, Pirotinib, Piroxantrone, Piroxantrone Hydrochloride, Pixantrone, Pixantrone Dimaleate, Pixatimod, PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231, PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521, PKC-beta Inhibitor MS-553, Placebo, Pladienolide Derivative E7107, Plamotamab, Plasmid DNA Vaccine pING-hHER3FL, Platinum, Platinum Acetylacetonate-Titanium Dioxide Nanoparticles, Platinum Compound, Plevitrexed, Plicamycin, Plinabulin, Plitidepsin, Plk1 Inhibitor BI 2536, PLK1 Inhibitor CYC140, PLK1 Inhibitor TAK-960, Plocabulin, Plozalizumab, pNGVL4a-CRT-E6E7L2 DNA Vaccine, pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2, Pol I Inhibitor CX5461, Polatuzumab Vedotin, Polidocanol, Poliglusam, Polo-like Kinase 1 Inhibitor GSK461364, Polo-like Kinase 1 Inhibitor MK1496, Polo-like Kinase 1 Inhibitor NMS-1286937, Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate, Poly-alendronate Dextran-Guanidine Conjugate, Poly-gamma Glutamic Acid, Polyamine Analog SL11093, Polyamine Analogue PG11047, Polyamine Analogue SBP-101, Polyamine Transport Inhibitor AMXT-1501 Dicaprate, Polyandrol, Polyethylene Glycol Recombinant Endostatin, Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318, Polymer-conjugated IL-15 Receptor Agonist NKTR-255, Polymer-encapsulated Luteolin Nanoparticle, Polymeric Camptothecin Prodrug XMT-1001, Polypodium leucotomos Extract, Polysaccharide-K, Polysialic Acid, Polyunsaturated Fatty Acid, Polyvalent Melanoma Vaccine, Pomalidomide, Pomegranate Juice, Pomegranate Liquid Extract, Ponatinib, Ponatinib Hydrochloride, Porcupine Inhibitor CGX1321, Porcupine Inhibitor ETC-1922159, Porcupine Inhibitor RXC004, Porcupine Inhibitor WNT974, Porcupine Inhibitor XNW7201, Porfimer Sodium, Porfiromycin, Poziotinib, PPAR Alpha Antagonist TPST-1120, PR1 Leukemia Peptide Vaccine, Pracinostat, Pralatrexate, Pralsetinib, Praluzatamab Ravtansine, PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701, Pravastatin Sodium, Prednimustine, Prednisolone, Prednisolone Acetate, Prednisolone Sodium Phosphate, Prednisone, Prexasertib, Prexigebersen, PRIMA-1 Analog APR-246, Prime Cancer Vaccine MVA-BN-CV301, Prinomastat, PRMT1 Inhibitor GSK3368715, PRMT5 Inhibitor JNJ-64619178, PRMT5 Inhibitor PRT811, Proapoptotic Sulindac Analog CP-461, Procarbazine, Procarbazine Hydrochloride, Procaspase Activating Compound-1 VO-100, Progestational IUD, Prohibitin-Targeting Peptide 1, Prolgolimab, Prostaglandin E2 EP4 Receptor Inhibitor AN0025, Prostaglandin E2 EP4 Receptor Inhibitor E7046, Prostate Cancer Vaccine ONY-P1, Prostate Health Cocktail Dietary Supplement, Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024, Protease-activated Anti-PD-L1 Antibody Prodrug CX-072, Protein Arginine Methyltransferase 5 Inhibitor GSK3326595, Protein Arginine Methyltransferase 5 Inhibitor PF-06939999, Protein Arginine Methyltransferase 5 Inhibitor PRT543, Protein Kinase C Inhibitor IDE196, Protein Phosphatase 2A Inhibitor LB-100, Protein Stabilized Liposomal Docetaxel Nanoparticles, Protein Tyrosine Kinase 2 Inhibitor IN10018, Proxalutamide, PSA/IL-2/GM-CSF Vaccine, PSA/PSMA DNA Plasmid INO-5150, Pseudoisocytidine, PSMA-targeted Docetaxel Nanoparticles BIND-014, PSMA-targeted Tubulysin B-containing Conjugate EC1169, PSMA/CD3 Tri-specific T-cell Activating Construct HPN424, PTEF-b/CDK9 Inhibitor BAY1251152, Pterostilbene, Pumitepa, Puquitinib, Puquitinib Mesylate, Puromycin, Puromycin Hydrochloride, PV-10, PVA Microporous Hydrospheres/Doxorubicin Hydrochloride, Pyrazinamide, Pyrazoloacridine, Pyridyl Cyanoguanidine CHS 828, Pyrotinib, Pyrotinib Dimaleate, Pyroxamide, Pyruvate Kinase Inhibitor TLN-232, Pyruvate Kinase M2 Isoform Activator TP-1454, Qilisheng Immunoregulatory Oral Solution, Quadrivalent Human Papillomavirus (types 6; 11; 16; 18) Recombinant Vaccine, Quarfloxin, Quinacrine Hydrochloride, Quinine, Quisinostat, Quizartinib, R-(-)-Gossypol Acetic Acid, Rabusertib, Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88, Racotumomab, RAD51 Inhibitor CYT-0851, Radgocitabine, Radgocitabine Hydrochloride, Radioactive Iodine, Radiolabeled CC49, Radium Ra 223 Dichloride, Radium Ra 224-labeled Calcium Carbonate Microparticles, Radix Angelicae Sinensis/Radix Astragali Herbal Supplement, Radotinib Hydrochloride, Raf Kinase Inhibitor HM95573, RAF Kinase Inhibitor L-779450, RAF Kinase Inhibitor XL281, Ragifilimab, Ralaniten Acetate, Ralimetinib Mesylate, Raloxifene, Raloxifene Hydrochloride, Raltitrexed, Ramucirumab, Ranibizumab, Ranimustine, Ranolazine, Ranpirnase, RARalpha Agonist IRX5183, Ras Inhibitor, Ras Peptide ASP, Ras Peptide CYS, Ras Peptide VAL, Razoxane, Realgar-Indigo naturalis Formulation, Rebastinib Tosylate, Rebeccamycin, Rebimastat, Receptor Tyrosine Kinase Inhibitor R1530, Recombinant Adenovirus-p53 SCH-58500, Recombinant Anti-WT1 Immunotherapeutic GSK2302024A, Recombinant Bacterial Minicells VAX014, Recombinant Bispecific Single-Chain Antibody rM28, Recombinant CD40-Ligand, Recombinant Erwinia asparaginase JZP-458, Recombinant Erythropoietin, Recombinant Fas Ligand, Recombinant Fractalkine, Recombinant Granulocyte-Macrophage Colony-Stimulating Factor, Recombinant Human 6Ckine, Recombinant Human Adenovirus Type 5 H101, Recombinant Human Angiotensin Converting Enzyme 2 APN01, Recombinant Human Apolipoprotein(a) Kringle V MG1102, Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine, Recombinant Human Endostatin, Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine, Recombinant Human Papillomavirus 11-valent Vaccine, Recombinant Human Papillomavirus Bivalent Vaccine, Recombinant Human Papillomavirus Nonavalent Vaccine, Recombinant Human Plasminogen Kringle 5 Domain ABT 828, Recombinant Human TRAIL-Trimer Fusion Protein SCB-313, Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301, Recombinant Interferon, Recombinant Interferon Alfa, Recombinant Interferon Alfa-1b, Recombinant Interferon Alfa-2a, Recombinant Interferon Alfa-2b, Recombinant Interferon Alpha 2b-like Protein, Recombinant Interferon Beta, Recombinant Interferon Gamma, Recombinant Interleukin-12, Recombinant Interleukin-13, Recombinant Interleukin-18, Recombinant Interleukin-2, Recombinant Interleukin-6, Recombinant KSA Glycoprotein CO17-1A, Recombinant Leukocyte Interleukin, Recombinant Leukoregulin, Recombinant Luteinizing Hormone, Recombinant Macrophage Colony-Stimulating Factor, Recombinant MAGE-3.1 Antigen, Recombinant MIP1-alpha Variant ECI301, Recombinant Modified Vaccinia Ankara-5T4 Vaccine, Recombinant Oncolytic Poliovirus PVS-RIPO, Recombinant Platelet Factor 4, Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A, Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207, Recombinant Super-compound Interferon, Recombinant Thyroglobulin, Recombinant Thyrotropin Alfa, Recombinant Transforming Growth Factor-Beta, Recombinant Transforming Growth Factor-Beta-2, Recombinant Tumor Necrosis Factor-Alpha, Recombinant Tyrosinase-Related Protein-2, Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter, Redaporfin, Refametinib, Regorafenib, Relacorilant, Relatlimab, Relugolix, Remetinostat, Renal Cell Carcinoma Peptides Vaccine IMA901, Reparixin, Repotrectinib, Resiquimod, Resiquimod Topical Gel, Resistant Starch, Resminostat, Resveratrol, Resveratrol Formulation SRT501, RET Inhibitor DS-5010, RET Mutation/Fusion Inhibitor BLU-667, RET/SRC Inhibitor TPX-0046, Retaspimycin, Retaspimycin Hydrochloride, Retelliptine, Retifanlimab, Retinoic Acid Agent Ro 16-9100, Retinoid 9cUAB30, Retinol, Retinyl Acetate, Retinyl Palmitate, Retrovector Encoding Mutant Anti-Cyclin G1, Revdofilimab, Rexinoid NRX 194204, Rezivertinib, RFT5-dgA Immunotoxin IMTOX25, Rhenium Re 188 BMEDA-labeled Liposomes, Rhenium Re-186 Hydroxyethylidene Diphosphonate, Rhenium Re-188 Ethiodized Oil, Rhenium Re-188 Etidronate, Rhizoxin, RhoC Peptide Vaccine RV001V, Ribociclib, Ribociclib/Letrozole, Ribonuclease QBI-139, Ribosome-Inactivating Protein CY503, Ribozyme RPI.4610, Rice Bran, Ricolinostat, Ridaforolimus, Rigosertib, Rigosertib Sodium, Rilimogene Galvacirepvec, Rilimogene Galvacirepvec/Rilimogene Glafolivec, Rilimogene Glafolivec, Rilotumumab, Rindopepimut, Ripertamab, RIPK1 Inhibitor GSK3145095, Ripretinib, Risperidone Formulation in Rumenic Acid, Ritrosulfan, Rituximab, Rituximab and Hyaluronidase Human, Rituximab Conjugate CON-4619, Riviciclib, Rivoceranib, Rivoceranib Mesylate, RNR Inhibitor COH29, Robatumumab, Roblitinib, ROBO1-targeted BiCAR-NKT Cells, Rocakinogene Sifuplasmid, Rocapuldencel-T, Rociletinib, Rodorubicin, Roducitabine, Rofecoxib, Roflumilast, Rogaratinib, Rogletimide, Rolinsatamab Talirine, Romidepsin, Roneparstat, Roniciclib, Ropeginterferon Alfa-2B, Ropidoxuridine, Ropocamptide, Roquinimex, RORgamma Agonist LYC-55716, Rosabulin, Rose Bengal Solution PV-10, Rosiglitazone Maleate, Rosmantuzumab, Rosopatamab, Rosuvastatin, Rovalpituzumab Tesirine, RSK1-4 Inhibitor PMD-026, Rubitecan, Rucaparib, Rucaparib Camsylate, Rucaparib Phosphate, Ruthenium Ru-106, Ruthenium-based Small Molecule Therapeutic BOLD-100, Ruthenium-based Transferrin Targeting Agent NKP-1339, Ruxolitinib, Ruxolitinib Phosphate, Ruxotemitide, S-Adenosylmethionine, S-equol, S1P Receptor Agonist KRP203, Sabarubicin, Sabatolimab, Sacituzumab Govitecan, Sacubitril/Valsartan, Safingol, Sagopilone, Salirasib, Salmonella VNP20009, Sam68 Modulator CWP232291, Samalizumab, Samarium Sm 153-DOTMP, Samotolisib, Samrotamab Vedotin, Samuraciclib, Sapacitabine, Sapanisertib, Sapitinib, Saracatinib, Saracatinib Difumarate, SarCNU, Sardomozide, Sargramostim, Sasanlimab, Satraplatin, Savolitinib, SBIL-2, Scopoletin, SDF-1 Receptor Antagonist PTX-9908, Seclidemstat, Sedoxantrone Trihydrochloride, Selatinib Ditosilate, Selective Androgen Receptor Modulator RAD140, Selective Cytokine Inhibitory Drug CC-1088, Selective Estrogen Receptor Degrader AZD9496, Selective Estrogen Receptor Degrader AZD9833, Selective Estrogen Receptor Degrader LSZ102, Selective Estrogen Receptor Degrader LX-039, Selective Estrogen Receptor Degrader LY3484356, Selective Estrogen Receptor Degrader SRN-927, Selective Estrogen Receptor Modulator CC-8490, Selective Estrogen Receptor Modulator TAS-108, Selective Glucocorticoid Receptor Antagonist CORT125281, Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352, Seliciclib, Selicrelumab, Selinexor, Selitrectinib, Selonsertib, Selpercatinib, Selumetinib, Selumetinib Sulfate, Semaxanib, Semuloparin, Semustine, Seneca Valley Virus-001, Seocalcitol, Sepantronium Bromide, Serabelisib, Serclutamab Talirine, SERD D-0502, SERD G1T48, SERD GDC-9545, SERD SAR439859, SERD SHR9549, SERD ZN-c5, Serdemetan, Sergiolide, Seribantumab, Serine/Threonine Kinase Inhibitor CBP501, Serine/Threonine Kinase Inhibitor XL418, Serplulimab, Sevacizumab, Seviteronel, Shared Anti-Idiotype-AB-S006, Shared Anti-Idiotype-AB-S024A, Shark Cartilage, Shark Cartilage Extract AE-941, Shenqi Fuzheng Injection SQ001, Sho-Saiko-To, Short Chain Fatty Acid HQK-1004, SHP-1 Agonist SC-43, SHP2 Inhibitor JAB-3068, SHP2 Inhibitor RLY-1971, SHP2 Inhibitor RMC-4630, SHP2 Inhibitor TNO155, Shu Yu Wan Formula, Sialyl Tn Antigen, Sialyl Tn-KLH Vaccine, Sibrotuzumab, siG12D LODER, Silatecan AR-67, Silibinin, Silicon Phthalocyanine 4, Silmitasertib Sodium, Siltuximab, Simalikalactone D, Simeprevir, Simlukafusp Alfa, Simmitinib, Simotaxel, Simtuzumab, Simurosertib, Sintilimab, Siplizumab, Sipuleucel-T, Siremadlin, siRNA-transfected Peripheral Blood Mononuclear Cells APN401, Sirolimus, SIRPa-4-1BBL Fusion Protein DSP107, SIRPa-Fc Fusion Protein TTI-621, SIRPa-Fc-CD40L Fusion Protein SL-172154, SIRPa-IgG4-Fc Fusion Protein TTI-622, Sitimagene Ceradenovec, Sitravatinib, Sivifene, Sizofiran, SLC6A8 Inhibitor RGX-202, SLCT Inhibitor GNS561, SMAC Mimetic BI 891065, Smac Mimetic GDC-0152, Smac Mimetic GDC-0917, Smac Mimetic LCL161, SMO Protein Inhibitor ZSP1602, Smoothened Antagonist BMS-833923, Smoothened Antagonist LDE225 Topical, Smoothened Antagonist LEQ506, Smoothened Antagonist TAK-441, SN-38-Loaded Polymeric Micelles NK012, SNS01-T Nanoparticles, Sobuzoxane, Sodium Borocaptate, Sodium Butyrate, Sodium Dichloroacetate, Sodium Iodide I-131, Sodium Metaarsenite, Sodium Phenylbutyrate, Sodium Salicylate, Sodium Selenite, Sodium Stibogluconate, Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108, Sofituzumab Vedotin, Solitomab, Sonepcizumab, Sonidegib, Sonolisib, Sorafenib, Sorafenib Tosylate, Sorghum bicolor Supplement, Sotigalimab, Sotorasib, Sotrastaurin, Sotrastaurin Acetate, Soy Isoflavones, Soy Protein Isolate, Spanlecortemlocel, Sparfosate Sodium, Sparfosic Acid, Spartalizumab, Spebrutinib, Spherical Nucleic Acid Nanoparticle NU-0129, Spirogermanium, Spiromustine, Spiroplatin, Splicing Inhibitor H3B-8800, Spongistatin, Squalamine Lactate, SR-BP1/HSI Inhibitor SR31747A, SR-T100 Gel, Src Kinase Inhibitor AP 23846, Src Kinase Inhibitor KX2-391, Src Kinase Inhibitor KX2-391 Ointment, Src Kinase Inhibitor M475271, Src/Abl Kinase Inhibitor AZD0424, Src/tubulin Inhibitor KX02, SRPK1/ABCG2 Inhibitor SCO-101, ssRNA-based Immunomodulator CV8102, SSTR2-targeting Protein/DM1 Conjugate PEN-221, St. John's Wort, Stallimycin, Staphylococcal Enterotoxin A, Staphylococcal Enterotoxin B, STAT Inhibitor OPB-111077, STAT3 Inhibitor DSP-0337, STAT3 Inhibitor OPB-31121, STAT3 Inhibitor OPB-51602, STAT3 Inhibitor TTI-101, STAT3 Inhibitor WP1066, Staurosporine, STING Agonist BMS-986301, STING Agonist GSK3745417, STING Agonist IMSA101, STING Agonist MK-1454, STING Agonist SB 11285, STING Agonist TAK-676, STING-activating Cyclic Dinucleotide Agonist MIW815, STING-expressing E. coli SYNB1891, Streptonigrin, Streptozocin, Strontium Chloride Sr-89, Submicron Particle Paclitaxel Sterile Suspension, Sugemalimab, Sulfatinib, Sulforaphane, Sulindac, Sulofenur, Sumoylation Inhibitor TAK-981, Sunitinib, Sunitinib Malate, Super Enhancer Inhibitor GZ17-6.02, Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803, Superoxide Dismutase Mimetic GC4711, Suramin, Suramin Sodium, Survivin Antigen, Survivin Antigen Vaccine DPX-Survivac, Survivin mRNA Antagonist EZN-3042, Survivin-expressing CVD908ssb-TXSVN Vaccine, Sustained-release Lipid Inhaled Cisplatin, Sustained-release Mitomycin C Hydrogel Formulation UGN-101, Sustained-release Mitomycin C Hydrogel Formulation UGN-102, Syk Inhibitor HMPL-523, Synchrotope TA2M Plasmid DNA Vaccine, Synchrovax SEM Plasmid DNA Vaccine, Synthetic Alkaloid PM00104, Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2, Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1, Synthetic hTERT DNA Vaccine INO-1400, Synthetic hTERT DNA Vaccine INO-1401, Synthetic Hypericin, Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201, Synthetic Long E6/E7 Peptides Vaccine HPV-01, Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b, Synthetic Plumbagin PCUR-101, T900607, Tabalumab, Tabelecleucel, Tacedinaline, Tafasitamab, Tagraxofusp-erzs, Talabostat, Talabostat Mesylate, Talacotuzumab, Talactoferrin Alfa, Taladegib, Talampanel, Talaporfin Sodium, Talazoparib, Taletrectinib, Talimogene Laherparepvec, Tallimustine, Talmapimod, Talotrexin, Talotrexin Ammonium, Taltobulin, TAM/c-Met Inhibitor RXDX-106, Tamibarotene, Taminadenant, Tamoxifen, Tamoxifen Citrate, Tamrintamab Pamozirine, Tandutinib, Tanespimycin, Tanibirumab, Tankyrase Inhibitor STP1002, Tanomastat, Tapotoclax, Tarenflurbil, Tarextumab, Tariquidar, Tasadenoturev, Taselisib, Tasidotin, Tasisulam, Tasisulam Sodium, Tasquinimod, Taurolidine, Tauromustine, Taurultam, Taurultam Analogue GP-2250, Tavokinogene Telseplasmid, Tavolimab, Taxane Analogue TPI 287, Taxane Compound, Taxol Analogue SID 530, Tazarotene, Tazemetostat, Tebentafusp, Teclistamab, Tecogalan Sodium, Tefinostat, Tegafur, Tegafur-gimeracil-oteracil Potassium, Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation, Tegafur-Uracil, Tegavivint, Teglarinad, Teglarinad Chloride, Telaglenastat, Telaglenastat Hydrochloride, Telapristone, Telapristone Acetate, Telatinib Mesylate, Telisotuzumab, Telisotuzumab Vedotin, Telomerase Inhibitor FJ5002, Telomerase-specific Type 5 Adenovirus OBP-301, Teloxantrone, Teloxantrone Hydrochloride, Telratolimod, Temarotene, Temoporfin, Temozolomide, Temsirolimus, Tenalisib, Tenifatecan, Teniposide, Tepoditamab, Tepotinib, Teprotumumab, Terameprocol, Terfluranol, Tergenpumatucel-L, Teroxirone, Tertomotide, Tesetaxel, Tesevatinib, Tesidolumab, Testolactone, Testosterone Enanthate, Tetanus Toxoid Vaccine, Tetradecanoylphorbol Acetate, Tetrahydrouridine, Tetraphenyl Chlorin Disulfonate, Tetrathiomolybdate, Tezacitabine, Tezacitabine Anhydrous, TGF-beta Receptor 1 Inhibitor PF-06952229, TGF-beta Receptor 1 Kinase Inhibitor SH3051, TGF-beta Receptor 1 Kinase Inhibitor YL-13027, TGFa-PE38 Immunotoxin, TGFbeta Inhibitor LY3200882, TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200, Thalicarpine, Thalidomide, Theliatinib, Theramide, Therapeutic Angiotensin-(1-7), Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907, Therapeutic Cancer Vaccine ATP128, Therapeutic Estradiol, Therapeutic Hydrocortisone, Therapeutic Liver Cancer Peptide Vaccine IMA970A, Thiarabine, Thiodiglycol, Thioguanine, Thioguanine Anhydrous, Thioinosine, Thioredoxin-1 Inhibitor PX-12, Thiotepa, Thioureidobutyronitrile, THL-P, Thorium Th 227 Anetumab, Thorium Th 227 Anetumab Corixetan, Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439, Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497, Threonine Tyrosine Kinase Inhibitor CFI-402257, Thymidylate Synthase Inhibitor CX1106, Thymidylate Synthase Inhibitor DFP-11207, Thymopentin, Thyroid Extract, Tiazofurin, Tidutamab, Tigapotide, Tigatuzumab, TIGIT Inhibitor M6223, TIGIT-targeting Agent MK-7684, Tilarginine, Tilogotamab, Tilsotolimod Sodium, Timonacic, Tin Ethyl Etiopurpurin, Tinostamustine, Tinzaparin Sodium, Tiomolibdate Choline, Tiomolibdate Diammonium, Tipapkinogene Sovacivec, Tipifarnib, Tipiracil, Tipiracil Hydrochloride, Tirabrutinib, Tiragolumab, Tirapazamine, Tirbanibulin, Tisagenlecleucel, Tislelizumab, Tisotumab Vedotin, Tivantinib, Tivozanib, TLC ELL-12, TLR Agonist BDB001, TLR Agonist BSG-001, TLR Agonist CADI-05, TLR-Directed Cationic Lipid-DNA Complex JVRS-100, TLR7 Agonist 852A, TLR7 agonist BNT411, TLR7 Agonist LHC165, TLR7/8/9 Antagonist IMO-8400, TLR8 Agonist DN1508052, TLR9 Agonist AST-008, TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells, Tocilizumab, Tocladesine, Tocotrienol, Tocotrienol-rich Fraction, Tolebrutinib, Toll-like Receptor 7 Agonist DSP-0509, Tolnidamine, Tomaralimab, Tomato-Soy Juice, Tomivosertib, Topical Betulinic Acid, Topical Celecoxib, Topical Fluorouracil, Topical Gemcitabine Hydrochloride, Topical Potassium Dobesilate, Topical Trichloroacetic Acid, Topixantrone, Topoisomerase I Inhibitor Genz-644282, Topoisomerase I Inhibitor LMP400, Topoisomerase I Inhibitor LMP776, Topoisomerase I/II Inhibitor NEV-801, Topoisomerase-1 Inhibitor LMP744, Topoisomerase-II Inhibitor Racemic XK469, Topoisomerase-II-beta Inhibitor Racemic XK469, Topotecan, Topotecan Hydrochloride, Topotecan Hydrochloride Liposomes, Topotecan Sustained-release Episcleral Plaque, Topsalysin, TORC1/2 Kinase Inhibitor DS-3078a, Toremifene, Toremifene Citrate, Toripalimab, Tosedostat, Tositumomab, Total Androgen Blockade, Tovetumab, Tozasertib Lactate, TP40 Immunotoxin, Trabectedin, Trabedersen, TRAIL Receptor Agonist ABBV-621, Trametinib, Trametinib Dimethyl Sulfoxide, Trans Sodium Crocetinate, Transdermal 17beta-Estradiol Gel BHR-200, Transdermal 4-Hydroxytestosterone, Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01, Transferrin Receptor-Targeted Liposomal p53 cDNA, Transferrin-CRM107, Tranylcypromine Sulfate, Trapoxin, Trastuzumab, Trastuzumab Conjugate BI-CON-02, Trastuzumab Deruxtecan, Trastuzumab Duocarmazine, Trastuzumab Emtansine, Trastuzumab Monomethyl Auristatin F, Trastuzumab-TLR 7/8 Agonist BDC-1001, Trastuzumab/Hyaluronidase-oysk, Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502, Trebananib, Tremelimumab, Treosulfan, Tretazicar, Tretinoin, Tretinoin Liposome, Triamcinolone Acetonide, Triamcinolone Hexacetonide, Triapine, Triazene Derivative CB10-277, Triazene Derivative TriN2755, Triazinate, Triaziquone, Tributyrin, Triciribine Phosphate, Trientine Hydrochloride, Triethylenemelamine, Trifluridine, Trifluridine and Tipiracil Hydrochloride, Trigriluzole, Trilaciclib, Trimelamol, Trimeric GITRL-Fc OMP-336B11, Trimethylcolchicinic Acid, Trimetrexate, Trimetrexate Glucuronate, Trioxifene, Triplatin Tetranitrate, Triptolide Analog, Triptorelin, Triptorelin Pamoate, Tris-acryl Gelatin Microspheres, Tritylcysteine, TRK Inhibitor AZD6918, TRK Inhibitor TQB3558, TrkA Inhibitor VMD-928, Trodusquemine, Trofosfamide, Troglitazone, Tropomyosin Receptor Kinase Inhibitor AZD7451, Troriluzole, Troxacitabine, Troxacitabine Nucleotide Prodrug MIV-818, TRPM8 Agonist D-3263, TRPV6 Calcium Channel Inhibitor SOR-C13, TSP-1 Mimetic ABT-510, TSP-1 Mimetic Fusion Protein CVX-045, Tubercidin, Tubulin Binding Agent TTI-237, Tubulin Inhibitor ALB 109564 Dihydrochloride, Tubulin Inhibitor ALB-109564, Tubulin Polymerization Inhibitor AEZS 112, Tubulin Polymerization Inhibitor CKD-516, Tubulin Polymerization Inhibitor VERU-111, Tubulin-Binding Agent SSR97225, Tucatinib, Tucidinostat, Tucotuzumab Celmoleukin, Tyroserleutide, Tyrosinase Peptide, Tyrosinase-KLH, Tyrosinase:146-156 Peptide, Tyrosine Kinase Inhibitor, Tyrosine Kinase Inhibitor OSI-930, Tyrosine Kinase Inhibitor SU5402, Tyrosine Kinase Inhibitor TL-895, Tyrosine Kinase Inhibitor XL228, UAE Inhibitor TAK-243, Ubenimex, Ubidecarenone Nanodispersion BPM31510n, Ublituximab, Ulinastatin, Ulixertinib, Ulocuplumab, Umbralisib, Uncaria tomentosa Extract, Upamostat, Upifitamab, Uproleselan, Uprosertib, Urabrelimab, Uracil Ointment, Urelumab, Uroacitides, Urokinase-Derived Peptide A6, Ursolic Acid, USP14/UCHL5 Inhibitor VLX1570, Utomilumab, Uzansertib, V930 Vaccine, Vaccine-Sensitized Draining Lymph Node Cells, Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules, Vactosertib, Vadacabtagene Leraleucel, Vadastuximab Talirine, Vadimezan, Valecobulin, Valemetostat, Valproic Acid, Valrubicin, Valspodar, Vandetanib, Vandetanib-eluting Radiopaque Bead BTG-002814, Vandortuzumab Vedotin, Vantictumab, Vanucizumab, Vapreotide, Varlilumab, Varlitinib, Varlitinib Tosylate, Vascular Disrupting Agent BNC105, Vascular Disrupting Agent BNC105P, Vascular Disrupting Agent ZD6126, Vatalanib, Vatalanib Succinate, Vecabrutinib, Vector-peptide Conjugated Paclitaxel, Vedolizumab, VEGF Inhibitor PTC299, VEGF/HGF-targeting DARPin MP0250, VEGFR Inhibitor KRN951, VEGFR-2 DNA Vaccine VXM01, VEGFR/FGFR Inhibitor ODM-203, VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593, VEGFR2 Tyrosine Kinase Inhibitor PF-00337210, VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813, Veliparib, Veltuzumab, Vemurafenib, Venetoclax, Verapamil, Verpasep Caltespen, Verubulin, Verubulin Hydrochloride, Vesencumab, Vesigenurtucel-L, VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220, VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820, Viagenpumatucel-L, Vibecotamab, Vibostolimab, Vilaprisan, Vinblastine, Vinblastine Sulfate, Vincristine, Vincristine Liposomal, Vincristine Sulfate, Vincristine Sulfate Liposome, Vindesine, Vinepidine, Vinflunine, Vinflunine Ditartrate, Vinfosiltine, Vinorelbine, Vinorelbine Tartrate, Vinorelbine Tartrate Emulsion, Vinorelbine Tartrate Oral, Vintafolide, Vinzolidine, Vinzolidine Sulfate, Virulizin, Vismodegib, Vistusertib, Vitamin D3 Analogue ILX23-7553, Vitamin E Compound, Vitespen, VLP-encapsulated TLR9 Agonist CMP-001, Vocimagene Amiretrorepvec, Vofatamab, Volasertib, Volociximab, Vonlerolizumab, Vopratelimab, Vorasidenib, Vorinostat, Vorolanib, Vorsetzumab Mafodotin, Vosaroxin, Vosilasarm, Voxtalisib, Vulinacimab, Warfarin Sodium, Wee1 Inhibitor ZN-c3, Wee1 Kinase Inhibitor Debio 0123, White Carrot, Wnt Signaling Inhibitor SM04755, Wnt Signaling Pathway Inhibitor SM08502, Wnt-5a Mimic Hexapeptide Foxy-5, Wobe-Mugos E, WT1 Peptide Vaccine OCV-501, WT1 Peptide Vaccine WT2725, WT1 Protein-derived Peptide Vaccine DSP-7888, WT1-A10/AS01B Immunotherapeutic GSK2130579A, WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401, Xanthohumol, XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410, Xeloda, Xentuzumab, Xevinapant, Xiaoai Jiedu Decoction, XIAP Antisense Oligonucleotide AEG35156, XIAP/cIAP1 Antagonist ASTX660, Xiliertinib, Xisomab 3G3, XPO1 Inhibitor SL-801, Y 90 Monoclonal Antibody CC49, Y 90 Monoclonal Antibody HMFG1, Y 90 Monoclonal Antibody Lym-1, Y 90 Monoclonal Antibody m170, Y 90 Monoclonal Antibody M195, Yang Yin Fu Zheng, Yangzheng Xiaoji Extract, Yiqi-yangyin-jiedu Herbal Decoction, Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12, Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12, Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8, Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101, Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66, Yttrium Y 90 Basiliximab, Yttrium Y 90 Colloid, Yttrium Y 90 Daclizumab, Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A, Yttrium Y 90 Glass Microspheres, Yttrium Y 90 Monoclonal Antibody B3, Yttrium Y 90 Monoclonal Antibody BrE-3, Yttrium Y 90 Monoclonal Antibody Hu3S193, Yttrium Y 90 Monoclonal Antibody MN-14, Yttrium Y 90 Resin Microspheres, Yttrium Y 90 Tabituximab Barzuxetan, Yttrium Y 90-DOTA-Biotin, Yttrium Y 90-DOTA-di-HSG Peptide IMP-288, Yttrium Y 90-Edotreotide, Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101, Yttrium Y-90 Clivatuzumab Tetraxetan, Yttrium Y-90 Epratuzumab Tetraxetan, Yttrium Y-90 Ibritumomab Tiuxetan, Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium-90 Polycarbonate Brachytherapy Plaque, Z-Endoxifen Hydrochloride, Zalcitabine, Zalifrelimab, Zalutumumab, Zandelisib, Zanidatamab, Zanolimumab, Zanubrutinib, Zebularine, Zelavespib, Zibotentan, Zinc Finger Nuclease ZFN-603, Zinc Finger Nuclease ZFN-758, Zinostatin, Zinostatin Stimalamer, Zirconium Zr 89 Panitumumab, Ziv-Aflibercept, Zolbetuximab, Zoledronic Acid, Zoptarelin Doxorubicin, Zorifertinib, Zorubicin, Zorubicin Hydrochloride, Zotatifin, Zotiraciclib Citrate, Zuclomiphene Citrate, Unknown, Not Reported",,FALSE,,,,,
Model Primary Diagnosis,"Text term used to describe the histologic diagnosis relevant to the model system, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O).","Abdominal desmoid, Abdominal fibromatosis, Achromic nevus, Acidophil adenocarcinoma, Acidophil adenoma, Acidophil carcinoma, Acinar adenocarcinoma, Acinar adenocarcinoma; sarcomatoid, Acinar adenoma, Acinar carcinoma, Acinar cell adenoma, Acinar cell carcinoma, Acinar cell cystadenocarcinoma, Acinar cell tumor, Acinic cell adenocarcinoma, Acinic cell adenoma, Acinic cell tumor, Acoustic neuroma, Acquired cystic disease-associated renal cell carcinoma (RCC), Acquired tufted hemangioma, Acral lentiginous melanoma; malignant, ACTH-producing tumor, Acute basophilic leukaemia, Acute bilineal leukemia, Acute biphenotypic leukemia, Acute erythremia, Acute erythremic myelosis, Acute erythroid leukaemia, Acute granulocytic leukemia, Acute leukemia; Burkitt type, Acute leukemia; NOS, Acute lymphatic leukemia, Acute lymphoblastic leukemia-lymphoma; NOS, Acute lymphoblastic leukemia; L2 type; NOS, Acute lymphoblastic leukemia; mature B-cell type, Acute lymphoblastic leukemia; NOS, Acute lymphoblastic leukemia; precursor cell type, Acute lymphocytic leukemia, Acute lymphoid leukemia, Acute megakaryoblastic leukaemia, Acute mixed lineage leukemia, Acute monoblastic and monocytic leukemia, Acute monoblastic leukemia, Acute monocytic leukemia, Acute myeloblastic leukemia, Acute myelocytic leukemia, Acute myelofibrosis, Acute myelogenous leukemia, Acute myeloid leukaemia; t(8;21)(q22;q22), Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1, Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants), Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2); RPN1-EVI1, Acute myeloid leukemia with maturation, Acute myeloid leukemia with multilineage dysplasia, Acute myeloid leukemia with mutated CEBPA, Acute myeloid leukemia with mutated NPM1, Acute myeloid leukemia with myelodysplasia-related changes, Acute myeloid leukemia with prior myelodysplastic syndrome, Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214, Acute myeloid leukemia with t(8;21)(q22;q22); RUNX1-RUNX1T1, Acute myeloid leukemia with t(9;11)(p22;q23); MLLT3-MLL, Acute myeloid leukemia without maturation, Acute myeloid leukemia without prior myelodysplastic syndrome, Acute myeloid leukemia; AML1(CBF-alpha)/ETO, Acute myeloid leukemia; CBF-beta/MYH11, Acute myeloid leukemia; inv(16)(p13;q22), Acute myeloid leukemia; M6 type, Acute myeloid leukemia; minimal differentiation, Acute myeloid leukemia; MLL, Acute myeloid leukemia; NOS, Acute myeloid leukemia; PML/RAR-alpha, Acute myeloid leukemia; t(15:17)(g22;q11-12), Acute myeloid leukemia; t(16;16)(p 13;q 11), Acute myelomonocytic leukemia, Acute myelomonocytic leukemia with abnormal eosinophils, Acute myelosclerosis; NOS, Acute myloid leukemia; 11q23 abnormalities, Acute non-lymphocytic leukemia, Acute panmyelosis with myelofibrosis, Acute panmyelosis; NOS, Acute progressive histiocytosis X, Acute promyelocytic leukaemia; PML-RAR-alpha, Acute promyelocytic leukaemia; t(15;17)(q22;q11-12), Acute promyelocytic leukemia; NOS, Adamantinoma of long bones, Adamantinoma; malignant, Adamantinoma; NOS, Adenoacanthoma, Adenoameloblastoma, Adenocarcinoid tumor, Adenocarcinoma admixed with neuroendocrine carcinoma, Adenocarcinoma combined with other types of carcinoma, Adenocarcinoma in a polyp; NOS, Adenocarcinoma in adenomatous polyp, Adenocarcinoma in adenomatous polyposis coli, Adenocarcinoma in multiple adenomatous polyps, Adenocarcinoma in polypoid adenoma, Adenocarcinoma in situ in a polyp; NOS, Adenocarcinoma in situ in adenomatous polyp, Adenocarcinoma in situ in polypoid adenoma, Adenocarcinoma in situ in tubular adenoma, Adenocarcinoma in situ in tubulovillous adenoma, Adenocarcinoma in situ in villous adenoma, Adenocarcinoma in situ; mucinous, Adenocarcinoma in situ; non-mucinous, Adenocarcinoma in situ; NOS, Adenocarcinoma in tubolovillous adenoma, Adenocarcinoma in tubular adenoma, Adenocarcinoma in villous adenoma, Adenocarcinoma of anal ducts, Adenocarcinoma of anal glands, Adenocarcinoma of rete ovarii, Adenocarcinoma with apocrine metaplasia, Adenocarcinoma with cartilaginous and osseous metaplasia, Adenocarcinoma with cartilaginous metaplasia, Adenocarcinoma with mixed subtypes, Adenocarcinoma with neuroendocrine differentiation, Adenocarcinoma with osseous metaplasia, Adenocarcinoma with spindle cell metaplasia, Adenocarcinoma with squamous metaplasia, Adenocarcinoma; cribriform comedo-type, Adenocarcinoma; cylindroid, Adenocarcinoma; diffuse type, Adenocarcinoma; endocervical type, Adenocarcinoma; intestinal type, Adenocarcinoma; metastatic; NOS, Adenocarcinoma; NOS, Adenocarcinoma; pancreatobiliary type, Adenocystic carcinoma, Adenofibroma; NOS, Adenoid basal carcinoma, Adenoid cystic carcinoma, Adenolipoma, Adenolymphoma, Adenoma of nipple, Adenoma; NOS, Adenomatoid odontogenic tumor, Adenomatoid tumor; NOS, Adenomatosis; NOS, Adenomatous polyp; NOS, Adenomatous polyposis coli, Adenomyoepithelioma, Adenomyoepithelioma with carcinoma, Adenomyoma, Adenosarcoma, Adenosquamous carcinoma, Adnexal carcinoma, Adnexal tumor; benign, Adrenal cortical adenocarcinoma, Adrenal cortical adenoma; clear cell, Adrenal cortical adenoma; compact cell, Adrenal cortical adenoma; glomerulosa cell, Adrenal cortical adenoma; mixed cell, Adrenal cortical adenoma; NOS, Adrenal cortical adenoma; pigmented, Adrenal cortical carcinoma, Adrenal cortical tumor; benign, Adrenal cortical tumor; malignant, Adrenal cortical tumor; NOS, Adrenal medullary paraganglioma, Adrenal medullary paraganglioma; malignant, Adrenal rest tumor, Adult cystic teratoma, Adult granulosa cell tumor, Adult rhabdomyoma, Adult T-cell leukemia, Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants), Adult T-cell lymphoma, Adult T-cell lymphoma/leukemia, Adult teratoma; NOS, Aggressive angiomyxoma, Aggressive digital papillary adenoma, Aggressive fibromatosis, Aggressive NK-cell leukaemia, Aggressive osteoblastoma, Aggressive systemic mastocytosis, Agnogenic myeloid metaplasia, AIN III, Aleukemic granulocytic leukemia, Aleukemic leukemia; NOS, Aleukemic lymphatic leukemia, Aleukemic lymphocytic leukemia, Aleukemic lymphoid leukemia, Aleukemic monocytic leukemia, Aleukemic myelogenous leukemia, Aleukemic myeloid leukemia, ALK positive large B-cell lymphoma, Alpha cell tumor; malignant, Alpha cell tumor; NOS, Alpha heavy chain disease, Alveolar adenocarcinoma, Alveolar adenoma, Alveolar carcinoma, Alveolar cell carcinoma, Alveolar rhabdomyosarcoma, Alveolar soft part sarcoma, Amelanotic melanoma, Ameloblastic carcinoma, Ameloblastic fibro-odontoma, Ameloblastic fibro-odontosarcoma, Ameloblastic fibrodentinoma, Ameloblastic fibrodentinosarcoma, Ameloblastic fibroma, Ameloblastic fibrosarcoma, Ameloblastic odontosarcoma, Ameloblastic sarcoma, Ameloblastoma; malignant, Ameloblastoma; NOS, AML M6, Anal intraepithelial neoplasia; grade III, Anal intraepithelial neoplasia; low grade, Anaplastic astrocytoma; IDH-mutant, Anaplastic astrocytoma; IDH-wildtype, Anaplastic large B-cell lymphoma, Anaplastic large cell lymphoma; ALK negative, Anaplastic large cell lymphoma; ALK positive, Anaplastic large cell lymphoma; CD30+, Anaplastic large cell lymphoma; NOS, Anaplastic large cell lymphoma; T cell and Null cell type, Anaplastic medulloblastoma, Anaplastic oligoastrocytoma, Anaplastic oligodendroglioma; IDH-mutant and 1p/19q-codeleted, Anaplastic pleomorphic xanthroastrocytoma, Ancient schwannoma, Androblastoma; benign, Androblastoma; malignant, Androblastoma; NOS, Angioblastic meningioma, Angioblastoma, Angiocentric glioma, Angiocentric immunoproliferative lesion, Angiocentric T-cell lymphoma, Angioendothelioma, Angioendotheliomatosis, Angiofibroma; NOS, Angioimmunoblastic lymphadenopathy, Angioimmunoblastic lymphoma, Angioimmunoblastic T-cell lymphoma, Angiokeratoma, Angioleiomyoma, Angiolipoma; NOS, Angioma; NOS, Angiomatoid fibrous histiocytoma, Angiomatous meningioma, Angiomyofibroblastoma, Angiomyolipoma, Angiomyoma, Angiomyosarcoma, Angiomyxoma, Angiosarcoma, Angiotropic lymphoma, Aortic body paraganglioma, Aortic body tumor, Aorticopulmonary paraganglioma, Apocrine adenocarcinoma, Apocrine adenoma, Apocrine cystadenoma, Apudoma, Argentaffinoma; malignant, Argentaffinoma; NOS, Arrhenoblastoma; benign, Arrhenoblastoma; malignant, Arrhenoblastoma; NOS, Arteriovenous hemangioma, Askin tumor, Astroblastoma, Astrocytic glioma, Astrocytoma; anaplastic, Astrocytoma; low grade, Astrocytoma; NOS, Astroglioma, Atypical adenoma, Atypical carcinoid tumor, Atypical choroid plexus papilloma, Atypical chronic myeloid leukemia; BCR/ABL negative, Atypical chronic myeloid leukemia; Philadelphia chromosome (Ph1) negative, Atypical fibrous histiocytoma, Atypical fibroxanthoma, Atypical follicular adenoma, Atypical hyperplasia/Endometrioid intraepithelial neoplasm, Atypical leiomyoma, Atypical lipoma, Atypical medullary carcinoma, Atypical meningioma, Atypical polypoid adenomyoma, Atypical proliferating clear cell tumor, Atypical proliferating serous tumor, Atypical proliferative endometrioid tumor, Atypical proliferative mucinous tumor, Atypical proliferative papillary serous tumor, Atypical teratoid/rhabdoid tumor, B cell lymphoma; NOS, B lymphoblastic leukemia/lymphoma with hyperdiploidy, B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL), B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1), B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1), B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH, B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1, B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged, B lymphoblastic leukemia/lymphoma; NOS, B-ALL, B-cell lymphocytic leukemia/small lymphocytic lymphoma, B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma, B-cell lymphoma; unclassifiable; with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma, Balloon cell melanoma, Balloon cell nevus, BALT lymphoma, Basal cell adenocarcinoma, Basal cell adenoma, Basal cell carcinoma; desmoplastic type, Basal cell carcinoma; fibroepithelial, Basal cell carcinoma; micronodular, Basal cell carcinoma; morpheic, Basal cell carcinoma; nodular, Basal cell carcinoma; NOS, Basal cell epithelioma, Basal cell tumor, Basaloid carcinoma, Basaloid squamous cell carcinoma, Basophil adenocarcinoma, Basophil adenoma, Basophil carcinoma, Basosquamous carcinoma, Bednar tumor, Bellini duct carcinoma, Benign cystic nephroma, Benign fibrous histiocytoma, Beta cell adenoma, Beta cell tumor; malignant, Bile duct adenocarcinoma, Bile duct adenoma, Bile duct carcinoma, Bile duct cystadenocarcinoma, Bile duct cystadenoma, Biliary intraepithelial neoplasia; grade 3, Biliary intraepithelial neoplasia; high grade, Biliary intraepithelial neoplasia; low grade, Biliary papillomatosis, Biphenotypic sinonasal sarcoma, Bizarre leiomyoma, Black adenoma, Blast cell leukemia, Blastic NK cell lymphoma, Blastic plasmacytoid dendritic cell neoplasm, Blastoma; NOS, Blue nevus; malignant, Blue nevus; NOS, Botryoid sarcoma, Bowen disease, Brenner tumor; borderline malignancy, Brenner tumor; malignant, Brenner tumor; NOS, Brenner tumor; proliferating, Bronchial adenoma; carcinoid, Bronchial adenoma; cylindroid, Bronchial adenoma; NOS, Bronchial-associated lymphoid tissue lymphoma, Bronchio-alveolar carcinoma; mixed mucinous and non-mucinous, Bronchio-alveolar carcinoma; mucinous, Bronchiolar adenocarcinoma, Bronchiolar carcinoma, Bronchiolo-alveolar adenocarcinoma; NOS, Bronchiolo-alveolar carcinoma; Clara cell, Bronchiolo-alveolar carcinoma; Clara cell and goblet cell type, Bronchiolo-alveolar carcinoma; goblet cell type, Bronchiolo-alveolar carcinoma; indeterminate type, Bronchiolo-alveolar carcinoma; non-mucinous, Bronchiolo-alveolar carcinoma; NOS, Bronchiolo-alveolar carcinoma; type II pneumocyte and goblet cell type, Bronchiolo-alveolar carcinoma; type II pneumocyte, Brooke tumor, Brown fat tumor, Burkitt cell leukemia, Burkitt lymphoma; NOS (Includes all variants), Burkitt tumor, Burkitt-like lymphoma, C cell carcinoma, c-ALL, Calcifying epithelial odontogenic tumor, Calcifying epithelioma of Malherbe, Calcifying nested epithelial stromal tumor, Calcifying odontogenic cyst, Canalicular adenoma, Cancer, Capillary hemangioma, Capillary lymphangioma, Carcinofibroma, Carcinoid tumor of uncertain malignant potential, Carcinoid tumor; argentaffin; malignant, Carcinoid tumor; argentaffin; NOS, Carcinoid tumor; NOS, Carcinoid tumor; NOS; of appendix, Carcinoid; NOS, Carcinoid; NOS; of appendix, Carcinoma in a polyp; NOS, Carcinoma in adenomatous polyp, Carcinoma in pleomorphic adenoma, Carcinoma in situ in a polyp; NOS, Carcinoma in situ in adenomatous polyp, Carcinoma in situ; NOS, Carcinoma showing thymus-like differentiation, Carcinoma showing thymus-like element, Carcinoma simplex, Carcinoma with apocrine metaplasia, Carcinoma with chondroid differentiation, Carcinoma with neuroendocrine differentiation, Carcinoma with osseous differentiation, Carcinoma with osteoclast-like giant cells, Carcinoma with other types mesenchymal differentiation, Carcinoma with productive fibrosis, Carcinoma; anaplastic; NOS, Carcinoma; diffuse type, Carcinoma; intestinal type, Carcinoma; metastatic; NOS, Carcinoma; NOS, Carcinoma; undifferentiated; NOS, Carcinomatosis, Carcinosarcoma; embryonal, Carcinosarcoma; NOS, Carotid body paraganglioma, Carotid body tumor, Cartilaginous exostosis, CASTLE, Cavernous hemangioma, Cavernous lymphangioma, Cellular angiofibroma, Cellular blue nevus, Cellular ependymoma, Cellular fibroma, Cellular leiomyoma, Cellular schwannoma, Cementifying fibroma, Cemento-ossifying fibroma, Cementoblastoma; benign, Cementoma; NOS, Central neuroblastoma, Central neurocytoma, Central odontogenic fibroma, Central osteosarcoma, Central primitive neuroectodermal tumor; NOS, Cerebellar liponeurocytoma, Cerebellar sarcoma; NOS, Ceruminous adenocarcinoma, Ceruminous adenoma, Ceruminous carcinoma, Cervical intraepithelial neoplasia; grade III, Cervical intraepithelial neoplasia; low grade, Chemodectoma, Chief cell adenoma, Chloroma, Cholangiocarcinoma, Cholangioma, Chondroblastic osteosarcoma, Chondroblastoma; malignant, Chondroblastoma; NOS, Chondroid chordoma, Chondroid lipoma, Chondroid syringoma, Chondroma; NOS, Chondromatosis; NOS, Chondromatous giant cell tumor, Chondromyxoid fibroma, Chondrosarcoma grade 2/3, Chondrosarcoma; NOS, Chordoid glioma, Chordoid glioma of third ventricle, Chordoid meningioma, Chordoma; NOS, Chorioadenoma, Chorioadenoma destruens, Chorioangioma, Choriocarcinoma combined with embryonal carcinoma, Choriocarcinoma combined with other germ cell elements, Choriocarcinoma combined with teratorna, Choriocarcinoma; NOS, Chorioepithelioma, Chorionepithelioma, Choroid plexus carcinoma, Choroid plexus papilloma; anaplastic, Choroid plexus papilloma; malignant, Choroid plexus papilloma; NOS, Chromaffin paraganglioma, Chromaffin tumor, Chromaffinoma, Chromophobe adenocarcinoma, Chromophobe adenoma, Chromophobe carcinoma, Chromophobe cell renal carcinoma, Chronic eosinophilic leukemia; NOS, Chronic erythremia, Chronic granulocytic leukemia; BCR/ABL, Chronic granulocytic leukemia; NOS, Chronic granulocytic leukemia; Philadelphia chromosome (Ph1) positive, Chronic granulocytic leukemia; t(9;22)(q34;q11), Chronic idiopathic myelofibrosis, Chronic leukemia; NOS, Chronic lymphatic leukemia, Chronic lymphocytic leukemia, Chronic lymphocytic leukemia; B-cell type (includes all variants of BCLL), Chronic lymphoid leukemia, Chronic lymphoproliferative disorder of NK cells, Chronic monocytic leukemia, Chronic myelocytic leukemia; NOS, Chronic myelogenous leukemia; BCR-ABL positive, Chronic myelogenous leukemia; Philadelphia chromosome (Ph 1) positive, Chronic myelogenous leukemia; t(9;22)(q34;q11), Chronic myeloid leukemia; NOS, Chronic myelomonocytic leukemia in transformation, Chronic myelomonocytic leukemia; NOS, Chronic myelomonocytic leukemia; Type 1, Chronic myelomonocytic leukemia; Type II, Chronic myeloproliferative disease; NOS, Chronic myeloproliferative disorder, Chronic neutrophilic leukemia, CIN III with severe dysplasia, Cin III; NOS, Circumscribed arachnoidal cerebellar sarcoma, Classical Hodgkin lymphoma; lymphocyte depletion; diffuse fibrosis, Classical Hodgkin lymphoma; lymphocyte depletion; NOS, Classical Hodgkin lymphoma; lymphocyte depletion; reticular, Classical Hodgkin lymphoma; lymphocyte-rich, Classical Hodgkin lymphoma; mixed cellularity; NOS, Classical Hodgkin lymphoma; nodular sclerosis; cellular phase, Classical Hodgkin lymphoma; nodular sclerosis; grade 1, Classical Hodgkin lymphoma; nodular sclerosis; grade 2, Classical Hodgkin lymphoma; nodular sclerosis; NOS, Clear cell (glycogen-rich) urothelial carcinoma, Clear cell adenocarcinofibroma, Clear cell adenocarcinoma; mesonephroid, Clear cell adenocarcinoma; NOS, Clear cell adenofibroma, Clear cell adenofibroma of borderline malignancy, Clear cell adenoma, Clear cell carcinoma, Clear cell chondrosarcoma, Clear cell cystadenocarcinofibroma, Clear cell cystadenofibroma, Clear cell cystadenofibroma of borderline malignancy, Clear cell cystadenoma, Clear cell cystic tumor of borderline malignancy, Clear cell ependymoma, Clear cell hidradenoma, Clear cell meningioma, Clear cell odontogenic carcinoma, Clear cell odontogenic tumor, Clear cell sarcoma of kidney, Clear cell sarcoma; NOS, Clear cell sarcoma; of tendons and aponeuroses, Clear cell tumor; NOS, Cloacogenic carcinoma, CNS Embryonal tumor with rhabdoid features, Codman tumor, Collecting duct carcinoma, Colloid adenocarcinoma, Colloid adenoma, Colloid carcinoma, Columnar cell papilloma, Combined carcinoid and adenocarcinoma, Combined hepatocellular carcinoma and cholangiocarcinoma, Combined large cell neuroendocrine carcinoma, Combined small cell carcinoma, Combined small cell-adenocarcinoma, Combined small cell-large carcinoma, Combined small cell-squamous cell carcinoma, Combined/mixed carcinoid and adenocarcinoma, Comedocarcinoma; noninfiltrating, Comedocarcinoma; NOS, Common ALL, Common precursor B ALL, Complete hydatidiform mole, Complex odontoma, Composite carcinoid, Composite Hodgkin and non-Hodgkin lymphoma, Compound nevus, Compound odontoma, Condylomatous carcinoma, Congenital fibrosarcoma, Congenital generalized fibromatosis, Congenital peribronchial myofibroblastic tumor, Conventional central osteosarcoma, Cortical T ALL, CPNET, Craniopharyngioma, Craniopharyngioma; adamantinomatous, Craniopharyngioma; papillary, Cribriform carcinoma in situ, Cribriform carcinoma; NOS, Cribriform comedo-type carcinoma, Cutaneous histiocytoma; NOS, Cutaneous lymphoma; NOS, Cutaneous mastocytosis, Cutaneous T-cell lymphoma; NOS, Cylindrical cell carcinoma, Cylindrical cell papilloma, Cylindroma of skin, Cylindroma; NOS, Cyst-associated renal cell carcinoma, Cystadenocarcinoma; NOS, Cystadenofibroma; NOS, Cystadenoma; NOS, Cystic astrocytoma, Cystic hygroma, Cystic hypersecretory carcinoma, Cystic lymphangioma, Cystic mesothelioma; benign, Cystic mesothelioma; NOS, Cystic partially differentiated nephroblastoma, Cystic teratoma; NOS, Cystic tumor of atrio-ventricular node, Cystoma; NOS, Cystosarcoma phyllodes; benign, Cystosarcoma phyllodes; malignant, Cystosarcoma phyllodes; NOS, Dabska tumor, DCIS; comedo type, DCIS; NOS, DCIS; papillary, Dedifferentiated chondrosarcoma, Dedifferentiated chordoma, Dedifferentiated liposarcoma, Deep histiocytoma, Degenerated schwannoma, Dendritic cell sarcoma; NOS, Dentinoma, Dermal and epidermal nevus, Dermal nevus, Dermatofibroma lenticulare, Dermatofibroma; NOS, Dermatofibrosarcoma protuberans; NOS, Dermatofibrosarcoma; NOS, Dermoid cyst with malignant transformation, Dermoid cyst with secondary tumor, Dermoid cyst; NOS, Dermoid; NOS, Desmoid; NOS, Desmoplastic fibroma, Desmoplastic infantile astrocytoma, Desmoplastic infantile ganglioglioma, Desmoplastic medulloblastoma, Desmoplastic melanoma; amelanotic, Desmoplastic melanoma; malignant, Desmoplastic mesothelioma, Desmoplastic nodular medulloblastoma, Desmoplastic small round cell tumor, Di Guglielmo disease, Differentiated penile intraepithelial neoplasia, Differentiated-type vulvar intraepithelial neoplasia, Diffuse astrocytoma, Diffuse astrocytoma; IDH-mutant, Diffuse astrocytoma; IDH-wildtype, Diffuse astrocytoma; low grade, Diffuse cutaneous mastocytosis, Diffuse intraductal papillomatosis, Diffuse large B-cell lymphoma associated with chronic inflammation, Diffuse large B-cell lymphoma; NOS, Diffuse leptomeningeal glioneuronal tumor, Diffuse melanocytosis, Diffuse meningiomatosis, Diffuse midline glioma; H3 K27M-mutant, Digital papillary adenocarcinoma, Diktyoma; benign, Diktyoma; malignant, DIN 3, Duct adenocarcinoma; NOS, Duct adenoma; NOS, Duct carcinoma; desmoplastic type, Duct carcinoma; NOS, Duct cell carcinoma, Ductal carcinoma in situ; comedo type, Ductal carcinoma in situ; cribriform type, Ductal carcinoma in situ; micropapillary, Ductal carcinoma in situ; NOS, Ductal carcinoma in situ; papillary, Ductal carcinoma in situ; solid type, Ductal carcinoma; cribriform type, Ductal carcinoma; NOS, Ductal intraepithelial neoplasia 3, Ductal papilloma, Dysembryoplastic neuroepithelial tumor, Dysgerminoma, Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos), Dysplastic nevus, EBV positive diffuse large B-cell lymphoma of the elderly, EC cell carcinoid, Ecchondroma, Ecchondrosis, Eccrine acrospiroma, Eccrine adenocarcinoma, Eccrine cystadenoma, Eccrine dermal cylindroma, Eccrine papillary adenocarcinoma, Eccrine papillary adenoma, Eccrine poroma, Eccrine poroma; malignant, Eccrine spiradenoma, ECL cell carcinoid; malignant, ECL cell carcinoid; NOS, Ectomesenchymoma, Ectopic hamartomatous thymoma, Elastofibroma, Embryonal adenocarcinoma, Embryonal adenoma, Embryonal carcinoma; infantile, Embryonal carcinoma; NOS, Embryonal carcinoma; polyembryonal type, Embryonal hepatoma, Embryonal rhabdomyosarcoma; NOS, Embryonal rhabdomyosarcoma; pleomorphic, Embryonal sarcoma, Embryonal teratoma, Embryonal tumor with multilayered rosettes C19MC-altered, Embryonal tumor with multilayered rosettes; NOS, Embryonal tumor with rhabdoid features, Encapsulated follicular variant of papillary thyroid carcinoma; NOS (EFVPTC; NOS), Encapsulated papillary carcinoma, Encapsulated papillary carcinoma with invasion, Enchondroma, Endocervical adenocarcinoma usual type, Endocrine adenomatosis, Endocrine tumor; functioning; NOS, Endodermal sinus tumor, Endolymphatic stromal myosis, Endometrial sarcoma; NOS, Endometrial stromal nodule, Endometrial stromal sarcoma; high grade, Endometrial stromal sarcoma; low grade, Endometrial stromal sarcoma; NOS, Endometrial stromatosis, Endometrioid adenocarcinoma; ciliated cell variant, Endometrioid adenocarcinoma; NOS, Endometrioid adenocarcinoma; secretory variant, Endometrioid adenocarcinoma; villoglandular, Endometrioid adenofibroma; borderline malignancy, Endometrioid adenofibroma; malignant, Endometrioid adenofibroma; NOS, Endometrioid adenoma; borderline malignancy, Endometrioid adenoma; NOS, Endometrioid carcinoma with squamous differentiation, Endometrioid carcinoma; NOS, Endometrioid cystadenocarcinoma, Endometrioid cystadenofibroma; borderline malignancy, Endometrioid cystadenofibroma; malignant, Endometrioid cystadenofibroma; NOS, Endometrioid cystadenoma; borderline malignancy, Endometrioid cystadenoma; NOS, Endometrioid tumor of low malignant potential, Endotheliomatous meningioma, Endovascular papillary angioendothelioma, Enteric adenocarcinoma, Enterochromaffin cell carcinoid, Enterochromaffin-like cell carcinoid; NOS, Enterochromaffin-like cell tumor; malignant, Enteroglucagonoma; malignant, Enteroglucagonoma; NOS, Enteropathy associated T-cell lymphoma, Enteropathy type intestinal T-cell lymphoma, Eosinophil adenocarcinoma, Eosinophil adenoma, Eosinophil carcinoma, Eosinophilic granuloma, Eosinophilic leukemia, Ependymoblastoma, Ependymoma; anaplastic, Ependymoma; NOS, Ependymoma; RELA fusion-positive, Epidermoid carcinoma in situ with questionable stromal invasion, Epidermoid carcinoma in situ; NOS, Epidermoid carcinoma; keratinizing, Epidermoid carcinoma; large cell; nonkeratinizing, Epidermoid carcinoma; NOS, Epidermoid carcinoma; small cell; nonkeratinizing, Epidermoid carcinoma; spindle cell, Epithelial ependymoma, Epithelial tumor; benign, Epithelial tumor; malignant, Epithelial-myoepithelial carcinoma, Epithelioid and spindle cell nevus, Epithelioid cell melanoma, Epithelioid cell nevus, Epithelioid cell sarcoma, Epithelioid glioblastoma, Epithelioid hemangioendothelioma; malignant, Epithelioid hemangioendothelioma; NOS, Epithelioid hemangioma, Epithelioid leiomyoma, Epithelioid leiomyosarcoma, Epithelioid malignant peripheral nerve sheath tumor, Epithelioid mesothelioma; benign, Epithelioid mesothelioma; malignant, Epithelioid mesothelioma; NOS, Epithelioid MPNST, Epithelioid sarcoma, Epithelioma adenoides cysticum, Epithelioma; benign, Epithelioma; malignant, Epithelioma; NOS, Erythremic myelosis; NOS, Erythroleukemia, Esophageal glandular dysplasia (intraepithelial neoplasia); high grade, Esophageal glandular dysplasia (intraepithelial neoplasia); low grade, Esophageal intraepithelial neoplasia; high grade, Esophageal squamous intraepithelial neoplasia (dysplasia); high grade, Esophageal squamous intraepithelial neoplasia (dysplasia); low grade, Essential hemorrhagic thrombocythaemia, Essential thrombocythemia, Esthesioneuroblastoma, Esthesioneurocytoma, Esthesioneuroepithelioma, Ewing sarcoma, Ewing tumor, Extra-abdominal desmoid, Extra-adrenal paraganglioma; malignant, Extra-adrenal paraganglioma; NOS, Extracutaneous mastocytoma, Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue, Extranodal NK/T-cell lymphoma; nasal type, Extraosseous plasmacytoma, Extraventricular neurocytoma, FAB L2, FAB L3, FAB Ll, FAB M1, FAB M2; AML1(CBF-alpha)/ETO, FAB M2; NOS, FAB M2; t(8;21)(q22;q22), FAB M3 (includes all variants), FAB M4, FAB M4Eo, FAB M5 (includes all variants), FAB M6, FAB M7, FAB MO, Familial polyposis coli, Fascial fibroma, Fascial fibrosarcoma, Fetal adenocarcinoma, Fetal adenoma, Fetal fat cell lipoma, Fetal lipoma; NOS, Fetal lipomatosis, Fetal rhabdomyoma, Fibrillary astrocytoma, Fibro-osteoma, Fibroadenoma; NOS, Fibroameloblastic odontoma, Fibroblastic liposarcoma, Fibroblastic meningioma, Fibroblastic osteosarcoma, Fibroblastic reticular cell tumor, Fibrochondrosarcoma, Fibroepithelial basal cell carcinoma; Pinkus type, Fibroepithelioma of Pinkus type, Fibroepithelioma; NOS, Fibrofolliculoma, Fibroid uterus, Fibrolipoma, Fibroliposarcoma, Fibroma; NOS, Fibromatosis-like metaplastic carcinoma, Fibromyoma, Fibromyxolipoma, Fibromyxoma, Fibromyxosarcoma, Fibrosarcoma; NOS, Fibrosarcomatous dermatofibrosarcoma protuberans, Fibrous astrocytoma, Fibrous histiocytoma of tendon sheath, Fibrous histiocytoma; NOS, Fibrous meningioma, Fibrous mesothelioma; benign, Fibrous mesothelioma; malignant, Fibrous mesothelioma; NOS, Fibrous papule of nose, Fibroxanthoma; malignant, Fibroxanthoma; NOS, Flat adenoma, Flat intraepithelial glandular neoplasia; high grade, Flat intraepithelial neoplasia; high grade, Florid osseous dysplasia, Follicular adenocarcinoma; moderately differentiated, Follicular adenocarcinoma; NOS, Follicular adenocarcinoma; trabecular, Follicular adenocarcinoma; well differentiated, Follicular adenoma, Follicular adenoma; oxyphilic cell, Follicular carcinoma; encapsulated, Follicular carcinoma; minimally invasive, Follicular carcinoma; moderately differentiated, Follicular carcinoma; NOS, Follicular carcinoma; oxyphilic cell, Follicular carcinoma; trabecular, Follicular carcinoma; well differentiated, Follicular dendritic cell sarcoma, Follicular dendritic cell tumor, Follicular fibroma, Follicular lymphoma; grade 1, Follicular lymphoma; grade 2, Follicular lymphoma; grade 3, Follicular lymphoma; grade 3A, Follicular lymphoma; grade 3B, Follicular lymphoma; NOS, Follicular lymphoma; small cleaved cell, Follicular thyroid carcinoma (FTC); encapsulated angioinvasive, Folliculome lipidique, Franklin disease, G cell tumor; malignant, G cell tumor; NOS, Gamma heavy chain disease, Gangliocytic paraganglioma, Gangliocytoma, Ganglioglioma; anaplastic, Ganglioglioma; NOS, Ganglioneuroblastoma, Ganglioneuroma, Ganglioneuromatosis, GANT, Gastrin cell tumor, Gastrin cell tumor; malignant, Gastrinoma; malignant, Gastrinoma; NOS, Gastrointestinal autonomic nerve tumor, Gastrointestinal pacemaker cell tumor, Gastrointestinal stromal sarcoma, Gastrointestinal stromal tumor; benign, Gastrointestinal stromal tumor; malignant, Gastrointestinal stromal tumor; NOS, Gastrointestinal stromal tumor; uncertain malignant potential, Gelatinous adenocarcinoma, Gelatinous carcinoma, Gemistocytic astrocytoma, Gemistocytoma, Genital rhabdomyoma, Germ cell tumor; nonseminomatous, Germ cell tumor; NOS, Germ cell tumors with associated hematological malignancy, Germinoma, Ghost cell odontogenic carcinoma, Giant cell and spindle cell carcinoma, Giant cell angiofibroma, Giant cell carcinoma, Giant cell fibroblastoma, Giant cell glioblastoma, Giant cell sarcoma, Giant cell sarcoma of bone, Giant cell tumor of bone; malignant, Giant cell tumor of bone; NOS, Giant cell tumor of soft parts; NOS, Giant cell tumor of tendon sheath, Giant cell tumor of tendon sheath; malignant, Giant fibroadenoma, Giant osteoid osteoma, Giant pigmented nevus; NOS, Gigantiform cementoma, GIST; benign, GIST; malignant, GIST; NOS, Glandular intraepithelial neoplasia; grade I, Glandular intraepithelial neoplasia; grade II, Glandular intraepithelial neoplasia; grade III, Glandular intraepithelial neoplasia; high grade, Glandular intraepithelial neoplasia; low grade, Glandular papilloma, Glassy cell carcinoma, Glioblastoma, Glioblastoma multiforme, Glioblastoma with sarcomatous component, Glioblastoma; IDH wildtype, Glioblastoma; IDH-mutant, Gliofibroma, Glioma; malignant, Glioma; NOS, Gliomatosis cerebri, Glioneuroma, Gliosarcoma, Glomangioma, Glomangiomyoma, Glomangiosarcoma, Glomoid sarcoma, Glomus jugulare tumor; NOS, Glomus tumor; malignant, Glomus tumor; NOS, Glucagon-like peptide-producing tumor, Glucagonoma; malignant, Glucagonoma; NOS, Glycogen-rich carcinoma, Glycogenic rhabdomyoma, Goblet cell carcinoid, Gonadal stromal tumor; NOS, Gonadoblastoma, Gonocytoma, Granular cell adenocarcinoma, Granular cell carcinoma, Granular cell myoblastoma; malignant, Granular cell myoblastoma; NOS, Granular cell tumor of the sellar region, Granular cell tumor; malignant, Granular cell tumor; NOS, Granulocytic leukemia; NOS, Granulocytic sarcoma, Granulosa cell carcinoma, Granulosa cell tumor; adult type, Granulosa cell tumor; juvenile, Granulosa cell tumor; malignant, Granulosa cell tumor; NOS, Granulosa cell tumor; sarcomatoid, Granulosa cell-theca cell tumor, Grawitz tumor, Gynandroblastoma, Haemangioblastoma, Haemangiosarcoma, Hairy cell leukaemia variant, Hairy cell leukemia, Hairy cell leukemia variant, Hairy nevus, Halo nevus, Hand-Schuller-Christian disease, Heavy chain disease; NOS, Hemangioblastic meningioma, Hemangioendothelial sarcoma, Hemangioendothelioma; benign, Hemangioendothelioma; malignant, Hemangioendothelioma; NOS, Hemangioma simplex, Hemangioma; NOS, Hemangiopericytic meningioma, Hemangiopericytoma; benign, Hemangiopericytoma; malignant, Hemangiopericytoma; NOS, Hemolymphangioma, Hepatoblastoma, Hepatoblastoma; epithelioid, Hepatoblastoma; mixed epithelial-mesenchymal, Hepatocarcinoma, Hepatocellular adenoma, Hepatocellular carcinoma; clear cell type, Hepatocellular carcinoma; fibrolamellar, Hepatocellular carcinoma; NOS, Hepatocellular carcinoma; pleomorphic type, Hepatocellular carcinoma; sarcomatoid, Hepatocellular carcinoma; scirrhous, Hepatocellular carcinoma; spindle cell variant, Hepatocholangiocarcinoma, Hepatoid adenocarcinoma, Hepatoid carcinoma, Hepatoid yolk sac tumor, Hepatoma; benign, Hepatoma; malignant, Hepatoma; NOS, Hepatosplenic gamma-delta cell lymphoma, Hepatosplenic T-cell lymphoma, Hereditary leiomyomatosis & RCC-associated renal cell carcinoma, Hibernoma, Hidradenocarcinoma, Hidradenoma papilliferum, Hidradenoma; NOS, Hidrocystoma, High grade surface osteosarcoma, High-grade neuroendocrine carcinoma, High-grade serous carcinoma, Hilar cell tumor, Hilus cell tumor, Histiocyte-rich large B-cell lymphoma, Histiocytic medullary reticulosis, Histiocytic sarcoma, Histiocytoid hemangioma, Histiocytoma; NOS, Histiocytosis X; NOS, Hodgkin disease; lymphocyte predominance; diffuse, Hodgkin disease; lymphocyte predominance; NOS, Hodgkin disease; lymphocytic-histiocytic predominance, Hodgkin disease; nodular sclerosis; lymphocyte depletion, Hodgkin disease; nodular sclerosis; lymphocyte predominance, Hodgkin disease; nodular sclerosis; mixed cellularity, Hodgkin disease; nodular sclerosis; NOS, Hodgkin disease; nodular sclerosis; syncytial variant, Hodgkin disease; NOS, Hodgkin granuloma, Hodgkin lymphoma; lymphocyte depletion; diffuse fibrosis, Hodgkin lymphoma; lymphocyte depletion; NOS, Hodgkin lymphoma; lymphocyte depletion; reticular, Hodgkin lymphoma; lymphocyte predominance; nodular, Hodgkin lymphoma; lymphocyte-rich, Hodgkin lymphoma; mixed cellularity; NOS, Hodgkin lymphoma; nodular lymphocyte predominance, Hodgkin lymphoma; nodular sclerosis; cellular phase, Hodgkin lymphoma; nodular sclerosis; grade 1, Hodgkin lymphoma; nodular sclerosis; grade 2, Hodgkin lymphoma; nodular sclerosis; NOS, Hodgkin lymphoma; NOS, Hodgkin paragranuloma; nodular, Hodgkin paragranuloma; NOS, Hodgkin sarcoma, Hurthle cell adenocarcinoma, Hurthle cell adenoma, Hurthle cell carcinoma, Hurthle cell tumor, Hutchinson melanotic freckle; NOS, Hyalinizing trabecular adenoma, Hydatid mole, Hydatidiform mole; NOS, Hydroa vacciniforme-like lymphoma, Hygroma; NOS, Hypereosinophilic syndrome, Hypernephroid tumor, Hypernephroma, Idiopathic hemorrhagic thrombocythaemia, Idiopathic thrombocythemia, Immature teratoma; malignant, Immature teratoma; NOS, Immunoblastic sarcoma, Immunocytoma, Immunoglobulin deposition disease, Immunoproliferative disease; NOS, Immunoproliferative small intestinal disease, Indeterminate dendritic cell tumor, Indolent systemic mastocytosis, Infantile fibrosarcoma, Infantile hemangioma, Infantile myofibromatosis, Infiltrating and papillary adenocarcinoma, Infiltrating angiolipoma, Infiltrating basal cell carcinoma; non-sclerosing, Infiltrating basal cell carcinoma; NOS, Infiltrating basal cell carcinoma; sclerosing, Infiltrating duct adenocarcinoma, Infiltrating duct and colloid carcinoma, Infiltrating duct and cribriform carcinoma, Infiltrating duct and lobular carcinoma, Infiltrating duct and lobular carcinoma in situ, Infiltrating duct and mucinous carcinoma, Infiltrating duct and tubular carcinoma, Infiltrating duct carcinoma; NOS, Infiltrating duct mixed with other types of carcinoma, Infiltrating ductular carcinoma, Infiltrating lipoma, Infiltrating lobular carcinoma and ductal carcinoma in situ, Infiltrating lobular carcinoma; NOS, Infiltrating lobular mixed with other types of carcinoma, Infiltrating papillary adenocarcinoma, Inflammatory adenocarcinoma, Inflammatory carcinoma, Inflammatory liposarcoma, Inflammatory myofibroblastic tumor, Insular carcinoma, Insulinoma; malignant, Insulinoma; NOS, Interdigitating cell sarcoma, Interdigitating dendritic cell sarcoma, Intermediate and giant congenital nevus, Interstitial cell tumor; benign, Interstitial cell tumor; malignant, Interstitial cell tumor; NOS, Intestinal T-cell lymphoma, Intestinal-type adenocarcinoma, Intimal sarcoma, Intracanalicular fibroadenoma, Intracortical osteosarcoma, Intracystic carcinoma; NOS, Intracystic papillary adenocarcinoma, Intracystic papillary adenoma, Intracystic papillary neoplasm with associated invasive carcinoma, Intracystic papillary neoplasm with high grade intraepithelial neoplasia, Intracystic papillary neoplasm with intermediate grade intraepithelial neoplasia, Intracystic papillary neoplasm with low grade intraepithelial neoplasia, Intracystic papillary tumor with high grade dysplasia, Intracystic papillary tumor with high grade entraepithelial neoplasia, Intracystic papillary tumor with high grade intraepithelial neoplasia, Intracystic papilloma, Intradermal nevus, Intraductal adenocarcinoma; noninfiltrating; NOS, Intraductal and lobular carcinoma, Intraductal carcinoma and lobular carcinoma in situ, Intraductal carcinoma; clinging, Intraductal carcinoma; noninfiltrating; NOS, Intraductal carcinoma; NOS, Intraductal carcinoma; solid type, Intraductal micropapillary carcinoma, Intraductal papillary adenocarcinoma with invasion, Intraductal papillary adenocarcinoma; NOS, Intraductal papillary carcinoma, Intraductal papillary mucinous neoplasm (IPMN) with an associated invasive carcinoma, Intraductal papillary mucinous neoplasm with an associated invasive carcinoma, Intraductal papillary mucinous neoplasm with high grade dysplasia, Intraductal papillary neoplasm with associated invasive carcinoma, Intraductal papillary neoplasm with high grade dysplasia, Intraductal papillary neoplasm with high grade intraepithelial neoplasia, Intraductal papillary neoplasm with intermediate grade neoplasia, Intraductal papillary neoplasm with low grade intraepithelial neoplasia, Intraductal papillary neoplasm; NOS, Intraductal papillary tumor with high grade dysplasia, Intraductal papillary tumor with high grade intraepithelial neoplasia, Intraductal papillary-mucinous adenoma, Intraductal papillary-mucinous carcinoma; invasive, Intraductal papillary-mucinous carcinoma; non-invasive, Intraductal papillary-mucinous neoplasm with low grade dysplasia, Intraductal papillary-mucinous neoplasm with moderate dysplasia, Intraductal papillary-mucinous tumor with intermediate dysplasia, Intraductal papillary-mucinous tumor with low grade dysplasia, Intraductal papillary-mucinous tumor with moderate dysplasia, Intraductal papilloma, Intraductal papilloma with ductal carcinoma in situ, Intraductal papilloma with lobular carcinoma in situ, Intraductal papillomatosis; NOS, Intraductal tubular-papillary neoplasm; high grade, Intraductal tubular-papillary neoplasm; low grade, Intraductal tubulopapillary neoplasm, Intraepidermal carcinoma; NOS, Intraepidermal epithelioma of Jadassohn, Intraepidermal nevus, Intraepidermal squamous cell carcinoma; Bowen type, Intraepithelial carcinoma; NOS, Intraepithelial squamous cell carcinoma, Intraglandular papillary neoplasm with low grade intraepithelial neoplasia, Intramuscular hemangioma, Intramuscular lipoma, Intraneural perineurioma, Intraosseous low grade osteosarcoma, Intraosseous well differentiated osteosarcoma, Intratubular germ cell neoplasia, Intratubular malignant germ cells, Intravascular B-cell lymphoma, Intravascular bronchial alveolar tumor, Intravascular large B-cell lymphoma, Intravascular leiomyomatosis, Invasive carcinoma of no special type, Invasive carcinoma; NST, Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC), Invasive fibroma, Invasive hydatidiform mole, Invasive lobular carcinoma, Invasive lobular carcinoma; alveolar type, Invasive lobular carcinoma; solid type, Invasive lobular carcinoma; tubulolobular variant, Invasive mammary carcinoma, Invasive micropapillary carcinoma, Invasive mole; NOS, Invasive mucinous adenocarcinoma, Involuting nevus, Islet cell adenocarcinoma, Islet cell adenoma, Islet cell adenomatosis, Islet cell carcinoma, Islet cell tumor; benign, Islet cell tumor; NOS, Jadassohn blue nevus, Jugular paraganglioma, Jugulotympanic paraganglioma, Junction nevus, Junctional nevus; NOS, Juvenile angiofibroma, Juvenile astrocytoma, Juvenile carcinoma of breast, Juvenile chronic myelomonocytic leukemia, Juvenile fibroadenoma, Juvenile hemangioma, Juvenile histiocytoma, Juvenile melanoma, Juvenile myelomonocytic leukemia, Juvenile nevus, Juxtacortical chondroma, Juxtacortical chondrosarcoma, Juxtacortical osteosarcoma, Juxtaglomerular tumor, Kaposi sarcoma, Kaposiform hemangioendothelioma, Keratotoc papilloma, Klatskin tumor, Krukenberg tumor, Kupffer cell sarcoma, L-cell tumor, Lactating adenoma, Langerhans cell granulomatosis, Langerhans cell granulomatosis; unifocal, Langerhans cell histiocytosis; disseminated, Langerhans cell histiocytosis; generalized, Langerhans cell histiocytosis; mono-ostotic, Langerhans cell histiocytosis; multifocal, Langerhans cell histiocytosis; NOS, Langerhans cell histiocytosis; poly-ostotic, Langerhans cell histiocytosis; unifocal, Langerhans cell sarcoma, Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease, Large cell (Ki-1+) lymphoma, Large cell calcifying Sertoli cell tumor, Large cell carcinoma with rhabdoid phenotype, Large cell carcinoma; NOS, Large cell medulloblastoma, Large cell neuroendocrine carcinoma, Large granular lymphocytosis; NOS, LCIS; NOS, Leiomyoblastoma, Leiomyofibroma, Leiomyoma; NOS, Leiomyomatosis; NOS, Leiomyosarcoma; NOS, Lennert lymphoma, Lentigo maligna, Lentigo maligna melanoma, Lepidic adenocarcinoma, Lepidic predominant adenocarcinoma, Leptomeningeal sarcoma, Letterer-Siwe disease, Leukemia; NOS, Leukemic reticuloendotheliosis, Leydig cell tumor; benign, Leydig cell tumor; malignant, Leydig cell tumor; NOS, Linitis plastica, Lipid cell tumor of ovary, Lipid-rich carcinoma, Lipid-rich Sertoli cell tumor, Lipid-rich urothelial carcinoma, Lipoadenoma, Lipoblastoma, Lipoblastomatosis, Lipoid cell tumor of ovary, Lipoleiomyoma, Lipoma-like liposarcoma, Lipoma; NOS, Lipomatous medulloblastoma, Liposarcoma; differentiated, Liposarcoma; NOS, Liposarcoma; well differentiated, Liver cell adenoma, Liver cell carcinoma, Lobular adenocarcinoma, Lobular and ductal carcinoma, Lobular carcinoma in situ; NOS, Lobular carcinoma; noninfiltrating, Lobular carcinoma; NOS, Localized fibrous tumor, Low grade adenosquamous carcinoma, Low grade appendiceal mucinous neoplasm, Low grade cribriform cystadenocarcinoma (LGCCC), Low-grade central osteosarcoma, Low-grade fibromyxoid sarcoma, Low-grade intramedullary osteosarcoma, Low-grade myofibroblastic sarcoma, Low-grade serous carcinoma, Luteinoma, Luteoma; NOS, Lymphangioendothelial sarcoma, Lymphangioendothelioma; malignant, Lymphangioendothelioma; NOS, Lymphangioleiomyomatosis, Lymphangioma; NOS, Lymphangiomyoma, Lymphangiomyomatosis, Lymphangiosarcoma, Lymphatic leukemic; NOS, Lymphoblastic leukemia; NOS, Lymphoblastoma, Lymphocytic leukemia; NOS, Lymphoepithelial carcinoma, Lymphoepithelioid lymphoma, Lymphoepithelioma, Lymphoepithelioma-like carcinoma, Lymphoid leukemia; NOS, Lymphoma; NOS, Lymphomatoid granulomatosis, Lymphomatoid papulosis, Lymphoplasmacyte-rich meningioma, Lymphoproliferative disease; NOS, Lymphoproliferative disorder; NOS, Lymphosarcoma cell leukemia, Lymphosarcoma; diffuse, Lymphosarcoma; NOS, M6A, M6B, Macrofollicular adenoma, Magnocellular nevus, Malignancy, Malignant chondroid syringoma, Malignant cystic nephroma, Malignant eccrine spiradenoma, Malignant fibrous histiocytoma, Malignant fibrous histiocytoma (MFH) of bone, Malignant giant cell tumor of soft parts, Malignant histiocytosis, Malignant hydatidiform mole, Malignant lymphoma; centroblastic; diffuse, Malignant lymphoma; centroblastic; follicular, Malignant lymphoma; centroblastic; NOS, Malignant lymphoma; centroblasticcentrocytic; diffuse, Malignant lymphoma; centroblasticcentrocytic; follicular, Malignant lymphoma; centroblasticcentrocytic; NOS, Malignant lymphoma; centrocytic, Malignant lymphoma; cleaved cell; NOS, Malignant lymphoma; convoluted cell, Malignant lymphoma; diffuse; NOS, Malignant lymphoma; follicle center; follicular, Malignant lymphoma; follicle center; NOS, Malignant lymphoma; follicular; NOS, Malignant lymphoma; histiocytic; diffuse, Malignant lymphoma; histiocytic; nodular, Malignant lymphoma; histiocytic; NOS, Malignant lymphoma; Hodgkin, Malignant lymphoma; immunoblastic; NOS, Malignant lymphoma; large B-cell; diffuse; centroblastic; NOS, Malignant lymphoma; large B-cell; diffuse; immunoblastic; NOS, Malignant lymphoma; large B-cell; diffuse; NOS, Malignant lymphoma; large B-cell; NOS, Malignant lymphoma; large cell; cleaved and noncleaved, Malignant lymphoma; large cell; cleaved; diffuse, Malignant lymphoma; large cell; cleaved; NOS, Malignant lymphoma; large cell; diffuse; NOS, Malignant lymphoma; large cell; follicular; NOS, Malignant lymphoma; large cell; immunoblastic, Malignant lymphoma; large cell; noncleaved; diffuse, Malignant lymphoma; large cell; noncleaved; follicular, Malignant lymphoma; large cell; noncleaved; NOS, Malignant lymphoma; large cell; NOS, Malignant lymphoma; large cleaved cell; follicular, Malignant lymphoma; large cleaved cell; NOS, Malignant lymphoma; lymphoblastic; NOS, Malignant lymphoma; lymphocytic; diffuse; NOS, Malignant lymphoma; lymphocytic; intermediate differentiation; diffuse, Malignant lymphoma; lymphocytic; intermediate differentiation; nodular, Malignant lymphoma; lymphocytic; nodular; NOS, Malignant lymphoma; lymphocytic; NOS, Malignant lymphoma; lymphocytic; poorly differentiated; diffuse, Malignant lymphoma; lymphocytic; poorly differentiated; nodular, Malignant lymphoma; lymphocytic; well differentiated; diffuse, Malignant lymphoma; lymphocytic; well differentiated; nodular, Malignant lymphoma; lymphoplasmacytic, Malignant lymphoma; lymphoplasmacytoid, Malignant lymphoma; mixed cell type; diffuse, Malignant lymphoma; mixed cell type; follicular, Malignant lymphoma; mixed cell type; nodular, Malignant lymphoma; mixed lymphocytic-histiocytic; diffuse, Malignant lymphoma; mixed lymphocytic-histiocytic; nodular, Malignant lymphoma; mixed small and large cell; diffuse, Malignant lymphoma; mixed small cleaved and large cell; follicular, Malignant lymphoma; nodular; NOS, Malignant lymphoma; non-cleaved cell; NOS, Malignant lymphoma; non-Hodgkin; NOS, Malignant lymphoma; noncleaved cell; follicular; NOS, Malignant lymphoma; noncleaved; diffuse; NOS, Malignant lymphoma; noncleaved; NOS, Malignant lymphoma; NOS, Malignant lymphoma; plasmacytoid, Malignant lymphoma; small B lymphocytic; NOS, Malignant lymphoma; small cell diffuse, Malignant lymphoma; small cell; noncleaved; diffuse, Malignant lymphoma; small cell; NOS, Malignant lymphoma; small cleaved cell; diffuse, Malignant lymphoma; small cleaved cell; follicular, Malignant lymphoma; small cleaved cell; NOS, Malignant lymphoma; small lymphocytic; diffuse, Malignant lymphoma; small lymphocytic; NOS, Malignant lymphoma; small noncleaved; Burkitt type, Malignant lymphoma; undifferentiated cell type; NOS, Malignant lymphoma; undifferentiated cell; non-Burkitt, Malignant lymphoma; undifferentiated; Burkitt type, Malignant lymphomatous polyposis, Malignant mast cell tumor, Malignant mastocytoma, Malignant mastocytosis, Malignant melanoma in congenital melanocytic nevus, Malignant melanoma in giant pigmented nevus, Malignant melanoma in Hutchinson melanotic freckle, Malignant melanoma in junctional nevus, Malignant melanoma in precancerous melanosis, Malignant melanoma; NOS, Malignant melanoma; regressing, Malignant midline reticulosis, Malignant mucinous adenofibroma, Malignant mucinous cystadenofibroma, Malignant multilocular cystic nephroma, Malignant myelosclerosis, Malignant myoepithelioma, Malignant peripheral nerve sheath tumor, Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation, Malignant perivascular epithelial cell tumor, Malignant reticulosis; NOS, Malignant rhabdoid tumor, Malignant schwannoma with rhabdomyoblastic differentiation, Malignant schwannoma; NOS, Malignant serous adenofibroma, Malignant serous cystadenofibroma, Malignant tenosynovial giant cell tumor, Malignant teratoma; anaplastic, Malignant teratoma; intermediate, Malignant teratoma; trophoblastic, Malignant teratoma; undifferentiated, Malignant tumor; clear cell type, Malignant tumor; fusiform cell type, Malignant tumor; giant cell type, Malignant tumor; small cell type, Malignant tumor; spindle cell type, MALT lymphoma, Mammary carcinoma; in situ, MANEC, Mantle cell lymphoma (Includes all variants blastic; pleomorphic; small cell), Mantle zone lymphoma, Marginal zone B-cell lymphoma; NOS, Marginal zone lymphoma; NOS, Masculinovoblastoma, Mast cell leukaemia, Mast cell sarcoma, Mast cell tumor; NOS, Mastocytoma; NOS, Matrical carcinoma, Mature T ALL, Mature T-cell lymphoma; NOS, Mature teratoma, Mediastinal (thymic) large B-cell lymphoma, Mediterranean lymphoma, Medullary adenocarcinoma, Medullary carcinoma with amyloid stroma, Medullary carcinoma with lymphoid stroma, Medullary carcinoma; NOS, Medullary osteosarcoma, Medulloblastoma with extensive nodularity, Medulloblastoma; classic, Medulloblastoma; group 3, Medulloblastoma; group 4, Medulloblastoma; non-WNT/non-SHH, Medulloblastoma; NOS, Medulloblastoma; SHH-activated and TP53-mutant, Medulloblastoma; SHH-activated and TP53-wildtype, Medulloblastoma; WNT-activated, Medullocytoma, Medulloepithelioma; benign, Medulloepithelioma; NOS, Medullomyoblastoma, Megakaryocytic leukemia, Megakaryocytic myelosclerosis, Melanoameloblastoma, Melanocytic nevus, Melanocytoma; eyeball, Melanocytoma; NOS, Melanoma in situ, Melanoma; malignant; of soft parts, Melanoma; NOS, Melanotic medulloblastoma, Melanotic MPNST, Melanotic neuroectodermal tumor, Melanotic neurofibroma, Melanotic progonoma, Melanotic psammomatous MPNST, Melanotic schwannoma, Meningeal melanocytoma, Meningeal melanoma, Meningeal melanomatosis, Meningeal sarcoma, Meningeal sarcomatosis, Meningioma; anaplastic, Meningioma; malignant, Meningioma; NOS, Meningiomatosis; NOS, Meningothelial meningioma, Meningothelial sarcoma, Merkel cell carcinoma, Merkel cell tumor, Mesenchymal chondrosarcoma, Mesenchymal tumor; malignant, Mesenchymoma; benign, Mesenchymoma; malignant, Mesenchymoma; NOS, Mesenteric fibromatosis, Mesoblastic nephroma, Mesodermal mixed tumor, Mesonephric adenocarcinoma, Mesonephric adenoma, Mesonephric tumor; NOS, Mesonephroma; benign, Mesonephroma; malignant, Mesonephroma; NOS, Mesothelial papilloma, Mesothelioma; benign, Mesothelioma; biphasic; malignant, Mesothelioma; biphasic; NOS, Mesothelioma; malignant, Mesothelioma; NOS, Metanephric adenoma, Metaplastic carcinoma of no special type, Metaplastic carcinoma with chondroid differentiation, Metaplastic carcinoma with osseous differentiation, Metaplastic carcinoma with other types mesenchymal differentiation, Metaplastic carcinoma; NOS, Metaplastic meningioma, Metastasizing leiomyoma, Metastatic signet ring cell carcinoma, Metatypical carcinoma, MGUS, Microcystic adenoma, Microcystic adnexal carcinoma, Microcystic meningioma, Microcystic urothelial carcinoma, Microfollicular adenoma; NOS, Microglioma, Micropapillary adenocarcinoma, Micropapillary carcinoma; NOS, Micropapillary serous carcinoma, Midline carcinoma of children and young adults with NUT rearrangement, Minimally invasive adenocarcinoma; mucinous, Minimally invasive adenocarcinoma; non-mucinous, Minimally invasive adenocarcinoma; NOS, MiT family translocation renal cell carcinoma, Mixed acidophil-basophil adenoma, Mixed acidophil-basophil carcinoma, Mixed acinar-ductal carcinoma, Mixed acinar-endocrine carcinoma, Mixed acinar-endocrine-ductal carcinoma, Mixed adenocarcinoma and epidermoid carcinoma, Mixed adenocarcinoma and squamous cell carcinoma, Mixed adenomatous and hyperplastic polyp, Mixed adenoneuroendocrine carcinoma, Mixed basal-squamous cell carcinoma, Mixed carcinoid-adenocarcinoma, Mixed cell adenocarcinoma, Mixed cell adenoma, Mixed ductal-endocrine carcinoma, Mixed embryonal carcinoma and teratoma, Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma, Mixed endocrine and exocrine adenocarcinoma, Mixed epithelioid and spindle cell melanoma, Mixed germ cell sex cord-stromal tumor; unclassified, Mixed germ cell tumor, Mixed glioma, Mixed hepatocellular and bile duct carcinoma, Mixed invasive mucinous and non-mucinous adenocarcinoma, Mixed islet cell and exocrine adenocarcinoma, Mixed liposarcoma, Mixed medullary-follicular carcinoma, Mixed medullary-papillary carcinoma, Mixed meningioma, Mixed mesenchymal sarcoma, Mixed mesenchymal tumor, Mixed pancreatic endocrine and exocrine tumor; malignant, Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1, Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged, Mixed phenotype acute leukemia; B/myeloid; NOS, Mixed phenotype acute leukemia; T/myeloid; NOS, Mixed pineal tumor, Mixed pineocytoma-pineoblastoma, Mixed small cell carcinoma, Mixed squamous cell and glandular papilloma, Mixed subependymoma-ependymoma, Mixed teratoma and seminoma, Mixed tumor; malignant; NOS, Mixed tumor; NOS, Mixed tumor; salivary gland type; malignant, Mixed tumor; salivary gland type; NOS, Mixed type rhabdomyosarcoma, Monoblastic leukemia; NOS, Monoclonal gammopathy of undetermined significance, Monoclonal gammopathy; NOS, Monocytic leukemia; NOS, Monocytoid B-cell lymphoma, Monomorphic adenoma, Monstrocellular sarcoma, MPNST with glandular differentiation, MPNST with mesenchymal differentiation, MPNST with rhabdomyoblastic differentiation, MPNST; NOS, Mu heavy chain disease, Mucin-producing adenocarcinoma, Mucin-producing carcinoma, Mucin-secreting adenocarcinoma, Mucin-secreting carcinoma, Mucinous adenocarcinofibroma, Mucinous adenocarcinoma, Mucinous adenocarcinoma; endocervical type, Mucinous adenofibroma of borderline malignancy, Mucinous adenofibroma; NOS, Mucinous adenoma, Mucinous carcinoid, Mucinous carcinoma, Mucinous carcinoma; gastric type, Mucinous carcinoma; intestinal type, Mucinous cystadenocarcinofibroma, Mucinous cystadenocarcinoma; non-invasive, Mucinous cystadenocarcinoma; NOS, Mucinous cystadenofibroma of borderline malignancy, Mucinous cystadenofibroma; NOS, Mucinous cystadenoma; borderline malignancy, Mucinous cystadenoma; NOS, Mucinous cystic neoplasm with an associated invasive carcinoma, Mucinous cystic neoplasm with high-grade dysplasia, Mucinous cystic neoplasm with high-grade intraepithelial neoplasia, Mucinous cystic neoplasm with intermediate-grade dysplasia, Mucinous cystic neoplasm with intermediate-grade intraepithelial neoplasia, Mucinous cystic neoplasm with low-grade dysplasia, Mucinous cystic neoplasm with low-grade intraepithelial neoplasia, Mucinous cystic tumor of borderline malignancy, Mucinous cystic tumor with an associated invasive carcinoma, Mucinous cystic tumor with high-grade dysplasia, Mucinous cystic tumor with intermediate dysplasia, Mucinous cystic tumor with low grade dysplasia, Mucinous cystic tumor with moderate dysplasia, Mucinous cystoma, Mucinous tubular and spindle cell carcinoma, Mucinous tumor; NOS; of low malignant potential, Mucocarcinoid tumor, Mucoepidermoid carcinoma, Mucoepidermoid tumor, Mucoid adenocarcinoma, Mucoid carcinoma, Mucoid cell adenocarcinoma, Mucoid cell adenoma, Mucosal lentiginous melanoma, Mucosal-associated lymphoid tissue lymphoma, Mucous adenocarcinoma, Mucous carcinoma, Mullerian adenosarcoma, Mullerian mixed tumor, Multicentric basal cell carcinoma, Multicystic mesothelioma; benign, Multifocal superficial basal cell carcinoma, Multiple adenomatous polyps, Multiple endocrine adenomas, Multiple hemorrhagic sarcoma, Multiple meningiomas, Multiple myeloma, Multiple neurofibromatosis, Mycosis fungoides, Myelocytic leukemia; NOS, Myelodysplastic syndrome with 5q deletion (5q-) syndrome, Myelodysplastic syndrome with isolated del (5q), Myelodysplastic syndrome; NOS, Myelodysplastic syndrome; unclassifiable, Myelodysplastic/myeloproliferative neoplasm; unclassifiable, Myelofibrosis as a result of myeloproliferative disease, Myelofibrosis with myeloid metaplasia, Myelogenous leukemia; NOS, Myeloid and lymphoid neoplasms with FGFR1 abnormalities, Myeloid and lymphoid neoplasms with PDGFRA rearrangement, Myeloid leukemia associated with Down Syndrome, Myeloid leukemia; NOS, Myeloid neoplasms with PDGFRB rearrangement, Myeloid sarcoma, Myelolipoma, Myeloma; NOS, Myelomatosis, Myelomonocytic leukemia; NOS, Myeloproliferative disease; NOS, Myeloproliferative neoplasm; NOS, Myelosclerosis with myeloid metaplasia, Myloproliferative neoplasm; unclassifiable, Myoepithelial adenoma, Myoepithelial carcinoma, Myoepithelial tumor, Myoepithelioma, Myofibroblastic sarcoma, Myofibroblastic tumor; NOS, Myofibroblastic tumor; peribronchial, Myofibroblastoma, Myofibroma, Myofibromatosis, Myoma, Myosarcoma, Myxofibroma; NOS, Myxoid chondrosarcoma, Myxoid fibroma, Myxoid leiomyosarcoma, Myxoid liposarcoma, Myxoinflammatory fibroblastic sarcoma (MIFS), Myxolipoma, Myxoliposarcoma, Myxoma; NOS, Myxopapillary ependymoma, Myxosarcoma, Neoplasm; benign, Neoplasm; malignant, Neoplasm; malignant; uncertain whether primary or metastatic, Neoplasm; metastatic, Neoplasm; NOS, Neoplasm; secondary, Neoplasm; uncertain whether benign or malignant, Nephroblastoma; NOS, Nephrogenic adenofibroma, Nephroma; NOS, Nerve sheath myxoma, Nesidioblastoma, Nested urothelial carcinoma, Neurilemoma; malignant, Neurilemoma; NOS, Neurilemosarcoma, Neurinoma, Neurinomatosis, Neuroastrocytoma, Neuroblastoma; NOS, Neurocytoma, Neuroectodermal tumor; NOS, Neuroendocrine carcinoma; low grade, Neuroendocrine carcinoma; moderately differentiated, Neuroendocrine carcinoma; NOS, Neuroendocrine carcinoma; poorly differentiated, Neuroendocrine carcinoma; well-differentiated, Neuroendocrine tumor; grade 1, Neuroendocrine tumor; grade 2, Neuroendocrine tumor; well differentiated, Neuroepithelioma; NOS, Neurofibroma; NOS, Neurofibromatosis; NOS, Neurofibrosarcoma, Neurogenic sarcoma, Neurolipocytoma, Neuroma; NOS, Neuronevus, Neurosarcoma, Neurothekeoma, Neurotropic melanoma; malignant, Nevus; NOS, NK-cell large granular lymphocytic leukemia, NK/T-cell lymphoma; nasal and nasal-type, Nodal marginal zone lymphoma, Nodular hidradenoma, Nodular hidradenoma; malignant, Nodular melanoma, Non-Hodgkin lymphoma; NOS, Non-invasive EFVPTC, Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC), Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), Non-invasive FTP, Non-invasive low grade serous carcinoma, Non-invasive mammary carcinoma, Non-lymphocytic leukemia; NOS, Non-small cell carcinoma, Nonchromaffin paraganglioma; malignant, Nonchromaffin paraganglioma; NOS, Nonencapsulated sclerosing adenocarcinoma, Nonencapsulated sclerosing carcinoma, Nonencapsulated sclerosing tumor, Noninfiltrating intracystic carcinoma, Noninfiltrating intraductal papillary adenocarcinoma, Noninfiltrating intraductal papillary carcinoma, Noninvasive pancreatobiliary papillary neoplasm with high grade dysplasia, Noninvasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia, Noninvasive pancreatobiliary papillary neoplasm with low grade dysplasia, Noninvasive pancreatobiliary papillary neoplasm with low grade intraepithelial neoplasia, Nonlipid reticuloendotheliosis, Nonpigmented nevus, NUT carcinoma, NUT midline carcinoma, Oat cell carcinoma, Odontoameloblastoma, Odontogenic carcinoma, Odontogenic carcinosarcoma, Odontogenic fibroma; NOS, Odontogenic fibrosarcoma, Odontogenic ghost cell tumor, Odontogenic myxofibroma, Odontogenic myxoma, Odontogenic sarcoma, Odontogenic tumor; benign, Odontogenic tumor; malignant, Odontogenic tumor; NOS, Odontoma; NOS, Olfactory neuroblastoma, Olfactory neurocytoma, Olfactory neuroepithelioma, Olfactory neurogenic tumor, Oligoastrocytoma, Oligodendroblastoma, Oligodendroglioma; anaplastic, Oligodendroglioma; IDH-mutant and 1p/19q-codeleted, Oligodendroglioma; NOS, Oncocytic adenocarcinoma, Oncocytic adenoma, Oncocytic carcinoma, Oncocytic Schneiderian papilloma, Oncocytoma, Orchioblastoma, Ossifying fibroma, Ossifying fibromyxoid tumor, Ossifying fibromyxoid tumor; malignant, Ossifying renal tumor, Osteoblastic sarcoma, Osteoblastoma; malignant, Osteoblastoma; NOS, Osteocartilaginous exostosis, Osteochondroma, Osteochondromatosis; NOS, Osteochondrosarcoma, Osteofibroma, Osteofibrosarcoma, Osteogenic sarcoma; NOS, Osteoid osteoma; NOS, Osteoma; NOS, Osteosarcoma in Paget disease of bone, Osteosarcoma; NOS, Ovarian stromal tumor, Oxyphilic adenocarcinoma, Oxyphilic adenoma, Pacinian tumor, Paget disease and infiltrating duct carcinoma of breast, Paget disease and intraductal carcinoma of breast, Paget disease of breast, Paget disease; extramammary, Paget disease; mammary, Pagetoid reticulosis, Pancreatic endocrine tumor; benign, Pancreatic endocrine tumor; malignant, Pancreatic endocrine tumor; nonfunctioning, Pancreatic endocrine tumor; NOS, Pancreatic microadenoma, Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor, Pancreatobiliary neoplasm; non-invasive, Pancreatobiliary-type carcinoma, Pancreatoblastoma, Papillary adenocarcinoma; follicular variant, Papillary adenocarcinoma; NOS, Papillary adenofibroma, Papillary adenoma; NOS, Papillary and follicular adenocarcinoma, Papillary and follicular carcinoma, Papillary carcinoma in situ, Papillary carcinoma of thyroid, Papillary carcinoma; columnar cell, Papillary carcinoma; diffuse sclerosing, Papillary carcinoma; encapsulated, Papillary carcinoma; follicular variant, Papillary carcinoma; NOS, Papillary carcinoma; oxyphilic cell, Papillary carcinoma; tall cell, Papillary cystadenocarcinoma; NOS, Papillary cystadenoma lymphomatosum, Papillary cystadenoma; borderline malignancy, Papillary cystadenoma; NOS, Papillary cystic tumor, Papillary ependymoma, Papillary epidermoid carcinoma, Papillary glioneuronal tumor, Papillary hidradenoma, Papillary meningioma, Papillary microcarcinoma, Papillary mucinous cystadenocarcinoma, Papillary mucinous cystadenoma; borderline malignancy, Papillary mucinous cystadenoma; NOS, Papillary mucinous tumor of low malignant potential, Papillary neoplasm; pancreatobiliary-type; with high grade intraepithelial neoplasia, Papillary pseudomucinous cystadenocarcinoma, Papillary pseudomucinous cystadenoma; borderline malignancy, Papillary pseudomucinous cystadenoma; NOS, Papillary renal cell carcinoma, Papillary serous adenocarcinoma, Papillary serous cystadenocarcinoma, Papillary serous cystadenoma; borderline malignancy, Papillary serous cystadenoma; NOS, Papillary serous tumor of low malignant potential, Papillary squamous cell carcinoma, Papillary squamous cell carcinoma in situ, Papillary squamous cell carcinoma; non-invasive, Papillary syringadenoma, Papillary syringocystadenoma, Papillary transitional cell carcinoma, Papillary transitional cell carcinoma; non-invasive, Papillary transitional cell neoplasm of low malignant potential, Papillary tumor of the pineal region, Papillary urothelial carcinoma, Papillary urothelial carcinoma; non-invasive, Papillary urothelial neoplasm of low malignant potential, Papillocystic adenocarcinoma, Papilloma of bladder, Papilloma; NOS, Papillomatosis; glandular, Papillomatosis; NOS, Papillotubular adenocarcinoma, Papillotubular adenoma, Parachordoma, Parafollicular cell carcinoma, Paraganglioma; benign, Paraganglioma; malignant, Paraganglioma; NOS, Parasympathetic paraganglioma, Parietal cell adenocarcinoma, Parietal cell carcinoma, Parosteal osteosarcoma, Partial hydatidiform mole, PEComa; malignant, Periapical cemental dysplasia, Periapical cemento-osseous dysplasia, Pericanalicular fibroadenoma, Periductal stromal tumor; low grade, Perifollicular fibroma, Perineural MPNST, Perineurioma; malignant, Perineurioma; NOS, Periosteal chondroma, Periosteal chondrosarcoma, Periosteal fibroma, Periosteal fibrosarcoma, Periosteal osteosarcoma, Periosteal sarcoma; NOS, Peripheral neuroectodermal tumor, Peripheral odontogenic fibroma, Peripheral primitive neuroectodermal tumor; NOS, Peripheral T-cell lymphoma; AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia), Peripheral T-cell lymphoma; large cell, Peripheral T-cell lymphoma; NOS, Peripheral T-cell lymphoma; pleomorphic medium and large cell, Peripheral T-cell lymphoma; pleomorphic small cell, Perivascular epithelioid cell tumor; malignant, Pheochromoblastoma, Pheochromocytoma; malignant, Pheochromocytoma; NOS, Phosphaturic mesenchymal tumor; malignant, Phyllodes tumor; benign, Phyllodes tumor; borderline, Phyllodes tumor; malignant, Phyllodes tumor; NOS, Pick tubular adenoma, Pigmented adenoma, Pigmented basal cell carcinoma, Pigmented dermatofibrosarcoma protuberans, Pigmented nevus; NOS, Pigmented schwannoma, Pigmented spindle cell nevus of Reed, Pilar tumor, Pilocytic astrocytoma, Piloid astrocytoma, Pilomatricoma; malignant, Pilomatricoma; NOS, Pilomatrix carcinoma, Pilomatrixoma; malignant, Pilomatrixoma; NOS, Pilomyxoid astrocytoma, PIN III, Pindborg tumor, Pineal parenchymal tumor of intermediate differentiation, Pinealoma, Pineoblastoma, Pineocytoma, Pinkus tumor, Pituicytoma, Pituitary adenoma; NOS, Pituitary carcinoma; NOS, Placental site trophoblastic tumor, Plasma cell leukemia, Plasma cell myeloma, Plasma cell tumor, Plasmablastic lymphoma, Plasmacytic leukemia, Plasmacytic lymphoma, Plasmacytoma of bone, Plasmacytoma; extramedullary, Plasmacytoma; NOS, Pleomorphic adenoma, Pleomorphic carcinoma, Pleomorphic cell sarcoma, Pleomorphic leiomyoma, Pleomorphic lipoma, Pleomorphic liposarcoma, Pleomorphic lobular carcinoma, Pleomorphic lobular carcinoma in situ, Pleomorphic rhabdomyosarcoma; adult type, Pleomorphic rhabdomyosarcoma; NOS, Pleomorphic xanthoastrocytoma, Pleuropulmonary blastoma, Plexiform fibrohistiocytic tumor, Plexiform fibromyxoma, Plexiform hemangioma, Plexiform leiomyoma, Plexiform neurofibroma, Plexiform neuroma, Plexiform schwannoma, PNET; NOS, Pneumoblastoma, Polar spongioblastoma, Polycythemia rubra vera, Polycythemia vera, Polyembryoma, Polygonal cell carcinoma, Polymorphic post transplant lymphoproliferative disorder, Polymorphic reticulosis, Polymorphous low grade adenocarcinoma, Polypoid adenoma, Polyvesicular vitelline tumor, Poorly cohesive carcinoma, Porocarcinoma, Post transplant lymphoproliferative disorder; NOS, PP/PYY producing tumor, PPNET, Pre-B ALL, Pre-pre-B ALL, Pre-T ALL, Precancerous melanosis; NOS, Precursor B-cell lymphoblastic leukemia, Precursor B-cell lymphoblastic lymphoma, Precursor cell lymphoblastic leukemia; NOS, Precursor cell lymphoblastic leukemia; not phenotyped, Precursor cell lymphoblastic lymphoma; NOS, Precursor T-cell lymphoblastic leukemia, Precursor T-cell lymphoblastic lymphoma, Preleukemia, Preleukemic syndrome, Primary amyloidosis, Primary cutaneous anaplastic large cell lymphoma, Primary cutaneous CD30+ large T-cell lymphoma, Primary cutaneous CD30+ T-cell lymphoproliferative disorder, Primary cutaneous CD4-positive small/medium T-cell lymphoma, Primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma, Primary cutaneous DLBCL; leg type, Primary cutaneous follicle centre lymphoma, Primary cutaneous gamma-delta T-cell lymphoma, Primary cutaneous neuroendocrine carcinoma, Primary diffuse large B-cell lymphoma of the CNS, Primary effusion lymphoma, Primary intraosseous carcinoma, Primary myelofibrosis, Primary serous papillary carcinoma of peritoneum, Primitive neuroectodermal tumor; NOS, Primitive polar spongioblastoma, Pro-B ALL, Pro-T ALL, Prolactinoma, Proliferating trichilemmal cyst, Proliferating trichilemmal tumor, Proliferative dermal lesion in congenital nevus, Proliferative polycythemia, Prolymphocytic leukemia; B-cell type, Prolymphocytic leukemia; NOS, Prolymphocytic leukemia; T-cell type, Prostatic intraepithelial neoplasia; grade III, Protoplasmic astrocytoma, Psammomatous meningioma, Psammomatous schwannoma, Pseudomucinous adenocarcinoma, Pseudomucinous cystadenocarcinoma; NOS, Pseudomucinous cystadenoma; borderline malignancy, Pseudomucinous cystadenoma; NOS, Pseudomyxoma peritonei, Pseudomyxoma peritonei with unknown primary site, Pseudosarcomatous carcinoma, PTLD; NOS, Pulmonary adenomatosis, Pulmonary artery intimal sarcoma, Pulmonary blastoma, Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation, Queyrat erythroplasia, Racemose hemangioma, RAEB, RAEB I, RAEB II, RAEB-T, RARS, Rathke pouch tumor, Recklinghausen disease, Refractory anemia, Refractory anemia with excess blasts, Refractory anemia with excess blasts in transformation, Refractory anemia with ring sideroblasts associated with marked thrombocytosis, Refractory anemia with ringed sideroblasts, Refractory anemia with sideroblasts, Refractory anemia without sideroblasts, Refractory cytopenia of childhood, Refractory cytopenia with multilineage dysplasia, Refractory neutropenia, Refractory thrombocytopenia, Regressing nevus, Renal carcinoma; collecting duct type, Renal cell adenocarcinoma, Renal cell carcinoma; chromophobe type, Renal cell carcinoma; NOS, Renal cell carcinoma; sarcomatoid, Renal cell carcinoma; spindle cell, Renal cell carcinoma; unclassified, Renal medullary carcinoma, Reninoma, Renomedullary fibroma, Renomedullary interstitial cell tumor, Reserve cell carcinoma, Reticulohistiocytoma, Reticulosarcoma; diffuse, Reticulosarcoma; NOS, Reticulum cell sarcoma; diffuse, Reticulum cell sarcoma; NOS, Retinal anlage tumor, Retinoblastoma; differentiated, Retinoblastoma; diffuse, Retinoblastoma; NOS, Retinoblastoma; spontaneously regressed, Retinoblastoma; undifferentiated, Retinocytoma, Retroperitoneal fibromatosis, Rhabdoid meningioma, Rhabdoid sarcoma, Rhabdoid tumor; NOS, Rhabdomyoma; NOS, Rhabdomyosarcoma with ganglionic differentiation, Rhabdomyosarcoma; NOS, Rhabdosarcoma, Rodent ulcer, Rosette-forming glioneuronal tumor, Round cell carcinoma, Round cell liposarcoma, Round cell osteosarcoma, Round cell sarcoma, Salivary duct carcinoma, SALT lymphoma, Sarcoma botryoides, Sarcoma; NOS, Sarcomatoid carcinoma, Sarcomatoid mesothelioma, Sarcomatosis; NOS, Schmincke tumor, Schneiderian carcinoma, Schneiderian papilloma; inverted, Schneiderian papilloma; NOS, Schwannoma; NOS, Scirrhous adenocarcinoma, Scirrhous carcinoma, Sclerosing epithelioid fibrosarcoma, Sclerosing hemangioma, Sclerosing hepatic carcinoma, Sclerosing liposarcoma, Sclerosing rhabdomyosarcoma, Sclerosing stromal tumor, Sclerosing sweat duct carcinoma, Sebaceous adenocarcinoma, Sebaceous adenoma, Sebaceous carcinoma, Sebaceous epithelioma, Secondary carcinoma, Secretory carcinoma of breast, Secretory meningioma, Seminoma with high mitotic index, Seminoma; anaplastic, Seminoma; NOS, Seromucinous carcinoma, Serotonin producing carcinoid, Serous adenocarcinofibroma, Serous adenocarcinoma; NOS, Serous adenofibroma of borderline malignancy, Serous adenofibroma; NOS, Serous borderline tumor-micropapillary variant, Serous carcinoma; NOS, Serous cystadenocarcinofibroma, Serous cystadenocarcinoma; NOS, Serous cystadenofibroma of borderline malignancy, Serous cystadenofibroma; NOS, Serous cystadenoma; borderline malignancy, Serous cystadenoma; NOS, Serous cystoma, Serous endometrial intraepithelial carcinoma, Serous microcystic adenoma, Serous papillary cystic tumor of borderline malignancy, Serous surface papillary carcinoma, Serous surface papillary tumor of borderline malignancy, Serous surface papilloma, Serous tubal intraepithelial carcinoma, Serous tumor; NOS; of low malignant potential, Serrated adenocarcinoma, Serrated adenoma, Sertoli cell adenoma, Sertoli cell carcinoma, Sertoli cell tumor with lipid storage, Sertoli cell tumor; NOS, Sertoli-Leydig cell tumor of intermediate differentiation, Sertoli-Leydig cell tumor; intermediate differentiation; with heterologous elements, Sertoli-Leydig cell tumor; NOS, Sertoli-Leydig cell tumor; poorly differentiated, Sertoli-Leydig cell tumor; poorly differentiated; with heterologous elements, Sertoli-Leydig cell tumor; retiform, Sertoli-Leydig cell tumor; retiform; with heterologous elements, Sertoli-Leydig cell tumor; sarcomatoid, Sertoli-Leydig cell tumor; well differentiated, Sessile serrated adenoma, Sessile serrated polyp, SETTLE, Sex cord tumor with annular tubules, Sex cord tumor; NOS, Sex cord-gonadal stromal tumor; incompletely differentiated, Sex cord-gonadal stromal tumor; mixed forms, Sex cord-gonadal stromal tumor; NOS, Sezary disease, Sezary syndrome, Sialoblastoma, Signet ring cell adenocarcinoma, Signet ring cell carcinoma, Sinonasal papilloma; exophytic, Sinonasal papilloma; fungiform, Sinonasal papilloma; NOS, Skin appendage adenoma, Skin appendage carcinoma, Skin appendage tumor; benign, Skin-associated lymphoid tissue lymphoma, Small cell carcinoma pulmonary type, Small cell carcinoma; fusiform cell, Small cell carcinoma; hypercalcemic type, Small cell carcinoma; intermediate cell, Small cell carcinoma; NOS, Small cell neuroendocrine carcinoma, Small cell osteosarcoma, Small cell sarcoma, Small congenital nevus, Smooth muscle tumor of uncertain malignant potential, Smooth muscle tumor; NOS, Soft tissue perineurioma, Soft tissue sarcoma, Soft tissue tumor; benign, Soft tissue tumor; malignant, Solid adenocarcinoma with mucin formation, Solid and cystic tumor, Solid and papillary epithelial neoplasm, Solid carcinoma with mucin formation, Solid carcinoma; NOS, Solid papillary carcinoma in situ, Solid papillary carcinoma with invasion, Solid pseudopapillary carcinoma, Solid pseudopapillary tumor, Solid teratoma, Solitary fibrous tumor, Solitary fibrous tumor; malignant, Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS), Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS), Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS), Solitary mastocytoma of skin, Solitary myeloma, Solitary plasmacytoma, Somatostatin cell tumor; malignant, Somatostatin cell tumor; NOS, Somatostatinoma; malignant, Somatostatinoma; NOS, Spermatocytic seminoma, Spermatocytoma, Spindle cell angioendothelioma, Spindle cell carcinoma; NOS, Spindle cell hemangioendothelioma, Spindle cell lipoma, Spindle cell melanoma; NOS, Spindle cell melanoma; type A, Spindle cell melanoma; type B, Spindle cell nevus; NOS, Spindle cell oncocytoma, Spindle cell rhabdomyosarcoma, Spindle cell sarcoma, Spindle epithelial tumor with thymus-like differentiation, Spindle epithelial tumor with thymus-like element, Spindled mesothelioma, Spiradenoma; NOS, Spitz nevus, Splenic B-cell lymphoma/leukemia; unclassifiable, Splenic diffuse red pulp small B-cell lymphoma, Splenic lymphoma with villous lymphocytes, Splenic marginal zone B-cell lymphoma, Splenic marginal zone lymphoma; NOS, Spongioblastoma multiforme, Spongioblastoma polare, Spongioblastoma; NOS, Spongioneuroblastoma, Squamotransitional cell carcinoma, Squamous carcinoma, Squamous cell carcinoma in situ with questionable stromal invasion, Squamous cell carcinoma in situ; NOS, Squamous cell carcinoma with horn formation, Squamous cell carcinoma; acantholytic, Squamous cell carcinoma; adenoid, Squamous cell carcinoma; clear cell type, Squamous cell carcinoma; HPV-negative, Squamous cell carcinoma; HPV-positive, Squamous cell carcinoma; keratinizing; NOS, Squamous cell carcinoma; large cell; keratinizing, Squamous cell carcinoma; large cell; nonkeratinizing; NOS, Squamous cell carcinoma; metastatic; NOS, Squamous cell carcinoma; microinvasive, Squamous cell carcinoma; nonkeratinizing; NOS, Squamous cell carcinoma; NOS, Squamous cell carcinoma; pseudoglandular, Squamous cell carcinoma; sarcomatoid, Squamous cell carcinoma; small cell; nonkeratinizing, Squamous cell carcinoma; spindle cell, Squamous cell epithelioma, Squamous cell papilloma; inverted, Squamous cell papilloma; NOS, Squamous intraepithelial neoplasia; grade I, Squamous intraepithelial neoplasia; grade II, Squamous intraepithelial neoplasia; grade III, Squamous intraepithelial neoplasia; high grade, Squamous intraepithelial neoplasia; low grade, Squamous odontogenic tumor, Squamous papilloma, Squamous papillomatosis, Stem cell leukemia, Steroid cell tumor; malignant, Steroid cell tumor; NOS, Stromal endometriosis, Stromal myosis; NOS, Stromal sarcoma; NOS, Stromal tumor with minor sex cord elements, Stromal tumor; benign, Stromal tumor; NOS, Struma ovarii and carcinoid, Struma ovarii; malignant, Struma ovarii; NOS, Strumal carcinoid, Subacute granulocytic leukemia, Subacute leukemia; NOS, Subacute lymphatic leukemia, Subacute lymphocytic leukemia, Subacute lymphoid leukemia, Subacute monocytic leukemia, Subacute myelogenous leukemia, Subacute myeloid leukemia, Subareolar duct papillomatosis, Subcutaneous panniculitis-like T-cell lymphoma, Subependymal astrocytoma; NOS, Subependymal giant cell astrocytoma, Subependymal glioma, Subependymoma, Subepidermal nodular fibrosis, Superficial spreading adenocarcinoma, Superficial spreading melanoma, Superficial well differentiated liposarcoma, Supratentorial PNET, Sweat gland adenocarcinoma, Sweat gland adenoma, Sweat gland carcinoma, Sweat gland tumor; benign, Sweat gland tumor; malignant, Sweat gland tumor; NOS, Sympathetic paraganglioma, Sympathicoblastoma, Symplastic leiomyoma, Syncytial meningioma, Synovial sarcoma; biphasic, Synovial sarcoma; epithelioid cell, Synovial sarcoma; monophasic fibrous, Synovial sarcoma; NOS, Synovial sarcoma; spindle cell, Synovioma; benign, Synovioma; malignant, Synovioma; NOS, Syringadenoma; NOS, Syringocystadenoma papilliferum, Syringofibroadenoma, Syringoma; NOS, Syringomatous carcinoma, Systemic EBV positive T-cell lymphoproliferative disease of childhood, Systemic light chain disease, Systemic mastocytosis with AHNMD, Systemic mastocytosis with associated hematological clonal non-mast cell disorder, Systemic tissue mast cell disease, T lymphoblastic leukemia/lymphoma, T-cell large granular lymphocytic leukemia, T-cell large granular lymphocytosis, T-cell lymphoma; NOS, T-cell rich large B-cell lymphoma, T-cell rich/histiocyte-rich large B-cell lymphoma, T-gamma lymphoproliferative disease, T-zone lymphoma, T/NK-cell lymphoma, Tanycytic ependymoma, Telangiectatic osteosarcoma, Tenosynovial giant cell tumor, Teratoblastoma; malignant, Teratocarcinoma, Teratoid medulloepithelioma, Teratoid medulloepithelioma; benign, Teratoma with malignant transformation, Teratoma; benign, Teratoma; differentiated, Teratoma; malignant; NOS, Teratoma; NOS, Terminal duct adenocarcinoma, Testicular adenoma, Testicular stromal tumor, Theca cell tumor, Theca cell-granulosa cell tumor, Thecoma; luteinized, Thecoma; malignant, Thecoma; NOS, Therapy related myeloid neoplasm, Therapy-related acute myeloid leukemia; alkylating agent related, Therapy-related acute myeloid leukemia; epipodophyllotoxin-related, Therapy-related acute myeloid leukemia; NOS, Therapy-related myelodysplastic syndrome; alkylating agent related, Therapy-related myelodysplastic syndrome; epipodophyllotoxin-related, Therapy-related myelodysplastic syndrome; NOS, Thymic carcinoma with adenoid cystic carcinoma-like features, Thymic carcinoma; NOS, Thymic large B-cell lymphoma, Thymoma; atypical; malignant, Thymoma; atypical; NOS, Thymoma; benign, Thymoma; cortical; malignant, Thymoma; cortical; NOS, Thymoma; epithelial; malignant, Thymoma; epithelial; NOS, Thymoma; lymphocyte-rich; malignant, Thymoma; lymphocyte-rich; NOS, Thymoma; lymphocytic; malignant, Thymoma; lymphocytic; NOS, Thymoma; malignant; NOS, Thymoma; medullary; malignant, Thymoma; medullary; NOS, Thymoma; mixed type; malignant, Thymoma; mixed type; NOS, Thymoma; NOS, Thymoma; organoid; malignant, Thymoma; organoid; NOS, Thymoma; predominantly cortical; malignant, Thymoma; predominantly cortical; NOS, Thymoma; spindle cell; malignant, Thymoma; spindle cell; NOS, Thymoma; type A; malignant, Thymoma; type A; NOS, Thymoma; type AB; malignant, Thymoma; type AB; NOS, Thymoma; type B1; malignant, Thymoma; type B1; NOS, Thymoma; type B2; malignant, Thymoma; type B2; NOS, Thymoma; type B3; malignant, Thymoma; type B3; NOS, Thymoma; type C, Tibial adamantinoma, Trabecular adenocarcinoma, Trabecular adenoma, Trabecular carcinoma, Traditional serrated adenoma, Traditional sessile serrated adenoma, Transient abnormal myelopoiesis, Transitional carcinoma, Transitional cell carcinoma, Transitional cell carcinoma in situ, Transitional cell carcinoma; micropapillary, Transitional cell carcinoma; sarcomatoid, Transitional cell carcinoma; spindle cell, Transitional cell papilloma; benign, Transitional cell papilloma; inverted; benign, Transitional cell papilloma; inverted; NOS, Transitional cell papilloma; NOS, Transitional meningioma, Transitional papilloma, Transitional papilloma; inverted; benign, Transitional papilloma; inverted; NOS, Transitional pineal tumor, Trichilemmal carcinoma, Trichilemmocarcinoma, Trichilemmoma, Trichodiscoma, Trichoepithelioma, Trichofolliculoma, Triton tumor; malignant, Trophoblastic tumor; epithelioid, True histiocytic lymphoma, Tubular adenocarcinoma, Tubular adenoma; NOS, Tubular androblastoma with lipid storage, Tubular androblastoma; NOS, Tubular carcinoid, Tubular carcinoma, Tubulo-papillary adenoma, Tubulocystic renal cell carcinoma, Tubulolobular carcinoma, Tubulopapillary adenocarcinoma, Tubulovillous adenoma; NOS, Tumor cells; benign, Tumor cells; malignant, Tumor cells; NOS, Tumor cells; uncertain whether benign or malignant, Tumor embolus, Tumor; benign, Tumor; malignant; NOS, Tumor; metastatic, Tumor; NOS, Tumor; secondary, Tumorlet; benign, Tumorlet; NOS, Turban tumor, Typical carcinoid, Unclassified tumor; benign, Unclassified tumor; borderline malignancy, Unclassified tumor; malignant, Unclassified tumor; malignant; uncertain whether primary or metastatic, Unclassified tumor; uncertain whether benign or malignant, Undifferentiated epithelioid sarcoma, Undifferentiated high-grade pleomorphic sarcoma, Undifferentiated leukaemia, Undifferentiated pleomorphic sarcoma, Undifferentiated round cell sarcoma, Undifferentiated sarcoma, Undifferentiated spindle cell sarcoma, Undifferentiated uterine sarcoma, Urachal carcinoma, Urothelial carcinoma in situ, Urothelial carcinoma with divergent differentiation, Urothelial carcinoma with squamous differentiation, Urothelial carcinoma with trophoblastic differentiation, Urothelial carcinoma; NOS, Urothelial papilloma; NOS, Urticaria pigmentosa, Vaginal intraepithelial neoplasia; grade III, VAIN III, Vascular leiomyoma, Venous hemangioma, Verrucous carcinoma; NOS, Verrucous epidermoid carcinoma, Verrucous keratotic hemangioma, Verrucous papilloma, Verrucous squamous cell carcinoma, Villoglandular adenoma, Villoglandular carcinoma, Villous adenocarcinoma, Villous adenoma; NOS, Villous papilloma, VIN III, Vipoma; malignant, Vipoma; NOS, Von Recklinghausen disease, Vulvar intraepithelial neoplasia; grade III, Waldenstrom macroglobulinemia, Warthin tumor, Warty carcinoma, Water-clear cell adenocarcinoma, Water-clear cell adenoma, Water-clear cell carcinoma, Well differentiated liposarcoma of superficial soft tissue, Well differentiated papillary mesothelioma; benign, Well differentiated thymic carcinoma, Wilms tumor, Wolffian duct adenoma, Wolffian duct carcinoma, Wolffian duct tumor, Xanthofibroma, Yolk sac tumor, Unknown, Not Reported, Source Data Not Available ",,TRUE,,,,CDS Metadata v1.3.3/Diagnosis,
Model Site of Origin,The text term used to describe the anatomic site of origin associated with the malignant disease model.,"Abdomen, Abdominal Esophagus, Adrenal Cortex, Adrenal Gland, Adrenal Medulla, Ampulla of Vater, Anal Canal, Anal Transitional Zone, Anterior Mediastinum, Anterior Surface of the Epiglottis, Anterior Wall of the Bladder, Anterior Wall of the Nasopharynx, Antrum Pylori, Anus, Appendage of the Uterus, Appendix, Ascending Colon, Autonomic Nervous System, Axillary Lymph Node, Axillary Tail of the Breast, Base of the Tongue, Biliary Tract, Bladder Neck, Bladder Trigone, Bladder, Blood, Body of Stomach, Body of the Pancreas, Body of the Penis, Bone Marrow, Bone of the Extremity, Bone, Brain Stem, Brain Ventricle, Brain, Branchial Cleft Remnant, Breast, Broad Ligament, Buccal Mucosa, Carotid Body, Cauda Equina, Cecum, Central Portion of the Breast, Cerebellum, Cerebral Hemisphere, Cerebral Meninges, Cervical Esophagus, Cervix Uteri, Choroid, Ciliary Body, Clitoris, Cochlear Nerve, Colon, Commissure of the Lip, Conjunctiva, Cornea, Corpus Uteri, Cranial Nerve, Craniopharyngeal Duct, Descending Colon, Dome of the Bladder, Duodenum, Ectocervix, Endocervix, Endocrine Gland, Endometrium, Epididymis, Esophagus, Ethmoid Sinus, External Ear, External Lip, External Lower Lip, External Upper Lip, Extrahepatic Bile Duct, Eyelid, Eye, Fallopian Tube, Female Genitalia, Floor of Mouth, Frontal Lobe, Frontal Sinus, Fundus of the Stomach, Fundus Uteri, Gallbladder, Gastric Cardia, Gastrointestinal Tract, Gingiva, Glans Penis, Glottis, Greater Curvature of the Stomach, Hard Palate, Head and Neck Lymph Node, Head of the Pancreas, Heart, Hematopoietic System, Hepatic Flexure, Hypopharynx, Ileum, Ill-Defined Anatomic Site, Intestine, Intra-Abdominal Lymph Node, Intrahepatic Bile Duct, Intrathoracic Lymph Node, Islet of Langerhans, Isthmus Uteri, Jejunum, Kidney, Labium Majus, Labium Minus, Lacrimal Gland, Laryngeal Cartilage, Larynx, Lateral Wall of the Bladder, Lateral Wall of the Nasopharynx, Lateral Wall of the Oropharynx, Lesser Curvature of the Stomach, Lingual Tonsil, Lip, Liver, Lower Extremity, Lower Gingiva, Lower Lobe of the Lung, Lower Third of the Esophagus, Lower-Inner Quadrant of the Breast, Lower-Outer Quadrant of the Breast, Lung, Lymph Node of Inguinal Region or Leg, Lymph Node, Main Bronchus, Male Genitalia, Mandible, Maxillary Sinus, Meckel Diverticulum, Mediastinum, Meninges, Middle Ear, Middle Lobe of the Right Lung, Middle Third of the Esophagus, Mucosa of the Lip, Mucosa of the Lower Lip, Mucosa of the Upper Lip, Myometrium, Nasal Cavity, Nasopharynx, Nervous System, Nipple, Not Reported, Occipital Lobe, Olfactory Nerve, Optic Nerve, Oral Cavity, Orbit, Oropharynx, Other and Ill-Defined Sites within Respiratory System and Intrathoracic Organs ICD-O-3, Other and Unspecified Female Genital Organs ICD-O-3, Other and Unspecified Male Genital Organs ICD-O-3, Other Specified Parts of Pancreas, Ovary, Palate, Palatine Tonsil, Pancreas, Pancreatic Duct, Parametrium, Paranasal Sinus, Parathyroid Gland, Parietal Lobe, Parotid Gland, Pelvic Lymph Node, Pelvis, Penis, Peritoneum, Pharynx, Pineal Gland, Pituitary Gland, Placenta, Pleura, Postcricoid Region, Posterior Mediastinum, Posterior Wall of the Bladder, Posterior Wall of the Hypopharynx, Posterior Wall of the Nasopharynx, Posterior Wall of the Oropharynx, Prepuce, Primary Site Unknown, Prostate Gland, Pylorus, Pyriform Sinus, Rectosigmoid Region, Rectum, Renal Pelvis, Reticuloendothelial System, Retina, Retromolar Trigone, Retroperitoneum, Round Ligament, Salivary Gland, Scrotum, Sigmoid Colon, Skene Gland, Skin of the Face, Skin of the Lip, Skin of the Lower Limb and Hip, Skin of the Scalp and Neck, Skin of the Trunk, Skin of the Upper Limb and Shoulder, Skin, Small Intestine, Soft Palate, Spermatic Cord, Sphenoid Sinus, Spinal Cord, Spinal Meninges, Spleen, Splenic Flexure, Stomach, Subglottis, Sublingual Salivary Gland, Submandibular Gland, Superior Wall of the Nasopharynx, Supraglottis, Tail of the Pancreas, Temporal Lobe, Testis, Thoracic Esophagus, Thorax, Thymus Gland, Thyroid Gland, Tongue, Tonsillar Fossa, Tonsillar Pillar, Trachea, Transverse Colon, Undescended Testes, Unknown, Upper Extremity, Upper Gingiva, Upper Lobe of the Lung, Upper Respiratory System, Upper Third of the Esophagus, Upper-Inner Quadrant of the Breast, Upper-Outer Quadrant of the Breast, Urachus, Ureteric Orifice, Ureter, Urethra, Urinary System, Uterus, Uvula, Vagina, Vallecula, Vertebral Column, Vestibule of Mouth, Vulva, Waldeyer Ring",,TRUE,,,,CDS Imaging v1.0/File information,
Name,Name of the individual,,,TRUE,,,,,
Alternative Names,"Other ways the individual's name is displayed. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
Email,Email address of the individual,,,FALSE,,,,,
Url,"URL, e.g., individual's home page address",,,FALSE,,,,,
Orcid Id,Unique identifier (ORCID ID) of the individual,,,FALSE,,,,,regex search \d{4}\-\d{4}\-\d{4}\-\d{3}(\d|X)
Synapse Profile Id,Unique identifier (Synapse Profile ID) of the individual. See identifer in the url of the synapse profile page. ,,,FALSE,,,,,unique
Last Known Institution,Last known institutional affiliation of the individual.,,,TRUE,,,,,
Working Group Participation,"CSBC/PSON working group(s) of which the individual is a member (current and former). Multiple values permitted, comma separated.","Cancer Metabolism, Cell and Tissue Mechanics, Education and Outreach, Image Analysis, Navigating Cancer with Science and Art, None, Patient Advocacy Working Group, Protein-Protein Interactions, Resource and Data Sharing",,TRUE,,,,,list like
Chair Roles,"Committee or working group chair role(s) the individual fulfilled (current and former). Multiple values permitted, comma separated.","Annual Meeting, None, Steering Committee, Working Group",,TRUE,,,,,list like
Consent For Portal Display,Consent from individual to display Person information in the CCKP,"No, Yes",,TRUE,,,,,
Portal Display,Display content in CCKP,"FALSE, TRUE",,TRUE,,,,,
Person View,The denormalized manifest for person submission.,,"Component, PersonView_id, GrantView Key, Person Consortium Name, Name, Alternative Names, Email, Url, Orcid Id, Synapse Profile Id, Last Known Institution, Working Group Participation, Chair Roles, Consent For Portal Display, Portal Display, Person Publications, Person Datasets, Person Tools, Person Educational Resources",FALSE,,,Grant View,,
Person Grant Number,"Grant number(s) associated with the person. Multiple values permitted, comma separated.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
Person Consortium Name,"Consortium(s) associated with the person. Multiple values permitted, comma separated.","CCBIR, CSBC, HTAN, ICBP, MetNet, NCI, NCI Clinical and Translational Exploratory/Developmental Studies, PDMC, PS-ON, Sage Bionetworks, TEC",,TRUE,,,,,list like
Person Publications,"A list of the pubmed Ids associated with the person. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
Person Datasets,"A list of the dataset aliases (An alias of the dataset must be unique. Can be the GEO identifier such as GSE12345, or a DOI. No Greek Letters) associated with the person. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
Person Tools,"A list of the tool names associated with the person. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
Person Educational Resources,"A list of educational resource identifiers associated with the person. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
PersonView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Project Name,Name of the project,,,TRUE,,,,,
Project Type,Type of project,"Core, Project",,TRUE,,,,,
Project Description,Description of the project,,,TRUE,,,,,
Project Investigator,Investigator(s) associated witht the project.,,,TRUE,,,,,list like
Project View,The denormalized manifest for project submission.,,"Component, ProjectView_id, GrantView Key, Project Name, Project Type, Project Description, Project Investigator",FALSE,,,Grant View,,
Project Grant Number,Grant number(s) associated with the project,"Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
Project Consortium Name,Consortia associated with the project.,"CCBIR, CSBC, HTAN, ICBP, MetNet, NCI, NCI Clinical and Translational Exploratory/Developmental Studies, PDMC, PS-ON, Sage Bionetworks, TEC",,TRUE,,,,,
ProjectView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Publication Doi,The digital object identifier associated with the publication in the form of https://www.doi.org/{doi} to comply with CrossRef DOI display guidelines.,,,FALSE,,,,,unique
Publication Journal,The name of the periodical publication in which the publication was published.,,,TRUE,,,,,
Pubmed Id,The PubMed identifier associated with the publication.,,,TRUE,,,,,unique
Pubmed Url,Pubmed URL for the publication,,,TRUE,,,,,url
Publication Title,Title of the publication,,,TRUE,,,,,
Publication Year,Year of the publication,,,TRUE,,,,,
Publication Keywords,"Keywords associated with the publication. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
Publication Authors,"Authors of the publication. Multiple values permitted, comma separated.",,,TRUE,,,,,list like
Publication Abstract,The abstract of the publication.,,,TRUE,,,,,
Publication Assay,"Assay(s) associated with the publication. Multiple values permitted, comma separated.","10-cell RNA Sequencing, 16S Ribosomal Gene Sequencing Assay, 3' RNA-seq, 3C, 3C-qPCR, 3D Bioprinting, 3D Cell Culture, 4C, 5C, ATAC-Seq, ATP Bioluminescence Assay, Affinity Purification Mass Spectrometry, Allograft, Amplicon Sequencing, Angiogenesis Assay, Apoptosis Assay, Atomic Absorption Spectrophotometry, Atomic Absorption Spectroscopy, Atomic Force Microscopy, Autoradiography, Barcode-Seq, Bicinchoninic Acid Assay, Binding Assay, Bio-Layer Interferometry, Bioluminescence Imaging, Bisulfite Sequencing, Brightfield Microscopy, Brillouin Microscopy, CASFISH, CITE-seq, CLIP-qPCR, CRISPR, CUT&RUN, CUT&Tag-Sequencing, Cell Adhesion Assay, Cell Proliferation Assay, Cell Viability Assay, Cell-spreading Assay, CellTiter-Glo Luminescent Cell Viability Assay, Cerenkov Luminescence Imaging, ChIA-PET, ChIP-PCR, ChIP-Seq, ChIP-qPCR assay, Chemiluminescent Assay, Chemotaxis Assay, Circular Dichroism Spectroscopy, Co-Immunoprecipitation, Co-culture Assay, Collision-Induced Dissociation, Colorimetric Cell Viability Assay, Computational Modeling, Computational Tool, Computed Tomography, Confocal Microscopy, Confocal Reflectance Quantitative Phase Microscopy, Cross-Linking Immunoprecipitation High-throughput Sequencing, Cross-Linking Mass Spectrometry, Cyclic Immunofluorescence, Cytochemical Stain, Cytokine Expression Profile, Cytometric Bead Array Assay, Cytotoxicity Assay, DBiT-Seq, DNA Gene-Expression Microarray, DNA Methylation Array, DNA Sequencing, DNase-Seq, DRIP-seq, Dark Field Microscopy, Deep Mutational Scanning, Desorption Electrospray Ionization, Dideoxy Chain Termination DNA Sequencing, Differential Interference Contrast Microscopy, Differential Scanning Fluorimetry, Diffusion Weighted Imaging, Direct Long-Read RNA Sequencing, Drop-Seq, Droplet Digital PCR, Dual-Luciferase Reporter Assay, Dye Endocytosis Assay, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Force Spectroscopy, Dynamic Light Scattering, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, ELISA, Efferocytosis Assay, Electron Diffraction, Electron Microscopy, Electron Paramagnetic Resonance Spectroscopy, Electrophoretic Mobility Shift Assay, Electrospray Ionization Time-of-Flight Mass Spectrometry, Endotoxin Assay, Energy-Dispersive X-Ray Spectroscopy, Enzyme Activity Assay, Enzyme-Linked Immunospot Assay, Epidemiological Method, FAIRE-Seq, FISH, Flow Cytometry, Fluorescence Activated Cell Sorting, Fluorescence Correlation Spectroscopy, Fluorescence Imaging, Fluorescence Lifetime Imaging Microscopy, Fluorescence Microscopy, Fluorescence Recovery After Photo-Bleaching, Fluorescent Antibody Procedure, Fluorescent Cell Barcoding, Fluorescent In Situ Sequencing , Focused Ion Beam Scanning Electron Microscopy, Forster Resonance Energy Transfer, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Fourier-Transform Infrared Spectroscopy, Gas Chromatography Mass Spectrometry, Gelatin Zymography, Genotyping, Global Chromatin Profiling, Global Run-On Sequencing, Graphite Furnace Atomic Absorption Spectrometry, HL-Chip, HPLC-MSMS, Hematoxylin and Eosin Staining Method, Hi-C, HiChIP, High Throughput Screening, High-Content Screen, Hydrogels, Hydrophilic Interaction Chromatography, Image Cytometry, Imaging, Immobilized Metal Affinity Chromatography, ImmunoFISH, Immunoassay, Immunocytochemistry, Immunohistochemistry Staining Method, Immunoprecipitation, In Situ Hybridization, In Vitro Cell Killing Assay, In Vitro Model, In Vitro Selection, In Vitro Translation, In Vivo Bioluminescence, In-Cell Western Assay, Inductively-Coupled Plasma Mass Spectrometry, Interference Reflection Microscopy, Intravital Microscopy, Invasion Assay, Karyotyping, Knife-Edge Scanning Microscopy, L1000 mRNA Profiling Assay, Lattice Light Sheet Microscopy, Liquid Chromatography Mass Spectrometry, Liquid Chromatography/Tandem Mass Spectrometry, Low-Vacuum Scanning Electron Microscopy, Luciferase Reporter Assay, Luminescent Cell Viability Assay, MALDI-TOF Mass Spectrometry, MEMA Cell Growth Assay, MNase-Seq, MULTI-Seq, Macrophage Polarization Assay, Magnetic Resonance Imaging, Magnetic Tweezers, Magnetic Twisting Cytometry, Magnetically Activated Cell Sorting, Mammosphere Formation Assay, Mass Cytometry, Mass Spectrometry, Mathematical Modeling, MeDIP, MeRIP-Seq, Methyl Binding Domain Sequencing, Methylation-Specific PCR, Micro-computed Tomography, MicroRNA Expression Array, MicroRNA Sequencing, Microcontact Printing, Microfluidics, Micropipette Adhesion Assay, Micropipette Aspiration, Microscopy, Migration Assay, Mint-ChIP, Modeling, Molecular Simulations, Monolayer Stress Microscopy, Multi-Angle Light Scattering, Multi-Isotope Mass Spectrometry, Multiparametric Magnetic Resonance Imaging, Multiphoton Microscopy, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Multiplexed Immunofluorescence, Multiplexed Immunohistochemistry, Multiplexed Ion Beam Imaging, Murine Model, Nano-hmC-Seal, NanoString Digital Spatial Profiling, Nanopatterning, Nanopore Sequencing, Nanowire, Nested PCR, Next Generation Sequencing, Nm-seq, Not Applicable, Nuclear Magnetic Resonance, Optical Coherence Tomography, Optical Emission Spectroscopy, Optical Mapping, Optical Stretcher, Optical Tweezers, Optogenetic Assay, Organoid, PCR, PET-CT, Paraquat Survival Assay, Partial Wave Spectroscopy, Patient Derived Xenograft, Pending Annotation, Permeability Assay, Phagocytosis Assay, Photoacoustic Imaging, Photolithography, Plasmid Construction, PlateSeq, Point Accumulation for Imaging in Nanoscale Topography, Positron Emission Tomography, Precision Run-On Sequencing, Proteomics Assay, Proximity Ligation Assay, Pull-Down Assay, QFISH, Quantitative Multiplex Immunofluorescence, Quantitative Point Accumulation for Imaging in Nanoscale Topography, Questionnaire, RAS Protein Family Activation Assay, RIP, RIP-Seq, RNA Sequencing, RNAi Screen, RT-PCR, RT-qPCR, Raman Spectroscopy, Reduced Representation Bisulfite Sequencing, Reverse Phase Protein Array, Reverse-Phase High-Performance liquid Chromatography, Rheometry, Ribo-Seq, Ribosomal P Protein Antibody Measurement, Scanning Angle Interference Microscopy, Scanning Electron Microscopy, Second-Harmonic Imaging Microscopy, Shotgun Mass Spectrometry, Single Cell ATAC-Seq, Single Cell Cytokine Detection Chip Assay, Single Cell DNA Sequencing, Single Cell Gel Electrophoresis, Single Cell RNA-Sequencing, Single Molecule Forster Resonance Energy Transfer, Single Nucleotide Polymorphism Array, Single Nucleus RNA-Sequencing, Single-Cell BCR Sequencing, Single-Cell Barcode Chip, Single-Cell TCR Sequencing, Single-Molecule Tracking, Sirius Red Staining, Size Exclusion Chromatography, Small-Angle X-ray Scattering, Soft Agar Assay, Southern Blotting, Spectroscopy, Statistical Modeling, Stimulated Emission Depletion Microscopy, Stimulated Raman Scattering, Stochastic Optical Reconstruction Microscopy, Super-Resolution Microscopy, Surface Plasmon Resonance, Surveyor Nuclease Assay, Synaptophysin Staining Method, Synthetic Genetic Array, TAB-Seq, TCR Sequencing, TIRF Microscopy, TRAP Staining, TUNEL assay, Tandem Mass Spectrometry, Tandem Mass Tagging, Target Engagement Assay, Targeted Genome Sequencing, Targeted Transcriptome Sequencing, Thermal Shift Assay, Thin-Layer Chromatography, Tiling Array, Time Lapse Microscopy, Time-Correlated Single Photon Counting, Tissue Engineering, Tissue Microarray, Total Internal Reflection Fluorescence Microscopy, Traction Force Microscopy, Transmission Electron Microscopy, Transwell Assay, UPLC-MSMS, UV Photocrosslinking, Unspecified, Vibrational Spectroscopy, Virus Plaque Assay, Von Kossa Staining, Western Blotting, Whole Exome Sequencing, Whole Genome Bisulfite Sequencing, Whole Genome Sequencing, Widefield Fluorescence Microscopy, Wound-Healing Assay, X-Ray Crystallography, X-Ray Diffraction, X-Ray Micro-Computed Tomography, Xenograft, cDNA Array, eCLIP-Seq, mRNA Sequencing, qPCR, scCGI-seq, scNT-Seq, scSLAM-seq, seqFISH, shRNA, siRNA, smFISH, smRNA-seq, snRNA-seq, Isothermal Titration Calorimetry, Suspended Microchannel Resonator, 10x Multiome, Visium Spatial Gene Expression, Antitumor Drug Screening Assay, Bioelectrochemical Analysis, Chimeric Antigen Receptor T-Cell Therapy, Cell Cycle Assay, Clonality Analysis, Comparative Genomic Hybridization, Cryo-Electron Microscopy, Cryo-Electron Tomography, Data Integration, Field-Emission Scanning Electron Microscopy, Label-free Protein Quantification by LC/MS, Metabolite Profiling Assay, Reporter Gene Assay, Single-Molecule Localization Microscopy, Synthesis, Targeted Therapy Agent, Trichrome Staining Method, Ultrasound Imaging, Transcription profiling by NanoString, Alcian Blue Staining Method, Artificial Intelligence, Cell Culture, Clinical Study, Cell-free Circulating Tumor DNA Assay, Co-Immunoprecipitation Mass Spectrometry, Deep Learning, Fluorescent In Situ Sequencing, Gene Ontology Enrichment Analysis, Gene Set Enrichment Analysis, Gene Silencing , Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Culture, Imaging Mass Cytometry, Immunofluorescent Staining Method, Immunotherapy, Viral Transduction, Metastatic Colonization Assay, Phylogenetic Analysis, Picrosirius Staining, Scratch Assay, Structural Variant Analysis, Survival Analysis, Targeted Error Correction Sequencing, Tuba-Seq, SDS-PAGE, Cell Fractionation, Multiscale Light Sheet Microscopy, Light Sheet Microscopy",,TRUE,,,,,list like
Publication Tumor Type,"Tumor type(s) associated with the publication. Multiple values permitted, comma separated.","Cutaneous Melanoma, Acinar Cell Carcinoma, Acute Lymphoblastic Leukemia, Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Adenocarcinoma, Angiosarcoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, B Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Barrett Esophagus, Basal Cell Neoplasm, Basal-Like Breast Carcinoma, Biliary Tract Carcinoma, Bladder Carcinoma, Bladder Neoplasm, Bone Neoplasm, Brain Neoplasm, Breast Adenocarcinoma, Breast Carcinoma, Breast Neoplasm, Carcinoma, Carcinoma In Situ, Castration-Resistant Prostate Carcinoma, Cellular Schwannoma, Central Nervous System Cavernous Hemangioma, Central Nervous System Neoplasm, Cerebellar Neoplasm, Cervical Carcinoma, Cervical Neoplasm, Cervical Small Cell Carcinoma, Cholangiocarcinoma, Chondroblastoma, Choriocarcinoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Clear Cell Renal Cell Carcinoma, Colon Adenocarcinoma, Colon Carcinoma, Colorectal Adenocarcinoma, Colorectal Adenoma, Colorectal Carcinoma, Colorectal Neoplasm, Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Craniopharyngioma, Cutaneous T Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Ductal Breast Carcinoma In Situ, Dysembryoplastic Neuroepithelial Neoplasm, Endometrial Carcinoma, Endometrial Neoplasm, Ependymoma, Esophageal Adenocarcinoma, Esophageal Carcinoma, Esophageal Squamous Cell Carcinoma, Ewing Sarcoma, Extraventricular Neurocytoma, Fibroepithelial Polyp, Fibrolamellar Carcinoma, Fibrosarcoma, Follicular Lymphoma, Gallbladder Carcinoma, Gastric Adenocarcinoma, Gastric Carcinoma, Gastric Neoplasm, Gastroesophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Gastrointestinal Stromal Neoplasm, Giant Cell Tumor, Glioblastoma, Glioma, Head and Neck Carcinoma, Head and Neck Neoplasm, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High Grade Ovarian Serous Adenocarcinoma, Histiocytic Sarcoma, Hodgkin Lymphoma, Intestinal Neoplasm, Intrahepatic Cholangiocarcinoma, Invasive Ductal Breast Carcinoma, Kaposi Sarcoma, Leiomyoma, Leukemia, Liver and Intrahepatic Bile Duct Carcinoma, Liver and Intrahepatic Bile Duct Neoplasm, Low Grade Glioma, Luminal A Breast Carcinoma, Lung Adenocarcinoma, Lung Carcinoma, Lung Neoplasm, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Lung Squamous Cell Carcinoma, Lymphoid Leukemia, Lymphoma, Malignant Brain Neoplasm, Malignant Digestive System Neoplasm, Malignant Genitourinary System Neoplasm, Malignant Glioma, Malignant Neoplasm, Malignant Ovarian Neoplasm, Malignant Pancreatic Neoplasm, Malignant Peripheral Nerve Sheath Tumor, Malignant Peritoneal Neoplasm, Malignant Skin Neoplasm, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Medulloblastoma, Melanoma, Meningioma, Mesothelioma, Multiple Myeloma, Mycosis Fungoides, Myeloid Leukemia, Myeloid Neoplasm, Myeloproliferative Neoplasm, Myoepithelioma, Nasopharyngeal Carcinoma, Neuroblastoma, Neuroendocrine Neoplasm, Neuroepithelial Neoplasm, Neurofibroma, Non-Functioning Pituitary Gland Adenoma, Non-Hodgkin Lymphoma, Not Applicable, Oral Cavity Neoplasm, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Neoplasm, Osteosarcoma, Ovarian Adenosarcoma, Ovarian Carcinoma, Ovarian Neoplasm, Ovarian Serous Adenocarcinoma, Pan-cancer, Pancreatic Adenocarcinoma, Pancreatic Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm, Pancreatic Neuroendocrine Carcinoma, Pending Annotation, Penile Carcinoma, Pheochromocytoma, Pilocytic Astrocytoma, Pituitary Gland Adenoma, Plasmablastic Lymphoma, Plasmacytoma, Plexiform Schwannoma, Precursor B-cell lymphoblastic leukemia, Primary Central Nervous System Lymphoma, Primary Myelofibrosis, Prostate Adenocarcinoma, Prostate Carcinoma, Prostate Neoplasm, Rectal Adenocarcinoma, Renal Cell Carcinoma, Retinoblastoma, Rhabdomyosarcoma, Rosette-Forming Glioneuronal Tumor, Salivary Gland Adenoid Cystic Carcinoma, Sarcoma, Schwannoma, Serous Tubal Intraepithelial Carcinoma, Sinonasal Squamous Cell Carcinoma, Skin Carcinoma, Skin Neoplasm, Soft Tissue Sarcoma, Squamous Cell Carcinoma, Synovial Sarcoma, T Acute Lymphoblastic Leukemia, T-Cell Lymphoma, Teratoma, Testicular Embryonal Carcinoma, Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Carcinoma, Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features, Triple-Negative Breast Carcinoma, Urothelial Carcinoma, Uterine Adenosarcoma, Uveal Melanoma, Uveal Neoplasm, Vascular Neoplasm, Not-Applicable, Plexiform Neurofibroma",,TRUE,,,,,list like
Publication Tissue,"Tissue type(s) associated with the publication. Multiple values permitted, comma separated.","Gonad, Abdominal Esophagus, Adipose Tissue, Adrenal Gland, Alveolus, Aorta, Artery, Ascending Colon, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Brain, Breast, Caecum, Cancer-Associated Fibroblast, Cardia, Cartilage, Cervix Uteri, Choroid, Colon, Connective and Soft Tissue, Cornea, Duodenum, Ear, Embryo, Embryonic Heart, Endocervix, Endometrium, Endothelium, Epithelium, Esophagus, Eye, Fallopian Tube, Foreskin, Frontal Lobe, Gastroesophageal Junction, Gastrointestinal Tract, Genitourinary, Hair Follicle, Head and Neck, Heart, Heart Muscle, Hematopoietic System, Hippocampus, Intestine, Intra-Abdominal Lymph Nodes, Intrathoracic Lymph Nodes, Joint, Kidney, Larynx, Ligament, Liver, Lung, Lymph, Lymph Node, Lymph Nodes of Axilla or Arm, Lymph Nodes of Inguinal Region or Leg, Lymphatic System, Lymphoid Tissue, Main Bronchus, Mammary Gland, Meninges, Mesenchyme, Mucosa, Muscle, Nasal Cavity, Nervous System, Not Applicable, Olfactory Mucosa, Omentum, Oral Cavity, Oral Mucosa, Ovary, Pancreas, Pelvic Lymph Nodes, Pending Annotation, Periodontal Ligament, Peripheral Nerves, Peritoneum, Pharynx, Pituitary Gland, Placenta, Pleura, Prostate Gland, Rectum, Reproductive System, Respiratory System, Salivary Gland, Sclera, Sinonasal Tract, Skin, Small Intestine, Spinal Cord, Spleen, Stomach, Synovial Membrane, Tendon, Testis, Thymus, Thyroid Gland, Tongue, Tonsil, Trachea, Umbilical Cord, Unspecified, Uterus, Vagina, Vascular Endothelium, Vein, Vertebra, Peripheral Blood Mononuclear Cell",,TRUE,,,,,list like
Publication Accessibility,Whether there are non-monetary restrictions on accessing an the publication.,"Open Access, Restricted Access",,TRUE,,,,,
Publication View,The denormalized manifest for publication submission.,,"Component, PublicationView_id, Study Key, Publication Doi, Publication Journal, Pubmed Id, Pubmed Url, Publication Title, Publication Year, Publication Keywords, Publication Authors, Publication Abstract, Publication Assay, Publication Tumor Type, Publication Tissue, Publication Accessibility",FALSE,,,Study,,
Publication Grant Number,"Relevant grant number associated witht the publication's development. Multiple values permitted, comma separated.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
Publication Dataset Alias,"A list of the dataset aliases (An alias of the dataset must be unique. Can be the GEO identifier such as GSE12345, or a DOI. No Greek Letters) associated with the publication. Multiple values permitted, comma separated.",,,FALSE,,,,,list like
PublicationView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Sequencing Level 1,Unaligned/unprocessed sequencing data ,,"Component, SequencingLevel1_id, Filename, NGS Library Strategy, NGS Library Source, NGS Library Selection Method, NGS Library Layout, NGS Sequencing Platform, NGS Sequencing Design Description, NGS Library Preparation Kit Name, NGS Library Preparation Kit Vendor, NGS Library Preparation Kit Version, NGS Read Indicator, NGS Library Preparation Days from Index, NGS Sequencing Library Construction Days from Index",FALSE,,,,MC2,
SequencingLevel1_id,A unique identifier used by schematic for record updates and as a reference key in other schemas,,,TRUE,,,,MC2,unique
NGS Sequencing Coverage,Depth of coverage on assembly used. Found by (Unique Aligned Basecalls)/(Reference Length),,,TRUE,,,,HTAN,num
NGS Read Length,"The average length of the sequencing reads. Can be integer, null",,,TRUE,,,,HTAN,num
NGS Library Selection Method,How nucleic acid molecules are isolated.,"5-methylcytidine antibody, CAGE, cDNA, cDNA_oligo_dT, cDNA_randomPriming, CF-H, CF-M, CF-S, CF-T, ChIP, DNAse, HMPR, Hybrid Selection, Inverse rRNA, MBD2 protein methyl-CpG binding domain, MDA, MF, MNase, MSLL, Oligo-dT, other, Padlock probes capture method, PCR, PolyA, RACE, RANDOM, RANDOM PCR, Reduced Representation, repeat fractionation, Restriction Digest, RT-PCR, size fractionation, unspecified",,FALSE,,,,HTAN,str
NGS Library Strategy,"The assay associated with the nucleic acid library (e.g., RNA-Seq, ChIP-Seq)","AMPLICON, ATAC-seq, Bisulfite-Seq, ChIA-PET, ChIP-Seq, CLONE, CLONEEND, CTS, DNase-Hypersensitivity, EST, FAIRE-seq, FINISHING, FL-cDNA, Hi-C, MBD-Seq, MeDIP-Seq, miRNA-Seq, MNase-Seq, MRE-Seq, ncRNA-Seq, OTHER, POOLCLONE, RAD-Seq, RIP-Seq, RNA-Seq, SELEX, ssRNA-seq, Synthetic-Long-Read, Targeted-Capture, Tethered Chromatin Conformation Capture, Tn-Seq, WCS, WGA, WGS, WXS",,TRUE,,,,CDS/sequencing,str
NGS Library Source,The type of source material being sequenced.,"GENOMIC, GENOMIC SINGLE CELL, METAGENOMIC, METATRANSCRIPTOMIC, OTHER, SYNTHETIC, TRANSCRIPTOMIC, TRANSCRIPTOMIC SINGLE CELL, VIRAL RNA",,TRUE,,,,CDS/sequencing,str
NGS Library Layout,"Text description of the library layout, one of Paired-end or Single.","Paired-end, Single-end",,TRUE,,,,CDS/sequencing,str
NGS Library Preparation Kit Name,Name of Library Preparation Kit. String,,,FALSE,,,,HTAN,str
NGS Library Preparation Kit Vendor,Vendor of Library Preparation Kit. String,,,FALSE,,,,HTAN,str
NGS Library Preparation Kit Version,Version of Library Preparation Kit. String,,,FALSE,,,,HTAN,str
NGS Sequencing Platform,A platform is an object aggregate that is the set of instruments and software needed to perform a process [OBI_0000050]. Specific model of the sequencing instrument.,"454 GS, 454 GS 20, 454 GS FLX, 454 GS FLX Titanium, 454 GS FLX Titanium, 454 GS FLX+, 454 GS Junior, AB 310 Genetic Analyzer, AB 3130 Genetic Analyzer, AB 3130xL Genetic Analyzer, AB 3500 Genetic Analyzer, AB 3500xL Genetic Analyzer, AB 3730 Genetic Analyzer, AB 3730xL Genetic Analyzer, AB 5500 Genetic Analyzer, AB 5500x-Wl Genetic Analyzer, AB 5500xl Genetic Analyzer, AB SOLiD 3 Plus System, AB SOLiD 4 System, AB SOLiD 4hq System, AB SOLiD PI System, AB SOLiD System, AB SOLiD System 2.0, AB SOLiD System 3.0, BGISEQ-500, Complete Genomics, DNBSEQ-G400, DNBSEQ-G50, DNBSEQ-T7, Helicos HeliScope, Illumina Genome Analyzer, Illumina Genome Analyzer II, Illumina Genome Analyzer IIx, Illumina HiScanSQ, Illumina HiSeq 1000, Illumina HiSeq 1500, Illumina HiSeq 2000, Illumina HiSeq 2500, Illumina HiSeq 3000, Illumina HiSeq 4000, Illumina HiSeq X Five, Illumina HiSeq X Ten, Illumina iSeq 100, Illumina MiniSeq, Illumina MiSeq, Illumina NextSeq, Illumina NextSeq 1000, Illumina NextSeq 2000, Illumina NextSeq 2500, Illumina NextSeq 500, Illumina NextSeq 550, Illumina NovaSeq 6000, Illumina NovaSeq 6000, Ion Torrent PGM, Ion Torrent Proton, Ion Torrent S5, Ion Torrent S5 XL, MGISEQ-2000RS, Oxford Nanopore GridION, Oxford Nanopore MinION, Oxford Nanopore PromethION, PacBio RS, PacBio RS II, PacBio Sequel, PacBio Sequel II, Revio, Ultima Genomics UG100, ",,TRUE,,,,HTAN,str
NGS Sequencing Design Description,Free-form description of the methods used to create the sequencing library; a brief 'materials and methods' section.,,,TRUE,,,,CDS/sequencing,str
NGS Read Indicator,"Indicate if this is Read 1 (R1), Read 2 (R2), Index Reads (I1), or Other","R1, R2, R1&R2, I1, Other",,TRUE,,,,HTAN,str
NGS Library Preparation Days from Index,Number of days between sample for assay was received in lab and the libraries were prepared for sequencing [number]. If not applicable please enter 'Not Applicable',,,FALSE,,,,HTAN,regex match \d+$|Not\sApplicable$|unknown$
NGS Sequencing Library Construction Days from Index,Number of days between sample for assay was received in lab and day of sequencing library construction [number]. If not applicable please enter 'Not Applicable',,,TRUE,,,,HTAN,regex match \d+$|Not\sApplicable$|unknown$
Sequencing Level 2,"Sequencing data that has been aligned with a reference genome.",,"Component, SequencingLevel2_id, SequencingLevel1 Key, Filename, NGS Library Strategy, NGS Library Source, NGS Library Selection Method, NGS Library Layout, NGS Sequencing Platform, NGS Sequencing Design Description, NGS Raw reads, NGS Stitched reads, NGS Aligned reads, NGS Deduplicated reads, NGS Trimmed reads, NGS MapQ30, NGS Unique Bases, NGS Read Length, NGS Sequencing Coverage, Genomic Reference, Software and Version",FALSE,,,,,
SequencingLevel2_id,A unique identifier used by schematic for record updates and as a reference key in other schemas,,,TRUE,,,,MC2,unique
NGS Raw reads,"Reads not yet analyzed in any way to be used for data analysis. The number of reads that pass filter from the flow cell represented in the FASTQ file. ",,,FALSE,,,,HTAN,num
NGS Stitched reads,"Represents consensus from the overlapping sequence of read 1 and 2. This is a % of the aligned reads that were overlapped and consensus confirmed, usually upward of 80% but less in terms of number of reads than aligned reads",,,FALSE,,,,HTAN,num
NGS Aligned reads,Is a sequence that has been aligned to a gene/probe. Typically these reads can number from the hundreds of thousands to tens of millions. In GeoMx alignment is via mapping the RTS ID to a white list of sequences that represent targets.,,,FALSE,,,,HTAN,num
NGS Deduplicated reads,Is the replacement of blocks of duplicate data with a Virtual Index Pointer linking the new sub-block to the existing block of data in a duplicate repository. This is used to reduce the amount of space need to store the data.,,,FALSE,,,,HTAN,num
NGS Trimmed reads,Number of the reads remaining after trimming has been applied.,,,FALSE,,,,STE,num
NGS MapQ30,Number of reads with Quality >= 30.,,,FALSE,,,,HTAN,num
NGS Unique Bases,Count of unique basecalls present in the data.,,,FALSE,,,,CDS/Sequencing,num
NGS Sequencing Coverage,Depth of coverage on assembly used. Found by (Unique Aligned Basecalls)/(Reference Length),,,FALSE,,,,CDS/Sequencing,num
Sequencing Level 3,Sequencing data that has been aligned with a reference genome.,,"Component, SequencingLevel3_id, SequencingLevel2 Key, Filename, NGS Unique Probe Count, NGS Unique Target Count, NGS Matrix Type, Software and Version",FALSE,,,,,
SequencingLevel3_id,A unique identifier used by schematic for record updates and as a reference key in other schemas,,,TRUE,,,,MC2,unique
NGS Unique Probe Count,Total number of unique probes reported.,,,FALSE,,,,HTAN,num
NGS Unique Target Count,Total number of unique genes reported.,,,FALSE,,,,HTAN,num
NGS Matrix Type,Type of count data stored in matrix.,"Raw Counts, Normalized Counts, Scaled Counts, Batch Corrected Counts",,FALSE,,,,HTAN,
Sequencing RNA Level 1,Unaligned/unprocessed RNA sequencing data ,,"Component, SequencingRNALevel1_id, Filename, NGS RNA End Bias, NGS RNA Reverse Transcription Primer, NGS RNA RIN, NGS RNA DV200",FALSE,,,Sequencing Level 1,MC2,
SequencingRNALevel1_id,A unique identifier used by schematic for record updates and as a reference key in other schemas,,,TRUE,,,,MC2,unique
NGS RNA End Bias,"The end of the cDNA molecule that is preferentially sequenced, e.g. 3/5 prime tag/end or the full length transcript","3 Prime, 5 Prime, Full Length Transcript",,TRUE,,,,HTAN,str
NGS RNA Reverse Transcription Primer,"An oligo to which new deoxyribonucleotides can be added by DNA polymerase [SO_0000112]. The type of primer used for reverse transcription, e.g. oligo-dT or random primer. This allows users to identify content of the cDNA library input e.g. enriched for mRNA","Oligo-dT, Poly-dT, Feature barcoding, Random",,TRUE,,,,HTAN,str
NGS RNA RIN,A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample including the presence or absence of degradation products. Number,,,FALSE,,,,HTAN,num
NGS RNA DV200,Represents the percentage of RNA fragments that are >200 nucleotides in size. Number,,,FALSE,,,,HTAN,num
Component,"Category of metadata (e.g. Tools, Publications, etc.); provide the same one for all items/rows.",,,TRUE,,shared,,,
Data Use Codes,"DUO code - A data item that is used to indicate consent permissions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used. Available DUO code definitions can be found here: https://mc2-center.github.io/data-models/valid_values/file/#attribute-data-use-codes","IRB, HMB, PUB, US, NPOA, COL, NCU, NPUNCU, RS, TS, NRES, NPU, DUM, POA, MOR, GSO, RTN, CC, NMDS, IS, GS, DS, GRU, PS",,FALSE,,shared,,Data Use Ontology,list like
ProjectView Key,"Unique ProjectView_id foreign key(s) that group the resource with other components, as part of the same grant-associated studies. Please provide multiple values as a comma-separated list.",,,FALSE,,project,,MC2,matchAtLeastOne ProjectView.ProjectView_id Value 
Study Key,"The unique Study_id foreign keys associated with the resource, found in the grant Study information. Used to group the resource with other components. Please provide multiple values as a comma-separated list.",,,FALSE,,study,,MC2,matchAtLeastOne Study.Study_id Value 
PersonView Key,"Unique PersonView_id foreign key(s) that group the resource with other components, as part of the same person-associated studies. Please provide multiple values as a comma-separated list.",,,FALSE,,person,,MC2,matchAtLeastOne PersonView.PersonView_id Value 
Consortium Key,"Unique Consortium_id foreign key(s) that group the resource with other components, as part of the same consortium-associated grants. Please provide multiple values as a comma-separated list.",,,FALSE,,consortium,,MC2,matchAtLeastOne Consortium.Consortium_id Value 
GrantView Key,"Unique GrantView_id foreign key(s) that group the resource with other components, as part of the same grant-associated collection. Please provide multiple values as a comma-separated list.",,,FALSE,,grant,,MC2,matchAtLeastOne GrantView.GrantView_id Value
DatasetView Key,Unique DatasetView_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,dataset,,MC2,matchAtLeastOne DatasetView.DatasetView_id Value 
Biospecimen Key,Unique Biospecimen_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,biospecimen,,MC2,matchAtLeastOne Biospecimen.Biospecimen_id Value 
Individual Key,Unique Individual_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,individual,,MC2,matchAtLeastOne Individual.Individual_id Value 
PublicationView Key,Unique PublicationView_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,publication,,MC2,matchAtLeastOne PublicationView.PublicationView_id Value 
ToolView Key,Unique ToolView_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,tool,,MC2,matchAtLeastOne ToolView.ToolView_id Value 
EducationalResource Key,Unique EducationalResource_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,education,,MC2,matchAtLeastOne EducationalResource.EducationalResource_id Value 
DataDSP Key,Unique DataDSP_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separated list.,,,FALSE,,sharingPlans,,MC2,matchAtLeastOne DataDSP.DataDSP_id Value
Model Key,Unique Model_id foreign key(s) that link metadata entries as part of the same collection. Please provide multiple values as a comma-separate list.,,,FALSE,,model,,MC2,matchAtLeastOne Model.Model_id Value
FileView Key,Unique FileView_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,file,,MC2,matchAtLeastOne FileView.FileView_id Value
NanoStringGeoMxAuxiliaryFiles Key,Unique NanoStringGeoMxAuxiliaryFiles_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,geomx,,MC2,matchAtLeastOne NanoStringGeoMxAuxiliaryFiles.NanoStringGeoMxAuxiliaryFiles_id Value
NanoStringGeoMxDSPImaging Key,Unique NanoStringGeoMxDSPImaging_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,geomx,,MC2,matchAtLeastOne NanoStringGeoMxDSPImaging.NanoStringGeoMxDSPImaging_id Value
NanoStringGeoMxDSPLevel1 Key,Unique NanoStringGeoMxDSPLevel1_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,geomx,,MC2,matchAtLeastOne NanoStringGeoMxDSPLevel1.NanoStringGeoMxDSPLevel1_id Value
NanoStringGeoMxDSPLevel2 Key,Unique NanoStringGeoMxDSPLevel2_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,geomx,,MC2,matchAtLeastOne NanoStringGeoMxDSPLevel2.NanoStringGeoMxDSPLevel2_id Value
NanoStringGeoMxDSPLevel3 Key,Unique NanoStringGeoMxDSPLevel3_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,geomx,,MC2,matchAtLeastOne NanoStringGeoMxDSPLevel3.NanoStringGeoMxDSPLevel3_id Value
NanoStringGeoMXROISegmentAnnotation Key,Unique NanoStringGeoMXROISegmentAnnotation_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,geomx,,MC2,matchAtLeastOne NanoStringGeoMXROISegmentAnnotation.NanoStringGeoMXROISegmentAnnotation_id Value
ImagingChannel Key,Unique ImagingChannel_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,TRUE,,imaging,,MC2,matchAtLeastOne ImagingChannel.ImagingChannel_id Value
ImagingLevel1 Key,Unique ImagingLevel1_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,imaging,,MC2,matchAtLeastOne ImagingLevel1.ImagingLevel1_id Value
ImagingLevel2 Key,Unique ImagingLevel2_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,imaging,,MC2,matchAtLeastOne ImagingLevel2.ImagingLevel2_id Value
ImagingLevel3Image Key,Unique ImagingLevel3Image_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,imaging,,MC2,matchAtLeastOne ImagingLevel3Image.ImagingLevel3Image_id Value
ImagingLevel3Segments Key,Unique ImagingLevel3Segments_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,imaging,,MC2,matchAtLeastOne ImagingLevel3Segments.ImagingLevel3Segments_id Value
ImagingLevel4 Key,Unique ImagingLevel4_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,imaging,,MC2,matchAtLeastOne ImagingLevel4.ImagingLevel4_id Value
SequencingLevel1 Key,Unique SequencingLevel1_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,sequencing,,MC2,matchAtLeastOne SequencingLevel1.SequencingLevel1_id Value
SequencingLevel2 Key,Unique SequencingLevel2_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,sequencing,,MC2,matchAtLeastOne SequencingLevel2.SequencingLevel2_id Value
SequencingLevel3 Key,Unique SequencingLevel3_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,sequencing,,MC2,matchAtLeastOne SequencingLevel3.SequencingLevel3_id Value
SequencingLevel4 Key,Unique SequencingLevel4_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,sequencing,,MC2,matchAtLeastOne SequencingLevel4.SequencingLevel4_id Value
SequencingRNALevel1 Key,Unique SequencingRNALevel1_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,sequencing RNA,,MC2,matchAtLeastOne SequencingRNALevel1.SequencingRNALevel1_id Value
10xVisiumRNALevel1 Key,Unique 10xVisiumRNALevel1_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,visium,,MC2,matchAtLeastOne 10xVisiumRNALevel1.10xVisiumRNALevel1_id Value
10xVisiumRNALevel2 Key,Unique 10xVisiumRNALevel2_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,visium,,MC2,matchAtLeastOne 10xVisiumRNALevel2.10xVisiumRNALevel2_id Value
10xVisiumRNALevel3 Key,Unique 10xVisiumRNALevel3_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,visium,,MC2,matchAtLeastOne 10xVisiumRNALevel3.10xVisiumRNALevel3_id Value
10xVisiumRNALevel4 Key,Unique 10xVisiumRNALevel4_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,visium,,MC2,matchAtLeastOne 10xVisiumRNALevel4.10xVisiumRNALevel4_id Value
10xVisiumAuxiliaryFiles Key,Unique 10xVisiumAuxiliaryFiles_id foreign key(s) that link metadata entries as part of the same Dataset. Please provide multiple values as a comma-separate list.,,,FALSE,,visium,,MC2,matchAtLeastOne 10xVisiumAuxiliaryFiles.10xVisiumAuxiliaryFiles_id Value
Filename,"The path of a file in Synapse, relative to the project. The file associated with the path will be annotated with attributes contained in this sheet.",,,TRUE,,shared,,MC2,str
Workflow Type,Type of computational workflow used to generate the file.,,,FALSE,,shared,,HTAN,str
Workflow Link,Link to documentation or webpage associated with the computational workflow used to generate the file.,,,FALSE,,shared,,HTAN,url
Workflow Parameter Description,Link or text description of flags or options provided to the workflow used to generate the file.,,,FALSE,,shared,,HTAN,str
Software and Version,Name of software used to generate the information contained in the file. String,,,FALSE,,shared,,HTAN,str
Workflow Version,Major version of the workflow (e.g. Cell Ranger v3.1),,,FALSE,,shared,,HTAN,str
Genomic Reference,Exact version of the human genome reference used in the alignment of reads (e.g. GCF_000001405.39),,,TRUE,,shared,,HTAN,str
Genomic Reference URL,Link to human genome sequence; ftp or reference URL will be accepted.,,,TRUE,,shared,,HTAN,url
Genome Annotation URL,Link to the human genome annotation (GTF) file; ftp or reference URL will be accepted.,,,TRUE,,shared,,HTAN,url
DataDSP,Dataset sharing plan information. Used to indicate planned usage of MC2 Center supported Synapse projects.,,"Component, DataDSP_id, Study Key, DatasetView Key, DSP Dataset Alias, DSP Dataset Name, DSP Dataset Url, DSP Dataset Assay, DSP Dataset Level, DSP Dataset Species, DSP Dataset Tumor Type, DSP Dataset Tissue, DSP Dataset File Formats, DSP Number of Files, DSP Number of Samples, DSP Number of Participants, DSP Storage Size, DSP Dataset Description, DSP Planned Upload Date, DSP Planned Release Date, DSP Data Use Codes, DSP IRB Form, DSP Dataset Destination",FALSE,,,Study,,
DSP Dataset Name,Name of the dataset,,,TRUE,,,,,str
DSP Dataset Alias,"Alias of the dataset. For Synapse storage, the Synapse id associated with the dataset should be used. Must be unique.",,,FALSE,,,,,unique
DSP Dataset Assay,"The type of data contained in this group of files. Multiple values permitted, comma separated.","10-cell RNA Sequencing, 16S Ribosomal Gene Sequencing Assay, 3' RNA-seq, 3C, 3C-qPCR, 3D Bioprinting, 3D Cell Culture, 4C, 5C, ATAC-Seq, ATP Bioluminescence Assay, Affinity Purification Mass Spectrometry, Allograft, Amplicon Sequencing, Angiogenesis Assay, Apoptosis Assay, Atomic Absorption Spectrophotometry, Atomic Absorption Spectroscopy, Atomic Force Microscopy, Autoradiography, Barcode-Seq, Bicinchoninic Acid Assay, Binding Assay, Bio-Layer Interferometry, Bioluminescence Imaging, Bisulfite Sequencing, Brightfield Microscopy, Brillouin Microscopy, CASFISH, CITE-seq, CLIP-qPCR, CRISPR, CUT&RUN, CUT&Tag-Sequencing, Cell Adhesion Assay, Cell Proliferation Assay, Cell Viability Assay, Cell-spreading Assay, CellTiter-Glo Luminescent Cell Viability Assay, Cerenkov Luminescence Imaging, ChIA-PET, ChIP-PCR, ChIP-Seq, ChIP-qPCR assay, Chemiluminescent Assay, Chemotaxis Assay, Circular Dichroism Spectroscopy, Co-Immunoprecipitation, Co-culture Assay, Collision-Induced Dissociation, Colorimetric Cell Viability Assay, Computational Modeling, Computational Tool, Computed Tomography, Confocal Microscopy, Confocal Reflectance Quantitative Phase Microscopy, Cross-Linking Immunoprecipitation High-throughput Sequencing, Cross-Linking Mass Spectrometry, Cyclic Immunofluorescence, Cytochemical Stain, Cytokine Expression Profile, Cytometric Bead Array Assay, Cytotoxicity Assay, DBiT-Seq, DNA Gene-Expression Microarray, DNA Methylation Array, DNA Sequencing, DNase-Seq, DRIP-seq, Dark Field Microscopy, Deep Mutational Scanning, Desorption Electrospray Ionization, Dideoxy Chain Termination DNA Sequencing, Differential Interference Contrast Microscopy, Differential Scanning Fluorimetry, Diffusion Weighted Imaging, Direct Long-Read RNA Sequencing, Drop-Seq, Droplet Digital PCR, Dual-Luciferase Reporter Assay, Dye Endocytosis Assay, Dynamic Contrast-Enhanced Magnetic Resonance Imaging, Dynamic Force Spectroscopy, Dynamic Light Scattering, Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, ELISA, Efferocytosis Assay, Electron Diffraction, Electron Microscopy, Electron Paramagnetic Resonance Spectroscopy, Electrophoretic Mobility Shift Assay, Electrospray Ionization Time-of-Flight Mass Spectrometry, Endotoxin Assay, Energy-Dispersive X-Ray Spectroscopy, Enzyme Activity Assay, Enzyme-Linked Immunospot Assay, Epidemiological Method, FAIRE-Seq, FISH, Flow Cytometry, Fluorescence Activated Cell Sorting, Fluorescence Correlation Spectroscopy, Fluorescence Imaging, Fluorescence Lifetime Imaging Microscopy, Fluorescence Microscopy, Fluorescence Recovery After Photo-Bleaching, Fluorescent Antibody Procedure, Fluorescent Cell Barcoding, Fluorescent In Situ Sequencing , Focused Ion Beam Scanning Electron Microscopy, Forster Resonance Energy Transfer, Fourier Transform Ion Cyclotron Resonance Mass Spectrometry, Fourier-Transform Infrared Spectroscopy, Gas Chromatography Mass Spectrometry, Gelatin Zymography, Genotyping, Global Chromatin Profiling, Global Run-On Sequencing, Graphite Furnace Atomic Absorption Spectrometry, HL-Chip, HPLC-MSMS, Hematoxylin and Eosin Staining Method, Hi-C, HiChIP, High Throughput Screening, High-Content Screen, Hydrogels, Hydrophilic Interaction Chromatography, Image Cytometry, Imaging, Immobilized Metal Affinity Chromatography, ImmunoFISH, Immunoassay, Immunocytochemistry, Immunohistochemistry Staining Method, Immunoprecipitation, In Situ Hybridization, In Vitro Cell Killing Assay, In Vitro Model, In Vitro Selection, In Vitro Translation, In Vivo Bioluminescence, In-Cell Western Assay, Inductively-Coupled Plasma Mass Spectrometry, Interference Reflection Microscopy, Intravital Microscopy, Invasion Assay, Karyotyping, Knife-Edge Scanning Microscopy, L1000 mRNA Profiling Assay, Lattice Light Sheet Microscopy, Liquid Chromatography Mass Spectrometry, Liquid Chromatography/Tandem Mass Spectrometry, Low-Vacuum Scanning Electron Microscopy, Luciferase Reporter Assay, Luminescent Cell Viability Assay, MALDI-TOF Mass Spectrometry, MEMA Cell Growth Assay, MNase-Seq, MULTI-Seq, Macrophage Polarization Assay, Magnetic Resonance Imaging, Magnetic Tweezers, Magnetic Twisting Cytometry, Magnetically Activated Cell Sorting, Mammosphere Formation Assay, Mass Cytometry, Mass Spectrometry, Mathematical Modeling, MeDIP, MeRIP-Seq, Methyl Binding Domain Sequencing, Methylation-Specific PCR, Micro-computed Tomography, MicroRNA Expression Array, MicroRNA Sequencing, Microcontact Printing, Microfluidics, Micropipette Adhesion Assay, Micropipette Aspiration, Microscopy, Migration Assay, Mint-ChIP, Modeling, Molecular Simulations, Monolayer Stress Microscopy, Multi-Angle Light Scattering, Multi-Isotope Mass Spectrometry, Multiparametric Magnetic Resonance Imaging, Multiphoton Microscopy, Multiplexed Error-Robust Fluorescence In Situ Hybridization, Multiplexed Immunofluorescence, Multiplexed Immunohistochemistry, Multiplexed Ion Beam Imaging, Murine Model, Nano-hmC-Seal, NanoString Digital Spatial Profiling, Nanopatterning, Nanopore Sequencing, Nanowire, Nested PCR, Next Generation Sequencing, Nm-seq, Not Applicable, Nuclear Magnetic Resonance, Optical Coherence Tomography, Optical Emission Spectroscopy, Optical Mapping, Optical Stretcher, Optical Tweezers, Optogenetic Assay, Organoid, PCR, PET-CT, Paraquat Survival Assay, Partial Wave Spectroscopy, Patient Derived Xenograft, Pending Annotation, Permeability Assay, Phagocytosis Assay, Photoacoustic Imaging, Photolithography, Plasmid Construction, PlateSeq, Point Accumulation for Imaging in Nanoscale Topography, Positron Emission Tomography, Precision Run-On Sequencing, Proteomics Assay, Proximity Ligation Assay, Pull-Down Assay, QFISH, Quantitative Multiplex Immunofluorescence, Quantitative Point Accumulation for Imaging in Nanoscale Topography, Questionnaire, RAS Protein Family Activation Assay, RIP, RIP-Seq, RNA Sequencing, RNAi Screen, RT-PCR, RT-qPCR, Raman Spectroscopy, Reduced Representation Bisulfite Sequencing, Reverse Phase Protein Array, Reverse-Phase High-Performance liquid Chromatography, Rheometry, Ribo-Seq, Ribosomal P Protein Antibody Measurement, Scanning Angle Interference Microscopy, Scanning Electron Microscopy, Second-Harmonic Imaging Microscopy, Shotgun Mass Spectrometry, Single Cell ATAC-Seq, Single Cell Cytokine Detection Chip Assay, Single Cell DNA Sequencing, Single Cell Gel Electrophoresis, Single Cell RNA-Sequencing, Single Molecule Forster Resonance Energy Transfer, Single Nucleotide Polymorphism Array, Single Nucleus RNA-Sequencing, Single-Cell BCR Sequencing, Single-Cell Barcode Chip, Single-Cell TCR Sequencing, Single-Molecule Tracking, Sirius Red Staining, Size Exclusion Chromatography, Small-Angle X-ray Scattering, Soft Agar Assay, Southern Blotting, Spectroscopy, Statistical Modeling, Stimulated Emission Depletion Microscopy, Stimulated Raman Scattering, Stochastic Optical Reconstruction Microscopy, Super-Resolution Microscopy, Surface Plasmon Resonance, Surveyor Nuclease Assay, Synaptophysin Staining Method, Synthetic Genetic Array, TAB-Seq, TCR Sequencing, TIRF Microscopy, TRAP Staining, TUNEL assay, Tandem Mass Spectrometry, Tandem Mass Tagging, Target Engagement Assay, Targeted Genome Sequencing, Targeted Transcriptome Sequencing, Thermal Shift Assay, Thin-Layer Chromatography, Tiling Array, Time Lapse Microscopy, Time-Correlated Single Photon Counting, Tissue Engineering, Tissue Microarray, Total Internal Reflection Fluorescence Microscopy, Traction Force Microscopy, Transmission Electron Microscopy, Transwell Assay, UPLC-MSMS, UV Photocrosslinking, Unspecified, Vibrational Spectroscopy, Virus Plaque Assay, Von Kossa Staining, Western Blotting, Whole Exome Sequencing, Whole Genome Bisulfite Sequencing, Whole Genome Sequencing, Widefield Fluorescence Microscopy, Wound-Healing Assay, X-Ray Crystallography, X-Ray Diffraction, X-Ray Micro-Computed Tomography, Xenograft, cDNA Array, eCLIP-Seq, mRNA Sequencing, qPCR, scCGI-seq, scNT-Seq, scSLAM-seq, seqFISH, shRNA, siRNA, smFISH, smRNA-seq, snRNA-seq, Isothermal Titration Calorimetry, Suspended Microchannel Resonator, 10x Multiome, Visium Spatial Gene Expression, Antitumor Drug Screening Assay, Bioelectrochemical Analysis, Chimeric Antigen Receptor T-Cell Therapy, Cell Cycle Assay, Clonality Analysis, Comparative Genomic Hybridization, Cryo-Electron Microscopy, Cryo-Electron Tomography, Data Integration, Field-Emission Scanning Electron Microscopy, Label-free Protein Quantification by LC/MS, Metabolite Profiling Assay, Reporter Gene Assay, Single-Molecule Localization Microscopy, Synthesis, Targeted Therapy Agent, Trichrome Staining Method, Ultrasound Imaging, Transcription profiling by NanoString, Alcian Blue Staining Method, Artificial Intelligence, Cell Culture, Clinical Study, Cell-free Circulating Tumor DNA Assay, Co-Immunoprecipitation Mass Spectrometry, Deep Learning, Fluorescent In Situ Sequencing, Gene Ontology Enrichment Analysis, Gene Set Enrichment Analysis, Gene Silencing , Human Induced Pluripotent Stem Cell-derived Cardiomyocytes Culture, Imaging Mass Cytometry, Immunofluorescent Staining Method, Immunotherapy, Viral Transduction, Metastatic Colonization Assay, Phylogenetic Analysis, Picrosirius Staining, Scratch Assay, Structural Variant Analysis, Survival Analysis, Targeted Error Correction Sequencing, Tuba-Seq, SDS-PAGE, Cell Fractionation, Multiscale Light Sheet Microscopy, Light Sheet Microscopy",,TRUE,,,,,list like
DSP Dataset Species,"The species the data was collected on. Multiple values permitted, comma separated.","African Bush Elephant, Armadillo, Asian Elephant, Boar, Cat, Chicken, Cow, Dog, Escherichia coli, Guinea Pig, Horse, Human, Human Patient, Human Cell Line, Mouse, Multispecies, Opossum, Rabbit, Rat, Rhesus monkey, Sheep, Trichoplax adhaerens, Unknown, Unspecified, Worm, Yeast, Fruit Fly, Zebrafish",,TRUE,,,,,list like
DSP Dataset Tumor Type,"The tumor type(s), if applicable, of the data collected on. Multiple values permitted, comma separated.","Cutaneous Melanoma, Acinar Cell Carcinoma, Acute Lymphoblastic Leukemia, Acute Monocytic Leukemia, Acute Myeloid Leukemia, Acute Promyelocytic Leukemia, Adenocarcinoma, Angiosarcoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, B Acute Lymphoblastic Leukemia, B-Cell Non-Hodgkin Lymphoma, Barrett Esophagus, Basal Cell Neoplasm, Basal-Like Breast Carcinoma, Biliary Tract Carcinoma, Bladder Carcinoma, Bladder Neoplasm, Bone Neoplasm, Brain Neoplasm, Breast Adenocarcinoma, Breast Carcinoma, Breast Neoplasm, Carcinoma, Carcinoma In Situ, Castration-Resistant Prostate Carcinoma, Cellular Schwannoma, Central Nervous System Cavernous Hemangioma, Central Nervous System Neoplasm, Cerebellar Neoplasm, Cervical Carcinoma, Cervical Neoplasm, Cervical Small Cell Carcinoma, Cholangiocarcinoma, Chondroblastoma, Choriocarcinoma, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Clear Cell Renal Cell Carcinoma, Colon Adenocarcinoma, Colon Carcinoma, Colorectal Adenocarcinoma, Colorectal Adenoma, Colorectal Carcinoma, Colorectal Neoplasm, Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Craniopharyngioma, Cutaneous T Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Ductal Breast Carcinoma In Situ, Dysembryoplastic Neuroepithelial Neoplasm, Endometrial Carcinoma, Endometrial Neoplasm, Ependymoma, Esophageal Adenocarcinoma, Esophageal Carcinoma, Esophageal Squamous Cell Carcinoma, Ewing Sarcoma, Extraventricular Neurocytoma, Fibroepithelial Polyp, Fibrolamellar Carcinoma, Fibrosarcoma, Follicular Lymphoma, Gallbladder Carcinoma, Gastric Adenocarcinoma, Gastric Carcinoma, Gastric Neoplasm, Gastroesophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Gastrointestinal Stromal Neoplasm, Giant Cell Tumor, Glioblastoma, Glioma, Head and Neck Carcinoma, Head and Neck Neoplasm, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, High Grade Ovarian Serous Adenocarcinoma, Histiocytic Sarcoma, Hodgkin Lymphoma, Intestinal Neoplasm, Intrahepatic Cholangiocarcinoma, Invasive Ductal Breast Carcinoma, Kaposi Sarcoma, Leiomyoma, Leukemia, Liver and Intrahepatic Bile Duct Carcinoma, Liver and Intrahepatic Bile Duct Neoplasm, Low Grade Glioma, Luminal A Breast Carcinoma, Lung Adenocarcinoma, Lung Carcinoma, Lung Neoplasm, Lung Non-Small Cell Carcinoma, Lung Small Cell Carcinoma, Lung Squamous Cell Carcinoma, Lymphoid Leukemia, Lymphoma, Malignant Brain Neoplasm, Malignant Digestive System Neoplasm, Malignant Genitourinary System Neoplasm, Malignant Glioma, Malignant Neoplasm, Malignant Ovarian Neoplasm, Malignant Pancreatic Neoplasm, Malignant Peripheral Nerve Sheath Tumor, Malignant Peritoneal Neoplasm, Malignant Skin Neoplasm, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Medulloblastoma, Melanoma, Meningioma, Mesothelioma, Multiple Myeloma, Mycosis Fungoides, Myeloid Leukemia, Myeloid Neoplasm, Myeloproliferative Neoplasm, Myoepithelioma, Nasopharyngeal Carcinoma, Neuroblastoma, Neuroendocrine Neoplasm, Neuroepithelial Neoplasm, Neurofibroma, Non-Functioning Pituitary Gland Adenoma, Non-Hodgkin Lymphoma, Not Applicable, Oral Cavity Neoplasm, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Neoplasm, Osteosarcoma, Ovarian Adenosarcoma, Ovarian Carcinoma, Ovarian Neoplasm, Ovarian Serous Adenocarcinoma, Pan-cancer, Pancreatic Adenocarcinoma, Pancreatic Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Neoplasm, Pancreatic Neuroendocrine Carcinoma, Pending Annotation, Penile Carcinoma, Pheochromocytoma, Pilocytic Astrocytoma, Pituitary Gland Adenoma, Plasmablastic Lymphoma, Plasmacytoma, Plexiform Schwannoma, Precursor B-cell lymphoblastic leukemia, Primary Central Nervous System Lymphoma, Primary Myelofibrosis, Prostate Adenocarcinoma, Prostate Carcinoma, Prostate Neoplasm, Rectal Adenocarcinoma, Renal Cell Carcinoma, Retinoblastoma, Rhabdomyosarcoma, Rosette-Forming Glioneuronal Tumor, Salivary Gland Adenoid Cystic Carcinoma, Sarcoma, Schwannoma, Serous Tubal Intraepithelial Carcinoma, Sinonasal Squamous Cell Carcinoma, Skin Carcinoma, Skin Neoplasm, Soft Tissue Sarcoma, Squamous Cell Carcinoma, Synovial Sarcoma, T Acute Lymphoblastic Leukemia, T-Cell Lymphoma, Teratoma, Testicular Embryonal Carcinoma, Thyroid Gland Anaplastic Carcinoma, Thyroid Gland Carcinoma, Thyroid Gland Noninvasive Follicular Neoplasm with Papillary-Like Nuclear Features, Triple-Negative Breast Carcinoma, Urothelial Carcinoma, Uterine Adenosarcoma, Uveal Melanoma, Uveal Neoplasm, Vascular Neoplasm, Not-Applicable, Plexiform Neurofibroma",,FALSE,,,,,list like
DSP Dataset Tissue,"Tissue type(s) associated with the dataset. Multiple values permitted, comma separated.","Gonad, Abdominal Esophagus, Adipose Tissue, Adrenal Gland, Alveolus, Aorta, Artery, Ascending Colon, Bile Duct, Bladder, Blood, Blood Vessel, Bone, Bone Marrow, Brain, Breast, Caecum, Cancer-Associated Fibroblast, Cardia, Cartilage, Cervix Uteri, Choroid, Colon, Connective and Soft Tissue, Cornea, Duodenum, Ear, Embryo, Embryonic Heart, Endocervix, Endometrium, Endothelium, Epithelium, Esophagus, Eye, Fallopian Tube, Foreskin, Frontal Lobe, Gastroesophageal Junction, Gastrointestinal Tract, Genitourinary, Hair Follicle, Head and Neck, Heart, Heart Muscle, Hematopoietic System, Hippocampus, Intestine, Intra-Abdominal Lymph Nodes, Intrathoracic Lymph Nodes, Joint, Kidney, Larynx, Ligament, Liver, Lung, Lymph, Lymph Node, Lymph Nodes of Axilla or Arm, Lymph Nodes of Inguinal Region or Leg, Lymphatic System, Lymphoid Tissue, Main Bronchus, Mammary Gland, Meninges, Mesenchyme, Mucosa, Muscle, Nasal Cavity, Nervous System, Not Applicable, Olfactory Mucosa, Omentum, Oral Cavity, Oral Mucosa, Ovary, Pancreas, Pelvic Lymph Nodes, Pending Annotation, Periodontal Ligament, Peripheral Nerves, Peritoneum, Pharynx, Pituitary Gland, Placenta, Pleura, Prostate Gland, Rectum, Reproductive System, Respiratory System, Salivary Gland, Sclera, Sinonasal Tract, Skin, Small Intestine, Spinal Cord, Spleen, Stomach, Synovial Membrane, Tendon, Testis, Thymus, Thyroid Gland, Tongue, Tonsil, Trachea, Umbilical Cord, Unspecified, Uterus, Vagina, Vascular Endothelium, Vein, Vertebra, Peripheral Blood Mononuclear Cell",,FALSE,,,,,list like
DSP Dataset File Formats,"A list of file formats associated with the dataset. Multiple values permitted, comma separated.","AVI, BAI, BAM, BED, CDS, CHP, COOL, CSV, DAE, DB, DS_Store, FASTA, FASTQ, FCS, FIG, FREQ, GCG, GCT, GCTx, GFF3, GTF, GZIP Format, HDF, HDF5, HTML, IDAT, JPG, JSON, LIF, MAP, MAT, MATLAB script, MSF, MTX, PDF, PNG, PZFX, Python Script, R File Format, RAW, RDS, ROUT, RPROJ, RTF, SGI, SRA, STAT, TAR Format, TDF, TIFF, TSV, TXT, VCF, WIG, XML, ZIP, bed12, bedgraph, cel, cloupe, docx, mzIdentML, mzXML, pptx, rcc, xls, xlsx, MGF, BIGWIG, H5AD, H5, SF, PKL, BPM, Unspecified, Pending Annotation, maf, CLS, SCN, SVS",,FALSE,,,,,list like
DataDSP_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
DSP Dataset Level,The level of processing associated with the dataset.,"Level 1, Level 2, Level 3, Level 4, Auxiliary, Not Applicable",,FALSE,,,,,list like
DSP Number of Files,The number of files that will be uploaded as part of this dataset.,,,FALSE,,,,,num
DSP Number of Samples,The number of biospecimens associated with the files included in the dataset,,,FALSE,,,,,num
DSP Number of Participants,The number of individuals or model organisms from which samples were collected to generate the dataset.,,,FALSE,,,,,num
DSP Storage Size,The expected total storage space required for the dataset in gigabytes (GB),,,FALSE,,,,,num
DSP Planned Upload Date,"A non-binding, estimated date by which the files are expected to be uploaded to a repository.",,,TRUE,,,,,date
DSP Planned Release Date,The projected date that marks the end of any requested or required sharing embargo for the dataset.,,,FALSE,,,,,date
DSP Dataset Grant Number,"Grant number(s) associated with the dataset's development. Multiple values permitted, comma separated.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
DSP Dataset Url,The url of where the dataset is or will be stored.,,,FALSE,,,,,url
DSP Data Use Codes,"DUO code - A data item that is used to indicate consent permissions for datasets and/or materials, and relates to the purposes for which datasets and/or material might be removed, stored or used. Available DUO code definitions can be found here: https://mc2-center.github.io/data-models/valid_values/sharingPlans/#attribute-dsp-data-use-codes ","IRB, HMB, PUB, US, NPOA, COL, NCU, NPUNCU, RS, TS, NRES, NPU, DUM, POA, MOR, GSO, RTN, CC, NMDS, IS, GS, DS, GRU, PS",,FALSE,,,,Data Use Ontology,list like
DSP IRB Form,The Synapse Id for the executed IRB protocol or exemption document that was uploaded to Synapse. Required if human-derived data was generated for this study and will be uploaded as part of this dataset,,,FALSE,,,,,regex match syn\d+
DSP Dataset Description,A text description of the files contained in this dataset.,,,FALSE,,,,,str
DSP Dataset Destination,An identifier representing the repository in which this dataset is intended to be held for long term preservation.,,,FALSE,,,,,str
Study,Studies associated with a grant,,"Component, Study_id, GrantView Key, ProjectView Key, Study dbGaP Accession Id, Study Name, Study Description, Study Investigator, PersonView Key, Study Number of Participants, Study De-identification Method Type, Study De-identification Method Description, Study De-identification Method Software, Study Reuse Statement, Study Data Use Codes, Study License",FALSE,,,Grant View,,
Study Name,Name of the study,,,TRUE,,,,,str
Study Description,"Description of the study, including the types of experimental assays, model systems, types of analysis, etc.",,,TRUE,,,,,str
Study Investigator,Investigator(s) associated with the project. Multiple names should be provided as a comma-separated list.,,,TRUE,,,,,list like
Study Reuse Statement,"The funder-, contributor-, patient-, etc., derived content that includes terms, conditions, or statements associated with accessing and reusing the resource(s).",,,FALSE,,,,,str
Study_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
Study Number of Participants,The number of participant instances associated with systematic investigation into a subject. ,,,TRUE,,,,CDS/collection,int
Study De-identification Method Type,General description of the de-identification method,"Manual , Semiautomatic , Automatic , Not applicable",,TRUE,,,,CDS/collection,
Study De-identification Method Description,Description of the process of removing potentially identifying data or data elements to render data into a form that does not identify individuals and where identification is not likely to take place.,,,FALSE,,,,CDS/collection,str
Study De-identification Method Software,Software that was used to de-identify the images (if used),,,FALSE,,,,CDS/collection,str
Study dbGaP Accession Id,A stable unique alphanumeric identifier assigned to a study and any objects by the database of Genotypes and Phenotypes (dbGaP). Required for controlled access data being submitted to CDS/CRDC.,,,FALSE,,,,CDS/collection,str
Study License,Official or legal permission to do or own a specified thing. Studies with data that will be submitted to CDS are required to provide a license.,"CC BY 3.0, CC BY 4.0, CC BY-NC 4.0, CC BY-NC 3.0",,FALSE,,,,CDS/collection,
Study Data Use Codes,"DUO code - A data item that is used to indicate consent permissions for datasets and/or materials and relates to the purposes for which datasets and/or material might be removed, stored, or used. Available DUO code definitions can be found here: https://mc2-center.github.io/data-models/valid_values/sharingPlans/#attribute-dsp-data-use-codes","IRB, HMB, PUB, US, NPOA, COL, NCU, NPUNCU, RS, TS, NRES, NPU, DUM, POA, MOR, GSO, RTN, CC, NMDS, IS, GS, DS, GRU, PS",,FALSE,,,,Data Use Ontology, list like
Theme,Themes associated with resources derived from consortia activities,,"Component, Theme Name, Theme Display Name, Theme Description",FALSE,,,,,
Theme Name,"Machine readable name of the research theme. (e.g. compuational_resource, drug_resistance_sensitivity).",,,TRUE,,,,,
Theme Display Name,"Human readable display name of the research theme. (e.g. Computational Resource, Drug Resistance/Sensitivity)",,,TRUE,,,,,
Theme Description,Description of the research theme.,,,TRUE,,,,,
Tool Accessibility,Whether there are non-monetary restrictions on accessing an online service.,"Open Access, Open Access (With Restrictions), Restricted Access",,FALSE,,,,biotoolsschema,
Tool Cmd,"Relevant command, command-line fragment, or option for executing this function/running the tool in this mode.",,,FALSE,,,,biotoolsschema,
Tool Compute Requirements,"Component dependency requirements for application. This includes runtime environments and shared libraries that are not included in the application distribution package, but required to run the application (examples: DirectX, Java or .NET runtime).",,,FALSE,,,,schema.org,"list like, url"
Tool Cost,Monetary cost of acquiring the software.,"Commercial, Free of Charge, Free of Charge (With Restrictions)",,FALSE,,,,biotoolsschema,
Tool Date Last Modified,"The date indicating when the tool's entry was most recently modified or updated, providing a timestamp of the latest changes made to the tool's information.",,,FALSE,,,,schema.org,date
Tool Description,Textual description of the tool.,,,TRUE,,,,biotoolsschema,
Tool Documentation Note,Comment about the documentation.,,,FALSE,,,,biotoolsschema,
Tool Documentation Type,"Type of documentation that is linked to. Multiple values permitted, comma separated.","API Documentation, Citation Instructions, Code of Conduct, Command-Line Options, Contributions Policy, FAQ, General, Governance, Installation Instructions, Other, Quick Start Guide, Release Notes, Terms of Use, Training Material, User Manual",,FALSE,,,,biotoolsschema,list like
Tool Documentation Url,Link to documentation on the web for the tool.,,,FALSE,,,,biotoolsschema,
Tool Download Note,Comment about the download.,,,FALSE,,,,biotoolsschema,
Tool Download Type,"The type of data, information, or system that is obtained when the link is resolved.","API Specification, Binaries, Biological Data, Command-Line Specification, Container File, Downloads Page, Icon, Other, Screenshot, Software Package, Source Code, Test Data, Test Script, Tool Wrapper (CWL), Tool Wrapper (Galaxy), Tool Wrapper (Taverna), Tool wrapper (Other), VM Image",,FALSE,,,,biotoolsschema,
Tool Download Url,Link to download (or repo providing a download) for the software.,,,FALSE,,,,biotoolsschema,
Tool Download Version,Version information (typically a version number) of the software applicable to this download.,,,FALSE,,,,biotoolsschema,
Tool Entity Name,Name of the entities that may be credited,,,FALSE,,,,,list like
Tool Entity Role,"Role performed by entity that is credited, e.g. “Developer”","Developer, Maintainer, Provider, Documentor, Contributor, Support, Primary Contact",,TRUE,,,,biotoolsschema,list like
Tool Entity Type,"Types of entities that may be credited, e.g. ‘Person’.","Person, Project, Division, Institute, Research Consortium, Funding Agency",,TRUE,,,,biotoolsschema,list like
Tool Function Note,"Concise comment about this function, if not apparent from the software description and EDAM annotations.",,,FALSE,,,,biotoolsschema,
Tool Grant Number,"Grant number associated with the tool's development. Multiple values permitted, comma separated.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
Tool Homepage,"Homepage of the software, or some URL that best serves this purpose.",,,TRUE,,,,biotoolsschema,url
Tool Input Data,"Type of primary input data. Multiple values permitted, comma separated.","Accession, Alignment, Biological Model ID, Biological Model Name, Cell Line Name, Cell Migration Track Image, Cell Type Identifier, Cell Type Name, Cell Type Ontology ID, Chromosome Name, Chromosome Report, Clustered Expression Profiles, Codon Number, Comparison Matrix, Compound Identifier, Compound Name, Concentration, Count Matrix, DNA Sequence, Data Index, Data Reference, Database Search Results, Drug Identifier, Drug Name, Drug Report, Electronic Health Record, Enzyme Kinetics Data, Experimental Measurement, Expression Data, GO-Term Enrichment Data, Gene Expression Matrix, Gene Expression Profile, Gene ID, Gene ID (NCBI), Gene Identifier, Gene Name, Gene Report, Gene Symbol, Gene Tree, Genetic Map, Genotype/Phenotype Report, Heat Map, Hidden Markov Model, Hierarchy, Histogram, Identifier, Image, Image Metadata, Kinetic Model, MRI Image, Map, Map Data, Mass Spectrometry Data, Mass Spectrum, Mathematical Model, Matrix, Molecular Property, Molecular Simulation Data, Molecule Identifier, Molecule Name, Morphology Parameter, Mutation ID, Not Applicable, Nucleic Acid Identifier, Nucleic Acid Report, Nucleic Acid Sequence, Ontology, Ontology Concept Data, Ontology Data, Ontology Identifier, Ontology Mapping, Ontology Name, Ontology Term, Organism Identifier, Organism Name, Over-Represesntation Data, P-Value, Pair Sequence Alignment, Pathway Or Network, Pathway Or Network Report, Pathway Overrepresentation Data, Peptide Identification, Peptide Property, Phenotype Name, Phylogenetic Data, Phylogenetic Tree, Plain Text, Plot, Position Weight Matrix, Position-Specific Scoring Matrix, Protein Contact Map, Protein Identifier, Protein Interaction Data, Protein Name, Protein Property, Protein Report, Protein Sequence, Protein Structure Report, Quality Control Report, RNA Sequence, Raw Image, Reaction Data, RefSeq Accession, Report, Resource Metadata, Sample Annotation, Sample ID, Score, Sequence, Sequence Alignment, Sequence Attribute, Sequence Cluster, Sequence Composition Plot, Sequence Composition Report, Sequence Coordinates, Sequence Features, Sequence Image, Sequence Motif, Sequence Position, Sequence Property, Sequence Range, Sequence Record, Sequence Report, Sequence Search Results, Sequence Set, Sequence Signature Data, Sequence Similarity, Sequence Similarity Score, Sequence Variations, Simulation, Small Molecule Report, Spectrum, Statistical Estimate Score, Strain Identifier, Strain Name, Structure, Structure Report, Taxonomy, Text Data, Text Mining Report, Topology Data, Training Material, Trajectory Data, Transcription Factor Identifier, Transcription Factor Name, Vmax, dbSNP ID",,TRUE,,,,biotoolsschema,list like
Tool Input Format,"Allowed format(s) of the input data. Multiple values permitted, comma separated.","Alignment Format, Alignment Format (Pair Only), Alignment Format (Text), Annotated Text Format, Antimony, BAM, BCF, BED, BLAST Results, BNGL, Binary Format, Biological Model Format, Biological Pathway Or Network Format, CSV, Chemical Data Format, Cytoband Format, Cytoscape Input File Format, DCC, DCD, DSV, Database Hits (Sequence) Format , Docker Image Format, Document Format, Dot-Bracket Format, FASTA, FASTQ, FASTQ-Illumina, FCS, GCT/Res Format, GFF, GFF3, GIF, GML, GTF, Gene Annotation Format, Gene Cluster Format, Gene Expression Report Format, Genotype And Phenotype Annotation Format, Graph Format, H5AD, HDF, HDF5, HTML, Hidden Markov Model Format, Image Format, Individual Genetic Data Format, JPG, JSON, LSM, MAF, MAGE-ML, MAGE-TAB, MAT, MATLAB Script, MSF, Map Format, Mass Spectrometry Data Format, Matrix Format, NIFTI Format, Nexus Format, Not Applicable, NumPy Format, OME-TIFF, Ontology Format, PDF, PNG, PS, PSF, Phylip Format, Phylip Format Variant, Phylogenetic Tree Format, Phylogenetic Tree Format (Text), Protein Interaction Format, Python Script, R File Format, R Script, RDS, RNA Annotation Format, RNA Secondary Structure Format, RPKM, Raw Sequence Format, SAM, SBML, SQLite Format, SVG, Scores Format, Sequence Annotation Track Format, Sequence Cluster Format, Sequence Cluster Format (Protein), Sequence Feature Annotation Format, Sequence Feature Table Format, Sequence Feature Table Format (Text), Sequence Profile Format, Sequence Range Format, Sequence Record Format, Sequence Trace Format, Sequence Variation Annotation Format, TIFF, TSV, TXT, Tertiary Structure Format, Textual Format, Topology Format, Trajectory Format, VCF, Workflow Format, XML, YAML, bedgraph, bigWig, cel, imzML Metadata File, mzML, nii, pkl, sif, xls, xlsx, PDB, HED, MRC, Unspecified",,TRUE,,,,biotoolsschema,list like
Tool Language,"Name of programming language the software source code was written in. Multiple values permitted, comma separated.","AWK, ActionScript, Ada, AppleScript, Assembly Language, Bash, C, C#, C++, COBOL, CSS, CWL, ColdFusion, D, Delphi, Dockerfile, Dylan, Eiffel, Elm, Forth, Fortran, Go, Groovy, HTML, Haskell, Icarus, JSP, Java, JavaScript, Julia, LabVIEW, Lisp, Lua, MATLAB, MLXTRAN, Maple, Mathematica, NMTRAN, Netlogo, Nextflow, Ocaml, OpenEdge ABL, Other, PHP, Pascal, Perl, PostScript, PowerShell, Prolog, PyMOL, Python, R, REXX, Racket, Ruby, SAS, SQL, Scala, Scheme, Shell, TeX, Turing, VHDL, Verilog, Visual Basic, WDL, XAML",,FALSE,,,,biotoolsschema,list like
Tool License,"Software or data usage license. Multiple values permitted, comma separated.","AAL, ADSL, AFL-1.1, AFL-1.2, AFL-2.0, AFL-2.1, AFL-3.0, AGPL-1.0, AGPL-3.0, AMDPLPA, AML, AMPAS, ANTLR-PD, APAFML, APL-1.0, APSL-1.0, APSL-1.1, APSL-1.2, APSL-2.0, Abstyles, Adobe-2006, Adobe-Glyph, Afmparse, Aladdin, Apache-1.0, Apache-1.1, Apache-2.0, Artistic-1.0, Artistic-1.0-Perl, Artistic-1.0-cl8, Artistic-2.0, BSD-2-Clause, BSD-2-Clause-FreeBSD, BSD-2-Clause-NetBSD, BSD-3-Clause, BSD-3-Clause-Attribution, BSD-3-Clause-Clear, BSD-3-Clause-LBNL, BSD-3-Clause-No-Nuclear-License, BSD-3-Clause-No-Nuclear-License-2014, BSD-3-Clause-No-Nuclear-Warranty, BSD-4-Clause, BSD-4-Clause-UC, BSD-Protection, BSD-Source-Code, BSD-style, BSL-1.0, Bahyph, Barr, Beerware, BitTorrent-1.0, BitTorrent-1.1, Borceux, CATOSL-1.1, CC-BY-1.0, CC-BY-2.0, CC-BY-2.5, CC-BY-3.0, CC-BY-4.0, CC-BY-NC-1.0, CC-BY-NC-2.0, CC-BY-NC-2.5, CC-BY-NC-3.0, CC-BY-NC-4.0, CC-BY-NC-ND-1.0, CC-BY-NC-ND-2.0, CC-BY-NC-ND-2.5, CC-BY-NC-ND-3.0, CC-BY-NC-ND-4.0, CC-BY-NC-SA-1.0, CC-BY-NC-SA-2.0, CC-BY-NC-SA-2.5, CC-BY-NC-SA-3.0, CC-BY-NC-SA-4.0, CC-BY-ND-1.0, CC-BY-ND-2.0, CC-BY-ND-2.5, CC-BY-ND-3.0, CC-BY-ND-4.0, CC-BY-SA-1.0, CC-BY-SA-2.0, CC-BY-SA-2.5, CC-BY-SA-3.0, CC-BY-SA-4.0, CC0-1.0, CDDL-1.0, CDDL-1.1, CECILL-1.0, CECILL-1.1, CECILL-2.0, CECILL-2.1, CECILL-B, CECILL-C, CNRI-Jython, CNRI-Python, CNRI-Python-GPL-Compatible, CPAL-1.0, CPL-1.0, CPOL-1.02, CUA-OPL-1.0, Caldera, ClArtistic, Condor-1.1, Crossword, CrystalStacker, Cube, D-FSL-1.0, DOC, DSDP, Dotseqn, ECL-1.0, ECL-2.0, EFL-1.0, EFL-2.0, EPL-1.0, EUDatagrid, EUPL-1.0, EUPL-1.1, Entessa, ErlPL-1.1, Eurosym, FSFAP, FSFUL, FSFULLR, FTL, Fair, Frameworx-1.0, FreeImage, Freeware, GFDL-1.1, GFDL-1.2, GFDL-1.3, GL2PS, GPL-1.0, GPL-2.0, GPL-3.0, Giftware, Glide, Glulxe, HPND, HaskellReport, IBM-pibs, ICU, IJG, IPA, IPL-1.0, ISC, ImageMagick, Imlib2, Info-ZIP, Intel, Intel-ACPI, Interbase-1.0, JSON, JasPer-2.0, LAL-1.2, LAL-1.3, LGPL-2.0, LGPL-2.1, LGPL-3.0, LGPLLR, LPL-1.0, LPL-1.02, LPPL-1.0, LPPL-1.1, LPPL-1.2, LPPL-1.3a, LPPL-1.3c, Latex2e, Leptonica, LiLiQ-P-1.1, LiLiQ-R-1.1, LiLiQ-Rplus-1.1, Libpng, MIT, MIT-CMU, MIT-advertising, MIT-enna, MIT-feh, MITNFA, MPL-1.0, MPL-1.1, MPL-2.0, MPL-2.0-no-copyleft-exception, MS-PL, MS-RL, MTLL, MakeIndex, MirOS, Motosoto, Multics, Mup, NASA-1.3, NBPL-1.0, NCSA, NGPL, NLOD-1.0, NLPL, NOSL, NPL-1.0, NPL-1.1, NPOSL-3.0, NRL, NTP, Naumen, NetCDF, Newsletr, Nokia, Not licensed, Noweb, Nunit, OCCT-PL, OCLC-2.0, ODbL-1.0, OFL-1.0, OFL-1.1, OGTSL, OLDAP-1.1, OLDAP-1.2, OLDAP-1.3, OLDAP-1.4, OLDAP-2.0, OLDAP-2.0.1, OLDAP-2.1, OLDAP-2.2, OLDAP-2.2.1, OLDAP-2.2.2, OLDAP-2.3, OLDAP-2.4, OLDAP-2.5, OLDAP-2.6, OLDAP-2.7, OLDAP-2.8, OML, OPL-1.0, OSET-PL-2.1, OSL-1.0, OSL-1.1, OSL-2.0, OSL-2.1, OSL-3.0, OpenSSL, Other, PDDL-1.0, PHP-3.0, PHP-3.01, Plexus, PostgreSQL, Proprietary, Python-2.0, QPL-1.0, Qhull, RHeCos-1.1, RPL-1.1, RPL-1.5, RPSL-1.0, RSA-MD, RSCPL, Rdisc, Ruby, SAX-PD, SCEA, SGI-B-1.0, SGI-B-1.1, SGI-B-2.0, SISSL, SISSL-1.2, SMLNJ, SMPPL, SNIA, SPL-1.0, SWL, Saxpath, Sendmail, SimPL-2.0, Sleepycat, Spencer-86, Spencer-94, Spencer-99, SugarCRM-1.1.3, TCL, TMate, TORQUE-1.1, TOSL, UPL-1.0, Unicode-TOU, Unlicense, VOSTROM, VSL-1.0, Vim, W3C, W3C-19980720, WTFPL, Watcom-1.0, Wsuipa, X11, XFree86-1.1, XSkat, Xerox, Xnet, YPL-1.0, YPL-1.1, ZPL-1.1, ZPL-2.0, ZPL-2.1, Zed, Zend-2.0, Zimbra-1.3, Zimbra-1.4, Zlib, bzip2-1.0.5, bzip2-1.0.6, curl, diffmark, dvipdfm, eGenix, gSOAP-1.3b, gnuplot, iMatix, libtiff, mpich2, psfrag, psutils, xinetd, xpp, zlib-acknowledgement",,FALSE,,,,biotoolsschema,list like
Tool Link Note,Comment about the link.,,,FALSE,,,,biotoolsschema,
Tool Link Type,"The type of data, information or system that is obtained when the link is resolved. Multiple values permitted, comma separated.","Discussion Forum, Galaxy Service, Helpdesk, Issue Tracker, Mailing list, Mirror, Other, Repository, Service, Social Media, Software Catalogue, Technical Monitoring",,FALSE,,,,biotoolsschema,list like
Tool Link Url,A link of some relevance to the software (URL).,,,FALSE,,,,biotoolsschema,
Tool Name,Canonical tool name provided by the tool developer or service provider.,,,TRUE,,,,biotoolsschema,unique
Tool Operating System,"The operating system supported by a downloadable software package. Multiple values permitted, comma separated.","Linux, Mac, Windows",,FALSE,,,,biotoolsschema,list like
Tool Operation,"The basic operation(s) performed by this software function. Multiple values permitted, comma separated.","Aggregation, Allele Frequency Distribution Analysis, Analysis, Annotation, Box-Whisker Plot Plotting, Calculation, Cell Migration Analysis, Cell Modelling, Cell Number Quantification, Cell Type Enrichment Analysis, Classification, Clustering, Clustering Profile Plotting, Comparison, Conversion, Copy Number Variation Detection, Correlation, DNA Barcoding, Data Handling, Data Retrieval, Database Search, De Novo Sequencing, Demultiplexing, Differential Gene Expression Profiling, Differential Protein Expression Profiling, Dimensionality Reduction, Editing, Enrichment Analysis, Expression Analysis, Expression Correlation Analysis, Expression Data Visualisation, Expression Profile Clustering, Expression Profile Comparison, Functional Clustering, Gene Expression Profiling, Gene Methylation Analysis, Gene Regulatory Network Analysis, Gene Regulatory Network Prediction, Gene-Set Enrichment Analysis, Generation, Genetic Mapping, Genetic Variation Analysis, Genome Analysis, Genome Annotation, Genome Visualisation, Genotyping, Heat Map Generation, Image Analysis, Imputation, Incident Curve Plotting, Information Retrieval, Linkage Analysis, Mapping, Metabolic Pathway Prediction, Methylation Analysis, Microscope Image Visualisation, Modelling and Simulation, Molecular Dynamics, Network Analysis, Network Visualisation, Nucleic Acid Feature Detection, Nucleic Acid Sequence Analysis, Nucleosome Position Prediction, Ontology Visualisation, Pathway Analysis, Pathway Modelling, Peak Calling, Phylogenetic Analysis, Prediction and Recognition, Principal Component Analysis, Protein Comparison, Protein Function Comparison, Protein Function Prediction, Protein Identification, Protein Interaction Network Analysis, Protein Quantification, Protein-Protein Interaction Analysis, Quantification, Query and Retrieval, RNA Secondary Structure Prediction, RNA-Seq Analysis, RNA-Seq Quantification, Regression Analysis, SNP Annotation, SNP Detection, Scatter Plot Plotting, Sequence Alignment Analysis, Sequence Alignment Comparison, Sequence Analysis, Sequence Annotation, Sequence Classification, Sequence Cluster Visualisation, Sequence Clustering, Sequence Comparison, Sequence Composition Calculation, Sequence Editing, Sequence File Editing, Sequence Read Processing, Sequencing Quality Control, Simulated Gene Expression Data Generation, Sorting, Spectral Analysis, Standardisation and Normalisation, Statistical Calculation, Statistical Inference, Statistical Modelling, Structural Variation Detection, Structure Analysis, Text Mining, Tissue Modelling, Validation, Variant Calling, Variant Classification, Variant Effect Prediction, Visualisation, scRNA-Seq Analysis, Agent-Based Cell Modelling, Not Applicable",,TRUE,,,,biotoolsschema,list like
Tool Output Data,"Type of primary output data. Multiple values permitted, comma separated.","Accession, Alignment, Biological Model ID, Biological Model Name, Cell Line Name, Cell Migration Track Image, Cell Type Identifier, Cell Type Name, Cell Type Ontology ID, Chromosome Name, Chromosome Report, Clustered Expression Profiles, Codon Number, Comparison Matrix, Compound Identifier, Compound Name, Concentration, Count Matrix, DNA Sequence, Data Index, Data Reference, Database Search Results, Drug Identifier, Drug Name, Drug Report, Electronic Health Record, Enzyme Kinetics Data, Experimental Measurement, Expression Data, GO-Term Enrichment Data, Gene Expression Matrix, Gene Expression Profile, Gene ID, Gene ID (NCBI), Gene Identifier, Gene Name, Gene Report, Gene Symbol, Gene Tree, Genetic Map, Genotype/Phenotype Report, Heat Map, Hidden Markov Model, Hierarchy, Histogram, Identifier, Image, Image Metadata, Kinetic Model, MRI Image, Map, Map Data, Mass Spectrometry Data, Mass Spectrum, Mathematical Model, Matrix, Molecular Property, Molecular Simulation Data, Molecule Identifier, Molecule Name, Morphology Parameter, Mutation ID, Not Applicable, Nucleic Acid Identifier, Nucleic Acid Report, Nucleic Acid Sequence, Ontology, Ontology Concept Data, Ontology Data, Ontology Identifier, Ontology Mapping, Ontology Name, Ontology Term, Organism Identifier, Organism Name, Over-Represesntation Data, P-Value, Pair Sequence Alignment, Pathway Or Network, Pathway Or Network Report, Pathway Overrepresentation Data, Peptide Identification, Peptide Property, Phenotype Name, Phylogenetic Data, Phylogenetic Tree, Plain Text, Plot, Position Weight Matrix, Position-Specific Scoring Matrix, Protein Contact Map, Protein Identifier, Protein Interaction Data, Protein Name, Protein Property, Protein Report, Protein Sequence, Protein Structure Report, Quality Control Report, RNA Sequence, Raw Image, Reaction Data, RefSeq Accession, Report, Resource Metadata, Sample Annotation, Sample ID, Score, Sequence, Sequence Alignment, Sequence Attribute, Sequence Cluster, Sequence Composition Plot, Sequence Composition Report, Sequence Coordinates, Sequence Features, Sequence Image, Sequence Motif, Sequence Position, Sequence Property, Sequence Range, Sequence Record, Sequence Report, Sequence Search Results, Sequence Set, Sequence Signature Data, Sequence Similarity, Sequence Similarity Score, Sequence Variations, Simulation, Small Molecule Report, Spectrum, Statistical Estimate Score, Strain Identifier, Strain Name, Structure, Structure Report, Taxonomy, Text Data, Text Mining Report, Topology Data, Training Material, Trajectory Data, Transcription Factor Identifier, Transcription Factor Name, Vmax, dbSNP ID",,TRUE,,,,biotoolsschema,list like
Tool Output Format,"Allowed format(s) of the output data. Multiple values permitted, comma separated.","Alignment Format, Alignment Format (Pair Only), Alignment Format (Text), Annotated Text Format, Antimony, BAM, BCF, BED, BLAST Results, BNGL, Binary Format, Biological Model Format, Biological Pathway Or Network Format, CSV, Chemical Data Format, Cytoband Format, Cytoscape Input File Format, DCC, DCD, DSV, Database Hits (Sequence) Format , Docker Image Format, Document Format, Dot-Bracket Format, FASTA, FASTQ, FASTQ-Illumina, FCS, GCT/Res Format, GFF, GFF3, GIF, GML, GTF, Gene Annotation Format, Gene Cluster Format, Gene Expression Report Format, Genotype And Phenotype Annotation Format, Graph Format, H5AD, HDF, HDF5, HTML, Hidden Markov Model Format, Image Format, Individual Genetic Data Format, JPG, JSON, LSM, MAF, MAGE-ML, MAGE-TAB, MAT, MATLAB Script, MSF, Map Format, Mass Spectrometry Data Format, Matrix Format, NIFTI Format, Nexus Format, Not Applicable, NumPy Format, OME-TIFF, Ontology Format, PDF, PNG, PS, PSF, Phylip Format, Phylip Format Variant, Phylogenetic Tree Format, Phylogenetic Tree Format (Text), Protein Interaction Format, Python Script, R File Format, R Script, RDS, RNA Annotation Format, RNA Secondary Structure Format, RPKM, Raw Sequence Format, SAM, SBML, SQLite Format, SVG, Scores Format, Sequence Annotation Track Format, Sequence Cluster Format, Sequence Cluster Format (Protein), Sequence Feature Annotation Format, Sequence Feature Table Format, Sequence Feature Table Format (Text), Sequence Profile Format, Sequence Range Format, Sequence Record Format, Sequence Trace Format, Sequence Variation Annotation Format, TIFF, TSV, TXT, Tertiary Structure Format, Textual Format, Topology Format, Trajectory Format, VCF, Workflow Format, XML, YAML, bedgraph, bigWig, cel, imzML Metadata File, mzML, nii, pkl, sif, xls, xlsx, PDB, HED, MRC, Unspecified",,TRUE,,,,biotoolsschema,list like
Tool Package Dependencies,"Specifies the software libraries, frameworks, or other components that a tool or package relies on for its proper functioning. This attribute helps users understand the prerequisites needed for installation and usage of the tool within a given computational environment",,,FALSE,,,,CWL,list like
Tool Package Dependencies Present,Indicates whether the required package dependencies for tool are present.,"True, False",,TRUE,,,,CWL,
Tool Grant Number,"Grant number associated with the tool's development. Multiple values permitted, comma separated.","Affiliated/Non-Grant Associated, CA184897, CA184898, CA188388, CA193313, CA193417, CA193419, CA193461, CA193489, CA195469, CA199315, CA202123, CA202144, CA202177, CA202229, CA202241, CA209891, CA209923, CA209971, CA209975, CA209978, CA209988, CA209992, CA209997, CA210152, CA210173, CA210180, CA210181, CA210184, CA210190, CA214282, CA214292, CA214297, CA214300, CA214354, CA214369, CA214381, CA214411, CA215709, CA215794, CA215798, CA215845, CA215848, CA217297, CA217376, CA217377, CA217378, CA217450, CA217456, CA217514, CA217613, CA217617, CA217655, CA220378, CA223976, CA224012, CA224013, CA224044, CA225088, CA225566, CA227136, CA227544, CA227550, CA228608, CA228963, CA231978, CA232137, CA232161, CA232209, CA232216, CA232382, CA232517, CA234787, CA235747, CA238475, CA238720, CA238728, CA240301, CA241137, CA241927, CA243004, CA243007, CA243072, CA243073, CA243075, CA244100, CA244101, CA244107, CA244109, CA245313, CA248890, CA249799, CA250040, CA250044, CA250046, CA250481, CA251443, CA253248, CA253472, CA253540, CA253547, CA253553, CA254200, CA254886, CA256054, CA256481, CA260432, CA261694, CA261701, CA261717, CA261719, CA261822, CA261841, CA261842, CA263001, CA264583, CA264610, CA264611, CA264620, CA267170, CA268069, CA268072, CA268083, CA268084, CA271273, CA274492, CA274494, CA274499, CA274502, CA274509, CA275808, CA279408, CA279560, CA280984, CA280849, CA280829, CA284090, CA284086, CA274504, CA283114, CA274507, CA274506, CA274511, CA282451",,TRUE,,,,,list like
Tool Pubmed Id,The pubMed identifer associated with the development of the tool.,,,FALSE,,,,,int
Tool Release Date,The release date of a product or product model. This can be used to distinguish the exact variant of a product.,,,TRUE,,,,schema.org,date
Tool Topic,"General scientific domain the software serves, or other general category. Multiple values permitted, comma separated.","Allergy Clinical Immunology and Immunotherapeutics, Biochemistry, Bioimaging, Bioinformatics, Biological Databases, Biology, Biomedical Science, Biomolecular Simulation, Biophysics, Biotechnology, Biotherapeutics, Cell Biology, Cell Culture Collection, Chemistry, Chip-Seq, Chromosome Conformation Capture, Comparative Genomics, Compound Libraries and Screening, Computational Biology, Computer Science, Cytogenetics, Cytometry, DNA, DNA Mutation, DNA Packaging, DNA Polymorphism, Data Architecture Analysis and Design, Data Identity and Mapping, Data Mining, Data Submission Annotation and Curation, Data Visualisation, Developmental Biology, Drug Development, Drug Discovery, Drug Metabolism, Electron Microscopy, Epigenetics, Evolutionary Biology, Exome Sequencing, Experimental Design and Studies, Function Analysis, Functional Genomics, Functional Regulatory and Non-Coding RNA, GWAS Study, Gene Expression, Gene Regulation, Gene Structure, Gene Transcripts, Gene and Protein Families, Genetic Engineering, Genetic Variation, Genetics, Genomics, Genotype and Phenotype, Imaging, Immunoinformatics, Immunology, Immunomics, Immunoprecipitation Experiment, Immunoproteins and Antigens, Infectious Disease, Informatics, Laboratory Techniques, Light Microscopy, Lipids, Machine Learning, Mapping, Mathematics, Medical Imaging, Medical Informatics, Medicine, Medicines Research and Development, Membrane and Lipoproteins, Metagenomics, Molecular Biology, Molecular Genetics, Molecular Interactions Pathways and Networks, Nucleic Acid Structure Analysis, Nucleic Acids, Omics, Oncology, Ontology and Terminology, Pathology, Pharmacogenomics, Pharmacology, Pharmacovigilance, Phylogenetics, Phylogenomics, Phylogeny, Preclinical and Clinical Studies, Probes and Primers, Protein Expression, Protein Modifications, Protein Properties, Proteins, Proteomics, Proteomics Experiment, RNA, RNA-Seq, Safety Sciences, Sample Collections, Sequence Analysis, Sequencing, Simulation Experiment, Software Engineering, Statistics and Probability, Structural Analysis, Structural Biology, Systems Biology, Transcription Factors and Regulatory Sites, Transcriptomics, Virology, Whole Genome Sequencing, Workflows, scRNA-Seq",,FALSE,,,,biotoolsschema,list like
Tool Type,"A type of application software: a discrete software entity can have more than one type. Multiple values permitted, comma separated.","Bioinformatics Portal, Command-Line Tool, Database Portal, Desktop Application, Library, Notebook, Ontology, Other, Plug-In, SPARQL Endpoint, Script, Serialized Model, Suite, Web API, Web Application, Web Service, Workbench, Workflow",,FALSE,,,,biotoolsschema,list like
Tool Version,Version information (typically a version number) of the software applicable to this entry.,,,FALSE,,,,biotoolsschema,
Tool View,The denormalized manifest for tool submission.,,"Component, ToolView_id, Study key, DatasetView Key, PublicationView Key, Tool Name, Tool Description, Tool Homepage, Tool Version, Tool Operation, Tool Input Data, Tool Output Data, Tool Input Format, Tool Output Format, Tool Function Note, Tool Cmd, Tool Type, Tool Topic, Tool Operating System, Tool Language, Tool License, Tool Cost, Tool Accessibility, Tool Download Url, Tool Download Type, Tool Download Note, Tool Download Version, Tool Documentation Url, Tool Documentation Type, Tool Documentation Note, Tool Link Url, Tool Link Type, Tool Link Note, Tool Date Last Modified, Tool Release Date, Tool Package Dependencies, Tool Package Dependencies Present, Tool Compute Requirements, Tool Entity Name, Tool Entity Type, Tool Entity Role",FALSE,,,Study,,
ToolView_id,A unique primary key that enables record updates using schematic.,,,TRUE,,,,,unique
10x Visium Auxiliary Files,"Auxiliary data associated with spot/slide analysis (aligned Images, quality control files, etc)  from Spatial Transcriptomics.",,"Component, Filename, 10xVisiumAuxiliaryFiles_id, 10xVisiumRNALevel1 Key, 10xVisiumRNALevel2 Key, 10xVisiumRNALevel3 Key, 10xVisiumRNALevel4 Key, Visium Run ID, Visium File Type, Visium Slide ID, Capture Area, Workflow Version, Workflow Link",FALSE,,visium,"10x Visium RNA Level 1, 10x Visium RNA Level 2, 10x Visium RNA Level 3, 10x Visium RNA Level 4",HTAN,
10xVisiumAuxiliaryFiles_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,visium,,MC2,unique
10x Visium RNA Level 1,Files contain raw RNA-seq data associated with spot/slide data.,,"Component, 10xVisiumRNALevel1_id, Filename, Visium Run ID, NGS Read Indicator, Visium Spatial Read1, Visium Spatial Read2, Visium Spatial Library Construction Method, NGS Library Preparation Days from Index, NGS Sequencing Library Construction Days from Index, NGS RNA End Bias, NGS RNA Reverse Transcription Primer, NGS Sequencing Platform, Visium Capture Area, Protocol Link, Visium Slide Version, Visium Slide ID, Visium Image Re-orientation, Visium Permeabilization Time, NGS RNA RIN, NGS RNA DV200",FALSE,,,File View,,
10xVisiumRNALevel1_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,visium,,,unique
Visium Run ID,A unique identifier for this individual run (typically associated with a single slide) of the spatial transcriptomic processing workflow.,,,TRUE,,visium,,HTAN,unique
Visium Capture Area,"Area (or Capture Area) - One of the either four or two active regions where tissue can be placed on a Visium slide. Each area is intended to contain only one tissue sample. Slide areas are named consecutively from top to bottom: A1, B1, C1, D1 for Visium slides with 6.5 mm Capture Area and A, B for CytAssist slides with 11 mm Capture Area. Both CytAssist slides with 6.5 mm Capture Area and Gateway Slides contain only two slide areas, A1 and D1.","A, B, C, D, A1, B1, C1, D1",,FALSE,,visium,,HTAN,str
Visium Slide Version,Version of imaging slide used. Slide version is critical for the analysis of the sequencing data as different slides have different capture area layouts.,"V1, V2, V3, V4",,TRUE,,visium,,HTAN,str
Visium Spatial Read1,Read 1 content description,"cDNA, Spatial Barcode and UMI",,TRUE,,visium,,HTAN,str
Visium Spatial Read2,Read 2 content description,"cDNA, Spatial Barcode and UMI",,TRUE,,visium,,HTAN,str
Visium Spatial Library Construction Method,Process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors [OBI_0000711],"Smart-seq2, Smart-SeqV4, 10xV1.0, 10xV1.1, 10xV2, 10xV3, 10xV3.1, Drop-seq, inDropsV2, inDropsV3, TruDrop, Nextera XT",,TRUE,,visium,,HTAN,str
Visium Slide ID,"For Visium, it is the unique identifier printed on the label of each Visium slide. The serial number starts with V followed by a number which can range between one through five and ends with a dash and a three digit number, such as 123. For CosMx, this refers to the loaded Flow Cell ID. For Xenium, this ID indicates the slide orientation, as it matches the relative location of the ID on the physical Xenium slide.",,,TRUE,,visium,,HTAN,str
Visium Image Re-orientation,"To ensure good fiducial alignment and tissue spots detection, it is important to correct for this shift in orientation.","True, False",,FALSE,,visium,,HTAN,str
Visium Permeabilization Time,Fixed and stained tissue sections are permeabilized for different times. Each Capture Area captures polyadenylated mRNA from the attached tissue section. Measure is provided in minutes.,,,FALSE,,visium,,HTAN,num
10x Visium RNA Level 2,Alignment workflows downstream of Spatial Transcriptomics RNA-seq Level 1.,,"Component,10xVisiumRNALevel2_id,Filename,File Format,Checksum,10xVisiumRNALevel1 Key,File Alias,Visium UMI Tag,Visium Whitelist Spatial Barcode File Link,Visium Spatial Barcode Tag,Visium Applied Hard Trimming,Workflow Version,Workflow Link,Genomic Reference,Genomic Reference URL,Genome Annotation URL,Biospecimen Key,Visium Run ID,Visium Capture Area",FALSE,,visium,10x Visium RNA Level 1,HTAN,
10xVisiumRNALevel2_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,visium,,MC2,unique
Visium UMI Tag,"SAM tag for the UMI field; please provide a valid tag-type pair, consisting of a tag (e.g. UB or UR) and type (e.g. Z) separated by a colon.",,,TRUE,,visium,,HTAN,str
Visium Whitelist Spatial Barcode File Link,Link to file listing all possible spatial barcodes. URL,,,TRUE,,visium,,HTAN,url
Visium Spatial Barcode Tag,"SAM tag for spot barcode field; please provide a valid tag-type pair, consisting of a tag (e.g. CB or CR) and type (e.g. Z) separated by a colon.",,,TRUE,,visium,,HTAN,str
Visium Applied Hard Trimming,Was Hard Trimming applied,"True, False",,TRUE,,visium,,HTAN,str
10x Visium RNA Level 3,Processed data files based on Spatial Transcriptomics RNA-seq Level 2 and Spatial Transcriptomics Auxiliary files.,,"Component, 10xVisiumRNALevel3_id, Filename, 10xVisiumRNALevel2 Key, 10xVisiumAuxiliaryFiles Key, Visium Run ID, Visium File Type, Workflow Version, Workflow Link, Visium Capture Area, Visium Spots under tissue, Visium Mean Reads per Spatial Spot, Visium Median Number Genes per Spatial Spot, NGS Sequencing Coverage, Visium Proportion Reads Mapped, Visium Proportion Reads Mapped to Transcriptome, Visium Median UMI Counts per Spot",FALSE,,visium,10x Visium RNA Level 2,HTAN,
10xVisiumRNALevel3_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,visium,,MC2,unique
Visium File Type,The file type generated for the visium experiment.,"reference png, reference jpg, json scale factors, probe dataset csv, qc result html, filtered mex, unfiltered mex, tissue_positions, barcodes, features, fiducial image png, fiducial image jpg, detected image png, detected jpg, high res image, low res image, json scale factors, probe dataset csv",,TRUE,,visium,,HTAN,str
Visium Spots under tissue,The number of barcodes associated with a spot under tissue.,,,TRUE,,visium,,HTAN,num
Visium Mean Reads per Spatial Spot,"The number of reads, both under and outside of tissue, divided by the number of barcodes associated with a spot under tissue.",,,TRUE,,visium,,HTAN,num
Visium Median Number Genes per Spatial Spot,The median number of genes detected per spot under tissue-associated barcode. Detection is defined as the presence of at least 1 UMI count.,,,TRUE,,visium,,HTAN,num
Visium Proportion Reads Mapped,Proportion of mapped reads collected from samtools. Number,,,FALSE,,visium,,HTAN,num
Visium Proportion Reads Mapped to Transcriptome,Fraction of reads that mapped to a unique gene in the transcriptome. The read must be consistent with annotated splice junctions. These reads are considered for UMI counting.,,,TRUE,,visium,,HTAN,num
Visium Median UMI Counts per Spot,The median number of UMI counts per tissue covered spot.,,,TRUE,,visium,,HTAN,num
10x Visium RNA Level 4,Processed data files based on Spatial Transcriptomics RNA-seq Level 3.,,"Component, 10xVisiumRNALevel4_id, Filename, 10xVisiumRNALevel3 Key, Visium Run ID, Workflow Version, Workflow Link, Visium Workflow Type, Visium Workflow Parameters Description",FALSE,,visium,10x Visium RNA Level 3,HTAN,
10xVisiumRNALevel4_id,"Unique row identifier, used as a primary key for record updates",,,TRUE,,visium,,MC2,unique
Visium Workflow Type,Generic name for the workflow used to analyze the visium data set.,,,TRUE,,visium,,HTAN,str
Visium Workflow Parameters Description,Parameters used to run the workflow.,,,TRUE,,visium,,HTAN,str